{"id":157,"date":"2023-11-29T15:48:53","date_gmt":"2023-11-29T06:48:53","guid":{"rendered":"https:\/\/plaza.umin.ac.jp\/~lab-tky\/wordpress\/?page_id=157"},"modified":"2025-06-16T22:50:02","modified_gmt":"2025-06-16T13:50:02","slug":"achievements","status":"publish","type":"page","link":"https:\/\/plaza.umin.ac.jp\/~lab-tky\/research\/achievements\/","title":{"rendered":"\u696d\u7e3e"},"content":{"rendered":"\n
\n

2024\u5e74<\/h3>\n\n\n\n

\u82f1\u6587\u539f\u8457\u8ad6\u6587\uff1aEnglish Original Articles<\/h4>\n\n\n\n
    \n
  1. Daimon M, Watanabe H, Nakanishi K, Abe Y, Hirata K, Ishii K, Iwakura K, Izumi C, Abe H, Negishi K, Ito H, Tanabe K, Tanaka N, Nakatani S. Is left ventricular diameter indexed for body surface area appropriate for assessing left ventricular dilation? J Cardiol<\/strong><\/em> 84:67-9, 2024.<\/li>\n\n\n\n
  2. Hirano Y, Kanda S, Hidaka M, Kato M, Nishikawa M, Yatomi Y, Tanaka H, Kinumaki A, Kajiho Y, Harita Y. Post-renal Biopsy Retroperitoneal Haematoma Accompanied by Decreased Coagulation Factor XIII Levels in Immunoglobulin A Nephropathy Cureus<\/strong><\/em> 16(2):e54026<\/a>, 2024.<\/li>\n\n\n\n
  3. Hirose K, Nakanishi K, Daimon M, Fujiu K, Iwama K, Yoshida Y, Hirose K, Mukai Y, Yamamoto Y, Nakao T, Oshima T, Matsubara T, Shimizu Y, Oguri G, Kojima T, Hasumi E, Morita H, Kurano M, Komuro I. Body Fat Distribution and Left Atrial Reverse Remodeling After Catheter Ablation for Atrial Fibrillation JACC Adv<\/strong><\/em> 3:100973, 2024.<\/li>\n\n\n\n
  4. Hirose K, Nakanishi K, Daimon M, Iwama K, Yoshida Y, Mukai Y, Yamamoto Y, Nakao T, Oshima T, Matsubara T, Shimizu Y, Oguri G, Kojima T, Hasumi E, Fujiu K, Morita H, Komuro I. Association of Atrial Fibrillation Progression with Left Atrial Functional Reserve and Its Reversibility J Am Heart Assoc<\/strong><\/em> 13:e032215, 2024.<\/li>\n\n\n\n
  5. Kobayashi T, Nakatsuka T, Sato M, Soroida Y, Hikita H, Gotoh H, Iwai T, Tateishi R, Kurano M, Fujishiro M. Diagnostic performance of two-dimensional shear wave elastography and attenuation imaging for fibrosis and steatosis assessment in chronic liver disease J Med Ultrason<\/strong><\/em> Online ahead of print, 2024.<\/li>\n\n\n\n
  6. Ma R, Nakanishi K, Nakao T, Hirokawa M, Kimura K, Suzuki H, Yatomi Y, Daimon M. Three-Dimensional Geometry Values and Clinical Determinants for the Annulus of the Tricuspid Valve in a Japanese Population Int Heart J<\/strong><\/em> 65:808-16, 2024.<\/li>\n\n\n\n
  7. Morita Y, Kurano M. Urinary Lipid Mediators as Novel Biomarkers for Kidney Disease. Medical Mass Spectrometry<\/strong><\/em> 8: 54-64<\/a>, 2024.<\/li>\n\n\n\n
  8. Morita Y, Sakai E, Isago H, Ono Y, Yatomi Y, Kurano M. Alterations in urinary ceramides, sphingoid bases, and their phosphates among patients with kidney Front Nephrol<\/strong><\/em> 7;4:1343181, 2024.<\/li>\n\n\n\n
  9. Nakanishi K, Daimon M, Fujiu K, Iwama K, Yoshida Y, Hirose K, Mukai Y, Yamamoto Y, Nakao T, Oshima T, Matsubara T, Shimizu Y, Oguri G, Kojima T, Hasumi E, Morita H, Kurano M, Komuro I. Prevalence of abnormal atrial and ventricular mechanics and its reversibility in patients with atrial fibrillation JACC Cardiovasc Imaging<\/strong><\/em> 17:1504-6, 2024.<\/li>\n\n\n\n
  10. Nakao T, Nakanishi K, Sawada N, Kawahara T, Miyoshi T, Takeuchi M, Asch FM, Lang RM, Daimon M. Racial Differences in Age-Related Changes in Left Ventricular Structural and Functional Echocardiographic Measurements Among Healthy Japanese and American Participants – A Subanalysis of the World Alliance Society of Echocardiography Normal Values Study Circ J<\/strong><\/em> 88:1461-71, 2024.<\/li>\n\n\n\n
  11. Nakatsuka T., Tateishi R, Sato M, Hashizume N, Kamada A, Nakano H, Kabeya Y, Yonezawa S, Irie R, Tsujikawa H, Sumida Y, Yoneda M, Akuta N, Kawaguchi T, Takahashi H, Eguchi Y, Seko Y, Itoh Y, Murakami E, Chayama K, Taniai M, Tokushige K, Okanoue T, Sakamoto M, Fujishiro M, Koike K. Deep learning and digital pathology powers prediction of HCC development in steatotic liver disease Hepatology<\/strong><\/em> Online ahead of print<\/a>, 2024.<\/li>\n\n\n\n
  12. Okushin K., Tateishi R, Hirakawa S, Tachimori H, Uchino K, Nakagomi R, Yamada T, Nakatsuka T, Minami T, Sato M, Fujishiro M, Hasegawa K, Eguchi Y, Kanto T, Yoshiji H, Izumi N, Kudo M, Koike K. The impact of COVID-19 on the diagnosis and treatment of HCC: analysis of a nationwide registry for advanced liver diseases (REAL) Scientific Reports<\/strong><\/em> 14(1):2826<\/a>, 2024.<\/li>\n\n\n\n
  13. Okushin K., Tateishi R, Hirakawa S, Tachimori H, Uchino K, Nakagomi R, Yamada T, Nakatsuka T, Minami T, Sato M, Fujishiro M, Hasegawa K, Eguchi Y, Kanto T, Yoshiji H, Izumi N, Kudo M, Koike K. Comparable outcomes among etiologies in early-stage hepatocellular carcinoma: Analysis of a nationwide registry in Japan Hepatology Research<\/strong><\/em> Online ahead of print, 2024.<\/li>\n\n\n\n
  14. Sato M., Moriyama M, Fukumoto T, Yamada T, Wake T, Nakagomi R, Nakatsuka T, Minami T, Uchino K, Enooku K, Nakagawa H, Shiina S, Koike K, Fujishiro M, Tateishi R. Development of a transformer model for predicting the prognosis of patients with hepatocellular carcinoma after radiofrequency ablation Hepatology International<\/strong><\/em> 18(1):131-137<\/a>, 2024.<\/li>\n\n\n\n
  15. Shirota Y., Akita M, Tajima S, Mochida T, Masaki K, Yumoto M.. Origin coordinate influence on performance of temporally extended signal space separation in magnetoencephalography Clin Neurophysiol<\/strong><\/em> 163:143-151<\/a>, 2024.<\/li>\n\n\n\n
  16. Tochinai R, Kimura K, Saika T, Fujii W, Morita H, Nakanishi K, Tsuru Y, Sekizawa SI, Yamanouchi K, Kuwahara M. Ivabradine ameliorates cardiomyopathy progression in a Duchenne muscular dystrophy model rat Exp Anim<\/strong><\/em> 73:145-53, 2024.<\/li>\n\n\n\n
  17. Wakisaka A, Kimura K, Morita H, Nakanishi K, Daimon M, Nojima M, Itoh H, Takeda A, Kitao R, Imai T, Ikeda T, Nakajima T, Watanabe C, Furukawa T, Ohno I, Ishida C, Takeda N, Komai K. Efficacy and Tolerability of Ivabradine for Cardiomyopathy in Patients with Duchenne Muscular Dystrophy Int Heart J<\/strong><\/em> 65:211-7, 2024.<\/li>\n\n\n\n
  18. Yoshida Y, Jin Z, Mannina C, Homma S, Nakanishi K, Leibowitz D, Elkind MSV, Rundek T, Di Tullio MR. Aortic Arch Plaques and the Long-Term Risk of Stroke and Cardiovascular Events in the Statin Era Stroke<\/strong><\/em> 55:69-77, 2024.<\/li>\n<\/ol>\n\n\n\n

    \u56fd\u5185\u5b66\u4f1a\u767a\u8868\uff1aDomestic Conference Presentation<\/h4>\n\n\n\n
      \n
    1. \u7802\u91d1 \u79c0\u7ae0, \u8535\u91ce \u4fe1. \u65b0\u898f\u8840\u6e05\u62bd\u51fa\u6cd5\u958b\u767a\u306b\u5411\u3051\u305f\u3001\u9ad8\u5206\u5b50\u5316\u5408\u7269\u304c\u8840\u6db2\u51dd\u56fa\u306b\u4e0e\u3048\u308b\u5f71\u97ff\u306e\u89e3\u6790. \u7b2c71\u56de\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a. 2024.11.28-12.1.<\/li>\n\n\n\n
    2. \u4e95\u4e0a \u7fd4\u592a, \u4e2d\u897f \u5f18\u6bc5, \u4e0a\u7530 \u548c\u5b5d, \u5ee3\u5ddd \u611b\u7f8e, \u9234\u6728 \u535a\u82f1, \u4f50\u3005\u6728 \u8cc0\u6d25\u4e43, \u5bae\u5d0e \u4ee4\u5b50, \u5343\u660e \u771f\u5f13, \u6301\u7530 \u82b3\u5b9f, \u539f\u7530 \u5357\u4e43, \u5c0f\u91ce \u4f73\u4e00, \u8535\u91ce \u4fe1. \u4e0b\u5927\u9759\u8108\u6d78\u6f64\u3092\u4f34\u308f\u306a\u3044\u814e\u7d30\u80de\u764c\u306e\u5fc3\u81d3\u8ee2\u79fb\u306e\u4e00\u4f8b. \u65e5\u672c\u5fc3\u30a8\u30b3\u30fc\u56f3\u5b66\u4f1a\u7b2c36\u56de\u5b66\u8853\u96c6\u4f1a. 2024.4.19-21.<\/li>\n\n\n\n
    3. \u5c0f\u91ce \u4f73\u4e00. \u5f53\u9662\u3067\u306e\u304c\u3093\u30b2\u30ce\u30e0\u30d7\u30ed\u30d5\u30a1\u30a4\u30ea\u30f3\u30b0\uff08CGP\uff09\u691c\u67fb\u306e\u9662\u5185\u5b9f\u88c5\u306b\u5411\u3051\u305f\u53d6\u308a\u7d44\u307f\u3068ISO 15189\u306b\u914d\u616e\u3057\u305f\u907a\u4f1d\u5b50\u691c\u67fb\u5ba4\u306e\u69cb\u7bc9. \u7b2c 31 \u56de\u65e5\u672c\u907a\u4f1d\u5b50\u8a3a\u7642\u5b66\u4f1a\u5927\u4f1a. 2024.9.6-7.<\/li>\n\n\n\n
    4. \u5c0f\u91ce \u4f73\u4e00. \u300c\u5909\u308f\u308a\u3086\u304f\u81e8\u5e8a\u5316\u5b66\u691c\u67fb\u306e\u73fe\u5834\u306b\u8981\u6c42\u3055\u308c\u308b\u3082\u306e\u300d \uff5e\u3000\u3053\u308c\u304b\u3089\u306e\u81e8\u5e8a\u5316\u5b66\u691c\u67fb\u5ba4\u306b\u671f\u5f85\u3059\u308b\u3053\u3068\u3000\uff5e. \u7b2c32\u56de\u65e5\u672c\u81e8\u5e8a\u5316\u5b66\u4f1a\u3000\u95a2\u6771\u652f\u90e8\u5b66\u8853\u8b1b\u6f14\u4f1a. 2024.7.14.<\/li>\n\n\n\n
    5. \u4e45\u7c73 \u5e78\u592b, \u5c0f\u91ce \u4f73\u4e00,\u8535\u91ce \u4fe1. \u30cb\u30d7\u30ed\u793e\u88fd\u30a4\u30ce\u30b7\u30f3\u5165\u308a\u63a1\u8840\u7ba1\u306b\u304a\u3051\u308b\u89e3\u7cd6\u963b\u6b62\u80fd\u3068\u81e8\u5e8a\u5fdc\u7528\u3078\u306e\u53ef\u80fd\u6027. \u7b2c71\u56de\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a. 2024.11.28-12.1.<\/li>\n\n\n\n
    6. \u4e45\u7c73 \u5e78\u592b, \u5c0f\u91ce \u4f73\u4e00,\u8535\u91ce \u4fe1. \u30a4\u30ce\u30b7\u30f3\u6dfb\u52a0\u63a1\u8840\u7ba1\u306e\u691c\u8a0e. \u7b2c64\u56de\u65e5\u672c\u81e8\u5e8a\u5316\u5b66\u4f1a\u5e74\u6b21\u5b66\u8853\u96c6\u4f1a. 2024.08.30-9.1.<\/li>\n\n\n\n
    7. \u5f8c\u85e4 \u5bdb\u662d, \u5c0f\u6797 \u7389\u5b9c\uff0c\u9234\u6728 \u535a\u82f1\uff0c\u5c0f\u91ce \u4f73\u4e00. \u60aa\u6027\u3067\u306f\u306a\u304b\u3063\u305f\u8180\u80f1\u816b\u7624\u306e2\u4f8b. \u7b2c73\u56de\u65e5\u672c\u533b\u5b66\u691c\u67fb\u5b66\u4f1a. 2024.5.11-12.<\/li>\n\n\n\n
    8. \u4f50\u85e4 \u96c5\u54c9, \u5efa\u77f3 \u826f\u4ecb\uff0c\u5c0f\u6c60 \u548c\u5f66. \u751f\u6d3b\u7fd2\u6163\u95a2\u9023\u809d\u75be\u60a3\u306e\u4eca\u5f8c\u306e\u5c55\u671b\u3000\u975e\u30a2\u30eb\u30b3\u30fc\u30eb\u6027\u8102\u80aa\u809d\u708e(NASH)\u3092\u5bfe\u8c61\u3068\u3057\u305f\u30c7\u30b8\u30bf\u30eb\u7642\u6cd5(DTx)\u4ecb\u5165\u306e\u63a2\u7d22\u7684\u81e8\u5e8a(\u7b2c\u4e8c\u76f8)\u8a66\u9a13. \u7b2c60\u56de\u65e5\u672c\u809d\u81d3\u5b66\u4f1a\u7dcf\u4f1a. 2024.6.13-14.<\/li>\n\n\n\n
    9. \u4f50\u85e4 \u96c5\u54c9. Python\u3067\u59cb\u3081\u308b\u6a5f\u68b0\u5b66\u7fd2\u306e\u57fa\u790e\u3068\u5b9f\u8df5. \u7b2c71\u56de\u65e5\u672c\u81e8\u5e8a\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a. 2024.11.28.-12.1.<\/li>\n\n\n\n
    10. \u4f50\u85e4 \u512a\u5b9f\u5b50. \u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\uff1aIn house\u3067\u306e\u30b2\u30ce\u30e0\u691c\u67fb\u300eNCC\u306e\u5c0e\u5165\u300f. \u7b2c42\u56de\u65e5\u672c\u67d3\u8272\u4f53\u907a\u4f1d\u5b50\u691c\u67fb\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a. 2024.12.14-15.<\/li>\n\n\n\n
    11. \u9ad8\u6a4b \u5343\u7531\u7d00. FCM\u691c\u67fb\u7528\u691c\u4f53\u306e\u524d\u51e6\u7406\u3084\u7d30\u80de\u6d6e\u904a\u6db2\u4f5c\u88fd\u306e\u5b9f\u969b\u3068\u6ce8\u610f\u3059\u3079\u304d\u30dd\u30a4\u30f3\u30c8. \u65e5\u672c\u533b\u7642\u691c\u67fb\u79d1\u5b66\u4f1a \u7b2c56\u56de\u5927\u4f1a. 2024.10.4-6.<\/li>\n\n\n\n
    12. \u9ad8\u6a4b \u7531\u8389, \u771e\ufa11 \u6842, \u6301\u7530 \u667a\u4e4b, \u5c71\u7530 \u306f\u308b\u9999, \u79cb\u7530 \u840c, \u5ca9\u6fa4 \u8309\u8389\u7d75, \u4ee3\u7530 \u60a0\u4e00\u90ce. Swan-Ganz\u30ab\u30c6\u30fc\u30c6\u30eb\u88c5\u7740\u60a3\u8005\u306b\u304a\u3051\u308b\u8133\u6ce2\u691c\u67fb\u306e\u30a2\u30fc\u30c1\u30d5\u30a1\u30af\u30c8. \u65e5\u672c\u795e\u7d4c\u5b66\u4f1a. 2024.5.29-6.1.<\/li>\n\n\n\n
    13. \u4e2d\u897f \u5f18\u6bc5. Stage A\/B\u5fc3\u4e0d\u5168\u60a3\u8005\u306b\u304a\u3051\u308b\u65e9\u671f\u5fc3\u6a5f\u80fd\u969c\u5bb3\u306e\u691c\u51fa. \u7b2c28\u56de\u65e5\u672c\u5fc3\u4e0d\u5168\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a. 2024.10.4-6.<\/li>\n\n\n\n
    14. \u4e2d\u897f \u5f18\u6bc5, \u5927\u9580 \u96c5\u592b, \u5ee3\u702c \u548c\u4fca, \u5409\u7530 \u7531\u7406\u5b50, \u5411\u4e95 \u5eb7\u6d69, \u95a2 \u5149\u91cc, \u5ee3\u5ddd \u611b\u7f8e, \u4e2d\u5c3e \u502b\u5b50, \u8535\u91ce \u4fe1, \u6b66\u7530 \u61b2\u5f66. \u5fc3\u623f\u7d30\u52d5\u75c7\u4f8b\u306b\u304a\u3051\u308b\u30a2\u30eb\u30d6\u30df\u30f3\u5c3f\u3068\u5de6\u623f\u30ea\u30e2\u30c7\u30ea\u30f3\u30b0\u306e\u691c\u8a0e. \u65e5\u672c\u8d85\u97f3\u6ce2\u533b\u5b66\u4f1a\u7b2c97\u56de\u5b66\u8853\u96c6\u4f1a. 2024.5.31-6.2.<\/li>\n\n\n\n
    15. \u897f\u5ddd \u771f\u5b50, \u5b89\u6c38 \u611b, \u7267 \u5b8f\u5f70, \u68ee\u7530 \u5263, \u6b63\u672c \u5eb8\u4ecb, \u8535\u91ce \u4fe1, \u9ed2\u5ddd \u5cf0\u592b. \u30db\u30b9\u30bf\u30de\u30c1\u30cb\u30d6\u304c\u8457\u52b9\u3057\u305f\u96e3\u6cbb\u6027\u6162\u6027\u7279\u767a\u6027\u8840\u5c0f\u677f\u6e1b\u5c11\u6027\u7d2b\u6591\u75c5\u306e\u4e00\u4f8b. \u7b2c46\u56de\u65e5\u672c\u8840\u6813\u6b62\u8840\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a. 2024.6.13-15.<\/li>\n\n\n\n
    16. \u6751\u5c71 \u656c\u7950, \u5927\u4e45\u4fdd \u57fa\u535a, \u5c0f\u6797 \u771f\u8863, \u4e2d\u6e21 \u4e00\u8cb4, \u5409\u5ddd \u76f4\u4e4b, \u5c0f\u91ce \u4f73\u4e00, \u8535\u91ce \u4fe1. \u8d85\u9060\u5fc3\u306b\u3088\u308b\u4e73\u3073\u691c\u4f53\u51e6\u7406\u306e\u6709\u7528\u6027\u306b\u95a2\u3059\u308b\u691c\u8a0e\u30fcAST\u304a\u3088\u3073ALT\u6e2c\u5b9a\u306b\u7740\u76ee\u3057\u3066\u30fc. \u7b2c64\u56de\u65e5\u672c\u81e8\u5e8a\u5316\u5b66\u4f1a. 2024.8.30-9.1.<\/li>\n\n\n\n
    17. \u6301\u7530 \u667a\u4e4b, \u4ee3\u7530 \u60a0\u4e00\u90ce. \u7b2c5\u56de\u751f\u7406\u691c\u67fb\u6280\u8853\u30bb\u30df\u30ca\u30fc \u795e\u7d4c\u751f\u7406\u691c\u67fb. \u7b2c56\u56de\u65e5\u672c\u533b\u7642\u691c\u67fb\u79d1\u5b66\u4f1a. 2024.10.4-6.<\/li>\n\n\n\n
    18. \u68ee\u7530 \u8ce2\u53f2, \u6a2a\u5c71 \u96a3, \u4e45\u672b \u5d07\u53f8, \u4e2d\u53f8 \u6210, \u5c0f\u91ce \u4f73\u4e00, \u7530\u4e2d \u96c5\u7f8e, \u5409\u7530 \u8f1d\u5f66, \u8535\u91ce \u4fe1. \u5168\u81ea\u52d5\u5c3f\u4e2d\u6709\u5f62\u6210\u5206\u5206\u6790\u88c5\u7f6eUF-5000\u306e\u30b9\u30ad\u30e3\u30c3\u30bf\u30b0\u30e9\u30e0\u60c5\u5831\u3092\u7528\u3044\u305f\u5c3f\u4e2d\u8d64\u8840\u7403\u5f62\u614b\u5224\u5225\u30a2\u30eb\u30b4\u30ea\u30ba\u30e0\u306e\u4f5c\u6210\uff0e. \u65e5\u672c\u533b\u7642\u691c\u67fb\u79d1\u5b66\u4f1a\u7b2c56\u56de\u5927\u4f1a. 2024.10.4-6.<\/li>\n\n\n\n
    19. \u68ee\u7530 \u8ce2\u53f2, \u6a2a\u5c71 \u96a3, \u4e2d\u53f8 \u6210, \u4e45\u672b \u5d07\u53f8, \u660e\u8cc0 \u4f0a\u7e54, \u7530\u4e2d \u96c5\u7f8e, \u5c0f\u91ce \u4f73\u4e00, \u8535\u91ce \u4fe1. \u5c3f\u4e2d\u30d7\u30ed\u30b9\u30bf\u30b0\u30e9\u30f3\u30b8\u30f3E\u4ee3\u8b1d\u7269\u306e\u6e2c\u5b9a\u6cd5\u6bd4\u8f03\u3068\u81e8\u5e8a\u7684\u6709\u7528\u6027\u306e\u89e3\u6790\u2015CLEIA\u6cd5\u3068LC-MS\/MS\u6cd5\u3068\u306e\u76f8\u95a2\u6027\u2015\uff0e. \u7b2c64\u56de\u65e5\u672c\u81e8\u5e8a\u5316\u5b66\u4f1a. 2024.8.30-9.1.<\/li>\n\n\n\n
    20. \u68ee\u7530 \u8ce2\u53f2. \u65b0\u578b\u30b3\u30ed\u30ca\u30ef\u30af\u30c1\u30f3\u3068\u8840\u5c3f\u306e\u8003\u3048\u65b9\uff0e\u30d1\u30cd\u30eb\u30c7\u30a3\u30b9\u30ab\u30c3\u30b7\u30e7\u30f32\uff5e\u8840\u5c3f\u8a3a\u65ad\u30ac\u30a4\u30c9\u30e9\u30a4\u30f32023\u3092\u691c\u67fb\u90e8\u3067\u6d3b\u304b\u3059\uff5e\uff0e. \u7b2c73\u56de\u65e5\u672c\u533b\u5b66\u691c\u67fb\u5b66\u4f1a. 2024.5.11-12.<\/li>\n\n\n\n
    21. \u6a2a\u5c71 \u96a3, \u5409\u7530\u8f1d\u5f66, \u68ee\u7530 \u8ce2\u53f2, \u4e2d\u53f8 \u6210, \u4e45\u672b \u5d07\u53f8, \u7530\u4e2d \u96c5\u7f8e, \u5c0f\u91ce \u4f73\u4e00, \u8535\u91ce \u4fe1. \u5c3f\u691c\u67fb\u306b\u3088\u308b\u5c3f\u8def\u7d50\u77f3\u306e\u6210\u5206\u4e88\u6e2c. \u7b2c71\u56de\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a. 2024.11.28-12.1.<\/li>\n\n\n\n
    22. \u5409\u7530 \u8f1d\u5f66. APOL1-G1\u30d0\u30ea\u30a2\u30f3\u30c8\u306f\u30de\u30a6\u30b9\u3068\u30d2\u30c8\u3067\u6c34\u982d\u75c7\u3092\u60f9\u8d77\u3059\u308b. \u7b2c26\u56de\u65e5\u672c\u6b63\u5e38\u5727\u6c34\u982d\u75c7\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a. 2025.2.8-9.<\/li>\n\n\n\n
    23. \u5409\u7530 \u8f1d\u5f66, \u68ee\u7530 \u8ce2\u53f2,\u6a2a\u5c71 \u96a3,\u4e2d\u53f8 \u6210,\u4e45\u672b \u5d07\u53f8,\u7530\u4e2d \u96c5\u7f8e,\u5c0f\u91ce \u4f73\u4e00,\u8535\u91ce \u4fe1. \u5c3f\u4e2d\u7cf8\u7403\u4f53\u578b\u8d64\u8840\u7403\u306e\u75c5\u7406\u8a3a\u65ad\u306b\u57fa\u3065\u304f\u814e\u75be\u60a3\u5225\u983b\u5ea6. \u7b2c71\u56de\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a. 2024.11.28-12.1.<\/li>\n<\/ol>\n\n\n\n

      \u82f1\u6587\u7dcf\u8aac\uff1aEnglish Review Articles<\/h4>\n\n\n\n
        \n
      1. Isago H. The Association between Dyslipidemia and Pulmonary Diseases J Atheroscler Thromb<\/strong><\/em> 31; 9: 1249-1259<\/a>, 2024.<\/li>\n\n\n\n
      2. Lefaucheur JP, Moro E, Shirota Y, Ugawa Y, Grippe T, Chen R, Benninger DH, Jabbari B, Attaripour S, Hallett M, Paulus W. Clinical neurophysiology in the treatment of movement disorders: IFCN handbook chapter Clin Neurophysiol<\/strong><\/em> 164:57-99<\/a>, 2024.<\/li>\n<\/ol>\n\n\n\n

        \u56fd\u969b\u5b66\u4f1a\u767a\u8868\uff1aInternational Conference Presentation<\/h4>\n\n\n\n
          \n
        1. Sato M. Laboratyro Medicine-based Machine Learning Applicaiton in the Diagnosis and Management of Liver Disease. The 13th Cherry Blossom Symposium. 2024.3.20-22.<\/li>\n\n\n\n
        2. Sato M. Application of Machine Learning in the Diagnosis and Management of Liver Disease. The 33rd Annual Meeting of the Asian Pacific Association for the Study of the Liver (APASL) . 2024.3.27-31.<\/li>\n\n\n\n
        3. Yoshida T, Yang Z, Ashida S, Yu Z, Shrivastav S, Springer D, Starost M, Rosenberg A, Remaley A, Kopp J. Apolipoprotein-L1 G1 variant contributes to hydrocephalus but not to atherosclerosis. American Society of Nephrology Kidney Week 2024. 2024.10.23-27.<\/li>\n\n\n\n
        4. Yoshida Y, Nakanishi K, Daimon M, Hirose K, Iwama K, Mukai M, Yamamoto Y, Seki H, Hirokawa M, Nakao T, Oshima T, Matsubara T, Shimizu Y, Oguri G, Kojima T, Hasumi E, Fujiu K, Morita H, Kurano M, Takeda N. Left atrial functional reserve and recurrence of atrial arrhythmias in patients with persistent atrial fibrillation. American Heart Association. 2024.11.16-18.<\/li>\n<\/ol>\n\n\n\n

          \u548c\u6587\u539f\u8457\u8ad6\u6587\uff1aJapanese Original Articles<\/h4>\n\n\n\n
            \n
          1. \u5409\u5ddd \u76f4\u4e4b, \u91ce\u7530 \u7406\u7f8e, \u5c0f\u91ce \u4f73\u4e00, \u8535\u91ce \u4fe1. LT\u30aa\u30fc\u30c8\u30ef\u30b3\u30fcRF(II)\u306e\u57fa\u790e\u7684\u691c\u8a0e. \u533b\u5b66\u691c\u67fb 74(1): 94-102, 2025.<\/li>\n<\/ol>\n\n\n\n

            \u548c\u6587\u7dcf\u8aac\uff1aJapanese Review Articles<\/h4>\n\n\n\n
              \n
            1. \u7802\u91d1 \u79c0\u7ae0. \u304c\u3093\u907a\u4f1d\u5b50\u30d1\u30cd\u30eb\u691c\u67fb. \u691c\u67fb\u3068\u6280\u8853 52(9) 970-981, 2024.<\/li>\n\n\n\n
            2. \u7802\u91d1 \u79c0\u7ae0. \u30b2\u30ce\u30e0\u533b\u7642\u3068\u81e8\u5e8a\u691c\u67fb\u306e\u672a\u6765\u3000\u6b21\u4e16\u4ee3\u30b7\u30fc\u30af\u30a8\u30f3\u30b5\u30fc\u5c0e\u5165\u30fb\u691c\u67fb\u5185\u88fd\u5316\u306e\u7d4c\u9a13\u304b\u3089. \u691c\u67fb\u3068\u6280\u8853 52(8): 778-780, 2024.<\/li>\n\n\n\n
            3. \u4e95\u4e0a \u7fd4\u592a. \u898b\u843d\u3068\u3057\u6ce8\u610f\uff01\u8840\u6813\u585e\u6813\u75c7\u306e\u30ea\u30b9\u30af\u3000Libman-Sacks\u5fc3\u5185\u819c\u708e. \u5fc3\u30a8\u30b3\u30fc 25:166-170, 2024.<\/li>\n\n\n\n
            4. \u5c0f\u91ce \u4f73\u4e00. \u30a2\u30c9\u30d0\u30a4\u30b9\u30b5\u30fc\u30d3\u30b9\u3092\u7528\u3044\u305f\u691c\u67fb\u5ba4\u304b\u3089\u306e\u60c5\u5831\u767a\u4fe1. \u691c\u67fb\u3068\u6280\u8853 pp.829-832. \u533b\u5b66\u66f8\u9662, 2024.<\/li>\n\n\n\n
            5. \u4f50\u85e4 \u96c5\u54c9. \u975e\u4fb5\u8972\u7684\u306a\u809d\u7dda\u7dad\u5316\u30de\u30fc\u30ab\u30fc\u3000\u8840\u6db2\u3067\u809d\u81d3\u306e\u72b6\u614b\u3092\u898b\u629c\u304f\u691c\u67fb. SRL\u5b9d\u51fd 45\u53f7(2), 41-44, 2024.<\/li>\n\n\n\n
            6. \u4f50\u85e4 \u96c5\u54c9. MASH\u306e\u30c7\u30b8\u30bf\u30eb\u7642\u6cd5\u3068\u306f. \u809d\u81d3\u30af\u30ea\u30cb\u30ab\u30eb\u30a2\u30c3\u30d7\u30c7\u30fc\u30c8 10: 1: 86-91, 2024.<\/li>\n\n\n\n
            7. \u4f50\u85e4 \u96c5\u54c9. \u81e8\u5e8a\u691c\u67fb\u3068AI\u306e\u878d\u5408 AI\u306b\u3088\u308b\u81e8\u5e8a\u691c\u67fb\u30c7\u30fc\u30bf\u306e\u7d71\u5408. \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u8a8c 72: 3: 213, 2024.<\/li>\n\n\n\n
            8. \u4f50\u85e4 \u96c5\u54c9. \u81e8\u5e8a\u691c\u67fb\u3068AI. \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u8a8c 72: 2: 118-124, 2024.<\/li>\n\n\n\n
            9. \u4f50\u85e4 \u96c5\u54c9. \u30a2\u30d7\u30ea\u3092\u7528\u3044\u305fMASH\u6cbb\u7642\u306e\u53ef\u80fd\u6027. \u533b\u5b66\u306e\u3042\u3086\u307f 289: 5: 410-415, 2024.<\/li>\n\n\n\n
            10. \u5e38\u540d \u653f\u5f18, \u897f\u5ddd \u771f\u5b50. \u9aa8\u9ac4\u691c\u67fb\u3000. \u691c\u67fb\u3068\u6280\u8853\u3000\u5897\u5927\u53f7\u3000\u81e8\u5e8a\u533b\u306b\u4f1d\u308f\u308a\u3084\u3059\u3044\u3000\u691c\u67fb\u5831\u544a\u66f8\u3068\u30d1\u30cb\u30c3\u30af\u5024\u5831\u544a\u306e\u5fc3\u5f97 52(9): 873-880, 2024.<\/li>\n\n\n\n
            11. \u6edd\u53e3 \u7d14, \u897f\u5ddd \u771f\u5b50. \u597d\u9178\u7403\u5897\u591a\u75c7\u306f\u3069\u3053\u304b\u3089\u816b\u760d\u6027\u3092\u7591\u3048\u3070\u3088\u3044\u306e\u3067\u3059\u304b\uff1f. \u691c\u67fb\u3068\u6280\u8853 52, 726-729, 2024.<\/li>\n\n\n\n
            12. \u7530\u4e2d \u96c5\u7f8e. \u81e8\u5e8a\u533b\u306b\u4f1d\u308f\u308a\u3084\u3059\u3044\u691c\u67fb\u5831\u544a\u66f8\u3068\u30d1\u30cb\u30c3\u30af\u5024\u5831\u544a\u306e\u5fc3\u5f97 2\u7ae0 \u9ac4\u6db2\u691c\u67fb. \u691c\u67fb\u3068\u6280\u8853 52: 839-843, 2024.<\/li>\n\n\n\n
            13. \u91ce\u3005\u90e8 \u4eae\u5b50. SMBG\u3001CGM\u3068\u9759\u8108\u8840\u306e\u8840\u7cd6\u5024\u306e\u9055\u3044. \u6708\u520a\u7cd6\u5c3f\u75c5\u30e9\u30a4\u30d5\u3000\u3055\u304b\u3048 64(1): 46-48, 2024.<\/li>\n\n\n\n
            14. \u91ce\u3005\u90e8 \u4eae\u5b50. 3\u7ae0 \u8840\u6db2\u691c\u67fb \u8840\u5c0f\u677f\u51dd\u96c6\u80fd\u691c\u67fb. \u691c\u67fb\u3068\u6280\u8853\uff08\u5897\u5927\u53f7\uff09 52(9): 895-900, 2024.<\/li>\n\n\n\n
            15. \u4e45\u672b \u76f4\u5b50. \u899a\u3048\u3066\u304a\u304d\u305f\u3044! \u63a1\u8840\u3067\u5f79\u7acb\u3064\u82f1\u4f1a\u8a71\u30d5\u30ec\u30fc\u30ba. Medical Technology 52: 1360-1362, 2024.<\/li>\n\n\n\n
            16. \u68ee\u7530 \u8ce2\u53f2. \u5c3f\u6c88\u6e23\u6210\u5206\u9451\u5225\u306b\u304a\u3051\u308b\u67d3\u8272\u65b9\u6cd5\u306e\u9078\u629e. Medical Technology 52: 1061-1065, 2024.<\/li>\n\n\n\n
            17. \u68ee\u7530 \u8ce2\u53f2. \u81e8\u5e8a\u533b\u306b\u4f1d\u308f\u308a\u3084\u3059\u3044\u691c\u67fb\u5831\u544a\u66f8\u3068\u30d1\u30cb\u30c3\u30af\u5024\u5831\u544a\u306e\u5fc3\u5f97 2\u7ae0 \u80f8\u6c34\u30fb\u8179\u6c34\u691c\u67fb. \u691c\u67fb\u3068\u6280\u8853 52: 844-849, 2024.<\/li>\n<\/ol>\n\n\n\n

              \u548c\u6587\u8457\u66f8\uff1aJapanese Book Chapter<\/h4>\n\n\n\n
                \n
              1. \u5c0f\u6cb3 \u5e78\u5b50. \u30d1\u30eb\u30b9\u30aa\u30ad\u30b7\u30e1\u30fc\u30bf. \u547c\u5438\u6a5f\u80fd\u691c\u67fb\u6280\u8853\u6559\u672c \u7b2c2\u7248 pp. 200-203. \u3058\u307b\u3046, 2024.<\/li>\n\n\n\n
              2. \u5c0f\u6cb3 \u5e78\u5b50. \u611f\u67d3\u5bfe\u7b56. \u547c\u5438\u6a5f\u80fd\u691c\u67fb\u6280\u8853\u6559\u672c \u7b2c2\u7248 pp.253-260. \u3058\u307b\u3046, 2024.<\/li>\n\n\n\n
              3. \u5c0f\u91ce \u4f73\u4e00. \u5171\u901a\u6a5f\u68b0\u5668\u5177\u306e\u539f\u7406\u30fb\u69cb\u9020\uff08K.\u96fb\u6c17\u5316\u5b66\u88c5\u7f6e\uff09. \u300c\u6700\u65b0\u81e8\u5e8a\u691c\u67fb\u5b66\u8b1b\u5ea7\u3000\u691c\u67fb\u6a5f\u5668\u7dcf\u8ad6\u3000\u7b2c2\u7248\u300d pp.129-145. \u533b\u6b6f\u85ac\u51fa\u7248\u682a\u5f0f\u4f1a\u793e, 2025.<\/li>\n\n\n\n
              4. \u5c0f\u91ce \u4f73\u4e00. 6.\u8cc7\u6e90\u306b\u95a2\u3059\u308b\u8981\u6c42\u4e8b\u9805\uff086.1\uff5e6.3\uff09. \u300cISO_15189_2022\u304c\u81e8\u5e8a\u691c\u67fb\u5ba4\u3092\u5909\u3048\u308b\u300d pp.27\uff5e36. \u4e00\u822c\u793e\u56e3\u6cd5\u4eba\u3000RMA, 2024.<\/li>\n\n\n\n
              5. \u6edd\u53e3\u3000\u7d14, \u897f\u5ddd\u3000\u771f\u5b50. case11\u300030\u4ee3\u5973\u6027\uff0c\u7d2b\u6591\u3068\u6b6f\u8089\u51fa\u8840\u306e\u305f\u3081\u7d39\u4ecb\u53d7\u8a3a\u3068\u306a\u3063\u305f\u3000case12\u300060\u4ee3\u5973\u6027\uff0c\u624b\u8853\u5f8c\u306b\u547c\u5438\u82e6\u304c\u51fa\u73fe\u3057\u305f. \u75c5\u614b\u304c\u307f\u3048\u308b\u691c\u67fb\u5024\u306e\u672c\u5f53\u306e\u8aad\u307f\u65b9 pp. 217-224, 225-233. \u7f8a\u571f\u793e, 2024.<\/li>\n\n\n\n
              6. \u7530\u4e2d \u96c5\u7f8e. \u9ac4\u6db2\u306e\u9855\u5fae\u93e1\u691c\u67fb. \u898b\u3066\u5b66\u3076 \u4e00\u822c\u691c\u67fb\u5b66\u30a2\u30c8\u30e9\u30b9\u2015\u5916\u89b3\u691c\u67fb\u304b\u3089\u9855\u5fae\u93e1\u691c\u67fb\u307e\u3067 pp.100-112. \u533b\u5b66\u66f8\u9662, 2024.<\/li>\n\n\n\n
              7. \u897f\u5ddd\u3000\u771f\u5b50. \u51fa\u8840\u6642\u9593\uff0c\u8840\u5c0f\u677f\u51dd\u96c6\u80fd\u691c\u67fb. \u81e8\u5e8a\u691c\u67fb\u30ac\u30a4\u30c9\u30002025\u5e74\u6539\u8a02\u7248 pp. 501-504. \u6587\u5149\u5802, 2024.<\/li>\n\n\n\n
              8. \u897f\u5ddd\u3000\u771f\u5b50. \u8f38\u8840\u7642\u6cd5\u3068\u691c\u67fb\u5024\u306e\u5909\u52d5. \u75c5\u614b\u304c\u307f\u3048\u308b\u691c\u67fb\u5024\u306e\u672c\u5f53\u306e\u8aad\u307f\u65b9 pp. 92-96. \u7f8a\u571f\u793e, 2024.<\/li>\n\n\n\n
              9. \u897f\u5ddd\u3000\u771f\u5b50. \u8ca7\u8840\u306b\u95a2\u9023\u3059\u308b\u8840\u6db2\u691c\u67fb. Medical Practice 41, 1324-1328. \u6587\u5149\u5802, 2024.<\/li>\n<\/ol>\n\n\n\n

                \u548c\u6587\u7de8\u8457\u7b49\uff1aJapanese Book Editing<\/h4>\n<\/div><\/div>\n\n\n\n
                \n

                2023\u5e74<\/h3>\n\n\n\n

                \u82f1\u6587\u539f\u8457\u8ad6\u6587\uff1aEnglish Original Articles<\/h4>\n\n\n\n
                  \n
                1. Cotella J, Miyoshi T, Mor-Avi V, Addetia K, Schreckenberg M, Blankenhagen M, Hitschrich N, Amuthan V, Citro R, Daimon M, Gutie\u00b4rrez-Fajardo P, Kasliwal R, Kirkpatrick JN, Monaghan MJ, Muraru D, Ogunyankin KO, Park SW, Rodrigues ACT, Ronderos R, Sadeghpour A, Scalia G, Takeuchi M, Tsang W, Tucay ES, Zhang M, Prado AD, Asch FA, and Lang RM. Normative Values of the Aortic Valve Area and Doppler Measurements Using Two-Dimensional Transthoracic Echocardiography: Results from the Multicenter World Alliance of Societies of Echocardiography Study. Eur. Heart J. Cardiovasc Imaging<\/em><\/strong>. , in press.<\/li>\n\n\n\n
                2. Deng Y, Tay HM, Zhou Y, Fei X, Tang X, Nishikawa M, Yatomi Y, Hou HW., Xiao TH., and Goda K. Studying the efficacy of antiplatelet drugs on atherosclerosis by optofluidic imaging on a chip. Lab. Chip.<\/em><\/strong>, in press.<\/li>\n\n\n\n
                3. Drexler Y, Molina J, Elfassy T, Ma R, Christoffersen C, Kurano M, Yatomi Y, Mariani L, Contreras G, Merscher S, and Fornoni A. Identification of Glomerular and Plasma Apolipoprotein M as Novel Biomarkers in Glomerular Disease. Kidney Int. Rep.<\/em><\/strong> , in press. <\/li>\n\n\n\n
                4. Hirabayashi T, Kawaguchi M, Harada S, Mouri M, Takamiya R, Miki Y, Sato, H., Taketomi Y, Yokoyama K, Kobayashi T, Tokuoka SM, Kita Y, Yoda E, Hara S, Mikami K, Nishito Y, Kikuchi N, Nakata R, Kaneko M, Kiyonari H, Kasahara K, Aiba T, Ikeda K, Soga T, Kurano M, Yatomi Y, and Murakami M. Hepatic phosphatidylcholine catabolism driven by PNPLA7 and PNPLA8 supplies endogenous choline to replenish the methionine cycle with methyl groups. Cell Rep.<\/em><\/strong> 42: 111940<\/a>, 2023.  <\/li>\n\n\n\n
                5. Hirose K, Nakanishi K, Daimon M, Yoshida Y, Ishiwata J, Nakao T, Morita H, Di Tullio MR, Homma S, and Komuro I. Prevalence, Determinants and Prognostic Value of Left Atrial Dysfunction in Patients with Chronic Coronary Syndrome and Normal Left Ventricular Ejection Fraction. Am. J. Cardiol<\/em><\/strong> 187: 30-37<\/a>, 2023.<\/li>\n\n\n\n
                6. Kage H, Shinozaki-Ushiku A, Ishigaki K, Sato Y, Tanabe M, Tanaka S, Tanikawa M, Watanabe K, Kato S, Akagi K, Uchino K, Mitani K, Takahashi S, Miura Y, Ikeda S, Kojima Y, Watanabe K, Mochizuki H, Yamaguchi H, Kawazoe Y, Kashiwabara K, Kohsaka S, Tatsuno K, Ushiku T, Ohe K, Yatomi Y, Seto Y, Aburatani H, Mano H, Miyagawa K, and Oda K. Clinical utility of Todai OncoPanel in the setting of approved comprehensive cancer genomic profiling tests in Japan. Cancer Sci.<\/em><\/strong> , in press. <\/li>\n\n\n\n
                7. Kurano M, Tsukamoto K, Kamitsuji S, Kamatani N, Hasegawa K, Hara M, Ishikawa T, Yatomi Y, and Teramoto T. Apolipoprotein D modulates lipid mediators and osteopontin in an anti-inflammatory direction. Inflamm Res.<\/em><\/strong> ,in press.<\/li>\n\n\n\n
                8. Lee L, Cotella JI, Miyoshi T, Addetia K, Schreckenberg M, Hitschrich N, Blankenhagen M, Amuthan V, Citro R, Daimon M, Gutie\u00b4rrez-Fajardo P, Kasliwal R, Kirkpatrick JN, Monaghan MJ, Muraru D, Ogunyankin KO, Park SW, Tude Rodrigues AC, Ronderos R, Sadeghpour A, Scalia GM, Takeuchi M, Tsang W, Tucay ES, Zhang M, Mor-Avi V, Asch FM, and Lang RM. Normal Values of Left Ventricular Mass by 2D and 3D Echocardiography: Results from the World Alliance Societies of Echocardiography Normal Values Study. J. Am. Soc. Echocardiogr.<\/em><\/strong> , in press.<\/li>\n\n\n\n
                9. Matsumoto Y, Kage H, Morota M, Zokumasu K, Ando T, Maemura K, Watanabe K, Kawakami M, Hinata M, Ushiku T, Nakajima J, and Nagase T. Integrin alpha 2 is associated with tumor progression and postoperative recurrence in non-small cell lung cancer. Jpn. J. Clin. Oncol.<\/em><\/strong> 53: 63-73<\/a>, 2023.<\/li>\n\n\n\n
                10. Seki H, Nakanishi K, Daimon M, Hirose K, Mukai Y, Yoshida Y, Nakao T, Morita H, Di Tullio MR, Homma S, and Komuro I. Epicardial fat accumulation and left heart remodeling in patients with chronic coronary syndrome. Eur. Heart J. Open.<\/em><\/strong> 3: oeac082<\/a>, 2023.<\/li>\n\n\n\n
                11. Singulane CC, Miyoshi T, Mor-Avi V, Cotella JI, Schreckenberg M, Blankenhagen M, Hitschrich N, Addetia K, Amuthan V, Citro R, Daimon M, Gutie\u00b4rrez-Fajardo P, Kasliwal R, Kirkpatrick JN, Monaghan MJ, Muraru D, Ogunyankin KO, Park SW, Tude Rodrigues AC, Ronderos R, Sadeghpour A, Scalia GM, Takeuchi M, Tsang W, Tucay ES, Zhang Y, Asch FM, Lang RM. Age-, Sex- and Race-based Normal Values for Left Ventricular Circumferential Strain from the World Alliance of Societies of Echocardiography Study. J. Am. Soc. Echocardiogr.<\/em><\/strong> , in press.<\/li>\n\n\n\n
                12. Sugimoto N, Morita Y, Sakai E, Yatomi Y, and Kurano M. Modulations of urinary lipid mediators in acute bladder cystitis. Prostaglandins Other Lipid Mediat.<\/em><\/strong> 164: 106690<\/a>, 2023. <\/li>\n\n\n\n
                13. Yoshida M, Morita K, Fukushima H, Jona M, Nishikawa M, Yatomi Y, Kishino Y, Iwasaki A, Ushiku T, Imadome KI, Honda A, Maki H, and Kurokawa M. Development of Epstein-Barr virus-associated lymphoproliferative disorder and hemophagocytic lymphohistiocytosis during long-term lenalidomide maintenance therapy in multiple myeloma. Int. J. Hematol.<\/em><\/strong> , in press.<\/li>\n\n\n\n
                14. Yoshida Y, Nakanishi K, Daimon M, Hirose K, Ishiwata J, Kaneko H, Nakao T, Mizuno Y, Morita H, Di Tullio MR, Homma S, and Komuro I. Aortic valve sclerosis and subclinical LV dysfunction in the general population with normal LV geometry. Eur. J. Prev. Cardiol.<\/strong><\/em> , in press.<\/li>\n\n\n\n
                15. Zhou Y, Nishikawa M, Kanno H, Yang R, Ibayashi Y, Xiao TH, Peterson W, Herbig M, Nitta N, Miyata S, Kanthi Y, Rohde GK, Moriya K, Yatomi Y, and Goda K. Long-term effects of Pfizer-BioNTech COVID-19 vaccinations on platelets. Cytometry A<\/strong><\/em>, in press.<\/li>\n\n\n\n
                16. Matsumoto Y, Kage H, Morota M, Zokumasu K, Ando T, Maemura K, Watanabe K, Kawakami M, Hinata M, Ushiku T, Nakajima J, and Nagase T. Integrin alpha 2 is associated with tumor progression and postoperative recurrence in non-small cell lung cancer. Jpn. J. Clin. Oncol.<\/em><\/strong> 53(1): 63-73<\/a>, 2023.<\/li>\n\n\n\n
                17. Matsumura H, Shen LT, Isozaki A, Mikami H, Yuan D, Miura T, Kondo Y, Mori T, Kusumoto Y, Nishikawa M, Yasumoto A, Ueda A, Bando H, Hara H, Liu Y, Deng Y, Sonoshita M, Yatomi Y, Goda K, and Matsusaka S. Virtual-freezing fluorescence imaging flow cytometry with 5-aminolevulinic acid stimulation and antibody labeling for detecting all forms of circulating tumor cells. Lab Chip.<\/strong><\/em> 23:1561-1575<\/a>, 2023.<\/li>\n\n\n\n
                18. Minami T, Sato M, Toyoda H, Yasuda S, Yamada T, Nakatsuka T, Enooku K, Nakagawa H, Fujinaga H, Izumiya M, Tanaka Y, Otsuka M, Ohki T, Arai M, Asaoka Y, Tanaka A, Yasuda K, Miura H, Ogata I, Kamoshida T, Inoue K, Nakagomi R, Akamatsu M, Mitsui H, Fujie H, Ogura K, Uchino K, Yoshida H, Hanajiri K, Wada T, Kurai K, Maekawa H, Kondo Y, Obi S, Teratani T, Masaki N, Nagashima K, Ishikawa T, Kato N, Yotsuyanagi H, Moriya K, Kumada T, Fujishiro M, Koike K, and Tateishi R. Machine learning for individualized prediction of hepatocellular carcinoma development after the eradication of hepatitis C virus with antivirals. J Hepatol.<\/strong><\/em> S0168-8278(23)00424-5<\/a>, 2023.<\/li>\n\n\n\n
                19. Morita Y, Yokoyama R, Tanaka M, Nakatsuka N, Hisasue T, Ono Y, and Kurano M.Evaluation of the Fully Automated Urine Particle Analyzer UF-1500. J Clin Lab Anal.<\/strong><\/em> e24993<\/a>, 2023.<\/li>\n\n\n\n
                20. Mukai Y, Nakanishi K, Daimon M, Iwama K, Yoshida Y, Hirose K, Yamamoto Y, Seki H, Nakao T, Oshima T, Matsubara T, Shimizu Y, Oguri G, Kojima T, Hasumi E, Fujiu K, Morita H, and Komuro I. Prevalence, Associated Factors, and Echocardiographic Estimation of Left Atrial Hypertension in Patients With Atrial Fibrillation. J Am Heart Assoc.<\/strong><\/em> 12:e030325, 2023.<\/li>\n\n\n\n
                21. Nakanishi K, Daimon M, Fujiu K, Iwama K, Yoshida Y, Hirose K, Mukai Y, Yamamoto Y, Nakao T, Oshima T, Matsubara T, Shimizu Y, Oguri G, Kojima T, Hasumi E, Morita H, and Komuro I. Prevalence of glucose metabolism disorders and its association with left atrial remodelling before and after catheter ablation in patients with atrial fibrillation. Europace.<\/strong><\/em> 25:euad119, 2023.<\/li>\n\n\n\n
                22. Oyama T, Yasunaga M, Jona M, Nishikawa M, Yatomi Y, Honda A, Maki H, Morita K, Masamoto Y, and Kurokawa M. Acalabrutinib and steroid for autoimmune thrombocytopenia due to relapsed chronic lymphocytic leukemia with severe bone marrow infiltration. J Clin Exp Hematop.<\/strong><\/em> 63:187-192<\/a>, 2023.<\/li>\n\n\n\n
                23. Sato M. Impact of a Novel Digital Therapeutics System on Nonalcoholic Steatohepatitis: The NASH App Clinical Trial. Am J Gastroenterol.<\/strong><\/em> 1;118(8):1365-1372<\/a>, 2023.<\/li>\n\n\n\n
                24. Sato M. Development of a transformer model for predicting the prognosis of patients with hepatocellular carcinoma after radiofrequency ablation. Hepatol Int.<\/strong><\/em> doi: 10,1007\/s12072-023-10585-y<\/a>. Online ahead of print, in press.<\/li>\n\n\n\n
                25. Sawada N, Nakanishi K, Nakao T, Miyoshi T, Takeuchi M, Asch FM, Lang RM, and Daimon M. Normal Values of Echocardiographic Right Ventricular Size and Systolic Function Measurements in a Healthy Japanese Population – Subanalysis of the WASE Study. Circ Rep.<\/strong><\/em> 5:424-429, 2023.<\/li>\n\n\n\n
                26. Seki H, Nakanishi K, Daimon M, Hirose K, Mukai Y, Yoshida Y, Nakao T, Morita H, Di Tullio MR, Homma S, and Komuro I. Epicardial fat accumulation and left heart remodeling in patients with chronic coronary syndrome. Eur. Heart J. Open.<\/em><\/strong> 3: oeac082<\/a>, 2023.<\/li>\n\n\n\n
                27. Shirota Y, Fushimi M, Sekino M, and Yumoto M. Investigating the technical feasibility of magnetoencephalography during transcranial direct current stimulation. Front Hum Neurosci.<\/strong><\/em> 17:1270605<\/a>, 2023.<\/li>\n\n\n\n
                28. Singulane CC, Miyoshi T, Mor-Avi V, Cotella JI, Schreckenberg M, Blankenhagen M, Hitschrich N, Addetia K, Amuthan V, Citro R, Daimon M, Gutie\u00b4rrez-Fajardo P, Kasliwal R, Kirkpatrick JN, Monaghan MJ, Muraru D, Ogunyankin KO, Park SW, Tude Rodrigues AC, Ronderos R, Sadeghpour A, Scalia GM, Takeuchi M, Tsang W, Tucay ES, Zhang Y, Asch FM, Lang RM. Age-, Sex- and Race-based Normal Values for Left Ventricular Circumferential Strain from the World Alliance of Societies of Echocardiography Study. J. Am. Soc. Echocardiogr.<\/em><\/strong> , in press.<\/li>\n\n\n\n
                29. Sugimoto N, Morita Y, Sakai E, Yatomi Y, and Kurano M. Modulations of urinary lipid mediators in acute bladder cystitis. Prostaglandins Other Lipid Mediat.<\/em><\/strong> 164: 106690<\/a>, 2023. <\/li>\n\n\n\n
                30. Yoshida M, Morita K, Fukushima H, Jona M, Nishikawa M, Yatomi Y, Kishino Y, Iwasaki A, Ushiku T, Imadome KI, Honda A, Maki H, and Kurokawa M. Development of Epstein-Barr virus-associated lymphoproliferative disorder and hemophagocytic lymphohistiocytosis during long-term lenalidomide maintenance therapy in multiple myeloma. Int. J. Hematol.<\/em><\/strong> 117:769-773<\/a>, 2023.<\/li>\n\n\n\n
                31. Yoshida M, Matsuda K, Taoka K, Honda A, Maki H, Masamoto Y, Jona M, Nishikawa M, Yatomi Y, and Kurokawa M. Expansion of large granular lymphocytes after autologous hematopoietic stem cell transplantation. Int J Hematol.<\/strong><\/em> 117:839-844<\/a>, 2023.<\/li>\n\n\n\n
                32. Yoshida Y, Nakanishi K, Daimon M, Hirose K, Ishiwata J, Kaneko H, Nakao T, Mizuno Y, Morita H, Di Tullio MR, Homma S, and Komuro I. Aortic valve sclerosis and subclinical LV dysfunction in the general population with normal LV geometry. Eur. J. Prev. Cardiol.<\/strong><\/em> , in press.<\/li>\n\n\n\n
                33. Yoshida Y, Jin Z, Russo C, Homma S, Nakanishi K, Ito K, Mannina C, Elkind MSV, Rundek T, Yoshita M, DeCarli C, Wright CB, Sacco RL, and Di Tullio MR. Subclinical left ventricular systolic dysfunction and incident stroke in the elderly: long-term findings from Cardiovascular Abnormalities and Brain Lesions. Eur Heart J Cardiovasc Imaging.<\/strong><\/em> 24:522-531, 2023.<\/li>\n\n\n\n
                34. Yoshida Y, Yoshida Y, Jin Z, Nakanishi K, Matsumoto K, Homma S, Mannina C, Shames S, Elkind MSV, Rundek T, and Di Tullio MR. Subclinical Left Ventricular Dysfunction and Ventricular Arrhythmias in Older Adults With Normal Ejection Fraction. J Am Heart Assoc.<\/strong><\/em> 12:e030274, 2023.<\/li>\n\n\n\n
                35. Zhang C, Herbig M, Zhou Y, Nishikawa M, Shifat-E-Rabbi M, Kanno H, Yang R, Ibayashi Y, Xiao TH, Rohde GK, Sato M, Kodera S, Daimon M, Yatomi Y, and Goda K. Real-time intelligent classification of COVID-19 and thrombosis via massive image-based analysis of platelet aggregates. Cytometry A.<\/strong><\/em> 103:492-499<\/a>, 2023.<\/li>\n\n\n\n
                36. Zhou Y, Nishikawa M, Kanno H, Yang R, Ibayashi Y, Xiao TH, Peterson W, Herbig M, Nitta N, Miyata S, Kanthi Y, Rohde GK, Moriya K, Yatomi Y, and Goda K. Long-term effects of Pfizer-BioNTech COVID-19 vaccinations on platelets. Cytometry A.<\/strong> <\/em>103:162-167<\/a>, 2023.<\/li>\n<\/ol>\n\n\n\n

                  \u56fd\u5185\u5b66\u4f1a\u767a\u8868\uff1aDomestic Conference Presentation<\/h4>\n\n\n\n
                    \n
                  1. \u6301\u7530\u667a\u4e4b\uff0c\u4ee3\u7530\u60a0\u4e00\u90ce\uff0e\u7b2c4\u56de\u751f\u7406\u691c\u67fb\u6280\u8853\u30bb\u30df\u30ca\u30fc\u3000\u6ce2\u5f62\u30b8\u30a7\u30cd\u30ec\u30fc\u30bf\u306b\u3088\u308b\u7cbe\u5ea6\u7ba1\u7406\uff0e\u7b2c55\u56de\u65e5\u672c\u533b\u7642\u691c\u67fb\u79d1\u5b66\u4f1a\uff0e2023.10.6-8,\u6a2a\u6d5c<\/li>\n\n\n\n
                  2. \u6a2a\u5c71 \u96a3, \u68ee\u7530 \u8ce2\u53f2, \u4e2d\u53f8 \u6210, \u7530\u4e2d \u96c5\u7f8e, \u5c0f\u91ce \u4f73\u4e00, \u8535\u91ce \u4fe1, \u77e2\u51a8 \u88d5. \u7a7a\u80de\u5909\u6027\u5186\u67f1\u3092\u518d\u8003\u3059\u308b. \u814e\u30fb\u6ccc\u5c3f\u5668\u691c\u67fb\u7814\u7a76\u4f1a \u7b2c\uff11\uff18\u56de\u5b66\u8853\u96c6\u4f1a. 2023.3.4.<\/li>\n\n\n\n
                  3. \u6a2a\u5c71 \u96a3, \u68ee\u7530 \u8ce2\u53f2, \u4e45\u672b \u5d07\u53f8, \u4e2d\u53f8 \u6210, \u5c0f\u91ce \u4f73\u4e00, \u7530\u4e2d \u96c5\u7f8e, \u8535\u91ce \u4fe1. \u4e8c\u9805\u30ed\u30b8\u30b9\u30c6\u30a3\u30c3\u30af\u56de\u5e30\u5206\u6790\u3092\u7528\u3044\u305f\u7a7a\u80de\u5909\u6027\u5186\u67f1\u306e\u51fa\u73fe\u306b\u95a2\u9023\u3059\u308b\u56e0\u5b50\u306e\u63a2\u7d22. \u65e5\u672c\u533b\u7642\u691c\u67fb\u79d1\u5b66\u4f1a \u7b2c55\u56de\u5927\u4f1a. 2023.10.6-8.<\/li>\n\n\n\n
                  4. \u4e95\u4e0a \u7fd4\u592a, \u4e2d\u897f \u5f18\u6bc5, \u5ee3\u5ddd \u611b\u7f8e, \u9234\u6728 \u535a\u82f1, \u5c0f\u91ce \u4f73\u4e00, \u5927\u9580 \u96c5\u592b, \u8535\u91ce \u4fe1. Vector Flow Mapping\u3092\u7528\u3044\u305f\u80a5\u5927\u578b\u5fc3\u7b4b\u75c7\u306b\u304a\u3051\u308b\u5de6\u5ba4\u5185\u5727\u8f03\u5dee\u306e\u691c\u8a0e. \u7b2c70\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a. 2023.11.17-19.<\/li>\n\n\n\n
                  5. \u4e45\u7c73 \u5e78\u592b, \u5409\u5ddd \u76f4\u4e4b,\u5c0f\u91ce \u4f73\u4e00,\u8535\u91ce \u4fe1. \u30a4\u30ce\u30b7\u30f3\u3092\u5229\u7528\u3057\u305f\u65b0\u898f\u7cd6\u5c3f\u75c5\u95a2\u9023\u63a1\u8840\u7ba1\u306e\u958b\u767a. \u7b2c70\u56de\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a. 2023.11.16-19.<\/li>\n\n\n\n
                  6. \u4e2d\u6e21 \u4e00\u8cb4, \u5409\u5ddd \u76f4\u4e4b, \u5c0f\u91ce \u4f73\u4e00, \u8535\u91ce \u4fe1, \u98db\u7530 \u660e\u5b50. SCC\u6297\u539f\u6e2c\u5b9a\u306b\u304a\u3051\u308b\u8a66\u85ac\u9593\u5dee\u306b\u95a2\u3059\u308b\u691c\u8a0e\uff0dAIA-CL2400\u3092\u7528\u3044\u305f\u81ea\u5df1\u6297\u4f53\u691c\u51fa\u304a\u3088\u3073\u53c2\u8003\u57fa\u6e96\u7bc4\u56f2\u306e\u518d\u691c\u8a0e\uff0d. \u65e5\u672c\u533b\u7642\u691c\u67fb\u79d1\u5b66\u4f1a \u7b2c55\u56de\u5927\u4f1a\uff08\u8ad6\u6587\u8cde\u53d7\u8cde\u8b1b\u6f14\uff09. 2023.10.6-8.<\/li>\n\n\n\n
                  7. \u4e2d\u6e21 \u4e00\u8cb4, \u5409\u5ddd \u76f4\u4e4b, \u5c0f\u91ce \u4f73\u4e00, \u8535\u91ce \u4fe1, \u98db\u7530 \u660e\u5b50. \u5168\u81ea\u52d5\u5316\u5b66\u767a\u5149\u9175\u7d20\u514d\u75ab\u6e2c\u5b9a\u88c5\u7f6eAIA-CL1200\u3092\u7528\u3044\u305fIGF-1\u6e2c\u5b9a\u8a66\u85ac\u306e\u57fa\u790e\u7684\u691c\u8a0e. \u65e5\u672c\u533b\u7642\u691c\u67fb\u79d1\u5b66\u4f1a \u7b2c55\u56de\u5927\u4f1a\uff08\u4e00\u822c\u6f14\u984c\uff09. 2023.11.6-8.<\/li>\n\n\n\n
                  8. \u5c71\u7530 \u306f\u308b\u9999, \u67ff\u672c \u512a,\u79cb\u7530 \u840c,\u837b\u6fa4 \u6075\u7f8e,\u8597\u7530 \u7531\u8389,\u6301\u7530 \u667a\u4e4b,\u771e\ufa11 \u6842,\u570b\u4e95 \u5c1a\u4eba,\u4ee3\u7530 \u60a0\u4e00\u90ce. \u691c\u67fb\u5ba4\u8133\u6ce2\u306b\u304a\u3051\u308b\u767a\u4f5c\u6642\u5bfe\u5fdc\u7968\u306e\u4f5c\u6210\u3068\u6539\u5584\u306e\u53d6\u308a\u7d44\u307f. \u7b2c10\u56de\u5168\u56fd\u3066\u3093\u304b\u3093\u30bb\u30f3\u30bf\u30fc\u5354\u8b70\u4f1a\u7dcf\u4f1a. 2023.2.10-12.<\/li>\n\n\n\n
                  9. \u4f50\u85e4 \u96c5\u54c9. \u533b\u7642AI\u306b\u304a\u3051\u308b\u57fa\u790e. \u7b2c15\u56de\u690d\u8fbc\u307f\u30c7\u30d0\u30a4\u30b9\u5b66\u4f1a. 2023.2.24-26.<\/li>\n\n\n\n
                  10. \u4f50\u85e4 \u96c5\u54c9. \u6a5f\u68b0\u5b66\u7fd2\u30e2\u30c7\u30eb\u306b\u3088\u308b\u753b\u50cf\u3068\u8a3a\u7642\u60c5\u5831\u306e\u878d\u5408. \u7b2c79\u56de\u65e5\u672c\u653e\u5c04\u7dda\u6280\u8853\u5b66\u4f1a\u7dcf\u4f1a. 2023.4.13-16.<\/li>\n\n\n\n
                  11. \u4f50\u85e4 \u96c5\u54c9, \u85e4\u57ce \u5149\u5f18, \u5efa\u77f3 \u826f\u4ecb. Transformer\u3092\u7528\u3044\u305fSVR\u5f8c\u767a\u764c\u4e88\u6e2c\u30e2\u30c7\u30eb\u306e\u6709\u7528\u6027\u306e\u691c\u8a0e.\u7b2c59\u56de\u65e5\u672c\u809d\u81d3\u5b66\u4f1a\u7dcf\u4f1a. 2023.6.15-16.<\/li>\n\n\n\n
                  12. \u4f50\u85e4 \u96c5\u54c9, \u85e4\u57ce \u5149\u5f18, \u5efa\u77f3 \u826f\u4ecb. Transformer\u3092\u7528\u3044\u305f\u809d\u7d30\u80de\u764c\u30e9\u30b8\u30aa\u6ce2\u713c\u707c\u8853 (RFA)\u5f8c\u306e\u4e88\u5f8c\u4e88\u6e2c\u306e\u691c\u8a0e. \u7b2c59\u56de\u65e5\u672c\u809d\u764c\u7814\u7a76\u4f1a. 2023.7.27-28.<\/li>\n\n\n\n
                  13. \u4f50\u85e4 \u96c5\u54c9. \u81e8\u5e8a\u691c\u67fb\u3068AI. \u7b2c35\u56de\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a \u95a2\u6771\u30fb\u7532\u4fe1\u8d8a\u652f\u90e8\u7dcf\u4f1a. 2023.11.3.<\/li>\n\n\n\n
                  14. \u4f50\u85e4 \u96c5\u54c9. AI\u306b\u3088\u308b\u81e8\u5e8a\u691c\u67fb\u30c7\u30fc\u30bf\u306e\u7d71\u5408. \u7b2c70\u56de\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a. 2023.11.16-19.<\/li>\n\n\n\n
                  15. \u68ee\u7530 \u8ce2\u53f2, \u6a2a\u5c71 \u96a3, \u4e45\u672b \u5d07\u53f8, \u4e2d\u53f8 \u6210, \u5c0f\u91ce \u4f73\u4e00, \u7530\u4e2d \u96c5\u7f8e, \u8535\u91ce \u4fe1. UF-5000\u306eSmall RBC\u306f\u8d64\u8840\u7403\u5f62\u614b\u5206\u985e\u306b\u304a\u3044\u3066\u65b0\u305f\u306a\u6307\u6a19\u3068\u3057\u3066\u6709\u7528\u3067\u3042\u308b. \u7b2c55\u56de\u65e5\u672c\u533b\u7642\u691c\u67fb\u79d1\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a. 2023.10.6-8.<\/li>\n\n\n\n
                  16. \u68ee\u7530 \u8ce2\u53f2, \u5c0f\u91ce \u4f73\u4e00, \u8535\u91ce \u4fe1. \u30eb\u30fc\u30d7\u30b9\u814e\u708e\u306e\u75c5\u614b\u751f\u7406\u306b\u304a\u3051\u308b\u5c3f\u4e2d\u30ea\u30be\u30ea\u30f3\u8102\u8cea\u306e\u95a2\u9023\u6027. \u7b2c70\u56de\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a. 2023.11.16-19.<\/li>\n\n\n\n
                  17. \u7802\u91d1 \u79c0\u7ae0, Baasanjav Uranbileg, \u8535\u91ce \u4fe1. \u5bb6\u5ead\u3067\u5b9f\u65bd\u53ef\u80fd\u306a\u30a4\u30e0\u30ce\u30a2\u30c3\u30bb\u30a4\u306e\u305f\u3081\u306e\u5fae\u91cf\u8840\u6db2\u691c\u4f53\u30b5\u30f3\u30d7\u30ea\u30f3\u30b0\u6cd5\u53ca\u3073\u691c\u51fa\u6cd5\u306e\u57fa\u790e\u7684\u691c. \u7b2c70\u56de\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a. 2023.11.16-19.<\/li>\n\n\n\n
                  18. \u5c0f\u91ce \u4f73\u4e00. \u304c\u3093\u30b2\u30ce\u30e0\u30d7\u30ed\u30d5\u30a1\u30a4\u30ea\u30f3\u30b0\uff08CGP\uff09\u691c\u67fb\u306e \u9662\u5185\u5316\u306b\u5411\u3051\u305f\u53d6\u308a\u7d44\u307f\u3068\u8ab2\u984c. \u7b2c41\u56de\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u3000\u6771\u6d77\u30fb\u5317\u9678\u652f\u90e8\u4f8b\u4f1a\u3000\u6559\u80b2\u8b1b\u6f14. 2023.7.30.<\/li>\n\n\n\n
                  19. \u5c0f\u91ce \u4f73\u4e00. \u304c\u3093\u907a\u4f1d\u5b50\u30d1\u30cd\u30eb\uff08CGP\uff09\u691c\u67fb\u306e\u9662\u5185\u5316\uff08\u6280\u5e2b\u9577\u306e\u7acb\u5834\u304b\u3089\uff09\u3001 ISO\u306b\u3064\u3044\u3066. \u7b2c30\u56de\u65e5\u672c\u907a\u4f1d\u5b50\u8a3a\u7642\u5b66\u4f1a\u5927\u4f1a\u3000\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0. 2023.7.28-29.<\/li>\n\n\n\n
                  20. \u897f\u5ddd \u771f\u5b50. \u30d5\u30ed\u30fc\u30b5\u30a4\u30c8\u691c\u67fb\u3092\u6975\u3081\u308b\u305f\u3081\u306e\u521d\u5fc3\u8005\u8b1b\u5ea7\u3000\u81e8\u5e8a\u533b\u304c\u6c42\u3081\u308b\u30d5\u30ed\u30fc\u30b5\u30a4\u30c8\u691c\u67fb. \u7b2c24\u56de\u65e5\u672c\u691c\u67fb\u8840\u6db2\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a. 2023.7.29-30.<\/li>\n\n\n\n
                  21. \u897f\u5ddd \u771f\u5b50. JSTH\/APSTH Joint Symposium 2023, The landscape of circulating platelet aggregates in COVID-19. \u7b2c45\u56de\u65e5\u672c\u8840\u6813\u6b62\u8840\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a. 2023.6.15-17.<\/li>\n\n\n\n
                  22. \u897f\u5ddd \u771f\u5b50, \u5e38\u540d \u653f\u5f18, \u672c\u7530 \u6643, \u5c0f\u91ce \u4f73\u4e00, \u77e2\u51a8 \u88d5. \u81ea\u52d5\u8840\u7403\u8a08\u6570\u5668\u306e\u30b9\u30ad\u30e3\u30c3\u30bf\u30b0\u30e9\u30e0\u306e\u6709\u7528\u6027\u3000\u65e9\u671f\u8a3a\u65ad\u304c\u53ef\u80fd\u3068\u306a\u3063\u305f\u6025\u6027\u767d\u8840\u75c5\u306e\u4e00\u4f8b. \u7b2c98\u56de\u65e5\u672c\u533b\u7642\u6a5f\u5668\u5b66\u4f1a\u5927\u4f1a. 2023.6.29-7.1.<\/li>\n\n\n\n
                  23. \u897f\u5ddd \u771f\u5b50, \u5e38\u540d \u653f\u5f18, \u5c0f\u91ce \u4f73\u4e00, \u77e2\u51a8 \u88d5, \u8535\u91ce \u4fe1. COVID-19\u306b\u304a\u3051\u308b\u51dd\u8840\u5b66\u7684\u691c\u67fb\u9805\u76ee\u306e\u7db2\u7f85\u7684\u89e3\u6790. \u7b2c70\u56de\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a. 2023.11.16-19.<\/li>\n\n\n\n
                  24. \u897f\u5ddd \u771f\u5b50. \u907a\u4f1d\u5b50\u691c\u67fb\u306e\u57fa\u790e\u77e5\u8b58\u3000\u2010\u7a2e\u985e\u3068\u624b\u9806\u306e\u7406\u89e3\u306e\u30c4\u30dc\u2010. \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u5c02\u9580\u533b\u4f1a\u3000\u7b2c2\u56de\u5e74\u6b21\u5927\u4f1a. 2023.6.23-24.<\/li>\n\n\n\n
                  25. \u5b89\u5ddd \u6075\u5b50, \u5ddd\u53e3 \u667a\u4e5f, \u4f50\u85e4 \u96c5\u54c9, \u9752\u5c71 \u502b\u4e45, \u5c71\u5185 \u654f\u6b63, \u77e2\u51a8 \u88d5. \u8840\u4e2d\u9178\u5316\u578b\u30a2\u30eb\u30d6\u30df\u30f3\uff08HNA\uff09\u3068\u4ed6\u306e\u9178\u5316\u30b9\u30c8\u30ec\u30b9\u30de\u30fc\u30ab\u3068\u306e\u95a2\u9023 . \u7b2c63\u56de\u65e5\u672c\u81e8\u5e8a\u5316\u5b66\u4f1a. 2023.10. 27-29.<\/li>\n\n\n\n
                  26. \u4e2d\u897f \u5f18\u6bc5, \u4e2d\u5c3e \u502b\u5b50, \u5927\u9580 \u96c5\u592b, \u5c0f\u5ba4 \u4e00\u6210. Association of epicardial fat accumulation with coronary microcirculation, cardiac remodeling and cardiovascular outcomes. \u65e5\u672c\u5faa\u74b0\u5668\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a. 2023.3.10-12.<\/li>\n\n\n\n
                  27. \u4e2d\u897f \u5f18\u6bc5. \u5de6\u623f\u6a5f\u80fd\u306b\u5f71\u97ff\u3092\u53ca\u307c\u3059\u56e0\u5b50\u306f\u4f55\u304b. \u65e5\u672c\u5fc3\u81d3\u75c5\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a. 2023.9.8-10.<\/li>\n\n\n\n
                  28. \u4e2d\u897f \u5f18\u6bc5, \u5927\u9580 \u96c5\u592b, \u5ee3\u702c \u548c\u4fca, \u5409\u7530 \u7531\u7406\u5b50, \u77f3\u6e21 \u60c7\u5e73, \u4e2d\u5c3e \u502b\u5b50, \u68ee\u7530 \u5553\u884c, \u5c0f\u5ba4 \u4e00\u6210. \u6162\u6027\u51a0\u75c7\u5019\u7fa4\u60a3\u8005\u306b\u304a\u3051\u308b\u5de6\u623f\u6a5f\u80fd\u4f4e\u4e0b\u306e\u983b\u5ea6\u3068\u4e88\u5f8c\u306b\u4e0e\u3048\u308b\u5f71\u97ff. \u65e5\u672c\u5185\u79d1\u5b66\u4f1a\u7dcf\u4f1a. 2023.4.14-16.<\/li>\n\n\n\n
                  29. \u4e2d\u897f \u5f18\u6bc5, \u5ee3\u702c \u548c\u4fca, \u5ca9\u9593 \u5065\u592a\u90ce, \u5409\u7530 \u7531\u7406\u5b50, \u5411\u4e95 \u5eb7\u6d69, \u5c71\u672c \u88d5\u5b50, \u4e2d\u5c3e \u502b\u5b50, \u5927\u9580 \u96c5\u592b, \u5c0f\u5ba4 \u4e00\u6210. \u5fc3\u623f\u7d30\u52d5\u4f8b\u306b\u304a\u3051\u308b\u7cd6\u4ee3\u8b1d\u7570\u5e38\u304c\u5de6\u623f \u30ea\u30e2\u30c7\u30ea\u30f3\u30b0\u3068\u305d\u306e\u53ef\u9006\u6027\u306b\u4e0e\u3048\u308b\u5f71\u97ff. \u65e5\u672c\u8d85\u97f3\u6ce2\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a. 2023.5.27-29.<\/li>\n\n\n\n
                  30. \u9ad8\u6a4b \u5343\u7531\u7d00, \u5bfa\u5cf6 \u9053\u5b50, \u5e38\u540d \u653f\u5f18, \u5c0f\u91ce \u4f73\u4e00, \u897f\u5ddd \u771f\u5b50, \u672c\u7530 \u6643, \u9ed2\u5ddd \u5cf0\u592b, \u77e2\u51a8 \u88d5. \u771f\u6027\u8d64\u8840\u7403\u5897\u52a0\u75c7\u306e\u6cbb\u7642\u4e2d\u306bAML-M6\u3092\u767a\u75c7\u3057\u305f\u4e00\u75c7\u4f8b. \u7b2c24\u56de\u65e5\u672c\u691c\u67fb\u8840\u6db2\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a. 2023.7.29-30.<\/li>\n\n\n\n
                  31. \u6e21\u908a \u5e83\u7950. CGP\u691c\u67fb\u306e\u9662\u5185\u5b9f\u65bd\u3068\u54c1\u8cea\u5411\u4e0a\u306b\u5411\u3051\u305f\u75c5\u9662\u691c\u67fb\u5ba4\u306e\u5f79\u5272. \u7b2c70\u56de\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a. 2023.11.16-19.<\/li>\n\n\n\n
                  32. \u5bae\u8107 \u7dbe, \u5bfa\u5cf6 \u9053\u5b50, \u5e38\u540d \u653f\u5f18, \u5c0f\u91ce \u4f73\u4e00, \u897f\u5ddd \u771f\u5b50, \u4e95\u4e0a \u79c0\u592a\u90ce, \u65e5\u9ad8 \u3082\u3048, \u52a0\u85e4 \u5143\u535a, \u77e2\u51a8 \u88d5. \u30e6\u30fc\u30a4\u30f3\u30b0\u8089\u816b\u306e\u9aa8\u9ac4\u6d78\u6f64\u3092\u8a8d\u3081\u305f\u4e00\u4f8b. \u7b2c24\u56de\u65e5\u672c\u691c\u67fb\u8840\u6db2\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a. 2023.7.29-30.<\/li>\n\n\n\n
                  33. \u5b89\u5ddd \u6075\u5b50. \u30a2\u30eb\u30d6\u30df\u30f3\u306e\u7cd6\u5316\u3068\u9178\u5316\u3001HPLC\u5206\u6790\u304b\u3089\u65e5\u5e38\u81e8\u5e8a\u3078\u306e\u5fdc\u7528. \u7b2c 387 \u56de\u6db2\u4f53\u30af\u30ed\u30de\u30c8\u30b0\u30e9\u30d5\u30a3\u30fc\u7814\u7a76\u61c7\u8ac7\u4f1a. 2023.<\/li>\n\n\n\n
                  34. \u4f50\u85e4 \u78e8\u5b9f\u5b50, \u5c0f\u6797 \u7389\u5b9c, \u5ddd\u5d8b \u4e45\u96c4, \u6de1\u8def \u5065\u592a\u90ce, \u5c3e\u677e \u6df3, \u6c38\u4e95 \u5e78\u53f8\u90ce, \u5bae\u5ddd \u5353\u4e5f, \u4f50\u85e4 \u96c5\u54c9, \u5c0f\u91ce \u4f73\u4e00, \u77e2\u51a8 \u88d5. \u9686\u8d77\u6027\u76ae\u819a\u7dda\u7dad\u8089\u816b\u306e\u8702\u5de3\u69d8\u69cb\u9020\u306f\u8d85\u97f3\u6ce2\u3067\u89b3\u5bdf\u53ef\u80fd\u304b-\u9ad8\u5468\u6ce2\u50cf\u3068\u75c5\u7406\u7d44\u7e54\u50cf\u306e\u6bd4\u8f03-. \u65e5\u672c\u8d85\u97f3\u6ce2\u533b\u5b66\u4f1a\u7b2c96\u56de\u5b66\u8853\u96c6\u4f1a. 2023.5.27-29.<\/li>\n\n\n\n
                  35. \u4f50\u85e4 \u78e8\u5b9f\u5b50, \u5b89\u6c38 \u611b, \u4f50\u85e4 \u60a0\u4f51, \u7530\u4e2d \u9ebb\u7406\u5b50, \u5f8c\u85e4 \u5bdb\u662d, \u5ca9\u4e95 \u53cb\u7f8e, \u9234\u6728 \u535a\u82f1, \u4f50\u85e4 \u96c5\u54c9, \u5c0f\u91ce \u4f73\u4e00, \u77e2\u51a8 \u88d5. \u8d85\u97f3\u6ce2\u691c\u67fb\u306b\u3066\u9451\u5225\u53ef\u80fd\u3067\u3042\u3063\u305f\u53f3\u814e \u60aa\u6027\u30ea\u30f3\u30d1\u816b \u3068\u5de6\u814e \u814e\u7d30\u80de\u764c\u306e1\u4f8b. \u65e5\u672c\u8d85\u97f3\u6ce2\u533b\u5b66\u4f1a\u7b2c96\u56de\u5b66\u8853\u96c6\u4f1a. 2023.5.27-29.<\/li>\n<\/ol>\n\n\n\n

                    \u82f1\u6587\u7dcf\u8aac\uff1aEnglish Review Articles<\/h4>\n\n\n\n

                    \u56fd\u969b\u5b66\u4f1a\u767a\u8868\uff1aInternational Conference Presentation<\/h4>\n\n\n\n

                    \u548c\u6587\u539f\u8457\u8ad6\u6587\uff1aJapanese Original Articles<\/h4>\n\n\n\n
                      \n
                    1. \u77f3\u539f \u6709\u7406 , \u4fdd\u7530 \u5948\u7dd2\u7f8e, \u5409\u5ddd \u76f4\u4e4b, \u5c0f\u91ce \u4f73\u4e00, \u8535\u91ce \u4fe1. \u6297\u30b9\u30c8\u30ec\u30d7\u30c8\u30a2\u30d3\u30b8\u30f3\u6297\u4f53\u306e\u5f71\u97ff\u3092\u56de\u907f\u3059\u308b\u65b0\u898f\u6297Sm\u6297\u4f53\u691c\u67fb\u8a66\u85ac\u306e\u57fa\u790e\u7684\u6027\u80fd\u8a55\u4fa1. \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u8a8c 71(11): 757-762, 2023.<\/li>\n<\/ol>\n\n\n\n

                      \u548c\u6587\u7dcf\u8aac\uff1aJapanese Review Articles<\/h4>\n\n\n\n
                        \n
                      1. \u68ee\u7530 \u8ce2\u53f2, \u8535\u91ce \u4fe1, \u77e2\u51a8 \u88d5.LC-MS\/MS\u3092\u7528\u3044\u305f\u30bb\u30e9\u30df\u30c9\u6e2c\u5b9a\u7cfb\u306e\u4e00\u822c\u691c\u67fb\u9818\u57df\u3078\u306e\u5fdc\u7528. \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u8a8c 71: 599-602, 2023.<\/li>\n\n\n\n
                      2. \u4e95\u4e0a \u7fd4\u592a, \u9234\u6728 \u535a\u82f1. LVAD\u690d\u8fbc\u307f\u5f8c\u306e\u5fc3\u30a8\u30b3\u30fc\u306f\u3053\u3053\u3092\u898b\u308b. \u5fc3\u30a8\u30b3\u30fc 24: 196-201, 2023.<\/li>\n\n\n\n
                      3. \u4f50\u85e4 \u96c5\u54c9. \u6162\u6027\u809d\u708e\u30fb\u809d\u786c\u5909\u306b\u307e\u3064\u308f\u308b\u75c5\u6c17\u3001\u75c7\u72b6\u306f?\uff5e\u6162\u6027\u809d\u708e\u30fb\u809d\u786c\u5909\u3067\u5165\u9662\u3057\u3066\u304f\u308b\u60a3\u8005\u3055\u3093\u306f\u3053\u3093\u306a\u75c7\u72b6\u3067\u56f0\u3063\u3066\u3044\u308b\uff5e\u3000\u809d\u81d3\u304c\u3093. \u6d88\u5316\u5668\u30ca\u30fc\u30b7\u30f3\u30b0 56-64, 2023.<\/li>\n\n\n\n
                      4. \u68ee\u7530 \u8ce2\u53f2. \u5c3f\u6c88\u6e23\u691c\u67fb\u304b\u3089\u306e\u75c5\u614b\u63a8\u6e2c\u3068\u8a3a\u7642\u3078\u306e\u30a2\u30d7\u30ed\u30fc\u30c1 2. 4\uff09\u7570\u5e38\u7d50\u6676. Medical Technology 51: 1234-1238, 2023.<\/li>\n\n\n\n
                      5. \u68ee\u7530 \u8ce2\u53f2. \u5c3f\u4e2d\u6709\u5f62\u6210\u5206\u5206\u6790\u88c5\u7f6e\uff1a\u30d5\u30ed\u30fc\u30b5\u30a4\u30c8\u30e1\u30c8\u30ea\u30fc\u6cd5\u3068\u753b\u50cf\u89e3\u6790\u6cd5\u306e\u6bd4\u8f03\u3092\u4e2d\u5fc3\u306b. \u691c\u67fb\u3068\u6280\u8853 51:1240-1244, 2023.<\/li>\n\n\n\n
                      6. \u897f\u5ddd \u771f\u5b50, \u77e2\u51a8 \u88d5. \u81e8\u5e8a\u691c\u67fb\u30c7\u30fc\u30bf\u89e3\u91c8\u306e\u57fa\u672c\u3068\u30d4\u30c3\u30c8\u30d5\u30a9\u30fc\u30eb. \u81e8\u7240\u3068\u7814\u7a76 100: 139-143, 2023.<\/li>\n\n\n\n
                      7. \u897f\u5ddd \u771f\u5b50. COVID-19\u306b\u304a\u3051\u308b\u5faa\u74b0\u8840\u5c0f\u677f\u51dd\u96c6\u584a\u306e\u89e3\u6790. \u65e5\u672c\u8840\u6813\u6b62\u8840\u5b66\u4f1a\u8a8c 34: 488-493, 2023.<\/li>\n\n\n\n
                      8. \u6e21\u908a \u5e83\u7950. \u5c0f\u7d30\u80de\u80ba\u764c\u3001\u8a3a\u65ad\u3068\u6cbb\u7642\u306e\u6700\u524d\u7dda. SRL\u5b9d\u51fd 43(4) 12-18, 2023.<\/li>\n\n\n\n
                      9. \u6e21\u908a \u5e83\u7950. FOCUS \u975e\u5c0f\u7d30\u80de\u80ba\u304c\u3093 \u85ac\u7269\u6cbb\u7642\u306e\u52d5\u5411\u3068\u907a\u4f1d\u5b50\u691c\u67fb\u306e\u610f\u7fa9. \u691c\u67fb\u3068\u6280\u8853 51(4) 472-474, 2023.<\/li>\n<\/ol>\n\n\n\n

                        \u548c\u6587\u8457\u66f8\uff1aJapanese Book Chapter<\/h4>\n\n\n\n
                          \n
                        1. \u4f50\u85e4 \u96c5\u54c9. \u809d\u816b\u760d \u6a5f\u68b0\u5b66\u7fd2\u306b\u3088\u308b\u809d\u764c\u8a3a\u65ad. \u809d\u75be\u60a3 \u81e8\u5e8a\u691c\u67fb\u3067\u3069\u3046\u8feb\u308b? 1190-1195. \u533b\u5b66\u66f8\u9662, 2023.<\/li>\n\n\n\n
                        2. \u4f50\u85e4 \u96c5\u54c9. MNASH\u306e\u975e\u85ac\u7269\u7642\u6cd5\u3068\u3057\u3066\u306e\u6cbb\u7642\u7528\u30a2\u30d7\u30ea. Medical Practice 1402-1404. \u6587\u5149\u5802, 2023.<\/li>\n\n\n\n
                        3. \u4f50\u85e4 \u96c5\u54c9. \u6cbb\u7642\u7528\u30a2\u30d7\u30ea\u306b\u3088\u308bNASH\u306e\u30c7\u30b8\u30bf\u30eb\u7642\u6cd5\u5b9f\u7528\u5316\u306e\u8a66\u307f. \u65b0\u533b\u7642 88-91. \u30a8\u30e0\u30a4\u30fc\u632f\u8208\u5354\u4f1a, 2023.<\/li>\n\n\n\n
                        4. \u4f50\u85e4 \u96c5\u54c9. \u30d3\u30ea\u30eb\u30d3\u30f3\u4ee3\u8b1d\u3068\u9ec4\u75b8\u306e\u767a\u75c7\u6a5f\u5e8f. \u81e8\u5e8a\u6d88\u5316\u5668\u5185\u79d1 247-252. \u65e5\u672c\u30e1\u30c7\u30a3\u30ab\u30eb\u30bb\u30f3\u30bf\u30fc, 2023.<\/li>\n\n\n\n
                        5. \u5c0f\u91ce \u4f73\u4e00. \u6301\u7d9a\u76ae\u4e0b\u30b0\u30eb\u30b3\u30fc\u30b9\u691c\u67fb\uff08CGM\uff09. \u691c\u67fb\u3068\u6280\u8853 \u691c\u67fb\u3068\u6280\u8853 50\u5dfb 12\u53f7 pp. 1321-1328. \u533b\u5b66\u66f8\u9662, 2022.<\/li>\n\n\n\n
                        6. \u897f\u5ddd \u771f\u5b50. 4\u7ae0\u3000\u672b\u68a2\u8840\u6db2\u691c\u67fb\uff0c5\u7ae0\u3000\u9aa8\u9ac4\u691c\u67fb\uff0c6\u7ae0\u3000\u9020\u8840\u5668\u816b\u760d\u95a2\u9023\u691c\u67fb. \u4eca\u65e5\u306e\u81e8\u5e8a\u691c\u67fb2023-2024 pp. 55-87. \u5357\u6c5f\u5802, 2023.<\/li>\n\n\n\n
                        7. \u5c0f\u91ce \u4f73\u4e00. \u4e8c\u7d1a\u30fb\u4e00\u7d1a\u81e8\u5e8a\u691c\u67fb\u58eb\u8cc7\u683c\u53d6\u5f97\u3068\u535a\u58eb\u53f7\u53d6\u5f97\u305d\u3057\u3066\u6280\u5e2b\u9577\u306b. \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u8a8c 71\uff1a5, 301-305, 2023<\/li>\n<\/ol>\n\n\n\n

                          \u548c\u6587\u7de8\u8457\u7b49\uff1aJapanese Book Editing<\/h4>\n<\/div><\/div>\n\n\n\n
                          \n

                          2022\u5e74<\/h3>\n\n\n\n

                          \u82f1\u6587\u539f\u8457\u8ad6\u6587\uff1aEnglish Original Articles<\/h4>\n\n\n\n
                            \n
                          1. Addetia, K., Miyoshi, T., Amuthan, V., Citro, R., Daimon, M., Fajardo, P.G., Kasliwal, R.R., Kirkpatrick, J.N., Monaghan, M.J., Muraru, D., Ogunyankin, K.O., Park, S.W., Ronderos, R.E., Sadeghpour, A., Scalia, G.M., Takeuchi, M., Tsang, W., Tucay, E.S., Tude Rodrigues, A.C., Zhang, Y., Hitschrich, N., Blankenhagen, M., Degel, M., Schreckenberg, M., Mor-Avi, V., Asch, F.M., and Lang, R.M. Normal values of left ventricular size and function on 3D echocardiography: Results of the World Alliance of Societies of Echocardiography Study. J. Am. Soc. Echocardiogr.<\/em><\/strong> 35: 449-459<\/a>, 2022.<\/li>\n\n\n\n
                          2. Bujo, S., Amiya, E., Hashimoto Maeda, M., Ishida, J., Hatano, M., Ishizuka, M., Uehara, M., Oshima, T., Kojima, T., Nakanishi, K., Daimon, M., Shimizu, J., Toda, T., and Komuro, I. The effect of immunosuppressive therapy on cardiac involvements in anti-mitochondrial antibody-positive myositis. ESC Heart Fail.<\/strong><\/em> 9: 4112-4119<\/a>, 2022.<\/li>\n\n\n\n
                          3. Chaichuum, S., Chiang, S.J., Daimon, M., Chang, S.C., Chan, C.L., Hsu, C.Y., Chen, H.H., and Tseng, C.L. Segmental tissue speckle tracking predicts the stenosis severity in patients with coronary artery disease. Front. Cardiovasc. Med. <\/em><\/strong>8: 832096<\/a>, 2022.<\/li>\n\n\n\n
                          4. Edamura, T., Sumitani, M., Hayakawa, K., Inoue, R., Abe, H., Tsuchida, R., Chikuda, H., Ogata, T., Kurano, M., Aoki, J., Yatomi, Y., and Uchida, K. Different Profiles of the Triad of Lysophosphatidylcholine, Lysophosphatidic Acid, and Autotaxin in Patients with Neuropathic Pain Diseases: a Preliminary Observational Study. Pain Ther.<\/em><\/strong> 11: 1439-1449<\/a>, 2022.<\/li>\n\n\n\n
                          5. Fujikura, Y., Kimura, K., Yamanouchi, K., Sugihara, H., Hatakeyama, M., Zhuang, H., Daimon, M., Morita, H., Komuro, I., and Oishi, K. A medium-chain triglyceride containing ketogenic diet exacerbates cardiomyopathy in a CRISPR\/Cas9 gene-edited rat model with Duchenne muscular dystrophy. Sci. Rep.<\/em><\/strong> 12: 11580<\/a>, 2022.<\/li>\n\n\n\n
                          6. Henry, M.P., Cotella, J., Mor-Avi, V., Addetia, K., Miyoshi, T., Schreckenberg, M., Blankenhagen, M., Hitschrich, N., Amuthan, V., Citro, R., Daimon, M., Gutie\u00b4rrez-Fajardo P., Kasliwal, R., Kirkpatrick, J.N., Monaghan, M.J., Muraru, D., Ogunyankin, K.O., Park, S.W., Tude Rodrigues, A.C., Ronderos, R., Sadeghpour, A., Scalia, G., Takeuchi, M., Tsang, W., Tucay, E.S., Zhang, M., Lang, R.M., and Asch, F.M. 3D transthoracic static and dynamic normative values of the mitral valve apparatus: Results from the multicenter World Alliance of Societies of Echocardiography Study. J. Am. Soc. Echocardiogr.<\/em><\/strong> 35: 738-751<\/a>, 2022.<\/li>\n\n\n\n
                          7. Inoue, S., Nakao, T., Kinoshita, O., Suzuki, H., Yatomi, Y., and Daimon, M. Preoperative diagnosis of acute aortic regurgitation caused by a ruptured anomalous cord in a patient with a bicuspid aortic valve using transesophageal echocardiography. J. Med. Ultrason.(2001)<\/em><\/strong> 49: 493-494<\/a>, 2022.<\/li>\n\n\n\n
                          8. Jubishi, D., Okamoto, K., Hamada, K., Ishii, T., Hashimoto, H., Shinohara, T., Yamashita, M., Wakimoto, Y., Otani, A., Hisasue, N., Ikeda, M., Harada, S., Okugawa, S., Moriya, K., and Yanagimoto, S. The association between adverse reactions and immune response against SARS-CoV-2 spike protein after vaccination with BNT162b2 among healthcare workers in a single healthcare system: a prospective observational cohort study. Hum. Vaccin. Immunother.<\/strong><\/em> 18: 2048559<\/a>, 2022.<\/li>\n\n\n\n
                          9. Kaiume, M., Kurokawa, M., Maeda, E., Daimon, M., and Abe, O. Detection of Left Ventricular Dysfunction on Axial Non-Contrast Chest CT. Eur. J. Radiol.<\/strong> 150: 110274<\/a>, 2022.<\/li>\n\n\n\n
                          10. Kashiwakura, Y., Baatartsogt, N., Yamazaki, S., Nagao, A., Amano, K., Suzuki, N., Matsushita, T., Sawada, A., Higasa, S., Yamasaki, N., Fujii, T., Ogura, T., Takedani, H., Taki, M., Matsumoto, T., Yamanouchi, J., Sakai, M., Nishikawa, M., Yatomi, Y., Yada, K., Nogami, K., Watano, R., Hiramoto, T., Hayakawa, M., Kamoshita, N., Kume, A., Mizukami, H., Ishikawa, S., Sakata, Y., Ohmori, T. The seroprevalence of neutralizing antibodies against the adeno-associated virus capsids in Japanese hemophiliacs. Mol Ther Methods Clin Dev.<\/em><\/strong> 27: 404-414<\/a>, 2022.<\/li>\n\n\n\n
                          11. Kawata, T., Daimon, M., Nakanishi, K., Kimura, K., Sawada, N., Nakao, T., Hirokawa, M., Ishiwata, J., Takeda, N., Yatomi, Y., and Komuro I. Factors influencing inferior vena cava diameter and its respiratory variation: Simultaneous comparison with hemodynamic data. J. Cardiol.<\/strong><\/em> 79: 642-647<\/a>, 2022.<\/li>\n\n\n\n
                          12. Kokubo, T., Kodera, S., Sawano, S., Katsushika, S., Nakamoto, M., Takeuchi, H., Kimura, N., Shinohara, H., Matsuoka, R., Nakanishi, K., Nakao, T., Higashikuni, Y., Takeda, N., Fujiu, K., Daimon, M., Akazawa, H., Morita, H., Matsuyama, Y., and Komuro, I. Automatic Detection of Left Ventricular Dilatation and Hypertrophy from Electrocardiograms using Deep Learning. Int Heart J.<\/em><\/strong> 63: 939-947<\/a>, 2022.<\/li>\n\n\n\n
                          13. Kurano, M., Jubishi, D., Okamoto, K., Hashimoto, H., Sakai, E., Morita, Y., Saigusa, D., Kano, K., Aoki, J., Harada, S., Okugawa, S., Doi, K., Moriya, K., and Yatomi, Y. Dynamic modulations of urinary sphingolipid and glycerophospholipid levels in COVID-19 and correlations with COVID-19-associated kidney injuries. J. Biomed Sci.<\/em><\/strong> 29: 94<\/a>, 2022.<\/li>\n\n\n\n
                          14. Kurano, M., Morita, Y., Nakano, Y., Yokoyama, R., Shimura, T., Qian, C., Xia, F., He, F., Zheng, L., Ohmiya, H., Kishi, Y., Okada, J., Yoshikawa, N., Nakajima, K., Nagura, Y., Okazaki, H., Jubishi, D., Moriya, K., Seto, Y., Yasui, F., Kohara, M., Wakui, M., Kawamura, T., Kodama, T., and Yatomi, Y. Response kinetics of different classes of antibodies to SARS-CoV2 infection in the Japanese population: The IgA and IgG titers increased earlier than the IgM titers. Int. Immunopharmacol.<\/strong><\/em> 103: 108491<\/a>, 2022.<\/li>\n\n\n\n
                          15. Kurano, M., Ohmiya, H., Kishi, Y., Okada, J., Nakano, Y., Yokoyama, R., Qian, C., Xia, F., He, F., Zheng, L., Yu, Y., Jubishi, D., Okamoto, K., Moriya, K., Kodama, T., and Yatomi, Y.Measurement of SARS-CoV-2 Antibody Titers Improves the Prediction Accuracy of COVID-19 Maximum Severity by Machine Learning in Non-Vaccinated Patients. Front. Immunol.<\/strong><\/em> 13: 811952<\/a>, 2022.<\/li>\n\n\n\n
                          16. Kurano, M., Okamoto, K., Jubishi, D., Hashimoto, H., Sakai, E., Saigusa, D., Kano, K., Aoki, J., Harada, S., Okugawa, S., Doi, K., Moriya, K., and Yatomi Y. Dynamic modulations of sphingolipids and glycerophospholipids in COVID-19. Clin. Transl. Med.<\/strong><\/em> 12: e1069<\/a>, 2022.<\/li>\n\n\n\n
                          17. Kurano, M., Saito, Y., Uranbileg, B., Saigusa, D., Kano, K., Aoki, J., and Yatomi, Y. Modulations of bioactive lipids and their receptors in postmortem Alzheimer’s disease brains. Front. Aging. Neurosci.<\/em><\/strong> 14: 1066578<\/a>, 2022.<\/li>\n\n\n\n
                          18. Kurano, M., Sakai, E., and Yatomi, Y. Understanding modulations of lipid mediators in cancer using a murine model of carcinomatous peritonitis. Cancer Med.<\/strong><\/em>11: 3491-3507<\/a>, 2022.<\/li>\n\n\n\n
                          19. Kurano, M., Tsukamoto, K., Sakai, E., Hara, M., and Yatomi Y. Isoform-Dependent Effects of Apolipoprotein E on Sphingolipid Metabolism in Neural Cells. J. Alzheimers Dis.<\/em><\/strong> 85: 1529-1544<\/a>, 2022.<\/li>\n\n\n\n
                          20. Kurano, M., Tsukamoto, K., Sakai, E., and Yatomi, Y. Differences in the Distribution of Ceramides and Sphingosine among Lipoprotein and Lipoprotein-Depleted Fractions in Patients with Type 2 Diabetes Mellitus. J. Atheroscler Thromb.<\/em><\/strong>29: 1727-1758<\/a>, 2022.<\/li>\n\n\n\n
                          21. Kusumoto, Y., Sato, M., Ikeda, H., Yasukawa, K., Tang, X., and Yatomi, Y. Redox state as assessed using the measurement of human non-mercaptalbumin in embryo culture media is associated with successful embryo development in human in vitro fertilization. J. Clin. Biochem. Nutr.<\/em><\/strong> 71: 69-72<\/a>, 2022.<\/li>\n\n\n\n
                          22. Liu, Y., Yamagishi, R., Honjo, M., Kurano, M., Yatomi, Y., Igarashi, K., and Aihara, M. Role of Autotaxin in High Glucose-Induced Human ARPE-19 Cells. Int. J. Mol. Sci.<\/em><\/strong> 23: 9181<\/a>, 2022.<\/li>\n\n\n\n
                          23. Liu, M., Honjo, M., Yamagishi, R., Igarashi, N., Nakamura, N., Kurano, M., Yatomi, Y., Igarashi, K., and Aihara, M. Fibrotic Response of Human Trabecular Meshwork Cells to Transforming Growth Factor-Beta 3 and Autotaxin in Aqueous Humor. Biomolecules.<\/em><\/strong> 12: 1231<\/a>, 2022.<\/li>\n\n\n\n
                          24. Mietani, K., Hasegawa-Moriyama, M., Inoue, R., Ogata, T., Shimojo, N., Kurano, M., Yatomi, Y., Uchida, K., and Sumitani, M. Serum levels of apolipoprotein A-I and E are associated with postoperative delirium: A post hoc analysis. Medicine (Baltimore)<\/em><\/strong> 101: e29906<\/a>, 2022.<\/li>\n\n\n\n
                          25. Mitani, A., Horie, T., Yokoyama, R., Nakano, Y., Hamada, K., Inoue, Y., Saito, M., Ishii, T., Sunohara, M., Takahashi, R., Usui, T., Emoto, N., Nishimoto, N., Murano, Y., Okazaki, S., Tateishi, S., Iwasawa, K., Yao, A., Kurano, M., Yatomi, Y., and Yanagimoto, S. Interpretations of SARS-CoV-2 IgM and IgG antibody titers in the seroepidemiological study of asymptomatic healthy volunteers. J. Infect. Chemother.<\/strong><\/em> 28: 266-272<\/a>, 2022.<\/li>\n\n\n\n
                          26. Miyamoto, S., Yamazaki, T., Shimizu, K., Matsubara, T., Kage, H., Watanabe, K., Kobo, H., Matsuyama, Y., Rodin, G., and Yoshiuchi, K. Brief, manualised and semistructured individual psychotherapy programme for patients with advanced cancer in Japan: study protocol for Managing Cancer and Living Meaningfully (CALM) phase 2 trial. BMJ Open.<\/em><\/strong> 12: e056136<\/a>, 2022.<\/li>\n\n\n\n
                          27. Morita, Y., Kurano, M., Jubishi, D., Ikeda, M., Okamoto, K., Tanaka, M., Harada, S., Okugawa, S., Moriya, K., Yatomi, Y. Urine sediment findings were milder in patients with COVID-19-associated renal injuries than in those with non-COVID-19-associated renal injuries. Int. J. Infect. Dis.<\/em><\/strong> 117: 302-311<\/a>, 2022.<\/li>\n\n\n\n
                          28. Mukai, Y., Nakanishi, K., Daimon, M., Sawada, N., Hirose, K., Iwama, K., Yamamoto, Y., Yoshida, Y., Ishiwata, J., Koyama, K., Nakao, T., Morita, H., Di Tullio, M.R., Homma, S., and Komuro, I. Association of arterial properties with left ventricular morphology and function in the community. J. Hypertens.<\/em><\/strong> 40: 2423-2429<\/a>, 2022.<\/li>\n\n\n\n
                          29. Murakami, K., Tamada, T., Saigusa, D., Miyauchi, E., Nara, M., Ichinose, M., Kurano, M., Yatomi, Y., and Sugiura, H. Urine autotaxin levels reflect the disease activity of sarcoidosis. Sci. Rep.<\/em><\/strong> 12: 4372<\/a>, 2022.<\/li>\n\n\n\n
                          30. Nakanishi, K., Daimon, M., Yoshida, Y., Ishiwata, J., Sawada, N., Hirokawa, M., Kaneko, H., Nakao, T., Mizuno, Y., Morita, H., Di Tullio, M.R., Homma, S., and Komuro, I. Blood pressure categorization and subclinical left ventricular dysfunction in antihypertensive medication\u2010naive subjects. ESC Heart Fail.<\/em><\/strong> 9: 1766-1774<\/a>, 2022.<\/li>\n\n\n\n
                          31. Naito, Y., Sunami, K., Kage, H., Komine, K., Amano, T., Imai, M., Koyama, T., Ennishi, D., Kanai, M., Kenmotsu, H., Maeda, T., Morita, S., Sakai, D., Watanabe, K., Shirota, H., Kinoshita, I., Yoshioka, M., Mamesaya, N., Ito, M., Kohsaka, S., Saigusa, Y., Yamamoto, K., Hirata, M., Tsuchihara, K., and Yoshino, T. Concordance Between Recommendations From Multidisciplinary Molecular Tumor Boards and Central Consensus for Cancer Treatment in Japan. JAMA Netw Open.<\/em><\/strong> 5: e2245081<\/a>, 2022.<\/li>\n\n\n\n
                          32. Sato, M., Kobayashi, T., Soroida, Y., Tanaka, T., Nakatsuka, T., Nakagawa, H., Nakamura, A., Kurihara, M., Endo, M., Hikita, H., Sato, M., Gotoh, H., Iwai, T., Tateishi, R., Koike, K., and Yatomi, Y. Development of novel deep multimodal representation learning-based model for the differentiation of liver tumors on B-mode ultrasound images. J. Gastroenterol Hepatol. <\/strong><\/em>37: 678-684<\/a>, Press Release.<\/a><\/li>\n\n\n\n
                          33. Shimura, T., Kurano, M., Okamoto, K., Jubishi, D., Hashimoto, H., Kano, K., Igarashi, K., Shimamoto, S., Aoki, J., Moriya, K., and Yatomi Y. Decrease in serum levels of autotaxin in COVID-19 patients. Ann. Med.<\/em><\/strong> 54: 3189-3200<\/a>, 2022.<\/li>\n\n\n\n
                          34. Tada, S., Yasukawa, K., Yatomi, Y., and Uchiki, T. A simple colorimetric assay to determine the concentration and proportion of human mercaptalbumin. Pract. Lab. Med.<\/em><\/strong> 31: e00281<\/a>, 2022.<\/li>\n\n\n\n
                          35. Takano, H., Yasunaga, M., Yamazaki, I., Nishikawa, M., Masamoto, Y., Shinozaki-Ushiku, A., Kawakami, M., Yatomi, Y., and Kurokawa, M. Degenerated mitochondria in leukemic blast appeared as granules on May-Grunwald-Giemsa staining. Ann. Hematol. 101: 1135-1136<\/a>, 2022.<\/li>\n\n\n\n
                          36. Tokuoka, S.M., Kita, Y., Sato, M., Shimizu, T., Yatomi, Y., and Oda, Y. Lipid Profiles of Human Serum Fractions Enhanced with CD9 Antibody-Immobilized Magnetic Beads. Metabolites.<\/em><\/strong> 12: 230<\/a>, 2022.<\/li>\n\n\n\n
                          37. Tsuchida, Y., Shoda, H., Nakano, M., Ota, M., Okamura, T., Yamamoto, K., Kurano, M., Yatomi, Y., Fujio, K., and Sawada, T. Autotaxin is a potential link between genetic risk factors and immunological disturbances of plasmacytoid dendritic cells in systematic lupus erythematosus. Lupus.<\/em><\/strong> 31: 1578-1585<\/a>, 2022.<\/li>\n\n\n\n
                          38. Uranbileg, B., Kurano, M., Kano, K., Sakai, E., Arita, J., Hasegawa, K., Nishikawa, T., Ishihara, S., Yamashita, H., Seto, Y., Ikeda, H., Aoki, J., and Yatomi Y. Sphingosine 1-phosphate lyase facilitates cancer progression through converting sphingolipids to glycerophospholipids. Clin. Transl. Med.<\/em><\/strong> 12: e1056<\/a>, 2022.<\/li>\n\n\n\n
                          39. Yamamoto, Y., Kiriyama, H., Daimon, M., Mori, Y., Yamauchi, H., Miura, M., and Komuro, I. Esophageal hematoma associated with transesophageal echocardiography during transcatheter aortic valve replacement in an elderly Japanese woman. J. Med. Ultrason (2001)<\/em><\/strong>. 49: 481-483<\/a>, 202.<\/li>\n\n\n\n
                          40. Yamamoto, Y., Daimon, M., Nakanishi, K., Nakao, T., Hirokawa, M., Ishiwata, J., Kiriyama, H., Yoshida, Y., Iwama, K., Hirose, K., Mukai, Y., Takeda, N., Yatomi, Y., and Komuro, I. Incidence of atrial functional tricuspid regurgitation and its correlation with tricuspid valvular deformation in patients with persistent atrial fibrillation. Front. Cardiovasc. Med.<\/em><\/strong> 9: 1023732<\/a>, 2022.<\/li>\n\n\n\n
                          41. Yasuda, N., Nishikawa, M., Shimosaka, H., Ono, Y., and Yatomi, Y. Effect of administration of immunoglobulin preparations on the results of tests for autoantibodies. Mod. Rheumatol.<\/em><\/strong> 32: 946-952<\/a>, 2022.<\/li>\n\n\n\n
                          42. Yoshioka, K., Hirakawa, Y., Kurano, M., Ube, Y., Ono, Y., Kojima, K., Iwama, T., Kano, K., Hasegawa, S., Inoue, T., Shimada, T., Aoki, J., Yatomi, Y., Nangaku, M., and Inagi, R. Lysophosphatidylcholine mediates fast decline in kidney function in diabetic kidney disease. Kidney Int.<\/strong><\/em> 101: 510-526<\/a>, 2022.<\/li>\n\n\n\n
                          43. Zhang, C., Herbig, M. , Zhou, Y., Nishikawa, M., Shifat-E-Rabbi, M., Kanno, H., Yang, R., Ibayashi, Y., Xiao, T., Rohde, G.K., Sato, M., Kodera, S., Daimon, M., Yatomi, Y., and Goda, K. Real-time intelligent classification of COVID-19 and thrombosis via massive image-based analysis of platelet aggregates. medRxiv<\/em><\/strong><\/a>, 2022.<\/li>\n<\/ol>\n\n\n\n

                            \u56fd\u5185\u5b66\u4f1a\u767a\u8868\uff1aDomestic Conference Presentation<\/h4>\n\n\n\n
                              \n
                            1. \u8352\u5c71 \u3042\u305a\u3055\uff0c\u5f71\u5c71 \u7950\u5b50\uff0c\u67f3\u7530 \u9053\u5b5d\uff0c\u68ee\u8c4a \u9686\u5fd7\uff0c\u4e38\u5c71 \u9054\u4e5f\uff0e\u6cbb\u9a13\u691c\u4f53\u51e6\u7406\u306b\u304a\u3051\u308b\u7167\u5408\u30b7\u30b9\u30c6\u30e0\u306e\u5c0e\u5165\u3068\u305d\u306e\u52b9\u679c\uff0e\u7b2c43\u56de \u65e5\u672c\u81e8\u5e8a\u85ac\u7406\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a\uff0e2022.11.30-12.3\uff0e\u6a2a\u6d5c\uff0e<\/li>\n\n\n\n
                            2. \u7802\u91d1 \u79c0\u7ae0\uff0c\u6e21\u908a \u5e83\u7950\uff0c\u4f50\u85e4 \u512a\u5b9f\u5b50\uff0c\u5c0f\u91ce \u4f73\u4e00\uff0c\u77e2\u51a8 \u88d5\uff0e\u5f53\u9662\u306b\u304a\u3051\u308bNGS\u30d1\u30cd\u30eb\u691c\u67fb\u306evisual inspection\u3078\u306e\u53d6\u308a\u7d44\u307f\uff0e\u7b2c69\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2022.11.18-20\uff0e\u5b87\u90fd\u5bae\uff0e<\/li>\n\n\n\n
                            3. \u7802\u91d1 \u79c0\u7ae0\uff0c\u6e21\u908a \u5e83\u7950\uff0c\u4f50\u85e4 \u512a\u5b9f\u5b50\uff0c\u5c0f\u91ce \u4f73\u4e00\uff0c\u77e2\u51a8 \u88d5\uff0e\u5f53\u9662\u306b\u304a\u3051\u308b\u304c\u3093\u907a\u4f1d\u5b50\u30d1\u30cd\u30eb\u691c\u67fb\u306e\u5185\u88fd\u5316\u3068\u30b2\u30ce\u30e0\u7248ISO 15189\u8a8d\u5b9a\u53d6\u5f97\u306e\u7d4c\u9a13\uff0e\u7b2c69\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2022.11.18-20\uff0e\u5b87\u90fd\u5bae\uff0e<\/li>\n\n\n\n
                            4. \u4e95\u4e0a \u7fd4\u592a\uff0c\u5927\u9580 \u96c5\u592b\uff0c\u4e2d\u5c3e \u502b\u5b50\uff0c\u9234\u6728 \u535a\u82f1\uff0c\u4f50\u3005\u6728 \u8cc0\u6d25\u4e43\uff0c\u5bae\u5d0e \u4ee4\u5b50\uff0c\u5343\u660e \u771f\u5f13\uff0c\u9808\u85e4 \u82b3\u5b9f\uff0c\u5c0f\u91ce \u4f73\u4e00\uff0c\u77e2\u51a8 \u88d5\uff0eRaphalcord\u65ad\u88c2\u306b\u3088\u308a\u5927\u52d5\u8108\u5f01\u9589\u9396\u4e0d\u5168\u75c7\u304c\u6025\u6027\u5897\u60aa\u3057\u305f\u5927\u52d5\u8108\u4e8c\u5c16\u5f01\u306e\u4e00\u75c7\u4f8b\uff0e\u65e5\u672c\u5fc3\u30a8\u30b3\u30fc\u56f3\u5b66\u4f1a \u7b2c33\u56de\u5b66\u8853\u96c6\u4f1a\uff0e2022.4.8-10\uff0e\u9ce5\u53d6\uff0e<\/li>\n\n\n\n
                            5. \u4e95\u4e0a \u7fd4\u592a\uff0e\u30e9\u30f3\u30c1\u30e7\u30f3\u30bb\u30df\u30ca\u30fc \u3053\u308c\u3067\u8a3a\u65ad\u3057\u3066\u3044\u3044\u306e\uff1f\u5fc3\u4e0d\u5168 Vector Flow Mapping\u6307\u6a19\u306b\u3064\u3044\u3066\u8003\u3048\u308b\uff0e\u65e5\u672c\u5fc3\u30a8\u30b3\u30fc\u56f3\u5b66\u4f1a \u7b2c33\u56de\u5b66\u8853\u96c6\u4f1a\uff0e2022.4.8-10\uff0e\u9ce5\u53d6\uff0e<\/li>\n\n\n\n
                            6. \u4e95\u4e0a \u7fd4\u592a\uff0c\u5927\u9580 \u96c5\u592b\uff0c\u4e2d\u5c3e \u502b\u5b50\uff0c\u9234\u6728 \u535a\u82f1\uff0c\u83c5\u539f \u5c06\u4ee3\uff0c\u5c0f\u91ce \u4f73\u4e00\uff0c\u77e2\u51a8 \u88d5\uff0eVector Flow Mapping(VFM)\u3092\u7528\u3044\u305f\u5fc3\u30a8\u30b3\u30fc\u56f3\u306b\u3088\u308b\u5de6\u5ba4\u5185\u8840\u884c\u52d5\u614b\u3092\u89e3\u6790\u3057\u305f\u5fc3\u5c16\u90e8\u80a5\u5927\u578b\u5fc3\u7b4b\u75c7\u306e\uff16\u75c7\u4f8b\uff0e\u7b2c69\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2022.11.18-20\uff0e\u5b87\u90fd\u5bae\uff0e<\/li>\n\n\n\n
                            7. \u5c0f\u91ce \u4f73\u4e00\uff0eISO 15189\u5be9\u67fb\u306b\u304a\u3051\u308b\u5f53\u9662\u306e\u6307\u6458\u9805\u76ee\u306e\u89e3\u6790\u3068\u8840\u6db2\u691c\u67fb\u5ba4\u306e\u6539\u5584\u6d3b\u52d5\uff0e\u7b2c23\u56de \u65e5\u672c\u691c\u67fb\u8840\u6db2\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2022.7.30-31\uff0e\u6771\u4eac\uff0e<\/li>\n\n\n\n
                            8. \u5c0f\u91ce \u4f73\u4e00\uff0e\u30e9\u30f3\u30c1\u30e7\u30f3\u30bb\u30df\u30ca\u30fc\uff0e\u9662\u5185\u5b8c\u7d50\u578b\u30b2\u30ce\u30e0\u30e9\u30dc\u306e\u69cb\u7bc9\uff5e\u898b\u3048\u3066\u304d\u305f\u5c55\u671b\u3068\u8ab2\u984c\uff5e\u81e8\u5e8a\u691c\u67fb\u6280\u5e2b\u9577\u306e\u7acb\u5834\u304b\u3089\uff0e\u65e5\u672c\u533b\u7642\u691c\u67fb\u79d1\u5b66\u4f1a \u7b2c54\u56de\u5927\u4f1a\uff0e2022.10.7-9\uff0e\u6a2a\u6d5c\uff0e<\/li>\n\n\n\n
                            9. \u5c0f\u91ce \u4f73\u4e00\uff0e\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u300c\u7d99\u7d9a\u7684\u306a\u5352\u5f8c\u6559\u80b2\u30fb\u751f\u6daf\u5b66\u7fd2\u3067\u81e8\u5e8a\u691c\u67fb\u6280\u5e2b\u306e\u8cea\u3092\u62c5\u4fdd\u300d\uff0e\u4e8c\u7d1a\u30fb\u4e00\u7d1a\u81e8\u5e8a\u691c\u67fb\u58eb\u8cc7\u683c\u53d6\u5f97\u3068\u535a\u58eb\u53f7\u53d6\u5f97\u305d\u3057\u3066\u6280\u5e2b\u9577\u306b\uff0e\u7b2c69\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2022.11.18-20\uff0e\u5b87\u90fd\u5bae\uff0e<\/li>\n\n\n\n
                            10. \u5f71\u5c71 \u7950\u5b50\uff0eE6R3\u6642\u4ee3\u306e\u54c1\u8cea\u7ba1\u7406\u306e\u3042\u308a\u65b9\uff5e\u73fe\u5834\u304c\u6c42\u3081\u308b\u54c1\u8cea\u7ba1\u7406\u306b\u5411\u3051\u305f\u6d3b\u52d5\uff0e\u7b2c19\u56de DIA\u65e5\u672c\u5e74\u4f1a\uff0e2022.10.9-11\uff0e\u6771\u4eac\uff0e<\/li>\n\n\n\n
                            11. \u83c5\u91ce \u5bdb\u5fd7\uff0cZhang Chenqi\uff0cHerbig Maik\uff0cZhou Yuqi\uff0c\u897f\u5ddd \u771f\u5b50\uff0cYang Ruoxi\uff0c\u4f0a\u6797 \u4f91\u771f\uff0cXiao Ting-Hui\uff0c\u77e2\u51a8 \u88d5\uff0c\u5408\u7530 \u572d\u4ecb\uff0e\u8840\u5c0f\u677f\u51dd\u96c6\u584a\u306e\u5927\u898f\u6a21\u753b\u50cf\u89e3\u6790\u306b\u3088\u308b\u8840\u6813\u75c7\u3068COVID-19\u95a2\u9023\u8840\u6813\u75c7\u306e\u30a2\u30eb\u30b4\u30ea\u30ba\u30e0\u5206\u985e\uff0e\u7b2c23\u56de \u65e5\u672c\u691c\u67fb\u8840\u6db2\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2022.7.31-8.1. \u6771\u4eac\uff0e<\/li>\n\n\n\n
                            12. \u7b20\u539f \u88d5\u5b50\uff0c\u8352\u5c71 \u3042\u305a\u3055\uff0c\u5409\u5ddd \u76f4\u4e4b\uff0c\u5c0f\u91ce \u4f73\u4e00\uff0c\u77e2\u51a8 \u88d5\uff0c\u8535\u91ce \u4fe1\uff0c\u98db\u7530 \u660e\u5b50\uff0e\u81ea\u52d5\u5316\u5b66\u767a\u5149\u9175\u7d20\u514d\u75ab\u5206\u6790\u88c5\u7f6eAccuraseed\u306b\u3088\u308bTSH\uff0cFT3\uff0cFT4\uff0cTRAb\uff0cTgAb\uff0cTPOAb\u6e2c\u5b9a\u8a66\u85ac\u306e\u6709\u7528\u6027\uff0e\u7b2c54\u56de \u65e5\u672c\u533b\u7642\u691c\u67fb\u79d1\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2022.10.7-9\uff0e\u795e\u6238\uff0e<\/li>\n\n\n\n
                            13. \u5c0f\u6797 \u7389\u5b9c\uff0c\u4e2d\u585a \u62d3\u99ac\u3001\uff0c\u758b\u7530 \u5b8f\u7f8e\uff0c\u5ca9\u4e95 \u53cb\u7f8e\uff0c\u9234\u6728 \u535a\u82f1\uff0c\u63c3\u7530 \u967d\u5b50\uff0c\u5c0f\u91ce \u4f73\u4e00\uff0c\u77e2\u51a8 \u88d5 \uff0c\u4f50\u85e4 \u96c5\u54c9\uff0e\u6162\u6027\u809d\u75be\u60a3\u306b\u304a\u3051\u308b2D Shear Wave Elastography\u3068Attenuation Imaging\u306e\u6709\u7528\u6027\uff0e\u65e5\u672c\u8d85\u97f3\u6ce2\u533b\u5b66 \u7b2c95\u56de\u5b66\u8853\u96c6\u4f1a\uff0e2022.5.20-22\uff0e\u611b\u77e5\uff0e<\/li>\n\n\n\n
                            14. \u67f4\u5c71 \u6625\u5948\uff0c\u4e38\u5c71 \u9054\u4e5f\uff0c\u9ad8\u6728 \u88d5\u7f8e\u5b50\uff0c\u6c38\u677e \u660e\u7f8e\uff0c\u5fb3\u5c71 \u53cb\u5e0c\u4e43\uff0c\u5317\u6751 \u9ebb\u7f8e\uff0c\u5409\u7530 \u660e\u5b50\uff0c\u5357\u689d \u88d5\u5b50\uff0c\u67f3\u7530 \u9053\u5b5d\uff0c\u6c38\u677e \u5065\uff0c\u68ee\u8c4a \u9686\u5fd7\uff0c\u5f71\u5c71 \u7950\u5b50\uff0e\u9589\u7d4c\u5f8c\u5065\u5eb7\u5973\u6027\u5bfe\u8c61\u8a66\u9a13\u306b\u304a\u3051\u308b\u9078\u629e\u57fa\u6e96\u306e\u59a5\u5f53\u6027\u306b\u3064\u3044\u3066\uff0e\u7b2c43\u56de \u65e5\u672c\u81e8\u5e8a\u85ac\u7406\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a\uff0e2022.11.30-12.3\uff0e\u6a2a\u6d5c\uff0e<\/li>\n\n\n\n
                            15. \u30b7\u30e3\u30af\u30de\u30c8\u30d5 \u7406\u4eba\uff0c\u5e73 \u529b\u9020\uff0c\u91ce\u5ddd \u8aa0\u4e4b\uff0c\u897f\u5ddd \u771f\u5b50\uff0c\u30d8\u30eb\u30d3\u30c3\u30b0 \u30de\u30a4\u30af\uff0c\u5bae\u7530 \u8302\u6a39\uff0c\u77e2\u51a8 \u88d5\uff0c\u5ef6 \u8f1d\u8096\uff0c\u5408\u7530 \u572d\u4ecb\uff0e\u9ad8\u901f\u6d41\u4f53\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u3068\u6a5f\u68b0\u5b66\u7fd2\u3092\u7528\u3044\u305f\u8840\u5c0f\u677f\u88fd\u5264\u4e2d\u306e\u7d30\u83cc\u306e\u691c\u51fa\uff0e\u7b2c23\u56de \u65e5\u672c\u691c\u67fb\u8840\u6db2\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2022.7.31-8.1\uff0e\u6771\u4eac\uff0e<\/li>\n\n\n\n
                            16. \u5468 \u96e8\u5947\uff0c\u767b \u7950\u54c9\uff0c\u897f\u5ddd \u771f\u5b50\uff0c\u8096 \u5ef7\u8f1d\uff0c\u5b89\u6a02 \u771f\u6a39\uff0c\u77e2\u51a8 \u88d5\uff0c\u5408\u7530 \u572d\u4ecb\uff0e\u30a2\u30b4\u30cb\u30b9\u30c8\u306e\u7a2e\u985e\u306b\u3088\u308b\u8840\u5c0f\u677f\u51dd\u96c6\u584a\u306e\u5206\u985e \u6df1\u5c64\u5b66\u7fd2\u3092\u7528\u3044\u305f\u89e3\u6790\uff0e\u7b2c44\u56de \u65e5\u672c\u8840\u6813\u6b62\u8840\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2022.6.23-25\uff0e\u4ed9\u53f0\uff0e<\/li>\n\n\n\n
                            17. \u5468 \u96e8\u5947\uff0c\u30c6\u30f3 \u30a6\u30f3\u30b1\u30c4\uff0c\u30c9\u30a5\u30b1 \u30cf\u30a4\u30e1\u30a2\u30eb\u30d0\u30ec\u30b9\uff0c\u8607 \u6210\u8fc5\uff0c\u897f\u5ddd \u771f\u5b50\uff0c\u8096 \u5ef7\u8f1d\uff0c\u77e2\u51a8 \u88d5\uff0c\u4faf \u7ff0\u5049\uff0c\u5408\u7530 \u572d\u4ecb\uff0e\u30aa\u30f3\u30c1\u30c3\u30d7\u8840\u7ba1\u72ed\u7a84\u3068\u9ad8\u901f\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u3092\u7528\u3044\u305f\u8840\u5c0f\u677f\u51dd\u96c6\u306e\u7d71\u8a08\u89e3\u6790\uff0e\u7b2c44\u56de \u65e5\u672c\u8840\u6813\u6b62\u8840\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2022.6.23-25\uff0e\u4ed9\u53f0\uff0e<\/li>\n\n\n\n
                            18. \u5468 \u96e8\u5947\uff0c\u897f\u5ddd \u771f\u5b50\uff0c\u83c5\u91ce \u5bdb\u5fd7\uff0cYang Ruoxi\uff0cXiao Ting-Hui\uff0c\u77e2\u51a8 \u88d5\uff0c\u5408\u7530 \u572d\u4ecb\uff0emRNA COVID-19\u30ef\u30af\u30c1\u30f3\u63a5\u7a2e\u306e\u8840\u5c0f\u677f\u3078\u306e\u9577\u671f\u7684\u5f71\u97ff\uff0e\u7b2c23\u56de \u65e5\u672c\u691c\u67fb\u8840\u6db2\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2022.7.31-8.1\uff0e\u6771\u4eac\uff0e<\/li>\n\n\n\n
                            19. \u5e38\u540d \u653f\u5f18\uff0c\u5bfa\u5cf6 \u9053\u5b50\uff0c\u897f\u5ddd \u771f\u5b50\uff0c\u5b89\u6c38 \u611b\uff0c\u6b63\u672c \u5eb8\u4ecb\uff0c\u9ed2\u5ddd \u5cf0\u592b\uff0c\u77e2\u51a8 \u88d5\uff0e\u30b7\u30f3\u30dd\u30b8\u30a6\u30e08 \u8c4a\u5bcc\u306a\u30a2\u30ba\u30fc\u30eb\u597d\u6027\u9846\u7c92\u3092\u6709\u3057\u305f\u6df7\u5408\u8868\u73fe\u578b\u6025\u6027\u767d\u8840\u75c5\u306e\u4e00\u75c7\u4f8b\uff0e\u7b2c69\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2022.11.18-20\uff0e\u5b87\u90fd\u5bae\uff0e<\/li>\n\n\n\n
                            20. \u83c5\u539f \u5c06\u4ee3\uff0c\u4e2d\u5c3e \u502b\u5b50\uff0c\u9234\u6728 \u535a\u82f1\uff0c\u4e95\u4e0a \u7fd4\u592a\uff0c\u5c0f\u91ce \u4f73\u4e00\uff0c\u77e2\u51a8 \u88d5\uff0c\u5927\u9580 \u96c5\u592b\uff0e\u982d\u981a\u90e8\u764c\u60a3\u8005\u306b\u304a\u3051\u308b\u653e\u5c04\u7dda\u8a98\u767a\u6027\u9838\u52d5\u8108\u72ed\u7a84\u75c7\u306e\u7d4c\u904e\u89b3\u5bdf\u306b\u8d85\u97f3\u6ce2\u691c\u67fb\u304c\u6709\u7528\u3067\u3042\u3063\u305f1\u75c7\u4f8b\uff0e\u7b2c69\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2022.11.18-20\uff0e\u5b87\u90fd\u5bae\uff0e<\/li>\n\n\n\n
                            21. \u9ad8\u6a4b \u5343\u7531\u7d00\uff0c\u5897\u6238 \u68a8\u6075\uff0c\u5e38\u540d \u653f\u5f18\uff0c\u5c0f\u91ce \u4f73\u4e00\uff0c\u517c\u677e \u8475\uff0c\u8107\u672c \u512a\u53f8\uff0c\u5ca1\u672c \u8015\uff0c\u897f\u5ddd \u771f\u5b50\uff0c\u68ee\u5c4b \u606d\u723e\uff0c\u77e2\u51a8 \u88d5\uff0e\u5f62\u8cea\u7d30\u80de\u816b\u3068\u306e\u9451\u5225\u306b\u82e6\u616e\u3057\u305f\u591a\u4e2d\u5fc3\u6027\u30ad\u30e3\u30c3\u30b9\u30eb\u30de\u30f3\u75c5\u306e\u4e00\u75c7\u4f8b\uff0e\u7b2c23\u56de \u65e5\u672c\u691c\u67fb\u8840\u6db2\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2022.7.31-8.1. \u6771\u4eac\uff0e<\/li>\n\n\n\n
                            22. \u6edd\u53e3 \u7d14\uff0c\u897f\u5ddd \u771f\u5b50\uff0c\u5e38\u540d \u653f\u5f18\uff0c\u5c0f\u91ce \u4f73\u4e00\uff0c\u77e2\u51a8 \u88d5\uff0e\u8840\u5c0f\u677f\u51dd\u96c6\u80fd\u691c\u67fb\u306b\u3088\u308b\u6297\u8840\u5c0f\u677f\u85ac\u306e\u85ac\u52b9\u8a55\u4fa1\u306b\u57fa\u3065\u304f\u85ac\u5264\u6295\u4e0e\u91cf\u306e\u8abf\u7bc0 \uff0d\u81ea\u9a13\u4f8b\u306e\u63d0\u793a\u3068\u6587\u732e\u7684\u8003\u5bdf\uff0e\u7b2c69\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2022.11.18-20\uff0e\u5b87\u90fd\u5bae\uff0e<\/li>\n\n\n\n
                            23. \u5bfa\u5cf6 \u9053\u5b50\uff0c\u9ad8\u6a4b \u6075\uff0c\u8239\u6238 \u771f\u5948\u7f8e\uff0c\u4f50\u85e4 \u7f8e\u77e5\u5b50\uff0c\u8fbb\u4e95 \u4e9c\u5f25\uff0c\u4e38\u5c3e \u7406\u6075\uff0c\u5e38\u540d \u653f\u5f18\uff0c\u5c0f\u91ce \u4f73\u4e00\uff0c\u897f\u5ddd \u771f\u5b50\uff0c\u77e2\u51a8 \u88d5\uff0eCLL\u6cbb\u7642\u4e2d\u306bRichter\u75c7\u5019\u7fa4\u3092\u767a\u75c7\u3057\u305f\u4e00\u75c7\u4f8b\uff0e\u7b2c23\u56de \u65e5\u672c\u691c\u67fb\u8840\u6db2\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2022.7.31-8.1. \u6771\u4eac\uff0e<\/li>\n\n\n\n
                            24. \u4e2d\u6e21 \u4e00\u8cb4\uff0c\u5c0f\u6797 \u771f\u8863\uff0c\u4e2d\u91ce \u88d5\u6a39\uff0c\u5927\u4e45\u4fdd \u57fa\u535a\uff0c\u5409\u672c \u660e\uff0c\u68b6\u672c \u5e78\u4f38\uff0c\u5c0f\u5ddd \u821e\u5b50\uff0c\u6751\u5c71 \u656c\u7950\uff0c\u4e45\u7c73 \u5e78\u592b\uff0c\u5409\u5ddd \u76f4\u4e4b\uff0c\u5c0f\u91ce \u4f73\u4e00\uff0c\u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0e\u30b7\u30f3\u30dd\u30b8\u30a6\u30e05 \u65b0\u751f\u5150\u691c\u4f53\u306b\u304a\u3051\u308b\u76f4\u63a5\u30d3\u30ea\u30eb\u30d3\u30f3\u6e2c\u5b9a\u5024\u306e\u7d4c\u6642\u7684\u4e0a\u6607\uff0e\u7b2c62\u56de \u65e5\u672c\u81e8\u5e8a\u5316\u5b66\u4f1a\u5e74\u6b21\u5b66\u8853\u96c6\u4f1a\uff0e2022.9.30-10.2\uff0e\u5bcc\u5c71\uff0e<\/li>\n\n\n\n
                            25. \u897f\u5ddd \u5c1a\u5b50\uff0c\u8535\u91ce \u4fe1\uff0c\u6c60\u7530 \u5747\uff0c\u5c71\u9053 \u4fe1\u6bc5\uff0c\u77e2\u51a8 \u88d5\uff0c\u5c0f\u6c60 \u548c\u5f66\uff0c\u85e4\u57ce \u5149\u5f18\uff0e\u30ea\u30be\u30db\u30b9\u30d5\u30a1\u30c1\u30b8\u30eb\u30bb\u30ea\u30f3\u306f\u65b0\u898f\u809d\u7dda\u7dad\u5316\u4fc3\u9032\u56e0\u5b50\u304a\u3088\u3073\u7dda\u7dad\u5316\u30de\u30fc\u30ab\u30fc\u306e\u53ef\u80fd\u6027\u304c\u3042\u308b\uff0e\u7b2c29\u56de \u809d\u7d30\u80de\u7814\u7a76\u4f1a\uff0e2022.8.25-26\uff0e\u6771\u4eac\uff0e<\/li>\n\n\n\n
                            26. \u897f\u5ddd \u771f\u5b50\uff0e\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0 \u6765\u308b\u3079\u304d\u6642\u4ee3\u306e\u81e8\u5e8a\u691c\u67fb COVID-19\u306b\u304a\u3051\u308b\u5faa\u74b0\u8840\u5c0f\u677f\u51dd\u96c6\u584a\u306e\u5927\u898f\u6a21\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u89e3\u6790\uff0e\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u95a2\u6771\u30fb\u7532\u4fe1\u8d8a\u652f\u90e8 \u7b2c77\u56de\u4f8b\u4f1a\uff0e2022.6.4\uff0e\u7532\u5e9c\uff0e<\/li>\n\n\n\n
                            27. \u897f\u5ddd \u771f\u5b50\uff0c\u83c5\u91ce \u5bdb\u5fd7\uff0cZhou Yuqi\uff0cXiao Ting-Hui\uff0c\u65b0\u7530 \u5c1a\uff0c\u77e2\u51a8 \u88d5\uff0c\u5408\u7530 \u572d\u4ecb\uff0eCOVID-19\u306b\u304a\u3051\u308b\u8840\u5c0f\u677f\u51dd\u96c6\u584a\u306e\u5927\u898f\u6a21\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u89e3\u6790\uff0e\u7b2c44\u56de\u65e5\u672c\u8840\u6813\u6b62\u8840\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2022.6.23-25\uff0e\u4ed9\u53f0\uff0e<\/li>\n\n\n\n
                            28. \u897f\u5ddd \u771f\u5b50\uff0e\u30e9\u30f3\u30c1\u30e7\u30f3\u30bb\u30df\u30ca\u30fc \u591a\u767a\u6027\u9aa8\u9ac4\u816b\u306e\u30d5\u30ed\u30fc\u30b5\u30a4\u30c8\u30e1\u30c8\u30ea\u30fc\u89e3\u6790Up to Date \u8a3a\u65ad\u304b\u3089MRD\u89e3\u6790\u307e\u3067\uff0e\u7b2c23\u56de \u65e5\u672c\u691c\u67fb\u8840\u6db2\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2022.7.31-8.1. \u6771\u4eac\uff0e<\/li>\n\n\n\n
                            29. \u897f\u5ddd \u771f\u5b50\uff0cZhou Yuqi\uff0c\u83c5\u91ce \u5bdb\u5fd7\uff0cYang Ruoxi\uff0c\u5c0f\u91ce \u9999\u7e54\uff0cXiao Ting-Hui\uff0c\u65b0\u7530 \u5c1a\uff0c\u77e2\u51a8 \u88d5\uff0c\u5408\u7530 \u572d\u4ecb\uff0e\u64ad\u7a2e\u6027\u8840\u7ba1\u5185\u51dd\u56fa\u306b\u304a\u3051\u308b\u5faa\u74b0\u8840\u5c0f\u677f\u51dd\u96c6\u584a\u306e\u89e3\u6790\uff0e\u7b2c23\u56de \u65e5\u672c\u691c\u67fb\u8840\u6db2\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2022.7.31-8.1. \u6771\u4eac\uff0e<\/li>\n\n\n\n
                            30. \u897f\u5ddd \u771f\u5b50\uff0c\u5b89\u5ddd \u60e0\u5b50\uff0c\u6960\u672c \u4f73\u9999\uff0c\u5c0f\u91ce \u9999\u7e54\uff0c\u77e2\u51a8 \u88d5\uff0e\u6557\u8840\u75c7DIC\u3068\u9178\u5316\u578b\u30a2\u30eb\u30d6\u30df\u30f3\u306e\u89e3\u6790\uff0e\u7b2c23\u56de \u65e5\u672c\u691c\u67fb\u8840\u6db2\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2022.7.31-8.1. \u6771\u4eac\uff0e<\/li>\n\n\n\n
                            31. \u897f\u5ddd \u771f\u5b50\uff0e\u30b7\u30f3\u30dd\u30b8\u30a6\u30e03S07m \u65b0\u578b\u30b3\u30ed\u30ca\u30a6\u30a4\u30eb\u30b9\u611f\u67d3\u75c7\u306b\u304a\u3051\u308b\u5faa\u74b0\u8840\u5c0f\u677f\u51dd\u96c6\u584a\u89e3\u6790\uff0e\u7b2c95\u56de\u65e5\u672c\u751f\u5316\u5b66\u4f1a\u5927\u4f1a\uff0e2022.11.9-11. \u540d\u53e4\u5c4b<\/li>\n\n\n\n
                            32. \u897f\u5ddd \u771f\u5b50\uff0e\u30b7\u30f3\u30dd\u30b8\u30a6\u30e08 \u9020\u8840\u5668\u816b\u760d\u306e\u30d5\u30ed\u30fc\u30b5\u30a4\u30c8\u30e1\u30c8\u30ea\u30fc\u691c\u67fb\u5165\u9580\uff0e\u7b2c69\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2022.11.18-20\uff0e\u5b87\u90fd\u5bae\uff0e<\/li>\n\n\n\n
                            33. \u4e38\u5c3e \u7406\u6075\uff0c\u5bfa\u5cf6 \u9053\u5b50\uff0c\u4f50\u85e4 \u512a\u5b9f\u5b50\uff0c\u7530\u9089 \u4e45\u7f8e\u5b50\uff0c\u91ce\u3005\u90e8 \u4eae\u5b50\uff0c\u8fbb\u4e95 \u4e9c\u5f25\uff0c\u5e38\u540d \u653f\u5f18\uff0c\u5c0f\u91ce \u4f73\u4e00\uff0c\u897f\u5ddd \u771f\u5b50\uff0c\u77e2\u51a8 \u88d5\uff0e\u5f53\u9662\u3067\u7d4c\u9a13\u3057\u305fIgG-\u03bb\u578b\u30ea\u30f3\u30d1\u5f62\u8cea\u7d30\u80de\u6027\u30ea\u30f3\u30d1\u816b\u306e\u4e00\u4f8b\uff0e\u7b2c23\u56de \u65e5\u672c\u691c\u67fb\u8840\u6db2\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2022.7.31-8.1. \u6771\u4eac\uff0e<\/li>\n\n\n\n
                            34. \u5bae\u8107 \u7dbe\uff0c\u5ca9\u7530 \u516c\u91ce\uff0c\u9ad8\u6a4b \u5343\u7531\u7d00\uff0c\u8239\u6238 \u771f\u5948\u7f8e\uff0c\u9ad8\u6a4b \u6075\uff0c\u5bfa\u5cf6 \u9053\u5b50\uff0c\u5e38\u540d \u653f\u5f18\uff0c\u5c0f\u91ce \u4f73\u4e00\uff0c\u897f\u5ddd \u771f\u5b50\uff0c\u77e2\u51a8 \u88d5\uff0e\u30b9\u30ad\u30e3\u30c3\u30bf\u30b0\u30e9\u30e0\u306e\u6ce8\u610f\u6df1\u3044\u89b3\u5bdf\u304c\u65e9\u671f\u8a3a\u65ad\u306b\u5f79\u7acb\u3063\u305f\u79fb\u690d\u5f8c\u30ea\u30f3\u30d1\u5897\u6b96\u6027\u75be\u60a3\u306e\u4e00\u75c7\u4f8b\uff0e\u7b2c23\u56de \u65e5\u672c\u691c\u67fb\u8840\u6db2\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2022.7.31-8.1. \u6771\u4eac\uff0e<\/li>\n\n\n\n
                            35. \u68ee\u7530 \u8ce2\u53f2\uff0eCOVID-19\u60a3\u8005\u306b\u304a\u3051\u308b\u5c3f\u6c88\u6e23\u304a\u3088\u3073\u5c3f\u30d0\u30a4\u30aa\u30de\u30fc\u30ab\u30fc\u306e\u7279\u5fb4\uff08\u5b66\u8853\u7814\u7a76\u73ed\u4f01\u753b\uff1a\u4e00\u822c\u691c\u67fb\uff09\uff0e\u7b2c17\u56de \u6771\u4eac\u90fd\u533b\u5b66\u691c\u67fb\u5b66\u4f1a\uff0e2022.12.4. \u6771\u4eac\uff0e<\/li>\n\n\n\n
                            36. \u68ee\u7530 \u8ce2\u53f2\uff0c\u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0eLC-MS\/MS\u3092\u7528\u3044\u305f\u30bb\u30e9\u30df\u30c9\u6e2c\u5b9a\u7cfb\u306e\u4e00\u822c\u691c\u67fb\u9818\u57df\u3078\u306e\u5fdc\u7528\uff082020\u5e74\u5ea6\u5b66\u8853\u63a8\u9032\u30d7\u30ed\u30b8\u30a7\u30af\u30c8\u6700\u7d42\u5831\u544a\uff09\uff0e\u7b2c69\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2022.11.17-20. \u5b87\u90fd\u5bae\uff0e<\/li>\n\n\n\n
                            37. \u68ee\u7530 \u8ce2\u53f2\uff0c\u6a2a\u5c71 \u96a3\uff0c\u4e45\u672b \u5d07\u53f8\uff0c\u4e2d\u53f8 \u6210\uff0c\u5c0f\u91ce \u4f73\u4e00\uff0c\u7530\u4e2d \u96c5\u7f8e\uff0c\u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0e\u5168\u81ea\u52d5\u5c3f\u4e2d\u6709\u5f62\u6210\u5206\u5206\u6790\u88c5\u7f6e\u8a66\u4f5c\u6a5f\u306b\u304a\u3051\u308b\u93e1\u691c\u6cd5\u3068\u306e\u4e56\u96e2\u306e\u89e3\u6790\uff0d\u8840\u7403\u985e\u30fb\u7d50\u6676\u985e\u30fb\u9175\u6bcd\u69d8\u771f\u83cc\u306b\u95a2\u3057\u3066\uff0d\uff0e\u7b2c54\u56de \u65e5\u672c\u533b\u7642\u691c\u67fb\u79d1\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2022.10.7-9. \u795e\u6238\uff0e<\/li>\n\n\n\n
                            38. \u68ee\u7530 \u8ce2\u53f2\uff0c\u6a2a\u5c71 \u96a3\uff0c\u4e2d\u53f8 \u6210\uff0c\u5e38\u540d \u653f\u5f18\uff0c\u7530\u4e2d \u96c5\u7f8e\uff0c\u5c0f\u91ce \u4f73\u4e00\uff0c\u897f\u5ddd \u771f\u5b50\uff0c\u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0e\u4e2d\u67a2\u795e\u7d4c\u539f\u767a\u306e\u672a\u5206\u5316\u5927\u7d30\u80de\u578b\u30ea\u30f3\u30d1\u816b\u306e\u4e00\u75c7\u4f8b\uff0e\u7b2c23\u56de \u65e5\u672c\u691c\u67fb\u8840\u6db2\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2022.7.31-8.1. \u6771\u4eac\uff0e<\/li>\n\n\n\n
                            39. \u68ee\u7530 \u8ce2\u53f2\uff0e\u30ef\u30fc\u30af\u30b7\u30e7\u30c3\u30d74\uff08\u4e00\u822c\uff09\u4e00\u822c\u691c\u67fb\u7d50\u679c\u304b\u3089\u75c5\u614b\u3092\u89e3\u304d\u307b\u3069\u304f -\u75c7\u4f8b3-\uff0e\u7b2c71\u56de \u65e5\u672c\u533b\u5b66\u691c\u67fb\u5b66\u4f1a\uff0e2022.5.21-22\uff0e\u5927\u962a\uff0e<\/li>\n\n\n\n
                            40. \u5b89\u5ddd \u60e0\u5b50\uff0c\u897f\u5ddd \u771f\u5b50\uff0c\u897f\u5ddd \u5c1a\u5b50\uff0cUranbileg Baasanjav\uff0c\u4f50\u85e4 \u96c5\u54c9\uff0c\u77e2\u51a8 \u88d5\uff0e\u9178\u5316\u30b9\u30c8\u30ec\u30b9\u30de\u30fc\u30ab\u30fc\uff0c\u9178\u5316\u578b\u30a2\u30eb\u30d6\u30df\u30f3(HNA)\u5024\u306e\u5909\u52d5\u306b\u95a2\u3059\u308b\u8003\u5bdf\uff0e\u7b2c69\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2022.11.18-20\uff0e\u5b87\u90fd\u5bae\uff0e<\/li>\n\n\n\n
                            41. \u6a2a\u5c71 \u96a3\uff0c\u68ee\u7530 \u8ce2\u53f2\uff0c\u67f4\u5c71 \u6625\u5948\uff0c\u5e38\u540d \u653f\u5f18\uff0c\u5c0f\u91ce \u4f73\u4e00\uff0c\u77e2\u51a8 \u88d5\uff0e\u80f8\u30fb\u8179\u6c34\u4e2d\u30d7\u30ec\u30bb\u30d7\u30b7\u30f3\u6e2c\u5b9a\u306e\u81e8\u5e8a\u7684\u6709\u7528\u6027\u306b\u95a2\u3059\u308b\u691c\u8a0e\uff0e\u7b2c71\u56de \u65e5\u672c\u533b\u5b66\u691c\u67fb\u5b66\u4f1a\uff0e2022.5.21-22\uff0e\u5927\u962a\uff0e<\/li>\n\n\n\n
                            42. \u6a2a\u5c71 \u96a3\uff0c\u68ee\u7530 \u8ce2\u53f2\uff0c\u4e45\u672b \u5d07\u53f8\uff0c\u4e2d\u53f8 \u6210\uff0c\u7530\u4e2d \u96c5\u7f8e\uff0c\u5c0f\u91ce \u4f73\u4e00\uff0c\u77e2\u51a8 \u88d5\uff0e\u65b0\u578b\u30b3\u30ed\u30ca\u30a6\u30a4\u30eb\u30b9\u30ef\u30af\u30c1\u30f3\u63a5\u7a2e\u5f8c\u306b\u8089\u773c\u7684\u8840\u5c3f\u304c\u51fa\u73fe\u3057\u305f3\u75c7\u4f8b\uff0e\u7b2c71\u56de \u65e5\u672c\u533b\u5b66\u691c\u67fb\u5b66\u4f1a\uff0e2022.5.21-22\uff0e\u5927\u962a\uff0e<\/li>\n\n\n\n
                            43. \u6a2a\u5c71 \u96a3\uff0c\u68ee\u7530 \u8ce2\u53f2\uff0c\u4e2d\u53f8 \u6210\uff0c\u5e38\u540d \u653f\u5f18\uff0c\u7530\u4e2d \u96c5\u7f8e\uff0c\u897f\u5ddd \u771f\u5b50\uff0c\u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0e\u9ac4\u6db2\u4e2d\u306b\u82b1\u5f01\u69d8\u6838\u3092\u793a\u3059\u7d30\u80de\u304c\u51fa\u73fe\u3057\uff0c\u7d30\u80de\u9451\u5225\u306b\u82e6\u616e\u3057\u305f\u5f62\u8cea\u7d30\u80de\u816b\u306e\u4e00\u4f8b\uff0e\u7b2c23\u56de\u65e5\u672c\u691c\u67fb\u8840\u6db2\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2022.7.31-8.1. \u6771\u4eac\uff0e<\/li>\n\n\n\n
                            44. \u6a2a\u5c71 \u96a3\uff0c\u68ee\u7530 \u8ce2\u53f2\uff0c\u4e45\u672b \u5d07\u53f8\uff0c\u4e2d\u53f8 \u6210\uff0c\u5c0f\u91ce \u4f73\u4e00\uff0c\u7530\u4e2d \u96c5\u7f8e\uff0c\u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0e\u5168\u81ea\u52d5\u5c3f\u4e2d\u6709\u5f62\u6210\u5206\u5206\u6790\u88c5\u7f6e\u8a66\u4f5c\u6a5f\u306e\u6027\u80fd\u8a55\u4fa1\uff0d\u8840\u7403\u985e\u30fb\u7d50\u6676\u985e\u30fb\u9175\u6bcd\u69d8\u771f\u83cc\u306b\u95a2\u3057\u3066\uff0d\uff0e\u7b2c54\u56de \u65e5\u672c\u533b\u7642\u691c\u67fb\u79d1\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2022.10.7-9. \u795e\u6238\uff0e<\/li>\n\n\n\n
                            45. \u6e21\u908a \u5e83\u7950\uff0e\u9662\u5185\u5b8c\u7d50\u578bNGS\u691c\u67fb\u5ba4\u306e\u8a2d\u7acb\uff0e\u7b2c19\u56de \u65e5\u672c\u81e8\u5e8a\u816b\u760d\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e 2022.2.17-19\uff0e\u4eac\u90fd\uff0e<\/li>\n\n\n\n
                            46. \u6e21\u908a \u5e83\u7950\uff0c\u5c0f\u91ce \u4f73\u4e00. \u9662\u5185\u5b8c\u7d50\u578b\u30b2\u30ce\u30e0\u30e9\u30dc\u306e\u69cb\u7bc9\uff0e\u7b2c54\u56de \u65e5\u672c\u533b\u7642\u691c\u67fb\u79d1\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2022.10.7-9\uff0e\u795e\u6238\uff0e<\/li>\n\n\n\n
                            47. \u6e21\u908a\u5e83\u7950\uff0c\u7802\u91d1 \u79c0\u7ae0\uff0c\u4f50\u85e4 \u512a\u5b9f\u5b50\uff0c\u5c0f\u91ce \u4f73\u4e00\uff0c\u77e2\u51a8 \u88d5\uff0e\u304c\u3093\u907a\u4f1d\u5b50\u30d1\u30cd\u30eb\u691c\u67fbTodai Onco Panel\uff08TOP\uff09\u306e\u54c1\u8cea\u6307\u6a19\uff0e\u7b2c69\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2022.11.18-20\uff0e\u5b87\u90fd\u5bae\uff0e<\/li>\n<\/ol>\n\n\n\n

                              \u82f1\u6587\u7dcf\u8aac\uff1aEnglish Review Articles<\/h4>\n\n\n\n
                                \n
                              1. Daimon, M., Iwano, H., Onishi, T., Ohara, T., Tanaka, K., Hirano, Y., Yamada, H., Izumi, C., and Nakatani, S. Guideline from the Japanese Society of Echocardiography: Guidance for the Management and Maintenance of Echocardiography Equipment: 2022 Focused Update. J. Echocardiogr.<\/em><\/strong> 20: 195-200<\/a>, 2022.<\/li>\n\n\n\n
                              2. Kiriyama, H., Daimon, M. Is Concomitant mitral regurgitation with severe aortic stenosis benign or malignant? Circ. J.<\/strong><\/em> 86: 438-439<\/a>, 2022.<\/li>\n\n\n\n
                              3. Nakanishi, K., Daimon, M. Aging and myocardial strain. J. Med. Ultrason (2001)<\/strong><\/em>. 49: 53-60<\/a>, 2022.<\/li>\n\n\n\n
                              4. Ohte, N., Ishizu, T., Izumi, C., Itoh, H., Iwanaga, S., Okura, H., Otsuji, Y., Sakata, Y., Shibata, T., Shinke, T., Seo, Y., Daimon, M., Takeuchi, M., Tanabe, K., Nakatani, S., Nii, M., Nishigami, K., Hozumi, T., Yasukochi, S., Yamada, H., Yamamoto, K., Izumo, M., Inoue, K., Iwano, H., Okada, A., Kataoka, A., Kaji, S., Kusunose, K., Goda, A., Takeda, Y., Tanaka, H., Dohi, K., Hamaguchi, H., Fukuta, H., Yamada, S., Watanabe, N., Akaishi, M., Akasaka, T., Kimura, T., Kosuge, M., and Masuyama, T.; Japanese Circulation Society Joint Working Group. JCS 2021 Guideline on the Clinical Application of Echocardiography. Circ. J.<\/em><\/strong> 86: 2045-2119<\/a>, 2022.<\/li>\n<\/ol>\n\n\n\n

                                \u56fd\u969b\u5b66\u4f1a\u767a\u8868\uff1aInternational Conference Presentation<\/h4>\n\n\n\n
                                  \n
                                1. Morita, Y., Kurano, M., and Yatomi, Y. Possible usefulness of measuring urinary sphingolipids for the differential diagnosis of chronic kidney diseases. The 17th Congress of Asian Society of Clinical Pathology and Laboratory Medicine (ASCPaLM). 2022.10.7-9, Kobe.<\/li>\n\n\n\n
                                2. Nakatsuka, N., Morita, Y., Yokoyama, R., Hisasue, T., Ono, Y., Tanaka, M., Kurano, M., and Yatomi, Y. Validation of a urine sediment test workflow combining UF-5000 and microscopic examination in detecting malignant cells. The 17th Congress of Asian Society of Clinical Pathology and Laboratory Medicine (ASCPaLM). 2022.10.7-9, Kobe.<\/li>\n\n\n\n
                                3. Nishikawa, T., Kurano, M., Ikeda, H., Yamamichi, N., Yatomi, Y.,Koike,K., and Fujishiro, M. Lysophosphatidylserine may stimmulate liver fibrosis. EASL scientific programme committee of The International Liver CongressTM<\/sup> 2022. 2022.6.22-26, London.Poster Presentation<\/li>\n<\/ol>\n\n\n\n

                                  \u548c\u6587\u539f\u8457\u8ad6\u6587\uff1aJapanese Original Articles<\/h4>\n\n\n\n
                                    \n
                                  1. \u7b20\u539f \u88d5\u5b50\uff0c\u77f3\u539f \u6709\u7406\uff0c\u4e0b\u5742 \u6d69\u5247\uff0c\u5409\u5ddd \u76f4\u4e4b\uff0c\u5c0f\u91ce \u4f73\u4e00\uff0c\u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0c\u98db\u7530 \u660e\u5b50\uff0e\u514d\u75ab\u8840\u6e05\u9805\u76ee\u306e4\u793e\u6a5f\u5668\u30fb\u8a66\u85ac\u306e\u6bd4\u8f03\u2015\u7532\u72b6\u817a\u95a2\u9023\u691c\u67fb\u9805\u76ee\uff1aTSH\uff0cFT4\uff0cFT3\u2015\uff0e\u533b\u5b66\u691c\u67fb 72\uff1a105-114\uff0c2022\uff0e<\/li>\n\n\n\n
                                  2. \u4e2d\u91ce \u88d5\u6a39\uff0c\u5c0f\u91ce \u4f73\u4e00\uff0c\u897f\u68ee \u307e\u3069\u304b\uff0c\u5ca9\u7530 \u516c\u91ce\uff0c\u4e09\u6fa4 \u6176\u6a39\uff0c\u76db\u7530 \u548c\u6cbb\uff0c\u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0e e-learning\u30b7\u30b9\u30c6\u30e0\u3092\u7528\u3044\u305f\u5916\u6765\u63a1\u8840\u5ba4\u306e\u696d\u52d9\u6539\u5584\u2015e-learning \u554f\u984c\u306e\u5b9f\u65bd\u72b6\u6cc1\u304a\u3088\u3073\u5b9f\u65bd\u52b9\u679c\u306e\u5206\u6790\u3092\u901a\u3057\u3066\u2015 \u533b\u5b66\u691c\u67fb 71\uff1a201-209\uff0c2022\uff0e<\/li>\n\n\n\n
                                  3. \u4e2d\u6e21 \u4e00\u8cb4\uff0c\u5409\u5ddd \u76f4\u4e4b\uff0c\u4e0b\u5742 \u6d69\u5247\uff0c\u4f50\u85e4 \u667a\u660e\uff0c\u77e2\u51a8 \u88d5\uff0c\u98db\u7530 \u660e\u5b50\uff0eSCC\u6297\u539f\u6e2c\u5b9a\u306b\u304a\u3051\u308b\u8a66\u85ac\u9593\u5dee\u306b\u95a2\u3059\u308b\u691c\u8a0e\uff0dAIA-CL2400\u3092\u7528\u3044\u305f\u81ea\u5df1\u6297\u4f53\u691c\u51fa\u304a\u3088\u3073\u53c2\u8003\u57fa\u6e96\u7bc4\u56f2\u306e\u518d\u691c\u8a0e\uff0d\uff0e\u533b\u7642\u691c\u67fb\u3068\u81ea\u52d5\u5316 47\uff1a178-185\uff0c2022\uff0e<\/li>\n\n\n\n
                                  4. \u4e45\u672b \u76f4\u5b50\uff0c\u5742\u672c \u611b\u5b50\uff0c\u67f3\u5143 \u4f38\u592a\u90ce\uff0c\u516b\u5c3e \u539a\u53f2\uff0eSARS-CoV-2\u3092\u542b\u3080\u591a\u7a2e\u30a6\u30a4\u30eb\u30b9\u8fc5\u901f\u6297\u539f\u540c\u5b9a\u5b9a\u6027\u691c\u67fb\u30ad\u30c3\u30c8\u306e\u6709\u7528\u6027\u306b\u95a2\u3059\u308b\u691c\u8a0e\uff0e\u533b\u5b66\u691c\u67fb 71\uff1a712-718\uff0c2022\uff0e<\/li>\n<\/ol>\n\n\n\n

                                    \u548c\u6587\u7dcf\u8aac\uff1aJapanese Review Articles<\/h4>\n\n\n\n
                                      \n
                                    1. \u4e95\u4e0a \u7fd4\u592a\uff0c\u5927\u9580 \u96c5\u592b\uff0eMarfan\u75c7\u5019\u7fa4\u306e\u5fc3\u30a8\u30b3\u30fc\u6240\u898b\uff0e\u5fc3\u30a8\u30b3\u30fc 23\uff1a49-55\uff0c2022\uff0e<\/li>\n\n\n\n
                                    2. \u5c0f\u91ce \u4f73\u4e00\uff0e\u6301\u7d9a\u76ae\u4e0b\u30b0\u30eb\u30b3\u30fc\u30b9\u6e2c\u5b9a\uff0e\u691c\u67fb\u3068\u6280\u8853 50\uff1a1321-1328\uff0c2022\uff0e<\/li>\n\n\n\n
                                    3. \u8535\u91ce \u4fe1\uff0e\u65b0\u578b\u30b3\u30ed\u30ca\u30a6\u30a4\u30eb\u30b9\uff0cmRNA \u30ef\u30af\u30c1\u30f3\u306e\u6297\u4f53\u514d\u75ab\u5fdc\u7b54\uff0e\u708e\u75c7\u3068\u514d\u75ab 30\uff1a38-43 \uff0c2022\uff0e<\/li>\n\n\n\n
                                    4. \u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0e\u30ea\u30be\u30ea\u30f3\u8102\u8cea\u30e1\u30c7\u30a3\u30a8\u30fc\u30bf\u3068\u75be\u60a3\uff0eMedical Science Digest 48\uff1a9-15\uff0c2022\uff0e<\/li>\n\n\n\n
                                    5. \u8535\u91ce \u4fe1\uff0eSARS-CoV-2\u30ef\u30af\u30c1\u30f3\u3068\u6297\u4f53\u691c\u67fb\uff0eSRL\u5b9d\u51fd 42\uff1a40-43\uff0c2022\uff0e<\/li>\n\n\n\n
                                    6. \u5927\u9580 \u96c5\u592b\uff0e\u5fc3\u30bf\u30f3\u30dd\u30ca\u30fc\u30c7\uff0e\u5c02\u9580\u79d1\u306b\u3088\u308b\u79c1\u306e\u6cbb\u7642. \u65e5\u672c\u533b\u4e8b\u65b0\u5831 5125\uff1a48-49\uff0c2022\uff0e<\/li>\n\n\n\n
                                    7. \u5927\u9580 \u96c5\u592b\uff0e2020\u5e74\u6539\u8a02\u5f01\u819c\u75c7\u6cbb\u7642\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u304b\u3089\u307f\u305f\u533b\u7642\u9023\u643a\uff1a\u7d39\u4ecb\u306e\u30bf\u30a4\u30df\u30f3\u30b0\u304b\u3089\u30d5\u30a9\u30ed\u30fc\u307e\u3067\uff0e\u6771\u4eac\u90fd\u533b\u5e2b\u4f1a\u96d1\u8a8c 75\uff1a22-29\uff0c2022\uff0e<\/li>\n\n\n\n
                                    8. \u7530\u4e2d \u96c5\u7f8e\uff0e\u57fa\u790e\u304b\u3089\u5b66\u3076\u9ac4\u6db2\u691c\u67fb\uff0e\u6771\u4eac\u90fd\u533b\u5b66\u691c\u67fb 50\uff1a285-286\uff0c2022\uff0e<\/li>\n\n\n\n
                                    9. \u7530\u4e2d \u96c5\u7f8e\uff0e\u898b\u3066\u5b66\u3076\u4e00\u822c\u691c\u67fb\u5b66\u30a2\u30c8\u30e9\u30b9-\u5916\u89b3\u691c\u67fb\u304b\u3089\u9855\u5fae\u93e1\u691c\u67fb\u307e\u3067- \u9ac4\u6db2\u691c\u67fb\uff1a\u9ac4\u6db2\u306e\u9855\u5fae\u93e1\u691c\u67fb\uff0e\u691c\u67fb\u3068\u6280\u8853\uff08\u5897\u5927\u53f7\uff09 50\uff1a277-292\uff0c2022\uff0e<\/li>\n\n\n\n
                                    10. \u4e2d\u897f \u5f18\u6bc5\uff0c\u5927\u9580 \u96c5\u592b\uff0e\u30b9\u30c6\u30fc\u30b8A\/B\u5fc3\u4e0d\u5168\u306b\u5fc3\u30a8\u30b3\u30fc\u3092\u3069\u3046\u6d3b\u304b\u3059\u304b\uff1f\u5fc3\u81d3 54\uff1a314-319\uff0c2022\uff0e<\/li>\n\n\n\n
                                    11. \u897f\u5ddd \u771f\u5b50\uff0c\u5bfa\u5cf6 \u9053\u5b50\uff0c\u5e38\u540d \u653f\u5f18\uff0c\u77e2\u51a8 \u88d5\uff0e\u4f53\u8154\u6db2\u306eFCM\u691c\u67fb\u304c\u6cbb\u7642\u65b9\u91dd\u6c7a\u5b9a\u306b\u5f79\u7acb\u3063\u305f\u3073\u307e\u3093\u6027\u5927\u7d30\u80de\u578bB\u7d30\u80de\u30ea\u30f3\u30d1\u816b\u306e2\u75c7\u4f8b \u5e0c\u5c11\u691c\u4f53\u3067\u306e\u691c\u51fa\uff0e\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u8a8c70\uff1a130-135\uff0c2022\uff0e<\/li>\n\n\n\n
                                    12. \u897f\u5ddd \u771f\u5b50\uff0e\u300cPOCT\u306e\u73fe\u72b6\u3068\u5c06\u6765\u5c55\u671b\u300d\u8840\u7b97 CRP\u6e2c\u5b9a\u88c5\u7f6e\u3092\u542b\u3080\uff0e\u65e5\u672c\u533b\u5e2b\u4f1a\u96d1\u8a8c151\uff1a1185-1188\uff0c2022\uff0e<\/li>\n\n\n\n
                                    13. \u897f\u5ddd \u771f\u5b50\uff0e\u300c\u514d\u75ab\u5b66\u7684\u6a5f\u5e8f\u306b\u3088\u308b\u8840\u5c0f\u677f\u6e1b\u5c11\u300d\u30d8\u30d1\u30ea\u30f3\u8d77\u56e0\u6027\u8840\u5c0f\u677f\u6e1b\u5c11\u75c7(HIT)\uff0e\u81e8\u5e8a\u691c\u67fb 66\uff1a1056-1061\uff0c2022\uff0e<\/li>\n\n\n\n
                                    14. \u897f\u5ddd \u771f\u5b50\uff0ePT\u6b63\u5e38APTT\u5ef6\u9577(\u524d\u7de8) \u4f55\u3092\u78ba\u8a8d\u3001\u691c\u67fb\u3057\u305f\u3089\u3044\u3044\u306e\uff1f\u30ec\u30b8\u30c7\u30f3\u30c8\u30ce\u30fc\u30c8 24\uff1a652-653\uff0c2022\uff0e<\/li>\n\n\n\n
                                    15. \u897f\u5ddd \u771f\u5b50\uff0ePT\u6b63\u5e38APTT\u5ef6\u9577(\u5f8c\u7de8) \u3069\u3046\u89e3\u91c8\u3059\u308b\u306e\uff1f\u30ec\u30b8\u30c7\u30f3\u30c8\u30ce\u30fc\u30c8 24\uff1a1036-1037\uff0c2022\uff0e<\/li>\n\n\n\n
                                    16. \u897f\u5ddd \u771f\u5b50\uff0e\u300c\u691c\u67fb\u8840\u6db2\u5b66\u30ec\u30c3\u30b9\u30f3 \u691c\u67fb\u7d50\u679c\u306e\u4e56\u96e2\u3092\u3069\u3046\u5224\u65ad\u3059\u308b\u304b\u300d\u30d5\u30ed\u30fc\u30b5\u30a4\u30c8\u30e1\u30c8\u30ea\u30fc \u6297\u4f53\u88fd\u5264\u306e\u4f7f\u7528\u306e\u5f71\u97ff\uff0e\u81e8\u5e8a\u691c\u67fb 66\uff1a1196-1199\uff0c2022\uff0e<\/li>\n\n\n\n
                                    17. \u65b0\u7530 \u5c1a\uff0c\u897f\u5ddd \u771f\u5b50\uff0e\u300c\u8a08\u753b\u7684\u30bb\u30ec\u30f3\u30c7\u30a3\u30d4\u30c6\u30a3\u304c\u533b\u5b66\u30fb\u5275\u85ac\u3092\u9769\u65b0\u3059\u308b!\u300d\u8840\u6813\u75c7\u8a3a\u65ad\u306e\u8a08\u753b\u7684\u30bb\u30ec\u30f3\u30c7\u30a3\u30d4\u30c6\u30a3\uff0e\u533b\u5b66\u306e\u3042\u3086\u307f 282\uff1a805-808\uff0c2022\uff0e<\/li>\n\n\n\n
                                    18. \u5411\u4e95 \u5eb7\u6d69\uff0c\u5927\u9580 \u96c5\u592b\uff0e\u4e09\u5c16\u5f01\u9006\u6d41\u75c7\uff0c\u80ba\u9ad8\u8840\u5727\u75c7\uff0c\u80ba\u8840\u6813\u585e\u6813\u75c7\uff0c\u6df1\u90e8\u9759\u8108\u8840\u6813\u75c7\uff0e\u7279\u96c6\uff1a\u30d5\u30a3\u30b8\u30ab\u30eb\u5927\u5168\uff0e\u8aad\u3093\u3067\uff0c\u898b\u3066\uff0c\u8074\u3044\u3066\uff0c\u8eab\u4f53\u8a3a\u5bdf\u3092\u5b8c\u5168\u30de\u30b9\u30bf\u30fc\uff0eMedicina 59 \uff1a90-94\uff0c2022\uff0e<\/li>\n\n\n\n
                                    19. \u68ee\u7530 \u8ce2\u53f2\uff0e\u5c3f\u691c\u67fb\u6240\u898b\u304b\u3089\u75c5\u614b\u3092\u8003\u3048\u308b\uff0e\u6771\u4eac\u90fd\u533b\u5b66\u691c\u67fb 50\uff1a287-289\uff0c2022\uff0e<\/li>\n\n\n\n
                                    20. \u68ee\u7530 \u8ce2\u53f2\uff0e\u5c3f\u691c\u4f53\u3078\u306e\u8cea\u91cf\u5206\u6790\u306e\u5fdc\u7528\uff0e\u691c\u67fb\u3068\u6280\u8853 50\uff1a1309-1311\uff0c2022\uff0e<\/li>\n\n\n\n
                                    21. \u6e21\u908a \u5e83\u7950. \u80ba\u304c\u3093\u5206\u5b50\u8a3a\u65ad\u306e\u6700\u524d\u7dda\uff0e\u30e2\u30c0\u30f3\u30e1\u30c7\u30a3\u30a2 68\uff1a26-30\uff0c2022\uff0e<\/li>\n<\/ol>\n\n\n\n

                                      \u548c\u6587\u8457\u66f8\uff1aJapanese Book Chapter<\/h4>\n\n\n\n
                                        \n
                                      1. \u83c5\u539f \u5c06\u4ee3. \u62e1\u5f35\u578b\u5fc3\u7b4b\u75c7\uff0e\u62d8\u675f\u578b\u5fc3\u7b4b\u75c7\uff0e\u8840\u7ba1\u708e\u306a\u3069\uff0e\u5178\u578b\u753b\u50cf\u3092\u898b\u3066\u5b66\u3076\u5fc3\u30a8\u30b3\u30fc\u56f3\u9451\uff08\u5927\u9580 \u96c5\u592b \u7de8\uff09pp. 54-55, 62, 118-119. \u6587\u5149\u5802\uff0c\u6771\u4eac\uff0e2022\uff0e<\/li>\n\n\n\n
                                      2. \u5927\u9580 \u96c5\u592b\uff0e\u50e7\u5e3d\u5f01\u72ed\u7a84\u75c7\uff0e\u5faa\u74b0\u5668\u75be\u60a3\u6700\u65b0\u306e\u6cbb\u76422022-2023\uff08\u4f0a\u85e4 \u6d69\uff0c\u5c71\u4e0b \u6b66\u5fd7 \u7de8\uff09 pp. 179-181\uff0e\u5357\u6c5f\u5802\uff0c\u6771\u4eac\uff0c2022\uff0e<\/li>\n\n\n\n
                                      3. \u5927\u9580 \u96c5\u592b\uff0e\u5f01\u819c\u75c7\u8a3a\u7642\u30ac\u30a4\u30c9\uff08\u5206\u7b46\uff09\uff08\u65e5\u672c\u5faa\u74b0\u5668\u5b66\u4f1a\uff0c\u65e5\u672c\u80f8\u90e8\u5916\u79d1\u5b66\u4f1a\uff0c\u65e5\u672c\u5fc3\u81d3\u8840\u7ba1\u5916\u79d1\u5b66\u4f1a \u7de8\uff09\uff0e\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u51fa\u7248\uff0c\u6771\u4eac\uff0c2022\uff0e<\/li>\n\n\n\n
                                      4. \u5927\u9580 \u96c5\u592b\uff0e\u611f\u67d3\u6027\u5fc3\u5185\u819c\u708e\uff0e\u8a3a\u7642\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3up-to-date 2022-2023\uff08\u9580\u8107 \u5b5d\uff0c\u5c0f\u5ba4 \u4e00\u6210\u3001\u5bae\u5730 \u826f\u6a39 \u76e3\u4fee\uff09pp. 184-190\uff0e\u30e1\u30c7\u30a3\u30ab\u30eb\u30ec\u30d3\u30e5\u30fc\u793e\uff0c\u5927\u962a\uff0c2022\uff0e<\/li>\n\n\n\n
                                      5. \u5927\u9580 \u96c5\u592b \u5206\u7b46\uff0e\u65b0\u4eca\u3055\u3089\u805e\u3051\u306a\u3044\u5fc3\u30a8\u30b3\u30fc\u56f3\uff08\u7530\u4e2d \u79c0\u548c \u7de8\uff09\uff0e\u30e1\u30b8\u30ab\u30eb\u30d3\u30e5\u30fc\u793e\u3001\u6771\u4eac\uff0c2022\uff0e<\/li>\n\n\n\n
                                      6. \u5927\u9580 \u96c5\u592b\uff0e\u4e8c\u6b21\u6027\u4e09\u5c16\u5f01\u9589\u9396\u4e0d\u5168\u75c7\u306e\u6210\u56e0\u3068\u8a3a\u65ad\uff0c\u6cbb\u7642\u30b9\u30c8\u30e9\u30c6\u30b8\u30fc\uff0e\u5faa\u74b0\u5668\u30b3\u30f3\u30d7\u30ea\u30fc\u30c8 \u5f01\u819c\u75c7\uff08\u5c71\u672c\u4e00\u535a \u7de8\uff09pp. 206-220. \u5b66\u7814\u30e1\u30c7\u30a3\u30ab\u30eb\u79c0\u6f64\u793e\uff0c\u6771\u4eac\uff0c2022\uff0e<\/li>\n\n\n\n
                                      7. \u897f\u5ddd \u771f\u5b50\uff0c\u77e2\u51a8 \u88d5\uff0e\u300c\u8840\u6db2\u75be\u60a3\u6700\u65b0\u306e\u6cbb\u76422023-2025\u300d\u8840\u5c0f\u677f\u6a5f\u80fd\u7570\u5e38\u75c7\uff0e\uff08\u677e\u6751 \u5230\uff0c\u5f35\u66ff \u79c0\u90ce\uff0c\u795e\u7530 \u5584\u4f38 \u7de8\uff09pp. 210-213\uff0e\u5357\u6c5f\u5802\uff0c\u6771\u4eac\uff0c2022\uff0e<\/li>\n<\/ol>\n\n\n\n

                                        \u548c\u6587\u7de8\u8457\u7b49\uff1aJapanese Book Editing<\/h4>\n\n\n\n
                                          \n
                                        1. \u5927\u9580 \u96c5\u592b \u7de8\u96c6\uff0e \u5fc3\u30a8\u30b3\u30fc\u300c\u5168\u8eab\u6027\u75be\u60a3\u3092\u5fc3\u30a8\u30b3\u30fc\u3067\u8a3a\u308b\uff1a\u3053\u308c\u3060\u3051\u306f\u77e5\u3063\u3066\u304a\u304d\u305f\u3044\u5fc3\u30a8\u30b3\u30fc\u6240\u898b\u300d. \u6587\u5149\u5802\uff0c\u6771\u4eac\uff0c2022\uff0e<\/li>\n\n\n\n
                                        2. \u5927\u9580 \u96c5\u592b \u7de8\u96c6\uff0e \u5fc3\u30a8\u30b3\u30fc\u300c\u6cbb\u7642\u3092\u6210\u529f\u306b\u5c0e\u304f\u8853\u4e2d\u30a8\u30b3\u30fc\u300d. \u6587\u5149\u5802\uff0c\u6771\u4eac\uff0c2022\uff0e<\/li>\n\n\n\n
                                        3. \u5927\u9580 \u96c5\u592b\uff0e\u7de8\u96c6\u30fb\u8457\u66f8\uff0e\u5178\u578b\u753b\u50cf\u3092\u898b\u3066\u5b66\u3076\u5fc3\u30a8\u30b3\u30fc\u56f3\u9451\uff0e\u6587\u5149\u5802\uff0c\u6771\u4eac\uff0e2022\uff0e<\/li>\n\n\n\n
                                        4. \u5927\u9580 \u96c5\u592b\uff0e\u7de8\u96c6\u30fb\u8457\u66f8\uff0e\u30a8\u30ad\u30b9\u30d1\u30fc\u30c8\u3092\u76ee\u6307\u3059\u5fc3\u81d3\u5f01\u819c\u75c7\u8a3a\u7642\u30cf\u30f3\u30c9\u30d6\u30c3\u30af\uff0e\u4e2d\u5916\u533b\u5b66\u793e\uff0c\u6771\u4eac\uff0c2022\uff0e<\/li>\n<\/ol>\n<\/div><\/div>\n\n\n\n
                                          \n

                                          2021\u5e74<\/h3>\n\n\n\n

                                          \u82f1\u6587\u539f\u8457\u8ad6\u6587\uff1aEnglish Original Articles<\/h4>\n\n\n\n
                                            \n
                                          1. Chou, S., Yasukawa, K., Fujino, Y., Ishibashi, M., Haraguchi, M., Sato, M., Ikeda, H., Nakamura, S., and Yatomi, Y. Non-mercaptalbumin is significantly associated with the coronary plaque burden and the severity of coronary artery disease.Sci. Rep.<\/em><\/strong>11: 14242<\/a>, 2021.<\/li>\n\n\n\n
                                          2. Hirose, K., Nakanishi, K., Daimon, M., Sawada, N., Yoshida, Y., Iwama, K., Yamamoto, Y., Ishiwata, J., Hirokawa, M., Koyama, K., Morita, H., Di, Tullio, M.R., Homma, S., and Komuro I. Impact of insulin resistance on subclinical left ventricular dysfunction in normal weight and overweight\/obese japanese subjects in a general community. Cardiovasc. Diabetol.<\/strong><\/em> 20: 22<\/a>, 2021.<\/li>\n\n\n\n
                                          3. Honjo, M., Yamagishi, R., Igarashi, N., Ku, C.Y., Kurano, M., Yatomi, Y., Igarashi, K., and Aihara, M. Effect of postoperative corticosteroids on surgical outcome and aqueous autotaxin following combined cataract and microhook ab interno trabeculotomy. Sci. Rep.<\/strong><\/em> 11: 747<\/a>, 2021.<\/li>\n\n\n\n
                                          4. Igarashi, N., Honjo, M., Asaoka, R., Kurano, M., Yatomi, Y., Igarashi, K., Miyata, K., Kaburaki, T., and Aihara, M. Aqueous autotaxin and TGF-\u03b2s are promising diagnostic biomarkers for distinguishing open-angle glaucoma subtypes. Sci. Rep.<\/strong><\/em> 11: 1408<\/a>, 2021.<\/li>\n\n\n\n
                                          5. Igarashi, N., Honjo, M., Yamagishi, R., Kurano, M., Yatomi, Y., Igarashi, K., Kaburaki, T., and Aihara, M. Crosstalk between transforming growth factor beta-2 and Autotaxin in trabecular meshwork and different subtypes of glaucoma.J. Biomed. Sci<\/strong>.<\/em>28: 47<\/a>, 2021.<\/li>\n\n\n\n
                                          6. Isago, H., Mitani, A., Kohno, S., Nagoshi, S., Ishimori, T., Saito, M., Tamiya, H., Miyashita, N., Ishii, T., Matsuzaki, H., Yatomi, Y., Nagase, T., and Jo, T. The Japanese Herbal (Kampo) Medicine Hochuekkito Attenuates Lung Inflammation in Lung Emphysema. Biol. Pharm. Bull.<\/strong><\/em> 44: 39-45<\/a>, 2021.<\/li>\n\n\n\n
                                          7. Ishihara, Y., Okamoto, K., Shimosaka, H., Ono, Y., Kanno, Y., Ikeda, M., Harada, S., Kurano, M., Okugawa, S., Moriya, K., and Yatomi Y. Prevalence and clinical characteristics of patients with biologically false-positive reactions with serological syphilis testing in contemporary practice: 10-year experience at a tertiary academic hospital. Sex. Transm. Infect.<\/strong><\/em> 97: 397-401<\/a>, 2021.<\/li>\n\n\n\n
                                          8. Ishiwata, J., Daimon, M., Nakanishi, K., Sugimoto, T., Kawata, T., Shinozaki, T., Nakao, T., Hirokawa, M., Sawada, N., Yoshida, Y., Amiya, E., Hatano, M., Morita, H., Yatomi, Y., and Komuro, I. Combined evaluation of right ventricular function using echocardiography in non-ischaemic dilated cardiomyopathy. ESC Heart Fail.<\/strong><\/em> 8: 3947-3956<\/a>, 2021.<\/li>\n\n\n\n
                                          9. Iwata, Y., Kitajima, S., Yamahana, J., Shimomura, S., Yoneda-Nakagawa, S., Sakai, N., Furuichi, K., Ogura, H., Sato, K., Toyama, T., Yamamura, Y., Miyagawa, T., Hara, A., Shimizu, M., Ohkawa, R., Kurano, M., Yatomi, Y., and Wada, T. Higher serum levels of autotaxin and phosphatidylserine-specific phospholipase A1 in patients with lupus nephritis. Int. J. Rheum. Dis.<\/strong><\/em> 24: 231-239<\/a>, 2021.<\/li>\n\n\n\n
                                          10. Kaneko, H., Kiriyama, H., Kamon, T., Itoh, H., Kodera, K., Fujiu, K., Daimon, M., Morita, H., Hatano, M., and Komuro, I. Percutaneous mitral valve intervention using MitraClip for functional mitral regurgitation and heart failure. Int. Heart J.<\/strong><\/em> 62: 4-8<\/a>, 2021.<\/li>\n\n\n\n
                                          11. Kano, K., Matsumoto, H., Kono, N., Kurano, M., Yatomi, Y., and Aoki, J. Suppressing postcollection lysophosphatidic acid metabolism improves the precision of plasma LPA quantification. J. Lipid Res. <\/strong><\/em>62: 100029,<\/a> 2021.<\/li>\n\n\n\n
                                          12. Kamon, T., Kaneko, H., Kiriyama, H., Itoh, H., Fujiu, K., Kumazawa, R., Morita, K., Michihata, N., Jo, T., Miura, M., Kodera, S., Uehara, M., Ando, J., Inoue, T., Kinoshita, O., Yamauchi, H., Mori, Y., Nakao, T., Daimon, M., Takeda, N., Morita, H., Ono, M., Yasunaga, H., and Komuro, I. Transcatheter aortic valve implantation and surgical aortic valve replacement for aortic stenosis in Japan; Analysis of a nationwide inpatient database. Circ. Rep.<\/strong><\/em> 2: 753\u2013758<\/a>, 2021.<\/li>\n\n\n\n
                                          13. Kiriyama, H., Kaneko, H., Itoh, H., Kamon, T., Morita, K., Jo, T., Fujiu, K., Daimon, M., Takeda, N., Morita, H., Yasunaga, H., and Komuro I. Surgical treatment for infective endocarditis in the ageing society: a nationwide retrospective study in Japan. Open Heart<\/strong><\/em> 8: e001627<\/a>, 2021.<\/li>\n\n\n\n
                                          14. Kobayashi, T., Kurano, M., Nanya, M., Shimizu, T., Ohkawa, R., Tozuka, M., and Yatomi, Y. Glycation of HDL Polymerizes Apolipoprotein M and Attenuates Its Capacity to Bind to Sphingosine 1-Phosphate. J. Atheroscler. Thromb.<\/em><\/strong> 28: 730-741<\/a>, 2021.<\/li>\n\n\n\n
                                          15. Kurano, M., Kobayashi, T., Sakai, E., Tsukamoto, K., and Yatomi, Y. Lysophosphatidylinositol, especially albumin-bound form, induces inflammatory cytokines in macrophages.FASEB J<\/strong>.<\/em>35: e21673<\/a>, 2021.<\/li>\n\n\n\n
                                          16. Mitani, A., Hamada, K., Yoshikawa, N., Morita, Y., Horie, T., Inoue, Y., Saito, M., Ishii, T., Sunohara, M., Takahashi, R., Emoto, N., Nishimoto, N., Murano, Y., Okazaki, S., Tateishi, S., Yao, A., Shimura, T., Kurano, M., Yatomi, Y., and Yanagimoto, S. Epidemiological study using IgM and IgG antibody titers against SARS-CoV-2 in The University of Tokyo, Japan (UT-CATS).J. Infect. Chemother.<\/strong><\/em> 27: 1342-1349<\/a>, 2021.<\/li>\n\n\n\n
                                          17. Morita, Y., Kurano, M., Sakai, E., Sawabe, M., Aoki, J., Yatomi, Y. Simultaneous analyses of urinary eicosanoids and related mediators identified tetranor-prostaglandin E metabolite as a novel biomarker of diabetic nephropathy. J. Lipid Res.<\/strong><\/em> 62: 100120<\/a>, 2021.<\/li>\n\n\n\n
                                          18. Nakamura, N., Honjo, M., Yamagishi, R., Kurano, M., Yatomi, Y., Watanabe, S., and Aihara, M. Neuroprotective role of sphingolipid rheostat in excitotoxic retinal ganglion cell death.Exp. Eye. Res<\/strong>.<\/em>208: 108623<\/a>, 2021.<\/li>\n\n\n\n
                                          19. Nakano, Y., Kurano, M., Morita, Y., Shimura, T., Yokoyama, R., Qian, C., Xia, F., He, F., Kishi, Y., Okada, J., Yoshikawa, N., Nagura, Y., Okazaki, H., Moriya, K., Seto, Y., Kodama, T., and Yatomi Y. Time course of the sensitivity and specificity of anti-SARS-CoV-2 IgM and IgG antibodies for symptomatic COVID-19 in Japan. Sci. Rep.<\/strong><\/em> 11: 2776<\/a>, 2021.<\/li>\n\n\n\n
                                          20. Nakanishi, K., Daimon, M., Yoshida, Y., Ishiwata, J., Sawada, N., Hirose, K., Iwama, K., Yamamoto, Y., Hirokawa, M., Kaneko, H., Nakao, T., Mizuno, Y., Morita, H., Di, Tullio, M.R., Yatomi, Y., Homma, S., and Komuro I. Relation of Body Mass Index to Adverse Right Ventricular Mechanics. Am. J. Cardiol.<\/strong><\/em> 144: 137-142<\/a>, 2021.<\/li>\n\n\n\n
                                          21. Nishikawa, M., Kanno, H., Zhou, Y., Xiao, TH., Suzuki, T., Ibayashi, Y., Harmon, J., Takizawa, S., Hiramatsu, K., Nitta, N., Kameyama, R., Peterson, W., Takiguchi, J., Shifat-E-Rabbi, M., Zhuang, Y., Yin, X., Rubaiyat, AHM., Deng, Y., Zhang, H., Miyata, S., Rohde, GK., Iwasaki, W., Yatomi, Y., and Goda, K. Massive image-based single-cell profiling reveals high levels of circulating platelet aggregates in patients with COVID-19. Nat Commun.<\/strong><\/em> 12: 7135<\/a>, 2021. Press Release.<\/a><\/li>\n\n\n\n
                                          22. Osawa, I., Okamoto, K., Ikeda, M., Otani, A., Wakimoto, Y., Yamashita, M., Shinohara, T,, Kanno, Y., Jubishi, D., Kurano, M., Harada, S., Okugawa, S., Yatomi, Y., and Moriya, K. Dynamic changes in fibrinogen and D-dimer levels in COVID-19 patients on nafamostat mesylate. J. Thromb. Thrombolysis.<\/strong><\/em> 51: 649-656<\/a>, 2021.<\/li>\n\n\n\n
                                          23. Sato, M., Tateishi, R., Yatomi, Y., and Koike, K. Artificial intelligence in the diagnosis and management of hepatocellular carcinoma. J. Gastroenterol. Hepatol.<\/strong><\/em> 36: 551-560<\/a>, 2021.<\/li>\n\n\n\n
                                          24. Shimura, T., Kurano, M., Kanno, Y., Ikeda, M., Okamoto, K., Jubishi, D., Harada, S., Okugawa, S., Moriya, K., and Yatomi, Y. Clot waveform of APTT has abnormal patterns in subjects with COVID-19. Sci. Rep.<\/strong><\/em> 11: 5190<\/a>, 2021.<\/li>\n\n\n\n
                                          25. Shimura, T., Kurano, M., Okamoto, K., Jubishi, D., Kano, K., Igarashi, K., Shimamoto, S., Aoki, J., Moriya, K., and Yatomi, Y. Increase in serum levels of phosphatidylserine-specific phospholipase A1 in COVID-19 patients. Cell. Mol. Immunol.<\/em><\/strong> 18: 2275-2277<\/a>, 2021.<\/li>\n\n\n\n
                                          26. Soulat-Dufour, L., Addetia, K., Miyoshi, T., Citro, R., Daimon, M., Gutierrez, Fajardo, P., Kasliwal, R.R., Kirkpatrick, J.N., Monaghan, M.J., Muraru, D., Ogunyankin, K.O., Park, S.W., Ronderos, R.E., Sadeghpour, A., Scalia, G.M., Takeuchi, M., Tsang, W., Tucay, E.S., Tude, Rodrigues, A.C., Vivekanandan, A., Zhang, Y., Diehl, M., Schreckenberg, M., Mor-Avi, V., Asch, F.M., and Lang, R.L. Normal values of right atrial size and function according to age, sex and ethnicities: Results of the World Alliance of Societies of Echocardiography study. J. Am. Soc. Echocardiogr.<\/em><\/strong>34: 286-300<\/a>, 2021.<\/li>\n\n\n\n
                                          27. Sugawara, M., Hoshina, K., Chigira, M., Suzuki, H., Daimon, M., Takayama, T., Ono, Y., and Yatomi, Y. Usefulness of duplex ultrasonography to detect collagen sponge misplacement into the arterial lumen during the use of Angio-Seal: A case report. SAGE Open Medical Case Reports<\/strong><\/em> 9: 1-3<\/a>, 2021.<\/li>\n\n\n\n
                                          28. Sugawara, M., Nakao, T., Yatomi, Y., and Daimon, M. Development of aortic regurgitation due to non-bacterial thrombotic endocarditis.J. Med. Ultrason (2001).<\/em><\/strong> 48: 363\u2013364<\/a>, 2021.<\/li>\n\n\n\n
                                          29. Takami, A., Watanabe, S., Yamamoto, Y., Kondo, H., Bamba, Y., Ohata, M., Mishima, S., Kubota, H., Nishiura, A., Miura, R., Iwagami, M., Higashi, K., Yatomi, Y., Tohyama, K., Japanese Society for Laboratory Hematology Standardization, C., Joint Working Group of the, J., and the Japanese Association of Medical, T. Reference intervals of red blood cell parameters and platelet count for healthy adults in Japan.Int. J. Hematol.<\/em><\/strong> 114: 373-380<\/a>, 2021.<\/li>\n\n\n\n
                                          30. Takami, A., Watanabe, S., Yamamoto, Y., Miyachi, H., Bamba, Y., Ohata, M., Mishima, S., Kubota, H., Nishiura, A., Inaba, T., Enomoto, M., Mitsuhashi, T., Nakanishi, K., Miura, R., Nonaka, E., Shimbo, K., Yatomi, Y., Tohyama, K., and Japanese Society for Laboratory Hematology subcommittee on Standardization of Blood Cell, M. Reference intervals of white blood cell parameters for healthy adults in japan. Int. J. Lab. Hematol.<\/em><\/strong> 43: 948-958<\/a>, 2021.<\/li>\n\n\n\n
                                          31. Tanaka, R., Kaburaki, T., Taoka, K., Karakawa, A., Tsuji, H., Nishikawa, M., Yatomi, Y., Shinozaki-Ushiku, A., Ushiku, T., and Araki, F. More Accurate Diagnosis of Vitreoretinal Lymphoma Using a Combination of Diagnostic Test Results: A Prospective Observational Study. Ocul. Immunol. Inflamm.<\/strong><\/em> 4: 1-7<\/a>, 2021.<\/li>\n\n\n\n
                                          32. Takano, H., Yasunaga, M., Yamazaki, I., Nishikawa, M., Masamoto, Y., Shinozaki-Ushiku, A., Kawakami, M., Yatomi, Y., and Kurokawa, M. Degenerated mitochondria in leukemic blast appeared as granules on May-Grunwald-Giemsa staining. Ann Hematol.<\/em><\/strong> 10<\/a>, 2021. Online ahead of print.<\/li>\n\n\n\n
                                          33. Tarao, K., Daimon, M., Son, K., Nakanishi, K., Nakao, T., Suwazono, Y., Isono, S. Risk factors including preoperative echocardiographic parameters for post-induction hypotension in general anesthesia. J. Cardiol.<\/strong><\/em> 78: 230-236<\/a>, 2021.<\/li>\n\n\n\n
                                          34. Tokuoka, S.M., Kita, Y., Sato, M., Shimizu, T., Yatomi, Y., and Oda, Y. Development of Tandem Mass Tag Labeling Method for Lipid Molecules Containing Carboxy and Phosphate Groups, and Their Stability in Human Serum. Metabolites.<\/strong><\/em> 11:19<\/a>, 2021.<\/li>\n\n\n\n
                                          35. Tsuchida, R., Tanabe, Y., Nishizawa, D., Ikeda, K., Abe, H., Inoue, R., Kurano, M., Yatomi, Y., Tamura, K., Takano, T., Shimizu, C., Uchida, K., and Sumitani, M. Genetic polymorphisms of lysophosphatidic acid receptor 1 are associated with the onset of taxane-induced peripheral neuropathy. Br. J. Anaesth. <\/strong><\/em>7: e43-e46<\/a> ,2021.<\/li>\n\n\n\n
                                          36. Uranbileg, B., Ito, N., Kurano, M., Kano, K., Uchida, K., Sumitani, M., Aoki, J., and Yatomi Y. Inhibition of autotaxin activity ameliorates neuropathic pain derived from lumbar spinal canal stenosis. Sci. Rep. <\/strong><\/em>11: 3984<\/a>, 2021.<\/li>\n\n\n\n
                                          37. Xu, B., Daimon, M., Kawata, T., Nakao, T., Hirokawa, M., Sawada, N., Kimura, K., Yamanaka, Y., Morita, H., Komuro, I., and Yatomi Y. Relationship Between Mitral Leaflet Size and Coaptation and Their Associated Factors in Patients with Normal Left Ventricular Size and Systolic Function. Int. Heart J.<\/strong><\/em> 62: 95-103<\/a>, 2021.<\/li>\n\n\n\n
                                          38. Xu, B., Kawata, T., Nakao, T., Nakanishi, K., Hirokawa, M., Sawada, N., Kimura, K., Abe, Y., Komuro, I., Yatomi, Y., and Daimon, M. Mitral Valvular Coaptation-Zone Area Is Associated with the Severity of Atherosclerosis Assessed by Cardio-Ankle Vascular Index.Int. Heart J.<\/strong><\/em>62: 552-558<\/a>, 2021.<\/li>\n\n\n\n
                                          39. Yasuda, N., Nishikawa, M., Shimosaka, H., Ono, Y., and Yatomi, Y. Effect of administration of immunoglobulin preparations on the results of tests for autoantibodies. Mod. Rheumatol.<\/strong><\/em> roab085<\/a>, 2021.<\/li>\n\n\n\n
                                          40. Yokoyama, R., Kurano, M., Morita, Y., Shimura, T., Nakano, Y., Qian, C., Xia, F., He, F., Kishi, Y., Okada, J., Yoshikawa, N., Nagura, Y., Okazaki, H., Moriya, K., Seto, Y., Kodama, T., and Yatomi, Y. Validation of a new automated chemiluminescent anti-SARS-CoV-2 IgM and IgG antibody assay system detecting both N and S proteins in Japan. PLoS One.<\/strong><\/em> 16: e0247711<\/a>, 2021.<\/li>\n\n\n\n
                                          41. Yokoyama, R., Kurano, M., Nakano, Y., Morita, Y., Ohmiya, H., Kishi, Y., Okada, J., Qian, C., Xia, F., He, F., Zheng, L., Yu, Y., Jubishi, D., Okamoto, K., Moriya, K., Kodama, T., and Yatomi, Y. Association of the serum levels of the nucleocapsid antigen of SARS-CoV-2 with the diagnosis, disease severity, and antibody titers in patients with COVID-19: a retrospective cross-sectional study. Front. Microbiol.<\/strong><\/em> 12: 791489<\/a>, 2021.<\/li>\n\n\n\n
                                          42. Yoshida, Y., Nakanishi, K., Daimon, M., Ishiwata, J., Sawada, N., Hirokawa, M., Kaneko, H., Nakao, T., Mizuno, Y., Morita, H., Di, Tullio, M.R., Homma, S., and Komuro, I. Sex-specific Difference in the Association Between Arterial Stiffness and Subclinical Left Ventricular Dysfunction. Eur. Heart. J. Cardiovasc. Imaging<\/strong><\/em> 22: 817-823<\/a>, 2021.<\/li>\n<\/ol>\n\n\n\n

                                            \u56fd\u5185\u5b66\u4f1a\u767a\u8868\uff1aDomestic Conference Presentation<\/h4>\n\n\n\n
                                              \n
                                            1. \u4e95\u4e0a \u7fd4\u592a\uff0c\u5927\u9580 \u96c5\u592b\uff0c\u4e2d\u5c3e \u502b\u5b50\uff0c\u9234\u6728 \u535a\u82f1\uff0c\u4f50\u3005\u6728 \u8cc0\u6d25\u4e43\uff0c\u5bae\u5d0e \u4ee4\u5b50\uff0c\u5343\u660e \u771f\u5f13\uff0c\u9808\u85e4 \u82b3\u5b9f\uff0c\u83c5\u539f \u5c06\u4ee3\uff0c\u5bbf\u5229 \u6df3\uff0c\u4e45\u4fdd\u7530 \u3068\u3082\u3088\uff0c\u67f3\u6ca2 \u5f69\uff0c\u77e2\u51a8 \u88d5\uff0eLibman-Sacks\u5fc3\u5185\u819c\u708e\u306e\u5fc3\u30a8\u30b3\u30fc\u56f3\u6240\u898b\u304a\u3088\u3073\u81e8\u5e8a\u50cf \u5f53\u9662\u3067\u7d4c\u9a13\u3057\u305f12\u75c7\u4f8b\u306e\u307e\u3068\u3081\uff0e\u65e5\u672c\u5fc3\u30a8\u30b3\u30fc\u56f3\u5b66\u4f1a \u7b2c32\u56de\u5b66\u8853\u96c6\u4f1a\uff0e2021.4.23-25\uff0e\u57fc\u7389. web\u958b\u50ac\uff0e<\/li>\n\n\n\n
                                            2. \u4e95\u4e0a \u7fd4\u592a\uff0c\u5927\u9580 \u96c5\u592b\uff0c\u4e2d\u5c3e \u502b\u5b50\uff0c\u9234\u6728 \u535a\u82f1\uff0c\u4f50\u3005\u6728 \u8cc0\u6d25\u4e43\uff0c\u83c5\u539f \u5c06\u4ee3\uff0c\u5bbf\u5229 \u6df3\uff0c\u4e45\u4fdd\u7530 \u3068\u3082\u3088\uff0c\u5c0f\u91ce \u4f73\u4e00\uff0c\u77e2\u51a8 \u88d5\uff0e\u5fc3\u30a8\u30b3\u30fc\u56f3\u306b\u3088\u308bVector Flow Mapping\uff08VFM\uff09\u3092\u7528\u3044\u3066\u5de6\u5ba4\u5185\u8840\u884c\u52d5\u614b\u3092\u89e3\u6790\u3057\u305f\u62e1\u5f35\u578b\u5fc3\u7b4b\u75c7\u306e1\u75c7\u4f8b\uff0e\u7b2c68\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2021.11.11-14\uff0e\u5bcc\u5c71\uff0eweb\u958b\u50ac\uff0e<\/li>\n\n\n\n
                                            3. \u5c0f\u91ce \u4f73\u4e00\uff0e\u30e9\u30f3\u30c1\u30e7\u30f3\u30bb\u30df\u30ca\u30fc\uff0e\u5f53\u9662\u3067\u7d4c\u9a13\u3057\u305f\u5c45\u306a\u304c\u3089\u6539\u4fee\u3068\u65b0\u578b\u30b3\u30ed\u30ca\u30a6\u30a4\u30eb\u30b9\u611f\u67d3\u75c7\u5bfe\u7b56\u4e0b\u3067\u306e\u65b0\u3057\u3044\u63a1\u8840\u5ba4\u306e\u904b\u55b6\uff0e\u65e5\u672c\u533b\u7642\u691c\u67fb\u79d1\u5b66\u4f1a \u7b2c53\u56de\u5927\u4f1a\uff0e2021.10.8-10\uff0e\u6a2a\u6d5c\uff0e<\/li>\n\n\n\n
                                            4. \u5f71\u5c71 \u7950\u5b50\uff0c\u5409\u5ddd \u76f4\u4e4b\uff0c\u4e0b\u5742 \u6d69\u5247\uff0c\u5c0f\u91ce \u4f73\u4e00\uff0c\u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0e\u5f53\u9662\u3067\u7d4c\u9a13\u3057\u305f\u300c\u5c45\u306a\u304c\u3089\u6539\u4fee\u300d\u3068\u691c\u67fb\u30b7\u30b9\u30c6\u30e0\u66f4\u65b0\u306b\u304a\u3051\u308b\u5bfe\u5fdc\uff0e\u65e5\u672c\u533b\u7642\u691c\u67fb\u79d1\u5b66\u4f1a \u7b2c53\u56de\u5927\u4f1a\uff0e2021.10.8-10\uff0e\u6a2a\u6d5c\uff0e<\/li>\n\n\n\n
                                            5. \u5f71\u5c71 \u7950\u5b50\uff0c\u5409\u5ddd \u76f4\u4e4b\uff0c\u4e0b\u5742 \u6d69\u5247\uff0c\u5c0f\u91ce \u4f73\u4e00\uff0c\u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0e\u30b3\u30f3\u30bb\u30d7\u30c8\u306b\u57fa\u3065\u3044\u305f\u691c\u67fb\u5ba4\u306e\u69cb\u7bc9\u3068\u904b\u7528\u5f8c\u306e\u52b9\u679c\u30fb\u8ab2\u984c\uff0e\u65e5\u672c\u533b\u7642\u691c\u67fb\u79d1\u5b66\u4f1a \u7b2c53\u56de\u5927\u4f1a\uff0e2021.10.8-10\uff0e\u6a2a\u6d5c\uff0e<\/li>\n\n\n\n
                                            6. \u8535\u91ce \u4fe1\uff0c\u5c0f\u6797 \u7389\u5b9c\uff0c\u77e2\u51a8 \u88d5\uff0e\u7cd6\u5c3f\u75c5\u60a3\u8005\u3067\u306e\u30bb\u30e9\u30df\u30c9\uff0c\u30b9\u30d5\u30a3\u30f3\u30b4\u30b7\u30f3\u306e\u8840\u4e2d\u904b\u642c\u4f53\u9593\u5206\u5e03\u306e\u5909\u5316\uff0e\u7b2c118\u56de \u65e5\u672c\u5185\u79d1\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u8b1b\u6f14\u4f1a\uff0e2021.4.9-11\uff0e\u6771\u4eac\uff0e<\/li>\n\n\n\n
                                            7. \u8535\u91ce \u4fe1\uff0c\u5742\u4e95 \u82f1\u91cc\uff0c\u77e2\u51a8 \u88d5\uff0e\u8179\u819c\u64ad\u7a2e\u764c\u30e2\u30c7\u30eb\u30de\u30a6\u30b9\u306e\u30ea\u30d4\u30c9\u30df\u30af\u30b9\u89e3\u6790\u306b\u3088\u308b\u764c\u95a2\u9023\u751f\u7406\u6d3b\u6027\u8102\u8cea\u306e\u63a2\u7d22\uff0e\u7b2c46\u56de \u65e5\u672c\u533b\u7528\u30de\u30b9\u30b9\u30da\u30af\u30c8\u30eb\u5b66\u4f1a\u5e74\u4f1a\uff0e2021.9.17-18. \u4ed9\u53f0\uff0e<\/li>\n\n\n\n
                                            8. \u8535\u91ce \u4fe1\uff0c\u585a\u672c \u548c\u4e45\uff0c\u77e2\u51a8 \u88d5\uff0e\u30de\u30a4\u30ca\u30fc\u30a2\u30dd\u86cb\u767d\u306b\u3088\u308bHDL\u306e\u591a\u9762\u7684\u52b9\u679c\u306e\u533b\u7642\u5fdc\u7528\u3092\u76ee\u6307\u3057\u3066\uff08\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\uff09\uff0e\u7b2c94\u56de \u65e5\u672c\u751f\u5316\u5b66\u4f1a\u5927\u4f1a\uff0e2021.11.4. \u6a2a\u6d5c\uff0e<\/li>\n\n\n\n
                                            9. \u8535\u91ce \u4fe1\uff0c\u6edd\u53e3 \u7d14\uff0c\u77e2\u51a8 \u88d5\uff0eC\u53cd\u5fdc\u6027\u86cb\u767d\u306b\u3088\u308b\u8102\u8cea\u30e1\u30c7\u30a3\u30a8\u30fc\u30bf\u30fc\u306e\u5909\u52d5\uff0e\u7b2c68\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2021.11.11-14\uff0e\u5bcc\u5c71\uff0e<\/li>\n\n\n\n
                                            10. \u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0e\u4e2d\u67a2\u795e\u7d4c\u7cfb\u306b\u304a\u3051\u308b\u30a2\u30dd\u86cb\u767dE\u306b\u3088\u308b\u30b9\u30d5\u30a3\u30f3\u30b4\u8102\u8cea\u306e\u5236\u5fa1\uff0e\u7b2c68\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2021.11.11-14\uff0e\u5bcc\u5c71\uff0e<\/li>\n\n\n\n
                                            11. \u8535\u91ce \u4fe1\uff0c\u68ee\u7530 \u8ce2\u53f2\uff0c\u5742\u4e95 \u82f1\u91cc\uff0c\u77e2\u51a8 \u88d5\uff0e\u8cea\u91cf\u5206\u6790\u8a08\u306b\u3088\u308b\u5c3f\u4e2d\u751f\u7406\u6d3b\u6027\u8102\u8cea\u306e\u81e8\u5e8a\u691c\u67fb\u3078\u306e\u5fdc\u7528\uff0e\u7b2c68\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2021.11.11-14\uff0e\u5bcc\u5c71\uff0e<\/li>\n\n\n\n
                                            12. \u4f50\u85e4 \u96c5\u54c9\uff0c\u5efa\u77f3 \u826f\u4ecb\uff0c\u5c0f\u6c60 \u548c\u5f66\uff0e\u8d85\u97f3\u6ce2B\u30e2\u30fc\u30c9\u753b\u50cf\u3067\u306e\u809d\u816b\u7624\u6027\u75c5\u5909\u306e\u826f\u60aa\u6027\u8b58\u5225\u306b\u304a\u3051\u308b\u30de\u30eb\u30c1\u30e2\u30fc\u30c0\u30eb\u6df1\u5c64\u5b66\u7fd2\u306e\u6709\u7528\u6027\u306e\u691c\u8a0e\uff0e\u7b2c107\u56de \u65e5\u672c\u6d88\u5316\u5668\u75c5\u5b66\u4f1a\u7dcf\u4f1a\uff0e2021.4.15-17\uff0e\u6771\u4eac\uff0e<\/li>\n\n\n\n
                                            13. \u5e38\u540d \u653f\u5f18\uff0c\u30b7\u30f3 \u53cb\u559c\uff0c\u5897\u6238 \u68a8\u6075\uff0c\u4f50\u85e4 \u7f8e\u77e5\u5b50\uff0c\u8fbb\u4e95 \u4e9c\u5f25\uff0c\u4e38\u5c3e \u7406\u6075\uff0c\u5bfa\u5cf6 \u9053\u5b50\uff0c\u5c0f\u91ce \u4f73\u4e00\uff0c\u897f\u5ddd \u771f\u5b50\uff0c\u77e2\u51a8 \u88d5\uff0eRAL DIAGNOSTICS\u793e\u88fd\u8840\u6db2\u6a19\u672c\u67d3\u8272\u6db2\u306e\u6027\u80fd\u8a55\u4fa1(\u7b2c1\u5831)\u3000\u67d3\u8272\u6027\u306e\u57fa\u790e\u8a55\u4fa1\uff0e\u7b2c22\u56de \u65e5\u672c\u691c\u67fb\u8840\u6db2\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2021.9.11-12\uff0e\u5e73\u585a\u5e02\uff0e<\/li>\n\n\n\n
                                            14. \u5e38\u540d \u653f\u5f18\uff0c\u30b7\u30f3 \u53cb\u559c\uff0c\u5897\u6238 \u68a8\u6075\uff0c\u8239\u6238 \u771f\u5948\u7f8e\uff0c\u4e38\u5c3e \u7406\u6075\uff0c\u91ce\u3005\u90e8 \u4eae\u5b50\uff0c\u5bfa\u5cf6 \u9053\u5b50\uff0c\u5c0f\u91ce \u4f73\u4e00\uff0c\u897f\u5ddd \u771f\u5b50\uff0c\u77e2\u51a8 \u88d5\uff0eRAL DIAGNOSTICS\u793e\u88fd\u8840\u6db2\u6a19\u672c\u67d3\u8272\u6db2\u306e\u6027\u80fd\u8a55\u4fa1(\u7b2c2\u5831)\u3000\u30c7\u30b8\u30bf\u30eb\u624b\u6cd5\u3092\u7528\u3044\u305f\u67d3\u8272\u6027\u8a55\u4fa1\u306e\u8a66\u307f\uff0e\u7b2c22\u56de \u65e5\u672c\u691c\u67fb\u8840\u6db2\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2021.9.11-12\uff0e\u5e73\u585a\u5e02\uff0e<\/li>\n\n\n\n
                                            15. \u83c5\u539f \u5c06\u4ee3\uff0c\u5927\u9580 \u96c5\u592b\uff0c\u4e2d\u5c3e \u502b\u5b50\uff0c\u9234\u6728 \u535a\u82f1\uff0c\u4f50\u3005\u6728 \u8cc0\u6d25\u4e43\uff0c\u5bbf\u5229 \u6df3\uff0c\u4e95\u4e0a \u7fd4\u592a\uff0c\u4e45\u4fdd\u7530 \u3068\u3082\u3088\uff0c\u5c0f\u91ce \u4f73\u4e00\uff0c\u77e2\u51a8 \u88d5\uff0e\u5927\u52d5\u8108\u5f01\u9006\u6d41\u5897\u60aa\u306b\u3088\u308a\u8a3a\u65ad\u3055\u308c\u305f\u975e\u7d30\u83cc\u6027\u8840\u6813\u6027\u5fc3\u5185\u819c\u708e\u306e1\u75c7\u4f8b\uff0e\u7b2c68\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2021.11.11-14\uff0e\u5bcc\u5c71\uff0eweb\u958b\u50ac\uff0e<\/li>\n\n\n\n
                                            16. \u7530\u4e2d \u96c5\u7f8e\uff0e\u30d1\u30cd\u30eb\u30c7\u30a3\u30b9\u30ab\u30c3\u30b7\u30e7\u30f33 \u4e00\u822c\u691c\u67fb\u306e\u4eba\u6750\u80b2\u6210\u3068\u54c1\u8cea\u7ba1\u7406\uff08\u529b\u91cf\u7ba1\u7406\uff09\uff0e\u7b2c70\u56de \u65e5\u672c\u533b\u5b66\u691c\u67fb\u5b66\u4f1a\uff0e2021.5.15-16\uff0e\u798f\u5ca1\uff0e<\/li>\n\n\n\n
                                            17. \u5bfa\u5cf6 \u9053\u5b50\uff0c\u5e38\u540d \u653f\u5f18\uff0c\u4e38\u5c3e \u7406\u6075\uff0c\u8239\u6238 \u771f\u5948\u7f8e\uff0c\u4f50\u85e4 \u7f8e\u77e5\u5b50\uff0c\u5c0f\u91ce \u4f73\u4e00\uff0c\u6edd\u53e3 \u7d14\uff0c\u897f\u5ddd \u771f\u5b50\uff0c\u77e2\u51a8 \u88d5\uff0e\u5bd2\u51b7\u51dd\u96c6\u7d20\u75c7\u306e\u52a0\u7642\u4e2d\u306b\u3073\u307e\u3093\u6027\u5927\u7d30\u80de\u578bB\u7d30\u80de\u6027\u30ea\u30f3\u30d1\u816b\u3092\u767a\u75c7\u3057\u305f1\u75c7\u4f8b\uff0e\u7b2c22\u56de \u65e5\u672c\u691c\u67fb\u8840\u6db2\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2021.9.11-12\uff0e\u5e73\u585a\u5e02\uff0e<\/li>\n\n\n\n
                                            18. \u4e2d\u91ce \u88d5\u6a39\uff0c\u68ee\u7530 \u8ce2\u53f2\uff0c\u5742\u4e95 \u82f1\u91cc\uff0c\u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0eLC-MS\/MS\u306b\u3088\u308b\u5c3f\u4e2d\u751f\u7406\u6d3b\u6027\u8102\u8cea\u4e00\u6589\u5206\u6790\u3092\u7528\u3044\u305f\u6025\u6027\u814e\u969c\u5bb3\u306e\u30d0\u30a4\u30aa\u30de\u30fc\u30ab\u30fc\u63a2\u7d22\uff0e\u7b2c68\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2021.11.11-14\uff0e\u5bcc\u5c71\uff0e<\/li>\n\n\n\n
                                            19. \u4e2d\u6751 \u548c\u594f\uff0c\u897f\u68ee \u307e\u3069\u304b\uff0c\u5c0f\u91ce \u4f73\u4e00\uff0c\u76db\u7530 \u548c\u6cbb\uff0c\u5c71\u672c \u53cb\u52a0\u5229\uff0c\u5409\u672c \u660e\uff0c\u5ddd\u7aef \u307f\u3061\u308b\uff0c\u68ee\u7530 \u8ce2\u53f2\uff0c\u5409\u5ddd \u76f4\u4e4b\uff0c\u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0e\u5f53\u9662\u306b\u304a\u3051\u308b\u6539\u4fee\u30fb\u6a5f\u5668\u66f4\u65b0\u5f8c\u306e\u5916\u6765\u8840\u5ba4\u306e\u904b\u7528\u306b\u3064\u3044\u3066\uff0e\u7b2c53\u56de \u65e5\u672c\u533b\u7642\u691c\u67fb\u79d1\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2021.10.8-10\uff0e\u6a2a\u6d5c\uff0e<\/li>\n\n\n\n
                                            20. \u897f\u5ddd \u5c1a\u5b50\uff0c\u8535\u91ce \u4fe1\uff0c\u6c60\u7530 \u5747\uff0c\u77e2\u51a8 \u88d5\uff0c\u5c0f\u6c60 \u548c\u5f66\uff0e\u30ea\u30be\u30db\u30b9\u30d5\u30a1\u30c1\u30b8\u30eb\u30bb\u30ea\u30f3\u306f\u65b0\u898f\u809d\u7dda\u7dad\u5316\u30de\u30fc\u30ab\u30fc\u306e\u53ef\u80fd\u6027\u304c\u3042\u308b\uff0e\u7b2c107\u56de \u65e5\u672c\u6d88\u5316\u5668\u75c5\u5b66\u4f1a\u7dcf\u4f1a\uff0e2021.4.15-17\uff0e<\/li>\n\n\n\n
                                            21. \u897f\u5ddd \u771f\u5b50\uff0c\u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0e\u30d5\u30ed\u30fc\u30b5\u30a4\u30c8\u30e1\u30c8\u30ea\u30fc\u3092\u7528\u3044\u305f\u7cd6\u5c3f\u75c5\u306b\u304a\u3051\u308b\u8840\u5c0f\u677f\u53d7\u5bb9\u4f53\u306emRNA\u89e3\u6790\uff0e\u7b2c43\u56de \u65e5\u672c\u8840\u6813\u6b62\u8840\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2021.5.28-31\uff0e\u5bae\u5d0e\uff0e<\/li>\n\n\n\n
                                            22. \u897f\u5ddd \u771f\u5b50\uff0e\u30c6\u30af\u30cb\u30ab\u30eb\u30bb\u30df\u30ca\u30fc\uff12 \u591a\u767a\u6027\u9aa8\u9ac4\u816b\u306eFCM\u89e3\u6790\u3000\u2015\u8a3a\u65ad\u6642\u306e\u30dd\u30a4\u30f3\u30c8\u3092\u4e2d\u5fc3\u306b\u2015\uff0e\u7b2c22\u56de \u65e5\u672c\u691c\u67fb\u8840\u6db2\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2021.9.11-12\uff0e\u5e73\u585a\u5e02\uff0e<\/li>\n\n\n\n
                                            23. \u897f\u5ddd \u771f\u5b50\uff0c\u5bfa\u5cf6 \u9053\u5b50\uff0c\u5e38\u540d \u653f\u5f18\uff0c\u77e2\u51a8 \u88d5\uff0e\u30b7\u30f3\u30dd\u30b8\u30a6\u30e06 \u4f53\u8154\u6db2\u306eFCM\u691c\u67fb\u304c\u6cbb\u7642\u65b9\u91dd\u6c7a\u5b9a\u306b\u5f79\u7acb\u3063\u305f\u3073\u307e\u3093\u6027\u5927\u7d30\u80de\u578bB\u7d30\u80de\u30ea\u30f3\u30d1\u816b\u306e2\u75c7\u4f8b\uff0d\u5e0c\u5c11\u691c\u4f53\u3067\u306e\u691c\u51fa\uff0d\uff0e\u7b2c68\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2021.11.12-14\uff0e\u5bcc\u5c71\uff0e<\/li>\n\n\n\n
                                            24. \u4e45\u672b \u76f4\u5b50\uff0c\u5742\u672c \u611b\u5b50\uff0c\u67f3\u5143 \u4f38\u592a\u90ce\uff0c\u516b\u5c3e \u539a\u53f2\uff0e\u5927\u5b66\u4fdd\u5065\u696d\u52d9\u306b\u304a\u3051\u308bCOVID-19\u8fc5\u901f\u6297\u539f\u691c\u67fb\u30ad\u30c3\u30c8\u306e\u6709\u7528\u6027\u306b\u95a2\u3059\u308b\u691c\u8a0e\uff0e\u7b2c59\u56de \u5168\u56fd\u5927\u5b66\u4fdd\u5065\u7ba1\u7406\u7814\u7a76\u96c6\u4f1a\uff0e2021.10.6-7. \u5e83\u5cf6\uff0e<\/li>\n\n\n\n
                                            25. \u4e45\u672b \u76f4\u5b50\uff0c\u6625\u539f \u5149\u5b8f\uff0c\u4e95\u4e0a \u6709\u5e0c\u5b50\uff0c\u516b\u5c3e \u539a\u53f2\uff0c\u7acb\u77f3 \u6676\u5b50\uff0c\u6751\u91ce \u967d\u5b50\uff0c\u67f3\u5143 \u4f38\u592a\u90ce. \u6771\u4eac\u5927\u5b66\u4fdd\u5065\u30bb\u30f3\u30bf\u30fc\u306b\u304a\u3051\u308b\u65b0\u578b\u30b3\u30ed\u30ca\u30a6\u30a4\u30eb\u30b9\u611f\u67d3\u75c7\u691c\u67fb\u306e\u5b9f\u65bd\u306b\u3064\u3044\u3066. \u7b2c59\u56de \u5168\u56fd\u5927\u5b66\u4fdd\u5065\u7ba1\u7406\u7814\u7a76\u96c6\u4f1a\uff0e2021.10.6-7. \u5e83\u5cf6\uff0e<\/li>\n\n\n\n
                                            26. \u6301\u7530 \u667a\u4e4b\uff0c\u52a0\u85e4 \u58ef\uff0c\u837b\u6fa4 \u6075\u7f8e\uff0c\u5c71\u7530 \u306f\u308b\u9999\uff0c\u79cb\u7530 \u840c\uff0c\u7530\u5cf6 \u5c06\u592a\u90ce\uff0c\u771e\ufa11 \u6842\uff0c\u77e2\u51a8 \u88d5\uff0c\u4ee3\u7530 \u60a0\u4e00\u90ce\uff0e\u904b\u52d5\u8a98\u767a\u96fb\u4f4d\u3092\u7528\u3044\u305f\u8853\u4e2d\u810a\u9ac4\u30e2\u30cb\u30bf\u30ea\u30f3\u30b0\u306e\u6709\u7528\u6027\u306b\u95a2\u3059\u308b\u5f8c\u65b9\u8996\u7684\u691c\u8a0e\uff0e\u7b2c51\u56de \u65e5\u672c\u81e8\u5e8a\u795e\u7d4c\u751f\u7406\u5b66\u4f1a\uff0e2021.12.16-18\uff0e\u5bae\u57ce\uff0e<\/li>\n\n\n\n
                                            27. \u68ee\u7530 \u8ce2\u53f2\uff0c\u4e45\u672b \u5d07\u53f8\uff0c\u6a2a\u5c71 \u96a3\uff0c\u5409\u5ddd \u76f4\u4e4b\uff0c\u5c0f\u91ce \u4f73\u4e00\uff0c\u5bbf\u8c37 \u8ce2\u4e00\uff0c\u77e2\u51a8 \u88d5\uff0c\u7530\u4e2d \u96c5\u7f8e\uff0e\u5168\u81ea\u52d5\u5c3f\u4e2d\u6709\u5f62\u6210\u5206\u5206\u6790\u88c5\u7f6eUF-5000\u3092\u7528\u3044\u305f\u93e1\u691c\u30ed\u30b8\u30c3\u30af\u306e\u8a55\u4fa1\uff0e\u7b2c70\u56de \u65e5\u672c\u533b\u5b66\u691c\u67fb\u5b66\u4f1a\uff0e2021.5.15-16\uff0e\u798f\u5ca1\uff0e<\/li>\n\n\n\n
                                            28. \u68ee\u7530 \u8ce2\u53f2\uff0c\u6a2a\u5c71 \u96a3\uff0c\u7530\u4e2d \u96c5\u7f8e\uff0c\u4e45\u672b \u5d07\u53f8\uff0c\u5c0f\u91ce \u4f73\u4e00\uff0c\u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0e\u5c3f\u4e2dNAG\u304c\u507d\u9ad8\u5024\u3092\u5448\u3057\u305f\u591a\u767a\u6027\u9aa8\u9ac4\u816b\u306e\u4e00\u75c7\u4f8b\uff0e\u7b2c53\u56de \u65e5\u672c\u533b\u7642\u691c\u67fb\u79d1\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2021.10.8-10\uff0e\u6a2a\u6d5c\uff0e<\/li>\n\n\n\n
                                            29. \u68ee\u7530 \u8ce2\u53f2\uff0c\u6a2a\u5c71 \u96a3\uff0c\u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0eCOVID-19\u60a3\u8005\u306b\u304a\u3051\u308b\u5c3f\u6c88\u6e23\u304a\u3088\u3073\u5c3f\u30d0\u30a4\u30aa\u30de\u30fc\u30ab\u30fc\u306e\u7279\u5fb4\uff0e\u7b2c68\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2021.11.11-14\uff0e\u5bcc\u5c71\uff0e<\/li>\n\n\n\n
                                            30. \u5b89\u5ddd \u6075\u5b50\uff0c\u897f\u5ddd \u771f\u5b50\uff0c\u897f\u5ddd \u5c1a\u5b50\uff0cBaasanjav Uranbileg\uff0c\u4f50\u85e4 \u96c5\u54c9\uff0c\u6c60\u7530 \u5747\uff0c\u77e2\u51a8 \u88d5\uff0e\u9178\u5316\u578b\u30a2\u30eb\u30d6\u30df\u30f3\uff08HNA\uff09\u5024\uff08%\uff09\u306e\u5065\u5e38\u4eba\u306b\u304a\u3051\u308b\u5909\u52d5\u5e45\u306e\u691c\u8a0e\u7cd6\u8ca0\u8377\u8a66\u9a13\u524d\u5f8c\uff0c\u304a\u3088\u3073\u4e2d\u9577\u671f\u9593\u3067\u306e\u5909\u52d5\u5e45\u306e\u691c\u8a0e\uff0e\u7b2c71\u56de \u65e5\u672c\u4f53\u8cea\u533b\u5b66\u4f1a\u7dcf\u4f1a\uff0e2021.9.4-5\uff0e\u718a\u672c\uff0e<\/li>\n\n\n\n
                                            31. \u5c71\u672c \u53cb\u52a0\u5229\uff0c\u5409\u672c \u660e\uff0c\u4f50\u85e4 \u96c5\u54c9\uff0c\u68ee\u7530 \u8ce2\u53f2\uff0c\u5c0f\u91ce \u4f73\u4e00\uff0c\u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0e\u5916\u6765\u63a1\u8840\u5ba4\u306b\u304a\u3051\u308b\u795e\u7d4c\u640d\u50b7\u7591\u3044\u4e8b\u4f8b\u306e\u89e3\u6790\u306b\u3064\u3044\u3066. \u7b2c68\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2021.11.11-14\uff0e\u5bcc\u5c71\uff0e<\/li>\n\n\n\n
                                            32. \u6a2a\u5c71 \u96a3\uff0c\u4e2d\u91ce \u88d5\u6a39\uff0c\u68ee\u7530 \u8ce2\u53f2\uff0c\u5c0f\u91ce \u4f73\u4e00\uff0c\u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0eCOVID-19\u60a3\u8005\u306b\u304a\u3051\u308bSARS-CoV-2\u4e2d\u548c\u6297\u4f53\u4fa1\u306e\u5909\u52d5\uff0e\u7b2c68\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2021.11.11-14\uff0e\u5bcc\u5c71\uff0e<\/li>\n\n\n\n
                                            33. \u6a2a\u5c71 \u96a3\uff0c\u4e2d\u91ce \u88d5\u6a39\uff0c\u68ee\u7530 \u8ce2\u53f2\uff0c\u5c0f\u91ce \u4f73\u4e00\uff0c\u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0e\u8840\u4e2dSARS-CoV-2 N\u6297\u539f\u5b9a\u91cf\u691c\u67fb\u306e\u81e8\u5e8a\u7684\u6709\u7528\u6027\u306e\u691c\u8a0e\uff0e\u7b2c68\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2021.11.11-14\uff0e\u5bcc\u5c71\uff0e<\/li>\n\n\n\n
                                            34. Uranbileg,B., Kurano,M., Yatomi,Y. Involvement of SPL in the pathogenesis of cancer through converting sphingolipids to glycerophospholipids. \u7b2c68\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2021.11.11-14\uff0e\u5bcc\u5c71\uff0e<\/li>\n<\/ol>\n\n\n\n

                                              \u82f1\u6587\u7dcf\u8aac\uff1aEnglish Review Articles<\/h4>\n\n\n\n
                                                \n
                                              1. Zhou, Y., Isozaki, A., Yasumoto, A., Xiao, T.H., Yatomi, Y., Lei, C., and Goda, K. Intelligent Platelet Morphometry.Trends Biotechnol<\/strong><\/em> 39: 978-989<\/a> ,2021.<\/li>\n<\/ol>\n\n\n\n

                                                \u56fd\u969b\u5b66\u4f1a\u767a\u8868\uff1aInternational Conference Presentation<\/h4>\n\n\n\n
                                                  \n
                                                1. Morita,Y.,Kurano,M., Yatomi,Y. Modulation of urinary lysophospholipids and sphingolipids in kidney diseases. FASEB Scientific Research Conferences: The Lysophospholipid and Related Mediators Conference: From Bench to Clinic. 2021.7.13-15. Web Conference.<\/li>\n\n\n\n
                                                2. Makoto Kurano, Kazuhisa Tsukamoto, and Yutaka Yatomi. Pleiotropic effects of HDL via Apolipoprotein M\/Sphingosine 1-phosphate axis (Symposium) The 19th International Symposium on Atherosclerosis(ISA 2021). 2021.10.27. Kyoto.<\/li>\n\n\n\n
                                                3. Makoto Kurano, Kazuhisa Tsukamoto, Naoyuki Kamatani, Masumi Hara, Toshio Ishikawa, Yutaka Yatomi, and Tamio Teramoto. Genome-wide association study of CRP identified apolipoprotein D as a novel anti-inflammatory apolipoprotein. The 19th International Symposium on Atherosclerosis(ISA 2021). 2021.10.25. Kyoto.<\/li>\n\n\n\n
                                                4. Makoto Kurano, Yutaka Yatomi. Species dependent effects of lysophosphatidylserine on inflammation in macrophages FASEB Scientific Research Conferences: The Lysophospholipid and Related Mediators Conference: From Bench to Clinic. 2021.7.13-15. Web Conference.<\/li>\n\n\n\n
                                                5. Takako Nishikawa, Makoto Kurano, Hitoshi Ikeda, Nobutake Yamamichi, Yutaka Yatomi and Kazuhiko Koike. LYSOPHOSPHATIDYLSERINE MAY BE INVOLVED IN LIVER FIBROSIS. AASLD 2021.2021.11.12-15. Poster Presentation.<\/li>\n\n\n\n
                                                6. Uranbileg,B., Kurano,M., Sakai,E., Ikeda,H.,Yatomi,Y. Involvement of SPL in the pathogenesis of cancer through converting sphingolipids to glycerophospholipids. FASEB Scientific Research Conferences: The Lysophospholipid and Related Mediators Conference: From Bench to Clinic. 2021.7.13-15. Web Conference.<\/li>\n<\/ol>\n\n\n\n

                                                  \u548c\u6587\u539f\u8457\u8ad6\u6587\uff1aJapanese Original Articles<\/h4>\n\n\n\n
                                                    \n
                                                  1. \u6e05\u6c34 \u5eb7\u5e73\uff0c\u6c38\u53cb \u5229\u5f8b\u5b50\uff0c\u5c0f\u91ce \u4f73\u4e00\uff0c\u9ad8\u6a4b \u6075\uff0c\u4e09\u5b85 \u52a0\u5948\uff0c\u8535\u91ce \u4fe1\uff0c\u8107 \u5609\u4ee3\uff0c\u77e2\u51a8 \u88d5\uff0e\u30e1\u30c7\u30a3\u30bb\u30fc\u30d5\u30d5\u30a3\u30c3\u30c8\u00ae\u30d7\u30ed\u2161\u306e\u57fa\u790e\u7684\u691c\u8a0e\uff0e\u533b\u7642\u691c\u67fb\u3068\u81ea\u52d5\u5316 46\uff1a606-6011\uff0c2021\uff0e<\/li>\n\n\n\n
                                                  2. \u8c37\u6fa4 \u674e\u7d17\uff0c\u4e0b\u5742 \u6d69\u5247\uff0c\u5c0f\u91ce \u4f73\u4e00\uff0c\u77e2\u51a8 \u88d5\uff0c\u4fdd\u7530 \u5948\u7dd2\u7f8e\uff0e\u5168\u81ea\u52d5\u81e8\u5e8a\u691c\u67fb\u30b7\u30b9\u30c6\u30e0STACIA\u306b\u3088\u308b\u81ea\u5df1\u6297\u4f53\u691c\u67fb\u8a66\u85ac\u306e\u6027\u80fd\u8a55\u4fa1\uff0e\u533b\u7642\u691c\u67fb\u3068\u81ea\u52d5\u5316 46\uff1a59-68\uff0c2021\uff0e<\/li>\n\n\n\n
                                                  3. \u9db4\u7530 \u4e00\u4eba\uff0c\u7af9\u7530 \u77e5\u5e83\uff0c\u8fd1\u85e4 \u5f18\uff0c\u7530\u90e8 \u967d\u5b50\uff0c\u5c0f\u6c60 \u7531\u4f73\u5b50\uff0c\u677e\u4e0b \u5f18\u9053\uff0c\u6c60\u672c \u654f\u884c\uff0c\u5e38\u540d \u653f\u5f18\uff0c\u8352\u4e95 \u667a\u5b50\uff0c\u6c60\u7530 \u5343\u79cb\uff0c\u68ee \u6c99\u8036\u9999\uff0c\u6c38\u4e95 \u8c4a\uff0c\u6c60\u7530 \u5c1a\u9686\uff0c\u5ca9\u5d0e \u967d\u4ecb\uff0c\u5c0f\u5ddd \u6075\u6d25\u5b50\uff0c\u8fd1\u85e4 \u4e5f\u5bf8\u7d00\uff0c\u4e2d\u5c71 \u6d0b\u4e00\uff0c\u9ad8\u5c71 \u8ce2\u4e00\uff0c\u91ce\u6751 \u5c1a\u4e4b\uff0c\u9ad8\u91ce \u90a6\u5f66\uff0c\u7267 \u4e9c\u77e2\u5b50\uff0c\u6e21\u9089 \u73e0\u7dd2\uff0c\u7a32\u8449 \u4ea8\uff0c\u5927\u5ead \u6075\u5b50\uff0c\u76f4\u7530 \u5065\u592a\u90ce\uff0c\u7c73\u5ddd \u4fee\uff0c\u9ad8\u898b \u662d\u826f\uff0c\u77e2\u51a8 \u88d5\uff0c\u901a\u5c71 \u85ab\uff0e\u65b0\u9bae\u8840\u6db2\u3092\u7528\u3044\u305f6\u30e1\u30fc\u30ab\u30fc\u57fa\u6e96\u81ea\u52d5\u8840\u7403\u5206\u6790\u88c5\u7f6e\u306b\u3088\u308b\u5916\u90e8\u7cbe\u5ea6\u7ba1\u7406\u8abf\u67fb\u306e\u7d4c\u5e74\u7684\u8a55\u4fa1\u5831\u544a(2019\u5e74\u5ea6)\uff0e\u65e5\u672c\u691c\u67fb\u8840\u6db2\u5b66\u4f1a\u96d1\u8a8c 22\uff1a114-125\uff0c2021\uff0e<\/li>\n<\/ol>\n\n\n\n

                                                    \u548c\u6587\u7dcf\u8aac\uff1aJapanese Review Articles<\/h4>\n\n\n\n
                                                      \n
                                                    1. \u4e95\u4e0a \u7fd4\u592a\uff0e\u308f\u305f\u3057\u306e1\u679a\uff0e\u5fc3\u30a8\u30b3\u30fc 22\uff1a988\uff0c2021\uff0e<\/li>\n\n\n\n
                                                    2. \u5c0f\u91ce \u4f73\u4e00\uff0e\u60a3\u8005\u3055\u3093\u3078\u306e\u81ea\u5df1\u8840\u7cd6\u6e2c\u5b9a\u6307\u5c0e\uff0e\u691c\u67fb\u3068\u6280\u8853 49\uff1a1194-1195\uff0c2021\uff0e<\/li>\n\n\n\n
                                                    3. \u5f8c\u85e4 \u5bdb\u662d\uff0e\u8a8d\u5b9a\u30fb\u8cc7\u683c\u53d6\u5f97\u3067\u30b9\u30ad\u30eb\u3092\u78e8\u3053\u3046(8)\u8a8d\u5b9a\u6551\u6025\u691c\u67fb\u6280\u5e2b\uff0e\u81e8\u5e8a\u691c\u67fb 65\uff1a272-276\uff0c2021\uff0e<\/li>\n\n\n\n
                                                    4. \u8535\u91ce \u4fe1\uff0e\u4ee3\u8b1d\u5185\u5206\u6ccc\u9818\u57df\u306b\u304a\u3051\u308b\u30b9\u30d5\u30a3\u30f3\u30b4\u30b7\u30f31-\u30ea\u30f3\u9178\u53d7\u5bb9\u4f53\uff0e\u7cd6\u5c3f\u75c5\u30fb\u5185\u5206\u6ccc\u4ee3\u8b1d\u79d1 52\uff1a459-463\uff0c2021\uff0e<\/li>\n\n\n\n
                                                    5. \u6fa4\u7530 \u76f4\u5b50\uff0c\u5927\u9580 \u96c5\u592b\uff0e\u9ec4\u8272\u30d6\u30c9\u30a6\u7403\u83cc\u83cc\u8840\u75c7\u3068\u5fc3\u30a8\u30b3\u30fc\uff0e\u7279\u96c6\uff1a\u305d\u306e\u8003\u3048\u306f\u3082\u3046\u53e4\u3044\uff01\u6700\u65b0\u30fb\u611f\u67d3\u75c7\u8a3a\u7642\uff0eMedicina 58\uff1a594-599\uff0c2021\uff0e<\/li>\n\n\n\n
                                                    6. \u5468 \u96e8\u5947\uff0c\u83c5\u91ce \u5bdb\u5fd7\uff0c\u8096 \u5ef7\u8f1d\uff0c\u30b7\u30e3\u30af\u30de\u30c8\u30d5 \u7406\u4eba\uff0c\u4f0a\u6797 \u4f91\u771f\uff0c\u897f\u5ddd \u771f\u5b50\uff0c\u77e2\u51a8 \u88d5\uff0c\u5408\u7530 \u572d\u4ecb\uff0eCOVID-19\u95a2\u9023\u8840\u6813\u75c7\u306e\u8a3a\u65ad\u88dc\u52a9\u306b\u5411\u3051\u305f\u30bf\u30a4\u30e0\u30b9\u30c8\u30ec\u30c3\u30c1\u30fb\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\uff0e\u30ec\u30fc\u30b6\u30fc\u7814\u7a76 48\uff1a228-233\uff0c2021\uff0e<\/li>\n\n\n\n
                                                    7. \u7530\u4e2d \u96c5\u7f8e\uff0c\u5bbf\u8c37 \u8ce2\u4e00\uff0e\u5148\u8f29\u6280\u5e2b\u304c\u6559\u3048\u308b\u4e00\u822c\u691c\u67fbTips\uff1c\u5c3f\u691c\u67fb\u7de8\uff1e\u5c3f\u4e2d\u767d\u8840\u7403\u3068\u985e\u4f3c\u6027\u5206\u306e\u898b\u5206\u3051\u65b9\uff0eMedical Technology 49\uff1a1058-1061\uff0c2021\uff0e<\/li>\n\n\n\n
                                                    8. \u5927\u9580 \u96c5\u592b\uff0ePhysical examination\u304b\u3089\u75c5\u614b\u306b\u8feb\u308b\uff0e\u8840\u7ba1\u75c5\uff0e\u7279\u96c6 Physical examination\u8eab\u4f53\u6240\u898b\u3092\u5b66\u3073\uff0c\u7d4c\u9a13\u3092\u91cd\u306d\u8a3a\u7642\u306b\u6d3b\u304b\u3059\uff0eHeart View 25\uff1a58-63\uff0c2021\uff0e<\/li>\n\n\n\n
                                                    9. \u5927\u9580 \u96c5\u592b\uff0e\u9ad8\u8840\u5727\u60a3\u8005\u306e\u5916\u6765\u8a3a\u5bdf\uff0d\u305f\u307e\u306b\u306f\u304a\u8179\u3092\u89e6\u3063\u3066\u307f\u3088\u3046\uff0d\uff0eMedical Practice 38\uff1a71\uff0c2021\uff0e<\/li>\n\n\n\n
                                                    10. \u5927\u9580 \u96c5\u592b\uff0e\u7cd6\u5c3f\u75c5\u60a3\u8005\u306b\u5fc3\u30a8\u30b3\u30fc\u56f3\u3092\u884c\u3046\u3079\u304d\u6642\u306f\u3044\u3064\u3067\uff0c\u4f55\u304c\u308f\u304b\u308b\u306e\u304b\uff0e\u7279\u96c6\uff1a\u7cd6\u5c3f\u75c5\u5c02\u9580\u533b\u306b\u5fc5\u8981\u306a\u5fc3\u4e0d\u5168\u306e\u77e5\u8b58update\uff0e\u7cd6\u5c3f\u75c5\u30fb\u5185\u5206\u6ccc\u4ee3\u8b1d\u79d1 52\uff1a222-228\uff0c2021\uff0e<\/li>\n\n\n\n
                                                    11. \u897f\u5ddd \u771f\u5b50\uff0e\u300c\u5178\u578b\u4f8b\u306e\u81e8\u5e8a\u691c\u67fb\u3092\u5b66\u3076\u300d\u6025\u6027\u767d\u8840\u75c5\uff0e\u81e8\u5e8a\u691c\u67fb 65\uff1a642-645\uff0c2021\uff0e<\/li>\n\n\n\n
                                                    12. \u672c\u5e84 \u6075\uff0c\u76f8\u539f \u4e00\uff0c\u5c71\u5cb8 \u9e97\u5b50\uff0c\u8352\u6728 \u7950\u52a0\uff0c\u4e94\u5341\u5d50 \u5e0c\u671b\uff0c\u4e2d\u6751 \u5948\u6d25\u5b50\uff0c\u5bfa\u5c3e \u4eae\uff0c\u9577\u91ce \u54f2\u9053\uff0c\u856a\u57ce \u4fca\u514b\uff0c\u671d\u5ca1 \u4eae\uff0c\u897f\u7530 \u6df3\u5b50\uff0c\u5185\u7530 \u5b5d\u4fca\uff0c\u6e05\u6c34 \u7fd4\u592a\uff0c\u52a0\u6cbb \u512a\u4e00\uff0c\u5bae\u7530 \u548c\u5178\uff0c\u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0c\u53ef\u91ce \u90a6\u884c\uff0c\u9752\u6728 \u6df3\u8ce2\uff0c\u4e94\u5341\u5d50 \u6d69\u4e8c\uff0e\u773c\u75be\u60a3\u3068\u30d0\u30a4\u30aa\u30de\u30fc\u30ab\u30fc \u623f\u6c34\u30d0\u30a4\u30aa\u30de\u30fc\u30ab\u30fc\u306b\u3088\u308b\u7dd1\u5185\u969c\u773c\u5727\u4e0a\u6607\u6a5f\u5e8f\u306e\u89e3\u660e\u3068\u65b0\u898f\u6cbb\u7642\u6cd5\u306e\u958b\u767a\uff0e\u65e5\u672c\u773c\u79d1\u5b66\u4f1a\u96d1\u8a8c 125\uff1a285-322\uff0c2021\uff0e<\/li>\n\n\n\n
                                                    13. \u68ee\u7530 \u8ce2\u53f2\uff0e\u5c3f\u5b9a\u6027\u691c\u67fb\u306e\u7cbe\u5ea6\u7ba1\u7406\uff0e\u691c\u67fb\u3068\u6280\u8853 49\uff1a502-506\uff0c2021\uff0e<\/li>\n\n\n\n
                                                    14. \u68ee\u7530 \u8ce2\u53f2\uff0e\u65e5\u5f53\u76f4\u306b\u5fc5\u8981\u306a\u77e5\u8b58\u3068\u6280\u8853 -\u9ac4\u6db2\u691c\u67fb-\uff0e\u6771\u4eac\u90fd\u533b\u5b66\u691c\u67fb 49\uff1a147-153\uff0c2021\uff0e<\/li>\n\n\n\n
                                                    15. \u5b89\u5ddd \u6075\u5b50\uff0c\u77e2\u51a8 \u88d5\uff0e\u9178\u5316\u578b\u30a2\u30eb\u30d6\u30df\u30f3\uff08HNA\uff09\u6e2c\u5b9a\u6cd5\u306e\u81e8\u5e8a\u5fdc\u7528\uff0e\u691c\u67fb\u3068\u6280\u8853 49\uff1a94-98\uff0c2021\uff0e<\/li>\n\n\n\n
                                                    16. \u5b89\u5ddd \u6075\u5b50\uff0c\u77e2\u51a8 \u88d5\uff0e\u9178\u5316\u30b9\u30c8\u30ec\u30b9\u30de\u30fc\u30ab\u30fc\u3068\u3057\u3066\u306e\u9178\u5316\u578b\u30a2\u30eb\u30d6\u30df\u30f3\uff08Human Nonmercaptoalbumin:HNA\uff09\uff1a\u6e2c\u5b9a\u7cfb\u306e\u958b\u767a\u3068\u81e8\u5e8a\u5fdc\u7528. \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u8a8c 69\uff1a574-584\uff0c2021\uff0e<\/li>\n\n\n\n
                                                    17. \u6e21\u908a \u5e83\u7950\uff0e\u547c\u5438\u6a5f\u80fd\u691c\u67fb\uff0e\u8a3a\u65ad\u3068\u6cbb\u7642 109(suppl)\uff1a172-175\uff0c2021\uff0e<\/li>\n<\/ol>\n\n\n\n

                                                      \u548c\u6587\u8457\u66f8\uff1aJapanese Book Chapter<\/h4>\n\n\n\n
                                                        \n
                                                      1. \u4e95\u4e0a \u7fd4\u592a\uff0c\u5927\u9580\u96c5\u592b\uff0e\u4eba\u5de5\u5f01\u6a5f\u80fd\u8a55\u4fa1\uff0e\u300cHeart View\u300d\u5897\u520a\u53f7\u300c\u7279\u96c6 \u5fc3\u30a8\u30b3\u30fc\u8a08\u6e2c\uff0f\u62bd\u51fa\u306e\u30b3\u30c4\uff0c\u8eab\u306b\u3064\u3051\u305f\u3044\u8003\u3048\u65b9\uff0f\u9032\u3081\u65b9\u300d\uff08\u5927\u624b \u4f38\u4e4b \u4f01\u753b\uff09pp. 142-147\uff0c2021\uff0e\u30e1\u30b8\u30ab\u30eb\u30d3\u30e5\u30fc\u793e\uff0e\u6771\u4eac\uff0e2021\uff0e<\/li>\n\n\n\n
                                                      2. \u4ee3\u7530 \u60a0\u4e00\u90ce\uff0e\u4e09\u76f8\u6ce2\u306f\u3069\u3093\u306a\u3068\u304d\u306b\u307f\u3089\u308c\u307e\u3059\u304b\uff1f\u300c\u81e8\u5e8a\u691c\u67fb\u300d\u5897\u520a\u53f7\u300c\u7279\u96c6 \u3088\u304f\u3042\u308b\u8cea\u554f\u306b\u30d1\u30c3\u3068\u7b54\u3048\u3089\u308c\u308b\u898b\u958b\u304d\uff01\u691c\u67fb\u76f8\u8ac7\u5ba4\u300dpp. 482-483\uff0e\u533b\u5b66\u66f8\u9662\uff0c\u6771\u4eac\uff0e2021\uff0e<\/li>\n\n\n\n
                                                      3. \u4ee3\u7530 \u60a0\u4e00\u90ce\uff0e\u4e0d\u968f\u610f\u904b\u52d5\uff0d\u300c\u3075\u308b\u3048\u300d\u3092\u4e2d\u5fc3\u306b\uff0e\u300c\u81e8\u5e8a\u96d1\u8a8c\u5185\u79d1\u300d\u5897\u5927\u53f7 \u300c\u5185\u79d1\u75be\u60a3\u306e\u8a3a\u65ad\u57fa\u6e96\u30fb\u75c5\u578b\u5206\u985e\u30fb\u91cd\u75c7\u5ea6\u300dpp. 860\uff0e\u5357\u6c5f\u5802\uff0c\u6771\u4eac\uff0e2021\uff0e<\/li>\n\n\n\n
                                                      4. \u83c5\u539f \u5c06\u4ee3\uff0e\u30b3\u30e9\u30e02 \u8ab0\u306b\u3067\u3082\u3067\u304d\u308b\u4e0b\u80a2\u9759\u8108\u8840\u6813\u306e\u30a8\u30b3\u30fc\uff0eLiSA\u5225\u518a\uff0epp. 164-169\uff0cMEDSi\uff0c \u6771\u4eac\uff0c2021.<\/li>\n\n\n\n
                                                      5. \u7530\u4e2d \u96c5\u7f8e\uff0c\u5bbf\u8c37 \u8ce2\u4e00\uff0eV. \u5c3f\u6c88\u6e23\u691c\u67fb \u597d\u9178\u7403\u67d3\u8272\uff08\u30cf\u30f3\u30bb\u30eb\u67d3\u8272\uff09\uff0e\u67d3\u8272\u6cd5\u306e\u3059\u3079\u3066\uff08\u6c34\u53e3 \u570b\u96c4 \u7de8\uff09pp. 398-399\uff0e\u533b\u6b6f\u85ac\u51fa\u7248\uff0c\u6771\u4eac\uff0c2021\uff0e<\/li>\n\n\n\n
                                                      6. \u5927\u9580 \u96c5\u592b\uff0e\u5fc3\u30a8\u30b3\u30fc\u691c\u67fb\uff0e\u300c\u8a3a\u65ad\u3068\u6cbb\u7642\u300d\u5897\u520a\u53f7\u300c\u8a3a\u65ad\u3068\u6cbb\u7642\u306e\u624b\u6280-\u8a3a\u5bdf\u5ba4\u3053\u308c\u4e00\u518a\u300d\uff0e\uff08\u4eca\u679d \u535a\u4e4b\uff0c\u5c0f\u5ddd \u7d14\u4eba\uff0c\u68ee\u7530 \u5553\u884c\uff0c\u67f3\u5143 \u4f38\u592a\u90ce \u7de8\uff09pp. 94-100\uff0c\u8a3a\u65ad\u3068\u6cbb\u7642\u793e\uff0c\u6771\u4eac\uff0c2021\uff0e<\/li>\n\n\n\n
                                                      7. \u5927\u9580 \u96c5\u592b\uff0e\u9ad8\u9f62\u8005\u5927\u52d5\u8108\u7624\u306e\u75ab\u5b66\u3068\u6cbb\u7642\u306b\u3064\u3044\u3066\u6559\u3048\u3066\u4e0b\u3055\u3044\uff0e\u9ad8\u9f62\u8005\u306e\u5faa\u74b0\u5668\u8a3a\u7642Q\uff06A\uff0e\uff08\u4f0a\u85e4 \u6d69 \u7de8\uff09pp. 70-73\uff0c\u6587\u5149\u5802\uff0c\u6771\u4eac\uff0c2021\uff0e<\/li>\n\n\n\n
                                                      8. \u5927\u9580 \u96c5\u592b\uff0e\u9ad8\u9f62\u8005\u306e\u611f\u67d3\u6027\u5fc3\u5185\u819c\u708e\u306e\u7279\u5fb4\u3068\u6cbb\u7642\u306b\u95a2\u3057\u3066\u6559\u3048\u3066\u4e0b\u3055\u3044\uff0e\u9ad8\u9f62\u8005\u306e\u5faa\u74b0\u5668\u8a3a\u7642Q\uff06A\uff0e\uff08\u4f0a\u85e4 \u6d69 \u7de8\uff09pp. 132-133\uff0c\u6587\u5149\u5802\uff0c\u6771\u4eac\uff0c2021\uff0e<\/li>\n\n\n\n
                                                      9. \u5927\u9580 \u96c5\u592b\uff0e\u5fc3\u30a8\u30b3\u30fc\u56f3\uff0e\u81e8\u5e8a\u5faa\u74b0\u5668\u5b66\uff0e\uff08\u4f0a\u85e4 \u6d69\uff0c\u5742\u7530 \u6cf0\u53f2 \u7de8\uff09pp. 734-745\uff0c\u6587\u5149\u5802\uff0c\u6771\u4eac\uff0c2021\uff0e<\/li>\n\n\n\n
                                                      10. \u5927\u9580 \u96c5\u592b\uff0e\u7b2c\uff13\u7ae0\u5faa\u74b0\u5668\uff08\u5206\u7b46\uff09\uff0eThe \u7dcf\u5408\u5185\u79d1\u30c9\u30ea\u30eb\uff0e\uff08\u5ca1\u5d0e \u4ec1\u662d \u7de8\uff09pp. 121-126\uff0c\u533b\u5b66\u66f8\u9662\uff0c\u6771\u4eac\uff0c2021\uff0e<\/li>\n\n\n\n
                                                      11. \u6edd\u53e3\u3000\u7d14\uff0c\u897f\u5ddd\u3000\u771f\u5b50\uff0e\u8840\u7b97\u691c\u67fb\uff0e\u300c\u6551\u6025\u533b\u5b66\u300d\u81e8\u6642\u5897\u520a\u53f7\u300c\u8ff7\u308f\u306a\u3044\u305f\u3081\u306e\u57fa\u790e\u77e5\u8b58\u2161\u3000\u6551\u6025\u8a3a\u7642\u306b\u5fc5\u8981\u306a\u89e3\u5256\u30fb\u751f\u7406\u30fb\u751f\u5316\u5b66\u7684\u77e5\u8b58\u300dpp. 849-856\uff0e\u3078\u308b\u3059\u51fa\u7248\uff0c\u6771\u4eac\uff0c2021\uff0e<\/li>\n\n\n\n
                                                      12. \u6edd\u53e3\u3000\u7d14\uff0c\u897f\u5ddd\u3000\u771f\u5b50\uff0e\u8840\u6813\u3092\u5f62\u6210\u3059\u308b\u75be\u60a3\uff0e\u300cLiSA\u300d\u5225\u518a\u300c\u9ebb\u9154\u79d1\u533b\u306a\u3089\u77e5\u3063\u3066\u304a\u304d\u305f\u3044\u8840\u6813\u75c7\u30fb\u585e\u6813\u75c7\u300dpp. 53-58\uff0e\u30e1\u30c7\u30a3\u30ab\u30eb\u30fb\u30b5\u30a4\u30a8\u30f3\u30b9\u30fb\u30a4\u30f3\u30bf\u30fc\u30ca\u30b7\u30e7\u30ca\u30eb\uff0c\u6771\u4eac\uff0c2021\uff0e<\/li>\n\n\n\n
                                                      13. \u68ee\u7530 \u8ce2\u53f2\uff0e\u6025\u6027\u814e\u969c\u5bb3\uff08AKI\uff09\u306e\u65e9\u671f\u8a3a\u65ad\u306b\u7528\u3044\u3089\u308c\u3066\u3044\u308b\u5c3f\u4e2d\u30d0\u30a4\u30aa\u30de\u30fc\u30ab\u30fc\u3092\u6559\u3048\u3066\u304f\u3060\u3055\u3044\uff0e\u300c\u81e8\u5e8a\u691c\u67fb\u300d\u5897\u520a\u53f7\u300c\u7279\u96c6 \u3088\u304f\u3042\u308b\u8cea\u554f\u306b\u30d1\u30c3\u3068\u7b54\u3048\u3089\u308c\u308b\u898b\u958b\u304d\uff01\u691c\u67fb\u76f8\u8ac7\u5ba4\u300dpp. 296-297\uff0e\u533b\u5b66\u66f8\u9662\uff0c\u6771\u4eac\uff0e2021\uff0e<\/li>\n\n\n\n
                                                      14. \u6e21\u908a \u5e83\u7950\uff0e\u547c\u5438\u6a5f\u80fd\u691c\u67fb\uff0e\u300c\u8a3a\u65ad\u3068\u6cbb\u7642\u300d\u5897\u520a\u53f7\u300c\u8a3a\u65ad\u3068\u6cbb\u7642\u306e\u624b\u6280\uff0d\u8a3a\u5bdf\u5ba4\u3053\u308c1\u518a\uff0d\u300d\uff0e\uff08\u4eca\u679d \u535a\u4e4b\uff0c\u5c0f\u5ddd \u7d14\u4eba\uff0c\u68ee\u7530 \u5553\u884c\uff0c\u67f3\u5143 \u4f38\u592a\u90ce \u7de8\uff09pp. 172-175\uff0e\u8a3a\u65ad\u3068\u6cbb\u7642\u793e\uff0c\u6771\u4eac\uff0e2021\uff0e<\/li>\n<\/ol>\n\n\n\n

                                                        \u548c\u6587\u7de8\u8457\u7b49\uff1aJapanese Book Editing<\/h4>\n\n\n\n
                                                          \n
                                                        1. \u5927\u9580 \u96c5\u592b \u7de8\uff0e\u5fc3\u30a8\u30b3\u30fc\u300c\u65b0\u3057\u3044\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u304b\u3089\u5b66\u3076\u5f01\u819c\u75c7\u8a3a\u65ad\u306e\u4eca\uff1a\u50e7\u5e3d\u5f01\u75be\u60a3\u300d\uff0e\u6587\u5149\u5802\uff0c\u6771\u4eac\uff0c2021\uff0e<\/li>\n\n\n\n
                                                        2. \u5927\u9580 \u96c5\u592b \u7de8\uff0e\u5fc3\u30a8\u30b3\u30fc\u300c\u65b0\u3057\u3044\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u304b\u3089\u5b66\u3076\u5f01\u819c\u75c7\u8a3a\u65ad\u306e\u4eca\uff1a\u5927\u52d5\u8108\u5f01\u75be\u60a3\u30fb\u4e09\u5c16\u5f01\u75be\u60a3\u300d\uff0e\u6587\u5149\u5802\uff0c\u6771\u4eac\uff0c2021\uff0e<\/li>\n\n\n\n
                                                        3. \u6afb\u6797 \u90c1\u4e4b\u4ecb \u76e3\u4fee\uff0e\u77e2\u51a8 \u88d5\uff0c\u5ee3\u7551 \u4fca\u6210\uff0c\u5c71\u7530 \u4fca\u5e78\uff0c\u77f3\u9ed2 \u539a\u81f3 \u7de8\u96c6\uff0e\u4eca\u65e5\u306e\u81e8\u5e8a\u691c\u67fb2021-2022\uff0e\u5357\u6c5f\u5802\uff0c\u6771\u4eac\uff0e2021\uff0e<\/li>\n\n\n\n
                                                        4. \u65e5\u672c\u691c\u67fb\u8840\u6db2\u5b66\u4f1a \u7de8\uff0e\u30b9\u30bf\u30f3\u30c0\u30fc\u30c9\u691c\u67fb\u8840\u6db2\u5b66 \u7b2c4\u7248\uff0e\u533b\u6b6f\u85ac\u51fa\u7248\uff0c\u6771\u4eac\uff0e2021\uff0e<\/li>\n\n\n\n
                                                        5. \u77e2\u51a8 \u88d5 \u76e3\u4fee\uff0c\u5ca1\u7530 \u6d69\u4e00\uff0c\u9ed2\u5ddd \u5cf0\u592b \u7de8\uff0e\u65e5\u672c\u533b\u5e2b\u4f1a\u751f\u6daf\u6559\u80b2\u30b7\u30ea\u30fc\u30ba\u300c\u81e8\u5e8a\u691c\u67fb\u3092\u4f7f\u3044\u3053\u306a\u3059\u300d\uff0e\u65e5\u672c\u533b\u5e2b\u4f1a\uff0c\u6771\u4eac\uff0e2021\uff0e<\/li>\n<\/ol>\n<\/div><\/div>\n\n\n\n
                                                          \n

                                                          2020\u5e74<\/h3>\n\n\n\n

                                                          \u82f1\u6587\u539f\u8457\u8ad6\u6587\uff1aEnglish Original Articles<\/h4>\n\n\n\n
                                                            \n
                                                          1. Endo, Y., Araoka, H., Baba, M., Okada, C., Kimura, M., Higurashi, Y., Sato, T., Yatomi, Y., Moriya, K., and Yoneyama, A. Matrix-assisted laser desorption ionization-time of flight mass spectrometry can be used to identify Helicobacter cinaedi. Diagn. Microbiol. Infect. Dis.<\/strong><\/em> 96: 114964,<\/a> 2020.<\/li>\n\n\n\n
                                                          2. Fujisawa, M., Yasumoto, A., Kato, H., Sugawara, Y., Yoshida, Y., Yatomi, Y., and Nangaku, M. The role of anti-complement factor H antibodies in the development of atypical haemolytic uremic syndrome: a possible contribution to abnormality of platelet function. Br. J. Haematol.<\/strong><\/em> 189: 182-186<\/a>, 2020.<\/li>\n\n\n\n
                                                          3. Fukuhara, S., Yasukawa, K., Sato, M., Ikeda, H., Inoguchi, Y., Etoh, T., Masakado, M., Umeda, F., Yatomi, Y., Yamauchi, T., and Inoguchi, T. Clinical usefulness of human serum nonmercaptalbumin to mercaptalbumin ratio as a biomarker for diabetic complications and disability in activities of daily living in elderly patients with diabetes. Metabolism.<\/em><\/strong> 103: 153995<\/a>, 2020.<\/li>\n\n\n\n
                                                          4. Hirano, M., Kimura, K., Ishigaki, T., Nojima. M., Daimon, M., Morita, H., Takenaka, K., Xu, B., Sawada, N., Hirokawa, M., Komuro, I., Morisaki, T., Yotsuyanagi, H., Kawamata, T., Yokoyama, K., Konuma, T., Kato, S., Yasui, H.., Nagamura-Inoue, T., Uchimaru, K., Takahash i, S., Imai, Y., and Tojo, A. High prevalence of left ventricular non-compaction and its impact on chemotherapy-related cardiac dysfunction in patients with hematological diseases. Circ. J.<\/strong><\/em> 84: 1957-1964<\/a>, 2020.<\/li>\n\n\n\n
                                                          5. Hirokawa, M., Daimon, M., Kozuma, K., Shinozaki, T., Kimura, K., Nakao, T., Nakanishi, K., Sawada, N., Ishiwata, J., Yoshida, Y., Kato, T.S., Mizuno, Y., Morita, H.,Yatomi, Y., and Komuro, I. Are there gender differences in the association between body mass index and left ventricular diastolic function? A clinical observational study in the Japanese general population. Echocardiography.<\/strong><\/em> 37: 1749-1756<\/a>, 2020.<\/li>\n\n\n\n
                                                          6. Igarashi, N., Honjo, M., Yamagishi, R., Kurano, M., Yatomi, Y., Igarashi, K., Kaburaki, T., and Aihara, M. Involvement of autotaxin in the pathophysiology of elevated intraocular pressure in Posner-Schlossman syndrome. Sci. Rep.<\/em><\/strong>10: 6265<\/a>, 2020.<\/li>\n\n\n\n
                                                          7. Itoh, H., Kaneko, H., Kiriyama, H., Yoshida, Y., Nakanishi, K., Mizuno, Y., Daimon, M., Morita, H., Yatomi, Y., Yamamichi, N., and Komuro I. Effect of Metabolically Healthy Obesity on the Development of Carotid Plaque in the General Population: A Community-Based Cohort Study. J. Atheroscler. Thromb.<\/strong><\/em> 27: 155-163<\/a>, 2020.<\/li>\n\n\n\n
                                                          8. Izumi, C., Eishi, K., Ashihara, K., Arita, T., Otsuji, Y., Kunihara, T., Komiya, T., Shibata, T., Seo, Y., Daimon, M., Takanashi, S., Tanaka, H., Nakatani, S., Ninami, H., Nishi, H., Hayashida, K., Yaku, H., Yamaguchi, J., Yamamoto, K., Watanabe, H., Abe, Y., Amaki, M., Amano, M., Obase, K., Tabata, M. Miura, T., Miyake, M., Murata, M., Watanabe, N., Akasaka, T., Okita, Y., Kimura, T., Sawa, S., Yoshida, K. On behalf of the Japanese Circulation Society Joint Working Group. JCS\/JSCS\/JATS\/JSVS 2020 guidelines on the management of valvular heart disease. Circ. J.<\/strong><\/em> 84: 2037-2119<\/a>, 2020.<\/li>\n\n\n\n
                                                          9. Kageyama, Y., Uranbileg, B., Kusumoto, Y., Sakai, E., Ikeda, H., Kurano, M., Yatomi, Y. Suppression of sphingosine 1-phosphate lyase retards the liver regeneration in mice after partial hepatectomy. BioSci. Rep.<\/strong><\/em> 40: BSR20200592<\/a>, 2020.<\/li>\n\n\n\n
                                                          10. Kanoh, H., Nitta, T., Go, S., Inamori, K.I., Veillon, L., Nihei, W., Fujii, M., Kabayama, K., Shimoyama, A., Fukase, K., Ohto, U., Shimizu, T., Watanabe, T., Shindo, H., Aoki, S., Sato, K., Nagasaki, M.,Yatomi, Y., Komura, N., Ando, H., Ishida, H., Kiso, M., Natori, Y., Yoshimura, Y., Zonca, A., Cattaneo, A., Letizia, M., Ciampa, M., Mauri, L., Prinetti, A., Sonnino, S., Suzuki, A., and Inokuchi, J.I. Homeostatic and pathogenic roles of GM3 ganglioside molecular species in TLR4 signaling in obesity. EMBO J. <\/em><\/strong>39: e101732<\/a>, 2020.<\/li>\n\n\n\n
                                                          11. Kiriyama, H., Daimon, M., Nakanishi, K., Kaneko, H., Nakao, T., Morimoto-Ichikawa, R., Miyazaki, H., Morita, H., Daida, H., and Komuro I. Comparison between Healthcare-associated and Community-acquired Infective Endocarditis at Tertiary Care Hospitals in Japan. Circ. J.<\/strong><\/em>, 84: 670-676<\/a>, 2020.<\/li>\n\n\n\n
                                                          12. Kiriyama, H., Kodera, S., Minatsuki, S., Kaneko, H., Kikuchi, H., Kiyosue, A., Toko, H., Daimon, M., Ando, J., Morita, H., and Komuro I. Short-Term and Long-Term Efficacy of Drug-Coated Balloon for In-Stent Restenosis in Hemodialysis Patients with Coronary Artery Disease. Int. Heart J.<\/strong><\/em> 60: 1070-1076<\/a>, 2020.<\/li>\n\n\n\n
                                                          13. Kiriyama, H., Kaneko, H., Itoh, H., Yoshida, Y., Nakanishi, K., Mizuno, Y., Daimon, M., Morita, H., Yamamichi, N., and Komuro, I. Effect of cigarette smoking on carotid artery atherosclerosis: a community-based cohort study. Heart Vessels.<\/em><\/strong> 35: 22-29<\/a>, 2020.<\/li>\n\n\n\n
                                                          14. Kobayashi, Y., Suzuki, R., Yasukawa, K., Oba, K., Yamauchi, T., Yatomi, Y., and Kadowaki T. Oxidized albumin in blood reflects the severity of multiple vascular complications in diabetes mellitus. Metabol. Open<\/strong><\/em> 6: 100032<\/a>, 2020.<\/li>\n\n\n\n
                                                          15. Kurano, M., Tsukamoto, K., Hara, M., Tsuneyama, K., Nishikawa, T., Ikeda, H., and Yatomi, Y. Modulation of sphingosine 1-phosphate by hepatobiliary cholesterol handling. FASEB J.<\/strong><\/em> 34: 14655-14670<\/a>, 2020.<\/li>\n\n\n\n
                                                          16. Kurano, M., Tsukamoto, K., Shimizu, T., Kassai, H., Nakao, K., Aiba, A., Hara, M., and Yatomi, Y. Protection Against Insulin Resistance by Apolipoprotein M\/Sphingosine 1-Phosphate. Diabetes.<\/strong><\/em> 69: 867-881<\/a>, 2020.<\/li>\n\n\n\n
                                                          17. Mikami, Y., Jo, T., Matsuzaki, H., Ishimori, T., Saito, M., Sakamoto, Y., Yamauchi, Y., Takai, D., Yatomi, Y., and Nagase, T. Preoperative intervention with long-acting bronchodilators for the reduction of postoperative pulmonary complications in untreated patients with obstructive lung disease. Clin. Respir. J.<\/em><\/strong> 14: 92-101<\/a>, 2020.<\/li>\n\n\n\n
                                                          18. Miyoshi, T., Addetia, K., Citro, R., Daimon, M., Desale, S., Fajardo, P.G., Kasliwal, R.R., Kirkpatrick, J.N., Monaghan, M.J., Muraru, D., Ogunyankin, K.O., Park, S.W., Ronderos, R.E., Sadeghpour, A., Scalia, G.M., Takeuchi, M., Tsang, W., Tucay, E.S., Tude, Rodrigues, A.C., Vivekanandan, A., Zhang, Y., Blitz, A., Lang, R.M., Asch, F.M., and WASE Investigators. Left ventricular diastolic function in healthy adult individuals: Results of the world alliance societies of echocardiography (WASE) normal values study. J. Am. Soc. Echocardiogr.<\/strong><\/em> 33: 1223-1233<\/a>, 2020.<\/li>\n\n\n\n
                                                          19. Morita, Y., Kurano, M., Sakai, E., Nishikawa, T., Nishikawa, M., Sawabe, M., Aoki, J., and Yatomi, Y. Analysis of Urinary Sphingolipids using LC-MS\/MS in Diabetic Nephropathy. J. Diabetes Investig.<\/strong><\/em> 11: 441-449<\/a>, 2020.<\/li>\n\n\n\n
                                                          20. Morita, Y., Kurano, M., Tanaka, M., Hisasue, T., Sato, M., Ono, Y., Sato, T., Shukuya, K., and Yatomi, Y. Midstream urine sampling is necessary for accurate measurement of the urinary level of neutrophil gelatinase-associated lipocalin in healthy female subjects. Clin. Biochem.<\/strong><\/em> 79: 70-74<\/a>, 2020.<\/li>\n\n\n\n
                                                          21. Morita, Y., Kurano, M., Morita, E., Shimamoto, S., Igarashi, K., Sawabe, M., Aoki, J., and Yatomi, Y. Urinary autotaxin concentrations are associated with kidney injury. Clin. Chim. Acta.<\/strong><\/em> 509: 156-165<\/a>, 2020.<\/li>\n\n\n\n
                                                          22. Nagai, K., Uranbileg, B., Chen, Z., Fujioka, A., Yamazaki, T., Matsmoto, Y., Tsukamoto, H., Ikeda, H., Yatomi, Y., Chiba, H., Hui, S.P., Nakazawa, T., Saito, R., Koshiba, S., Aoki, J., Saigusa, D., and Tomioka, Y. Identification of novel biomarkers of hepatocellular carcinoma by high\u2010definition mass spectrometry: Ultrahigh\u2010performance liquid chromatography quadrupole time\u2010of\u2010flight mass spectrometry and desorption electrospray ionization mass spectrometry imaging. Rapid Commun Mass Spectrom.<\/strong><\/em>, 34(Suppl 1): e8551<\/a>. 2020.<\/li>\n\n\n\n
                                                          23. Nakanishi, K., Daimon, M., Yoshida, Y., Ishiwata, J., Sawada, N., Hirokawa, M., Kaneko, H., Nakao, T., Mizuno, Y., Morita, M., Di, Tullio, M.R., Homma, S., and Komuro, I. Serum uric acid level as a potential marker of subclinical left ventricular dysfunction: A community-based cohort study. ESC Heart Fail. <\/em><\/strong>7: 1031-1038<\/a>, 2020.<\/li>\n\n\n\n
                                                          24. Nakanishi, K., Daimon, M., Yoshida, Y., Ishiwata, J., Sawada, N., Hirokawa, M., Kaneko, H., Nakao, T., Mizuno, Y., Morita, H., Di, Tullio, M.R., Homma, S., and Komuro, I. Carotid intima-media thickness and subclinical left heart dysfunction in the general population. Atherosclerosis<\/strong><\/em> 305: 42-49<\/a>, 2020.<\/li>\n\n\n\n
                                                          25. Nakayama, A., Nakao, T., Daimon, M., Morita, H., Takayama, M., and Komuro, I. Safety Monitoring for Obstructive Hypertrophic Cardiomyopathy during Exercise. CJC Open<\/strong><\/em> 2: 732-734<\/a>, 2020.<\/li>\n\n\n\n
                                                          26. Nakawatari, K., Kurano, M., Araki, O., Nishikawa, M., Shimamoto, S., Igarashi, K., Aoki, J., Murakami, M., and Yatomi, Y. Elevated phosphatidylserine-specific phospholipase A1 level in hyperthyroidism. Clin. Chim. Acta.<\/strong><\/em> 503: 99-106<\/a>, 2020.<\/li>\n\n\n\n
                                                          27. Okawa, M., Sakoda, M., Ohta, S., Hasegawa, K.,Yatomi, Y., and Ito, T. The Balance between the Hemostatic Effect and Immune Response of Hyaluronan Conjugated with Different Chain Lengths of Inorganic Polyphosphate. Biomacromolecules. <\/strong><\/em>21: 2695-2704<\/a>, 2020.<\/li>\n\n\n\n
                                                          28. Saito, H., Hayakawa, M., Kamoshita, N., Yasumoto, A., Suzuki-Inoue, K.,Yatomi, Y., and Ohmori, T. Establishment of a megakaryoblastic cell line for conventional assessment of platelet calcium signaling. Int. J. Hematol.<\/em><\/strong> 111: 786-794<\/a>, 2020.<\/li>\n\n\n\n
                                                          29. Sakai, E., Kurano, M., Morita, Y., Aoki, J., and Yatomi Y. Establishment of a Measurement System for Sphingolipids in the Cerebrospinal Fluid Based on Liquid Chromatography-Tandem Mass Spectrometry, and Its Application in the Diagnosis of Carcinomatous Meningitis. J. Appl. Lab. Med.<\/em><\/strong> 5: 656-670<\/a>, 2020.<\/li>\n\n\n\n
                                                          30. Sakurai, S., Kato, H., Yoshida, Y., Sugawara, Y., Fujisawa, M., Yasumoto, A., Matsumoto, M., Fujimura, Y., Yatomi, Y., and Nangaku, M. Profiles of Coagulation and Fibrinolysis Activation-Associated Molecular Markers of Atypical Hemolytic Uremic Syndrome in the Acute Phase. J. Atheroscler Thromb.<\/strong><\/em> 27: 353-362<\/a>, 2020.<\/li>\n\n\n\n
                                                          31. Sawada, N., Daimon, M., Abe, H., Ushiku, T., Kato, T.S., Morita, H., and Komuro, I. An autopsy case of cardiac amyloidosis with heterogeneous deposition of amyloid protein: A possible mechanism for relative apical sparing of longitudinal strain. CASE<\/strong><\/em> 4: 54-56<\/a>, 2020.<\/li>\n\n\n\n
                                                          32. Sawada, N., Nakao, T., Daimon, M., Nawata, K., Tanaka, M., and Komuro, I. Multiple calcified amorphous tumors in a patient with end-stage renal disease. J. Echocardiogr.<\/strong><\/em> 18: 125-126<\/a>, 2020.<\/li>\n\n\n\n
                                                          33. Sawada, N., Nakanishi, K., Daimon, M., Yoshida, Y., Ishiwata, J., Hirokawa, M., Nakao, T., Morita, M., Di, Tullio, M.R., Homma, S., and Komuro, I. Influence of Visceral Adiposity Accumulation on Adverse Left and Right Ventricular Mechanics in the Community. Eur. J. Prev. Cardiol.<\/strong><\/em> 27: 2006-2015<\/a>, 2020.<\/li>\n\n\n\n
                                                          34. Teramoto, N., Sugihara, H., Yamanouchi, K., Nakamura, K., Kimura, K., Okano, T., Shiga, T., Shirakawa, T., Matsuo, M., Nagata, T., Daimon, M., Matsuwaki, T., and Nishihara, N. Pathological evaluation of rats carrying in-frame mutations in the dystrophin gene: A new model of Becker muscular dystrophy. Dis. Model. Mech.<\/strong><\/em> 13: dmm044701<\/a>, 2020.<\/li>\n\n\n\n
                                                          35. Tokuoka, S.M., Yasumoto, A., Kita, Y., Shimizu, T., Yatomi, Y., and Oda, Y. Limitations of deuterium-labeled internal standards for quantitative electrospray ionization mass spectrometry analysis of fatty acid metabolites. Rapid Commun. Mass. Spectrom.<\/strong><\/em> 34: e8814<\/a>, 2020.<\/li>\n\n\n\n
                                                          36. Ueno, S.I., Hatano, T., Okuzumi, A., Saiki, S., Oji, Y., Mori, A., Koinuma, T., Fujimaki, M., Takeshige-Amano, H., Kondo, A., Yoshikawa, N., Nojiri, T., Kurano, M., Yasukawa, K., Yatomi, Y., Ikeda, H., and Hattori, N. Nonmercaptalbumin as an oxidative stress marker in Parkinson’s and PARK2 disease. Ann Clin Transl Neurol.<\/strong><\/em> 7: 307-317<\/a>, 2020.<\/li>\n\n\n\n
                                                          37. Uranbileg, B, Kurano, M., Sato, M., Ikeda, H., Ishizawa, T., Hasegawa, K., Kokudo, N., and Yatomi, Y. Possible involvement of PS-PLA1 and lysophosphatidylserine receptor (LPS1) in hepatocellular carcinoma. Sci. Rep.<\/strong><\/em> 10: 2659<\/a>, 2020.<\/li>\n\n\n\n
                                                          38. Wang, C., Kawakami-Mori, F., Kang, L., Ayuzawa, N., Ogura, S., Koid, S.S., Reheman, L., Yeerbolati, A., Liu, B., Yatomi, Y., Chen, X., Fujita, T., and Shimosawa, T. Low-dose L-NAME induces salt sensitivity associated with sustained increased blood volume and sodium-chloride cotransporter activity in rodents. Kidney Int.<\/em><\/strong> 98: 1242-1252<\/a>, 2020.<\/li>\n\n\n\n
                                                          39. Wu, Y., Zhou, Y., Huang, C.J., Kobayashi, H., Yan, S., Ozeki, Y., Wu, Y., Sun, C.W., Yasumoto, A., Yatomi, Y., Lei, C., and Goda, K. Intelligent frequency-shifted optofluidic time-stretch quantitative phase imaging. Opt. Express.<\/strong><\/em> 28: 519-532<\/a>, 2020.<\/li>\n\n\n\n
                                                          40. Yoshida, Y., Nakanishi, K., Daimon, M., Ishiwata, J., Sawada, N., Hirokawa, M., Kaneko, H., Nakao, T., Mizuno, Y., Morita, M., Di, Tullio, M.R., Homma, S., and Komuro, I. Association of arterial stiffness with left atrial structure and phasic function: A community-based cohort study. J. Hypertension<\/strong><\/em> 38: 1140-1148<\/a>, 2020.<\/li>\n\n\n\n
                                                          41. Yoshimoto, A., Yasumoto, A., Kamiichi, Y., Shibayama, H., Sato, M., Misawa, Y., Morita, K., Ono, Y., Sone, S., Satoh, T., and Yatomi, Y. Analysis of vasovagal syncope in the blood collection room in patients undergoing phlebotomy. Sci. Rep.<\/strong><\/em> 10: 17933<\/a>, 2020.<\/li>\n\n\n\n
                                                          42. Yotsumoto, T., Maemura, K., Watanabe, K., Amano, Y., Matsumoto, Y., Zokumasu, K., Ando, T., Kawakami, M., Kage, H., Nakajima, J.,Yatomi, Y., Nagase, T., and Takai, D. NRXN1 as a novel potential target of antibody-drug conjugates for small cell lung cancer. Oncotarget<\/strong><\/em> 11: 3590-3600<\/a>, 2020.<\/li>\n\n\n\n
                                                          43. Zhou, Y., Yasumoto, A., Lei, C., Huang, C., Kobayashi, H., Wu, Y., Yan, S., Sun, C., Yatomi, Y., and Goda, K. Intelligent classification of platelet aggregates by agonist type. eLife<\/em><\/strong> 9: e52938<\/a>, 2020. Press Release.<\/a><\/li>\n<\/ol>\n\n\n\n

                                                            \u56fd\u5185\u5b66\u4f1a\u767a\u8868\uff1aDomestic Conference Presentation<\/h4>\n\n\n\n
                                                              \n
                                                            1. \u79cb\u7530 \u840c\uff0c\u771f\u5d0e \u6842\uff0c\u6301\u7530 \u667a\u4e4b\uff0c\u5c71\u7530 \u306f\u308b\u9999\uff0c\u7530\u5cf6 \u5c06\u592a\u90ce\uff0c\u837b\u6fa4 \u6075\u7f8e\uff0c\u77e2\u51a8 \u88d5\uff0c\u4ee3\u7530 \u60a0\u4e00\u90ce\uff0e\u904e\u547c\u5438\u8ce6\u6d3b\u304c\u8133\u6ce2\u691c\u67fb\u4e2d\u306e\u7761\u7720\u6df1\u5ea6\u306b\u4e0e\u3048\u308b\u5f71\u97ff\uff0e\u7b2c50\u56de \u65e5\u672c\u81e8\u5e8a\u795e\u7d4c\u751f\u7406\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a\uff0e2020.11.26-28\uff0e\u4eac\u90fd\uff0e<\/li>\n\n\n\n
                                                            2. Ishii, I., Yoshikawa, Y., Hyodo, E., Seo, Y., Kihara, H., Watanabe, H., Daimon, M., Tanaka, A., Akasaka, T., and Ito, H. Two-dimensional Speckle Tracking Echocardiography for Diagnosing Chest Pain in the Emergency Room: The Multicenter Prospective Study by A TRAC-SI Group. \u7b2c84\u56de \u65e5\u672c\u5faa\u74b0\u5668\u75c5\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2020.7.27-8.2\uff0eWEB\u958b\u50ac\uff0e<\/li>\n\n\n\n
                                                            3. \u77f3\u539f \u6709\u7406\uff0c\u5c0f\u91ce \u4f73\u4e00\uff0c\u4fdd\u7530 \u5948\u7dd2\u7f8e\uff0c\u5e38\u540d \u653f\u5f18\uff0c\u4e0b\u5742 \u6d69\u5247\uff0c\u897f\u5ddd \u771f\u5b50\uff0c\u77e2\u51a8 \u88d5\uff0e\u96fb\u6c17\u6cf3\u52d5\u3068\u81e8\u5e8a\u691c\u67fb\uff5e\u65b0\u305f\u306a\u5206\u91ce\u306e\u958b\u62d3\uff5e \u8840\u6e05\u86cb\u767d\u96fb\u6c17\u6cf3\u52d5\u306b\u304a\u3051\u308bM\u86cb\u767d\u7b97\u5b9a\u30a2\u30eb\u30b4\u30ea\u30ba\u30e0\u306e\u8a55\u4fa1\uff0e\u7b2c71\u56de \u65e5\u672c\u96fb\u6c17\u6cf3\u52d5\u5b66\u4f1a\u7dcf\u4f1a\uff0e2020.11.12\u201013\uff0e\u6771\u4eac\uff0e<\/li>\n\n\n\n
                                                            4. Ishiwata, J., Daimon, M., Nakanishi, K., Sugimoto, T., Kawata, T., Nakao, T., Hirokawa, M., Sawada, N., Yoshida, Y., Amiya, E., Hatano, M., Morita, H., and Komuro I. Prognostic value of the combined evaluation of right ventricular function by conventional and 2D speckle-tracking echocardiography in patients with non-ischemic dilated cardiomyopathy. \u7b2c84\u56de \u65e5\u672c\u5faa\u74b0\u5668\u75c5\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2020.7.27-8.2\uff0eWEB\u958b\u50ac\uff0e<\/li>\n\n\n\n
                                                            5. \u4e95\u4e0a \u7fd4\u592a\uff0c\u5927\u9580 \u96c5\u592b\uff0c\u4e2d\u5c3e \u502b\u5b50\uff0c\u9234\u6728 \u535a\u82f1\uff0c\u4f50\u3005\u6728 \u8cc0\u6d25\u4e43\uff0c\u5343\u660e \u771f\u5f13\uff0c\u5bae\u5d0e \u4ee4\u5b50\uff0c\u9808\u85e4 \u82b3\u7f8e\uff0c\u4e2d\u6751 \u548c\u594f\uff0c\u77e2\u51a8 \u88d5\uff0e\u751f\u4f53\u80ba\u79fb\u690d\u30c9\u30ca\u30fc\u8853\u5f8c\u306b\u5fc3\u819c\u5207\u958b\u5f8c\u75c7\u5019\u7fa4\u306b\u3088\u308b\u5fc3\u819c\u708e\u3092\u8a8d\u3081\u305f\u4e00\u4f8b\uff0e\u65e5\u672c\u5fc3\u30a8\u30b3\u30fc\u56f3\u5b66\u4f1a \u7b2c31\u56de\u5b66\u8853\u96c6\u4f1a\uff0e2020.8.14-15\uff0e\u5cf6\u6839\uff0e<\/li>\n\n\n\n
                                                            6. \u4e95\u4e0a \u7fd4\u592a\uff0c\u5927\u9580 \u96c5\u592b\uff0c\u4e2d\u5c3e \u502b\u5b50\uff0c\u9234\u6728 \u535a\u82f1\uff0c\u83c5\u539f \u5c06\u4ee3\uff0c\u5343\u660e \u771f\u5f13\uff0c\u4e45\u4fdd\u7530 \u3068\u3082\u3088\uff0c\u5c0f\u91ce \u4f73\u4e00\uff0c\u77e2\u51a8 \u88d5\uff0e\u5f53\u9662\u306b\u304a\u3051\u308bLibman-Sacks\u5fc3\u5185\u819c\u708e9\u75c7\u4f8b\u306e\u5fc3\u30a8\u30b3\u30fc\u56f3\u6240\u898b\u304a\u3088\u3073\u81e8\u5e8a\u50cf\u306e\u691c\u8a0e\uff0e\u7b2c67\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2020.11.19-22\uff0e\u76db\u5ca1\uff0e<\/li>\n\n\n\n
                                                            7. \u5927\u585a \u5341\u91cc\uff0c\u4ee3\u7530 \u60a0\u4e00\u90ce\uff0c\u5c0f\u7389 \u8061\uff0c\u6ff1\u7530 \u96c5\uff0c\u6238\u7530 \u9054\u53f2\uff0e\u95be\u5024\u63a2\u7d22\u6cd5\u3092\u7528\u3044\u305f\uff0c\u7b4b\u840e\u7e2e\u6027\u5074\u7d22\u786c\u5316\u75c7\u306e\u904b\u52d5\u91ce\u76ae\u8cea\u5185\u6291\u5236\u56de\u8def\u7570\u5e38\u306e\u691c\u8a0e\uff0e\u7b2c50\u56de \u65e5\u672c\u81e8\u5e8a\u795e\u7d4c\u751f\u7406\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a\uff0e2020.11.26-28\uff0e\u4eac\u90fd\uff0e<\/li>\n\n\n\n
                                                            8. \u5c0f\u91ce \u4f73\u4e00\uff0c\u77e2\u51a8 \u88d5\uff0e\u30df\u30cb\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\uff0e\u65b0\u578b\u30b3\u30ed\u30ca\u30a6\u30a4\u30eb\u30b9\u611f\u67d3\u75c7\u3078\u306e\u691c\u67fb\u5ba4\u306e\u5bfe\u5fdc\uff0d\u5f53\u9662\u691c\u67fb\u90e8\u3067\u306e\u53d6\u7d44\uff0d\uff0e\u7b2c67\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2020.11.19-22\uff0e\u76db\u5ca1\uff0e<\/li>\n\n\n\n
                                                            9. \u8535\u91ce \u4fe1\uff0c\u5c0f\u6797 \u7389\u5b9c\uff0c\u77e2\u51a8 \u88d5\uff0e2\u578b\u7cd6\u5c3f\u75c5\u60a3\u8005\u306b\u304a\u3051\u308b\u30b0\u30ea\u30bb\u30ed\u30ea\u30be\u30ea\u30f3\u8102\u8cea\u306e\u5909\u52d5\u3068\u305d\u306e\u610f\u7fa9\u306b\u3064\u3044\u3066\u306e\u691c\u8a0e\uff0e\u7b2c117\u56de \u65e5\u672c\u5185\u79d1\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u8b1b\u6f14\u4f1a\uff0e2020.4.11-2020.4.13\uff0e\u6771\u4eac\uff0e<\/li>\n\n\n\n
                                                            10. \u8535\u91ce \u4fe1\uff0c\u897f\u5ddd \u771f\u5b50\uff0c\u77e2\u51a8 \u88d5\uff0e\u30a2\u30dd\u86cb\u767dM\u306f\u6297NETosis\u4f5c\u7528\u3092\u6709\u3059\u308b\uff0e\u7b2c42\u56de \u65e5\u672c\u8840\u6813\u6b62\u8840\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2020.6.18-20\uff0e\u5927\u962a\uff0e<\/li>\n\n\n\n
                                                            11. \u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0e\u30b9\u30d5\u30a3\u30f3\u30b4\u30b7\u30f31-\u30ea\u30f3\u9178\u306b\u3088\u308bHDL\u306e\u591a\u9762\u7684\u52b9\u679c\u306e\u533b\u7642\u5fdc\u7528\u3092\u76ee\u6307\u3057\u3066\uff08\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\uff09\uff0e\u7b2c63\u56de \u65e5\u672c\u8102\u8cea\u751f\u5316\u5b66\u4f1a\uff0e2020.5.14-2020.5.15\uff0e\u6771\u4eac\uff0e<\/li>\n\n\n\n
                                                            12. \u8535\u91ce \u4fe1\uff0c\u585a\u672c \u548c\u4e45\uff0c\u77e2\u51a8 \u88d5\uff0e\u809d-\u80c6\u6c41\u9593\u30b3\u30ec\u30b9\u30c6\u30ed\u30fc\u30eb\u30cf\u30f3\u30c9\u30ea\u30f3\u30b0\u306b\u4f34\u3046\u30ea\u30be\u30ea\u30f3\u8102\u8cea\uff65\u30bb\u30e9\u30df\u30c9\u306e\u5909\u52d5\uff0e\u7b2c63\u56de \u65e5\u672c\u8102\u8cea\u751f\u5316\u5b66\u4f1a\uff0e2020.5.14-2020.5.15\uff0e\u6771\u4eac\uff0e<\/li>\n\n\n\n
                                                            13. \u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0e\u8102\u8cea\u30e1\u30c7\u30a3\u30a8\u30fc\u30bf\u30fc\u3068\u3057\u3066\u306e\u30ea\u30f3\u8102\u8cea\u3068\u305d\u306e\u95a2\u9023\u7269\u8cea\uff08\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\uff09\uff0e\u7b2c52\u56de \u65e5\u672c\u52d5\u8108\u786c\u5316\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u96c6\u4f1a\uff0e2020.7.17-2020.7.31\uff0e\u540d\u53e4\u5c4b\uff0e<\/li>\n\n\n\n
                                                            14. \u8535\u91ce \u4fe1\uff0c\u585a\u672c \u548c\u4e45\uff0c\u77e2\u51a8 \u88d5\uff0e\u30ea\u30be\u30db\u30b9\u30d5\u30a1\u30c1\u30b8\u30eb\u30a4\u30ce\u30b7\u30c8\u30fc\u30eb\u306f\uff0c\u50ac\u708e\u75c7\u30ea\u30be\u30ea\u30f3\u8102\u8cea\u30e1\u30c7\u30a3\u30a8\u30fc\u30bf\u30fc\u3067\u3042\u308b\uff0e\u7b2c52\u56de \u65e5\u672c\u52d5\u8108\u786c\u5316\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u96c6\u4f1a\uff0e2020.7.17-2020.7.31\uff0e\u540d\u53e4\u5c4b\uff0e<\/li>\n\n\n\n
                                                            15. \u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0e\u65b0\u898f\u50ac\u708e\u75c7\u30ea\u30be\u30ea\u30f3\u8102\u8cea\u30ea\u30be\u30db\u30b9\u30d5\u30a1\u30c1\u30b8\u30eb\u30a4\u30ce\u30b7\u30c8\u30fc\u30eb\u306e\u7cd6\u5c3f\u75c5\u306e\u75c5\u614b\u751f\u7406\u306b\u304a\u3051\u308b\u5f79\u5272\u306e\u691c\u8a0e\uff0e\u7b2c67\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2020.11.19-22\uff0e\u76db\u5ca1\uff0e<\/li>\n\n\n\n
                                                            16. \u8535\u91ce\u3000\u4fe1\uff0c\u68ee\u7530\u3000\u8ce2\u53f2\uff0c\u77e2\u51a8\u3000\u88d5\uff0e\u30a2\u30dd\u86cb\u767dM\u306f\uff0c\u30b7\u30b9\u30d7\u30e9\u30c1\u30f3\u814e\u75c7\u306b\u5bfe\u3057\u3066\u4fdd\u8b77\u7684\u4f5c\u7528\u3092\u6301\u3064\uff0e\u7b2c67\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2020.11.19-22\uff0e\u76db\u5ca1\uff0e<\/li>\n\n\n\n
                                                            17. \u5f8c\u85e4 \u5bdb\u662d\uff0c\u4e2d\u6751 \u6587\u9999\uff0c\u5c0f\u6797 \u7389\u5b9c\uff0c\u624b\u5cf6 \u6843\u6c5f\uff0c\u6817\u539f \u771f\u5e0c\u5b50\uff0c\u758b\u7530 \u5b8f\u7f8e\uff0c\u9234\u6728 \u535a\u82f1\uff0c\u77e2\u51a8 \u88d5\uff0e\u98df\u4e8b\u306b\u3088\u308b\u80c6\u56a2\u53ce\u7e2e\u306e\u7d4c\u6642\u7684\u5909\u5316\u306b\u3064\u3044\u3066. \u7b2c69\u56de \u65e5\u672c\u533b\u5b66\u691c\u67fb\u5b66\u4f1a\uff0e2020.9.5-6\uff0e\u5343\u8449\uff0e<\/li>\n\n\n\n
                                                            18. \u4f50\u85e4 \u96c5\u54c9\uff0c\u5efa\u77f3 \u826f\u4ecb\uff0c\u5c0f\u6c60 \u548c\u5f66\uff0eC\u578b\u809d\u708e\u60a3\u8005\u306b\u5bfe\u3059\u308b\u30a6\u30a3\u30eb\u30b9\u99c6\u9664\u304c\u3082\u305f\u3089\u3059\u30ea\u30b9\u30af\u4f4e\u6e1b\u52b9\u679c\u3092\u5b9a\u91cf\u5316\u3059\u308b\u4eba\u5de5\u77e5\u80fd\u30e2\u30c7\u30eb\u306e\u69cb\u7bc9\uff0e\u7b2c56\u56de \u65e5\u672c\u809d\u81d3\u5b66\u4f1a\u7dcf\u4f1a. 2020.8.28-29. \u5927\u962a\uff0e<\/li>\n\n\n\n
                                                            19. \u4f50\u85e4 \u96c5\u54c9\uff0c\u77e2\u51a8 \u88d5\uff0e\u60a3\u8005\u80cc\u666f\u60c5\u5831\u3092\u7528\u3044\u305f\u6a5f\u68b0\u5b66\u7fd2\u306b\u3088\u308b\u809d\u7dda\u7dad\u5316\u4e88\u6e2c\u306e\u6709\u7528\u6027\u306e\u691c\u8a0e\uff0e\u7b2c67\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2020.11.19-22\uff0e\u76db\u5ca1\uff0e<\/li>\n\n\n\n
                                                            20. \u4f50\u85e4 \u96c5\u54c9\uff0c\u77e2\u51a8 \u88d5\uff0e\u809d\u7d30\u80de\u764c\u306b\u5bfe\u3059\u308b\u30e9\u30b8\u30aa\u6ce2\u713c\u707c\u8853\u5f8c\u306e\u518d\u767a\u3092\u4e88\u6e2c\u3059\u308b\u6a5f\u68b0\u5b66\u7fd2\u30e2\u30c7\u30eb\u306e\u69cb\u7bc9\uff0e\u7b2c67\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2020.11.19-22\uff0e\u76db\u5ca1\uff0e<\/li>\n\n\n\n
                                                            21. \u4f50\u85e4 \u96c5\u54c9\uff0c\u89d2 \u52c7\u6a39\uff0c\u77e2\u51a8 \u88d5\uff0eDeep learning\u3092\u7528\u3044\u305f\u8d85\u97f3\u6ce2B\u30e2\u30fc\u30c9\u753b\u50cf\u3067\u306e\u809d\u816b\u7624\u6027\u75c5\u5909\u306e\u826f\u60aa\u6027\u8b58\u5225\u80fd\u306e\u691c\u8a0e\uff0e\u7b2c67\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2020.11.19-22\uff0e\u76db\u5ca1\uff0e<\/li>\n\n\n\n
                                                            22. Sawada, N., Nakanishi, K., Daimon, M., Yoshida, Y., Ishiwata, J., Hirokawa, J., Nakao, T., Morita, H., and Komuro I. Accumulation of visceral adiposity and adverse ventricular mechanics in the community. \u7b2c84\u56de \u65e5\u672c\u5faa\u74b0\u5668\u75c5\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2020.7.27-8.2\uff0eWEB\u958b\u50ac\uff0e<\/li>\n\n\n\n
                                                            23. \u4ee3\u7530 \u60a0\u4e00\u90ce\uff0e\u30ef\u30fc\u30af\u30b7\u30e7\u30c3\u30d7 7 \u78c1\u6c17\u523a\u6fc0\u3067\u306e\u30d4\u30c3\u30c8\u30db\u30fc\u30eb \u5358\u767a\u523a\u6fc0\u30fb\u4e8c\u767a\u523a\u6fc0\uff0e\u7b2c50\u56de \u65e5\u672c\u81e8\u5e8a\u795e\u7d4c\u751f\u7406\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a\uff0e2020.11.26-28\uff0e\u4eac\u90fd\uff0e<\/li>\n\n\n\n
                                                            24. \u4ee3\u7530 \u60a0\u4e00\u90ce\uff0eAdvanced Lecture 13 \u795e\u7d4c\u5909\u6027\u75be\u60a3\u3068TMS\uff0e\u7b2c50\u56de \u65e5\u672c\u81e8\u5e8a\u795e\u7d4c\u751f\u7406\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a\uff0e2020.11.26-28\uff0e\u4eac\u90fd\uff0e<\/li>\n\n\n\n
                                                            25. \u83c5\u539f \u5c06\u4ee3\uff0c\u5927\u9580 \u96c5\u592b\uff0c\u5343\u660e \u771f\u5f13\uff0c\u4e95\u4e0a \u7fd4\u592a\uff0c\u4e45\u4fdd\u7530 \u3068\u3082\u3088\uff0c\u9234\u6728 \u535a\u82f1\uff0c\u4e2d\u5c3e \u502b\u5b50\uff0c\u5c0f\u91ce \u4f73\u4e00\uff0c\u77e2\u51a8 \u88d5\uff0e\u30ec\u30cb\u30f3\u4f9d\u5b58\u6027\u9ad8\u8840\u5727\u3092\u5448\u3057\u305fNutcracker\u75c7\u5019\u7fa4\u306e\uff11\u75c7\u4f8b\uff0e\u7b2c67\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2020.11.19-22\uff0e\u76db\u5ca1\uff0eWEB\u4f75\u50ac\uff0e<\/li>\n\n\n\n
                                                            26. Daimon, M. Optimal Indication and Timing of Surgical Treatment of TR: From Cardiologists’ Viewpoint. \u7b2c84\u56de \u65e5\u672c\u5faa\u74b0\u5668\u75c5\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2020.7.27-8.2\uff0eWEB\u958b\u50ac\uff0e<\/li>\n\n\n\n
                                                            27. Daimon, M., Kiriyama, H., Nakanishi, K., Kaneko, H., Nakao, T., Ichikawa-Morimoto, R., Miyazaki, S., Daida, H., Morita, H., and Komuro I. Comparison between healthcare-associated and community-acquired infective endocarditis at tertiary care hospitals in Japan. \u7b2c84\u56de \u65e5\u672c\u5faa\u74b0\u5668\u75c5\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2020.7.27-8.2\uff0eWEB\u958b\u50ac\uff0e<\/li>\n\n\n\n
                                                            28. \u5927\u9580 \u96c5\u592b\uff0e\u5927\u52d5\u8108\u5f01\u72ed\u7a84\u75c7\u306e\u30c1\u30a7\u30f3\u30b8\u30d7\u30e9\u30af\u30c6\u30a3\u30b9Position statement\uff0e\u7b2c84\u56de \u65e5\u672c\u5faa\u74b0\u5668\u75c5\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2020.7.27-8.2\uff0eWEB\u958b\u50ac\uff0e<\/li>\n\n\n\n
                                                            29. \u5927\u9580 \u96c5\u592b\uff0e\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\uff12 \u65b0\u3057\u304f\u306a\u3063\u305f\u5f01\u819c\u75c7\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3 TR\u306e\u624b\u8853\u9069\u5fdc\u6c7a\u5b9a\u306b\u91cd\u8981\u306a\u5fc3\u30a8\u30b3\u30fc\u56f3\u6240\u898b\uff0e\u7b2c31\u56de \u65e5\u672c\u5fc3\u30a8\u30b3\u30fc\u56f3\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2020.8.14-15. \u51fa\u96f2\u5e02\uff0eWEB\u540c\u6642\u958b\u50ac\uff0e<\/li>\n\n\n\n
                                                            30. \u5927\u9580 \u96c5\u592b\uff0e\u6559\u80b2\u8b1b\u6f14 \u65e5\u5faa\u5f01\u819c\u75c7\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\uff1a\u4e09\u5c16\u5f01\u9006\u6d41\u306b\u95a2\u3059\u308b\u6539\u8a02\u30dd\u30a4\u30f3\u30c8\uff0e\u7b2c24\u56de \u65e5\u672c\u5fc3\u4e0d\u5168\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0c2020.10.15-17\uff0eWEB\u958b\u50ac\uff0e<\/li>\n\n\n\n
                                                            31. \u5927\u9580 \u96c5\u592b\uff0eKeynote lecture:Onco-cardiology\uff0e\u65e5\u672c\u8d85\u97f3\u6ce2\u533b\u5b66\u4f1a \u7b2c93\u56de\u5b66\u8853\u96c6\u4f1a\uff0c2020.12.1-3\uff0eWEB\u958b\u50ac\uff0e<\/li>\n\n\n\n
                                                            32. \u5927\u9580 \u96c5\u592b\uff0e\u7814\u4fee\u533b\u6559\u80b2\u30bb\u30df\u30ca\uff0d \u30d5\u30a3\u30b8\u30ab\u30eb\u30a4\u30b0\u30b6\u30df\u30cd\u30fc\u30b7\u30e7\u30f3\u3067\u7684\u78ba\u306a\u8a3a\u65ad\uff01\uff1a\u3053\u308c\u305e\u5faa\u74b0\u5668\u8a3a\u7642\u306e\u918d\u9190\u5473\uff0e\u7b2c129\u56de \u65e5\u672c\u5faa\u74b0\u5668\u5b66\u4f1a\u4e5d\u5dde\u5730\u65b9\u4f1a\uff0c2020.12.5\uff0eWEB\u958b\u50ac\uff0e<\/li>\n\n\n\n
                                                            33. \u9ad8\u6728 \u88d5\u7f8e\u5b50\uff0c\u5f71\u5c71 \u7950\u5b50\uff0c\u5bae\u672c \u548c\u5b50\uff0c\u67f3\u7530 \u9053\u5b5d\uff0c\u68ee\u8c4a \u9686\u5fd7\uff0c\u4e38\u5c71 \u9054\u4e5f\uff0e\u81e8\u5e8a\u8a66\u9a13\u3092\u5b89\u5168\u306b\u5b9f\u65bd\u3059\u308b\u305f\u3081\u306b\uff5e\u30b9\u30bf\u30c3\u30d5\u6559\u80b2\u306e\u89b3\u70b9\u304b\u3089\uff5e\uff0e\u7b2c41\u56de \u65e5\u672c\u81e8\u5e8a\u85ac\u7406\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a\uff0e2020.12.3-5\uff0e\u798f\u5ca1\uff0e<\/li>\n\n\n\n
                                                            34. \u4e2d\u5c3e \u502b\u5b50\uff0c\u5927\u9580 \u96c5\u592b\uff0c\u4e95\u4e0a \u7fd4\u592a\uff0c\u83c5\u539f \u5c06\u4ee3\uff0c\u9234\u6728 \u535a\u82f1\uff0c\u897f\u5ddd \u771f\u5b50\uff0c\u77e2\u51a8 \u88d5\uff0e\u30a2\u30b9\u30d4\u30ea\u30f3\u6295\u4e0e\u4e2d\u306e\u865a\u8840\u6027\u5fc3\u75be\u60a3\u60a3\u8005\u306b\u304a\u3051\u308b\u8840\u5c0f\u677f\u51dd\u96c6\u80fd\u306b\u5bfe\u3059\u308b\u5e74\u9f62\u306e\u5f71\u97ff\uff0e\u7b2c67\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2020.11.19-22\uff0e\u76db\u5ca1\uff0eWEB\u4f75\u50ac\uff0e<\/li>\n\n\n\n
                                                            35. \u4e2d\u897f \u5f18\u6bc5\uff0c\u5927\u9580 \u96c5\u592b\uff0c\u5409\u7530 \u7531\u7406\u5b50\uff0c\u77f3\u6e21 \u60c7\u5e73\uff0c\u6fa4\u7530 \u76f4\u5b50\uff0c\u5ee3\u5ddd \u611b\u7f8e\uff0c\u91d1\u5b50 \u82f1\u5f18\uff0c\u4e2d\u5c3e \u502b\u5b50\uff0c\u6c34\u91ce \u7531\u5b50\uff0c\u68ee\u7530 \u5553\u884c\uff0c\u5c0f\u5ba4 \u4e00\u6210\uff0e\u9838\u52d5\u8108\u5185\u819c\u4e2d\u819c\u8907\u5408\u4f53\u539a\u3068\u6f5c\u5728\u6027\u5de6\u5fc3\u6a5f\u80fd\u4f4e\u4e0b\u306b\u95a2\u3059\u308b\u691c\u8a0e\uff0e\u7b2c31\u56de \u65e5\u672c\u5fc3\u30a8\u30b3\u30fc\u56f3\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2020.8.14-15. \u51fa\u96f2\u5e02\uff0eWEB\u540c\u6642\u958b\u50ac\uff0e<\/li>\n\n\n\n
                                                            36. \u4e2d\u91ce \u88d5\u6a39\uff0c\u6a2a\u5c71 \u96a3\uff0c\u68ee\u7530\u8ce2\u53f2\uff0c\u5fd7\u6751 \u62d3\u4e5f\uff0c\u5409\u5ddd \u76f4\u4e4b\uff0c\u540d\u5009 \u8c4a\uff0c\u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0e\u65b0\u578b\u30b3\u30ed\u30ca\u30a6\u30a4\u30eb\u30b9\u6297\u4f53\u691c\u67fb\u306e\u8a3a\u65ad\u80fd\uff1a\u767a\u75c7\u5f8c\u7d4c\u6642\u7684\u5909\u5316\u306b\u3064\u3044\u3066\u306e\u691c\u8a0e\uff0e\u7b2c67\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2020.11.19-22\uff0e\u76db\u5ca1\uff0e<\/li>\n\n\n\n
                                                            37. \u897f\u5ddd \u5c1a\u5b50\uff0c \u8535\u91ce \u4fe1\uff0c\u6c60\u7530 \u5747\uff0c\u77e2\u51a8 \u88d5\uff0c\u5c0f\u6c60 \u548c\u5f66\uff0e\u30ea\u30be\u30db\u30b9\u30d5\u30a1\u30c1\u30b8\u30eb\u30bb\u30ea\u30f3\u306f\u65b0\u898f\u809d\u7dda\u7dad\u5316\u4fc3\u9032\u56e0\u5b50\u306e\u53ef\u80fd\u6027\u304c\u3042\u308b\uff0e\u7b2c<\/em>28\u56de \u65e5\u672c\u6d88\u5316\u5668\u95a2\u9023\u5b66\u4f1a<\/em>\u9031\u9593\uff0e 2020.11.5-8\uff0e\u795e\u6238\uff0e<\/li>\n\n\n\n
                                                            38. \u897f\u5ddd \u771f\u5b50\uff0c\u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0eP2Y10\u306e\u8840\u5c0f\u677f\u6a5f\u80fd\u306b\u304a\u3051\u308b\u5f79\u5272\u306e\u691c\u8a0e\uff0e\u7b2c42\u56de \u65e5\u672c\u8840\u6813\u6b62\u8840\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2020.6.18-20\uff0e\u5927\u962a\uff0e<\/li>\n\n\n\n
                                                            39. \u897f\u5ddd \u771f\u5b50\uff0c\u5b89\u672c \u7be4\u53f2\uff0c\u77e2\u51a8 \u88d5\uff0e\u30a8\u30df\u30b7\u30ba\u30de\u30d6\u5c0e\u5165\u5f8c\u306b\u95a2\u7bc0\u7f6e\u63db\u8853\u3092\u65bd\u884c\u3057\u305f\u30a4\u30f3\u30d2\u30d3\u30bf\u30fc\u975e\u4fdd\u6709\u8840\u53cb\u75c5A\u306e\uff11\u4f8b\uff0e\u7b2c82\u56de \u65e5\u672c\u8840\u6db2\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2020.10.10-11.8\uff0e\u4eac\u90fd\uff0e<\/li>\n\n\n\n
                                                            40. \u771f\u5d0e \u6842\uff0c\u6301\u7530 \u667a\u4e4b\uff0c\u5c0f\u53e3 \u7d62\u5b50\uff0c\u5c71\u7530 \u306f\u308b\u9999\uff0c\u7530\u5cf6 \u5c06\u592a\u90ce\uff0c\u79cb\u7530 \u840c\uff0c\u837b\u6fa4 \u6075\u7f8e\uff0c\u77e2\u51a8\u3000\u88d5\uff0c\u4ee3\u7530 \u60a0\u4e00\u90ce\uff0e\u65b0\u578b\u30b3\u30ed\u30ca\u30a6\u30a3\u30eb\u30b9\u611f\u67d3\u60a3\u8005\u306b\u304a\u3051\u308b\u8133\u6ce2\u691c\u67fb\u306e\u5b9f\u969b\uff0e\u7b2c50\u56de \u65e5\u672c\u81e8\u5e8a\u795e\u7d4c\u751f\u7406\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a\uff0e2020.11.26-28\uff0e\u4eac\u90fd\uff0e<\/li>\n\n\n\n
                                                            41. \u4e09\u597d \u9054\u4e5f\uff0c\u5927\u9580 \u96c5\u592b\uff0c\u7af9\u5185 \u6b63\u660e\uff0cLang Roberto\uff0cAsch Federico\uff0e\u4e16\u754c\u5404\u56fd\u3068\u6bd4\u8f03\u3057\u305f\u5065\u5e38\u6210\u4eba\u65e5\u672c\u4eba\u306e\u5fc3\u30a8\u30b3\u30fc\u56f3\u306b\u304a\u3051\u308b\u5de6\u5ba4\u30b5\u30a4\u30ba\u3068\u6a5f\u80fd\uff1aThe WASE study\u304b\u3089\u306e\u89e3\u6790\u7d50\u679c\uff0e\u7b2c31\u56de \u65e5\u672c\u5fc3\u30a8\u30b3\u30fc\u56f3\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2020.8.14-15. \u51fa\u96f2\u5e02\uff0eWEB\u540c\u6642\u958b\u50ac\uff0e<\/li>\n\n\n\n
                                                            42. \u68ee\u7530 \u8ce2\u53f2\uff0c\u7530\u4e2d \u96c5\u7f8e\uff0c\u4e45\u672b \u5d07\u53f8\uff0c\u5e38\u540d \u653f\u5f18\uff0c\u5c0f\u91ce \u4f73\u4e00\uff0c\u5409\u672c \u660e\uff0c\u5bbf\u8c37 \u8ce2\u4e00\uff0c\u897f\u5ddd \u771f\u5b50\uff0c\u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0e\u4e2d\u67a2\u795e\u7d4c\u6d78\u6f64\u3092\u7e70\u308a\u8fd4\u3057\u305f\u83cc\u72b6\u606f\u8089\u75c7\u306e\u4e00\u75c7\u4f8b\uff0e\u7b2c21\u56de \u65e5\u672c\u691c\u67fb\u8840\u6db2\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2020.7.11-12\uff0e\u91d1\u6ca2\uff0e<\/li>\n\n\n\n
                                                            43. \u68ee\u7530 \u8ce2\u53f2\uff0c\u4e45\u672b \u5d07\u53f8\uff0c\u5c0f\u91ce \u4f73\u4e00\uff0c\u5bbf\u8c37 \u8ce2\u4e00\uff0c\u4f50\u85e4 \u667a\u660e\uff0c\u77e2\u51a8 \u88d5\uff0c\u7530\u4e2d \u96c5\u7f8e\uff0e\u4e2d\u67a2\u795e\u7d4c\u6d78\u6f64\u3092\u304d\u305f\u3057\u305f\u767d\u8840\u75c5\u30fb\u30ea\u30f3\u30d1\u816b\u75c7\u4f8b\u306e\u5f8c\u65b9\u8996\u7684\u89e3\u6790\uff0e\u7b2c69\u56de \u65e5\u672c\u533b\u5b66\u691c\u67fb\u5b66\u4f1a\uff0e2020.9.5-6\uff0e\u5343\u8449\uff0e<\/li>\n\n\n\n
                                                            44. \u68ee\u7530 \u8ce2\u53f2\uff0c\u4e45\u672b \u5d07\u53f8\uff0c\u5c0f\u91ce \u4f73\u4e00\uff0c\u5409\u672c \u660e\uff0c\u4f50\u85e4 \u667a\u660e\uff0c\u5bbf\u8c37 \u8ce2\u4e00\uff0c\u77e2\u51a8 \u88d5\uff0c\u7530\u4e2d \u96c5\u7f8e\uff0e\u5f53\u9662\u306b\u304a\u3051\u308b\u5c3f\u691c\u67fb\u904b\u7528\u306e\u73fe\u72b6\u3068TAT\u306e\u8a55\u4fa1\uff0e\u7b2c69\u56de \u65e5\u672c\u533b\u5b66\u691c\u67fb\u5b66\u4f1a\uff0e2020.9.5-6\uff0e\u5343\u8449\uff0e<\/li>\n\n\n\n
                                                            45. \u68ee\u7530 \u8ce2\u53f2\uff0c\u7530\u4e2d \u96c5\u7f8e\uff0c\u5bbf\u8c37 \u8ce2\u4e00\uff0c\u4e45\u672b \u5d07\u53f8\uff0c\u5409\u672c \u660e\uff0c\u5409\u5ddd \u76f4\u4e4b\uff0c\u5c0f\u91ce \u4f73\u4e00\uff0c\u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0e\u5c3f\u6f5c\u8840\u3068\u6c88\u6e23\u8d64\u8840\u7403\u306e\u4e56\u96e2\u306b\u3088\u308b\u30df\u30aa\u30b0\u30ed\u30d3\u30f3\u5c3f\u30b9\u30af\u30ea\u30fc\u30cb\u30f3\u30b0\u6cd5\u306e\u78ba\u7acb\uff0e\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u81ea\u52d5\u5316\u5b66\u4f1a \u7b2c52\u56de\u5927\u4f1a\uff0e2020.9.24-26\uff0e\u6a2a\u6d5c\uff0e<\/li>\n\n\n\n
                                                            46. \u68ee\u7530 \u8ce2\u53f2\uff0c\u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0e\u5c3f\u4e2d\u8102\u8cea\u30e1\u30c7\u30a3\u30a8\u30fc\u30bf\u30fc\u7db2\u7f85\u7684\u5206\u6790\u306b\u3088\u308b\u7cd6\u5c3f\u75c5\u6027\u814e\u75c7\u306e\u30d0\u30a4\u30aa\u30de\u30fc\u30ab\u30fc\u63a2\u7d22\uff0e\u7b2c60\u56de \u65e5\u672c\u81e8\u5e8a\u5316\u5b66\u4f1a\uff0e2020.10.30-11.1\uff0e\u6771\u4eac\uff0e<\/li>\n\n\n\n
                                                            47. \u68ee\u7530 \u8ce2\u53f2\uff0c\u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0eLC-MS\/MS\u3092\u7528\u3044\u305f\u5c3f\u4e2d\u30ea\u30be\u30ea\u30f3\u8102\u8cea\u306e\u7db2\u7f85\u7684\u5206\u6790\u306b\u3088\u308b\u814e\u75be\u60a3\u30d7\u30ed\u30d5\u30a1\u30a4\u30ea\u30f3\u30b0\uff0e\u7b2c67\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2020.11.19-22\uff0e\u76db\u5ca1\uff0e<\/li>\n\n\n\n
                                                            48. \u68ee\u7530 \u8ce2\u53f2\uff0c\u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0e\u4e2d\u67a2\u795e\u7d4c\u7cfb\u75be\u60a3\u306b\u304a\u3051\u308bLC-MS\/MS\u3092\u7528\u3044\u305f\u9ac4\u6db2\u4e2d\u30ea\u30be\u30ea\u30f3\u8102\u8cea\u306e\u89e3\u6790\uff0e\u7b2c67\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2020.11.19-22\uff0e\u76db\u5ca1\uff0e<\/li>\n\n\n\n
                                                            49. \u5b89\u5ddd \u6075\u5b50\uff0c\u897f\u5ddd \u771f\u5b50\uff0c\u897f\u5ddd \u5c1a\u5b50\uff0cBaasanjav Uranbileg\uff0c\u4f50\u85e4 \u96c5\u54c9\uff0c\u77e2\u51a8 \u88d5\uff0e\u9178\u5316\u30b9\u30c8\u30ec\u30b9\u30de\u30fc\u30ab\uff0c\u8840\u4e2d\u9178\u5316\u578b\u30a2\u30eb\u30d6\u30df\u30f3(HNA)\u6bd4\u7387(%)\u306e\u500b\u4eba\u5909\u52d5\u5e45\u306e\u691c\u8a0e\uff0e\u7b2c60\u56de \u65e5\u672c\u81e8\u5e8a\u5316\u5b66\u4f1a\u5e74\u6b21\u5b66\u8853\u96c6\u4f1a\uff0e2020.10.30-11.1\uff0e\u6771\u4eac\uff0e<\/li>\n\n\n\n
                                                            50. \u5b89\u5ddd\u6075\u5b50\uff0e\u30b0\u30ea\u30b3\u30a2\u30eb\u30d6\u30df\u30f3(GA)\u56fd\u5185\u3067\u306e\u6d3b\u7528\u72b6\u6cc1\uff0e(\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0)\u7b2c60\u56de \u65e5\u672c\u81e8\u5e8a\u5316\u5b66\u4f1a\u5e74\u6b21\u5b66\u8853\u96c6\u4f1a\uff0e2020.10.30-11.1\uff0e\u6771\u4eac\uff0e<\/li>\n\n\n\n
                                                            51. \u4fdd\u7530 \u5948\u7dd2\u7f8e\uff0c\u4e0a\u5e02 \u88d5\u5b50\uff0c\u77f3\u539f \u6709\u7406\uff0c\u4e0b\u5742 \u6d69\u5247\uff0c\u4f50\u85e4 \u667a\u660e\uff0c\u897f\u5ddd \u771f\u5b50\uff0c\u77e2\u51a8 \u88d5\uff0e\u30c0\u30e9\u30c4\u30e0\u30de\u30d6\u6297\u4f53\u8a66\u85ac\u306e\u6027\u80fd\u8a55\u4fa1\uff0e\u7b2c69\u56de \u65e5\u672c\u533b\u5b66\u691c\u67fb\u5b66\u4f1a\uff0e2020.9.5-6\uff0e\u5343\u8449\uff0e<\/li>\n\n\n\n
                                                            52. \u4fdd\u7530 \u5948\u7dd2\u7f8e\uff0c\u4e0b\u5742 \u6d69\u5247\uff0c\u5c0f\u91ce \u4f73\u4e00\uff0c\u897f\u5ddd \u771f\u5b50\uff0c\u77e2\u51a8 \u88d5\uff0e\u514d\u75ab\u30b0\u30ed\u30d6\u30ea\u30f3\u88fd\u5264\u306e\u6295\u4e0e\u304c\u81ea\u5df1\u6297\u4f53\u691c\u67fb\u7d50\u679c\u306b\u4e0e\u3048\u308b\u5f71\u97ff\uff0e\u7b2c67\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2020.11.19-22\uff0e\u76db\u5ca1\uff0e<\/li>\n\n\n\n
                                                            53. \u77e2\u51a8 \u88d5\uff0e\u300c\u751f\u7406\u6d3b\u6027\u8102\u8cea\u306e\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u306e\u69cb\u7bc9\u300d\uff0e\u91d1\u6ca2\u5927\u5b66\u6a5f\u80fd\u8102\u8cea\u30b7\u30f3\u30dd\u30b8\u30a6\u30e02020\u300c\u751f\u547d\u6a5f\u80fd\u3068\u75be\u60a3\u3092\u5236\u5fa1\u3059\u308b\u6a5f\u80fd\u8102\u8cea\u300d\uff0e2020.1.31\uff0e\u91d1\u6ca2\uff0e<\/li>\n\n\n\n
                                                            54. \u77e2\u51a8 \u88d5\uff0e\u7279\u5225\u8b1b\u6f14\u300c\u65e5\u672c\u5185\u79d1\u5b66\u4f1a\u306e\u76ee\u6307\u3059\u65b9\u5411\u300d\uff0e\u7b2c65\u56de \u65e5\u672c\u53e3\u8154\u5916\u79d1\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u5927\u4f1a\uff0e2020.11.13-1<\/li>\n\n\n\n
                                                            55. \u5c71\u672c \u88d5\u5b50\uff0c\u5927\u9580 \u96c5\u592b\uff0c\u4e2d\u5c3e \u502b\u5b50\uff0c\u4e2d\u897f \u5f18\u6bc5\uff0c\u5ee3\u5ddd \u611b\u7f8e\uff0c\u6fa4\u7530 \u76f4\u5b50\uff0c\u77f3\u6e21 \u60c7\u5e73\uff0c\u6850\u5c71 \u7693\u884c\uff0c\u5409\u7530 \u7531\u7406\u5b50\uff0c\u5ca9\u9593 \u5065\u592a\u90ce\uff0c\u5ee3\u702c \u548c\u4fca\uff0c\u5c0f\u5ba4 \u4e00\u6210\uff0e\u30e9\u30df\u30f3A\/C\u907a\u4f1d\u5b50\u5909\u75705\u75c7\u4f8b\u306e\u5fc3\u30a8\u30b3\u30fc\u56f3\u6240\u898b\u306e\u691c\u8a0e\uff0e\u7b2c31\u56de \u65e5\u672c\u5fc3\u30a8\u30b3\u30fc\u56f3\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2020.8.14-15\uff0e\u51fa\u96f2\u5e02\uff0eWEB\u540c\u6642\u958b\u50ac\uff0e<\/li>\n\n\n\n
                                                            56. Yoshida, Y., Nakanishi, K., Daimon, M., Nakao, T., Iwama, K., Hirose, K., Yamamoto, Y., Ishiwata, J., Sawada, N., Hirokawa, M., Kaneko, H., Mizuno, Y., Morita, H., and Komuro, I. Arterial Stiffness and Subclinical Left Ventricular Dysfunction in the General Population. \u7b2c84\u56de \u65e5\u672c\u5faa\u74b0\u5668\u75c5\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2020.7.27-8.2\uff0eWEB\u958b\u50ac\uff0e<\/li>\n\n\n\n
                                                            57. \u5409\u7530 \u7531\u7406\u5b50\uff0c\u4e2d\u897f \u5f18\u6bc5\uff0c\u5927\u9580 \u96c5\u592b\uff0c\u91d1\u5b50 \u82f1\u5f18\uff0c\u4e2d\u5c3e \u502b\u5b50\uff0c\u6c34\u91ce \u7531\u5b50\uff0c\u68ee\u7530 \u5553\u884c\uff0c\u5c0f\u5ba4 \u4e00\u6210\uff0e\u52d5\u8108\u30b9\u30c6\u30a3\u30d5\u30cd\u30b9\u306e\u4ea2\u9032\u304c\u6f5c\u5728\u6027\u5de6\u5ba4\u6a5f\u80fd\u969c\u5bb3\u306b\u53ca\u307c\u3059\u5f71\u97ff\u3068\u305d\u306e\u6027\u5dee\u306e\u691c\u8a0e\uff0e\u65e5\u672c\u8d85\u97f3\u6ce2\u533b\u5b66\u4f1a \u7b2c93\u56de\u5b66\u8853\u96c6\u4f1a\uff0e2020.12.1-3\uff0eWEB\u958b\u50ac\uff0e<\/li>\n\n\n\n
                                                            58. \u6a2a\u5c71 \u96a3\uff0c\u5fd7\u6751 \u62d3\u4e5f\uff0c\u68ee\u7530 \u8ce2\u53f2\uff0c\u5409\u5ddd \u76f4\u4e4b\uff0c\u5e38\u540d \u653f\u5f18\uff0c\u4f50\u85e4 \u667a\u660e\uff0c\u77e2\u51a8 \u88d5\uff0e\u5168\u81ea\u52d5\u81e8\u5e8a\u691c\u67fb\u30b7\u30b9\u30c6\u30e0\u30b9\u30c6\u30a4\u30b7\u30a2\u306b\u3088\u308b\u80f8\u8179\u6c34\u4e2d\u30d7\u30ec\u30bb\u30d7\u30b7\u30f3\u6e2c\u5b9a\u306e\u57fa\u790e\u7684\u691c\u8a0e\uff0e\u7b2c69\u56de \u65e5\u672c\u533b\u5b66\u691c\u67fb\u5b66\u4f1a\uff0e2020.9.5-6\uff0e\u5343\u8449\uff0e<\/li>\n\n\n\n
                                                            59. \u6a2a\u5c71 \u96a3\uff0c\u4e2d\u91ce\u88d5\u6a39\uff0c\u5fd7\u6751\u62d3\u4e5f\uff0c\u68ee\u7530\u8ce2\u53f2\uff0c\u5409\u5ddd\u76f4\u4e4b\uff0c\u540d\u5009\u8c4a\uff0c\u8535\u91ce\u4fe1\uff0c\u77e2\u51a8\u88d5\uff0e\u5316\u5b66\u767a\u5149\u514d\u75ab\u6e2c\u5b9a\u6cd5\u306b\u3088\u308b\u65b0\u898f\u6297SARS-CoV-2\u6297\u4f53\u6e2c\u5b9a\u8a66\u85ac\u306e\u57fa\u790e\u7684\u6027\u80fd\u8a55\u4fa1\uff0e\u7b2c67\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2020.11.19-22\uff0e\u76db\u5ca1\uff0e<\/li>\n\n\n\n
                                                            60. \u5409\u5ddd \u76f4\u4e4b\uff0e\u30b7\u30f3\u30dd\u30b8\u30a6\u30e03\u300c\u81e8\u5e8a\u5316\u5b66\u691c\u67fb\u5ba4\u306b\u304a\u3051\u308b\u7cbe\u5ea6\u4fdd\u8a3c\u306e\u5de5\u592b\uff1a\u5206\u6790\u524d\uff5e\u5206\u6790\u5f8c\u307e\u3067\u306b\u3044\u304b\u306b\u691c\u67fb\u5024\u306e\u7cbe\u5ea6\u4fdd\u8a3c\u30fb\u4ed8\u52a0\u4fa1\u5024\u3092\u3064\u3051\u308b\u304b\u300d\uff1a\u6a5f\u5668\u30fb\u8a66\u85ac\u306f\u6280\u5e2b\u306e\u6b66\u5668\u2015\u57fa\u790e\u691c\u8a0e\u304b\u3089\u81e8\u5e8a\u7814\u7a76\u307e\u3067\u2015\uff0e\u7b2c60\u56de \u65e5\u672c\u81e8\u5e8a\u5316\u5b66\u4f1a\u5e74\u6b21\u5b66\u8853\u96c6\u4f1a\uff0e2020.10.30-11.1\uff0e\u6771\u4eac\uff0e<\/li>\n\n\n\n
                                                            61. Uranbileg Baasanjav\uff0c\u8535\u91ce \u4fe1\uff0c\u6c60\u7530 \u5747\uff0c\u77e2\u51a8 \u88d5\uff0ePossible involvement of the lysophopholipid-related factors in human esophageal cancer tissue. \u7b2c60\u56de \u65e5\u672c\u81e8\u5e8a\u5316\u5b66\u4f1a\u5e74\u6b21\u5b66\u8853\u96c6\u4f1a\uff0e2020.10.30-11.1\uff0e\u6771\u4eac\uff0e<\/li>\n\n\n\n
                                                            62. Uranbileg Baasanjav\uff0c\u4f0a\u85e4 \u4f38\u5b50\uff0c\u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0eInhibition of the autotoxin activity ameliorates neuropathic pain symptoms derived from a lumbar spinal stenosis\uff0e\u7b2c67\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2020.11.19-22\uff0e\u76db\u5ca1\uff0e<\/li>\n<\/ol>\n\n\n\n

                                                              \u82f1\u6587\u7dcf\u8aac\uff1aEnglish Review Articles<\/h4>\n\n\n\n
                                                                \n
                                                              1. Seo, Y., Daimon, M., Yamada, H., Kagiyama, N., Ohta, M., Izumi, C., Yamamoto, K., Nakatani, S., and on behalf of the member of the joint committee of the Education Committee, Public Relations Committee, and Guidelines Committee of the Japanese Society of Echocardiography. Review of the efforts of the Japanese Society of Echocardiography for coronavirus disease 2019 (Covid-19) during the initial outbreak in Japan. J. Echocardiogr.<\/strong><\/em> 18: 226-233<\/a>, 2020.<\/li>\n\n\n\n
                                                              2. Zhou, Y., Isozaki, A., Yasumoto, A., Xiao, T.H., Yatomi, Y., Lei, C., and Goda, K. Intelligent Platelet Morphometry. Trends Biotechnol<\/strong><\/em> 39: 978-989<\/a>, 2021.<\/li>\n<\/ol>\n\n\n\n

                                                                \u56fd\u969b\u5b66\u4f1a\u767a\u8868\uff1aInternational Conference Presentation<\/h4>\n\n\n\n
                                                                  \n
                                                                1. Ishii, K., Yoshikawa, Y., Hyodo, E., Seo, Y., Ishizu, T., Kihara, H., Daimon, M., Tanaka, A., Watanabe, H., Akasaka, T., Ito, H., Yoshikawa, J. Diagnostic accuracy of left ventricular diastolic transverse strain imaging by speckle tracking echocardiography for diagnosing chest pain in diabetic patients. European Society of Cardiology Congress 2020. 2020. 8. 29-9. 1. WEB conference.<\/li>\n\n\n\n
                                                                2. Kiriyama, H., Kaneko, H., Kamon, T., Itoh, H., Jo, T., Fujiu, K., Daimon, M., Morita, H., Yasunaga, H., and Komuro, I. Association between surgical treatment and in-hospital mortality in patients with infective endocarditis stratified by NYHA classification: a nationwide retrospective study in Japan. European Society of Cardiology Congress 2020. 2020. 8. 29-9. 1. WEB conference.<\/li>\n\n\n\n
                                                                3. Nakanishi, K., Daimon, M., Yoshida, Y., Ishiwata, J., Sawada, N., Hirokawa, M., Kaneko, H., Nakao, T., Mizuno, Y., Morita, H., Di, Tullio, M., Homma, S., and Komuro, I. Carotid intima-media thickness and subclinical left heart dysfunction in the general population. European Society of Cardiology Congress 2020. 2020. 8. 29-9. 1. WEB conference.<\/li>\n\n\n\n
                                                                4. Sawada, N., Nakanishi, K., Daimon, M., Yoshida, Y., Ishiwata, J., Hirokawa, M., Koyama, K., Nakao, T., Mizuno, Y., Morita, H., Di, Tullio, M., Homma, S., and Komuro, I. Visceral fat accumulation and left atrial phasic function in the general population. European Society of Cardiology Congress 2020. 2020. 8. 29-9. 1. WEB conference.<\/li>\n\n\n\n
                                                                5. Singh, A., Addetia, K., Miyoshi, T., Schreckenberg, M., Blankenhagen, M., Amuthan, V., Citro, R., Daimon, M., Guti\u00e9rrez-Fajardo, P., Kasliwal, R., Kirkpatrick, J.N., Monaghan, M.J., Muraru, D., Ogunyankin, K.O., Park, S.W., Tude, Rodrigues, A.C., Ronderos, R., Sadeghpour, A., Scalia, G., Takeuchi, M., Tsang, W., Tucay, E.S., Zhang, M., Soulat-Dufour, L., Asch, F.M., and Lang R.M. Differences in left atrial dimensions by 3D analysis: Insights from a subset of the World Alliance of Societies of Echocardiography (WASE) Normal Values Study. American Society of Echocardiography 31th Annual Scientific Sessions. 2020. 6. 19-22. Denver, Colorado, U.S.A.<\/li>\n\n\n\n
                                                                6. Singh, A., Addetia, K., Miyoshi, T., Schreckenberg, M., Blankenhagen, M., Amuthan, V., Citro, R., Daimon, M., Guti\u00e9rrez-Fajardo, P., Kasliwal, R., Kirkpatrick, J.N., Monaghan, M.J., Muraru, D., Ogunyankin, K.O., Park, S.W., Tude, Rodrigues, A.C., Ronderos, R., Sadeghpour, A., Scalia, G., Takeuchi, M., Tsang, W., Tucay, E.S., Zhang, M., Soulat-Dufour, L., Asch, F.M., and Lang, R.M. The evolving relationship of age and 3D left atrial phasic function using data from a subset of the World Alliance of Societies of Echocardiography (WASE) Normal Values Study. American Society of Echocardiography 31th Annual Scientific Sessions. 2020. 6. 19-22. Denver, Colorado, U.S.A.<\/li>\n\n\n\n
                                                                7. Shirota, Y. Automation of TMS procedures I (IFCN-SIG (Special Interest Group) \u201cNon-invasive Brain Stimulation\u201d New topics). 7th International Conference on Non-invasive Brain Stimulation. 2020. 11. 10-14. Germany(virtual).<\/li>\n\n\n\n
                                                                8. Shirota, Y. Combining SICF and ICF with QPS boosts excitability increase in the primary motor cortex. 7th International Conference on Non-invasive Brain Stimulation. 2020. 11. 10-14. Germany(virtual).<\/li>\n\n\n\n
                                                                9. Soulat-Dufour, L., Addetia, K., Miyoshi, T., Schreckenberg, M., Blankenhagen, M., Amuthan, V., Citro, R., Daimon, M., Guti\u00e9rrez-Fajardo, P., Kasliwal, R., Kirkpatrick, J.N., Monaghan, M.J., Muraru, D., Ogunyankin, K.O., Park, S.W., Tude, Rodrigues, A.C., Ronderos, R., Sadeghpour, A., Scalia, G., Takeuchi, M., Tsang, W., Tucay, E.S., Zhang, M., Asch, F.M., and Lang, R.M. 2D\/3D right atrial size according to age and gender: Results of the World Alliance of Societies of Echocardiography (WASE) Normal Values Study. American Society of Echocardiography 31th Annual Scientific Sessions. 2020. 6. 19-22. Denver, Colorado, U.S.A.<\/li>\n\n\n\n
                                                                10. Soulat-Dufour, L., Lang, R.M., Miyoshi, T., Schreckenberg, M., Blankenhagen, M., Amuthan, V., Citro, R., Daimon, M., Guti\u00e9rrez-Fajardo, P., Kasliwal, R., Kirkpatrick, J.N., Monaghan, M.J., Muraru, D., Ogunyankin, K.O., Park, S.W., Tude, Rodrigues, A.C., Ronderos, R., Sadeghpour, A., Scalia, G., Takeuchi, M., Tsang, W., Tucay, E.S., Zhang, M., Asch, F.M., and Addetia, K. Are there geographic differences in 2D\/3D right atrial size? Results of the World Alliance of Societies of Echocardiography (WASE) Normal Values Study. American Society of Echocardiography 31th Annual Scientific Sessions. 2020. 6. 19-22. Denver, Colorado, U.S.A.<\/li>\n\n\n\n
                                                                11. Soulat-Dufour, L., Lang, R.M., Miyoshi, T., Schreckenberg, M., Blankenhagen, M., Amuthan, V., Citro, R., Daimon, M., Guti\u00e9rrez-Fajardo, P., Kasliwal, R., Kirkpatrick, J.N., Monaghan, M.J., Muraru, D., Ogunyankin, K.O., Park, S.W., Tude, Rodrigues, A.C., Ronderos, R., Sadeghpour, A., Scalia, G., Takeuchi, M., Tsang, W., Tucay, E.S., Zhang, M., Asch, F.M., and Addetia, K. Impact of age on right atrial function: Results of the World Alliance of Societies of Echocardiography (WASE) Normal Values Study. American Society of Echocardiography 31th Annual Scientific Sessions. 2020. 6. 19-22. Denver, Colorado, U.S.A.<\/li>\n\n\n\n
                                                                12. Yoshida, Y., Nakanishi, K., Daimon, M., Ishiwata, J., Sawada, N., Hirokawa, M., Kaneko, H., Nakao, T., Mizuno, Y., Morita, H., Di, Tullio, M., Homma, S., and Komuro I. Sex-specific difference in the association between arterial stiffness and subclinical left ventricular dysfunction. European Society of Cardiology Congress 2020. 2020. 8. 29-9. 1. WEB conference.<\/li>\n<\/ol>\n\n\n\n

                                                                  \u548c\u6587\u539f\u8457\u8ad6\u6587\uff1aJapanese Original Articles<\/h4>\n\n\n\n
                                                                    \n
                                                                  1. \u77f3\u539f \u6709\u7406\uff0c\u4e0b\u5742 \u6d69\u5247\uff0c\u8535\u91ce \u4fe1\uff0c\u4f50\u85e4 \u667a\u660e\uff0c\u77e2\u51a8 \u88d5\uff0c\u4fdd\u7530 \u5948\u7dd2\u7f8e\uff0e\u514d\u75ab\u767a\u5149\u6e2c\u5b9a\u88c5\u7f6e\u30eb\u30df\u30d1\u30eb\u30b9L2400\u3092\u7528\u3044\u305f\u53ef\u6eb6\u6027\u30a4\u30f3\u30bf\u30fc\u30ed\u30a4\u30ad\u30f3-2\u30ec\u30bb\u30d7\u30bf\u30fc\u6e2c\u5b9a\u8a66\u85ac\u300c\u30eb\u30df\u30d1\u30eb\u30b9\u30d7\u30ec\u30b9\u30c8IL-2R\u300d\u306e\u57fa\u790e\u7684\u6027\u80fd\u8a55\u4fa1\uff0e\u533b\u5b66\u691c\u67fb 69\uff1a340-345\uff0c2020\uff0e<\/li>\n\n\n\n
                                                                  2. \u4e0a\u5e02 \u88d5\u5b50\uff0c\u5c0f\u5ddd \u821e\u5b50\uff0c\u98db\u7530 \u660e\u5b50\uff0c\u4e0b\u5742 \u6d69\u5247\uff0c\u4f50\u85e4 \u667a\u660e\uff0c\u77e2\u51a8 \u88d5\uff0c\u8535\u91ce \u4fe1\uff0e\u81ea\u52d5\u5316\u5b66\u767a\u5149\u9175\u7d20\u514d\u75ab\u5206\u6790\u88c5\u7f6eAccuraseed\u306b\u3088\u308b\u30ec\u30cb\u30f3\u53ca\u3073\u30a2\u30eb\u30c9\u30b9\u30c6\u30ed\u30f3\u6e2c\u5b9a\u306e\u57fa\u790e\u7684\u6027\u80fd\u8a55\u4fa1\uff0e\u533b\u5b66\u691c\u67fb 69\uff1a623-630\uff0c2020\uff0e<\/li>\n\n\n\n
                                                                  3. \u7530\u4e2d \u96c5\u7f8e\uff0c\u68ee\u7530 \u8ce2\u53f2\uff0c\u4e45\u672b \u5d07\u53f8\uff0c\u5c0f\u91ce \u4f73\u4e00\uff0c\u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0c\u5bbf\u8c37 \u8ce2\u4e00\uff0e\u5168\u81ea\u52d5\u5c3f\u4e2d\u6709\u5f62\u6210\u5206\u5206\u6790\u88c5\u7f6eUF-5000\u6539\u826f\u5f8c\u306e\u300c\u4f53\u6db2\u6e2c\u5b9a\u30e2\u30fc\u30c9\u300d\u306e\u6027\u80fd\u8a55\u4fa1 \uff0d\u591a\u9805\u76ee\u81ea\u52d5\u8840\u7403\u5206\u6790\u88c5\u7f6eXN-1000\u306e\u300c\u4f53\u6db2\u6e2c\u5b9a\u30e2\u30fc\u30c9\u300d\u3068\u306e\u6bd4\u8f03\u691c\u8a0e\uff0d\uff0e\u81e8\u5e8a\u5316\u5b66 49\uff1a276-280\uff0c2020\uff0e<\/li>\n\n\n\n
                                                                  4. \u677e\u4e95 \u4e9c\u7406\u6c99\uff0c\u4e0b\u5742 \u6d69\u5247\uff0c\u4f50\u85e4 \u667a\u660e\uff0c\u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0c\u98db\u7530 \u660e\u5b50\uff0e\u6539\u826f\u578bPIVKA-II\u30ad\u30c3\u30c8\u300c\u30eb\u30df\u30d1\u30eb\u30b9\u30d7\u30ec\u30b9\u30c8PIVKA II-N\u300d\u306e\u57fa\u790e\u6027\u80fd\u8a55\u4fa1\uff0e\u533b\u7642\u691c\u67fb\u3068\u81ea\u52d5\u5316 45\uff1a235-239\uff0c2020\uff0e<\/li>\n\n\n\n
                                                                  5. \u68ee\u7530 \u8ce2\u53f2\uff0c\u7530\u4e2d \u96c5\u7f8e\uff0c\u5e38\u540d \u653f\u5f18\uff0c\u5bfa\u5cf6 \u9053\u5b50\uff0c\u5897\u6238 \u68a8\u6075\uff0c\u5c0f\u91ce \u4f73\u4e00\uff0c\u5bbf\u8c37 \u8ce2\u4e00\uff0c\u897f\u5ddd \u771f\u5b50\uff0c\u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0e\u5c3f\u4e2d\u7d30\u80de\u8868\u9762\u6297\u539f\u89e3\u6790\u304c\u6709\u7528\u3067\u3042\u3063\u305f\u30ea\u30f3\u30d1\u816b\u306e2\u75c7\u4f8b\uff0e\u65e5\u672c\u691c\u67fb\u8840\u6db2\u5b66\u4f1a\u8a8c21\uff1a302-308\uff0c2020\uff0e<\/li>\n\n\n\n
                                                                  6. \u4fdd\u7530 \u5948\u7dd2\u7f8e\uff0c\u4e0b\u5742 \u6d69\u5247\uff0c\u4f50\u85e4 \u667a\u660e\uff0c\u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0e2\u7a2e\u306e\u6297dsDNA\u6297\u4f53\u691c\u67fb\u8a66\u85ac\u306e\u6bd4\u8f03\u304a\u3088\u3073\u81e8\u5e8a\u7684\u8a55\u4fa1\uff0e\u81e8\u5e8a\u75c5\u7406 68\uff1a761-767\uff0c2020\uff0e<\/li>\n<\/ol>\n\n\n\n

                                                                    \u548c\u6587\u7dcf\u8aac\uff1aJapanese Review Articles<\/h4>\n\n\n\n
                                                                      \n
                                                                    1. \u4e0a \u7fd4\u592a\uff0c\u9234\u6728 \u535a\u82f1\uff0e\u80ba\u9ad8\u8840\u5727\u75c7\u3092\u6b63\u3057\u304f\u8a55\u4fa1\u3059\u308b\uff0eHeart View 24\uff1a60-67\uff0c2020\uff0e<\/li>\n\n\n\n
                                                                    2. \u4e95\u4e0a \u7fd4\u592a\uff0c\u5927\u9580 \u96c5\u592b\uff0e\u6280\u8853\u8b1b\u5ea7 \u30a8\u30b3\u30fc\u3067\u80a5\u5927\u5fc3\u3092\u8a3a\u308b\uff1a\u80a5\u5927\u578b\u5fc3\u7b4b\u75c7\uff0eMedical Technology 48\uff1a1077-1084\uff0c2020\uff0e<\/li>\n\n\n\n
                                                                    3. \u5c0f\u91ce \u4f73\u4e00\uff0c\u4f50\u85e4 \u667a\u660e\uff0c\u77e2\u51a8 \u88d5\uff0e\u5404\u691c\u67fb\u9818\u57df\u306e\u5185\u90e8\u7cbe\u5ea6\u7ba1\u7406\u306e\u3042\u308a\u65b9 \u751f\u5316\u5b66\u7684\u691c\u67fb\u306e\u5185\u90e8\u7cbe\u5ea6\u7ba1\u7406.\u533b\u7642\u691c\u67fb\u3068\u81ea\u52d5\u5316 45\uff1a121-127\uff0c2020\uff0e<\/li>\n\n\n\n
                                                                    4. \u5c0f\u91ce \u4f73\u4e00\uff0c\u4f50\u85e4 \u667a\u660e\uff0c\u77e2\u51a8 \u88d5\uff0eISO15189\u53d6\u5f97\u306b\u5fc5\u8981\u306a\u63a1\u8840\u5ba4\u306e\u8981\u4ef6\uff0e\u691c\u67fb\u3068\u6280\u8853 48\uff1a312-318\uff0c2020\uff0e<\/li>\n\n\n\n
                                                                    5. \u5150\u7389 \u9f8d\u5f66\uff0c\u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0c\u6751\u7530 \u6e80\uff0e\u7b2c6\u56de \u65b0\u578b\u30b3\u30ed\u30ca\u30a6\u30a4\u30eb\u30b9\u611f\u67d3\u75c7 : (2) \u6297\u4f53\u691c\u67fb\uff0e\u533b\u5b66\u306e\u3042\u3086\u307f 273\uff1a1251-1255\uff0c2020\uff0e<\/li>\n\n\n\n
                                                                    6. \u5c0f\u5ba4 \u8cb4\u5b50\uff0eISO15189\u8a8d\u5b9a\u53d6\u5f97\u65bd\u8a2d\u304b\u3089\uff0e\u81e8\u5e8a\u75c5\u7406 68\uff1a718-724\uff0c2020\uff0e<\/li>\n\n\n\n
                                                                    7. \u6728\u6751 \u516c\u4e00\uff0c\u5927\u9580 \u96c5\u592b\uff0c\u68ee\u7530 \u5553\u884c\uff0c\u702c\u53e3 \u7406\uff0c\u702c\u5ddd \u548c\u5f66\uff0c\u9752\u6728 \u5409\u55e3\uff0e\u5c0f\u7530\u8ad6\u6587\u306b\u5bfe\u3059\u308bEditorial comment: \u6838\u9178\u6cbb\u7642\u85ac\u306e\u666e\u53ca\u3068\u30d9\u30c3\u30ab\u30fc\u578b\u7b4b\u30b8\u30b9\u30c8\u30ed\u30d5\u30a3\u30fc\u5fc3\u7b4b\u75c7\uff0e\u5fc3\u81d3 53\uff1a69-70\uff0c2020\uff0e<\/li>\n\n\n\n
                                                                    8. \u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0e\u30d2\u30c8\u30b5\u30f3\u30d7\u30eb\u3092\u7528\u3044\u305f\u751f\u7406\u6d3b\u6027\u8102\u8cea\u6e2c\u5b9a\u7cfb\u306b\u3088\u308b\u30d2\u30c8\u75be\u60a3\u75c5\u614b\u306e\u89e3\u660e\u3068\u81e8\u5e8a\u691c\u67fb\u3078\u306e\u5fdc\u7528\uff0e\u81e8\u5e8a\u75c5\u7406 68\uff1a628-632\uff0c2020\uff0e<\/li>\n\n\n\n
                                                                    9. \u8535\u91ce \u4fe1\uff0e\u30b9\u30d5\u30a3\u30f3\u30b4\u30b7\u30f31\uff0d\u30ea\u30f3\u9178\u3068\u52d5\u8108\u786c\u5316\uff0e\u7cd6\u5c3f\u75c5\u30fb\u5185\u5206\u6ccc\u4ee3\u8b1d\u79d1 51\uff1a141-145\uff0c2020\uff0e<\/li>\n\n\n\n
                                                                    10. \u5927\u9580 \u96c5\u592b\uff0c\u4e2d\u5c3e \u502b\u5b50\uff0c\u5ee3\u5ddd \u611b\u7f8e\uff0c\u6fa4\u7530 \u76f4\u5b50\uff0c\u6728\u6751 \u516c\u4e00\uff0e\u5fc3\u5185\u816b\u7624\u306e\u9451\u5225\uff1a\u8840\u6813\u304b\uff1f\u816b\u7624\u304b\uff1f\u8d85\u97f3\u6ce2\u533b\u5b6647\uff1a105-111\uff0c2020\uff0e<\/li>\n\n\n\n
                                                                    11. \u5927\u9580 \u96c5\u592b\uff0e\u4e09\u5c16\u5f01\u9589\u9396\u4e0d\u5168\u75c7\u306e\u8a3a\u65ad\u30fb\u6cbb\u7642\uff0e\u5fc3\u81d3 52\uff1a31-39\uff0c2020\uff0e<\/li>\n\n\n\n
                                                                    12. \u897f\u5ddd \u771f\u5b50\uff0e\u8840\u53cb\u75c5A\u6cbb\u7642\u306e\u6700\u524d\u7dda \u4e8c\u91cd\u7279\u7570\u6027\u6297\u4f53\u306e\u767b\u5834\uff0e\u691c\u67fb\u3068\u6280\u8853 48\uff1a1195-1197\uff0c2020\uff0e<\/li>\n\n\n\n
                                                                    13. \u897f\u5ddd \u771f\u5b50\uff0eALP\u3068LD\u306e\u6e2c\u5b9a\u6cd5\u5909\u66f4 JSCC\u6cd5\u304b\u3089IFCC\u6cd5\u3078\uff0eMedical Practice 37\uff1a1938-1940\uff0c2020\uff0e<\/li>\n<\/ol>\n\n\n\n

                                                                      \u548c\u6587\u8457\u66f8\uff1aJapanese Book Chapter<\/h4>\n\n\n\n
                                                                        \n
                                                                      1. \u5927\u9580 \u96c5\u592b\uff0e\u8ca0\u8377\u5fc3\u30a8\u30b3\u30fc\u306b\u3088\u308b\u51a0\u8840\u6d41\u4e88\u5099\u80fd\u8a55\u4fa1\uff0ePCI\u306e\u305f\u3081\u306e\u865a\u8840\u8a55\u4fa1\uff1a\u975e\u4fb5\u8972\u7684\u865a\u8840\u8a55\u4fa1\u30b9\u30bf\u30f3\u30c0\u30fc\u30c9\u30de\u30cb\u30e5\u30a2\u30eb\uff08\u677e\u672c \u76f4\u4e5f\uff0c\u7530\u4e2d \u4fe1\u5927 \u7de8\uff09pp. 92-100\uff0e\u30e1\u30b8\u30ab\u30eb\u30d3\u30e5\u30fc\u793e\uff0c\u6771\u4eac\uff0c2020\uff0e<\/li>\n\n\n\n
                                                                      2. \u5927\u9580 \u96c5\u592b\uff0e\u5b9f\u8df5\u306b\u6d3b\u304d\u308b\u81e8\u5e8a\u5fc3\u30a8\u30b3\u30fc\u56f3\u6cd5\uff0e\uff08\u4f0a\u85e4 \u6d69\uff0c\u6e21\u8fba \u5f18\u4e4b \u7de8\uff09\u5206\u7b46\uff0e\u5357\u6c5f\u5802\uff0c\u6771\u4eac\uff0c2020\uff0e<\/li>\n\n\n\n
                                                                      3. \u5927\u9580 \u96c5\u592b\uff0e\u2162-7 \u611f\u67d3\u6027\u5fc3\u5185\u819c\u708e\uff0e\u8a3a\u7642\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3up-to-date 2020-2021\uff08\u9580\u8107 \u5b5d\uff0c\u5c0f\u5ba4 \u4e00\u6210\uff0c\u5bae\u5730 \u826f\u6a39 \u76e3\u4fee\uff09pp. 190-196. \u30e1\u30c7\u30a3\u30ab\u30eb\u30ec\u30d3\u30e5\u30fc\u793e\uff0c\u5927\u962a\uff0c2020\uff0e<\/li>\n\n\n\n
                                                                      4. \u5927\u9580 \u96c5\u592b\uff0e\u53ce\u7e2e\u6027\u5fc3\u819c\u708e\uff0e\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u306b\u5fc3\u30a8\u30b3\u30fc\u3092\u751f\u304b\u3059\uff08\u702c\u5c3e \u7531\u5e83\uff0c\u4e0a\u5d8b \u5fb3\u4e45 \u7de8\uff09\uff0epp. 138-146. \u30e1\u30b8\u30ab\u30eb\u30d3\u30e5\u30fc\u793e\uff0c\u6771\u4eac\uff0c2020\uff0e<\/li>\n\n\n\n
                                                                      5. \u5927\u9580 \u96c5\u592b\uff0e\u5927\u52d5\u8108\u5f01\u9589\u9396\u4e0d\u5168\u75c7\uff0e\u6700\u65b0\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u306b\u57fa\u3065\u304f\u5faa\u74b0\u5668\u75be\u60a3 \u8a3a\u7642\u6307\u91dd2021-22\u2019\uff08\u6e05\u6c34 \u6e09 \u7de8\uff09\uff0epp. 160-164\uff0c\u7dcf\u5408\u533b\u5b66\u793e\uff0c\u6771\u4eac\uff0c2020\uff0e<\/li>\n\n\n\n
                                                                      6. \u7530\u4e2d \u96c5\u7f8e\uff0e\u5c3f\u30fb\u7cde\u4fbf\u691c\u67fb\uff0e\u81e8\u5e8a\u691c\u67fb\u6cd5\u63d0\u8981\uff08\u91d1\u4e95 \u6b63\u5149 \u76e3\u4fee\uff09pp.177-180\uff0c\u91d1\u539f\u51fa\u7248\uff0c\u6771\u4eac\uff0c2020\uff0e<\/li>\n\n\n\n
                                                                      7. \u897f\u5ddd \u771f\u5b50\uff0e\u6eb6\u8840\u6027\u8ca7\u8840\u306b\u95a2\u3059\u308b\u691c\u67fb\uff0e\u81e8\u5e8a\u691c\u67fb\u6cd5\u63d0\u8981\uff08\u91d1\u4e95 \u6b63\u5149 \u76e3\u4fee\uff09pp. 352-365\uff0c\u91d1\u539f\u51fa\u7248\uff0c\u6771\u4eac\uff0c2020\uff0e<\/li>\n\n\n\n
                                                                      8. \u897f\u5ddd \u771f\u5b50\uff0c\u77e2\u51a8 \u88d5\uff0e\u8840\u5c0f\u677f\u95a2\u9023IgG\uff08PAIgG\uff09\uff0cCYP2C19\uff0cCYP2C9\uff0cVKORC1\uff0e\u300c\u81e8\u5e8a\u96d1\u8a8c\u5185\u79d1\u300d\u5897\u5927\u53f7\u300c\u691c\u67fb\u5024\u3092\u8aad\u30802020\u300dpp. 843\uff0c1102-1104\uff0c\u5357\u6c5f\u5802\uff0c\u6771\u4eac\uff0c2020\uff0e<\/li>\n\n\n\n
                                                                      9. \u897f\u5ddd \u771f\u5b50\uff0c\u77e2\u51a8 \u88d5\uff0e\u3010\u6559\u3048\u3066! \u5065\u8a3a\/\u691c\u8a3a”\u30db\u30f3\u30c8\u306e\u3068\u3053\u308d”-\u30a8\u30d3\u30c7\u30f3\u30b9\u3092\u77e5\u308a\uff0c\u4f55\u3092\u4f1d\u3048\u308b\u304b\u3011\u5065\u8a3a\u3067\u3088\u304f\u5b9f\u65bd\u3055\u308c\u308b\u9805\u76ee \u8840\u7b97\uff0eMedicina 57\uff1a844-847\uff0c2020\uff0e<\/li>\n\n\n\n
                                                                      10. \u77e2\u51a8 \u88d5\uff0e\u81e8\u5e8a\u691c\u67fb\u6280\u5e2b\u304c\u7814\u7a76\u3092\u884c\u3046\u30e1\u30ea\u30c3\u30c8-\u81e8\u5e8a\u691c\u67fb\u533b\u306e\u8996\u70b9\u304b\u3089\uff0e\u691c\u67fb\u3068\u6280\u8853\u5897\u520a\u53f7\u300c\u5b66\u4f1a\u767a\u8868\u30fb\u8ad6\u6587\u57f7\u7b46\u306f\u3082\u3046\u6016\u304f\u306a\u3044! \u81e8\u5e8a\u691c\u67fb\u6280\u5e2b\u306e\u305f\u3081\u306e\u7814\u7a76\u5165\u9580\u300d\uff08\u83ca\u6c60 \u826f\u4ecb \u4f01\u753b\uff09\uff0e48\uff1a856-858\uff0c2020\uff0e<\/li>\n<\/ol>\n\n\n\n

                                                                        \u548c\u6587\u7de8\u8457\u7b49\uff1aJapanese Book Editing<\/h4>\n\n\n\n
                                                                          \n
                                                                        1. \u5927\u9580 \u96c5\u592b \u7de8\uff0e \u5fc3\u30a8\u30b3\u30fc\u300c\u53ce\u7e2e\u80fd\u306e\u4f4e\u4e0b\u3057\u305f\u5fc3\u4e0d\u5168HFrEF\u300d\uff0e\u6587\u5149\u5802\uff0c\u6771\u4eac. 2020\uff0e<\/li>\n\n\n\n
                                                                        2. \u5927\u9580 \u96c5\u592b \u7de8\uff0eHeart View \u7279\u96c6\u300c\u4e00\u4eba\u3067\u3082\u614c\u3066\u306a\u3044\u77e5\u3063\u3066\u304a\u304f\u3079\u304d\u5fc3\u30a8\u30b3\u30fc\u56f3\u306e\u639f\uff01\u4f55\u3092\u898b\u3066\u3069\u3046\u8a55\u4fa1\u3059\u308b\u304b\u300d\uff0e\u30e1\u30b8\u30ab\u30eb\u30d3\u30e5\u30fc\u793e\uff0c\u6771\u4eac\uff0c2020\uff0e<\/li>\n\n\n\n
                                                                        3. \u91d1\u4e95 \u6b63\u5149 \u76e3\u4fee\uff0e\u5965\u6751 \u4f38\u751f\uff0c\u6238\u585a \u5b9f\uff0c\u672c\u7530 \u5b5d\u884c\uff0c\u77e2\u51a8 \u88d5\u7de8\u96c6\uff0e\u81e8\u5e8a\u691c\u67fb\u6cd5\u63d0\u8981 \u6539\u8a02\u7b2c35\u7248\uff0e\u91d1\u539f\u51fa\u7248\uff0c\u6771\u4eac\uff0e2020\uff0e<\/li>\n\n\n\n
                                                                        4. \u4e2d\u897f \u5f18\u6bc5\uff0c\u5927\u9580 \u96c5\u592b \u7de8\uff0e \u5fc3\u30a8\u30b3\u30fc\u300c\u5fc3\u30a8\u30b3\u30fc\u3067\u8feb\u308b\uff01HFpEF\u306e\u75c5\u614b\u3068\u6cbb\u7642\u65b9\u91dd\u300d\uff0e\u6587\u5149\u5802\uff0c\u6771\u4eac. 2020\uff0e<\/li>\n\n\n\n
                                                                        5. \u6df1\u5ddd \u96c5\u53f2\uff0c\u6edd\u5ddd \u4e00\uff0c\u77e2\u51a8 \u88d5\u7de8\uff0e\u30e1\u30c7\u30a3\u30b3\u30d4\u30a261\u300c\u533b\u7642\u306b\u304a\u3051\u308bAI\u306e\u5f79\u5272\u3068\u672a\u6765\u300d\uff0e\u5bcc\u58eb\u30ec\u30d3\u30aa\uff0c\u6771\u4eac\uff0e2020\uff0e<\/li>\n\n\n\n
                                                                        6. \u77e2\u51a8 \u88d5\uff0c\u5927\u897f \u5b8f\u660e\uff0c\u66fd\u6839 \u4f38\u6cbb \u7de8\uff0e\u300c\u691c\u67fb\u3068\u6280\u8853\u300d\u5897\u520a\u53f7\u300c\u63a1\u8840\u306e\u3059\u3079\u3066\u300d\uff0e\u533b\u5b66\u66f8\u9662\uff0c\u6771\u4eac\uff0e2020\uff0e<\/li>\n<\/ol>\n<\/div><\/div>\n\n\n\n
                                                                          \n

                                                                          2019\u5e74<\/h3>\n\n\n\n

                                                                          \u82f1\u6587\u539f\u8457\u8ad6\u6587\uff1aEnglish Original Articles<\/h4>\n\n\n\n
                                                                            \n
                                                                          1. Asch, F.M,. Miyoshi, M., Addetia, K., Citro, R., Daimon, M., Desale, S., Fajardo, P.G., Kasliwal, R.R., Kirkpatrick, J.N,, Monaghan, M.J., Mor-Avi, V., Muraru, D., Ogunyankin K., Park, S.W., Ronderos, R.E,, Sadeghpour, A., Scalia, G.M., Takeuchi, M., Tsang, W., Tucay, E.S., Rodrigues, A.C.T., Vivekanandan, A., Zhang, Y., Blitz, A., and Lang, R.M.\u3000Similarities and Differences in Left Ventricular Size and Function Among Races and Nationalities. Results of the World Alliance Societies of Echocardiography (WASE) Normal Values Study. J. Am. Soc. Echocardiogr.<\/strong><\/em> 32: 1396\u20131406.e2. <\/a>, 2019.<\/li>\n\n\n\n
                                                                          2. Fujii, T., Nagamatsu, T., Schust, D.J., Ichikawa, M., Kumasawa, K., Yabe, S., Iriyama, T., Hirota, Y., Osuga, Y., Aoki, J., Yatomi, Y., and Fujii, T. Placental expression of lysophosphatidic acid receptors in normal pregnancy and preeclampsia. Am. J. Reprod Immunol.<\/strong><\/em> 82: e13176<\/a>, 2019.<\/a><\/li>\n\n\n\n
                                                                          3. Hayakawa, K., Kurano, M., Ohya, J., Oichi, T., Kano, K., Nishikawa, M., Uranbileg, B., Kuwajima, K., Sumitani, M., Tanaka, S., Aoki, J., Yatomi, Y., and Chikuda, H. Lysophosphatidic acids and their substrate lysophospholipids in cerebrospinal fluid as objective biomarkers for evaluating the severity of lumbar spinal stenosis. Sci. Rep.<\/strong><\/em> 9: 9144<\/a>, 2019.<\/li>\n\n\n\n
                                                                          4. Iino, H., Okano, T., Daimon, M., Sasaki, K., Chigira, M., Nakao, T., Mizuno, Y., Yamazaki, T., Kurano, M., Yatomi, Y., Sumi, Y., Sasano, T., and Miyata, T. Usefulness of Carotid Arterial Strain Values for Evaluating the Arteriosclerosis. J. Atheroscler Thromb.<\/strong><\/em> 26: 476-487<\/a>, 2019.<\/li>\n\n\n\n
                                                                          5. Inoue, O., Osada, M., Nakamura, J., Kazama, F., Shirai, T., Tsukiji, N., Sasaki, T., Yokomichi, H., Dohi, T., Kaneko, M., Kurano, M., Oosawa, M., Tamura, S., Satoh, K., Takano, K., Miyauchi, K., Daida, H., Yatomi, Y., Ozaki, Y., and Suzuki-Inoue, K. Soluble CLEC-2 is generated independently of ADAM10 and is increased in plasma in acute coronary syndrome: comparison with soluble GPVI. Int. J. Hematol.<\/strong><\/em> 110: 285-294<\/a>, 2019.<\/li>\n\n\n\n
                                                                          6. Ishimaru, K., Yoshioka, K., Kano, K., Kurano, M., Saigusa, D., Aoki, J., Yatomi, Y., Takuwa, N., Okamoto, Y., Proia, R.L., and Takuwa, Y. Sphingosine kinase-2 prevents macrophage cholesterol accumulation and atherosclerosis by stimulating autophagic lipid degradation. Sci. Rep.<\/strong><\/em> 9: 18329<\/a>, 2019.<\/li>\n\n\n\n
                                                                          7. Isozaki, A., Mikami, H., Hiramatsu, K., Sakuma, S., Kasai, Y., Iino, T., Yamano, T., Yasumoto, A., Oguchi, Y., Suzuki, N., Shirasaki, Y., Endo, T., Ito, T., Hiraki, K., Yamada, M., Matsusaka, S., Hayakawa, T., Fukuzawa, H., Yatomi, Y., Arai, F., Di Carlo D,, Nakagawa, A., Hoshino, Y., Hosokawa, Y., Uemura, S., Sugimura, T., Ozek,i Y., Nitta, N., and Goda, K. A practical guide to intelligent image-activated cell sorting. Nat. Protoc.<\/strong><\/em> 14: 2370-2415<\/a>, 2019.<\/li>\n\n\n\n
                                                                          8. Itoh, H., Kaneko, H., Kiriyama, H., Yoshida, Y., Nakanishi, K., Mizuno, Y., Daimon, M., Morita, H., Yatomi, Y., and Komuro, I. Relation between the Updated Blood Pressure Classification according to the American College of Cardiology\/American Heart Association Guidelines and Carotid Intima-Media Thickness. Am. J. Cardiol.<\/strong><\/em> 124: 396-401<\/a>, 2019.<\/li>\n\n\n\n
                                                                          9. Itoh, H., Kaneko, H., Kiriyama, H., Nakanishi, K., Mizuno, Y., Daimon, M., Morita, H., Yamamichi, N., and Komuro I. Effect of Body Weight Change on Blood Pressure in a Japanese General Population with a Body Mass Index \u2265 22 kg\/m2<\/sup>. Int. Heart J.<\/strong><\/em> 60: 1381-1386<\/a>.<\/li>\n\n\n\n
                                                                          10. Kiriyama, H., Kaneko, H., Itoh, H., Uehara, M., Kodera, S., Kiyosue, A., Yamauchi, H., Daimon, M., Ando, J., Morita, H., Ono, M., and Komuro, I. Left Main Coronary Artery Obstruction by Huge Non-coronary Cusp Calcification After Transcatheter Aortic Valve Replacement. JACC Cardiovasc Intervensions<\/strong><\/em> 12: 1285-1287<\/a>, 2019.<\/li>\n\n\n\n
                                                                          11. Kiriyama, H., Kaneko, H., Itoh, H., Yoshida, Y., Nakanishi, K., Mizuno, Y., Daimon, M., Morita, H., Yatomi, Y., and Komuro I. Role of anemia and proteinuria in the development of subsequent renal function deterioration in a general population with preserved glomerular filtration rate: a community-based cohort study. J. Nephrol<\/em><\/strong>.<\/strong><\/em>32: 843-846<\/a>, 2019.<\/li>\n\n\n\n
                                                                          12. Kiriyama, H., Kodera, S., Ando, J., Daimon, M., Morita, H., and Komuro, I. Worsening of mitral regurgitation by balloon aortic valvuloplasty for severe aortic stenosis: a case report. Int. Heart. J.<\/strong><\/em> 60: 768-771<\/a>, 2019.<\/li>\n\n\n\n
                                                                          13. Kobayashi ,H., Lei, C., Wu Y, Huang, C.J., Yasumoto, A., Jona, M., Li, W., Wu, Y., Yalikun, Y., Jiang, Y., Guo, B., Sun, C.W., Tanaka, Y., Yamada, M., Yatomi, Y., and Goda, K. Intelligent whole-blood imaging flow cytometry for simple, rapid, and cost-effective drug-susceptibility testing of leukemia. Lab Chip.<\/strong><\/em> 19: 2688-2698<\/a>, 2019.<\/li>\n\n\n\n
                                                                          14. Kohsaka, S., Tatsuno, K., Ueno, T., Nagano, M., Shinozaki-Ushiku, A., Ushiku, T., Takai, D., Ikegami, M., Kobayashi, H., Kage, H., Ando, M., Hata, K., Ueda, H., Yamamoto, S., Kojima, S., Oseto, K., Akaike, K., Suehara, Y., Hayashi, T., Saito, T., Takahashi, F., Takahashi, K., Takamochi, K., Suzuki, K., Nagayama, S., Oda, Y., Mimori ,K., Ishihara, S., Yatomi, Y., Nagase, T., Nakajima, J., Tanaka, S., Fukayama, M., Oda, K., Nangaku, M., Miyazono, K., Miyagawa, K., Aburatani, H., and Mano, H. Comprehensive assay for the molecular profiling of cancer by target enrichment from formalin-fixed paraffin-embedded specimens. Cancer Sci. <\/strong><\/em><\/strong>110: 1464-1479<\/a>, 2019.<\/li>\n\n\n\n
                                                                          15. Kurano, M., Kano, K., Hara, M., Tsukamoto, K., Aoki, J., and Yatomi, Y. Regulation of plasma glycero-lysophospholipid levels by lipoprotein metabolism. Biochem. J.<\/strong><\/em> 476: 3565-3581<\/a>, 2019.<\/li>\n\n\n\n
                                                                          16. Kurano, M., Yasukawa, K., Ikeda, H., Aoki, J., and Yatomi, Y. Redox state of albumin affects its lipid mediator binding characteristics. Free Radic Res.<\/strong><\/em> 53: 892-900<\/a>, 2019.<\/li>\n\n\n\n
                                                                          17. Kurano, M., Yatomi, Y. Use of gas chromatography mass spectrometry to elucidate metabolites predicting the phenotypes of IgA nephropathy in hyper IgA mice. PLoS One. <\/strong><\/em>14: e0219403<\/a>, 2019.<\/li>\n\n\n\n
                                                                          18. Kurano, M., Tsuneyama, K., Morimoto, Y., Nishikawa, M., and Yatomi, Y. Apolipoprotein M suppresses the phenotypes of IgA nephropathy in hyper-IgA mice. FASEB J. <\/strong><\/em>33: 5181-5195<\/a>, 2019.<\/li>\n\n\n\n
                                                                          19. Liu, B., Yasukawa, K., Koid, S.S., Yeerbolati, A., Reheman, L., Wang, C., Yatomi, Y., and Shimosawa, T. A rapid method for measuring serum oxidized albumin in a rat model of proteinuria and hypertension. Sci. Rep.<\/strong><\/em> 9:8620<\/a>, 2019.<\/li>\n\n\n\n
                                                                          20. Matsuura, Y., Daimon, M., Notomi, Y., Miyasaka, N., Yamaguchi, Y., and Doi, S. Feasibility and Reproducibility of Fetal Left Ventricular Twist using Two-Dimensional Speckle-Tracking Analysis in a Japanese Population. Int. Heart J.<\/strong><\/em> 60: 671-678<\/a>, 2019.<\/li>\n\n\n\n
                                                                          21. Morita, Y., Kurano, M., Sakai, E., Nishikawa, M., Sawabe, M., Aoki, J., Yatomi, Y. Evaluation of Lysophospholipid Measurement in Cerebrospinal Fluid Samples using Liquid Chromatography-Tandem Mass Spectrometry. Lipids. <\/strong><\/em>54: 487-500<\/a>, 2019.<\/li>\n\n\n\n
                                                                          22. Nakatsuka, T., Soroida, Y., Nakagawa, H., Shindo, T., Sato, M., Soma, K., Nakagomi, R., Kobayashi, T., Endo, M., Hikita, H., Sato, M., Gotoh, H., Iwai, T., Yasui, M., Shinozaki-Ushiku, A., Shiraga, K., Asakai, H., Hirata, Y., Fukayama, M., Ikeda, H., Yatomi, Y., Tateishi, R., Inuzuka, R., and Koike, K. Identification of Liver Fibrosis Using the Hepatic Vein Waveform in Patients with Fontan Circulation. Hepatol. Res.<\/em><\/strong> 49: 304-313<\/a>, 2019.<\/li>\n\n\n\n
                                                                          23. Nakatsuka, T., Soroida, Y., Nakagawa, H., Okura, N., Sato, J., Akahane, M., Sato, M., Yatomi, Y., Abe, O., Tateishi, R., and Koike, K. Utility of hepatic vein waveform and transient elastography in patients with Budd-Chiari syndrome who require angioplasty: Two case reports. Medicine<\/strong><\/em> 98:e17877<\/a>, 2019.<\/li>\n\n\n\n
                                                                          24. Nishikawa, M., Kurano, M., Nitta, T., Kanoh, H., Inokuchi, J.I., and Yatomi, Y. Serum GM3(d18:1-16:0) and GM3(d18:1-24:1) levels may be associated with lymphoma: An exploratory study with haematological diseases. Sci. Rep.<\/strong><\/em> 9: 6308<\/a>, 2019.<\/li>\n\n\n\n
                                                                          25. Nojiri, T., Kurano, M., Araki, O., Nakawatari, K., Nishikawa, M., Shimamoto, S., Igarashi, K., Kano, K., Aoki, J., Kihara, S., Murakami, M., and Yatomi, Y. Serum autotaxin levels are associated with Graves’ disease. Endocr J. <\/em><\/strong>66: 409-422<\/a>, 2019.<\/li>\n\n\n\n
                                                                          26. Sato, M., Morimoto, K., Kajihara, S., Tateishi, R., Shiina, S., Koike, K., and Yatomi, Y. Machine-learning Approach for the Development of a Novel Predictive Model for the Diagnosis of Hepatocellular Carcinoma. Sci. Rep.<\/strong><\/em> 9: 7704,<\/a> 2019. Press Release.<\/a><\/li>\n\n\n\n
                                                                          27. Sato, M., Ohkawa, R., Low, H., Nishimori, M., Okubo, S., Yoshimoto, A., Yano, K., Kameda, T., Yatomi, Y., and Tozuka, M. Serum amyloid A does not affect high-density lipoprotein cholesterol measurement by a homogeneous assay. Clin. Biochem.<\/strong><\/em> 63: 97-101<\/a>, 2019.<\/a><\/li>\n\n\n\n
                                                                          28. Sawada, T., Kurano, M., Shirai, H., Iwasaki, Y., Tahara, K., Hayashi, H., Igarashi, K., Fujio, K., Aoki, J., and Yatomi, Y. Serum phosphatidylserine-specific phospholipase A1 as a novel biomarker for monitoring systemic lupus erythematosus disease activity. Int. J. Rheum Dis.<\/strong><\/em> 22: 2059-2066<\/a>, 2019.<\/li>\n\n\n\n
                                                                          29. Sawada, N., Daimon, M., Abe, H., Ushiku, T., Kato, T.S., Morita, H., and Komuro, I. An autopsy case of cardiac amyloidosis with heterogeneous deposition of amyloid protein: A possible mechanism for relative apical sparing of longitudinal strain. CASE (Phila) <\/strong><\/em>4: 54-56,<\/a> 2019.<\/li>\n\n\n\n
                                                                          30. Sawada, N., Daimon, M., Kawata, T., Nakao, T., Kimura, K., Nakanishi, K., Kurano, M., Hirokawa, M., Xu, B., Yamanaka, Y., Kato, T.S., Watanabe, M., Yatomi, Y., and Komuro, I. The Significance of the Effect of Visceral Adiposity on Left Ventricular Diastolic Function in the General Population. Sci. Rep. <\/strong><\/em>9: 4435<\/a>, 2019.<\/li>\n\n\n\n
                                                                          31. Sawada, N., Kawata, T., Daimon, M., Nakao, T., Hatano, M., Maki, H., Kimura, K., Hirokawa, M., Ishiwata, J., Xu, B., Yataomi, Y., and Komuro I. Detection of Pulmonary Hypertension with Systolic Pressure Estimated by Doppler Echocardiography: Comparison with invasive mean pulmonary artery pressure. Int. Heart. J.<\/strong><\/em> 60: 836-844<\/a>, 2019.<\/li>\n\n\n\n
                                                                          32. Shimura, T., Kurano, M., Morita, Y., Yoshikawa, N., Nishikawa, M., Igarashi, K., Shimamoto, S., Aoki, J., and Yatomi Y. Autotaxin and soluble IL-2 receptor concentrations in cerebrospinal fluids are useful for the diagnosis of central nervous system invasion caused by haematological malignancies. Ann. Clin. Biochem.<\/strong><\/em> 56: 240-246<\/a>, 2019.<\/li>\n\n\n\n
                                                                          33. Soroida, Y., Nakatsuka, T., Sato, M., Nakagawa, H., Tanaka, M., Yamauchi, N., Wake, T., Nakagomi, R., Kinoshita, M.N., Minami, T., Uchino, K., Enooku, K., Asaoka, Y., Tanaka, Y., Endo, M., Nakamura, A., Kobayashi, T., Kurihara, M., Hikita, H., Sato, M., Gotoh, H., Iwai, T., Fukayama, M., Ikeda, H., Tateishi, R., Yatomi, Y., and Koike, K. A Novel Non-invasive Method for Predicting Liver Fibrosis by Quantifying the Hepatic Vein Waveform. Ultrasound Med. Biol. <\/strong><\/em>45: 2363-2371<\/a>, 2019.<\/li>\n\n\n\n
                                                                          34. Suzuki, Y., Kobayashi, K., Wakisaka, Y., Deng, D., Tanaka, S., Huang, C.J., Lei, C., Sun, CW., Liu, H., Fujiwaki, Y., Lee, S., Isozaki, A., Kasai, Y., Hayakawa, T., Sakuma, S,, Arai, F., Koizumi, K., Tezuka, H., Inaba, M., Hiraki, K., Ito, T., Hase, M., Matsusaka, S., Shiba, K., Suga, K., Nishikawa, M., Jona, M., Yatomi, Y., Yalikun, Y., Tanaka, Y., Sugimura, T., Nitta, N., Goda, K., Ozeki, Y. Label-free chemical imaging flow cytometry by high-speed multicolor stimulated Raman scattering. Proc. Natl. Acad .Sci. U.S. A.<\/strong><\/em> 116: 15842-15848<\/a>, 2019.<\/li>\n\n\n\n
                                                                          35. Terao, R., Honjo, M., Ueta, T., Obinata, H., Izumi, T., Kurano, M., Yatomi, Y., Koso, H., Watanabe, S., and Aihara, M. Light Stress-Induced Increase of Sphingosine 1-Phosphate in Photoreceptors and Its Relevance to Retinal Degeneration. Int. J. Mol. Sci.<\/strong><\/em> 20: 3670<\/a>, 2019.<\/li>\n\n\n\n
                                                                          36. Matsuura, Y., Daimon, M.,<\/strong> Notomi, Y., Miyasaka, N., Yamaguchi, Y., and Doi, S. Feasibility and Reproducibility of Fetal Left Ventricular Twist using Two-Dimensional Speckle-Tracking Analysis in a Japanese Population. Int. Heart. J.<\/strong><\/em> 3: 671-678<\/a>, 2019.<\/li>\n\n\n\n
                                                                          37. Uranbileg, B., Ito, N., Kurano, M., Saigusa, D., Saito, R., Uruno, A., Kano, K., Ikeda, H., Yamada, Y., Sumitani, M., Sekiguchi, M., Aoki, J., and Yatomi, Y. Alteration of the lysophosphatidic acid and its precursor lysophosphatidylcholine levels in spinal cord stenosis: A study using a rat cauda equina compression model. Sci. Rep. <\/strong><\/em>9: 16578<\/a>, 2019.<\/li>\n\n\n\n
                                                                          38. Yasukawa, K., Sato, M., Nojiri, T., Yoshikawa, N., Morita, K., Kai, M., Oike, Y., Yamazaki, T., Ikeda, H., and Yatomi, Y. Establishment of a stable sampling method to assay mercaptoalbumin\/non-mercaptoalbumin and reference ranges. Pract. Lab. Med.<\/strong><\/em> 17:e00132<\/a>, 2019.<\/li>\n\n\n\n
                                                                          39. Yoshida, Y., Nakanishi, K., Daimon, M.,<\/strong> Ishiwata, J., Sawada, N., Hirokawa, M., Kaneko, H., Nakao, T., Mizuno, Y., Morita, M., Di. Tullio, M.R., Homma, S., and Komuro, I. Alteration of cardiac performance and serum B-type natriuretic peptide level in healthy aging. J. Am. Coll. Cardiol. <\/strong><\/em>74: 1789-1800<\/a>, 2019.<\/li>\n<\/ol>\n\n\n\n

                                                                            \u56fd\u5185\u5b66\u4f1a\u767a\u8868\uff1aDomestic Conference Presentation<\/h4>\n\n\n\n
                                                                              \n
                                                                            1. \u79cb\u7530 \u840c\uff0c\u7530\u5cf6 \u5c06\u592a\u90ce\uff0c\u5c71\u7530 \u306f\u308b\u9999\uff0c\u6301\u7530 \u667a\u4e4b\uff0c\u771e\ufa11 \u6842\uff0c\u6e6f\u672c \u771f\u4eba\uff0e\u5149\u523a\u6fc0\u306b\u304a\u3051\u308b\u5149\u7b4b\u539f\u53cd\u5fdc\u306b\u985e\u4f3c\u3057\u305f\u30a2\u30fc\u30c1\u30d5\u30a1\u30af\u30c8\uff0e\u7b2c6\u56de \u5168\u56fd\u3066\u3093\u304b\u3093\u30bb\u30f3\u30bf\u30fc\u5354\u8b70\u4f1a\u7dcf\u4f1a\uff0e2019.2.23\uff0e\u9577\u5d0e\uff0e<\/li>\n\n\n\n
                                                                            2. \u77f3\u539f \u6709\u7406\uff0c\u4e0a\u5e02 \u88d5\u5b50\uff0c\u4e0b\u5742 \u6d69\u5247\uff0c\u8535\u91ce \u4fe1\uff0c\u4f50\u85e4 \u667a\u660e\uff0c\u77e2\u51a8 \u88d5\uff0c\u98db\u7530 \u660e\u5b50\uff0e\u514d\u75ab\u8840\u6e05\u9805\u76ee\u306e4\u793e\u6a5f\u5668\u30fb\u8a66\u85ac\u306e\u6bd4\u8f031 \u816b\u760d\u30de\u30fc\u30ab\u30fc\uff1aCA19-9\uff0c CA125\uff0e\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u81ea\u52d5\u5316\u5b66\u4f1a \u7b2c51\u56de\u5927\u4f1a\uff0e2019.10.3-5\uff0e\u6a2a\u6d5c\uff0e<\/li>\n\n\n\n
                                                                            3. \u77f3\u539f \u6709\u7406\uff0c\u4e0a\u5e02 \u88d5\u5b50\uff0c\u4e0b\u5742 \u6d69\u5247\uff0c\u8535\u91ce \u4fe1\uff0c\u4f50\u85e4 \u667a\u660e\uff0c\u77e2\u51a8 \u88d5\uff0c\u98db\u7530 \u660e\u5b50\uff0e\u514d\u75ab\u8840\u6e05\u9805\u76ee\u306e4\u793e\u6a5f\u5668\u30fb\u8a66\u85ac\u306e\u6bd4\u8f032 \u816b\u760d\u30de\u30fc\u30ab\u30fc\uff1aCEA\uff0cAFP\uff0cPSA\uff0e\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u81ea\u52d5\u5316\u5b66\u4f1a \u7b2c51\u56de\u5927\u4f1a\uff0e2019.10.3-5\uff0e\u6a2a\u6d5c\uff0e<\/li>\n\n\n\n
                                                                            4. \u77f3\u539f \u6709\u7406\uff0c\u5c0f\u91ce \u4f73\u4e00\uff0c\u4fdd\u7530 \u5948\u7dd2\u7f8e\uff0c\u5e38\u540d \u653f\u5f18\uff0c\u4e0b\u5742 \u6d69\u5247\uff0c\u77e2\u51a8 \u88d5\uff0c\u897f\u5ddd \u771f\u5b50\uff0e\u8840\u6e05\u86cb\u767d\u96fb\u6c17\u6cf3\u52d5\u306b\u304a\u3051\u308bM\u86cb\u767d\u7b97\u5b9a\u30a2\u30eb\u30b4\u30ea\u30ba\u30e0\u306e\u8a55\u4fa1\uff0e\u7b2c81\u56de \u65e5\u672c\u8840\u6db2\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2019.10.11\u201013\uff0e\u6771\u4eac\uff0e<\/li>\n\n\n\n
                                                                            5. Ito, H., Kaneko, H., Kiriyama, H., Yoshida, Y., Nakanishi, K., Mizumo, Y., Daimon, M., Morita, H., Yatomi, Y., and Komuro, I. Association between the Updated Blood Pressure Classification According to ACC\/AHA Guidelines and Carotid Intima-Media Thickness: A Community-Based Cohort Study. \u7b2c83\u56de \u65e5\u672c\u5faa\u74b0\u5668\u75c5\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2019.3.29-31\uff0e\u6a2a\u6d5c\uff0e<\/li>\n\n\n\n
                                                                            6. \u4e95\u4e0a \u7fd4\u592a\uff0c\u5927\u9580 \u96c5\u592b\uff0c\u9234\u6728 \u535a\u82f1\uff0c\u4e2d\u5c3e \u502b\u5b50\uff0c\u77e2\u51a8 \u88d5\uff0eRaphal cord\u65ad\u88c2\u306b\u3088\u308b\u5927\u52d5\u8108\u5f01\u9006\u6d41\u306e\u6025\u6027\u5897\u60aa\u3092\u89b3\u5bdf\u3057\u305f\u5927\u52d5\u8108\u4e8c\u5c16\u5f01\u306e\u4e00\u4f8b\uff0e\u7b2c66\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2019.11.21-24\uff0e\u5ca1\u5c71\uff0e<\/li>\n\n\n\n
                                                                            7. Ookawa, T., Fujimoto, N., Ishiyama, T., Tsubomitsu, Y., Harada, K., Arai, T., and Daimon, M. Infective Endocarditis with Mitral Annular Calcification in an Elderly Population who Underwent Postmortem Autopsy. \u7b2c83\u56de \u65e5\u672c\u5faa\u74b0\u5668\u75c5\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2019.3.29-31\uff0e\u6a2a\u6d5c\uff0e<\/li>\n\n\n\n
                                                                            8. \u5c0f\u91ce \u4f73\u4e00\uff0c\u6e05\u6c34 \u5eb7\u5e73\uff0c\u6c38\u53cb \u5229\u6d25\u5b50\uff0c\u4e09\u5b85 \u52a0\u5948\uff0c\u8535\u91ce \u4fe1\uff0c\u8107 \u5609\u4ee3\uff0c\u77e2\u51a8 \u88d5\uff0ePOCT\u6a5f\u5668\u30b0\u30eb\u30b3\u30fc\u30b9\u5206\u6790\u88c5\u7f6e \u30e1\u30c7\u30a3\u30bb\u30fc\u30d5\u30d5\u30a3\u30c3\u30c8\u00ae\u30d7\u30ed\u2161\u306e\u57fa\u790e\u7684\u691c\u8a0e. \u7b2c62\u56de \u65e5\u672c\u7cd6\u5c3f\u75c5\u5b66\u4f1a\u5e74\u6b21\u5b66\u8853\u96c6\u4f1a\uff0e2019.5.23-25\uff0e\u4ed9\u53f0\uff0e<\/li>\n\n\n\n
                                                                            9. \u5c0f\u91ce \u4f73\u4e00\uff0c\u77f3\u539f \u6709\u7406\uff0c\u4f50\u85e4 \u667a\u660e\uff0c\u77e2\u51a8 \u88d5\uff0c\u897f\u5ddd \u771f\u5b50\uff0eM\u86cb\u767d\u91cf\u7b97\u51fa\u30bd\u30d5\u30c8\uff08skim plus\u6cd5\uff09\u3092\u7528\u3044\u305fM\u86cb\u767d\u7b97\u5b9a\u6cd5\u306e\u691c\u8a3c\uff0e\u7b2c20\u56de \u65e5\u672c\u691c\u67fb\u8840\u6db2\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2019.7.6-7\uff0e\u5929\u7406\uff0e<\/li>\n\n\n\n
                                                                            10. \u5c0f\u91ce \u4f73\u4e00\uff0e\u5404\u691c\u67fb\u9818\u57df\u306e\u5185\u90e8\u7cbe\u5ea6\u7ba1\u7406\u306e\u3042\u308a\u65b9\uff08\u751f\u5316\u5b66\u691c\u67fb\uff09\uff0e\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u81ea\u52d5\u5316\u5b66\u4f1a \u7b2c51\u56de\u5927\u4f1a\uff0e2019.10.3-5\uff0e\u6a2a\u6d5c\uff0e<\/li>\n\n\n\n
                                                                            11. \u5f71\u5c71 \u7950\u5b50\uff0cBaasanjav Uranbileg\uff0c\u8535\u91ce \u4fe1\uff0c\u6c60\u7530 \u5747\uff0c\u77e2\u51a8 \u88d5\uff0eS1P\u30ea\u30a2\u30fc\u30bc\u306e\u809d\u518d\u751f\u306b\u304a\u3051\u308b\u5f79\u5272\u306e\u691c\u8a0e\uff0e\u7b2c68\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2019.11.21-24\uff0e\u5ca1\u5c71\uff0e<\/li>\n\n\n\n
                                                                            12. \u4e0a\u5e02 \u88d5\u5b50\uff0c\u77f3\u539f \u6709\u7406\uff0c\u4e0b\u5742 \u6d69\u5247\uff0c\u8535\u91ce \u4fe1\uff0c\u4f50\u85e4 \u667a\u660e\uff0c\u77e2\u51a8 \u88d5\uff0c\u98db\u7530 \u660e\u5b50\uff0e\u514d\u75ab\u8840\u6e05\u9805\u76ee\u306e4\u793e\u6a5f\u5668\u30fb\u8a66\u85ac\u306e\u6bd4\u8f033 \u7532\u72b6\u817a\u95a2\u9023\u691c\u67fb\u9805\u76ee\uff1aTSH\uff0cFT4\uff0cFT3\uff0e\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u81ea\u52d5\u5316\u5b66\u4f1a \u7b2c51\u56de\u5927\u4f1a\uff0e2019.10.3-5\uff0e\u6a2a\u6d5c\uff0e<\/li>\n\n\n\n
                                                                            13. \u4e0a\u5e02 \u88d5\u5b50\uff0c\u8535\u91ce \u4fe1\uff0c\u9f4b\u85e4 \u826f\u4e00\uff0c\u77e2\u51a8 \u88d5\uff0e\u5927\u8178\u83cc\u306b\u304a\u3051\u308b\u30ea\u30be\u30ea\u30f3\u8102\u8cea\u2015\u30b8\u30a2\u30b7\u30eb\u30ea\u30f3\u8102\u8cea\u7cfb\u306e\u5f79\u5272\u306b\u3064\u3044\u3066\u306e\u691c\u8a0e\uff0e\u7b2c66\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2019.11.21-24\uff0e\u5ca1\u5c71\uff0e<\/li>\n\n\n\n
                                                                            14. Kiriyama, H., Kaneko, H., Ito, H., Yoshida, Y., Nakanishi, K., Mizumo, Y., Daimon, M., Morita, H., Yatomi, Y., and Komuro, I. Role of Anemia and Proteinuria in the Development of Subsequent Renal Function Deterioration in General Population with Preserved Glomerular Filtration Rate: A community-based cohort study. \u7b2c83\u56de \u65e5\u672c\u5faa\u74b0\u5668\u75c5\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2019.3.29-31\uff0e\u6a2a\u6d5c\uff0e<\/li>\n\n\n\n
                                                                            15. \u8535\u91ce \u4fe1\uff0c\u897f\u5ddd \u771f\u5b50\uff0c\u4e94\u5341\u5d50 \u6d69\u4e8c\uff0c\u6751\u4e0a \u6b63\u5df3\uff0c\u77e2\u51a8 \u88d5\uff0e\u8840\u4e2d\u30b0\u30ea\u30bb\u30ed\u30ea\u30be\u30ea\u30f3\u8102\u8cea\u7523\u751f\u9175\u7d20\u306f\u30d0\u30bb\u30c9\u30a6\u75c5\u3067\u4e0a\u6607\u3059\u308b\uff0e\u7b2c116\u56de \u65e5\u672c\u5185\u79d1\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u8b1b\u6f14\u4f1a\uff0e2019.4.26-28\uff0e\u540d\u53e4\u5c4b\uff0e<\/li>\n\n\n\n
                                                                            16. \u8535\u91ce \u4fe1\uff0c\u585a\u672c \u548c\u4e45\uff0c\u539f \u771e\u7d14\uff0c\u77e2\u51a8 \u88d5\uff0e\u30b9\u30d5\u30a3\u30f3\u30b4\u30b7\u30f31-\u30ea\u30f3\u9178\/\u30a2\u30dd\u86cb\u767dM\u306b\u3088\u308b\u6297\u30a4\u30f3\u30b9\u30ea\u30f3\u62b5\u6297\u6027\u4f5c\u7528\u306e\u89e3\u660e\uff0e\u7b2c62\u56de \u65e5\u672c\u7cd6\u5c3f\u75c5\u5b66\u4f1a\u5e74\u6b21\u5b66\u8853\u96c6\u4f1a\uff0e2019.5.23-25\uff0e\u4ed9\u53f0\uff0e<\/li>\n\n\n\n
                                                                            17. \u8535\u91ce \u4fe1\uff0c\u897f\u5ddd \u771f\u5b50\uff0c\u77e2\u51a8 \u88d5\uff0e\u30ea\u30dd\u30dd\u30ea\u30b5\u30c3\u30ab\u30e9\u30a4\u30c9\u8a98\u767aDIC\u30e2\u30c7\u30eb\u30de\u30a6\u30b9\u306b\u304a\u3051\u308b\u30a2\u30dd\u86cb\u767dM\u306e\u6297\u8840\u6813\u4f5c\u7528\u306e\u30e1\u30ab\u30cb\u30ba\u30e0\u306e\u691c\u8a0e\u7b2c41\u56de \u65e5\u672c\u8840\u6813\u6b62\u8840\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2019.6.20-22\uff0e\u4e09\u91cd\uff0e<\/li>\n\n\n\n
                                                                            18. \u8535\u91ce \u4fe1\uff0c\u585a\u672c \u548c\u4e45\uff0c\u539f \u771e\u7d14\uff0c\u77e2\u51a8 \u88d5\uff0e\u30ea\u30dd\u86cb\u767d\u4ee3\u8b1d\u306b\u3088\u308b\u8840\u6f3f\u30b0\u30ea\u30bb\u30ed\u30ea\u30be\u30ea\u30f3\u8102\u8cea\u4ee3\u8b1d\u306e\u5236\u5fa1\uff0e\u7b2c51\u56de \u65e5\u672c\u52d5\u8108\u786c\u5316\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u96c6\u4f1a\uff0e2019.7.11-12\uff0e\u4eac\u90fd\uff0e<\/li>\n\n\n\n
                                                                            19. \u8535\u91ce \u4fe1\uff0c\u4f4f\u8c37 \u660c\u5f66\uff0c\u5742\u4e95 \u82f1\u91cc\uff0c\u53ef\u91ce \u90a6\u884c\uff0c\u9752\u6728 \u6df3\u8ce2\uff0c\u77e2\u51a8 \u88d5\uff0e\u9ac4\u6db2\u4e2d\u30ea\u30be\u30db\u30b9\u30d5\u30a1\u30c1\u30b8\u30f3\u9178\uff0c\u30ea\u30be\u30db\u30b9\u30d5\u30a1\u30c1\u30b8\u30eb\u30b3\u30ea\u30f3\u306f\u5ba2\u89b3\u7684\u75bc\u75db\u30de\u30fc\u30ab\u30fc\u3067\u3042\u308b\uff0e\u7b2c44\u56de \u65e5\u672c\u533b\u7528\u30de\u30b9\u30b9\u30da\u30af\u30c8\u30eb\u5b66\u4f1a\u5e74\u4f1a\uff0e2019.9.12-13\uff0e\u540d\u53e4\u5c4b\uff0e<\/li>\n\n\n\n
                                                                            20. \u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0e\u30ea\u30dd\u86cb\u767d\u306e\u9178\u5316\u306b\u3088\u308b\u30b0\u30ea\u30bb\u30ed\u30ea\u30be\u30ea\u30f3\u8102\u8cea\u306e\u5909\u5316\u306f\uff0c\u9178\u5316\u30ea\u30dd\u86cb\u767d\u306e\u50ac\u708e\u75c7\u4f5c\u7528\u306b\u5bc4\u4e0e\u3059\u308b\uff0e\u7b2c59\u56de \u65e5\u672c\u81e8\u5e8a\u5316\u5b66\u4f1a\u5e74\u6b21\u5b66\u8853\u96c6\u4f1a\uff0e2019.9.27-29\uff0e\u4ed9\u53f0\uff0e<\/li>\n\n\n\n
                                                                            21. \u8535\u91ce \u4fe1\uff0cUranbileg B\uff0c\u897f\u5ddd \u5c1a\u5b50\uff0c\u6e05\u6c34 \u77e5\uff0c\u6c60\u7530 \u5747\uff0c\u77e2\u51a8 \u88d5\uff0e\u809d\u75be\u60a3\u306b\u304a\u3051\u308b\u30a2\u30dd\u86cb\u767dM\u306e\u5909\u52d5\u3068\u75c5\u614b\u751f\u7406\u3078\u306e\u95a2\u4e0e\uff0e\u7b2c66\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2019.11.21-24\uff0e\u5ca1\u5c71\uff0e<\/li>\n\n\n\n
                                                                            22. \u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0e\u8179\u819c\u64ad\u7a2e\u764c\u306b\u304a\u3051\u308b\u30ea\u30be\u30ea\u30f3\u8102\u8cea\u304a\u3088\u3073\u95a2\u9023\u86cb\u767d\u306e\u5909\u52d5\uff0e\u7b2c66\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2019.11.21-24\uff0e\u5ca1\u5c71\uff0e<\/li>\n\n\n\n
                                                                            23. \u8535\u91ce \u4fe1\uff0c\u68ee\u7530 \u8ce2\u53f2\uff0c\u5742\u4e95 \u82f1\u91cc\uff0cUranbileg B\uff0c\u9752\u6728 \u6df3\u8ce2\uff0c\u77e2\u51a8 \u88d5\uff0e\u30d2\u30c8\u30b5\u30f3\u30d7\u30eb\u3092\u7528\u3044\u305f\u751f\u7406\u6d3b\u6027\u8102\u8cea\u6e2c\u5b9a\u7cfb\u306b\u3088\u308b\u30d2\u30c8\u75be\u60a3\u75c5\u614b\u306e\u89e3\u660e\u3068\u81e8\u5e8a\u691c\u67fb\u3078\u306e\u5fdc\u7528\uff0e\u7b2c66\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2019.11.21-24\uff0e\u5ca1\u5c71\uff0e<\/li>\n\n\n\n
                                                                            24. \u5c0f\u5ba4 \u8cb4\u5b50\uff0eISO 15189\u8a8d\u5b9a\u53d6\u5f97\u65bd\u8a2d\u304b\u3089\uff0e\u7b2c66\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2019.11.21-24\uff0e\u5ca1\u5c71\uff0e<\/li>\n\n\n\n
                                                                            25. \u5742\u4e95 \u82f1\u91cc\uff0c\u68ee\u7530 \u8ce2\u53f2\uff0c\u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0eLC-MS\/MS\u3092\u7528\u3044\u305f\u30d2\u30c8\u9ac4\u6db2\u4e2d\u30b9\u30d5\u30a3\u30f3\u30b4\u30b7\u30f31-\u30ea\u30f3\u9178\uff08S1P\uff09\u306e\u6e2c\u5b9a\u7cfb\u306e\u78ba\u7acb\u3068\u9ac4\u819c\u64ad\u7a2e\u764c\u306b\u304a\u3051\u308b\u30b9\u30d5\u30a3\u30f3\u30b4\u8102\u8cea\u306e\u89e3\u6790\uff0e\u7b2c44\u56de \u65e5\u672c\u533b\u7528\u30de\u30b9\u30b9\u30da\u30af\u30c8\u30eb\u5b66\u4f1a\u5e74\u4f1a\uff0e2019.9.12-13\uff0e\u540d\u53e4\u5c4b\uff0e<\/li>\n\n\n\n
                                                                            26. \u4f50\u85e4 \u7f8e\u77e5\u5b50\uff0c\u5e38\u540d \u653f\u5f18\u5b50\uff0c\u8fbb\u4e95 \u4e9c\u5f25\u5b50\uff0c\u4e38\u5c3e \u7406\u6075\u5b50\uff0c\u91ce\u3005\u90e8 \u4eae\u5b50\uff0c\u9ad8\u6a4b \u6075\uff0c\u5897\u6238 \u68a8\u6075\uff0c\u7530\u9089 \u4e45\u7f8e\u5b50\uff0c\u897f\u5ddd \u771f\u5b50\uff0c\u77e2\u51a8 \u88d5\uff0e\u6955\u5186\u8d64\u8840\u7403\u3092\u6709\u3059\u308bMDS\u306e\u4e00\u75c7\u4f8b\uff0e\u7b2c20\u56de \u65e5\u672c\u691c\u67fb\u8840\u6db2\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2019.7.6-7. \u5929\u7406\uff0e<\/li>\n\n\n\n
                                                                            27. \u4f50\u85e4 \u6075\u7f8e\uff0c\u68ee\u7530 \u8ce2\u53f2\uff0c\u4e45\u672b \u5d07\u53f8\uff0c\u5409\u672c \u660e\uff0c\u5c0f\u91ce \u4f73\u4e00\uff0c\u5bbf\u8c37 \u8ce2\u4e00,\u4f50\u85e4 \u667a\u660e\uff0c\u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0c\u7530\u4e2d \u96c5\u7f8e\uff0e\u5c3f\u4e2d\u30d0\u30a4\u30aa\u30de\u30fc\u30ab\u30fc\u6e2c\u5b9a\u5024\u306b\u5bfe\u3059\u308b\u9060\u5fc3\u51e6\u7406\u306e\u5f71\u97ff\uff0e\u7b2c66\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2019.11.21-24\uff0e\u5ca1\u5c71\uff0e<\/li>\n\n\n\n
                                                                            28. Sawada, N., Nakanishi, K., Daimon, M., Nakao, T., Yoshida, Y., Ishiwata, J., Hirokawa, M., Morita, H., Yatomi, Y., and Komuro, I. Visceral fat accumulation is independently associated with right ventricular dysfunction in general population. \u7b2c83\u56de \u65e5\u672c\u5faa\u74b0\u5668\u75c5\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2019.3.29-31\uff0e\u6a2a\u6d5c\uff0e<\/li>\n\n\n\n
                                                                            29. \u6fa4\u7530 \u76f4\u5b50\uff0c\u5927\u9580 \u96c5\u592b\uff0c\u4e2d\u5c3e \u502b\u5b50\uff0c\u5ee3\u5ddd \u611b\u7f8e\uff0c\u52a0\u85e4 \u502b\u5b50\uff0c\u963f\u90e8 \u6d69\u5e78\uff0c\u5b87\u91ce \u6f22\u6210\uff0c\u7af9\u4e2d \u514b\uff0c\u77e2\u51a8 \u88d5\uff0c\u5c0f\u5ba4 \u4e00\u6210. \u5de6\u5ba4\u9577\u8ef8\u30b9\u30c8\u30ec\u30a4\u30f3\u6240\u898b\u3068\u75c5\u7406\u7d44\u7e54\u50cf\u306e\u6bd4\u8f03\u691c\u8a0e\u3092\u884c\u3063\u305f\u5fc3\u30a2\u30df\u30ed\u30a4\u30c9\u30fc\u30b7\u30b9\u306e\u4e00\u5256\u691c\u4f8b\uff0e\u65e5\u672c\u8d85\u97f3\u6ce2\u533b\u5b66\u4f1a \u7b2c92\u56de\u5b66\u8853\u96c6\u4f1a\uff0e2019.5.24-26\uff0e\u6771\u4eac\uff0e<\/li>\n\n\n\n
                                                                            30. \u5fd7\u6751 \u62d3\u4e5f\uff0c\u5e38\u540d \u653f\u5f18\uff0c\u5bfa\u5cf6 \u9053\u5b50\uff0c\u4e38\u5c3e \u7406\u6075\uff0c\u9ad8\u6a4b \u6075\uff0c\u4f50\u85e4 \u7f8e\u667a\u5b50\uff0c\u8239\u6238 \u771f\u5948\u7f8e\uff0c\u8fbb\u4e95 \u4e9c\u5f25\uff0c\u897f\u5ddd \u771f\u5b50\uff0c\u77e2\u51a8 \u88d5\uff0e\u5f53\u9662\u8840\u6db2\u691c\u67fb\u5ba4\u306b\u304a\u3051\u308b\u7d44\u7e54\u637a\u5370\u6a19\u672c\u306e\u6709\u7528\u6027\u306e\u691c\u8a0e\uff0e\u7b2c20\u56de \u65e5\u672c\u691c\u67fb\u8840\u6db2\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2019.7.6-7\uff0e\u5929\u7406\uff0e<\/li>\n\n\n\n
                                                                            31. \u9234\u6728 \u535a\u82f1\uff0c\u5927\u9580 \u96c5\u592b\uff0e\u6559\u80b2\u30bb\u30c3\u30b7\u30e7\u30f3 \u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u306b\u57fa\u3065\u304f\u5fc3\u30a8\u30b3\u30fc\u56f3\u306e\u9032\u3081\u65b9\uff0c\u8003\u3048\u65b9\u300c\u53f3\u5fc3\u7cfb\u300d\uff0e\u7b2c83\u56de \u65e5\u672c\u5faa\u74b0\u5668\u75c5\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2019.3.29-31\uff0e\u6a2a\u6d5c\uff0e<\/li>\n\n\n\n
                                                                            32. \u4e0b\u5742 \u6d69\u5247\uff0c\u4e09\u8f2a \u7531\u8cb4\u5b50\uff0c\u8535\u91ce \u4fe1\uff0c\u4f50\u85e4 \u667a\u660e\uff0c\u77e2\u51a8 \u88d5\uff0e\u5546\u7528\u30cd\u30c3\u30c8\u30ef\u30fc\u30af\u57fa\u76e4\u3092\u7528\u3044\u305f\u767b\u9332\u885b\u751f\u691c\u67fb\u6240\u3068\u306e\u30c7\u30fc\u30bf\u4ea4\u63db\u306e\u6709\u7528\u6027\uff0e\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u81ea\u52d5\u5316\u5b66\u4f1a \u7b2c51\u56de\u5927\u4f1a\uff0e2019.10.3-5\uff0e\u6a2a\u6d5c\uff0e<\/li>\n\n\n\n
                                                                            33. \u7b4b\u91ce \u88d5\u7f8e\u5b50\uff0c\u5742\u4e2d \u5343\u6075\uff0c\u5f71\u5c71 \u7950\u5b50\uff0c\u5bae\u672c \u548c\u5b50\uff0c\u67f3\u7530 \u9053\u5b5d\uff0c\u4ef2\u6751 \u6075\uff0c\u68ee\u8c4a \u9686\u5fd7\uff0e\u81e8\u5e8a\u8a66\u9a13\u5c02\u9580\u75c5\u68df\u306e\u5186\u6ed1\u306a\u79fb\u8ee2\u3068\u8a66\u9a13\u518d\u958b\u306b\u5411\u3051\u305f\u53d6\u308a\u7d44\u307f\u306e\u7d4c\u9a13\u304b\u3089\uff0e\u7b2c40\u56de \u65e5\u672c\u81e8\u5e8a\u85ac\u7406\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a\uff0e2019.12.4-6\uff0e\u6771\u4eac\uff0e<\/li>\n\n\n\n
                                                                            34. Daimon, M. How can We Characterize Pathophysiology of Heart Failure with Mid-range Ejection Fraction?\u7b2c83\u56de \u65e5\u672c\u5faa\u74b0\u5668\u75c5\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2019.3.29-31, \u6a2a\u6d5c\uff0e<\/li>\n\n\n\n
                                                                            35. \u5927\u9580 \u96c5\u592b\uff0c\u5b87\u91ce \u6f22\u6210\uff0c\u4e2d\u5c3e \u502b\u5b50\uff0c\u6fa4\u7530 \u76f4\u5b50\uff0c\u5ee3\u5ddd \u611b\u7f8e\uff0e\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u300c\u4e8c\u6b21\u6027\u5fc3\u7b4b\u75c7\u306e\u5fc3\u30a8\u30b3\u30fc\u8a3a\u65ad\u306e\u6700\u524d\u7dda\u300d\uff1a\u5fc3\u30d5\u30a1\u30d6\u30ea\u30fc\u75c5\u306b\u304a\u3051\u308b\u753b\u50cf\u8a3a\u65ad\u306e\u73fe\u5728\uff0e\u65e5\u672c\u8d85\u97f3\u6ce2\u533b\u5b66\u4f1a \u7b2c31\u56de\u95a2\u6771\u7532\u4fe1\u8d8a\u5730\u65b9\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2019.10.19-20\uff0e\u6771\u4eac\uff0e<\/li>\n\n\n\n
                                                                            36. \u5927\u9580 \u96c5\u592b\uff0c\u4e2d\u5c3e \u502b\u5b50\uff0c\u9234\u6728 \u535a\u82f1\uff0c\u4e95\u4e0a \u7fd4\u592a\uff0c\u77e2\u51a8 \u88d5\uff0e\u5de6\u5ba4\u30b5\u30a4\u30ba\u5fc3\u30a8\u30b3\u30fc\u6307\u6a19\u3092\u4f53\u8868\u9762\u7a4d\u3067\u88dc\u6b63\u3059\u308b\u306e\u306f\u59a5\u5f53\u304b\uff1f\u7b2c66\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2019.11.21-24\uff0e\u5ca1\u5c71\uff0e<\/li>\n\n\n\n
                                                                            37. \u9ad8\u6a4b \u6075\uff0c\u5e38\u540d \u653f\u5f18\uff0c\u4f50\u85e4 \u512a\u5b9f\u5b50\uff0c\u7530\u9089 \u4e45\u7f8e\u5b50\uff0c\u91ce\u3005\u90e8 \u4eae\u5b50\uff0c\u4e38\u5c3e \u7406\u6075\uff0c\u8fbb\u4e95 \u4e9c\u5f25\uff0c\u5bfa\u5cf6 \u9053\u5b50\uff0c\u897f\u5ddd \u771f\u5b50\uff0c\u77e2\u51a8 \u88d5\uff0e\u597d\u9178\u7403\u5897\u591a\u304a\u3088\u3073FGFR1\u518d\u69cb\u6210\u3092\u4f34\u3046\u9aa8\u9ac4\u6027\/\u30ea\u30f3\u30d1\u6027\u816b\u760d\u306e\uff11\u75c7\u4f8b\uff0e\u7b2c20\u56de \u65e5\u672c\u691c\u67fb\u8840\u6db2\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2019.7.6-7. \u5929\u7406\uff0e<\/li>\n\n\n\n
                                                                            38. \u7530\u4e2d \u96c5\u7f8e\uff0c\u68ee\u7530 \u8ce2\u53f2\uff0c\u4e45\u672b \u5d07\u53f8\uff0c\u4f50\u85e4 \u6075\u7f8e\uff0c\u5c0f\u91ce \u4f73\u4e00\uff0c\u4f50\u85e4 \u667a\u660e\uff0c\u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0c\u5bbf\u8c37 \u8ce2\u4e00\uff0e\u5375\u5186\u5f62\u8102\u80aa\u4f53\u306e\u8a18\u8f09\u6cd5\u306e\u691c\u8a3c\uff0e\u814e\u30fb\u6ccc\u5c3f\u5668\u691c\u67fb\u7814\u7a76\u4f1a \u7b2c15\u56de\u5b66\u8853\u96c6\u4f1a\uff0e2019.3.23-24\uff0e\u6771\u4eac\uff0e<\/li>\n\n\n\n
                                                                            39. \u7530\u4e2d \u96c5\u7f8e\uff0c\u68ee\u7530 \u8ce2\u53f2\uff0c\u4e45\u672b \u5d07\u53f8\uff0c\u5409\u672c \u660e\uff0c\u5c0f\u91ce \u4f73\u4e00\uff0c\u4f50\u85e4 \u667a\u660e\uff0c\u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0c\u5bbf\u8c37 \u8ce2\u4e00\uff0e\u5168\u81ea\u52d5\u5c3f\u4e2d\u6709\u5f62\u6210\u5206\u5206\u6790\u88c5\u7f6eUF-5000\u6539\u826f\u5f8c\u306e\u300c\u4f53\u6db2\u6e2c\u5b9a\u30e2\u30fc\u30c9\u300d\u306e\u6027\u80fd\u8a55\u4fa1\uff0e\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u81ea\u52d5\u5316\u5b66\u4f1a \u7b2c51\u56de\u5927\u4f1a\uff0e2019.10.3-5\uff0e\u6a2a\u6d5c\uff0e<\/li>\n\n\n\n
                                                                            40. \u8c37\u53e3 \u5bdb\uff0c\u4e2d\u5c3e \u502b\u5b50\uff0c\u5927\u9580 \u96c5\u592b\uff0c\u5c71\u5185 \u6cbb\u96c4\uff0c\u5c0f\u5ba4 \u4e00\u6210\uff0e\u982d\u84cb\u5185\u9ac4\u819c\u816b\u8853\u5f8c\u306b\u5927\u52d5\u8108\u5f01\u8f2a\u90e8\u306b\u8840\u6813\u3092\u5f62\u6210\u3057\u305f\u4e00\u4f8b\uff0e\u7b2c67\u56de \u65e5\u672c\u5fc3\u81d3\u75c5\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2019.9.13\uff0e\u540d\u53e4\u5c4b\uff0e<\/li>\n\n\n\n
                                                                            41. \u8c37\u6fa4 \u674e\u7d17\uff0c\u91ce\u7530 \u7406\u7f8e\uff0c\u4e0b\u5742 \u6d69\u5247\uff0c\u4f50\u85e4 \u667a\u660e\uff0c\u77e2\u51a8 \u88d5\uff0c\u4fdd\u7530 \u5948\u7dd2\u7f8e\uff0e\u5168\u81ea\u52d5\u81e8\u5e8a\u691c\u67fb\u30b7\u30b9\u30c6\u30e0STACIA\u306b\u3088\u308b\u81ea\u5df1\u6297\u4f53\u691c\u67fb\u8a66\u85ac\u306e\u6027\u80fd\u8a55\u4fa1\uff0e\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u81ea\u52d5\u5316\u5b66\u4f1a \u7b2c51\u56de\u5927\u4f1a\uff0e2019.10.3-5\uff0e\u6a2a\u6d5c\uff0e<\/li>\n\n\n\n
                                                                            42. \u8c37\u6fa4 \u674e\u7d17\uff0c\u4e0b\u5742 \u6d69\u5247\uff0c\u4f50\u85e4 \u667a\u660e\uff0c\u77e2\u51a8 \u88d5\uff0c\u98db\u7530 \u660e\u5b50\uff0e\u5168\u81ea\u52d5\u5316\u5b66\u767a\u5149\u9175\u7d20\u514d\u75ab\u6e2c\u5b9a\u88c5\u7f6eAIA-CL2400\u306b\u3088\u308bKL-6\u6e2c\u5b9a\u8a66\u85ac\u306e\u6027\u80fd\u8a55\u4fa1\uff0e\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u81ea\u52d5\u5316\u5b66\u4f1a \u7b2c51\u56de\u5927\u4f1a\uff0e2019.10.3-5\uff0e\u6a2a\u6d5c\uff0e<\/li>\n\n\n\n
                                                                            43. \u5bfa\u5cf6 \u9053\u5b50\uff0c\u5e38\u540d \u653f\u5f18\uff0c\u8fbb\u4e95 \u4e9c\u5f25\uff0c\u4e38\u5c3e \u7406\u6075\uff0c\u91ce\u3005\u90e8 \u4eae\u5b50\uff0c\u9ad8\u6a4b \u6075\uff0c\u5897\u6238 \u68a8\u6075\uff0c\u7530\u9089 \u4e45\u7f8e\u5b50\uff0c\u897f\u5ddd \u771f\u5b50\uff0c\u77e2\u51a8 \u88d5\uff0e\u672b\u68a2\u8840\u306b\u591a\u6570\u306e\u5de8\u6838\u7403\u51fa\u73fe\u3092\u304d\u3063\u304b\u3051\u306b\u8a3a\u65ad\u3055\u308c\u305f\u6cbb\u7642\u95a2\u9023\u9aa8\u9ac4\u6027\u816b\u760d\u306e1\u75c7\u4f8b\uff0e\u7b2c20\u56de \u65e5\u672c\u691c\u67fb\u8840\u6db2\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2019.7.6-7. \u5929\u7406\uff0e<\/li>\n\n\n\n
                                                                            44. \u4e2d\u5c3e \u502b\u5b50\uff0c\u5927\u9580 \u96c5\u592b\uff0c\u4e95\u4e0a \u7fd4\u592a\uff0c\u9234\u6728 \u535a\u82f1\uff0c\u77e2\u51a8 \u88d5\uff0e\u53f3\u5ba4\u5fc3\u7b4b\u304c\u512a\u4f4d\u306b\u969c\u5bb3\u3055\u308c\u305f\u5fc3\u30b5\u30eb\u30b3\u30a4\u30c9\u30fc\u30b7\u30b9\u306e\u4e00\u75c7\u4f8b\uff0e\u7b2c66\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2019.11.21-24\uff0e\u5ca1\u5c71\uff0e<\/li>\n\n\n\n
                                                                            45. \u4e2d\u91ce \u88d5\u6a39\uff0c\u5fd7\u6751 \u62d3\u4e5f\uff0c\u5409\u5ddd \u76f4\u4e4b\uff0c\u5e38\u540d \u653f\u5f18\uff0c\u68ee\u7530 \u8ce2\u53f2\uff0c \u7530\u4e2d \u96c5\u7f8e\uff0c\u5c0f\u91ce \u4f73\u4e00\uff0c\u897f\u5ddd \u771f\u5b50\uff0c\u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0e\u9020\u8840\u5668\u816b\u760d\u4e2d\u67a2\u795e\u7d4c\u6d78\u6f64\u306e\u65b0\u3057\u3044\u6307\u6a19\u306e\u691c\u8a0e\uff0e\u7b2c20\u56de \u65e5\u672c\u691c\u67fb\u8840\u6db2\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2019.7.6-7. \u5929\u7406\uff0e<\/li>\n\n\n\n
                                                                            46. \u897f\u5ddd \u5c1a\u5b50\uff0c\u8535\u91ce \u4fe1\uff0cBaasanjav Uranbileg\uff0c\u6c60\u7530 \u5747\uff0c\u77e2\u51a8 \u88d5\uff0e\u809d\u7d30\u80de\u682a\u306b\u304a\u3051\u308b\u30a2\u30e9\u30ad\u30c9\u30f3\u9178\u307e\u305f\u306f\u30c9\u30b3\u30b5\u30d8\u30ad\u30b5\u30a8\u30f3\u9178\u6dfb\u52a0\u6642\u306e\u30ea\u30be\u30ea\u30f3\u8102\u8cea\u306e\u5909\u52d5\u3068\u305d\u306e\u751f\u7406\u7684\u610f\u7fa9\u306e\u691c\u8a0e\uff0e\u7b2c66\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2019.11.21-24\uff0e\u5ca1\u5c71\uff0e<\/li>\n\n\n\n
                                                                            47. \u897f\u5ddd \u5c1a\u5b50\uff0c\u8535\u91ce \u4fe1\uff0cBaasanjav Uranbileg\uff0c\u6c60\u7530 \u5747\uff0c\u77e2\u51a8 \u88d5\uff0e\u30ea\u30be\u30db\u30b9\u30d5\u30a1\u30c1\u30b8\u30eb\u30bb\u30ea\u30f3\u306f\u809d\u7dda\u7dad\u5316\u306b\u95a2\u4e0e\u3059\u308b\uff0e\u7b2c66\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2019.11.21-24\uff0e\u5ca1\u5c71\uff0e<\/li>\n\n\n\n
                                                                            48. \u897f\u5ddd \u771f\u5b50\uff0c\u8535\u91ce \u4fe1\uff0c\u4e94\u5341\u5d50 \u6d69\u4e8c\uff0c\u77e2\u51a8 \u88d5\uff0e\u8840\u6e05\u30aa\u30fc\u30c8\u30bf\u30ad\u30b7\u30f3\u306f\u65b0\u898f\u30ea\u30f3\u30d1\u816b\u30d0\u30a4\u30aa\u30de\u30fc\u30ab\u30fc\u3068\u3057\u3066\u6709\u7528\u3067\u3042\u308b\uff0e\u7b2c116\u56de \u65e5\u672c\u5185\u79d1\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u8b1b\u6f14\u4f1a\uff0e2019.4.26-28\uff0e\u540d\u53e4\u5c4b\uff0e<\/li>\n\n\n\n
                                                                            49. \u897f\u5ddd \u771f\u5b50\uff0c\u8535\u91ce \u4fe1\uff0c\u540d\u5009 \u8c4a\uff0c\u5ca1\u5d0e \u4ec1\uff0c\u9752\u6728 \u6df3\u8ce2\uff0c\u77e2\u51a8 \u88d5\uff0e\u30d5\u30ed\u30fc\u30b5\u30a4\u30c8\u30e1\u30c8\u30ea\u30fc\u3092\u7528\u3044\u305f\u30d2\u30c8\u8840\u5c0f\u677f\u306e\u30ea\u30be\u30db\u30b9\u30d5\u30a1\u30c1\u30b8\u30eb\u30bb\u30ea\u30f3\u53d7\u5bb9\u4f53mRNA\u767a\u73fe\u91cf\u89e3\u6790\u306e\u57fa\u790e\u691c\u8a0e\uff0e\u7b2c41\u56de \u65e5\u672c\u8840\u6813\u6b62\u8840\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2019.6.20-22\uff0e\u4e09\u91cd\uff0e<\/li>\n\n\n\n
                                                                            50. \u897f\u5ddd \u771f\u5b50\uff0c\u8535\u91ce \u4fe1\uff0c\u540d\u5009 \u8c4a\uff0c\u5ca1\u5d0e \u4ec1\uff0c\u9752\u6728 \u6df3\u8ce2\uff0c\u77e2\u51a8 \u88d5\uff0e\u30ea\u30be\u30db\u30b9\u30d5\u30a1\u30c1\u30b8\u30eb\u30bb\u30ea\u30f3\u306b\u7740\u76ee\u3057\u305f\u7cd6\u5c3f\u75c5\u306b\u304a\u3051\u308b\u8840\u5c0f\u677f\u6613\u51dd\u96c6\u6027\u3068\u65b0\u898f\u8840\u5c0f\u677f\u95a2\u9023\u691c\u67fb\u306e\u958b\u767a\uff0e\u7b2c20\u56de \u65e5\u672c\u691c\u67fb\u8840\u6db2\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2019.7.6-7. \u5929\u7406\uff0e<\/li>\n\n\n\n
                                                                            51. \u897f\u5ddd \u771f\u5b50\uff0c\u8535\u91ce \u4fe1\uff0c\u8c37\u53e3 \u5bdb\uff0c\u77e2\u51a8 \u88d5\uff0e\u5065\u5e38\u4eba\u306e\u8840\u5c0f\u677f\u6d3b\u6027\u5316\u306b\u3088\u308a\u653e\u51fa\u3055\u308c\u308b\u30ea\u30be\u30ea\u30f3\u8102\u8cea\u5206\u5b50\u7a2e\u306e\u89e3\u6790\uff0e\u7b2c66\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2019.11.21-24\uff0e\u5ca1\u5c71\uff0e<\/li>\n\n\n\n
                                                                            52. \u897f\u5ddd \u771f\u5b50\uff0c\u8535\u91ce \u4fe1\uff0c\u6c60\u7530 \u5747\uff0c\u77e2\u51a8 \u88d5\uff0e\u691c\u67fb\u90e8\u3060\u304b\u3089\u3053\u305d\u3067\u304d\u308b\u57fa\u790e\u533b\u5b66\u304b\u3089\u81e8\u5e8a\u533b\u5b66\u3078\u306eTranslational Research\uff0e\u30ef\u30fc\u30af\u30b7\u30e7\u30c3\u30d7\u300c\u81e8\u5e8a\u691c\u67fb\u5c02\u9580\u533b\u306e\u80b2\u6210\u3092\u8003\u3048\u308b\u300d\u7b2c66\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2019.11.21-24\uff0e\u5ca1\u5c71\uff0e<\/li>\n\n\n\n
                                                                            53. \u91ce\u3005\u90e8 \u4eae\u5b50\uff0c\u5b89\u672c \u7be4\u53f2\uff0c\u8fbb\u4e95 \u4e9c\u5f25\uff0c\u4e45\u7c73 \u5e78\u592b\uff0c\u5e38\u540d \u653f\u5f18\uff0c\u77e2\u51a8 \u88d5\uff0e\u65bd\u8a2d\u9593\u3067APTT\u304c\u4e56\u96e2\u3057\u3066\u767a\u898b\u3055\u308c\u305f\u30d7\u30ec\u30ab\u30ea\u30af\u30ec\u30a4\u30f3\u6b20\u640d\u75c7\u306e1\u75c7\u4f8b\uff0e\u7b2c19\u56de TTM\u30d5\u30a9\u30fc\u30e9\u30e0\uff0e2019.3.2\uff0e\u6771\u4eac\uff0e<\/li>\n\n\n\n
                                                                            54. \u91ce\u3005\u90e8 \u4eae\u5b50\uff0c\u5b89\u672c \u7be4\u53f2\uff0c\u8fbb\u4e95 \u4e9c\u5f25\uff0c\u4e45\u7c73 \u5e78\u592b\uff0c\u5e38\u540d \u653f\u5f18\uff0c\u77e2\u51a8 \u88d5\uff0e\u65bd\u8a2d\u9593\u3067APTT\u304c\u4e56\u96e2\u3057\u3066\u767a\u898b\u3055\u308c\u305f\u30d7\u30ec\u30ab\u30ea\u30af\u30ec\u30a4\u30f3\u6b20\u640d\u75c7\u306e1\u75c7\u4f8b\uff0e\u7b2c9\u56de \u8840\u6813\u6b62\u8840\u691c\u67fb\u7814\u7a76\u4f1a-Tokyo\uff0e2019.6.15\uff0e\u6771\u4eac\uff0e<\/li>\n\n\n\n
                                                                            55. \u6bd4\u5609 \u826f\u745a\uff0c\u5f71\u5c71 \u7950\u5b50\uff0c\u5bae\u672c \u548c\u5b50\uff0e\u6771\u5927\u75c5\u9662Phase1\u30e6\u30cb\u30c3\u30c8\u306b\u304a\u3051\u308b\u300c\u30d2\u30e4\u30ea\u30fb\u30cf\u30c3\u30c8\u5831\u544a\u300d\u306e\u904b\u7528\u3068\u30c6\u30ad\u30b9\u30c8\u30de\u30a4\u30cb\u30f3\u30b0\u3092\u7528\u3044\u305f\u5831\u544a\u5185\u5bb9\u306e\u5206\u6790\u306b\u3064\u3044\u3066\uff0e \u7b2c40\u56de \u65e5\u672c\u81e8\u5e8a\u85ac\u7406\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a\uff0e2019.12.4-6\uff0e\u6771\u4eac\uff0e<\/li>\n\n\n\n
                                                                            56. \u5897\u6238 \u68a8\u6075\uff0c\u5e38\u540d \u653f\u5f18\uff0c\u5bfa\u5cf6 \u9053\u5b50\uff0c\u5927\u91d1 \u4e9c\u5f25\uff0c\u4e38\u5c3e \u7406\u6075\uff0c\u9ad8\u6a4b \u6075\uff0c\u7530\u8fba \u4e45\u7f8e\u5b50\uff0c\u897f\u5ddd \u771f\u5b50\uff0c\u4f50\u85e4 \u667a\u660e\uff0c\u77e2\u51a8 \u88d5\uff0eCD30\u967d\u6027\u3092\u793a\u3057\u305f\u6210\u4ebaT\u7d30\u80de\u767d\u8840\u75c5\/\u30ea\u30f3\u30d1\u816b\u306e\u4e00\u75c7\u4f8b\uff0e\u7b2c20\u56de \u65e5\u672c\u691c\u67fb\u8840\u6db2\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2019.7.6-7. \u5929\u7406\uff0e<\/li>\n\n\n\n
                                                                            57. \u4e38\u5c3e \u7406\u6075\uff0c\u5e38\u540d \u653f\u5f18\uff0c\u5bfa\u5cf6 \u9053\u5b50\uff0c\u4f50\u85e4 \u7f8e\u77e5\u5b50\uff0c\u7530\u9089 \u4e45\u7f8e\u5b50\uff0c\u91ce\u3005\u90e8 \u4eae\u5b50\uff0c\u8fbb\u4e95 \u4e9c\u5f25\uff0c\u9ad8\u6a4b \u6075\uff0c\u897f\u5ddd \u771f\u5b50\uff0c\u77e2\u51a8 \u88d5\uff0et(13;14)(q12;q32)\u3068\u597d\u9178\u7403\u5897\u591a\u3092\u4f34\u3046\u9aa8\u9ac4\u7cfb\/\u30ea\u30f3\u30d1\u7cfb\u816b\u760d\u306e\u4e00\u4f8b\uff0e\u7b2c20\u56de \u65e5\u672c\u691c\u67fb\u8840\u6db2\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2019.7.6-7\uff0e\u5929\u7406\uff0e<\/li>\n\n\n\n
                                                                            58. \u6301\u7530 \u667a\u4e4b\uff0c\u79cb\u7530 \u840c\uff0c\u7530\u5cf6 \u5c06\u592a\u90ce\uff0c\u5c71\u7530 \u306f\u308b\u9999\uff0c\u5ca1\u91ce \u667a\u5b50\uff0c\u771e\ufa11 \u6842\uff0c\u6e6f\u672c \u771f\u4eba\uff0e\u5f53\u691c\u67fb\u5ba4\u306b\u304a\u3051\u308bISO 15189\u904b\u7528\u72b6\u6cc1\u306b\u3064\u3044\u3066\uff0e\u7b2c6\u56de \u5168\u56fd\u3066\u3093\u304b\u3093\u30bb\u30f3\u30bf\u30fc\u5354\u8b70\u4f1a\u7dcf\u4f1a\uff0e2019.2.23\uff0e\u9577\u5d0e\uff0e<\/li>\n\n\n\n
                                                                            59. \u68ee\u7530 \u8ce2\u53f2\uff0c\u7530\u4e2d \u96c5\u7f8e\uff0c\u4e45\u672b \u5d07\u53f8\uff0c\u4f50\u85e4 \u6075\u7f8e\uff0c\u5c0f\u91ce \u4f73\u4e00\uff0c\u4f50\u85e4 \u667a\u660e\uff0c\u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0c\u5bbf\u8c37 \u8ce2\u4e00\uff0e\u5c3f\u6f5c\u8840\u3068\u6c88\u6e23\u8d64\u8840\u7403\u306e\u4e56\u96e2\u306b\u304a\u3051\u308b\u30df\u30aa\u30b0\u30ed\u30d3\u30f3\u5c3f\u306e\u91cd\u8981\u6027\uff0e\u814e\u30fb\u6ccc\u5c3f\u5668\u691c\u67fb\u7814\u7a76\u4f1a \u7b2c15\u56de \u5b66\u8853\u96c6\u4f1a\uff0e2019.3.23-24\uff0e\u6771\u4eac\uff0e<\/li>\n\n\n\n
                                                                            60. \u68ee\u7530 \u8ce2\u53f2\uff0c\u7530\u4e2d \u96c5\u7f8e\uff0c\u4e45\u672b \u5d07\u53f8\uff0c\u4f50\u85e4 \u6075\u7f8e\uff0c\u5bbf\u8c37 \u8ce2\u4e00\uff0c\u5c0f\u91ce \u4f73\u4e00\uff0c\u4f50\u85e4 \u667a\u660e\uff0c\u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0e\u30a2\u30c7\u30ce\u30a6\u30a4\u30eb\u30b9\u611f\u67d3\u7591\u3044\u7d30\u80de\u306e\u81ea\u52d5\u5206\u6790\u88c5\u7f6e\u306b\u3088\u308b\u691c\u51fa\u306e\u8a66\u307f\uff0e\u7b2c68\u56de \u65e5\u672c\u533b\u5b66\u691c\u67fb\u5b66\u4f1a\uff0e2019.05.18-19\uff0e\u4e0b\u95a2\uff0e<\/li>\n\n\n\n
                                                                            61. \u68ee\u7530 \u8ce2\u53f2\uff0c\u7530\u4e2d \u96c5\u7f8e\uff0c\u5bfa\u5cf6 \u9053\u5b50\uff0c\u5897\u6238 \u68a8\u6075\uff0c\u5c0f\u91ce \u4f73\u4e00\uff0c\u5bbf\u8c37 \u8ce2\u4e00\uff0c\u5e38\u540d \u653f\u5f18\uff0c\u897f\u5ddd \u771f\u5b50\uff0c\u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0e\u5c3f\u306e\u7d30\u80de\u8868\u9762\u6297\u539f\u89e3\u6790\u304c\u6709\u7528\u3067\u3042\u3063\u305f\u60aa\u6027\u30ea\u30f3\u30d1\u816b\u306e2\u75c7\u4f8b\uff0e\u7b2c29\u56de \u65e5\u672c\u30b5\u30a4\u30c8\u30e1\u30c8\u30ea\u30fc\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2019.5.25-26\uff0e\u6771\u4eac\uff0e<\/li>\n\n\n\n
                                                                            62. \u68ee\u7530 \u8ce2\u53f2\uff0c\u7530\u4e2d \u96c5\u7f8e\uff0c\u5bfa\u5cf6 \u9053\u5b50\uff0c\u5897\u6238 \u68a8\u6075\uff0c\u5c0f\u91ce \u4f73\u4e00\uff0c\u5bbf\u8c37 \u8ce2\u4e00\uff0c\u5e38\u540d \u653f\u5f18\uff0c\u897f\u5ddd \u771f\u5b50\uff0c\u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0e\u5c3f\u6c88\u6e23\u691c\u67fb\u3068\u5c3f\u4e2d\u7d30\u80de\u8868\u9762\u6297\u539f\u89e3\u6790\u304c\u6709\u7528\u3067\u3042\u3063\u305f\u60aa\u6027\u30ea\u30f3\u30d1\u816b\u306e2\u75c7\u4f8b\uff0e\u7b2c20\u56de \u65e5\u672c\u691c\u67fb\u8840\u6db2\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2019.7.6-7\uff0e\u5948\u826f\uff0e<\/li>\n\n\n\n
                                                                            63. \u68ee\u7530 \u8ce2\u53f2\uff0c\u7530\u4e2d \u96c5\u7f8e\uff0c\u4e45\u672b \u5d07\u53f8\uff0c\u5409\u672c \u660e\uff0c\u5c0f\u91ce \u4f73\u4e00\uff0c\u4f50\u85e4 \u667a\u660e\uff0c\u5bbf\u8c37 \u8ce2\u4e00\uff0c\u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0eSamson\u67d3\u8272\u306b\u304a\u3051\u308b\u591a\u5f62\u6838\u7403\u5206\u985e\u306e\u91cd\u8981\u6027\uff0e\u7b2c11\u56de \u65e5\u672c\u81e8\u5e8a\u4e00\u822c\u691c\u67fb\u5b66\u4f1a\uff0e2019.8.31-9.1\uff0e\u6625\u65e5\u4e95\uff0e<\/li>\n\n\n\n
                                                                            64. \u68ee\u7530 \u8ce2\u53f2\uff0c\u7530\u4e2d \u96c5\u7f8e\uff0c\u4e45\u672b \u5d07\u53f8\uff0c\u5409\u672c \u660e\uff0c\u5c0f\u91ce \u4f73\u4e00\uff0c\u5bbf\u8c37 \u8ce2\u4e00\uff0c\u4f50\u85e4 \u667a\u660e\uff0c\u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0eAtellica UAS800\u306e\u753b\u50cf\u89e3\u6790\u306b\u3088\u308b\u7570\u578b\u7d30\u80de\u306e\u8a55\u4fa1\uff0e\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u81ea\u52d5\u5316\u5b66\u4f1a \u7b2c51\u56de\u5927\u4f1a\uff0e2019.10.3-5\uff0e\u6a2a\u6d5c\uff0e<\/li>\n\n\n\n
                                                                            65. \u68ee\u7530 \u8ce2\u53f2\uff0c\u95a2 \u512a\u6589\uff0c\u5c0f\u91ce \u4f73\u4e00\uff0c\u4e45\u672b \u5d07\u53f8\uff0c\u5409\u672c \u660e\uff0c\u4f50\u85e4 \u667a\u660e\uff0c\u5bbf\u8c37 \u8ce2\u4e00\uff0c\u7530\u4e2d \u96c5\u7f8e\uff0e\u968f\u6642\u5c3f\u3092\u7528\u3044\u305f\u98df\u5869\u6442\u53d6\u91cf\u63a8\u5b9a\u5f0f\u306e\u691c\u8a3c\uff0e\u7b2c56\u56de \u65e5\u81e8\u6280\u95a2\u7532\u4fe1\u652f\u90e8\u30fb\u9996\u90fd\u570f\u652f\u90e8\u533b\u5b66\u691c\u67fb\u5b66\u4f1a\uff0e2019.10.26-27. \u6771\u4eac\uff0e<\/li>\n\n\n\n
                                                                            66. \u68ee\u7530 \u8ce2\u53f2\uff0c\u8107\u7530 \u6e80\uff0c\u798f\u7530 \u5609\u660e\uff0c\u53cb\u7530 \u7f8e\u7a42\u5b50\uff0c\u5c0f\u6797 \u7d4b\u58eb\uff0c\u670d\u90e8 \u4eae\u8f14\uff0c\u68b6 \u660e\u9999\uff0c\u7530\u4e2d \u771f\u5f13\uff0e\u5e73\u621030\u5e74\u5ea6\u65e5\u672c\u81e8\u5e8a\u885b\u751f\u691c\u67fb\u6280\u5e2b\u4f1a\u7cbe\u5ea6\u7ba1\u7406\u5831\u544a\u306b\u3064\u3044\u3066 -\u6771\u4eac\u90fd\u306b\u304a\u3051\u308b\u5c3f\u5b9a\u6027\u691c\u67fb\u306e\u73fe\u72b6-\uff0e\u7b2c56\u56de \u65e5\u81e8\u6280\u95a2\u7532\u4fe1\u652f\u90e8\u30fb\u9996\u90fd\u570f\u652f\u90e8\u533b\u5b66\u691c\u67fb\u5b66\u4f1a\uff0e2019.10.26-27. \u6771\u4eac\uff0e<\/li>\n\n\n\n
                                                                            67. \u68ee\u7530 \u8ce2\u53f2\uff0c\u5bbf\u8c37 \u8ce2\u4e00\uff0c\u4e45\u672b \u5d07\u53f8\uff0c\u5409\u672c \u660e\uff0c\u5c0f\u91ce \u4f73\u4e00\uff0c\u4f50\u85e4 \u667a\u660e\uff0c\u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0c\u7530\u4e2d \u96c5\u7f8e\uff0e\u5c3f\u4e2dNGAL\u304a\u3088\u3073L-FABP\u3068\u5c3f\u6c88\u6e23\u6210\u5206\u306e\u95a2\u9023\uff0e\u7b2c66\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2019.11.21-24\uff0e\u5ca1\u5c71\uff0e<\/li>\n\n\n\n
                                                                            68. \u68ee\u7530 \u8ce2\u53f2\uff0c\u8535\u91ce \u4fe1\uff0c\u5742\u4e95 \u82f1\u7406\uff0c\u77e2\u51a8 \u88d5\uff0e\u5c3f\u4e2d\u30bb\u30e9\u30df\u30c9\u4e00\u6589\u5b9a\u91cf\u7cfb\u306e\u78ba\u7acb\u3068\u305d\u306e\u6e2c\u5b9a\u610f\u7fa9\uff0e\u7b2c66\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2019.11.21-24\uff0e\u5ca1\u5c71\uff0e<\/li>\n\n\n\n
                                                                            69. \u68ee\u7530 \u8ce2\u53f2\uff0c\u8535\u91ce \u4fe1\uff0c\u5742\u4e95 \u82f1\u7406\uff0c\u77e2\u51a8 \u88d5\uff0e\u5c3f\u4e2d\u8102\u8cea\u30e1\u30c7\u30a3\u30a8\u30fc\u30bf\u30fc\u306e\u6e2c\u5b9a\u306b\u304a\u3051\u308b\u524d\u51e6\u7406\u6cd5\u306e\u691c\u8a0e\uff0e\u7b2c66\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2019.11.21-24\uff0e\u5ca1\u5c71\uff0e<\/li>\n\n\n\n
                                                                            70. \u5c71\u672c \u88d5\u5b50\uff0c\u5927\u9580 \u96c5\u592b\uff0c\u4e2d\u5c3e \u502b\u5b50\uff0c\u4e2d\u897f \u5f18\u6bc5\uff0c\u5ee3\u5ddd \u611b\u7f8e\uff0c\u6fa4\u7530 \u76f4\u5b50\uff0c\u77f3\u6e21 \u60c7\u5e73\uff0c\u6850\u5c71 \u7693\u884c\uff0c\u5409\u7530 \u7531\u7406\u5b50\uff0c\u5ca9\u9593 \u5065\u592a\u90ce\uff0c\u5ee3\u702c \u548c\u4fca\uff0c\u5c0f\u5ba4 \u4e00\u6210\uff0e\u5de6\u5ba4\u6d41\u51fa\u8def\u306b\u53ef\u52d5\u6027\u75a3\u816b\u3092\u8a8d\u3081\u305f\u5927\u52d5\u8108\u4e8c\u5c16\u5f01\u611f\u67d3\u6027\u5fc3\u5185\u819c\u708e\u306e\u4e00\u4f8b\uff0e\u7b2c10\u56de \u65e5\u672c\u5fc3\u50cf\u5f01\u819c\u75c7\u5b66\u4f1a\uff0e2019.11.29-30\uff0e\u6771\u4eac\uff0e<\/li>\n\n\n\n
                                                                            71. Yoshida, Y., Nakanishi, K., Daimon, M., Nakao, T., Ishiwata, J., Sawada, N., Hirokawa, M., Kaneko, H., Mizuno, Y., Morita, H., Yatomi, Y., and Komuro, I. Association of arterial stiffness with left atrial volume and function: A community-based cohort study. \u7b2c83\u56de \u65e5\u672c\u5faa\u74b0\u5668\u75c5\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2019.3.29-31\uff0c\u6a2a\u6d5c\uff0e<\/li>\n\n\n\n
                                                                            72. Uranbileg, B., Ito, N., Kurano, M., Ikeda, H., and Yatomi, Y. Involvement of LPA and its precursor LPC, in spinal cord stenosis: A study using a rat CEC model. \u7b2c59\u56de \u65e5\u672c\u81e8\u5e8a\u5316\u5b66\u4f1a\u5e74\u6b21\u5b66\u8853\u96c6\u4f1a\uff0e2019.9.27-29\uff0e\u4ed9\u53f0\uff0e<\/li>\n\n\n\n
                                                                            73. Uranbileg, B., Kurano, M., Sato, M., Ikeda, H., and Yatomi, Y. Possible involvement of PS-PLA1 and lysophosphatidylserine receptor (LPS1) in hepatocellular carcinoma. \u7b2c66\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2019.11.21-24\uff0e\u5ca1\u5c71\uff0e<\/li>\n<\/ol>\n\n\n\n

                                                                              \u82f1\u6587\u7dcf\u8aac\uff1aEnglish Review Articles<\/h4>\n\n\n\n
                                                                                \n
                                                                              1. Akazawa, H., Toko, H., Harada, M., Ueda, K., Kodera, S., Kiyosue, A., Fujiu, K., Hatano, M., Daimon, M., Ando, J., Takimoto, E., Morita, H., and Komuro, I. Overview of the 83rd Annual Scientific Meeting of the Japanese Circulation Society- Renaissance of Cardiology for the Creation of Future Medicine, Circ. J.<\/strong><\/em> 83: 1829-1835<\/a>, 2019.<\/li>\n\n\n\n
                                                                              2. Kato, T.S., Daimon, M., and Satoh, T. Use of Cardiac Imaging to Evaluate Cardiac Function and Pulmonary Hemodynamics in Patients with Heart Failure. Curr Cardiol Rep.<\/strong><\/em> 21: 53<\/a>, 2019.<\/li>\n\n\n\n
                                                                              3. Nakao, T., Morita, H. Thrombospondin-2. Int. Heart. J.<\/strong><\/em> 60: 235-237<\/a>, 2019.<\/li>\n\n\n\n
                                                                              4. Nakao, T., Fujiu, K., Uehara, M., and Komuro, I. Asymptomatic Long-term Cardiac Perforation by a Pacemaker Lead. Intern. Med. <\/strong><\/em>58: 2409-2410<\/a>, 2019.<\/li>\n\n\n\n
                                                                              5. Nakanishi, K., Daimon, M. Coronary slow flow and subclinical left ventricular dysfunction: guilty or innocent bystander? Int. Heart. J<\/strong><\/em>. 60:495-496<\/a>, 2019.<\/li>\n\n\n\n
                                                                              6. Nakatani, S., Ohara, T., Ashihara, K., Izumi, C., Iwanaga, S., Eishi, K., Okita, Y., Daimon, M., Kimura, T., Toyoda, K., Nakase, H., Nakano, K., Higashi, M., Mitsutake, and K., Murakami. T, Yasukochi, S., Okazaki, S., Sakamoto, H., Tanaka, H., Nakagawa, I., Nomura, R., Fujiu, K., Miura, T., and Morizane, T. JCS 2017 Guideline on Prevention and Treatment of Infective Endocarditis. Circ. J.<\/strong><\/em> 83: 1767-1809<\/a>, 2019.<\/li>\n<\/ol>\n\n\n\n

                                                                                \u56fd\u969b\u5b66\u4f1a\u767a\u8868\uff1aInternational Conference Presentation<\/h4>\n\n\n\n
                                                                                  \n
                                                                                1. Addetia, K., Miyoshi, T., Blitz, A., Amuthan, V., Citro, R., Daimon, M., Guti\u00e9rrez-Fajardo, P., Kasliwal, R., Kirkpatrick, J.N., Monaghan, M.J., Muraru, D., Ogunyankin, K.O., Park, S.W., Prado, A., Rodrigues, A.C.T., Rossmanith, A., Sadeghpour, A., Scalia, G., Takeuchi, M., Tsang, W., Tucay, E.S., Zhang, M., Asch, F.M., and Lang, R.M. Worldwide Normal Values for Left and Right Ventricular Size and Function Using 3D Echocardiography: First Report from the World Alliance of Societies of Echocardiography (WASE) Normal Values Study. American Sosiety of Echocardiography 30th<\/sup> annual scientific sessions. 2019. 6. 21-25. Portland, Oregon, USA.<\/li>\n\n\n\n
                                                                                2. Addetia, K., Miyoshi, T., Blitz, A., Amuthan, V., Citro, R., Daimon, M., Guti\u00e9rrez-Fajardo, P., Kasliwal, R., Kirkpatrick, J.N., Monaghan, M.J., Muraru, D., Ogunyankin, K.O., Park, S.W., Prado, A., Rodrigues, A.C.T., Rossmanith, A., Sadeghpour, A., Scalia ,G., Takeuchi, M., Tsang, W., Tucay, E.S., Zhang, M., Asch, F.M., and Lang, R.M. Are There Differences in 3D LV and RV Size and Function Parameters Between Populations Around the World? First Report from the World Alliance of Societies of Echocardiography (WASE) Normal Values Study. American Sosiety of Echocardiography 30th<\/sup> annual scientific sessions. 2019. 6. 21-25. Portland, Oregon, USA.<\/li>\n\n\n\n
                                                                                3. Addetia, K., Miyoshi, T., Blitz, A., Amuthan, V., Citro, R., Daimon, M., Guti\u00e9rrez-Fajardo, P., Kasliwal, R., Kirkpatrick, J.N., Monaghan, M.J., Muraru, D., Ogunyankin, K.O., Park, S.W., Prado, A., Rodrigues, A.C.T., Rossmanith, A., Sadeghpour, A., Scalia, G., Takeuchi, M., Tsang, W., Tucay, E.S., Zhang, M., Asch, F.M., and Lang, R.M. Application of Machine Learning to Two-Dimensional Echocardiographic Chamber Dimension and Function Measurements. American Sosiety of Echocardiography 30th<\/sup> annual scientific sessions. 2019. 6. 21-25. Portland, Oregon, USA.<\/li>\n\n\n\n
                                                                                4. Ito, H., Kaneko, H., Kiriyama, H., Yoshida, Y., Nakanishi, K., Mizuno, Y., Daimon, M., Morita, H., Yatomi, Y., Yamamichi, N., and Komuro, I. Effect of Metabolically Health Obesity on Carotid Intima-Media Thickness in General Population: A community-based cohort study. European Society of Cardiology Congress 2019. 2019. 8. 31-9.4. Paris, France.<\/li>\n\n\n\n
                                                                                5. Ishii, K., Hyodo, E., Seo, Y., Ishizu, T., Tada, E., Kihara, H., Daimon, M., Tanaka, T., Akasaka, T., Watanabe, H., Ito, H., and Yoshikawa, J. Diagnostic accuracy of left ventricular diastolic strain imaging by speckle tracking echocardiography in detecting ischemic etiology of acute chest pain. EuroEhco 2019. 2019. 12. 4-7. Vienna, Austria.<\/li>\n\n\n\n
                                                                                6. Kebed, K., Genovese, D., Miyoshi, T., Addetia, K., Schreckenberg, M., Blitz, A., Z\u00f6rnack, S., Amuthan, V., Citro, R., Daimon, M., Guti\u00e9rrez-Fajardo, P., Kasliwal, R., Kirkpatrick, J.N., Monaghan, M.J., Muraru, D., Ogunyankin, K.O., Park, S.W., Rodrigues, A.C.T., Ronderos, R., Sadeghpour, A., Scalia, G., Takeuchi, M., Tsang, W., Tucay, E.S., Zhang, M., Asch, F.M., and Lang, R.M. Computer Identification of Standard Echocardiographic Views Using a Convolutional Neural Network. American Sosiety of Echocardiography 30th<\/sup> annual scientific sessions. 2019. 6. 21-25. Portland, Oregon, USA.<\/li>\n\n\n\n
                                                                                7. Kiriyama, H., Kaneko, H., Ito, H., Yoshida, Y., Nakanishi, K., Mizuno, Y., Daimon, M., Morita, H., Yatomi, Y., Yamamichi, N., and Komuro, I. Effect of cigarrete smoking on carotid artery atherosclerosis: a community-based cohort study. European Society of Cardiology Congress 2019. 2019. 8. 31-9.4. Paris, Franc.<\/li>\n\n\n\n
                                                                                8. Kurano, M. and Yatomi, Y. Apolipoprotein M and sphingosine 1-phosphate prevents the progression of diabetic nephropathy. 60th International Conference on the Bioscience of Lipid (ICBL). 2019. 6. 17-21. Tokyo, Japan.<\/li>\n\n\n\n
                                                                                9. Miyoshi, T., Addetia, K., Blitz, A., Amuthan, V., Citro, R., Daimon, M., Guti\u00e9rrez-Fajardo, P., Kasliwal, R., Kirkpatrick, J.N., Monaghan, M.J., Muraru, D., Ogunyankin, K.O., Park, S.W., Prado, A., Rodrigues, A.C.T, Rossmanith, A., Sadeghpour, A., Scalia, G., Takeuchi, M., Tsang, W., Tucay, E.S., Zhang, M., Lang, R.M., and Asch, F.M. Echocardiographic Diastolic Function by Age Decades: Results from the World Alliance of Societies of Echocardiography (WASE) Normal Values Study. American Sosiety of Echocardiography 30th<\/sup> annual scientific sessions. 2019. 6. 21-25. Portland, Oregon, USA.<\/li>\n\n\n\n
                                                                                10. Miyoshi, T., Addetia, K., Blitz, A., Amuthan, V., Citro, R., Daimon, M., Guti\u00e9rrez-Fajardo, P., Kasliwal, R., Kirkpatrick, J.N., Monaghan, M.J., Muraru, D., Ogunyankin, K.O., Park, S.W., Prado, A., Rodrigues, A.C.T., Rossmanith, A., Sadeghpour, A., Scalia, G., Takeuchi, M., Tsang, W., Tucay, E.S., Zhang, M., Lang, R.M., and Asch, F.M. World-wide Comparison of Echocardiographic Normal Values of Left Ventricular Size and Function in Healthy Adults: Results from the World Alliance of Societies of Echocardiography (WASE) Normal Values Study. American Sosiety of Echocardiography 30th<\/sup> annual scientific sessions. 2019. 6. 21-25. Portland, Oregon, USA.<\/li>\n\n\n\n
                                                                                11. Miyoshi, T., Addetia, K., Blitz, A., Amuthan, V., Citro, R., Daimon, M., Guti\u00e9rrez-Fajardo, P., Kasliwal, R., Kirkpatrick, J.N., Monaghan, M.J., Muraru, D., Ogunyankin, K.O., Park, S.W., Prado, A., Rodrigues, A.C.T., Rossmanith, A., Sadeghpour, A., Scalia, G., Takeuchi, M., Tsang, W., Tucay, E.S., Zhang, M., Lang, R.M., Asch, F.M. Applicability of Current Reference Values in Different Countries: Results from the World Alliance of Societies of Echocardiography (WASE) Normal Values Study. American Sosiety of Echocardiography 30th<\/sup> annual scientific sessions. 2019. 6. 21-25. Portland, Oregon, USA.<\/li>\n\n\n\n
                                                                                12. Mizuno, Y., Daimon, M., Uemura, K., Ito, I., Kiriyama, H., Yoshida, Y., Nakanishi, K., Kaneko, H., Koide, D., Yamamichi, Y., and Komuro, I. Lipoprotein(a) is associated with elevated mitral E\/e\u2019 ratio in Japanese non-Heart Failure population. American College of Cardiology 68st Annual Scientific Session\uff0e2019. 3. 16-18. New Orleans, Louisiana, USA.<\/li>\n\n\n\n
                                                                                13. Morita, Y., Shukuya, K., Tanaka, M., Hisasue, T., Sato, M., Ono, Y., Sato, T., Kurano, M., Yatomi, Y. Evaluation of the Atellica UAS800 urine sediment analyzer. 71st AACC Annual Scientific Meeting. 2019. 8. 4-8. Anaheim, California, USA.<\/li>\n\n\n\n
                                                                                14. Nakanishi, K., Daimon, M., Yoshida, Y., Ishiwata, J., Sawada, N., Hirokawa, M., Kaneko, H., Nakao, T., Mizuno, Y., Morita, H., Di. Tullio, M., Homma, S., and Komuro, I. Serum Uric Acid Level and Subclinical Left Ventricular Dysfunction: A Community-based Cohort Study. American Heart Association Scientific sessions 2019. 2019. 11. 16-18. Philadelphia, Pennsylvania, USA.<\/li>\n\n\n\n
                                                                                15. Nakanishi, K., Daimon, M., Yoshida, Y., Ishiwata, J., Sawada, N., Hirokawa, M., Kaneko, H., Nakao, T., Mizuno, Y., Morita, H., Di, Tullio, M., Homma, S., and Komuro I. Association Between Increased Body Mass Index and Adverse Right Ventricular Mechanics: A Community-based Cohort Study. American Heart Association Scientific sessions 2019. 2019. 11. 16-18. Philadelphia, Pennsylvania, USA.<\/li>\n\n\n\n
                                                                                16. Shimizu, K., Nakasone, M., Kubota, T., Miyata, N., Katoh, S., Kitano, K., Nakajima, J., Yatomi, Y., and Takai, D. Japanese Non-Smokers’ Predicted DLco Formula Using Generalized Additive Models for Location, Scale and Shape(GAMLSS). 2019. 5. 17-22. American Thoracic Society 2019 International Conference. Dallas, Texas, USA.<\/li>\n\n\n\n
                                                                                17. Uranbileg, B., Ito, N., Kurano, M.,Saigusa, D., Kano, K., Ikeda, H., Yamada, Y., Sekiguchi, M., Aoki, J., Sumitani, M., and Yatomi, Y.Involvement of Lysiphosphatidic acid and Autotaxin in neuropathic pain caused by spinal cord stenosis in rat models. 60th International Conference on the Bioscience of Lipid (ICBL). 2019. 6. 17-21. Tokyo, Japan.<\/li>\n\n\n\n
                                                                                18. Yatomi, Y. and Kurano, M. Lysophospholipids as disease biomarkers. 2nd International Conference on Lipoquality. 2019. 6. 17. Tokyo, Japan.<\/li>\n\n\n\n
                                                                                19. Yatomi, Y. and Kurano, M. Involvement of dysregulation of apolipoprotein M, a sphingosine 1-phosphate carrier, in human diseases. 16th International Conference on Bioactive Lipids in Cancer, Inflammation and Related Diseases. 2019. 10. 20-23. St. Petersburg, Florida, USA.<\/li>\n\n\n\n
                                                                                20. Yoshida, Y., Nakanishi, K., Daimon, M., Ishiwata, J., Sawada, N., Hirokawa, M., Kaneko, H., Nakao, T., Mizuno, Y., Morita, H., Di. Tullio, M., Homma, S., and Komuro, I. Association of atrial stiffness with left atrial structure and phasic function: a community-based cohort study. European Society of Cardiology Congress 2019. 2019. 8. 31-9.4. Paris, France.<\/li>\n<\/ol>\n\n\n\n

                                                                                  \u548c\u6587\u539f\u8457\u8ad6\u6587\uff1aJapanese Original Articles<\/h4>\n\n\n\n
                                                                                    \n
                                                                                  1. \u77f3\u539f \u6709\u7406\uff0c\u4fdd\u7530 \u5948\u7dd2\u7f8e\uff0c\u5409\u5ddd \u76f4\u4e4b\uff0c\u4e0b\u5742 \u6d69\u5247\uff0c\u897f\u5ddd \u771f\u5b50\uff0c\u77e2\u51a8 \u88d5\uff0c\u8535\u91ce \u4fe1\uff0e\u53ef\u6eb6\u6027IL-2R\u6e2c\u5b9a\u306b\u304a\u3044\u3066\u8f38\u8840\u5f8c\u4e00\u904e\u6027\u306b\u30d2\u30c8\u6297\u30de\u30a6\u30b9\u6297\u4f53(HAMA)\u306b\u3088\u308b\u507d\u9ad8\u5024\u3092\u793a\u3057\u305f1\u75c7\u4f8b\uff0e\u81e8\u5e8a\u75c5\u7406 67\uff1a815-819\uff0c2019\uff0e<\/li>\n\n\n\n
                                                                                  2. \u77f3\u539f \u6709\u7406\uff0c\u5409\u5ddd \u76f4\u4e4b\uff0c\u4e0b\u5742 \u6d69\u5247\uff0c\u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0c\u98db\u7530 \u660e\u5b50\uff0e\u514d\u75ab\u767a\u5149\u6e2c\u5b9a\u88c5\u7f6e\u30eb\u30df\u30d1\u30eb\u30b9L2400\u3092\u7528\u3044\u305f\u5fc3\u7b4b\u30c8\u30ed\u30dd\u30cb\u30f3I\u9ad8\u611f\u5ea6\u6e2c\u5b9a\u8a66\u85ac\u300c\u30eb\u30df\u30d1\u30eb\u30b9\u30d7\u30ec\u30b9\u30c8hs\u30c8\u30ed\u30dd\u30cb\u30f3I\u300d\u306e\u57fa\u790e\u7684\u6027\u80fd\u8a55\u4fa1\uff0e\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u81ea\u52d5\u5316\u5b66\u4f1a\u4f1a\u8a8c 44\uff1a238-244\uff0c2019\uff0e<\/li>\n\n\n\n
                                                                                  3. \u5c0f\u5ddd \u821e\u5b50\uff0c\u5c0f\u91ce \u4f73\u4e00\uff0c\u98db\u7530 \u660e\u5b50\uff0c\u4e0b\u5742 \u6d69\u5247\uff0c\u4f50\u85e4 \u667a\u660e\uff0c\u77e2\u51a8 \u88d5\uff0c\u8535\u91ce \u4fe1\uff0e\u5168\u81ea\u52d5\u5316\u5b66\u767a\u5149\u9175\u7d20\u514d\u75ab\u6e2c\u5b9a\u88c5\u7f6e\u30eb\u30df\u30d1\u30eb\u30b9L2400\u3092\u7528\u3044\u305f\u30a4\u30f3\u30b9\u30ea\u30f3\u304a\u3088\u3073C\u30da\u30d7\u30c1\u30c9\u6e2c\u5b9a\u7528\u8a66\u85ac\u306e\u57fa\u790e\u7684\u691c\u8a0e\uff0e\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u81ea\u52d5\u5316\u5b66\u4f1a\u4f1a\u8a8c 44\uff1a54-62\uff0c2019\uff0e<\/li>\n\n\n\n
                                                                                  4. \u5c0f\u91ce \u4f73\u4e00\uff0c\u4f50\u85e4 \u667a\u660e\uff0c\u77e2\u51a8 \u88d5\uff0eISO 15189\u53d6\u5f97\u30b5\u30dd\u30fc\u30c8\u30d6\u30c3\u30af\uff1b4\u7ae0\u7ba1\u7406\u4e0a\u306e\u8981\u6c42\u4e8b\u9805\uff1a\u81e8\u5e8a\u691c\u67fb 63\uff1a1094-1103\uff0c2019\uff0e<\/li>\n\n\n\n
                                                                                  5. \u4f50\u85e4 \u6075\u7f8e\uff0c\u7530\u4e2d \u96c5\u7f8e\uff0c\u68ee\u7530 \u8ce2\u53f2\uff0c\u4e45\u672b \u5d07\u53f8\uff0c\u5c0f\u91ce \u4f73\u4e00\uff0c\u4f50\u85e4 \u667a\u660e\uff0c\u5bbf\u8c37 \u8ce2\u4e00\uff0e\u9178\u6027\u5c3f\u9178\u30a2\u30f3\u30e2\u30cb\u30a6\u30e0\u7d50\u6676\u3092\u8a8d\u3081\u305f\u30cd\u30d5\u30ed\u30fc\u30bc\u75c7\u5019\u7fa4\u306e\u4e00\u4f8b\uff0e\u6771\u4eac\u90fd\u533b\u5b66\u691c\u67fb 47\uff1a100-104\uff0c2019\uff0e<\/li>\n\n\n\n
                                                                                  6. \u5bbf\u8c37 \u8ce2\u4e00\uff0c\u68ee\u7530 \u8ce2\u53f2\uff0c\u4e45\u672b \u5d07\u53f8\uff0c\u5c0f\u91ce \u4f73\u4e00\uff0c\u9ad8\u694a \u3086\u304d\uff0c\u5bcc\u5b89 \u8061\uff0c\u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0c\u7530\u4e2d \u96c5\u7f8e\uff0e\u5168\u81ea\u52d5\u5c3f\u4e2d\u6709\u5f62\u6210\u5206\u5206\u6790\u88c5\u7f6eUF-5000\u3068\u5168\u81ea\u52d5\u5c3f\u4e2d\u6709\u5f62\u6210\u5206\u64ae\u50cf\u30e6\u30cb\u30c3\u30c8UD-10\u306e\u6bd4\u8f03\u691c\u8a0e\uff0e\u533b\u5b66\u3068\u85ac\u5b66 76\uff1a1311-1323\uff0c2019\uff0e<\/li>\n\n\n\n
                                                                                  7. \u8c37\u6fa4 \u674e\u7d17\uff0c\u4e0b\u5742 \u6d69\u5247\uff0c\u4f50\u85e4 \u667a\u660e\uff0c\u77e2\u51a8 \u88d5\uff0c\u4fdd\u7530 \u5948\u7dd2\u7f8e\uff0e\u6297\u6838\u6297\u4f53\u691c\u67fb\u306b\u304a\u3051\u308b\u5168\u81ea\u52d5\u86cd\u5149\u6297\u4f53\u6cd5\u5206\u6790\u88c5\u7f6eHELIOS\u3068EUROPattern\u306e\u8a55\u4fa1\uff0e\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u81ea\u52d5\u5316\u5b66\u4f1a\u4f1a\u8a8c 44\uff1a231-237\uff0c2019\uff0e<\/li>\n\n\n\n
                                                                                  8. \u4e45\u672b \u5d07\u53f8\uff0c\u7530\u4e2d \u96c5\u7f8e\uff0c\u68ee\u7530 \u8ce2\u53f2\uff0c\u4f50\u85e4 \u6075\u7f8e\uff0c\u5bbf\u8c37 \u8ce2\u4e00\uff0e\u5c3f\u4e2dL\u578b\u8102\u80aa\u9178\u7d50\u5408\u86cb\u767d(L-FABP)\u6e2c\u5b9a\u8a66\u85ac\u300c\u30ce\u30eb\u30c7\u30a3\u30a2\u00aeL-FABP\u300d\u6539\u826f\u8a66\u85ac\u306e\u57fa\u790e\u7684\u691c\u8a0e\uff0e\u6771\u4eac\u90fd\u533b\u5b66\u691c\u67fb 47\uff1a13-17\uff0c2019\uff0e<\/li>\n\n\n\n
                                                                                  9. \u68ee\u7530 \u8ce2\u53f2\uff0c\u7530\u4e2d \u96c5\u7f8e\uff0c\u4e45\u672b \u5d07\u53f8\uff0c\u4f50\u85e4 \u6075\u7f8e\uff0c\u5c0f\u91ce \u4f73\u4e00\uff0c\u4f50\u85e4 \u667a\u660e\uff0c\u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0c\u5bbf\u8c37 \u8ce2\u4e00\uff0e\u5168\u81ea\u52d5\u5c3f\u5316\u5b66\u5206\u6790\u88c5\u7f6eUS-3500\u3068CLINITEK Novus\u306e\u6027\u80fd\u6bd4\u8f03\uff0e\u533b\u7642\u3068\u691c\u67fb\u6a5f\u5668\u30fb\u8a66\u85ac42\uff1a35-42\uff0c2019\uff0e<\/li>\n\n\n\n
                                                                                  10. \u68ee\u7530 \u8ce2\u53f2\uff0c\u5bbf\u8c37 \u8ce2\u4e00\uff0c\u7530\u4e2d \u96c5\u7f8e\uff0c\u4e45\u672b \u5d07\u53f8\uff0c\u4f50\u85e4 \u6075\u7f8e\uff0c\u5c0f\u91ce \u4f73\u4e00\uff0c\u4f50\u85e4 \u667a\u660e\uff0c\u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0e\u5c3f\u4e2d\u6709\u5f62\u6210\u5206\u5206\u6790\u88c5\u7f6e3\u6a5f\u7a2e\u306e\u6027\u80fd\u6bd4\u8f03\u3068\u30b7\u30b9\u30c6\u30e0\u30ed\u30b8\u30c3\u30af\u904b\u7528\u306e\u691c\u8a3c\uff0e\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u81ea\u52d5\u5316\u5b66\u4f1a\u4f1a\u8a8c 44\uff1a602-609\uff0c2019\uff0e<\/li>\n\n\n\n
                                                                                  11. \u68ee\u7530 \u8ce2\u53f2\uff0c\u7530\u4e2d \u96c5\u7f8e\uff0c\u4e45\u672b \u5d07\u53f8\uff0c\u4f50\u85e4 \u6075\u7f8e\uff0c\u5bbf\u8c37 \u8ce2\u4e00\uff0c\u5e38\u540d \u653f\u5f18\uff0c\u4f50\u85e4 \u667a\u660e\uff0c\u897f\u5ddd \u771f\u5b50\uff0c\u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0e\u5c3f\u6c88\u6e23\u691c\u67fb\u3067\u7570\u578b\u7d30\u80de\u3092\u691c\u51fa\u3057\u305f\u3073\u307e\u3093\u6027\u5927\u7d30\u80de\u578bB\u7d30\u80de\u30ea\u30f3\u30d1\u816b\u306e\u4e00\u75c7\u4f8b\uff0e\u65e5\u672c\u691c\u67fb\u8840\u6db2\u5b66\u4f1a\u8a8c 20\uff1a409-413\uff0c2019\uff0e<\/li>\n<\/ol>\n\n\n\n

                                                                                    \u548c\u6587\u7dcf\u8aac\uff1aJapanese Review Articles<\/h4>\n\n\n\n
                                                                                      \n
                                                                                    1. \u8535\u91ce \u4fe1\uff0e\u8102\u8cea\u306e\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u306e\u65b0\u6a5f\u8ef8 : \u30ea\u30be\u30ea\u30f3\u8102\u8cea\uff0e\u81e8\u5e8a\u75c5\u7406 67\uff1a331-337\uff0c2019\uff0e<\/li>\n\n\n\n
                                                                                    2. \u8535\u91ce \u4fe1\uff0e\u30a2\u30dd\u30bf\u30f3\u30d1\u30af\uff0e\u30ab\u30ec\u30f3\u30c8\u30c6\u30e9\u30d4\u30fc 37\uff1a1009\uff0c2019\uff0e<\/li>\n\n\n\n
                                                                                    3. \u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0e\u30ea\u30dd\u30af\u30aa\u30ea\u30c6\u30a3\u3068\u81e8\u5e8a\u691c\u67fb\uff0eThe Lipid 30\uff1a417-423\uff0c2019\uff0e<\/li>\n\n\n\n
                                                                                    4. \u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0e\u30ac\u30b9\u30af\u30ed\u30de\u30c8\u30b0\u30e9\u30d5\u30a3\u8cea\u91cf\u5206\u6790\u8a08\u3092\u7528\u3044\u305f\u75be\u60a3\u9032\u884c\u4e88\u77e5\u30de\u30fc\u30ab\u30fc\u306e\u63a2\u7d22\uff0e\u81e8\u5e8a\u75c5\u7406 67\uff1a1119-1122\uff0c2019\uff0e<\/li>\n\n\n\n
                                                                                    5. \u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0e\u30ea\u30dd\u30af\u30aa\u30ea\u30c6\u30a3\u3068\u81e8\u5e8a\u691c\u67fb\uff0eThe Lipid 30\uff1a417-423\uff0c2019\uff0e<\/li>\n\n\n\n
                                                                                    6. \u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0e\u751f\u7406\u6d3b\u6027\u8102\u8cea\u306e\u65b0\u305f\u306a\u5c55\u958b\uff0eHeart View 23\uff1a751-756\uff0c2019\uff0e<\/li>\n\n\n\n
                                                                                    7. \u4f50\u85e4 \u96c5\u54c9\uff0c\u68ee\u672c \u5065\u592a\u90ce\uff0c\u5efa\u77f3 \u826f\u4ecb\uff0c\u68b6\u539f \u8302\u6a39\uff0c\u77e2\u51a8 \u88d5\uff0c\u5c0f\u6c60 \u548c\u5f66\uff0e\u81e8\u5e8a\u30c7\u30fc\u30bf\u3092\u7528\u3044\u305f\u809d\u7d30\u80de\u764c\u306e\u5b58\u5728\u4e88\u6e2c\uff0e\u6d88\u5316\u5668\u30fb\u809d\u81d3\u5185\u79d1 6\uff1a541-547\uff0c2019\uff0e<\/li>\n\n\n\n
                                                                                    8. \u4f50\u85e4 \u96c5\u54c9\uff0c\u68ee\u672c \u5065\u592a\u90ce\uff0c\u5efa\u77f3 \u826f\u4ecb\uff0c\u68b6\u539f \u8302\u6a39\uff0c\u77e2\u51a8 \u88d5\uff0c\u5c0f\u6c60 \u548c\u5f66\uff0e\u691c\u67fb\u30c7\u30fc\u30bf\u306e\u7d71\u5408\u3068AI \u81e8\u5e8a\u30c7\u30fc\u30bf\u3092\u7528\u3044\u305f\u809d\u7d30\u80de\u764c\u306e\u5b58\u5728\u4e88\u6e2c\uff0e\u533b\u7642\u6a5f\u5668\u5b66 89\uff1a518-525\uff0c2019\uff0e<\/li>\n\n\n\n
                                                                                    9. \u6fa4\u7530 \u76f4\u5b50\uff0c\u5927\u9580 \u96c5\u592b\uff0e \u904b\u52d5\u8ca0\u8377\/\u30c9\u30d6\u30bf\u30df\u30f3\u8ca0\u8377\u5fc3\u30a8\u30b3\u30fc\uff1a\u6709\u7528\u6027\u3068\u4eca\u5f8c\u306e\u65b9\u5411\u6027\uff0e \u5faa\u74b0\u5668\u5185\u79d1 86\uff1a277-281\uff0c2019\uff0e<\/li>\n\n\n\n
                                                                                    10. \u5927\u9580 \u96c5\u592b\uff0eOne point advice \u898b\u843d\u3068\u3057\u306e\u306a\u3044\u5fc3\u30a8\u30b3\u30fc\u56f3\u691c\u67fb\u3092\u884c\u3046\u305f\u3081\u306b\uff0eMedical practice 36\uff1a488\uff0c2019\uff0e<\/li>\n\n\n\n
                                                                                    11. \u5927\u9580 \u96c5\u592b\uff0e\u5fc3\u30a8\u30b3\u30fc\u3067\u5fc3\u4e0d\u5168\u3092\u8a3a\u308b\uff1a\u5de6\u5ba4\u62e1\u5f35\u80fd\u3068\u53f3\u5fc3\u6a5f\u80fd\u306e\u8a55\u4fa1\uff0eMedical practice 36\uff1a889-903\uff0c2019\uff0e<\/li>\n\n\n\n
                                                                                    12. \u4e2d\u5c3e \u502b\u5b50\uff0eMitraClip\u6642\u4ee3\u306e\u50e7\u5e3d\u5f01\u30a8\u30b3\u30fc\u8a55\u4fa1 \u5fdc\u7528\u7de8\uff0eCATHLAB JIN 2\uff1a58-59\uff0c2019.\u3000<\/li>\n\n\n\n
                                                                                    13. \u5ee3\u702c \u90a6\u7ae0\uff0c\u5927\u9580\u96c5\u592b\uff0e\u5f01\u819c\u75c7\uff0e\u7279\u96c6\uff1a\u5fc3\u81d3\u8840\u7ba1\u75be\u60a3(I)\uff0e\u533b\u5b66\u3068\u85ac\u5b66 76\uff1a279-290\uff0c2019\uff0e<\/li>\n\n\n\n
                                                                                    14. \u68ee\u7530 \u8ce2\u53f2\uff0c\u5bbf\u8c37 \u8ce2\u4e00\uff0e\u9069\u5207\u306a\u5c3f\u691c\u4f53\u306e\u63a1\u308a\u65b9\uff0c\u691c\u4f53\u51e6\u7406\uff0c\u4fdd\u5b58\u306e\u65b9\u6cd5\uff0eMedical Practice 36\uff1a1503-1507\uff0c2019\uff0e<\/li>\n\n\n\n
                                                                                    15. \u5b89\u5ddd\u6075\u5b50\uff0e\u30b0\u30ea\u30b3\u30a2\u30eb\u30d6\u30df\u30f3\u306e\u73fe\u72b6\uff0e\u81e8\u5e8a\u691c\u67fb 63\uff1a1406-1413\uff0c2019\uff0e<\/li>\n\n\n\n
                                                                                    16. \u5b89\u672c \u7be4\u53f2\uff0c\u77e2\u51a8 \u88d5\uff0e\u30d8\u30d1\u30ea\u30f3\u8d77\u56e0\u6027\u8840\u5c0f\u677f\u6e1b\u5c11\u75c7(HIT)\uff0e\u65e5\u672c\u81e8\u5e8a 77\uff1a204-209\uff0c2019\uff0e<\/li>\n\n\n\n
                                                                                    17. \u5b89\u672c \u7be4\u53f2\uff0c\u77e2\u51a8 \u88d5\uff0e\u30d8\u30d1\u30ea\u30f3\u8d77\u56e0\u6027\u8840\u5c0f\u677f\u6e1b\u5c11\u75c7(HIT)\u306e\u8a3a\u65ad\uff0e\u65e5\u672c\u8840\u6813\u6b62\u8840\u5b66\u4f1a\u8a8c 30\uff1a178-183\uff0c2019\uff0e<\/li>\n\n\n\n
                                                                                    18. \u77e2\u51a8 \u88d5\uff0e\u691c\u4f53\u691c\u67fb\u306e\u54c1\u8cea\u30fb\u7cbe\u5ea6\u78ba\u4fdd\u306b\u4fc2\u308b\u533b\u7642\u6cd5\u7b49\u306e\u6539\u6b63 \u533b\u7642\u6a5f\u95a2\u81ea\u3089\u5b9f\u65bd\u3059\u308b\u691c\u4f53\u691c\u67fb\u306e\u7cbe\u5ea6\u78ba\u4fdd\uff0e\u65e5\u672c\u691c\u67fb\u8840\u6db2\u5b66\u4f1a\u96d1\u8a8c 20\uff1a447-454\uff0c2019\uff0e<\/li>\n\n\n\n
                                                                                    19. \u77e2\u51a8 \u88d5\uff0e\u533b\u7642\u6cd5\u7b49\u306e\u4e00\u90e8\u6539\u6b63\u306b\u4f34\u3046\u691c\u4f53\u691c\u67fb\u306e\u54c1\u8cea\u30fb\u7cbe\u5ea6\u306e\u78ba\u4fdd\u306e\u898f\u5b9a \u6211\u3005\u304c\u306a\u3059\u3079\u304d\u3053\u3068\uff0e\u81e8\u5e8a\u691c\u67fb\u5b66\u6559\u80b2 11\uff1a1-7\uff0c2019\uff0e<\/li>\n\n\n\n
                                                                                    20. \u5409\u7530 \u7531\u7406\u5b50\uff0c\u5927\u9580 \u96c5\u592b\uff0e\u30eb\u30fc\u30c1\u30f3\u306e\u5fc3\u30a8\u30b3\u30fc\u30ec\u30dd\u30fc\u30c8\u3068\u8a08\u6e2c\u9805\u76ee\uff0e\u5fc3\u30a8\u30b3\u30fc 20\uff1a12-21\uff0c2019\uff0e<\/li>\n<\/ol>\n\n\n\n

                                                                                      \u548c\u6587\u8457\u66f8\uff1aJapanese Book Chapter<\/h4>\n\n\n\n
                                                                                        \n
                                                                                      1. \u5f71\u5c71 \u7950\u5b50\uff0c\u7b4b\u91ce \u88d5\u7f8e\u5b50\uff0c\u5742\u4e2d \u5343\u6075\uff0e\u30a2\u30ab\u30c7\u30df\u30a2\u533b\u7642\u6a5f\u95a2\u3067Lean Six Sigma\u3092\u5fdc\u7528\u3057\u305f\u54c1\u8cea\u6d3b\u52d5\uff0e\u3010eCTD\uff0cCDISC\u306b\u3088\u308b\u3011\u533b\u85ac\u54c1\u627f\u8a8d\u7533\u8acb\u3068\u4f7f\u7528\u3059\u308b\u30c7\u30fc\u30bf\u306e\u7ba1\u7406\u3068\u4fe1\u983c\u6027\u78ba\u4fdd\uff0epp. 374-381\uff0e\uff08\u682a\uff09\u6280\u8853\u60c5\u5831\u5354\u4f1a\uff0c\u6771\u4eac\uff0e2019\uff0e<\/li>\n\n\n\n
                                                                                      2. \u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0e\u30b5\u30f3\u30d7\u30eb\u3054\u3068\u306e\u53d6\u308a\u6271\u3044\u30fb\u51e6\u7406\u306e\u9055\u3044 \u8840\u6f3f\u30fb\u8840\u6e05\uff0e\u5b9f\u9a13\u533b\u5b66\u5225\u518a\u300c\u8102\u8cea\u89e3\u6790\u30cf\u30f3\u30c9\u30d6\u30c3\u30af\u300d\uff0e\uff08\u65b0\u4e95 \u6d0b\u7531\uff0c\u6e05\u6c34 \u5b5d\u96c4\uff0c\u6a2a\u5c71 \u4fe1\u6cbb \u7de8\uff09pp. 148-153\uff0e\u7f8a\u571f\u793e\uff0c\u6771\u4eac\uff0e2019\uff0e<\/li>\n\n\n\n
                                                                                      3. \u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0e\u30b5\u30f3\u30d7\u30eb\u3054\u3068\u306e\u53d6\u308a\u6271\u3044\u30fb\u51e6\u7406\u306e\u9055\u3044 \u7d30\u80de\uff0e\u5b9f\u9a13\u533b\u5b66\u5225\u518a\u300c\u8102\u8cea\u89e3\u6790\u30cf\u30f3\u30c9\u30d6\u30c3\u30af\u300d\uff0e\uff08\u65b0\u4e95 \u6d0b\u7531\uff0c\u6e05\u6c34 \u5b5d\u96c4\uff0c\u6a2a\u5c71 \u4fe1\u6cbb \u7de8\uff09pp. 154-156\uff0e\u7f8a\u571f\u793e\uff0c\u6771\u4eac\uff0e2019\uff0e<\/li>\n\n\n\n
                                                                                      4. \u8535\u91ce \u4fe1\uff0cUranbileg B\uff0c\u77e2\u51a8 \u88d5\uff0e\u30b5\u30f3\u30d7\u30eb\u3054\u3068\u306e\u53d6\u308a\u6271\u3044\u30fb\u51e6\u7406\u306e\u9055\u3044 \u81d3\u5668\u30fb\u7d44\u7e54\uff0e\u5b9f\u9a13\u533b\u5b66\u5225\u518a\u300c\u8102\u8cea\u89e3\u6790\u30cf\u30f3\u30c9\u30d6\u30c3\u30af\u300d\uff0e\uff08\u65b0\u4e95 \u6d0b\u7531\uff0c\u6e05\u6c34 \u5b5d\u96c4\uff0c\u6a2a\u5c71 \u4fe1\u6cbb \u7de8\uff09pp. 157-160\uff0e\u7f8a\u571f\u793e\uff0c\u6771\u4eac\uff0e2019\uff0e<\/li>\n\n\n\n
                                                                                      5. \u8535\u91ce \u4fe1\uff0c\u68ee\u7530 \u8ce2\u53f2\uff0c\u77e2\u51a8 \u88d5\uff0e\u30b5\u30f3\u30d7\u30eb\u3054\u3068\u306e\u53d6\u308a\u6271\u3044\u30fb\u51e6\u7406\u306e\u9055\u3044 \u4f53\u8154\u6db2\u30fb\u9ac4\u6db2\uff0e\u5b9f\u9a13\u533b\u5b66\u5225\u518a\u300c\u8102\u8cea\u89e3\u6790\u30cf\u30f3\u30c9\u30d6\u30c3\u30af\u300d\uff0e\uff08\u65b0\u4e95 \u6d0b\u7531\uff0c\u6e05\u6c34 \u5b5d\u96c4\uff0c\u6a2a\u5c71 \u4fe1\u6cbb \u7de8\uff09pp. 161-163\uff0e\u7f8a\u571f\u793e\uff0c\u6771\u4eac\uff0e2019\uff0e<\/li>\n\n\n\n
                                                                                      6. \u8535\u91ce \u4fe1\uff0c\u68ee\u7530 \u8ce2\u53f2\uff0c\u77e2\u51a8 \u88d5\uff0e\u30b5\u30f3\u30d7\u30eb\u3054\u3068\u306e\u53d6\u308a\u6271\u3044\u30fb\u51e6\u7406\u306e\u9055\u3044 \u5c3f\uff0e\u5b9f\u9a13\u533b\u5b66\u5225\u518a\u300c\u8102\u8cea\u89e3\u6790\u30cf\u30f3\u30c9\u30d6\u30c3\u30af\u300d\uff0e\uff08\u65b0\u4e95 \u6d0b\u7531\uff0c\u6e05\u6c34 \u5b5d\u96c4\uff0c\u6a2a\u5c71 \u4fe1\u6cbb \u7de8\uff09pp. 164-166\uff0e\u7f8a\u571f\u793e\uff0c\u6771\u4eac\uff0e2019\uff0e<\/li>\n\n\n\n
                                                                                      7. \u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0e\u30d2\u30c8\u8840\u6db2\u691c\u4f53\u306b\u304a\u3051\u308b\u30b9\u30d5\u30a3\u30f3\u30b4\u30b7\u30f31-\u30ea\u30f3\u9178\u30fb\u30bb\u30e9\u30df\u30c9\u306a\u3069\u306e\u8cea\u91cf\u5206\u6790\u3068\u5b9a\u91cf\uff0e\u30bb\u30e9\u30df\u30c9\u7814\u7a76\u306e\u65b0\u5c55\u958b\uff5e\u57fa\u790e\u304b\u3089\u5fdc\u7528\u3078\uff5e\uff0e\uff08\u30bb\u30e9\u30df\u30c9\u7814\u7a76\u4f1a \u7de8\uff09pp. 274-277\uff0e\u98df\u54c1\u5316\u5b66\u65b0\u805e\u793e\uff0c\u6771\u4eac\uff0e2019\uff0e<\/li>\n\n\n\n
                                                                                      8. \u8535\u91ce \u4fe1\uff0c\u585a\u672c \u548c\u4e45\uff0e\u8102\u8cea\u7570\u5e38\u75c7\u6cbb\u7642\u85ac\uff0e\u300c\u533b\u85ac\u30b8\u30e3\u30fc\u30ca\u30eb\u300d\u5897\u520a\u53f7\u300c\u65b0\u85ac\u5c55\u671b2019\u300dpp. 397-402\uff0e\u533b\u85ac\u30b8\u30e3\u30fc\u30ca\u30eb\u793e\uff0c\u6771\u4eac\uff0e2019\uff0e<\/li>\n\n\n\n
                                                                                      9. \u5927\u9580 \u96c5\u592b\uff0eHFpEF\u306b\u304a\u3051\u308b\u5de6\u5ba4\u53ce\u7e2e\u80fd\u306f\u6b63\u5e38\u304b\uff1f\u300cHeart View\u300d\u7279\u96c6 \u62e1\u5f35\u4e0d\u5168 \u3042\u306a\u305f\u306e\u8a3a\u65ad\u30fb\u6cbb\u7642\u306f\u5927\u4e08\u592b\u3067\u3059\u304b\uff1f\uff08\u5927\u624b \u4fe1\u4e4b \u7de8\uff09pp. 38-42\uff0e\u30e1\u30b8\u30ab\u30eb\u30d3\u30e5\u30fc\u793e\uff0c\u6771\u4eac\uff0e2019\uff0e<\/li>\n\n\n\n
                                                                                      10. \u5927\u9580 \u96c5\u592b\uff0e\u62e1\u5f35\u578b\u5fc3\u7b4b\u75c7\uff0e\u300c\u65e5\u672c\u81e8\u5e8a\u300d\u5897\u520a\u53f7\u300c\u5fc3\u4e0d\u5168\uff08\u7b2c\uff12\u7248\uff09\u4e0b\u300dpp259-264\uff0e\u65e5\u672c\u81e8\u5e8a\u793e\uff0c\u6771\u4eac\uff0c2019\uff0e<\/li>\n\n\n\n
                                                                                      11. \u5927\u9580 \u96c5\u592b\uff0e\u753b\u50cf\u8a3a\u65ad\uff0ca) \u30a8\u30b3\u30fc\uff0e\u300c\u65e5\u672c\u533b\u5e2b\u4f1a\u96d1\u8a8c\u300d\u7279\u5225\u53f7(2)\u300c\u52d5\u8108\u786c\u5316\u8a3a\u7642\u306e\u3059\u3079\u3066\u300dpp513\uff0e\u65e5\u672c\u533b\u5e2b\u4f1a\uff0c\u6771\u4eac\uff0c2019\uff0e<\/li>\n\n\n\n
                                                                                      12. \u5927\u9580 \u96c5\u592b\uff0e\u611f\u67d3\u6027\u5fc3\u5185\u819c\u708e\uff0e\u8a3a\u7642\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3up-to-date 2020-2021\uff08\u9580\u8107 \u5b5d\uff0c\u5c0f\u5ba4 \u4e00\u6210\uff0c\u5bae\u5730 \u826f\u6a39 \u76e3\u4fee\uff09pp. 190-196\uff0e\u30e1\u30c7\u30a3\u30ab\u30eb\u30ec\u30d3\u30e5\u30fc\u793e\uff0c\u5927\u962a\uff0c2019\uff0e<\/li>\n\n\n\n
                                                                                      13. \u4e2d\u5c3e \u502b\u5b50\uff0e\u5f01\u819c\u75c7\u75be\u60a3\uff0e\u5faa\u74b0\u5668\u75be\u60a3 (\u516b\u5c3e \u539a\u53f2\uff0c\u843d\u5408 \u4eae\u592a \u7de8\uff09pp. 195-208\uff0e\u5357\u6c5f\u5802\uff0c\u6771\u4eac\uff0c2019\uff0e<\/li>\n\n\n\n
                                                                                      14. \u4e2d\u897f \u5f18\u6bc5\uff0c\u5927\u9580 \u96c5\u592b\uff0eStructural heart disease\u306b\u5bfe\u3059\u308b\u30ab\u30c6\u30fc\u30c6\u30eb\u6cbb\u7642\u306b\u304a\u3051\u308b\u5fc3\u30a8\u30b3\u30fc\u306e\u5f79\u5272\uff0e\u300cHeart View\u300d\u7279\u96c6 \u8a3a\u7642\u306b\u6d3b\u304b\u3059\u81e8\u5e8a\u691c\u67fb\u6d3b\u7528\u8853\uff01\uff08\u4e09\u4e95\u7530 \u5b5d \u7de8\uff09pp. 78-84\uff0e\u30e1\u30b8\u30ab\u30eb\u30d3\u30e5\u30fc\u793e\uff0c\u6771\u4eac\uff0e2019\uff0e<\/li>\n\n\n\n
                                                                                      15. \u524d\u5ddd \u771f\u4eba\uff0c\u5b89\u90e8 \u6b63\u7fa9\uff0c\u52a0\u85e4 \u667a\u884c\uff0c\u7e41\u7530 \u52dd\u7f8e\uff0c\u6edd\u91ce \u5bff\uff0c\u7530\u6fa4 \u88d5\u5149\uff0c\u5824 \u6b63\u597d\uff0c\u767b \u52c9\uff0c\u6771 \u4fca\u4e00\uff0c\u677e\u4e95 \u5553\u9686\uff0c\u677e\u4e0b \u4e00\u4e4b\uff0c\u6a2a\u7530 \u6d69\u5145\uff0c\u8fd1\u85e4 \u76f4\u4eba\uff0c\u5317\u5ddd \u660c\u4f38\uff0c\u77e2\u51a8 \u88d5\uff0c\u897f\u7530 \u7f8e\u548c\uff0c\u6e21\u8fba \u73b2\u5b50\uff0c\u81e8\u5e8a\u691c\u67fb\u632f\u8208\u5354\u8b70\u4f1a\uff0c\u81e8\u5e8a\u691c\u67fb\u632f\u8208\u5354\u8b70\u4f1a\u533b\u7642\u653f\u7b56\u59d4\u54e1\u4f1a\uff0c\u30b2\u30ce\u30e0\u691c\u67fb\u306b\u95a2\u3059\u308b\u5c0f\u59d4\u54e1\u4f1a\uff0e\u304c\u3093\u907a\u4f1d\u5b50\u30d1\u30cd\u30eb\u691c\u67fb\u306e\u54c1\u8cea\u30fb\u7cbe\u5ea6\u306e\u78ba\u4fdd\u306b\u95a2\u3059\u308b\u57fa\u672c\u7684\u8003\u3048\u65b9(\u7b2c2\uff0e0\u7248)\uff0e\u81e8\u5e8a\u75c5\u7406\u30ec\u30d3\u30e5\u30fc\uff1ap1-31\uff0c2019<\/li>\n<\/ol>\n\n\n\n

                                                                                        \u548c\u6587\u7de8\u8457\u7b49\uff1aJapanese Book Editing<\/h4>\n\n\n\n
                                                                                          \n
                                                                                        1. \u5927\u9580 \u96c5\u592b\uff0c\u9234\u6728 \u535a\u82f1 \u7de8\uff0e \u5fc3\u30a8\u30b3\u30fc\u300c\u3053\u308c\u3060\u3051\u306f\u77e5\u3063\u3066\u304a\u304d\u305f\u3044\u5fc3\u30a8\u30b3\u30fc\u306e\u57fa\u672cABC\uff1a\u4fe1\u983c\u3055\u308c\u308b\u5fc3\u30a8\u30b3\u30fc\u5ba4\u3068\u306a\u308b\u305f\u3081\u306b\u300d\uff0e\u6587\u5149\u5802\uff0c\u6771\u4eac\uff0c2019.<\/li>\n\n\n\n
                                                                                        2. \u5927\u9580 \u96c5\u592b\uff0c\u4e2d\u897f \u5f18\u6bc5 \u7de8\uff0e \u5fc3\u30a8\u30b3\u30fc\u300c\u5fc3\u30a8\u30b3\u30fc\u3067\u8a3a\u308b\u5fc3\u539f\u6027\u8133\u585e\u6813\u75c7\u300d\uff0e\u6587\u5149\u5802\uff0c\u6771\u4eac\uff0c2019.<\/li>\n<\/ol>\n<\/div><\/div>\n\n\n\n
                                                                                          \n

                                                                                          2018\u5e74<\/h3>\n\n\n\n

                                                                                          \u82f1\u6587\u539f\u8457\u8ad6\u6587\uff1aEnglish Original Articles<\/h4>\n\n\n\n
                                                                                            \n
                                                                                          1. Araoka, H., Baba, M., Okada, C., Kimura, M., Sato, T., Yatomi, Y., Moriya, K., and Yoneyama, A. Risk factors for recurrent Helicobacter cinaedi bacteremia and the efficacy of selective digestive decontamination with kanamycin to prevent recurrence. Clin. Infect. Dis.<\/em><\/strong> 67: 573-578<\/a>, 2018.<\/li>\n\n\n\n
                                                                                          2. Araoka, H., Baba, M., Okada, C., Kimura, M., Sato, T., Yatomi, Y., Moriya, K., and Yoneyama, A. First evidence of bacterial translocation from the intestinal tract as a route of Helicobacter cinaedi bacteremia. Helicobacter<\/em><\/strong> 23:e12458<\/a>, 2018.<\/li>\n\n\n\n
                                                                                          3. Hikita, H., Sato, M., Sato, M., Soroida, Y., Kobayashi, T., Gotoh, H., Iwai, T., Nakagomi, R., Tateishi, R., Komuro, T., Sone, S., Koike, K., Yatomi, Y., and Ikeda, H. Disappearance of Perihepatic lymph node enlargement achieving hepatitis C viral eradication using direct acting antivirals. J. Viral Hepat<\/strong><\/em>. 15: 329-334<\/a>, 2018.<\/li>\n\n\n\n
                                                                                          4. Hiyama, N., Ando, T., Maemura, K., Sakatani, T., Amano, Y., Watanabe, K., Kage, H., Yatomi, Y., Nagase, T., Nakajima, J., and Takai D. Glutamate-cysteine ligase catalytic subunit is associated with cisplatin resistance in lung adenocarcinoma. Jpn. J. Clin. Oncol.<\/strong><\/em> 48: 303-307<\/a>, 2018.<\/li>\n\n\n\n
                                                                                          5. Honjo, M., Igarashi, N., Kurano, M., Yatomi, Y., Igarashi, K., Kano, K., Aoki, J., Weinreb, R.N., and Aihara, M. Autotaxin-Lysophosphatidic Acid Pathway in Intraocular Pressure Regulation and Glaucoma Subtypes. Invest. Ophthalmol Vis. Sci.<\/strong><\/em> 59: 693-701<\/a>, 2018.<\/li>\n\n\n\n
                                                                                          6. Honjo, M., Igarashi, N., Nishida, J., Kurano, M., Yatomi, Y., Igarashi, K., Kano, K., Aoki, J., and Aihara, M. Role of the Autotaxin-LPA Pathway in Dexamethasone-Induced Fibrotic Responses and Extracellular Matrix Production in Human Trabecular Meshwork Cells. Invest. Ophthalmol. Vis. Sci.<\/strong><\/em> 59: 21-30<\/a>, 2018.<\/li>\n\n\n\n
                                                                                          7. Ikeda, H., Kobayashi, M., Kumada, H., Enooku, K., Koike, K., Kurano, M., Sato, M., , T., Kobayashi, T., Ohkawa, R., Shimamoto, S., Igarashi, K., Aoki, J., and Yatomi, Y. Performance of autotaxin as a serum marker of liver fibrosis. Ann. Clin. Biochem.<\/strong><\/em> 55: 469-477<\/a>, 2018.<\/li>\n\n\n\n
                                                                                          8. Igarashi, N., Honjo, M., Kurano, M. Yatomi, Y., Igarashi, K., Kano, K., Aoki, J., and Aihara M. Increased aqueous autotaxin and lysophosphatidic acid levels are potential prognostic factors after trabeculectomy in different types of glaucoma. Sci. Rep.<\/em><\/strong> 8: 11304<\/a>, 2018.<\/li>\n\n\n\n
                                                                                          9. Kurano, M., Hasegawa, K., Kunimi, M., Hara, M., Yatomi, Y., Teramoto, T., and Tsukamoto, K. Sitosterol prevents obesity-related chronic inflammation. Biochim. Biophys. Acta<\/strong><\/em> 1863: 191-198<\/a>, 2018.<\/li>\n\n\n\n
                                                                                          10. Kurano, M., Miyagaki, T., Miyagawa, T., Igarashi, K., Shimamoto, S., Ikeda, H., Aoki, J., Sato, S., and Yatomi Y. Association between serum autotaxin or phosphatidylserine-specific phospholipase A1 levels and melanoma. J. Dermatol.<\/strong><\/em> 45: 571-579<\/a>, 2018.<\/li>\n\n\n\n
                                                                                          11. Kurano, M., Tsuneyama, K., Morimoto, Y., Shimizu, T., Jona, M., Kassai, H.,Nakao, K., Aiba, A., and Yatomi, Y. Apolipoprotein M Protects Lipopolysaccharide-Treated Mice from Death and Organ Injury. Thromb. Haemost.<\/strong><\/em> 118: 1021-1035<\/a>, 2018.<\/li>\n\n\n\n
                                                                                          12. Kurano, M., Ikeda, H., Iso-O, N., Hara, M., Tsukamoto, K., and Yatomi, Y. Regulation of the metabolism of apolipoprotein M and sphingosine 1-phosphate by hepatic PPAR\u03b3 activity. Biochem. J.<\/strong><\/em> 475: 2009-2024<\/a>, 2018.<\/li>\n\n\n\n
                                                                                          13. Kuwajima, K., Sumitani, M., Kurano, M., Kano, K., Nishikawa, M., Uranbileg, B., Tsuchida, R., Ogata, T., Aoki, J., Yatomi, Y., and Yamada, Y. Lysophosphatidic acid is associated with neuropathic pain intensity in humans: An exploratory study. PLoS One<\/strong><\/em> 13: e0207310<\/a>, 2018.<\/li>\n\n\n\n
                                                                                          14. Lee, S.C., Daimon, M., Di Tullio, M.R., Homma, S., Hasegawa, T., Chiou, S.H., Nakao, T., Hirokawa, M., Mizuno, Y., Yatomi, Y., Yamazaki, T., and Komuro I. Beneficial effect of body weight control on left ventricular diastolic function in the general population: an analysis of longitudinal data from a health check-up clinic. Eur. Heart J. Cardiovasc. Imaging<\/strong><\/em> 19: 136-142<\/a>, 2018.<\/li>\n\n\n\n
                                                                                          15. Lei, C., Kobayashi, H., Wu, Y., Li, M., Isozaki, A., Yasumoto, A., Mikami, H., Ito, T., Nitta, N., Sugimura, T., Yamada, M., Yatomi, Y., Di Carlo, D., Ozeki, Y., and Goda, K. High-throughput imaging flow cytometry by optofluidic time-stretch microscopy. Nat. Protoc.<\/strong><\/em> 13: 1603-1631<\/a>, 2018.<\/li>\n\n\n\n
                                                                                          16. Maemura, K., Watanabe, K., Ando, T., Hiyama, N., Sakatani, T., Amano, Y., Kage, H., Nakajima, J., Yatomi, Y., Nagase, T., and Takai D. Altered editing level of microRNAs is a potential biomarker in lung adenocarcinoma. Cancer Sci.<\/strong><\/em> 109: 3326-3335<\/a>, 2018.<\/li>\n\n\n\n
                                                                                          17. Makita, K., Mikami, Y., Matsuzaki, H., Narumoto, O., Takai, D., Yatomi, Y., and Nagase, T. Utility of bronchoscopy in the definitive diagnosis of patients with haematological malignancies presenting with radiological abnormalities. Clin. Respir. J.<\/strong><\/em> 12: 1381-1388<\/a>, 2018.<\/li>\n\n\n\n
                                                                                          18. Makimoto, H., Shimizu, K., Fujiu, K., Lin, T., Oshima, T., Amiya, E., Yamagata, K., Kojima, T., Daimon, M., Nagatomo, R., Waki, K., Meyer, C., and Komuro, I. Effect of Sympatholytic Therapy on Circadian Cardiac Autonomic Activity in Non-Diabetic Chronic Kidney Disease. Int. Heart J.<\/strong><\/em> 59: 1352-1358<\/a>, 2018.<\/li>\n\n\n\n
                                                                                          19. Mishima, Y., Kurano, M., Kobayashi, T., Nishikawa, M., Ohkawa, R., Tozuka, M., and Yatomi, Y. Dihydro-sphingosine 1-phosphate interacts with carrier proteins in a manner distinct from that of sphingosine 1-phosphate. Biosci. Rep.<\/strong><\/em> 38: BSR20181288<\/a>, 2018.<\/li>\n\n\n\n
                                                                                          20. Murono, K., Ishihara, S., Kawai, K., Kaneko, M., Sasaki, K., Otani, K., Yasuda, K., Nishikawa, T., Tanaka, T., Kiyomatsu, T., Hata, K., Nozawa, H., Satoh, Y., Kurihara, M., Yatomi, Y., and Watanabe, T. Significance of carcinoembryonic antigen mRNA in peritoneal lavage determined by transcription-reverse transcription concerted method in patients with low rectal cancer. Asian J. Surg. <\/strong><\/em>41: 321-327<\/a>, 2018.<\/li>\n\n\n\n
                                                                                          21. Nakao, T., Yasumoto, A., Tokuoka, S., Kita, Y., Kawahara, T., Daimon, M., and Yatomi Y. The impact of night-shift work on platelet function in healthy medical staff. J. Occup. Health.<\/strong><\/em> 60: 324-332<\/a>, 2018.<\/li>\n\n\n\n
                                                                                          22. Nakatani, S., Yasukawa, K., Ishimura, E., Nakatani, A., Toi, N., Uedono, H., Tsuda, A., Yamada, S., Ikeda, H., Mori, K., Emoto, M., Yatomi, Y., and Inaba, M. Non-mercaptalbumin, Oxidized Form of Serum Albumin, Significantly Associated with Renal Function and Anemia in Chronic Kidney Disease Patients. Sci. Rep. <\/strong><\/em>8: 16796<\/a>, 2018.<\/li>\n\n\n\n
                                                                                          23. Nitta, N., Sugimura, T., Isozaki, A., Mikami, H., Hiraki, K., Sakuma, S., Iino, T., Arai, F., Endo, T., Fujiwaki, Y., Fukuzawa, H., Hase, M., Hayakawa, T., Hiramatsu, K., Hoshino, Y., Inaba, M., Ito, T., Karakawa, H., Kasai, Y., Koizumi, K., Lee, S., Lei, C., Li, M., Maeno, T., Matsusaka, S., Murakami, D., Nakagawa, A., Oguchi, Y., Oikawa, M., Ota, T., Shiba, K., Shintaku, H., Shirasaki, Y., Suga, K., Suzuki, Y., Suzuki, N., Tanaka, Y., Tezuka, H., Toyokawa, C., Yalikun, Y., Yamada, M., Yamagishi, M., Yamano, T., Yasumoto, A., Yatomi, Y., Yazawa, M., Di., Carlo, D., Hosokawa, Y., Uemura, S., Ozeki, Y., and Goda, K. Intelligent Image-Activated Cell Sorting. Cell<\/strong><\/em> 175: 266-276.e13<\/a>, 2018. Press Release.<\/a><\/li>\n\n\n\n
                                                                                          24. Ohkawa, R., Kurano, M., Sakai, N., Kishimoto, T., , T., Igarashi, K., Hosogaya, S., Ozaki, Y., Dohi, T., Miyauchi, K., Daida, H., Aoki, J., Okubo, S., Ikeda, H., Tozuka, M., and Yatomi Y. Measurement of plasma choline in acute coronary syndrome: importance of suitable sampling conditions for this assay. Sci. Rep.<\/strong><\/em> 8: 4725<\/a>, 2018.<\/li>\n\n\n\n
                                                                                          25. Sasada, K., Yamamoto, N., Masuda, H., Tanaka, Y., Ishihara, A., Takamatsu, Y., Yatomi, Y., Katsuda, W., Sato, I., and Matsui, H. Inter-observer variance and the need for standardization in the morphological classification of myelodysplastic syndrome. Leuk. Res.<\/strong><\/em> 69: 54-59<\/a>, 2018.<\/li>\n\n\n\n
                                                                                          26. Sakoda, M., Kaneko, M., Ohta, S., Qi, P., Ichimura, S., Yatomi, Y., and Ito, T. An Injectable Hemostat Composed of a Polyphosphate-Conjugated Hyaluronan Hydrogel. Biomacromolecules.<\/strong><\/em> 19: 3280-3290<\/a>, 2018.<\/li>\n\n\n\n
                                                                                          27. Shimizu,K., Soroida, Y., Sato, M., Hikita, H., Kobayashi, T., Endo, M., Sato, M., Gotoh, H., Iwai, T., Tateishi, R., Koike, K., Yatomi, Y., and Ikeda H. Eradication of hepatitis C virus is associated with the attenuation of steatosis as evaluated using a controlled attenuation parameter. Sci. Rep.<\/em><\/strong> 8: 7845<\/a>, 2018.<\/li>\n\n\n\n
                                                                                          28. Tokuhara, Y., Shukuya, K., Tanaka, M., Sogabe, K., Ejima, Y., Hosokawa, S., Ohsaki, H., Morinishi, T., Hirakawa, E., Yatomi, Y., and Shimosawa T. Absorbance measurements of oxidation of homogentisic acid accelerated by the addition of alkaline solution with sodium hypochlorite pentahydrate.\u3000Sci Rep<\/em><\/strong>. 8: 11364<\/a>, 2018.<\/li>\n\n\n\n
                                                                                          29. Uranbileg, B., Nishikawa, T., Ikeda, H., Kurano, M., Sato, M., Saigusa, D., Aoki, J., Watanabe, T., and Yatomi, Y. Evidence Suggests Sphingosine 1-Phosphate Might Be Actively Generated, Degraded, and Transported to Extracellular Spaces With Increased S1P2<\/sub> and S1P3<\/sub> Expression in Colon Cancer. Clin. Colorectal Cancer<\/em><\/strong> 17: e171-e182<\/a>, 2018.<\/li>\n\n\n\n
                                                                                          30. Watanabe, K., Yasumoto, A., Amano, Y., Kage, H., Goto, Y., Yatomi, Y., Takai, D., and Nagase, T. Mean platelet volume and lymphocyte-to-monocyte ratio are associated with shorter progression-free survival in EGFR-mutant lung adenocarcinoma treated by EGFR tyrosine kinase inhibitor. PLoS One.<\/strong><\/em> 13: e0203625<\/a>, 2018.<\/li>\n\n\n\n
                                                                                          31. Yasukawa, K., Shimosawa, T., Okubo, S., and Yatomi, Y. ANNALS EXPRESS: A simple, rapid, and validated high-performance liquid chromatography method suitable for clinical measurements of human mercaptalbumin and nonmercaptalbumin. Ann. Clin. Biochem. <\/strong><\/em>55: 121-127<\/a>, 2018.<\/li>\n\n\n\n
                                                                                          32. Yasunaga, M., Taoka, K., Nakagawa, H., Yamada, A., Abe, H., Jona, M., Nishikawa, M., Nakazaki, K., Yatomi, Y., Fukayama, M., Koike, K., and Kurokawa, M. Eculizumab treatment for ischemic enteritis accompanied with paroxysmal nocturnal hemoglobinuria: a case report and literature review. Ann. Hematol. <\/strong><\/em>97: 1513-1515<\/a>, 2018.<\/li>\n\n\n\n
                                                                                          33. Xu, B., Kawata, T., Daimon, M., Kimura, K., Nakao, T., Lee, S.C., Hirokawa, M., Yoshinaga, A., Watanabe, M., Yatomi, Y., and Komuro I. Prognostic Value of a Simple Echocardiographic Parameter, the Right Ventricular Systolic to Diastolic Duration Ratio, in Patients with Advanced Heart Failure with Non-Ischemic Dilated Cardiomyopathy. Int. Heart J. <\/strong><\/em>59: 968-975<\/a>, 2018.<\/li>\n<\/ol>\n\n\n\n

                                                                                            \u56fd\u5185\u5b66\u4f1a\u767a\u8868\uff1aDomestic Conference Presentation<\/h4>\n\n\n\n
                                                                                              \n
                                                                                            1. \u8352\u5c71 \u3042\u305a\u3055\uff0c\u5bae\u62dd \u7f8e\u6075\uff0c\u89d2\u7530 \u5e0c\u4e16\u7f8e\uff0c\u6e21\u9089 \u6625\u7f8e\uff0c\u6a58\u7530 \u8981\u4e00\uff0c\u8ecd\u795e \u6b63\u9686\uff0c\u5f71\u5c71 \u7950\u5b50\uff0c\u5bae\u672c \u548c\u5b50\uff0c\u5742\u4e2d \u5343\u6075\uff0e\u6771\u5927\u75c5\u9662Phase1\u30e6\u30cb\u30c3\u30c8\u306b\u304a\u3051\u308b\u88ab\u9a13\u8005\u306e\u5b89\u5168\u6027\u78ba\u4fdd\u306b\u5bfe\u3059\u308b\u53d6\u308a\u7d44\u307f\uff0e\u7b2c39\u56de \u65e5\u672c\u81e8\u5e8a\u85ac\u7406\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a\uff0e2018.7.1-6\uff0e\u4eac\u90fd\uff0e<\/li>\n\n\n\n
                                                                                            2. \u77f3\u539f \u6709\u7406\uff0c\u4fdd\u7530 \u5948\u7dd2\u7f8e\uff0c\u5409\u5ddd \u76f4\u4e4b\uff0c\u4e0b\u5742 \u6d69\u5247\uff0c\u897f\u5ddd \u771f\u5b50\uff0c\u77e2\u51a8 \u88d5\uff0c\u8535\u91ce \u4fe1\uff0e\u53ef\u6eb6\u6027IL-2R\u6e2c\u5b9a\u306b\u304a\u3044\u3066HAMA\u306b\u3088\u308b\u507d\u9ad8\u5024\u304c\u7591\u308f\u308c\u305f1\u75c7\u4f8b\uff0e\u7b2c65\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2018.11.15-18\uff0e\u6771\u4eac\uff0e<\/li>\n\n\n\n
                                                                                            3. \u5c0f\u91ce \u4f73\u4e00\uff0c\u77f3\u539f \u6709\u7406\uff0c\u4fdd\u7530 \u5948\u7dd2\u7f8e\uff0c\u4e0b\u5742 \u6d69\u5247\uff0c\u4f50\u85e4 \u667a\u660e\uff0c\u77e2\u51a8 \u88d5\uff0c\u897f\u5ddd \u771f\u5b50\uff0eM\u86cb\u767d\u91cf\u7b97\u51fa\u30bd\u30d5\u30c8(skim\u30d7\u30e9\u30b9\u6cd5)\u3092\u7528\u3044\u305fM\u86cb\u767d\u5b9a\u91cf\u6cd5\u306e\u691c\u8a3c\uff0e\u7b2c65\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2018.11.15\u201018\uff0e\u6771\u4eac\uff0e<\/li>\n\n\n\n
                                                                                            4. \u4e0a\u5e02 \u88d5\u5b50\uff0c\u98db\u7530 \u660e\u5b50\uff0c\u5c0f\u5ddd \u821e\u5b50\uff0c\u4e0b\u5742 \u6d69\u5247\uff0c\u66fd\u6839 \u4f38\u6cbb\uff0c\u77e2\u51a8 \u88d5\uff0e\u81ea\u52d5\u5316\u5b66\u767a\u5149\u9175\u7d20\u514d\u75ab\u5206\u6790\u88c5\u7f6eAccuraseed \u306b\u3088\u308b\u9ad8\u8840\u5727\u30de\u30fc\u30ab\u30fc\u6e2c\u5b9a\u306e\u6709\u7528\u6027\uff0e\u7b2c67\u56de \u65e5\u672c\u533b\u5b66\u691c\u67fb\u5b66\u4f1a\uff0e2018.5.12-13\uff0e\u6d5c\u677e\uff0e<\/li>\n\n\n\n
                                                                                            5. \u4e0a\u5e02 \u88d5\u5b50\uff0c\u98db\u7530 \u660e\u5b50\uff0c\u4e0b\u5742 \u6d69\u5247\uff0c\u4f50\u85e4 \u667a\u660e\uff0c\u77e2\u51a8 \u88d5\uff0c\u8535\u91ce \u4fe1\uff0e\u81ea\u52d5\u5316\u5b66\u767a\u5149\u9175\u7d20\u514d\u75ab\u5206\u6790\u88c5\u7f6eAccuraseed\u306b\u3088\u308b\u539f\u767a\u6027\u30a2\u30eb\u30c9\u30b9\u30c6\u30ed\u30f3\u75c7\u306e\u30b9\u30af\u30ea\u30fc\u30cb\u30f3\u30b0\u691c\u67fb\u306e\u6709\u7528\u6027\uff0e\u7b2c65\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2018.11.15-18\uff0e\u6771\u4eac\uff0e<\/li>\n\n\n\n
                                                                                            6. \u4e45\u4fdd\u7530 \u3068\u3082\u3088\uff0c\u6e05\u6c34 \u516c\u5e73\uff0c\u52a0\u85e4 \u5e78\u5b50\uff0c\u4f50\u85e4 \u96c5\u662d\uff0c\u4e2d\u5cf6 \u6df3\uff0c\u77e2\u51a8 \u88d5\uff0c\u9ad8\u4e95 \u5927\u54c9\uff0e\u6c17\u7ba1\u652f\u5185\u7570\u7269\u306b\u3088\u308aair trapping\u3092\u751f\u30581\u79d2\u91cf\u6e1b\u5c11\u3092\u8a8d\u3081\u305f\u8133\u6b7b\u80ba\u79fb\u690d\u5f8c\u306e\u4e00\u4f8b\uff0e\u7b2c65\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2018.11.15-18\uff0e\u6771\u4eac\uff0e<\/li>\n\n\n\n
                                                                                            7. \u8535\u91ce \u4fe1\uff0c\u585a\u672c \u548c\u4e45\uff0c\u539f \u771e\u7d14\uff0c\u77e2\u51a8 \u88d5\uff0c\u5bfa\u672c \u6c11\u751f\uff0eGWAS\u3088\u308a\u540c\u5b9a\u3055\u308c\u305f\u65b0\u898f\u708e\u75c7\u95a2\u9023\u30a2\u30dd\u86cb\u767d\uff1aApoD\u306e\u6a5f\u80fd\u89e3\u6790\uff0e\u7b2c61\u56de \u65e5\u672c\u7cd6\u5c3f\u75c5\u5b66\u4f1a\u5e74\u6b21\u5b66\u8853\u96c6\u4f1a\uff0e2018.5.24-26\uff0e\u6771\u4eac\uff0e<\/li>\n\n\n\n
                                                                                            8. \u8535\u91ce \u4fe1\uff0c\u585a\u672c \u548c\u4e45\uff0c\u6e05\u6c34 \u77e5\uff0c\u77e2\u51a8 \u88d5\uff0e\u7cd6\u4ee3\u8b1d\u7570\u5e38\u306b\u304a\u3051\u308b\u30b9\u30d5\u30a3\u30f3\u30b4\u30b7\u30f31-\u30ea\u30f3\u9178\/\u30a2\u30dd\u86cb\u767dM\u8ef8\u306e\u5f79\u5272\uff0e\u7b2c60\u56de \u65e5\u672c\u8102\u8cea\u751f\u5316\u5b66\u4f1a\uff0e2018.6.1\uff0e\u6771\u4eac\uff0e<\/li>\n\n\n\n
                                                                                            9. \u8535\u91ce \u4fe1\uff0c\u585a\u672c \u548c\u4e45\uff0c\u539f \u771e\u7d14\uff0c\u77e2\u51a8 \u88d5\uff0e\u809d\u81d3NPC1L1\u306f\u8840\u6f3f\u30b9\u30d5\u30a3\u30f3\u30b4\u30b7\u30f31-\u30ea\u30f3\u9178\u3092\u5897\u52a0\u3055\u305b\u308b\uff0e\u7b2c50\u56de \u65e5\u672c\u52d5\u8108\u786c\u5316\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u96c6\u4f1a\uff0e2018.7.12\uff0e\u5927\u962a\uff0e<\/li>\n\n\n\n
                                                                                            10. \u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5 \uff0e\u65b0\u898f\u751f\u7406\u6d3b\u6027\u8102\u8cea\u30ea\u30be\u30db\u30b9\u30d5\u30a1\u30c1\u30b8\u30eb\u30bb\u30ea\u30f3\u306e\u708e\u75c7\u3078\u306e\u95a2\u4e0e\uff1a\u5206\u5b50\u7a2e\u306b\u3088\u308b\u4f5c\u7528\u306e\u76f8\u9055\uff0e\u7b2c58\u56de \u65e5\u672c\u81e8\u5e8a\u5316\u5b66\u4f1a\u5e74\u6b21\u5b66\u8853\u96c6\u4f1a\uff0e2018.8.26\uff0e\u540d\u53e4\u5c4b\uff0e<\/li>\n\n\n\n
                                                                                            11. \u8535\u91ce \u4fe1\uff0c\u585a\u672c \u548c\u4e45\uff0c\u539f \u771e\u7d14\uff0c\u77e2\u51a8 \u88d5\uff0e\u30a2\u30dd\u86cb\u767dM\/\u30b9\u30d5\u30a3\u30f3\u30b4\u30b7\u30f31-\u30ea\u30f3\u9178\u8ef8\u306e\u7cd6\u5c3f\u75c5\u6027\u814e\u75c7\u306b\u304a\u3051\u308b\u5f79\u5272\uff0e\u7b2c33\u56de \u65e5\u672c\u7cd6\u5c3f\u75c5\u5408\u4f75\u75c7\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2018.10.19\uff0e\u6771\u4eac\uff0e<\/li>\n\n\n\n
                                                                                            12. \u8535\u91ce \u4fe1\uff0c\u5e38\u5c71 \u5e78\u4e00\uff0c\u77e2\u51a8 \u88d5\uff0e\u4e2d\u67a2\u795e\u7d4c\u7cfb\u306e\u30a2\u30dd\u86cb\u767dM\u306e\u5f79\u5272\uff0e\u7b2c65\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2018.11.15-18\uff0e\u6771\u4eac\uff0e<\/li>\n\n\n\n
                                                                                            13. \u8535\u91ce \u4fe1\uff0e\u8102\u8cea\u306e\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u306e\u65b0\u6a5f\u8ef8\uff1a\u30ea\u30be\u30ea\u30f3\u8102\u8cea\uff08\u5b66\u8853\u8cde\u53d7\u8cde\u8b1b\u6f14\uff09\uff0e\u7b2c65\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2018.11.15-18\uff0e\u6771\u4eac\uff0e<\/li>\n\n\n\n
                                                                                            14. \u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0e\u30ac\u30b9\u30af\u30ed\u30de\u30c8\u30b0\u30e9\u30d5\u30a3\u8cea\u91cf\u5206\u6790\u8a08\u3092\u7528\u3044\u305f\u75be\u60a3\u9032\u884c\u4e88\u77e5\u30de\u30fc\u30ab\u30fc\u306e\u63a2\u7d22\uff08\u5e73\u621028\u5e74\u5ea6\uff5e29\u5e74\u5ea6\u5b66\u8853\u63a8\u9032\u30d7\u30ed\u30b8\u30a7\u30af\u30c8\u7814\u7a76\u5831\u544a\uff09\uff0e\u7b2c65\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2018.11.15-18\uff0e\u6771\u4eac\uff0e<\/li>\n\n\n\n
                                                                                            15. \u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0e\u30a2\u30dd\u86cb\u767dM\/\u30b9\u30d5\u30a3\u30f3\u30b4\u30b7\u30f31\uff0d\u30ea\u30f3\u9178\u306e\u6297\u814e\u81d3\u75c5\u4f5c\u7528\uff0e\u7b2c13\u56de \u30b9\u30d5\u30a3\u30f3\u30b4\u30c6\u30e9\u30d4\u30fc\u7814\u7a76\u4f1a\uff0e2018.12.16\uff0e\u5bcc\u5c71\uff0e<\/li>\n\n\n\n
                                                                                            16. \u85e4\u91ce \u7950\u4ecb\uff0c\u5b89\u5ddd \u6075\u5b50\uff0c\u77f3\u6a4b \u307f\u3069\u308a\uff0c\u5468 \u8056\u6d66\uff0c\u539f\u53e3 \u7f8e\u8cb4\u5b50\uff0c\u6c60\u7530 \u5747\uff0c\u77e2\u51a8 \u88d5\uff0e\u4e2d\u6751\u6df3 \u8840\u6e05\u9178\u5316\u578b\u30a2\u30eb\u30d6\u30df\u30f3\u306f\u51a0\u52d5\u8108\u75c5\u5909\u306e\u91cd\u75c7\u5ea6\u306e\u4e88\u6e2c\u56e0\u5b50\u3068\u306a\u308b\uff0e\u7b2c61\u56de \u65e5\u672c\u7cd6\u5c3f\u75c5\u5b66\u4f1a\u5e74\u6b21\u5b66\u8853\u96c6\u4f1a\uff0e2018.5.24-26\uff0e\u6771\u4eac\uff0e<\/li>\n\n\n\n
                                                                                            17. \u5c0f\u6797 \u7531\u4f73\uff0c\u9234\u6728 \u4eae\uff0c\u5b89\u5ddd \u6075\u5b50\uff0c\u6c60\u7530 \u5747\uff0c\u5c71\u5185 \u654f\u6b63\uff0c\u77e2\u51a8 \u88d5\uff0c\u9580\u8107 \u5b5d\uff0e\u8840\u4e2d\u306e\u9178\u5316\u578b\u30a2\u30eb\u30d6\u30df\u30f3\u9ad8\u5024\u306f\u69d8\u3005\u306a\u7cd6\u5c3f\u75c5\u5408\u4f75\u75c7\u306e\u9032\u884c\u72b6\u614b\u3068\u76f8\u95a2\u3059\u308b\uff0e\u7b2c61\u56de \u65e5\u672c\u7cd6\u5c3f\u75c5\u5b66\u4f1a\u5e74\u6b21\u5b66\u8853\u96c6\u4f1a\uff0e2018.5.24-26\uff0e\u6771\u4eac\uff0e<\/li>\n\n\n\n
                                                                                            18. \u5c0f\u6797 \u7531\u4f73\uff0c\u9234\u6728 \u4eae\uff0c\u5b89\u5ddd \u6075\u5b50\uff0c\u6c60\u7530 \u5747\uff0c\u77e2\u51a8 \u88d5\uff0c\u5c71\u5185 \u654f\u6b63\uff0c\u9580\u8107 \u5b5d\uff0e\u8840\u4e2d\u306e\u9178\u5316\u578b\u30a2\u30eb\u30d6\u30df\u30f3\u9ad8\u5024\u306f\u69d8\u3005\u306a\u7cd6\u5c3f\u75c5\u5408\u4f75\u75c7\u306e\u9032\u884c\u72b6\u614b\u3068\u76f8\u95a2\u3059\u308b\uff0e\u7b2c33\u56de \u65e5\u672c\u7cd6\u5c3f\u75c5\u5408\u4f75\u75c7\u5b66\u4f1a\uff0e2018.10.18-19\uff0e\u6771\u4eac\uff0e<\/li>\n\n\n\n
                                                                                            19. \u4f50\u85e4 \u6075\u7f8e\uff0c\u68ee\u7530 \u8ce2\u53f2\uff0c\u4e45\u672b \u5d07\u53f8\uff0c\u7530\u4e2d \u96c5\u7f8e\uff0c\u5bbf\u8c37 \u8ce2\u4e00\uff0c\u66fd\u6839 \u4f38\u6cbb\uff0e\u9178\u6027\u5c3f\u9178\u30a2\u30f3\u30e2\u30cb\u30a6\u30e0\u7d50\u6676\u3092\u8a8d\u3081\u305f\u30cd\u30d5\u30ed\u30fc\u30bc\u75c7\u5019\u7fa4\u306e\u4e00\u4f8b\uff0e\u7b2c13\u56de \u6771\u4eac\u90fd\u533b\u5b66\u691c\u67fb\u5b66\u4f1a\uff0e2018.2.4\uff0e\u6771\u4eac\uff0e<\/li>\n\n\n\n
                                                                                            20. \u4f50\u85e4 \u6075\u7f8e\uff0c\u68ee\u7530 \u8ce2\u53f2\uff0c\u4e45\u672b \u5d07\u53f8\uff0c\u7530\u4e2d \u96c5\u7f8e\uff0c\u5bbf\u8c37 \u8ce2\u4e00\uff0c\u66fd\u6839 \u4f38\u6cbb\uff0c\u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0e\u6025\u6027\u30ea\u30f3\u30d1\u6027\u767d\u8840\u75c5\u306e\u9aa8\u9ac4\u79fb\u690d\u4e2d\u306b\u5c3f\u4e2d\u03b11-\u30df\u30af\u30ed\u30b0\u30ed\u30d6\u30ea\u30f3\u304c\u9ad8\u5024\u3092\u793a\u3057\u305f\u4e00\u4f8b\uff0e\u814e\u30fb\u6ccc\u5c3f\u5668\u691c\u67fb\u7814\u7a76\u4f1a \u7b2c14\u56de\u5b66\u8853\u96c6\u4f1a\uff0e2018.3.17-18\uff0e\u91d1\u6ca2\uff0e<\/li>\n\n\n\n
                                                                                            21. \u67f4\u5c71 \u6625\u5948\uff0c\u5409\u672c \u660e\uff0c\u4e0a\u5e02 \u88d5\u5b50\uff0c\u4e09\u6fa4 \u6176\u6a39\uff0c\u76db\u7530 \u548c\u6cbb\uff0c\u5c0f\u91ce \u4f73\u4e00\uff0c\u66fd\u6839\u4f38\u6cbb\uff0c\u5b89\u672c \u7be4\u53f2\uff0c\u4f50\u85e4 \u667a\u660e\uff0c\u77e2\u51a8 \u88d5\uff0e\u5916\u6765\u63a1\u8840\u5ba4\u306b\u5bfe\u3059\u308b\u6295\u66f8\u306e\u8a08\u91cf\u30c6\u30ad\u30b9\u30c8\u5206\u6790\u3092\u7528\u3044\u305f\u89e3\u6790\uff0e\u7b2c65\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2018.11.15-18\uff0e\u6771\u4eac\uff0e<\/li>\n\n\n\n
                                                                                            22. \u6e05\u6c34 \u5eb7\u5e73\uff0c\u63c3\u7530 \u967d\u5b50\uff0c\u4f50\u85e4 \u96c5\u54c9\uff0c\u758b\u7530 \u5b8f\u7f8e\uff0c\u5c0f\u6797 \u7389\u5b9c\uff0c\u9060\u85e4 \u6843\u6c5f\uff0c\u4f50\u85e4 \u78e8\u5b9f\u5b50\uff0c\u5f8c\u85e4 \u5bdb\u662d\uff0c\u5ca9\u4e95 \u53cb\u7f8e\uff0c\u5efa\u77f3 \u826f\u4ecb\uff0c\u5c0f\u6c60 \u548c\u5f66\uff0c\u77e2\u51a8 \u88d5\uff0c\u6c60\u7530 \u5747\uff0e\u6297\u30a6\u30a4\u30eb\u30b9\u7d4c\u53e3\u5264\uff08DAA\uff09\u6cbb\u7642\u306b\u3088\u308b\u809d\u8102\u80aa\u5316\u306e\u5909\u5316\uff0e\u7b2c65\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2018.11.15-18\uff0e\u6771\u4eac\uff0e<\/li>\n\n\n\n
                                                                                            23. \u5fd7\u6751 \u62d3\u4e5f\uff0c\u5409\u5ddd \u76f4\u4e4b\uff0c\u4fdd\u7530 \u5948\u7dd2\u7f8e\uff0c\u4e0b\u5742 \u6d69\u5247\uff0c\u5e38\u540d \u653f\u5f18\uff0c\u5bbf\u8c37 \u8ce2\u4e00\uff0c\u66fd\u6839 \u4f38\u6cbb\uff0c\u77e2\u51a8 \u88d5\uff0e\u5168\u81ea\u52d5\u81e8\u5e8a\u691c\u67fb\u30b7\u30b9\u30c6\u30e0STACIA\u306b\u3088\u308b\u9ac4\u6db2\u4e2dsIL-2R\u6e2c\u5b9a\u306e\u57fa\u790e\u7684\u691c\u8a0e\uff0e\u7b2c67\u56de \u65e5\u672c\u533b\u5b66\u691c\u67fb\u5b66\u4f1a\uff0e2018.5.12-13\uff0e\u6d5c\u677e\uff0e<\/li>\n\n\n\n
                                                                                            24. \u5fd7\u6751 \u62d3\u4e5f\uff0c\u8535\u91ce \u4fe1\uff0c\u5409\u5ddd \u76f4\u4e4b\uff0c\u68ee\u7530 \u8ce2\u53f2\uff0c\u7530\u4e2d \u96c5\u7f8e\uff0c\u897f\u5ddd \u771f\u5b50\uff0c\u5e38\u540d \u653f\u5f18\uff0c\u4e94\u5341\u5d50 \u6d69\u4e8c\uff0c\u77e2\u51a8 \u88d5\uff0e\u9020\u8840\u5668\u816b\u760d\u306e\u9ac4\u819c\u6d78\u6f64\u306b\u304a\u3051\u308bATX\/LPA axis\u306e\u95a2\u4e0e \u81e8\u5e8a\u691c\u4f53\u3092\u7528\u3044\u305f\u691c\u8a0e\uff0e\u7b2c19\u56de \u65e5\u672c\u691c\u67fb\u8840\u6db2\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2018.7.21-22\uff0e\u5927\u5bae\uff0e<\/li>\n\n\n\n
                                                                                            25. \u5fd7\u6751 \u62d3\u4e5f\uff0c\u8535\u91ce \u4fe1\uff0c\u68ee\u7530 \u8ce2\u53f2\uff0c\u897f\u5ddd \u771f\u5b50\uff0c\u5409\u5ddd \u76f4\u4e4b\uff0c\u7530\u4e2d \u96c5\u7f8e\uff0c\u4e0b\u5742 \u6d69\u5247\uff0c\u5e38\u540d \u653f\u5f18\uff0c\u5cf6\u672c \u601c\u53f2\uff0c\u4e94\u5341\u5d50 \u6d69\u4e8c\uff0c\u77e2\u51a8 \u88d5\uff0e\u9ac4\u6db2\u691c\u4f53\u306b\u304a\u3051\u308bsIL-2R\u3068ATX \u9020\u8840\u5668\u816b\u760d\u306e\u4e2d\u67a2\u795e\u7d4c\u6d78\u6f64\u30d0\u30a4\u30aa\u30de\u30fc\u30ab\u30fc\u3068\u3057\u3066\u306e\u6709\u7528\u6027\uff0e\u7b2c65\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2018.11.15-18\uff0e\u6771\u4eac\uff0e<\/li>\n\n\n\n
                                                                                            26. \u7b4b\u91ce \u88d5\u7f8e\u5b50\uff0c\u5f71\u5c71 \u7950\u5b50\uff0c\u5bae\u672c \u548c\u5b50\uff0c\u67f3\u7530 \u9053\u5b5d\uff0c\u5742\u4e2d \u5343\u6075\uff0e\u30a2\u30ab\u30c7\u30df\u30a2\u81e8\u5e8a\u8a66\u9a13\u5b9f\u65bd\u65bd\u8a2d\u306b\u304a\u3051\u308b\uff0c\u696d\u52d9\u52b9\u7387\u5316\u306b\u5411\u3051\u305f\u30ea\u30fc\u30f3\u30fb\u30b7\u30c3\u30af\u30b9\u30b7\u30b0\u30de\u306e\u5c0e\u5165\uff0e\u7b2c39\u56de \u65e5\u672c\u81e8\u5e8a\u85ac\u7406\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a\uff0e2018.7.1-6\uff0e\u4eac\u90fd\uff0e<\/li>\n\n\n\n
                                                                                            27. \u6b66\u7530 \u60a6\u5bdb\uff0c\u5927\u9580 \u96c5\u592b\uff0c\u5b89\u672c \u7be4\u53f2\uff0c\u4e2d\u5c3e \u502b\u5b50\uff0c\u8d64\u6fa4 \u5b8f\uff0c\u5b89\u6771 \u6cbb\u90ce\uff0c\u6e21\u8fba \u660c\u6587\uff0c\u5c0f\u5ba4
                                                                                              \u4e00\u6210\uff0c\u5ddd\u624b \u5eb7\u5fb3\uff0c\u77e2\u51a8 \u88d5\uff0eA novel automated blood coagulation analyzer for monit
                                                                                              oring the efficacy of dual or single antiplatelet therapy\uff0e\u7b2c82\u56de \u65e5\u672c\u5faa\u74b0\u5668\u5b66
                                                                                              \u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2018.3.23-25\uff0e\u5927\u962a\uff0e<\/li>\n\n\n\n
                                                                                            28. \u7530\u4e2d \u96c5\u7f8e\uff0c\u5bbf\u8c37 \u8ce2\u4e00\uff0c\u68ee\u7530 \u8ce2\u53f2\uff0c\u4e45\u672b \u5d07\u53f8\uff0c\u4f50\u85e4 \u6075\u7f8e\uff0c\u66fd\u6839 \u4f38\u6cbb\uff0c\u8535\u91ce \u4fe1\uff0eU-SCANNER(E)\u6e2c\u5b9a\u5f8c\u306e\u76ee\u8996\u518d\u691c\u3067\u30de\u30eb\u30d9\u30ea\u30fc\u5c0f\u4f53\u3092\u691c\u51fa\u3057\u305f\u75c7\u4f8b\uff0e\u814e\u30fb\u6ccc\u5c3f\u5668\u691c\u67fb\u7814\u7a76\u4f1a\u7b2c14\u56de\u5b66\u8853\u96c6\u4f1a\uff0e2018.3.17-18\uff0e\u91d1\u6ca2\uff0e<\/li>\n\n\n\n
                                                                                            29. \u7530\u4e2d \u96c5\u7f8e\uff0c\u68ee\u7530 \u8ce2\u53f2\uff0c\u4e45\u672b \u5d07\u53f8\uff0c\u4f50\u85e4 \u6075\u7f8e\uff0c\u5bbf\u8c37 \u8ce2\u4e00\uff0c\u66fd\u6839 \u4f38\u6cbb\uff0c\u77e2\u51a8 \u88d5\uff0e\u9ac4\u6db2\u7d30\u80de\u7b97\u5b9a\u691c\u67fb\u3067\u30ea\u30f3\u30d1\u7403\u5897\u52a0\u3092\u8a8d\u3081\u305f\u795e\u7d4c\u6885\u6bd2\u306e\u4e00\u75c7\u4f8b\uff0e\u7b2c67\u56de \u65e5\u672c\u533b\u5b66\u691c\u67fb\u5b66\u4f1a\uff0e2018.5.12-13\uff0e\u6d5c\u677e\uff0e<\/li>\n\n\n\n
                                                                                            30. \u5343\u660e \u771f\u5f13\uff0c\u5927\u9580 \u96c5\u592b\uff0c\u4e2d\u5c3e \u502b\u5b50\uff0c\u4f50\u3005\u6728 \u8cc0\u6d25\u4e43\uff0c\u5ca1\u91ce \u667a\u5b50\uff0c\u5bae\u5d0e \u4ee4\u5b50\uff0c\u83c5\u539f \u5c06\u4ee3\uff0c\u5b87\u91ce \u6f22\u6210\uff0c\u77e2\u51a8 \u88d5\uff0elow-flow low-gradient AS\u306e\u8a55\u4fa1\u306b\u306f\u671f\u5916\u53ce\u7e2e\u76f4\u5f8c\u306e\u5fc3\u62cd\u304c\u6709\u7528\uff0e\u7b2c29\u56de \u65e5\u672c\u5fc3\u30a8\u30b3\u30fc\u56f3\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2018.4.26-28\uff0e\u5ca9\u624b\uff0e<\/li>\n\n\n\n
                                                                                            31. \u98db\u7530 \u660e\u5b50\uff0c\u4e0b\u5742 \u6d69\u5247\uff0c\u5c0f\u5ddd \u821e\u5b50\uff0c\u4f50\u85e4 \u667a\u660e\uff0c\u77e2\u51a8 \u88d5\uff0c\u8535\u91ce \u4fe1\uff0e\u30df\u30e5\u30fc\u30bf\u30b9\u30ef\u30b3\u30fci50\u306b\u304a\u3051\u308bAFP-L3\uff0cPIVKA-\u2161\u6e2c\u5b9a\u8a66\u85ac\u306e\u6027\u80fd\u8a55\u4fa1\uff0e\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u81ea\u52d5\u5316\u5b66\u4f1a \u7b2c50\u56de\u5927\u4f1a\uff0e2018.10.11-13\uff0e\u795e\u6238\uff0e<\/li>\n\n\n\n
                                                                                            32. \u4e2d\u5c3e \u502b\u5b50\uff0c\u6b66\u7530 \u60a6\u5bdb\uff0c\u5b89\u672c \u7be4\u53f2\uff0c\u5927\u9580 \u96c5\u592b\uff0c\u8d64\u6fa4 \u5b8f\uff0c\u5b89\u6771 \u6cbb\u90ce\uff0c\u5c0f\u5ba4 \u4e00\u6210\uff0c\u5ddd\u624b
                                                                                              \u5eb7\u5fb3\uff0c\u77e2\u51a8 \u88d5\uff0e\u5168\u81ea\u52d5\u8840\u6db2\u51dd\u56fa\u6e2c\u5b9a\u88c5\u7f6eCS-2400\u3092\u7528\u3044\u305f\uff0c\u5b9f\u81e8\u5e8a\u3067\u306e\u6297\u8840\u5c0f\u677f\u7642\u6cd5\u306e
                                                                                              \u52b9\u679c\u5224\u5b9a\uff0e\u7b2c40\u56de \u65e5\u672c\u8840\u6813\u6b62\u8840\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2018.6.28-30\uff0e\u672d\u5e4c\uff0e<\/li>\n\n\n\n
                                                                                            33. \u4e2d\u6e21\u4e00 \u8cb4\uff0c\u8535\u91ce \u4fe1\uff0c\u91ce\u5c3b \u5353\u5b8f\uff0c\u5cf6\u672c \u601c\u53f2\uff0c\u4e94\u5341\u5d50 \u6d69\u4e8c\uff0c\u77e2\u51a8 \u88d5\uff0e\u30d0\u30bb\u30c9\u30a6\u75c5\u306b\u304a\u3051\u308bPS-PLA1\u306e\u65b0\u898f\u30d0\u30a4\u30aa\u30de\u30fc\u30ab\u30fc\u3068\u3057\u3066\u306e\u6709\u7528\u6027\u306b\u95a2\u3059\u308b\u691c\u8a0e\uff0e\u7b2c65\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2018.11.15-18\uff0e\u6771\u4eac\uff0e<\/li>\n\n\n\n
                                                                                            34. \u897f\u5ddd \u5c1a\u5b50\uff0c\u8535\u91ce \u4fe1\uff0cBaasanjav Uranbileg\uff0c\u6c60\u7530 \u5747\uff0c\u77e2\u51a8 \u88d5\uff0e\u30a2\u30e9\u30ad\u30c9\u30f3\u9178\u307e\u305f\u306fDHA\u6dfb\u52a0\u6642\u306e\u8102\u8cea\u30e1\u30c7\u30a3\u30a8\u30fc\u30bf\u30fc\u306e\u89e3\u6790\uff1a\u809d\u764c\u7d30\u80de\u682a\u304a\u3088\u3073\u5927\u8178\u764c\u7d30\u80de\u682a\u306b\u304a\u3051\u308b\u691c\u8a0e\uff0e\u7b2c65\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2018.11.15-18\uff0e\u6771\u4eac\uff0e<\/li>\n\n\n\n
                                                                                            35. \u897f\u5ddd \u771f\u5b50\uff0c\u8535\u91ce \u4fe1\uff0c\u5c0f\u5ba4 \u7531\u4f73\uff0c\u5fd7\u6751 \u62d3\u4e5f\uff0c\u4e94\u5341\u5d50 \u6d69\u4e8c\uff0c\u77e2\u51a8 \u88d5\uff0e\u30aa\u30fc\u30c8\u30bf\u30ad\u30b7\u30f3\u306f\u30ea\u30f3\u30d1\u816b\u30d0\u30a4\u30aa\u30de\u30fc\u30ab\u30fc\u3068\u3057\u3066\u53ef\u6eb6\u6027IL-2\u30ec\u30bb\u30d7\u30bf\u30fc\u3068\u540c\u7b49\u306e\u8a3a\u65ad\u80fd\u3092\u6709\u3059\u308b\uff0e\u7b2c19\u56de \u65e5\u672c\u691c\u67fb\u8840\u6db2\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2018.7.21-22\uff0e\u5927\u5bae\uff0e<\/li>\n\n\n\n
                                                                                            36. \u897f\u5ddd \u771f\u5b50\uff0c\u8535\u91ce \u4fe1\uff0c\u65b0\u7530 \u6634\u5927\uff0c\u72e9\u91ce \u88d5\u5b5d\uff0c\u4e95\u30ce\u53e3 \u4ec1\u4e00\uff0c\u77e2\u51a8 \u88d5\uff0e\u8840\u6e05GM3\u5206\u5b50\u7a2ed18:1-16:0,d18:1-24:1\u306f\uff0c\u30ea\u30f3\u30d1\u816b\u306e\u65b0\u898f\u30d0\u30a4\u30aa\u30de\u30fc\u30ab\u30fc\u3067\u3042\u308b\uff0e\u7b2c80\u56de \u65e5\u672c\u8840\u6db2\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2018.10.12\u201014\uff0e\u5927\u962a\uff0e<\/li>\n\n\n\n
                                                                                            37. \u897f\u5ddd \u771f\u5b50\uff0c\u8535\u91ce \u4fe1\uff0c\u4e94\u5341\u5d50 \u6d69\u4e8c\uff0c\u77e2\u51a8 \u88d5\uff0e\u9020\u8840\u5668\u816b\u760d\u306e\u75c5\u614b\u751f\u7406\u306b\u304a\u3051\u308b\u30aa\u30fc\u30c8\u30bf\u30ad\u30b7\u30f3\u306e\u95a2\u4e0e\uff0e \u7b2c65\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2018.11.15\u201018\uff0e\u6771\u4eac\uff0e<\/li>\n\n\n\n
                                                                                            38. \u6301\u7530 \u667a\u4e4b\uff0c\u79cb\u7530 \u840c\uff0c\u5bbf\u5229 \u6df3\uff0c\u7530\u5cf6 \u5c06\u592a\u90ce\uff0c\u5c71\u7530 \u306f\u308b\u9999\uff0c\u5ca1\u91ce \u667a\u5b50\uff0c\u771e\ufa11 \u6842\uff0c\u6e6f\u672c \u771f\u4eba\uff0e\u5f53\u9662\u306b\u304a\u3051\u308bAABR\u691c\u67fb\u3068ABR\u95be\u5024\u691c\u67fb\u306e\u4e00\u81f4\u7387\uff08\u7b2c1\u5831\uff09\uff0e\u7b2c48\u56de \u65e5\u672c\u81e8\u5e8a\u795e\u7d4c\u751f\u7406\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a\uff0e2018.11.8\uff0e\u6771\u4eac\uff0e<\/li>\n\n\n\n
                                                                                            39. \u798f\u539f \u6c99\u5e0c\uff0c\u4e95\u53e3 \u767b\u8207\u5fd7\uff0c\u5b89\u5ddd \u6075\u5b50\uff0c\u6c5f\u85e4 \u77e5\u660e\uff0c\u6b63\u9580 \u5149\u6cd5\uff0c\u6885\u7530 \u6587\u592b\uff0c\u6c60\u7530 \u5747\uff0c\u4f50\u85e4 \u96c5\u54c9\uff0c\u77e2\u51a8 \u88d5\uff0c\u5c71\u5185 \u7167\u7ae0\uff0e\u9ad8\u9f62\u7cd6\u5c3f\u75c5\u60a3\u8005\u306b\u304a\u3051\u308b\u9178\u5316\u30b9\u30c8\u30ec\u30b9\u4ea2\u9032\uff1a\u9178\u5316\u578b\u30a2\u30eb\u30d6\u30df\u30f3\u6bd4\u6e2c\u5b9a\u306e\u6709\u7528\u6027\uff0e\u7b2c56\u56de \u65e5\u672c\u7cd6\u5c3f\u75c5\u5b66\u4f1a\u4e5d\u5dde\u5730\u65b9\u4f1a\uff0e2018.10.12\uff0e\u798f\u5ca1\uff0e<\/li>\n\n\n\n
                                                                                            40. \u68ee\u7530 \u8ce2\u53f2\uff0c\u7530\u4e2d \u96c5\u7f8e\uff0c\u4f50\u85e4 \u6075\u7f8e\uff0c\u4e45\u672b \u5d07\u53f8\uff0c\u5bbf\u8c37 \u8ce2\u4e00\uff0c\u66fd\u6839 \u4f38\u6cbb\uff0c\u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0e\u5c3f\u4e2dNGAL\u6e2c\u5b9a\u8a66\u85ac\u306e\u57fa\u790e\u7684\u6027\u80fd\u8a55\u4fa1\u304a\u3088\u3073\u5c0e\u5165\u5f8c\u691c\u67fb\u72b6\u6cc1\uff0e\u814e\u30fb\u6ccc\u5c3f\u5668\u691c\u67fb\u7814\u7a76\u4f1a \u7b2c14\u56de\u5b66\u8853\u96c6\u4f1a\uff0e2018.3.17-18\uff0e\u91d1\u6ca2\uff0e<\/li>\n\n\n\n
                                                                                            41. \u68ee\u7530 \u8ce2\u53f2\uff0eImage J\u306b\u3088\u308b\u5c3f\u4e2d\u7d30\u80de\u89e3\u6790\uff0e\u814e\u30fb\u6ccc\u5c3f\u5668\u691c\u67fb\u7814\u7a76\u4f1a \u7b2c14\u56de\u5b66\u8853\u96c6\u4f1a \u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u2161\u300c\u5c3f\u691c\u67fb\u306e\u753b\u50cf\u51e6\u7406\u6280\u8853\u300d\uff0e2018.3.17-18\uff0e\u91d1\u6ca2\uff0e<\/li>\n\n\n\n
                                                                                            42. \u68ee\u7530 \u8ce2\u53f2\uff0c\u7530\u4e2d \u96c5\u7f8e\uff0c\u4f50\u85e4 \u6075\u7f8e\uff0c\u4e45\u672b \u5d07\u53f8\uff0c\u5bbf\u8c37 \u8ce2\u4e00\uff0c\u66fd\u6839 \u4f38\u6cbb\uff0c\u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0e\u5c3f\u6f5c\u8840\u8a66\u9a13\u7d19\u306b\u304a\u3051\u308b\u30df\u30aa\u30b0\u30ed\u30d3\u30f3\u53cd\u5fdc\u6027\u306e\u53cd\u5c04\u7387\u306b\u3088\u308b\u691c\u8a3c\uff0e\u7b2c67\u56de \u65e5\u672c\u533b\u5b66\u691c\u67fb\u5b66\u4f1a\uff0e<\/strong>2018.5.12-13\uff0e\u6d5c\u677e\uff0e<\/li>\n\n\n\n
                                                                                            43. \u68ee\u7530 \u8ce2\u53f2\uff0c\u4e45\u672b \u5d07\u53f8\uff0c\u5bbf\u8c37 \u8ce2\u4e00\uff0c\u4f50\u85e4 \u6075\u7f8e\uff0c\u5e38\u540d \u653f\u5f18\uff0c\u897f\u5ddd \u771f\u5b50\uff0c\u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0c\u7530\u4e2d\u96c5\u7f8e\uff0e\u5c3f\u4e2d\u306b\u7570\u578b\u7d30\u80de\u3092\u8a8d\u3081\u305f\u3073\u307e\u3093\u6027\u5927\u7d30\u80de\u578bB\u7d30\u80de\u30ea\u30f3\u30d1\u816b\u306e\u4e00\u75c7\u4f8b\uff0e\u7b2c19\u56de \u65e5\u672c\u691c\u67fb\u8840\u6db2\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2018.7.21-22\uff0e\u5927\u5bae\uff0e<\/li>\n\n\n\n
                                                                                            44. \u68ee\u7530 \u8ce2\u53f2\uff0c\u4e45\u672b \u5d07\u53f8\uff0c\u4f50\u85e4 \u6075\u7f8e\uff0c\u5c0f\u91ce \u4f73\u4e00\uff0c\u4f50\u85e4 \u667a\u660e\uff0c\u5bbf\u8c37 \u8ce2\u4e00\uff0c\u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0c\u7530\u4e2d \u96c5\u7f8e\uff0e\u6025\u6027\u814e\u969c\u5bb3\u306b\u304a\u3051\u308b\u5c3f\u6c88\u6e23\u306e\u6709\u7528\u6027 -\u5c3f\u7d30\u7ba1\u4e0a\u76ae\u7d30\u80de\u3068\u30d0\u30a4\u30aa\u30de\u30fc\u30ab\u30fc\u306e\u95a2\u9023-\uff0e\u7b2c10\u56de \u65e5\u672c\u81e8\u5e8a\u4e00\u822c\u691c\u67fb\u5b66\u4f1a\uff0e2018.8.25-26\uff0e\u91d1\u6ca2\uff0e<\/li>\n\n\n\n
                                                                                            45. \u68ee\u7530 \u8ce2\u53f2\uff0c\u7530\u4e2d \u96c5\u7f8e\uff0c\u4e45\u672b \u5d07\u53f8\uff0c\u4f50\u85e4 \u6075\u7f8e\uff0c\u5c0f\u91ce \u4f73\u4e00\uff0c\u4f50\u85e4 \u667a\u660e\uff0c\u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0c\u5bbf\u8c37 \u8ce2\u4e00\uff0e\u5c3f\u4e2d\u6709\u5f62\u6210\u5206\u5206\u6790\u88c5\u7f6eAtellica UAS800\u306e\u57fa\u790e\u7684\u691c\u8a0e1 -\u8840\u7403\u985e-\uff0e\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u81ea\u52d5\u5316\u5b66\u4f1a \u7b2c50\u56de\u5927\u4f1a\uff0e2018.10.11-13\uff0e\u795e\u6238\uff0e<\/li>\n\n\n\n
                                                                                            46. \u68ee\u7530 \u8ce2\u53f2\uff0c\u7530\u4e2d \u96c5\u7f8e\uff0c\u4e45\u672b \u5d07\u53f8\uff0c\u4f50\u85e4 \u6075\u7f8e\uff0c\u5c0f\u91ce \u4f73\u4e00\uff0c\u4f50\u85e4 \u667a\u660e\uff0c\u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0c\u5bbf\u8c37 \u8ce2\u4e00\uff0e\u5c3f\u4e2d\u6709\u5f62\u6210\u5206\u5206\u6790\u88c5\u7f6eAtellica UAS800\u306e\u57fa\u790e\u7684\u691c\u8a0e2 -\u4e0a\u76ae\u30fb\u5186\u67f1\u985e-\uff0e\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u81ea\u52d5\u5316\u5b66\u4f1a \u7b2c50\u56de\u5927\u4f1a\uff0e2018.10.11-13\uff0e\u795e\u6238\uff0e<\/li>\n\n\n\n
                                                                                            47. \u68ee\u7530 \u8ce2\u53f2\uff0e\u5c3f\u6c88\u6e23\u691c\u67fb\u306e\u81ea\u52d5\u5316\u3068\u65b0\u898f\u5c3f\u4e2d\u6709\u5f62\u6210\u5206\u5206\u6790\u88c5\u7f6eAtellica UAS800\uff0e\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u81ea\u52d5\u5316\u5b66\u4f1a \u7b2c50\u56de\u5927\u4f1a \u30e9\u30f3\u30c1\u30e7\u30f3\u30bb\u30df\u30ca\u30fc18\uff0e2018.10.11-13\uff0e\u795e\u6238\uff0e<\/li>\n\n\n\n
                                                                                            48. \u68ee\u7530 \u8ce2\u53f2\uff0c\u4e45\u672b \u5d07\u53f8\uff0c\u4f50\u85e4 \u6075\u7f8e\uff0c\u5c0f\u91ce \u4f73\u4e00\uff0c\u4f50\u85e4 \u667a\u660e\uff0c\u5bbf\u8c37 \u8ce2\u4e00\uff0c\u7530\u4e2d \u96c5\u7f8e\uff0eSamson\u67d3\u8272\u306b\u304a\u3051\u308b\u9ac4\u6db2\u7570\u578b\u7d30\u80de\u306e\u753b\u50cf\u89e3\u6790\u6280\u8853\u3092\u7528\u3044\u305f\u5f62\u614b\u8a55\u4fa1\uff0e\u7b2c55\u56de \u65e5\u81e8\u6280\u95a2\u7532\u4fe1\u652f\u90e8\u30fb\u9996\u90fd\u570f\u652f\u90e8\u533b\u5b66\u691c\u67fb\u5b66\u4f1a\uff0e2018.10.27-28\uff0e\u9ad8\u5d0e\uff0e<\/li>\n\n\n\n
                                                                                            49. \u68ee\u7530 \u8ce2\u53f2\uff0c\u8535\u91ce\u4fe1\uff0c\u77e2\u51a8\u88d5\uff0e\u764c\u6027\u9ac4\u819c\u708e\u306b\u304a\u3051\u308b\u9ac4\u6db2\u4e2d\u30ea\u30be\u30ea\u30f3\u8102\u8cea\u306e\u6e2c\u5b9a\u610f\u7fa9\uff0e\u7b2c65\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2018.11.15-18\uff0e\u6771\u4eac\uff0e<\/li>\n\n\n\n
                                                                                            50. \u68ee\u7530 \u8ce2\u53f2\uff0c\u5bbf\u8c37 \u8ce2\u4e00\uff0c\u4e45\u672b \u5d07\u53f8\uff0c\u4f50\u85e4 \u6075\u7f8e\uff0c\u5c0f\u91ce \u4f73\u4e00\uff0c\u4f50\u85e4 \u667a\u660e\uff0c\u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0c\u7530\u4e2d \u96c5\u7f8e\uff0e\u5c3f\u4e2dNGAL\u6e2c\u5b9a\u306b\u304a\u3051\u308b\u63a1\u5c3f\u6cd5\u306e\u91cd\u8981\u6027\uff0e\u7b2c65\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2018.11.15-18\uff0e\u6771\u4eac\uff0e<\/li>\n\n\n\n
                                                                                            51. \u68ee\u7530 \u8ce2\u53f2\uff0c\u7530\u4e2d \u96c5\u7f8e\uff0c\u5bbf\u8c37 \u8ce2\u4e00\uff0c\u4e45\u672b \u5d07\u53f8\uff0c\u4f50\u85e4 \u6075\u7f8e\uff0c\u5c0f\u91ce \u4f73\u4e00\uff0c\u4f50\u85e4 \u667a\u660e\uff0c\u77e2\u51a8 \u88d5\uff0c\u8535\u91ce \u4fe1\uff0e\u5c3f\u6c88\u6e23\u304c\u75c5\u614b\u3092\u53cd\u6620\u3057\u305f\u8840\u7403\u8caa\u98df\u75c7\u5019\u7fa4\u306e\u4e00\u4f8b\uff0e\u7b2c65\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2018.11.15-18\uff0e\u6771\u4eac\uff0e<\/li>\n\n\n\n
                                                                                            52. \u68ee\u7530 \u8ce2\u53f2\uff0c\u7530\u4e2d \u771f\u5f13\uff0c\u68b6 \u660e\u9999\uff0c\u670d\u90e8 \u4eae\u8f14\uff0c\u5c0f\u6797 \u7d4b\u58eb\uff0c\u53cb\u7530 \u7f8e\u7a42\u5b50\uff0c\u798f\u7530 \u5609\u660e\uff0c\u8107\u7530 \u6e80\uff0e\u6771\u4eac\u90fd\u306b\u304a\u3051\u308b\u5c3f\u6c88\u6e23\u30d5\u30a9\u30c8\u30b5\u30fc\u30d9\u30a4\u306e\u73fe\u72b6\uff0e\u7b2c14\u56de \u6771\u4eac\u90fd\u533b\u5b66\u691c\u67fb\u5b66\u4f1a\uff0e2018.12.2\uff0e\u6771\u4eac\uff0e<\/li>\n\n\n\n
                                                                                            53. \u6301\u7530 \u667a\u4e4b\uff0c\u79cb\u7530 \u840c\uff0c\u5bbf\u5229 \u6df3\uff0c\u7530\u5cf6 \u5c06\u592a\u90ce\uff0c\u5c71\u7530 \u306f\u308b\u9999\uff0c\u771e\ufa11 \u6842\uff0c\u6e6f\u672c \u771f\u4eba\uff0e\u5f53\u691c\u67fb\u5ba4\u306b\u304a\u3051\u308bISO 15189\u904b\u7528\u72b6\u6cc1\u306b\u3064\u3044\u3066\uff0e\u7b2c5\u56de \u5168\u56fd\u3066\u3093\u304b\u3093\u30bb\u30f3\u30bf\u65e5\u672c\u7cd6\u5c3f\u75c5\u5b66\u4f1a\u5e74\u6b21\u5b66\u8853\u96c6\u4f1a\u30fc\u5354\u8b70\u4f1a\u7dcf\u4f1a\uff0e2018.2.10\uff0e\u65b0\u6f5f\uff0e<\/li>\n\n\n\n
                                                                                            54. \u6301\u7530 \u667a\u4e4b\uff0c\u79cb\u7530 \u840c\uff0c\u5bbf\u5229 \u6df3\uff0c\u7530\u5cf6 \u5c06\u592a\u90ce\uff0c\u5c71\u7530 \u306f\u308b\u9999\uff0c\u771e\ufa11 \u6842\uff0c\u6e6f\u672c \u771f\u4eba\uff0e\u5f53\u691c\u67fb\u5ba4\u306b\u304a\u3051\u308bISO 15189\u904b\u7528\u72b6\u6cc1\u306b\u3064\u3044\u3066\uff0e\u7b2c5\u56de \u5168\u56fd\u3066\u3093\u304b\u3093\u30bb\u30f3\u30bf\u30fc\u5354\u8b70\u4f1a\u7dcf\u4f1a\uff0e2018.2.10\uff0e\u65b0\u6f5f\uff0e<\/li>\n\n\n\n
                                                                                            55. \u5b89\u5ddd \u6075\u5b50\uff0c\u91ce\u5c3b \u5353\u5b8f\uff0c\u5409\u5ddd \u76f4\u4e4b\uff0c\u5897\u6238 \u68a8\u6075\uff0c\u66fd\u6839 \u4f38\u6cbb\uff0c\u7532\u6590 \u4e09\u4e0e\u5b50\uff0c\u5927\u6c60 \u88d5\u7f8e\u5b50\uff0c\u5c71\u5d0e \u529b\uff0c\u4e0b\u6fa4 \u9054\u96c4\uff0c\u6c60\u7530 \u5747\uff0c\u77e2\u51a8 \u88d5\uff0e\u9178\u5316\u578b\u30a2\u30eb\u30d6\u30df\u30f3\u306e\u57fa\u6e96\u7bc4\u56f2\u306e\u8a2d\u5b9a\uff1a\u7cd6\u5c3f\u75c5\u95a2\u9023\u75be\u60a3\u306b\u304a\u3051\u308b\u81e8\u5e8a\u7684\u6709\u7528\u6027\u306e\u691c\u8a0e\u306e\u305f\u3081\u306b\uff0e\u7b2c61\u56de \u65e5\u672c\u7cd6\u5c3f\u75c5\u5b66\u4f1a\u5e74\u6b21\u5b66\u8853\u96c6\u4f1a\uff0e2018.5.24-26\uff0e\u6771\u4eac\uff0e<\/li>\n\n\n\n
                                                                                            56. \u5b89\u5ddd \u6075\u5b50\uff0e\u65b0\u30d0\u30a4\u30aa\u30de\u30fc\u30ab\u2015 \u201c\u9178\u5316\u578b\u30a2\u30eb\u30d6\u30df\u30f3\u201d\u306e \u6e2c\u5b9a\u6cd5\u3068\u81e8\u5e8a\u610f\u7fa9\uff0e\u30e9\u30f3\u30c1\u30e7\u30f3\u30bb\u30df\u30ca\u30fc \u7b2c65\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2018.11.17\uff0e\u6771\u4eac\uff0e<\/li>\n\n\n\n
                                                                                            57. \u4ef2\u8c37 \u614e\u4e5f\uff0c\u68ee \u514b\u4ec1\uff0c\u4ef2\u8c37 \u3042\u3086\u7f8e\uff0c\u90fd\u4e95 \u5f8b\u548c\uff0c\u5c71\u7530 \u771f\u4ecb\uff0c\u6d25\u7530 \u660c\u5b8f\uff0c\u4e0b\u6fa4 \u9054\u96c4\uff0c\u77f3\u6751 \u6804\u6cbb\uff0c\u5b89\u5ddd \u6075\u5b50\uff0c\u77e2\u51a8 \u88d5\uff0c\u7a32\u8449 \u96c5\u7ae0\uff0e\u4fdd\u5b58\u671f\u814e\u4e0d\u5168\u306b\u304a\u3051\u308b\u9178\u5316\u578b\u30fb\u9084\u5143\u578b\u30a2\u30eb\u30d6\u30df\u30f3\uff0e\u7b2c61\u56de \u65e5\u672c\u814e\u81d3\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a\uff0e<\/li>\n\n\n\n
                                                                                            58. \u5b89\u5ddd \u6075\u5b50\uff0c\u5c0f\u6797 \u7531\u4f73\uff0c\u9234\u6728 \u4eae\uff0c\u66fd\u6839 \u4f38\u6cbb\uff0c\u6c60\u7530 \u5747\uff0c\u9580\u8107 \u5b5d\uff0c\u77e2\u51a8 \u88d5\uff0e\u8840\u4e2d\u306e\u9178\u5316\u578b\u30a2\u30eb\u30d6\u30df\u30f3\u6bd4\u7387\uff08HNA%\uff09\u306f\u7cd6\u5c3f\u75c5\u5408\u4f75\u75c7\u3068\u3088\u304f\u95a2\u9023\u3057\uff0c\u305d\u306e\u767a\u75c7\u4e88\u6e2c\u30de\u30fc\u30ab\u30fc\u3068\u306a\u308a\u3046\u308b\uff0e\u7b2c58\u56de \u65e5\u672c\u81e8\u5e8a\u5316\u5b66\u4f1a\u5e74\u6b21\u5b66\u8853\u96c6\u4f1a\uff0e2018.8.24-26\uff0e\u540d\u53e4\u5c4b\uff0e<\/li>\n\n\n\n
                                                                                            59. Uranbileg, B., Hasegawa, K., Ito, N., Kurano, M., Saigusa, D., Kano, K., Ikeda, H., Sumitani, M., Aoki, J., and Yatomi, Y. The Status of the Sphingolipid Metabolism in Rat Cauda Equina Compression Model. \u7b2c58\u56de \u65e5\u672c\u81e8\u5e8a\u5316\u5b66\u4f1a\u5e74\u6b21\u5b66\u8853\u96c6\u4f1a\uff0e2018.8.24-26\uff0e\u540d\u53e4\u5c4b\uff0e<\/li>\n\n\n\n
                                                                                            60. Uranbileg, B., Kurano, M., Nishikawa, T., Sato, M., IkedaH., and Yatomi, Y. Possible involvement of Phosphatidylserine-LysoPS Axis in the Pathophysiology of Carcinogenesis. \u7b2c65\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2018.11.15-18\uff0e\u6771\u4eac\uff0e<\/li>\n<\/ol>\n\n\n\n

                                                                                              \u82f1\u6587\u7dcf\u8aac\uff1aEnglish Review Articles<\/h4>\n\n\n\n
                                                                                                \n
                                                                                              1. Daimon, M., Akaishi, M., Asanuma, T., Hashimoto, S., Izumi, C., Iwanaga, S., Kawai, H., Toide, H., Hayashida, A., Yamada, H., Murata, M., Hirano, Y., Suzuki, K., and Nakatani, S. Guideline from Japanese Society of Echocardiography: 2018 focused update Incorporated into Guidance for the Management and Maintenance of Echocardiography Equipment. J. Echocardiogr<\/strong><\/em>. 16: 1-5<\/a>, 2018.<\/li>\n\n\n\n
                                                                                              2. Guo, B., Lei, C., Wu, Y., Kobayashi, H., Ito, T., Yalikun, Y., Lee, S., Isozaki, A., Li, M., Jiang, Y., Yasumoto, A., Di, Carlo. D., Tanaka, Y., Yatomi, Y., Ozeki, Y., and Goda, K., Optofluidic time-stretch quantitative phase microscopy. Methods <\/strong><\/em>136: 116-125<\/a>, 2018.<\/li>\n\n\n\n
                                                                                              3. Kurano, M. and Yatomi, Y. Sphingosine 1-Phosphate and Atherosclerosis. J. Atheroscler Thromb. <\/strong><\/em>25: 16-26<\/a>, 2018.<\/li>\n\n\n\n
                                                                                              4. Nakanishi, K., Daimon, M. Early prediction of cardiotoxicity from cancer chemotherapy: can baseline strain identify high-risk patients? Circ. J.<\/strong><\/em> 82:2477-2478<\/a>, 2018.<\/li>\n\n\n\n
                                                                                              5. Suzuki, K., Hirano, Y., Yamada, H., Murata, M., Daimon, M., Takeuchi, M., Seo, Y., Izumi, C., and Akaishi, M. Practical Guidance for the Implementation of Stress Echocardiography. J. Echocardiogr<\/strong><\/em>. 16:105\u2013129<\/a>, 2018.<\/li>\n\n\n\n
                                                                                              6. Yatomi, Y., Kurano, M., Ikeda, H., Igarashi, K., Kano, K., and Aoki, J. Lysophospholipids in laboratory medicine. Proc. Jpn. Acad. Ser. B Phys. Biol. Sci.<\/strong><\/em> 94: 373-389<\/a>, 2018.<\/li>\n<\/ol>\n\n\n\n

                                                                                                \u56fd\u969b\u5b66\u4f1a\u767a\u8868\uff1aInternational Conference Presentation<\/h4>\n\n\n\n
                                                                                                  \n
                                                                                                1. Kageyama, Y., Miyamoto, K., Yanagida, M., and Sakanaka, C. How can we contribute to innovative drug development? ~From our experience in participating global study. The 18th World Congress of Basic and Clinical Pharmacology (WCP2018). 2018. 7. 1-6. Kyoto, Japan.<\/li>\n\n\n\n
                                                                                                2. Morita, Y., Shukuya, K., Tanaka, M., Hisasue, T., Sato,M., Sone, S., Kurano, M., and Yatomi, Y. Development and effectiveness of full-automated urinalysis system using urine aliquot processor. Cherry blossom symposium 2018. 2018. 4. 19-21. Morioka, Japan. Poster presentation.<\/li>\n\n\n\n
                                                                                                3. Uranbileg, B., Ikeda, H., Kurano, M., Saigusa, D., Kano, K., Aoki, J., and Yatomi, Y. The importance of S1P lyase in the pathophysiology of hepatocellular carcinoma and colon cancer. The 15th Congress of the Asian Society for Clinical Pathology and Laboratory Medicine (ASCPaLM). 2018. 9. 6-8. Ulaanbaatar, Mongolia.<\/li>\n\n\n\n
                                                                                                4. Yatomi, Y. Accreditation of Medical Laboratories in Japan. 2018 Asia Pacific Laboratory Accreditation Cooperation (APLAC)\/ Pacific Accreditation Cooperation (PAC) Joint Annual Meetings. 2018. 6. 1-9. Kyoto, Japan.<\/li>\n\n\n\n
                                                                                                5. Yatomi, Y. Bioactive lipids in laboratory medicine. 59th Annual Meeting of Korean Society for Laboratory Medicine. 2018. 11. 1-3. Seoul, Korea.<\/li>\n<\/ol>\n\n\n\n

                                                                                                  \u548c\u6587\u539f\u8457\u8ad6\u6587\uff1aJapanese Original Articles<\/h4>\n\n\n\n
                                                                                                    \n
                                                                                                  1. \u5927\u91d1 \u4e9c\u5f25\uff0c\u6c38\u53cb \u5229\u6d25\u5b50\uff0c\u4e45\u7c73 \u5e78\u592b\uff0c\u5e38\u540d \u653f\u5f18\uff0c\u66fd\u6839 \u4f38\u6cbb\uff0c\u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0eBioPlex2200\u3092\u7528\u3044\u305f\u65b0\u898f\u6297EBV\u6297\u4f53\u30b9\u30af\u30ea\u30fc\u30cb\u30f3\u30b0\u691c\u67fb\u306e\u6027\u80fd\u8a55\u4fa1\uff0e\u533b\u5b66\u691c\u67fb 67\uff1a13-22\uff0c2018\uff0e<\/li>\n\n\n\n
                                                                                                  2. \u5fd7\u6751 \u62d3\u4e5f\uff0c\u98db\u7530 \u660e\u5b50\uff0c\u4fdd\u7530 \u5948\u7dd2\u7f8e\uff0c\u4e0b\u5742 \u6d69\u5247\uff0c\u5927\u4e45\u4fdd \u6ecb\u592b\uff0c\u66fd\u6839 \u4f38\u6cbb\uff0c\u77e2\u51a8 \u88d5\uff0c\u5409\u5ddd \u76f4\u4e4b\uff0e\u5168\u81ea\u52d5\u5316\u5b66\u767a\u5149\u9175\u7d20\u514d\u75ab\u6e2c\u5b9a\u88c5\u7f6eAIA-CL2400\u3092\u7528\u3044\u305fPIVKA-II\u6e2c\u5b9a\u306e\u57fa\u790e\u7684\u691c\u8a0e\uff0e
                                                                                                    \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u81ea\u52d5\u5316\u5b66\u4f1a\u4f1a\u8a8c 43\uff1a630-635\uff0c2018\uff0e<\/li>\n\n\n\n
                                                                                                  3. \u4e2d\u6e21 \u4e00\u8cb4\uff0c\u98db\u7530 \u660e\u5b50\uff0c\u5409\u5ddd \u76f4\u4e4b\uff0c\u4e0b\u5742 \u6d69\u5247\uff0c\u66fd\u6839 \u4f38\u6cbb\uff0c\u6c60\u7530 \u5747\uff0c\u77e2\u51a8 \u88d5\uff0e\u5168\u81ea\u52d5\u5316\u5b66\u767a\u5149\u9175\u7d20\u514d\u75ab\u6e2c\u5b9a\u88c5\u7f6eAIA-CL2400\u3092\u7528\u3044\u305f\u30d5\u30a7\u30ea\u30c1\u30f3\u6e2c\u5b9a\u306e\u57fa\u790e\u7684\u691c\u8a0e\uff0e\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u81ea\u52d5\u5316\u5b66\u4f1a\u4f1a\u8a8c 43\uff1a69-75\uff0c2018\uff0e<\/li>\n\n\n\n
                                                                                                  4. \u4e2d\u6e21 \u4e00\u8cb4\uff0c\u5409\u5ddd \u76f4\u4e4b\uff0c\u4e0b\u5742 \u6d69\u5247\uff0c\u4f50\u85e4 \u667a\u660e\uff0c\u77e2\u51a8 \u88d5\uff0c\u98db\u7530 \u660e\u5b50\uff0e\u5168\u81ea\u52d5\u5316\u5b66\u767a\u5149\u9175\u7d20\u514d\u75ab\u6e2c\u5b9a\u88c5\u7f6eAIA-CL2400\u3092\u7528\u3044\u305fSCC\u6e2c\u5b9a\u306e\u57fa\u790e\u7684\u691c\u8a0e\uff0e\u533b\u5b66\u3068\u85ac\u5b66 75\uff1a945-953\uff0c2018\uff0e<\/li>\n\n\n\n
                                                                                                  5. \u4e45\u672b \u5d07\u53f8\uff0c\u5bbf\u8c37 \u8ce2\u4e00\uff0c\u7530\u4e2d \u96c5\u7f8e\uff0c\u6bdb\u5229 \u771f\u7406\u5b50\uff0c\u66fd\u6839 \u4f38\u6cbb\uff0c\u4e0b\u6fa4 \u9054\u96c4\uff0c\u6c60\u7530 \u5747\uff0c\u77e2\u51a8 \u88d5\uff0e\u30c6\u30e9\u30d7\u30ec\u30d3\u30eb\u670d\u7528\u6642\u306b\u5c3f\u4e2d\u306b\u7279\u5fb4\u7684\u306a\u7d50\u6676\u6210\u5206\u3092\u8a8d\u3081\u305f\u75c7\u4f8b\uff0e\u533b\u5b66\u691c\u67fb 67\uff1a605-610\uff0c2018\uff0e<\/li>\n\n\n\n
                                                                                                  6. \u677e\u4e95 \u4e9c\u7406\u6c99\uff0c\u4e45\u672b \u5d07\u53f8\uff0c\u9ad8\u6a4b \u6075\uff0c\u68ee\u7530 \u8ce2\u53f2\uff0c\u66fd\u6839 \u4f38\u6cbb\uff0c\u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0e\u30c7\u30fc\u30bf\u5206\u6790\u306b\u57fa\u3065\u304f\u63a1\u8840\u5ba4\u306e\u7ba1\u7406\u30fb\u904b\u55b6\uff0e\u81e8\u5e8a\u75c5\u7406 66 : 599-603\uff0c2018\uff0e<\/li>\n\n\n\n
                                                                                                  7. \u4e38\u5c3e \u7406\u6075\uff0c\u91d1\u5b50 \u8aa0\uff0c\u6e21\u908a \u3086\u308a\uff0c\u5ddd\u624b \u5eb7\u5fb3\uff0c\u5742\u5bc4 \u8f14\uff0c\u77e2\u51a8 \u88d5\uff0e\u5168\u81ea\u52d5\u8840\u6db2\u51dd\u56fa\u6e2c\u5b9a\u88c5\u7f6e\u3092\u7528\u3044\u305f\u8840\u5c0f\u677f\u51dd\u96c6\u80fd(\u900f\u904e\u5149\u6cd5)\u306e\u81ea\u52d5\u5316\u6e2c\u5b9a-\u8840\u5c0f\u677f\u51dd\u96c6\u80fd\u691c\u67fb\u306e\u6a19\u6e96\u5316\u306b\u3080\u3051\u3066\uff0e\u81e8\u5e8a\u75c5\u7406 66\uff1a1051-1057\uff0c2018\uff0e<\/li>\n\n\n\n
                                                                                                  8. \u68ee\u7530 \u8ce2\u53f2\uff0c\u5bbf\u8c37 \u8ce2\u4e00\uff0c\u7530\u4e2d \u96c5\u7f8e\uff0c\u4f50\u85e4 \u6075\u7f8e\uff0c\u4e45\u672b \u5d07\u53f8\uff0c\u66fd\u6839 \u4f38\u6cbb\uff0c\u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0e\u30af\u30ea\u30cb\u30c6\u30c3\u30af\u30ce\u30fc\u30d0\u30b9\u306b\u304a\u3051\u308b\u30d6\u30c9\u30a6\u7cd6\u6e2c\u5b9a\u5024\u306e\u5224\u5b9a\u57fa\u6e96\u5909\u66f4\u306b\u4f34\u3046\u30c7\u30fc\u30bf\u691c\u8a0e\uff0e\u533b\u5b66\u3068\u85ac\u5b66 75\uff1a235-240\uff0c2018\uff0e<\/li>\n\n\n\n
                                                                                                  9. \u68ee\u7530 \u8ce2\u53f2\uff0c\u5bbf\u8c37 \u8ce2\u4e00\uff0c\u7530\u4e2d \u96c5\u7f8e\uff0c\u6c34\u9593 \u77e5\u4e16\uff0c\u4e45\u672b \u5d07\u53f8\uff0c\u66fd\u6839 \u4f38\u6cbb\uff0c\u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0eSamson\u67d3\u8272\u3092\u7528\u3044\u305f\u9ac4\u6db2\u7d30\u80de\u7b97\u5b9a\u306b\u304a\u3051\u308b\u591a\u5f62\u6838\u7403\u306e\u5f62\u614b\u5206\u985e\u306e\u91cd\u8981\u6027 -\u597d\u9178\u7403\u6027\u9ac4\u819c\u708e\u306e4\u75c7\u4f8b-\uff0e\u533b\u5b66\u691c\u67fb 67\uff1a366-372\uff0c2018\uff0e<\/li>\n\n\n\n
                                                                                                  10. \u68ee\u7530 \u8ce2\u53f2\uff0c\u7530\u4e2d \u96c5\u7f8e\uff0c\u4e45\u672b \u5d07\u53f8\uff0c\u4f50\u85e4 \u6075\u7f8e\uff0c\u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0c\u5bbf\u8c37 \u8ce2\u4e00\uff0e\u5168\u81ea\u52d5\u5c3f\u5316\u5b66\u5206\u6790\u88c5\u7f6eUS-3500\u306b\u304a\u3051\u308b\u5c3f\u30af\u30ec\u30a2\u30c1\u30cb\u30f3\u5224\u5b9a\u57fa\u6e96\u5909\u66f4\u306e\u59a5\u5f53\u6027\u8a55\u4fa1\uff0e\u533b\u7642\u3068\u691c\u67fb\u6a5f\u5668\u30fb\u8a66\u85ac 41\uff1a417-422\uff0c2018\uff0e<\/li>\n\n\n\n
                                                                                                  11. \u5b89\u672c \u7be4\u53f2\uff0c\u77e2\u51a8 \u88d5\uff0e\u30d8\u30d1\u30ea\u30f3\u8d77\u56e0\u6027\u8840\u5c0f\u677f\u6e1b\u5c11\u75c7(HIT)\u306e\u75c5\u614b\u304b\u3089\u8003\u3048\u308b\u8a3a\u65ad\u3068\u6cbb\u7642\uff0eThrombosis Medicine 8\uff1a194-200\uff0c2018\uff0e<\/li>\n\n\n\n
                                                                                                  12. \u5b89\u672c \u7be4\u53f2\uff0c\u77e2\u51a8 \u88d5\uff0e\u51dd\u56fa\u30fb\u7dda\u6eb6\u95a2\u9023\u691c\u67fb \u03b2-\u30c8\u30ed\u30f3\u30dc\u30b0\u30ed\u30d6\u30ea\u30f3\u3001\u8840\u5c0f\u677f\u7b2c4\u56e0\u5b50\uff0e\u814e\u3068\u900f\u6790 84\uff1a229-230\uff0c2018\uff0e<\/li>\n<\/ol>\n\n\n\n

                                                                                                    \u548c\u6587\u7dcf\u8aac\uff1aJapanese Review Articles<\/h4>\n\n\n\n
                                                                                                      \n
                                                                                                    1. \u6c60\u7530 \u5747\uff0c\u77e2\u51a8 \u88d5\uff0e\u809d\u7dda\u7dad\u5316\u30de\u30fc\u30ab\u30fc\uff0eSRL\u5b9d\u51fd 39\uff1a4-11\uff0c2018\uff0e<\/li>\n\n\n\n
                                                                                                    2. \u5c0f\u91ce \u4f73\u4e00\uff0c\u4f50\u85e4 \u667a\u660e\uff0c\u77e2\u51a8 \u88d5\uff0e\u5185\u90e8\u7cbe\u5ea6\u7ba1\u7406\u306e\u5b9f\u969b\uff5e\u751f\u5316\u5b66\u691c\u67fb\uff5e\uff0eMedical Technology 46\uff1a1312-1320\uff0c2018\uff0e<\/li>\n\n\n\n
                                                                                                    3. \u5927\u9580 \u96c5\u592b\uff0e\u5f01\u819c\u75c7\u306e\u9375\u3092\u63e1\u308b\u5fc3\u30a8\u30b3\u30fc\u56f3\uff1a\u8a3a\u65ad\u30fb\u30d5\u30a9\u30ed\u30fc\u30a2\u30c3\u30d7\u30fb\u6cbb\u7642\u9069\u5fdc\uff0eVita 35\uff1a 40-52\uff0c2018\uff0e<\/li>\n\n\n\n
                                                                                                    4. \u8535\u91ce \u4fe1\uff0e\u8102\u8cea\u691c\u67fb\uff0e\u81e8\u5e8a\u6804\u990a 133\uff1a413-417\uff0c2018\uff0e<\/li>\n\n\n\n
                                                                                                    5. \u8535\u91ce \u4fe1\uff0eGWAS\u3068\u52d5\u8108\u786c\u5316\uff0e\u30ab\u30ec\u30f3\u30c8\u30c6\u30e9\u30d4\u30fc 36\uff1a1130-1130\uff0c2018\uff0e<\/li>\n\n\n\n
                                                                                                    6. \u8535\u91ce \u4fe1\uff0c\u585a\u672c \u548c\u4e45\uff0c\u6e05\u6c34 \u77e5\uff0c\u77e2\u51a8 \u88d5\uff0e\u7cd6\u4ee3\u8b1d\u7570\u5e38\u306b\u304a\u3051\u308b\u30b9\u30d5\u30a3\u30f3\u30b4\u30b7\u30f31-\u30ea\u30f3\u9178\/\u30a2\u30dd\u86cb\u767dM\u8ef8\u306e\u5f79\u5272\uff0e\u8102\u8cea\u751f\u5316\u5b66\u7814\u7a76 60\uff1a201-202\uff0c2018\uff0e<\/li>\n\n\n\n
                                                                                                    7. \u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0e\u8102\u80aa\u9178\u30af\u30aa\u30ea\u30c6\u30a3\u306b\u7740\u76ee\u3057\u305f\u65b0\u3057\u3044\u81e8\u5e8a\u691c\u67fb\u3078\u306e\u53ef\u80fd\u6027\uff0e\u533b\u5b66\u306e\u3042\u3086\u307f 264\uff1a979-983\uff0c2018\uff0e<\/li>\n\n\n\n
                                                                                                    8. \u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0e\u30ea\u30be\u30ea\u30f3\u8102\u8cea\u3068\u75c5\u614b\uff0e\u7d30\u80de 50\uff1a132-135\uff0c2018\uff0e<\/li>\n\n\n\n
                                                                                                    9. \u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0e\u30ea\u30dd\u30af\u30aa\u30ea\u30c6\u30a3\u306b\u6ce8\u76ee\u3057\u305f\u81e8\u5e8a\u691c\u67fb\u306e\u53ef\u80fd\u6027\uff0e\u5b9f\u9a13\u533b\u5b66 36\uff1a1767-1772\uff0c2018\uff0e<\/li>\n\n\n\n
                                                                                                    10. \u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0e\u30d2\u30c8\u75be\u60a3\u306b\u304a\u3051\u308b\u30ea\u30be\u30ea\u30f3\u8102\u8cea\u30e1\u30c7\u30a3\u30a8\u30fc\u30bf\u30fc\uff0e\u751f\u5316\u5b66 90\uff1a643-650\uff0c2018\uff0e<\/li>\n\n\n\n
                                                                                                    11. \u5e38\u540d \u653f\u5f18\uff0c\u5897\u6238 \u68a8\u6075\uff0c\u897f\u5ddd \u771f\u5b50\uff0c\u66fd\u6839 \u4f38\u6cbb\uff0c\u77e2\u51a8 \u88d5\uff0e\u5857\u62b9\u6a19\u672c\u4f5c\u6210\u30fb\u67d3\u8272\u306e\u30d4\u30c3\u30c8\u30d5\u30a9\u30fc\u30eb EDTA\u52a0\u9aa8\u9ac4\u6db2\u306e\u529f\u3068\u7f6a\uff0e\u65e5\u672c\u691c\u67fb\u8840\u6db2\u5b66\u4f1a\u96d1\u8a8c 19\uff1a74-81\uff0c2018\uff0e<\/li>\n\n\n\n
                                                                                                    12. \u7530\u4e2d \u96c5\u7f8e\uff0c\u5bbf\u8c37 \u8ce2\u4e00\uff0e\u6280\u8853\u8b1b\u5ea7 \u5168\u81ea\u52d5\u5c3f\u4e2d\u6709\u5f62\u6210\u5206\u5206\u6790\u88c5\u7f6e\u3092\u4f7f\u3044\u3053\u306a\u3059\uff0e\u691c\u67fb\u3068\u6280\u8853 46\uff1a458-463\uff0c2018\uff0e<\/li>\n\n\n\n
                                                                                                    13. \u4e2d\u5c3e \u502b\u5b50\uff0e\u50e7\u5e3d\u5f01\u3092\u89b3\u5bdf\u3059\u308b\u969b\u306e\u5fc3\u30a8\u30b3\u30fc\u57fa\u672c\u65ad\u9762\uff0eCATHLAB JIN 1\uff1a60- 63, 2018\uff0c2018\uff0e<\/li>\n\n\n\n
                                                                                                    14. \u5b89\u5ddd\u6075\u5b50\uff0e\u7cd6\u5c3f\u75c5\u95a2\u9023\u6307\u6a19\u306e\u6a19\u6e96\u5316\uff0eHbA1c\u3068\u30b0\u30ea\u30b3\u30a2\u30eb\u30d6\u30df\u30f3\uff08GA\uff09\uff0e\u81e8\u5e8a\u75c5\u7406 66\uff1a37-48\uff0c2018\uff0e<\/li>\n\n\n\n
                                                                                                    15. \u77e2\u51a8 \u88d5\uff0e\u691c\u67fb\u5024\u306e\u610f\u5473\u3068\u8aad\u307f\u65b9\u306e\u30dd\u30a4\u30f3\u30c8\uff1a\u7dcf\u8ad6\uff0e\u81e8\u5e8a\u6804\u990a 133\uff1a396-401\uff0c2018\uff0e<\/li>\n\n\n\n
                                                                                                    16. \u77e2\u51a8 \u88d5\uff0e\u9ad8\u5ea6\u306e\u5927\u7403\u6027\u8ca7\u8840\uff0eMedical Practice 35\uff1a653-655\uff0c2018\uff0e<\/li>\n\n\n\n
                                                                                                    17. \u77e2\u51a8 \u88d5\uff0c\u6afb\u4e95 \u6643\u6d0b\uff0c\u4e2d\u8c37 \u4e2d\uff0c\u5bae\u5730 \u52c7\u4eba\uff0c\u6a2a\u7530 \u6d69\u5145\uff0e\u30b2\u30ce\u30e0\u533b\u7642\u6642\u4ee3\u3092\u8fce\u3048\u3066\uff0eModern Media 64\uff1a1-25\uff0c2018\uff0e<\/li>\n<\/ol>\n\n\n\n

                                                                                                      \u548c\u6587\u8457\u66f8\uff1aJapanese Book Chapter<\/h4>\n\n\n\n
                                                                                                        \n
                                                                                                      1. \u77f3\u6e21 \u60c7\u5e73\uff0c\u5927\u9580 \u96c5\u592b\uff0e\u5fc3\u7b4b\u6897\u585e\u306e\u6a5f\u68b0\u7684\u5408\u4f75\u75c7\uff0e\u5fc3\u30a8\u30b3\u30fc \uff1a\u7279\u96c6\u300c\u5fc3\u30a8\u30b3\u30fc\u56f3\u691c\u67fb\u306b\u8eab\u4f53\u6240\u898b\u3092\u6d3b\u304b\u3059\uff1a\u30d5\u30a3\u30b8\u30ab\u30eb\uff06\u30a8\u30b3\u30fc\u300d\uff08\u5927\u9580 \u96c5\u592b \u7de8\uff09 pp. 60\uff0d69\uff0e\u6587\u5149\u5802\uff0c\u6771\u4eac\uff0e2018\uff0e<\/li>\n\n\n\n
                                                                                                      2. \u5927\u9580 \u96c5\u592b\uff0e\u89e6\u8a3a\u304b\u3089\u3053\u308c\u3060\u3051\u308f\u304b\u308b\uff0e\u7279\u96c6Physical examination\u3092\u8eab\u306b\u3064\u3051\u308b\uff0eHeart View \uff08\u5ba4\u751f \u5353 \u7de8\uff09 pp. 45-52\uff0e\u30e1\u30b8\u30ab\u30eb\u30d3\u30e5\u30fc\u793e\uff0c\u6771\u4eac\uff0e2018\uff0e<\/li>\n\n\n\n
                                                                                                      3. \u5927\u9580 \u96c5\u592b\uff0e\u7279\u96c6\uff1a\u5faa\u74b0\u5668\u75be\u60a3\u8a3a\u764250\u5e74\u3092\u632f\u308a\u8fd4\u3063\u3066-\u5f01\u819c\u75c7\u306b\u304a\u3051\u308b\u308f\u304c\u56fd\u306e\u6b69\u307f-\u8a3a\u65ad\u306e\u9032\u6b69\uff0e\u5fc3\u81d3\uff0e\uff08\u7aaa\u7530 \u535a \u4f01\u753b\uff09pp341-348\uff0e\u5fc3\u81d3\u8ca1\u56e3\uff0c\u6771\u4eac\uff0c2018\uff0e<\/li>\n\n\n\n
                                                                                                      4. \u7530\u4e2d \u96c5\u7f8e\uff0c\u5bbf\u8c37 \u8ce2\u4e00\uff0e\u5c3f\u4fbf\u691c\u67fb \u5c3f\u691c\u67fb\uff0e\u300c\u81e8\u5e8a\u6804\u990a\u300d\u5897\u520a\u53f7\u300c\u75c5\u68df\u7ba1\u7406\u6804\u990a\u58eb\u306e\u305f\u3081\u306e\u81e8\u5e8a\u691c\u67fb\u30d5\u30a1\u30fc\u30b9\u30c8\u30ac\u30a4\u30c9\u300d\uff08\u7aaa\u7530 \u76f4\u4eba\uff0c\u4f0a\u5730\u77e5 \u79c0\u660e\uff0c\u95a2\u6839 \u91cc\u6075 \u4f01\u753b\uff09 pp. 488-491\uff0e\u533b\u6b6f\u85ac\u51fa\u7248\u682a\u5f0f\u4f1a\u793e\uff0c\u6771\u4eac\uff0e2018\uff0e<\/li>\n\n\n\n
                                                                                                      5. \u897f\u5ddd \u5c1a\u5b50\uff0c\u6c60\u7530 \u5747\uff0e\u816b\u760d\u30de\u30fc\u30ab\u30fc AFP\uff0cAFP-L3\uff0cPIVKAII\uff0e\u304c\u3093\u306e\u81e8\u5e8a\u691c\u67fb\u30cf\u30f3\u30c9\u30d6\u30c3\u30af\uff08\u5c71\u7530 \u4fca\u4e4b\uff0c\u524d\u5ddd \u771f\u4eba \u7de8\uff09pp. 76-83\uff0e\u65e5\u672c\u533b\u4e8b\u65b0\u5831\u793e\uff0c\u6771\u4eac\uff0e2018\uff0e<\/li>\n\n\n\n
                                                                                                      6. \u6301\u7530 \u667a\u4e4b\uff0e\u8133\u6ce2\u691c\u67fb\u306f\u3069\u306e\u3088\u3046\u306b\u884c\u308f\u308c\u307e\u3059\u304b\uff1f\u3069\u306e\u3088\u3046\u306a\u3053\u3068\u304c\u308f\u304b\u308a\u307e\u3059\u304b\uff1f\u3066\u3093\u304b\u3093\u652f\u63f4Q&A \u30ea\u30cf\u30d3\u30ea\u30fb\u751f\u6d3b\u652f\u63f4\u306e\u5b9f\u8df5\uff0e\uff08\u8c37\u53e3 \u8c6a\uff0c\u897f\u7530 \u62d3\u53f8\uff0c\u5ee3\u5be6 \u771f\u5f13 \u7de8\uff09pp. 40-41\uff0e\u533b\u6b6f\u85ac\u51fa\u7248\u682a\u5f0f\u4f1a\u793e\uff0c\u6771\u4eac\uff0e2018\uff0e<\/li>\n\n\n\n
                                                                                                      7. \u5927\u9580 \u96c5\u592b\uff0e\u2162-8\u3000\u611f\u67d3\u6027\u5fc3\u5185\u819c\u708e\uff0e\u8a3a\u7642\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3up-to-date 2018-1029\uff08\u9580\u8107 \u5b5d\uff0c\u5c0f\u5ba4 \u4e00\u6210\uff0c\u5bae\u5730 \u826f\u6a39 \u76e3\u4fee\uff09pp. 174-179\uff0e\u30e1\u30c7\u30a3\u30ab\u30eb\u30ec\u30d3\u30e5\u30fc\u793e\uff0c\u5927\u962a\uff0c2018\uff0e<\/li>\n\n\n\n
                                                                                                      8. \u9f4b\u85e4 \u5ba3\u5f66\uff0c\u5927\u9580 \u96c5\u592b\uff0e\u30ca\u30fc\u30b9\u30fb\u30e1\u30c7\u30a3\u30ab\u30eb\u30b9\u30bf\u30c3\u30d5\u306e\u305f\u3081\u306e\u5faa\u74b0\u5668\u30ec\u30af\u30c1\u30e5\u30a2 \u7b2c4\u7248\uff0e\u6587\u5149\u5802\uff0c\u6771\u4eac\uff0c2018\uff0e<\/li>\n<\/ol>\n\n\n\n

                                                                                                        \u548c\u6587\u7de8\u8457\u7b49\uff1aJapanese Book Editing<\/h4>\n\n\n\n
                                                                                                          \n
                                                                                                        1. \u5927\u9580 \u96c5\u592b \u7de8\uff0e\u5fc3\u30a8\u30b3\u30fc \u300c\u5fc3\u30a8\u30b3\u30fc\u56f3\u691c\u67fb\u306b\u8eab\u4f53\u6240\u898b\u3092\u6d3b\u304b\u3059\uff1a\u30d5\u30a3\u30b8\u30ab\u30eb\uff06\u30a8\u30b3\u30fc\u300d\u6587\u5149\u5802\uff0c\u6771\u4eac\uff0e2018\uff0e<\/li>\n\n\n\n
                                                                                                        2. \u5927\u9580 \u96c5\u592b \u7de8\uff0e\u5fc3\u30a8\u30b3\u30fc \u300c\u4e8c\u6b21\u6027\u5fc3\u7b4b\u75c7\u3078\u306e\u30c8\u30fc\u30bf\u30eb\u30a2\u30d7\u30ed\u30fc\u30c1\u300d\u6587\u5149\u5802\uff0c\u6771\u4eac\uff0e2018\uff0e<\/li>\n<\/ol>\n<\/div><\/div>\n\n\n\n
                                                                                                          \n

                                                                                                          2017\u5e74<\/h3>\n\n\n\n

                                                                                                          \u82f1\u6587\u539f\u8457\u8ad6\u6587\uff1aEnglish Original Articles<\/h4>\n\n\n\n
                                                                                                            \n
                                                                                                          1. Aikawa, S., Kano, K., Inoue, A., Wang, J., Saigusa, D., Nagamatsu, T., Hirota, Y., Fujii, T., Tsuchiya, S., Taketomi, Y., Sugimoto, Y., Murakami, M., Arita, M., Kurano, M., Ikeda, H., Yatomi, Y., Chun, J., and Aoki, J. Autotaxin-lysophosphatidic acid-LPA3 signaling at the embryo-epithelial boundary controls decidualization pathways. EMBO J. <\/strong><\/em>36: 2146-2160<\/a>, 2017.<\/li>\n\n\n\n
                                                                                                          2. Baba, H., Kurano, M., Nishida, T., Hatta, H., Hokao, R., and Tsuneyama, K. Facilitatory effect of insulin treatment on hepatocellular carcinoma development in diabetes. BMC Res. Notes.<\/strong><\/em> 10:478<\/a>, 2017.<\/li>\n\n\n\n
                                                                                                          3. Chu-Su, Y., Shukuya, K., Yokoyama, T., Lin, W.C., Chiang, C.K., and Lin, C.W. Enhancing the Detection of Dysmorphic Red Blood Cells and Renal Tubular Epithelial Cells with a Modified Urinalysis Protocol. Sci. Rep.<\/em><\/strong> 7: 40521<\/a>, 2017.<\/li>\n\n\n\n
                                                                                                          4. Daikoku, T. and Yumoto, M. Single, but not dual, attention facilitates statistical learning of two concurrent auditory sequences. Sci. Rep.<\/strong><\/em> 7: 10108<\/a>, 2017.<\/li>\n\n\n\n
                                                                                                          5. Daikoku, T., Yatomi, Y., and Yumoto, M. Statistical learning of an auditory sequence and reorganization of acquired knowledge: A time course of word segmentation and ordering. Neuropsychologia.<\/strong><\/em> 95: 1-10<\/a>, 2017.<\/li>\n\n\n\n
                                                                                                          6. Emoto, S., Kurano, M., Kano, K., Matsusaki, K., Yamashita, H., Nishikawa, M., Igarashi, K., Ikeda, H., Aoki, J., Kitayama, J., and Yatomi, Y. Analysis of glycero-lysophospholipids in gastric cancerous ascites. J. Lipid Res.<\/strong><\/em> 58: 763-771<\/a>, 2017.<\/li>\n\n\n\n
                                                                                                          7. Endo, M., Soroida, Y., Sato, M., Kobayashi, T., Hikita, H., Sato, M., Gotoh, H., Iwai, T., , Sone, S., Sasano, T., Sumi, Y., Koike, K. Yatomi, Y., and Ikeda, H. Ultrasound evaluation of liver stiffness: accuracy of ultrasound imaging for the prediction of liver cirrhosis as evaluated using a liver stiffness measurement. J. Med. Dent. Sci.<\/strong><\/em> 64: 27-34<\/a>, 2017.<\/li>\n\n\n\n
                                                                                                          8. Hassan, A., Dohi, T., Miyauchi, K., Ogita, M., Kurano, M., Ohkawa, R., Nakamura, K., Tamura, H., Isoda, K., Okazaki, S., Yatomi, Y., and Daida, H. Prognostic impact of homocysteine levels and homocysteine thiolactonase activity on long-term clinical outcomes in patients undergoing percutaneous coronary intervention. J. Cardiol.<\/em><\/strong> 69: 830-835<\/a>, 2017.<\/li>\n\n\n\n
                                                                                                          9. Hirose, K., Daimon, M., Miyazaki, S., Chiang, S.J., Morimoto-Ichikawa, R., Maruyama, M., Kawata, T., Ohmura, H., and Daida, H. Estrogen variation during the menstrual cycle does not influence left ventricular diastolic function and untwisting rate in premenopausal women. J. Cardiol.<\/strong><\/em> 69: 389-393<\/a>, 2017.<\/li>\n\n\n\n
                                                                                                          10. Jiang, Y., Lei, C., Yasumoto, A., Kobayashi, H., Aisaka, Y., Ito, T., Guo, B., Nitta, N., Kutsuna, N., Ozeki, Y., Nakagawa, A., Yatomi, Y., and Goda K. Label-free detection of aggregated platelets in blood by machine-learning-aided optofluidic time-stretch microscopy. Lab. Chip.<\/strong><\/em> 17: 2426-2434<\/a>, 2017. Press Release.<\/a><\/li>\n\n\n\n
                                                                                                          11. Kawata, T., Daimon, M., Kimura, K., Nakao, T., Lee, S.L., Hirokawa, M., Kato, T.S., Watanabe, M., Yatomi, Y., and Komuro, I. Echocardiographic assessment of right ventricular function in routine practice: Which parameters are useful to predict one-year outcome in advanced heart failure patients with dilated cardiomyopathy? J. Cardiol. <\/strong><\/em>70: 316-322<\/a>, 2017.<\/li>\n\n\n\n
                                                                                                          12. Kawata, T., Daimon, M., Lee, S.L., Kimura, K., Sawada, N., Chiang, S.J., Mahara, K., Okubo, T., Nakao, T., Hirokawa, M., Xu, B., Kato, T.S., Watanabe, M., Yatomi, Y., and Komuro, I. Reconsideration of Inferior Vena Cava Parameters for Estimating Right Atrial Pressure in an East Asian Population – Comparative Simultaneous Ultrasound-Catheterization Study. Circ J.<\/strong><\/em> 81: 346-352<\/a>, 2017.<\/li>\n\n\n\n
                                                                                                          13. Komeno, Y., Uchida, N., Sato, Y., Uryu, H., Iwata, Y., Masuda, A., Iihara, K., Yatomi, Y., Taniguchi, S., and Ryu, T. Bosutinib as the fourth-line therapy for a patient with T315I-positive lymphoid blastic phase chronic myeloid leukemia. Oncology Letters<\/strong><\/em>13: 4285-4289<\/a>, 2017.<\/li>\n\n\n\n
                                                                                                          14. Kurano, M., Nishikawa, M., Kuma, H., Jona, M., and Yatomi, Y. Involvement of Band3 in the efflux of sphingosine 1-phosphate from erythrocytes. PLoS One<\/strong><\/em> 12: e0177543<\/a>, 2017.<\/li>\n\n\n\n
                                                                                                          15. Kurano, M., Hara, M., Ikeda, H., Tsukamoto, K., and Yatomi, Y. Involvement of Cholesteryl Ester Transfer Protein in the Shift of Sphingosine 1-Phosphate Among Lipoproteins and in the Modulation of its Functions. Arterioscler. Thromb. Vasc. Biol.<\/strong><\/em> 37: 506-514<\/a>, 2017.<\/li>\n\n\n\n
                                                                                                          16. Kurano, M., Kano, K., Dohi, T., Matsumoto, H., Igarashi, K., Nishikawa, M., Ohkawa, R., Ikeda, H., Miyauchi, K., Daida, H., Aoki, J., and Yatomi, Y. Different Origins of Lysophospholipid Mediators between Coronary and Peripheral Arteries in Acute Coronary Syndrome. J. Lipid Res.<\/strong><\/em> 58: 433-442<\/a>, 2017.<\/li>\n\n\n\n
                                                                                                          17. Lin, H.C., Daimon, M., Wang, C.H., Ho, Y., Uang, Y.S., Chiang, S.J., and Wang, L.H. Allopurinol, Benzbromarone and risk of coronary heart disease in gout patients: a population-based study. Int. J. Cardiol.<\/strong><\/em> 233: 85-90<\/a>, 2017.<\/li>\n\n\n\n
                                                                                                          18. Maeda, S., Nakamura, T., Harada, H., Tachibana, Y., Aritake, K., Shimosawa, T., Yatomi, Y., and Murata, T. Prostaglandin D2<\/sub> metabolite in urine is an index of food allergy. Sci. Rep.<\/strong><\/em> 7: 17687<\/a>, 2017. Press Release.<\/a><\/li>\n\n\n\n
                                                                                                          19. Masudo, R., Yasukawa, K., Nojiri, T., Yoshikawa, N., Shimosaka, H., Sone, S., Oike, Y., Ugawa, A., Yamazaki, T., Shimokado, K., Yatomi, Y., and Ikeda, H. Evaluation of human nonmercaptalbumin as a marker for oxidative stress and its association with various parameters in blood. J. Clin. Biochem. Nutr.<\/strong><\/em> 61: 79-84<\/a>, 2017.<\/li>\n\n\n\n
                                                                                                          20. Matsuda, K., Taoka, K., Jona, M., Masuda, A., Arai, S., Nakamura, F., Yatomi, Y., and Kurokawa, M. Clinical features of hematological disorders with increased large granular lymphocytes (LGLs): a retrospective study. Ann. Hematol.<\/em><\/strong> 96: 2113-2115<\/a>, 2017.<\/li>\n\n\n\n
                                                                                                          21. Momomura, S., Saito, Y., Yasumura, Y., Yamamoto, K., Sakata, Y., Daimon, M., Kinugawa, K., Okamoto, H., Dohi, N., and Komuro, I. Efficacy and safety of switching from oral bisoprolol to transdermal patch in Japanese patients with chronic heart failure. Circ. J. <\/strong><\/em>82: 141-147<\/a>, 2017.<\/li>\n\n\n\n
                                                                                                          22. Mori, E., Kurano, M., Tobita, A., Shimosaka, H., and Yatomi, Y. Existence of a squamous cell carcinoma antigen-immunoglobulin complex causes a deviation between squamous cell carcinoma antigen concentrations determined using two different immunoassays: first report of squamous cell carcinoma antigen coupling with immunoglobulin A. Ann. Clin. Biochem.<\/strong><\/em> 54: 655-663<\/a>, 2017.<\/li>\n\n\n\n
                                                                                                          23. Myojo, M., Ando, J., Uehara, M., Daimon, M., Watanabe, M., and Komuro, I. Feasibility of extracorporeal shock wave myocardial revascularization therapy for post-acute myocardial infarction patients and refractory angina pectoris patients. Int. Heart. J.<\/strong><\/em> 58: 185-190<\/a>, 2017.<\/li>\n\n\n\n
                                                                                                          24. Numata, N., Makinae, H., Yoshida, W., Daimon, M., and Murakami, H. Disaster Victim Identification using Orthopedic Implants in the 2011 East-Japan Earthquake and Tsunami. Tohoku J. Exp. Med.<\/strong><\/em> 241: 219-223<\/a>, 2017.<\/li>\n\n\n\n
                                                                                                          25. Sakatani, T., Maemura, K., Hiyama, N., Amano, Y., Watanabe, K., Kage, H., Fukayama, M., Nakajima, J., Yatomi, Y., Nagase, T., and Takai, D. High expression of IRE1 in lung adenocarcinoma is associated with a lower rate of recurrence. Jpn. J. Clin. Oncol.<\/strong><\/em> 47: 543-550<\/a>, 2017.<\/li>\n\n\n\n
                                                                                                          26. Sato, M., Tateishi, R., Yasunaga, H., Horiguchi, H., Matsui, H., Yoshida, H., Fushimi, K., and Koike K. The ADOPT-LC score: a novel predictive index of in-hospital mortality of cirrhotic patients following surgical procedures, based on a national survey. Hepatol. Res.<\/strong><\/em> 47: E35-E43<\/a>, 2017.<\/li>\n\n\n\n
                                                                                                          27. Sato, M., Tateishi, R., Yasunaga, H., Matsui, H., Fushimi, K., Ikeda, H., Yatomi, Y., and Koike, K. Association between hospital volume and in-hospital mortality following radiofrequency ablation for hepatocellular carcinoma. BJS Open<\/strong><\/em> 1:50-54<\/a>, 2017.<\/li>\n\n\n\n
                                                                                                          28. Sato, M., Tateishi, R., Yasunaga, H., Matsui, H., Horiguchi, H., Fushimi, K., and Koike K. Mortality and hemorrhagic complications associated with radiofrequency ablation for treatment of hepatocellular carcinoma in patients on hemodialysis for end-stage renal disease: a nationwide survey. J. Gastroenterol. Hepatol.<\/strong><\/em> 32: 1873-1878<\/a>, 2017.<\/li>\n\n\n\n
                                                                                                          29. Takahashi, C., Kurano, M., Nishikawa, M., Kano, K., Dohi, T,. Miyauchi, K., Daida, H., Shimizu, T., Aoki, J., and Yatomi, Y. Vehicle-dependent Effects of Sphingosine 1-phosphate on Plasminogen Activator Inhibitor-1 Expression. J. Atheroscler Thromb.<\/strong><\/em> 24: 954-969<\/a>, 2017.<\/li>\n\n\n\n
                                                                                                          30. Yamaguchi, H., Satoh, Y., Ishigami, H., Kurihara, M., Yatomi, Y., and Kitayama, J.Peritoneal Lavage CEA mRNA Levels Predict Conversion Gastrectomy Outcomes after Induction Chemotherapy with Intraperitoneal Paclitaxel in Gastric Cancer Patients with Peritoneal Metastasis. Ann. Surg. Oncol. <\/strong><\/em>24: 3345\u20133352<\/a>, 2017.<\/li>\n\n\n\n
                                                                                                          31. Yasumoto, A., Ishiura, R., Narushima, M., and Yatomi, Y. Successful treatment with dabigatran f xr consumptive coagulopathy associated with extensive vascular malformations. Blood Coagul Fibrinolysis<\/em>.<\/strong> 28: 670-674<\/a>, 2017.<\/li>\n\n\n\n
                                                                                                          32. Yasumoto, A., Tokuoka, S.M., Kita, Y., Shimizu, T., and Yatomi, Y. Multiplex quantitative analysis of eicosanoid mediators in human plasma and serum: Possible introduction into clinical testing. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.<\/strong> <\/em>1068-1069: 98-104<\/a>, 2017.<\/li>\n\n\n\n
                                                                                                          33. Watanabe, S., Ogasawara, T., Tamura, Y., Saito, T., Ikeda, T., Suzuki, N., Shimosawa, T., Shibata, S., Chung, U.I., Nangaku, M., and Uchida, S. Targeting gene expression to specific cells of kidney tubules in vivo, using adenoviral promoter fragments. PLoS One.<\/strong><\/em> 12: e0168638<\/a>, 2017.<\/li>\n<\/ol>\n\n\n\n

                                                                                                            \u56fd\u5185\u5b66\u4f1a\u767a\u8868\uff1aDomestic Conference Presentation<\/h4>\n\n\n\n
                                                                                                              \n
                                                                                                            1. \u77f3\u539f \u6709\u7406\uff0c\u98db\u7530 \u660e\u5b50\uff0c\u5c0f\u5ddd \u821e\u5b50\uff0c\u5409\u5ddd \u76f4\u4e4b\uff0c\u4e0b\u5742 \u6d69\u5247\uff0c\u66fd\u6839 \u4f38\u6cbb\uff0c\u6c60\u7530 \u5747\uff0c\u77e2\u51a8 \u88d5\uff0e\u30eb\u30df\u30d1\u30eb\u30b9L2400\u3092\u7528\u3044\u305f\u9ad8\u611f\u5ea6\u30c8\u30ed\u30dd\u30cb\u30f3I\u6e2c\u5b9a\u7528\u8a66\u85ac\u306e\u57fa\u790e\u7684\u691c\u8a0e\uff0e\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u81ea\u52d5\u5316\u5b66\u4f1a \u7b2c49\u56de\u5927\u4f1a\uff0e2017.9.21-23\uff0e\u6a2a\u6d5c\uff0e<\/li>\n\n\n\n
                                                                                                            2. \u5c0f\u5ddd \u821e\u5b50\uff0c\u5c0f\u91ce \u4f73\u4e00\uff0c\u98db\u7530 \u660e\u5b50\uff0c\u4e0b\u5742 \u6d69\u5247\uff0c\u66fd\u6839 \u4f38\u6cbb\uff0c\u6c60\u7530 \u5747\uff0c\u77e2\u51a8 \u88d5\uff0e\u5168\u81ea\u52d5\u5316\u5b66\u514d\u75ab\u6e2c\u5b9a\u88c5\u7f6e\u30eb\u30df\u30d1\u30eb\u30b9 L2400\u3092\u7528\u3044\u305f\u30a4\u30f3\u30b9\u30ea\u30f3\u53ca\u3073C\u30da\u30d7\u30c1\u30c9\u6e2c\u5b9a\u7528\u8a66\u85ac\u306e\u57fa\u790e\u7684\u691c\u8a0e\uff0e\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u81ea\u52d5\u5316\u5b66\u4f1a \u7b2c49\u56de\u5927\u4f1a\uff0e2017.9.21-23\uff0e\u6a2a\u6d5c\uff0e<\/li>\n\n\n\n
                                                                                                            3. \u5ca1\u91ce \u667a\u5b50\uff0c\u5927\u9ed2 \u9054\u4e5f\uff0c\u5b87\u5ddd \u7fa9\u4e00\uff0c\u6e6f\u672c \u771f\u4eba\uff0e\u8074\u899a\u7d71\u8a08\u5b66\u7fd2\u306e\u96e3\u6613\u5ea6\u306b\u3068\u3082\u306a\u3046\u8133\u78c1\u5834\u5fdc\u7b54\uff0e\u7b2c22\u56de \u8a8d\u77e5\u795e\u7d4c\u79d1\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2017.7.29-30\uff0e\u6771\u4eac\uff0e<\/li>\n\n\n\n
                                                                                                            4. \u5c0f\u91ce \u4f73\u4e00\uff0c\u66fd\u6839 \u4f38\u6cbb\uff0c\u77e2\u51a8 \u88d5\uff0e\u6771\u5927\u75c5\u9662\u691c\u67fb\u90e8\u306eISO15189\u306e\u73fe\u72b6\uff0e\u7b2c73\u56de\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u95a2\u6771\u7532\u4fe1\u8d8a\u652f\u90e8\u4f8b\u4f1a\uff0c2017.5.27\uff0e\u6771\u4eac\uff0e<\/li>\n\n\n\n
                                                                                                            5. \u5c0f\u91ce \u4f73\u4e00\uff0c\u66fd\u6839 \u4f38\u6cbb\uff0c\u77e2\u51a8 \u88d5\uff0eISO15189\u306e\u624b\u5f15\u304d\uff5eISO15189\u3092\u53d6\u5f97\u3059\u308b\u610f\u5473\u3068\u624b\u9806\uff5e\uff0e\u7b2c64\u56de\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0c2017.11.17\uff0e\u4eac\u90fd\uff0e<\/li>\n\n\n\n
                                                                                                            6. \u5f71\u5c71 \u7950\u5b50. \u30a2\u30ab\u30c7\u30df\u30a2\u3067Lean Six Sigma\u3092\u5fdc\u7528\u3057\u305f\u54c1\u8cea\u6d3b\u52d5\u4e8b\u4f8b\uff0e\u7b2c14\u56de DIA\u65e5\u672c\u5e74\u4f1a\uff0e2017.11.12-14\uff0e\u6771\u4eac\uff0e<\/li>\n\n\n\n
                                                                                                            7. \u5f71\u5c71 \u7950\u5b50\uff0c\u5c0f\u5009 \u5948\u3005\uff0c\u5bae\u672c \u548c\u5b50\uff0c\u67f3\u7530 \u9053\u5b5d\uff0c\u5c71\u5d0e \u529b\uff0c\u5742\u4e2d \u5343\u6075\uff0e\u56fd\u969b\u5171\u540c\u7b2c1\u76f8\u6cbb\u9a13\u3078\u306e\u53c2\u52a0\u306b\u5411\u3051\u3066\uff1b\u56fd\u5185\u5916\u65bd\u8a2d\u306e\u6bd4\u8f03\u3068\u8003\u5bdf\u304b\u3089\uff0e\u7b2c38\u56de \u65e5\u672c\u81e8\u5e8a\u85ac\u7406\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2017.12.7-9\uff0e\u6a2a\u6d5c\uff0e<\/li>\n\n\n\n
                                                                                                            8. \u8535\u91ce \u4fe1\uff0c\u9577\u8c37\u5ddd \u6d69\u53f8\uff0c\u56fd\u898b \u57fa\u7469\uff0c\u539f \u771e\u7d14\uff0c\u77e2\u51a8 \u88d5\uff0c\u585a\u672c \u548c\u4e45\uff0e\u690d\u7269\u30b9\u30c6\u30ed\u30fc\u30eb\u5438\u53ce\u4fc3\u9032\u306f\uff0c\u80a5\u6e80\u306b\u3088\u308b\u6162\u6027\u708e\u75c7\u3092\u6291\u5236\u3059\u308b\uff0e\u7b2c60\u56de \u65e5\u672c\u7cd6\u5c3f\u75c5\u5b66\u4f1a\u5e74\u6b21\u5b66\u8853\u96c6\u4f1a\uff0e2017.5.19\uff0e\u540d\u53e4\u5c4b\uff0e<\/li>\n\n\n\n
                                                                                                            9. \u8535\u91ce \u4fe1\uff0c\u897f\u5ddd \u771f\u5b50\uff0c\u77e2\u51a8 \u88d5\uff0e K562\u7d30\u80de\u306f\uff0c\u30ea\u30be\u30db\u30b9\u30d5\u30a1\u30c1\u30b8\u30eb\u30bb\u30ea\u30f3\u306b\u3088\u308a\u5de8\u6838\u7403\u3078\u306e\u5206\u5316\u8a98\u5c0e\u304c\u4fee\u98fe\u3055\u308c\u308b\uff0e\u7b2c39\u56de \u65e5\u672c\u8840\u6813\u6b62\u8840\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2017.6.9\uff0e\u540d\u53e4\u5c4b\uff0e<\/li>\n\n\n\n
                                                                                                            10. \u8535\u91ce \u4fe1\uff0c\u53ef\u91ce \u90a6\u884c\uff0c\u5c0f\u6797 \u7389\u5b9c\uff0c\u9752\u6728 \u6df3\u8ce2\uff0c\u77e2\u51a8 \u88d5\uff0e\u30ea\u30dd\u86cb\u767d\u4ee3\u8b1d\u30fb\u4fee\u98fe\u306b\u3088\u308b\u30b0\u30ea\u30bb\u30ed\u30ea\u30be\u30ea\u30f3\u8102\u8cea\u306e\u5909\u52d5\uff0e\u7b2c59\u56de \u65e5\u672c\u8102\u8cea\u751f\u5316\u5b66\u4f1a\uff0e2017.6.15\uff0e\u4eac\u90fd\uff0e<\/li>\n\n\n\n
                                                                                                            11. \u8535\u91ce \u4fe1\uff0c\u585a\u672c \u548c\u4e45\uff0c\u677e\u5cf6 \u7167\u5f66\uff0c\u6c0f\u5bb6 \u4e00\u548c\uff0c\u4e2d\u5c3e \u512a\u7f8e\u5b50\uff0c\u91ce\u4e2d \u9054\u4e5f\uff0c\u661f\u91ce \u6b63\u4fe1\uff0c\u5bfa\u672c \u6c11\u751f\uff0e\u9577\u5bff\u3067\u3042\u3063\u305f\u5bb6\u65cf\u6027\u9ad8\u30b3\u30ec\u30b9\u30c6\u30ed\u30fc\u30eb\u8840\u75c7\u30db\u30e2\u63a5\u5408\u4f53\u306e1\u75c7\u4f8b\uff0e \u7b2c49\u56de \u65e5\u672c\u52d5\u8108\u786c\u5316\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u96c6\u4f1a\uff0e2017.7.7\uff0e\u5e83\u5cf6\uff0e<\/li>\n\n\n\n
                                                                                                            12. \u8535\u91ce \u4fe1\uff0c\u53ef\u91ce \u90a6\u4e4b\uff0c\u9752\u6728 \u6df3\u8ce2\uff0c\u77e2\u51a8 \u88d5\uff0e\u9178\u5316\uff0c\u7cd6\u5316\u306b\u3088\u308b\u30ea\u30dd\u86cb\u767d\u4e2d\u306e\u30ea\u30be\u30ea\u30f3\u8102\u8cea\u5909\u5316\u3068\u305d\u306e\u610f\u7fa9\uff0e\u7b2c32\u56de \u65e5\u672c\u7cd6\u5c3f\u75c5\u5408\u4f75\u75c7\u5b66\u4f1a\uff0e2017.10.27\uff0e\u6771\u4eac\uff0e<\/li>\n\n\n\n
                                                                                                            13. \u8535\u91ce \u4fe1\uff0c\u4e94\u5341\u5d50 \u6d69\u4e8c\uff0c\u6c60\u7530 \u5747\uff0c\u585a\u672c \u548c\u4e45\uff0c\u77e2\u51a8 \u88d5\uff0e\u30db\u30b9\u30d5\u30a1\u30c1\u30b8\u30eb\u30bb\u30ea\u30f3\u7279\u7570\u7684\u30db\u30b9\u30db\u30ea\u30d1\u30fc\u30bcA1\uff0c\u30ea\u30be\u30db\u30b9\u30d5\u30a1\u30c1\u30b8\u30eb\u30bb\u30ea\u30f3\u306e\u7cd6\u5c3f\u75c5\u306e\u75c5\u614b\u751f\u7406\u3078\u306e\u95a2\u4e0e\u306e\u89e3\u660e \uff0e\u7b2c64\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2017.11.17\uff0e\u4eac\u90fd\uff0e<\/li>\n\n\n\n
                                                                                                            14. \u8535\u91ce \u4fe1\uff0e\u30ea\u30dd\u86cb\u767d\u306b\u3088\u308b\u30b9\u30d5\u30a3\u30f3\u30b4\u30b7\u30f31-\u30ea\u30f3\u9178\u306e\u4ee3\u8b1d\u30fb\u6a5f\u80fd\u306e\u4fee\u98fe\uff0e2017\u5e74\u5ea6 \u751f\u547d\u79d1\u5b66\u7cfb\u5b66\u4f1a\u5408\u540c\u5e74\u6b21\u5927\u4f1a\uff08ConBio2017\uff09\uff0e2017.12.8\uff0c\u795e\u6238\uff0e<\/li>\n\n\n\n
                                                                                                            15. \u5c0f\u5800 \u6075\u7406\uff0c\u66fd\u6839 \u4f38\u6cbb\uff0c\u4e0b\u5742 \u6d69\u5247\uff0c\u77e2\u51a8 \u88d5\uff0c\u6253\u4fdd \u662d\u5178\uff0e\u9854\u8a8d\u8a3c\u30b7\u30b9\u30c6\u30e0\u306e\u691c\u67fb\u90e8\u3067\u306e\u6d3b\u7528\u306b\u304a\u3051\u308b\u7814\u7a76\uff0e\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u81ea\u52d5\u5316\u5b66\u4f1a \u7b2c49\u56de\u5927\u4f1a\uff0e2017.9.21-23\uff0e\u6a2a\u6d5c\uff0e<\/li>\n\n\n\n
                                                                                                            16. \u4f50\u85e4 \u96c5\u54c9\uff0c\u5eb7\u6c38 \u79c0\u751f\uff0c\u5efa\u77f3 \u826f\u4ecb\uff0c\u5c0f\u6c60 \u548c\u5f66\uff0e\u30e9\u30b8\u30aa\u6ce2\u713c\u707c\u8853\u5f8c\u9662\u5185\u6b7b\u4ea1\u7387\u306f\u65bd\u8a2d\u5e74\u9593\u75c7\u4f8b\u6570\u306e\u5f71\u97ff\u3092\u53d7\u3051\u308b -36675\u4eba\u3092\u5bfe\u8c61\u3068\u3057\u305f\u5168\u56fd\u30c7\u30fc\u30bf\u30d9\u30fc\u30b9\u306e\u89e3\u6790-\uff0e\u7b2c53\u56de \u65e5\u672c\u809d\u764c\u7814\u7a76\u4f1a\uff0e2017.7.6-7\uff0e\u6771\u4eac\uff0e<\/li>\n\n\n\n
                                                                                                            17. \u4f50\u85e4 \u96c5\u54c9\uff0c\u5efa\u77f3 \u826f\u4ecb\uff0c\u5c0f\u6c60 \u548c\u5f66\uff0e\u5168\u56fd\u898f\u6a21\u30c7\u30fc\u30bf\u30d9\u30fc\u30b9\u3092\u7528\u3044\u305f\u65e5\u672c\u306b\u304a\u3051\u308b\u900f\u6790\u60a3\u8005\u306b\u5bfe\u3059\u308b\u809d\u52d5\u8108\u585e\u6813\u8853\u306e\u6b7b\u4ea1\u7387\u30fb\u5408\u4f75\u75c7\u7387\u306e\u691c\u8a0e\uff0e\u7b2c53\u56de \u65e5\u672c\u809d\u81d3\u5b66\u4f1a\u7dcf\u4f1a\uff0e2017.6.8-9\uff0e\u5e83\u5cf6\uff0e<\/li>\n\n\n\n
                                                                                                            18. \u5fd7\u6751 \u62d3\u4e5f\uff0c\u4fdd\u7530 \u5948\u7dd2\u7f8e\uff0c\u5409\u5ddd \u76f4\u4e4b\uff0c\u4e0b\u5742 \u6d69\u5247\uff0c\u6c60\u7530 \u5747\uff0c\u77e2\u51a8 \u88d5\uff0e\u30e9\u30c6\u30c3\u30af\u30b9\u514d\u75ab\u6bd4\u6fc1\u6cd5\u3068\u5316\u5b66\u767a\u5149\u9175\u7d20\u514d\u75ab\u6e2c\u5b9a\u6cd5\u3092\u539f\u7406\u3068\u3059\u308bsIL-2R\u8a66\u85ac\u306e\u6bd4\u8f03\uff0e\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u81ea\u52d5\u5316\u5b66\u4f1a \u7b2c49\u56de\u5927\u4f1a\uff0e2017.9.21-23\uff0e\u6a2a\u6d5c\uff0e<\/li>\n\n\n\n
                                                                                                            19. \u5fd7\u6751 \u62d3\u4e5f\uff0c\u5409\u5ddd \u76f4\u4e4b\uff0c\u4e0b\u5742 \u6d69\u5247\uff0c\u6df1\u6fa4 \u6bc5\u502b\uff0c\u5409\u5d0e \u6b69\uff0c\u4f50\u85e4 \u4f38\u4e00\uff0c\u6c60\u7530 \u5747\uff0c\u77e2\u51a8 \u88d5\uff0e\u6297\u7d30\u80de\u8cea\u6297\u4f53(\u30bb\u30f3\u30c8\u30ea\u30aa\u30fc\u30eb\u578b)\u3092\u8a8d\u3081\u305f\u9650\u5c40\u6027\u76ae\u819a\u786c\u5316\u578b\u5168\u8eab\u6027\u5f37\u76ae\u75c7\u306e1\u4f8b\uff0e\u7b2c54\u56de \u65e5\u81e8\u6280\u95a2\u7532\u4fe1\u652f\u90e8\u30fb\u9996\u90fd\u570f\u652f\u90e8\u533b\u5b66\u691c\u67fb\u5b66\u4f1a\uff0e2017.10.28-29\uff0e\u57fc\u7389\uff0e<\/li>\n\n\n\n
                                                                                                            20. \u4e0b\u5742 \u6d69\u5247\uff0c\u7247\u5ca1 \u6d69\u5df3\uff0c\u5897\u7530 \u4e9c\u5e0c\u5b50\uff0c\u5ddd\u4e0a \u8087\uff0c\u5e38\u540d \u653f\u5f18\uff0c\u5927\u9580 \u96c5\u592b\uff0c\u6a2a\u7530 \u614e\u4e00\u90ce\uff0c\u77e2\u51a8 \u88d5\uff0e\u81ea\u52d5\u8840\u7403\u8a08\u6570\u88c5\u7f6eXN\u306e\u30c7\u30fc\u30bf\u30de\u30a4\u30cb\u30f3\u30b0\u7814\u7a76 \u8133\u6897\u585e\u306b\u304a\u3051\u308b\u8d64\u8840\u7403 \u95a2\u9023\u30d1\u30e9\u30e1\u30fc\u30bf\u306e\u5dee\u7570\uff0e\u7b2c64\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2017.11.18\uff0e\u4eac\u90fd\uff0e<\/li>\n\n\n\n
                                                                                                            21. \u5bbf\u8c37 \u8ce2\u4e00\uff0e\u65b0\u3057\u3044\u30bf\u30a4\u30d7\u306e\u5c3f\u7d30\u7ba1\u4e0a\u76ae\u7d30\u80de\u306e\u81e8\u5e8a\u7684\u610f\u7fa9\uff0e\u7b2c66\u56de \u65e5\u672c\u533b\u5b66\u691c\u67fb\u5b66\u4f1a\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\uff0e2017.06.17-18\uff0e\u5343\u8449\uff0e<\/li>\n\n\n\n
                                                                                                            22. \u5bbf\u8c37 \u8ce2\u4e00\uff0c\u68ee\u7530 \u8ce2\u53f2\uff0c\u7530\u4e2d \u96c5\u7f8e\uff0c\u6c34\u9593 \u77e5\u4e16\uff0c\u4e45\u672b \u5d07\u53f8\uff0c\u66fd\u6839 \u4f38\u6cbb\uff0c\u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0e\u5168\u81ea\u52d5\u5c3f\u4e2d\u6709\u5f62\u6210\u5206\u64ae\u50cf\u30e6\u30cb\u30c3\u30c8UD-10\u306b\u304a\u3051\u308b\u64ae\u50cf\u6027\u80fd\u306b\u3064\u3044\u3066\uff0e\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u81ea\u52d5\u5316\u5b66\u4f1a \u7b2c49\u56de\u5927\u4f1a\uff0e2017.09.21-23\uff0e\u6a2a\u6d5c\uff0e<\/li>\n\n\n\n
                                                                                                            23. \u5bbf\u8c37 \u8ce2\u4e00\uff0e\u5c3f\u6c88\u6e23\u691c\u67fb\u6cd5\u306e\u65b0\u305f\u306a\u53ef\u80fd\u6027\u3092\u5207\u308a\u62d3\u304f\u91cd\u8981\u306a\u6210\u5206\uff0e\u7b2c54\u56de \u65e5\u81e8\u6280\u95a2\u7532\u4fe1\u652f\u90e8\u30fb\u9996\u90fd\u570f\u652f\u90e8\u533b\u5b66\u691c\u67fb\u5b66\u4f1a\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\uff0e2017.10.28-29\uff0e\u6d66\u548c\uff0e<\/li>\n\n\n\n
                                                                                                            24. \u7b4b\u91ce \u88d5\u7f8e\u5b50\uff0c\u5f71\u5c71 \u7950\u5b50\uff0c\u5bae\u672c \u548c\u5b50\uff0c\u67f3\u7530 \u9053\u5b5d\uff0c\u5c71\u5d0e \u529b\uff0c\u5742\u4e2d \u5343\u6075\uff0e\u5927\u5b66\u75c5\u9662\u7b2c1\u76f8\u8a66\u9a13\u5b9f\u65bd\u65bd\u8a2d\u306b\u304a\u3051\u308b\uff0c\u30ea\u30fc\u30f3\u30fb\u30b7\u30c3\u30af\u30b9\u30b7\u30b0\u30de\u624b\u6cd5\u3092\u7528\u3044\u305f\u696d\u52d9\u52b9\u7387\u5316\u3078\u306e\u53d6\u308a\u7d44\u307f\uff0e\u7b2c38\u56de \u65e5\u672c\u81e8\u5e8a\u85ac\u7406\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2017.12.7-9\uff0e\u6a2a\u6d5c\uff0e<\/li>\n\n\n\n
                                                                                                            25. \u7530\u4e2d \u96c5\u7f8e\uff0c\u6c34\u9593 \u77e5\u4e16\uff0c\u68ee\u7530 \u8ce2\u53f2\uff0c\u5f71\u5c71 \u7950\u5b50\uff0c\u5bbf\u8c37 \u8ce2\u4e00\uff0c\u66fd\u6839 \u4f38\u6cbb\uff0c\u4e0b\u6fa4 \u9054\u96c4\uff0c\u77e2\u51a8 \u88d5\uff0e\u5c3f\u8def\u816b\u760d\u306e\u7591\u3044\u304c\u7121\u304f\u5c3f\u6c88\u6e23\u691c\u67fb\u306b\u3066\u7570\u578b\u7d30\u80de\u3092\u691c\u51fa\u3057\u305f\u75c7\u4f8b\u306e\u89e3\u6790\uff0e\u7b2c13\u56de \u814e\u30fb\u6ccc\u5c3f\u5668\u691c\u67fb\u7814\u7a76\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2017.3.12-13. \u5ca1\u5c71\uff0e<\/li>\n\n\n\n
                                                                                                            26. \u8c37\u6fa4 \u674e\u7d17\uff0c\u4fdd\u7530 \u5948\u7dd2\u7f8e\uff0c\u5fd7\u6751 \u62d3\u4e5f\uff0c\u91ce\u7530 \u7406\u7f8e\uff0c\u4e0b\u5742 \u6d69\u5247\uff0c\u66fd\u6839 \u4f38\u6cbb\uff0c\u6c60\u7530 \u5747\uff0c\u77e2\u51a8 \u88d5\uff0e\u9593\u63a5\u86cd\u5149\u6297\u4f53\u6cd5\u306b\u3088\u308b\u6297\u6838\u6297\u4f53\u691c\u67fb\u306b\u304a\u3051\u308b\u5168\u81ea\u52d5\u5206\u6790\u88c5\u7f6e\u306e\u8a55\u4fa11\u2212\u5404\u6a5f\u5668\u306e\u7279\u5fb4\u3068\u6297\u4f53\u4fa1\u4e00\u81f4\u7387\u2212\uff0e\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u81ea\u52d5\u5316\u5b66\u4f1a \u7b2c49\u56de\u5927\u4f1a\uff0e2017.9.21-23\uff0e\u6a2a\u6d5c\uff0e<\/li>\n\n\n\n
                                                                                                            27. \u8c37\u6fa4 \u674e\u7d17\uff0c\u4fdd\u7530 \u5948\u7dd2\u7f8e\uff0c\u5fd7\u6751 \u62d3\u4e5f\uff0c\u91ce\u7530 \u7406\u7f8e\uff0c\u4e0b\u5742 \u6d69\u5247\uff0c\u66fd\u6839 \u4f38\u6cbb\uff0c\u6c60\u7530 \u5747\uff0c\u77e2\u51a8 \u88d5\uff0e\u9593\u63a5\u86cd\u5149\u6297\u4f53\u6cd5\u306b\u3088\u308b\u6297\u6838\u6297\u4f53\u691c\u67fb\u306b\u304a\u3051\u308b\u5168\u81ea\u52d5\u5206\u6790\u88c5\u7f6e\u306e\u8a55\u4fa12\u2212\u30d1\u30bf\u30fc\u30f3\u5224\u5b9a\u306e\u4e00\u81f4\u7387\u2212\uff0e\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u81ea\u52d5\u5316\u5b66\u4f1a \u7b2c49\u56de\u5927\u4f1a\uff0e2017.9.21-23\uff0e\u6a2a\u6d5c\uff0e<\/li>\n\n\n\n
                                                                                                            28. \u4f0a\u9054 \u4e9c\u7406\u6c99\uff0c\u98db\u7530 \u660e\u5b50\uff0c\u4e0b\u5742 \u6d69\u5247\uff0c\u66fd\u6839 \u4f38\u6cbb\uff0c\u77e2\u51a8 \u88d5\uff0e\u6539\u826f\u578bPIVKA-II\u30ad\u30c3\u30c8\u300c\u30eb\u30df\u30d1\u30eb\u30b9\u30d7\u30ec\u30b9\u30c8PIVKAII-N\u300d\u306e\u57fa\u790e\u6027\u80fd\u8a55\u4fa1\uff0e\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u81ea\u52d5\u5316\u5b66\u4f1a \u7b2c49\u56de\u5927\u4f1a\uff0e2017.9.21-23\uff0e\u6a2a\u6d5c\uff0e<\/li>\n\n\n\n
                                                                                                            29. \u4e2d\u5c3e \u502b\u5b50\uff0c\u5b89\u672c \u7be4\u53f2\uff0c\u5927\u9580 \u96c5\u592b\uff0c\u77e2\u51a8 \u88d5. Nightshift work may lead to platelet hypersensitivity in healthy medical staffs. \u7b2c39\u56de \u65e5\u672c\u8840\u6813\u6b62\u8840\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2017.6.8-10\uff0e\u540d\u53e4\u5c4b\uff0e<\/li>\n\n\n\n
                                                                                                            30. \u4e2d\u6e21 \u4e00\u8cb4\uff0c\u98db\u7530 \u660e\u5b50\uff0c\u5409\u5ddd \u76f4\u4e4b\uff0c\u4e0b\u5742 \u6d69\u5247\uff0c\u66fd\u6839 \u4f38\u6cbb\uff0c\u6c60\u7530 \u5747\uff0c\u77e2\u51a8 \u88d5\uff0e\u5168\u81ea\u52d5\u5316\u5b66\u767a\u5149\u9175\u7d20\u514d\u75ab\u6e2c\u5b9a\u88c5\u7f6eAIA\u2010CL2400\u3092\u7528\u3044\u305fSCC\u6e2c\u5b9a\u306e\u57fa\u790e\u7684\u691c\u8a0e\uff0e\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u81ea\u52d5\u5316\u5b66\u4f1a \u7b2c49\u56de\u5927\u4f1a\uff0e2017.9.21-23\uff0e\u6a2a\u6d5c\uff0e<\/li>\n\n\n\n
                                                                                                            31. \u897f\u5ddd \u771f\u5b50\uff0c\u5897\u7530 \u4e9c\u5e0c\u5b50\uff0c\u5bfa\u5cf6 \u9053\u5b50\uff0c\u5e38\u540d \u653f\u5f18\uff0c\u66fd\u6839 \u4f38\u6cbb\uff0c\u77e2\u51a8 \u88d5\uff0e\u9ac4\u6db2\u30d5\u30ed\u30fc\u30b5\u30a4\u30c8\u30e1\u30c8\u30ea\u30fc\u304c\u4e2d\u67a2\u795e\u7d4c\u6d78\u6f64\u306e\u8a3a\u65ad\u306b\u6709\u7528\u3067\u3042\u3063\u305fmonomorphic epitheliotropic intestinal T-cell lymphoma\u306e1\u75c7\u4f8b\uff0e\u7b2c18\u56de \u65e5\u672c\u691c\u67fb\u8840\u6db2\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2017.7.22-23\uff0e\u672d\u5e4c\uff0e<\/li>\n\n\n\n
                                                                                                            32. \u91ce\u7530 \u7406\u7f8e\uff0c\u4fdd\u7530 \u5948\u7dd2\u7f8e\uff0c\u5fd7\u6751 \u62d3\u4e5f\uff0c\u4e0b\u5742 \u6d69\u5247\uff0c\u66fd\u6839 \u4f38\u6cbb\uff0c\u77e2\u51a8 \u88d5\uff0e(1\u21923)-\u03b2-D-\u30b0\u30eb\u30ab\u30f3\u6e2c\u5b9a\u8a66\u85ac\u30d5\u30a1\u30f3\u30ae\u30c6\u30c3\u30afG\u30c6\u30b9\u30c8ES\u306e\u81e8\u5e8a\u7684\u8a55\u4fa1\uff0e\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u81ea\u52d5\u5316\u5b66\u4f1a \u7b2c49\u56de\u5927\u4f1a\uff0e2017.9.21-23\uff0e\u6a2a\u6d5c\uff0e<\/li>\n\n\n\n
                                                                                                            33. \u4e45\u672b \u5d07\u53f8\uff0c\u7530\u4e2d \u96c5\u7f8e\uff0c\u6c34\u9593 \u77e5\u4e16\uff0c\u4f50\u85e4 \u6075\u7f8e\uff0c\u5bbf\u8c37 \u8ce2\u4e00\uff0c\u66fd\u6839 \u4f38\u6cbb\uff0c\u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0e\u9ac4\u6db2\u691c\u67fb\u306b\u3066\u5f62\u8cea\u7d30\u80de\u3092\u78ba\u8a8d\u3057\u305f\u591a\u767a\u6027\u9aa8\u9ac4\u816b\u306e\u4e00\u75c7\u4f8b\uff0e\u7b2c9\u56de \u65e5\u672c\u81e8\u5e8a\u4e00\u822c\u691c\u67fb\u5b66\u4f1a\uff0e2017.8.26\uff0e\u611b\u77e5\uff0e<\/li>\n\n\n\n
                                                                                                            34. \u4e45\u672b \u5d07\u53f8\uff0c\u7530\u4e2d \u96c5\u7f8e\uff0c\u6c34\u9593 \u77e5\u4e16\uff0c\u4f50\u85e4 \u6075\u7f8e\uff0c\u5bbf\u8c37 \u8ce2\u4e00\uff0c\u66fd\u6839 \u4f38\u6cbb\uff0c\u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0e\u5f37\u5ea6\u767d\u8272\u8abf\u3092\u5448\u3057\u305f\u95a2\u7bc0\u6db2\u306e\u4e00\u75c7\u4f8b\uff0e\u7b2c9\u56de \u65e5\u672c\u81e8\u5e8a\u4e00\u822c\u691c\u67fb\u5b66\u4f1a\uff0e2017.8.26\uff0e\u611b\u77e5\uff0e<\/li>\n\n\n\n
                                                                                                            35. \u4e45\u672b \u5d07\u53f8\uff0c\u7530\u4e2d \u96c5\u7f8e\uff0c\u6c34\u9593 \u77e5\u4e16\uff0c\u4f50\u85e4 \u6075\u7f8e\uff0c\u5bbf\u8c37 \u8ce2\u4e00\uff0c\u66fd\u6839 \u4f38\u6cbb\uff0c\u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0e\u5c3f\u4e2dL\u578b\u8102\u80aa\u9178\u7d50\u5408\u86cb\u767d\u6e2c\u5b9a\u8a66\u85ac\u300c\u30ce\u30eb\u30c7\u30a3\u30a2L-FABP\u6539\u826f\u8a66\u85ac\u300d\u306e\u57fa\u790e\u7684\u691c\u8a0e\uff0e\u7b2c54\u56de \u65e5\u81e8\u6280\u95a2\u7532\u4fe1\u652f\u90e8\u30fb\u9996\u90fd\u570f\u652f\u90e8\u533b\u5b66\u691c\u67fb\u5b66\u4f1a\uff0e2017.10.28-29\uff0e\u57fc\u7389\uff0e<\/li>\n\n\n\n
                                                                                                            36. \u6301\u7530 \u667a\u4e4b\uff0c\u79cb\u7530 \u840c\uff0c\u7530\u5cf6 \u5c06\u592a\u90ce\uff0c\u5c71\u7530 \u306f\u308b\u9999\uff0c\u771e\ufa11 \u6842\uff0c\u570b\u4e95 \u5c1a\u4eba\uff0c\u8c37\u53e3 \u8c6a\uff0c\u6e6f\u672c \u771f\u4eba\uff0e\u3066\u3093\u304b\u3093\u30bb\u30f3\u30bf\u30fc\u958b\u8a2d\u306b\u4f34\u3046\u5f53\u691c\u67fb\u5ba4\u306e\u3066\u3093\u304b\u3093\u8a3a\u7642\u3078\u306e\u53d6\u308a\u7d44\u307f\uff0e\u7b2c4\u56de \u5168\u56fd\u3066\u3093\u304b\u3093\u30bb\u30f3\u30bf\u30fc\u5354\u8b70\u4f1a\u7dcf\u4f1a\uff0e2017.2.18\uff0e\u65b0\u6f5f\uff0e<\/li>\n\n\n\n
                                                                                                            37. \u6301\u7530 \u667a\u4e4b.\u3042\u306a\u305f\u306e\u75c5\u9662\u3067\u3082\u51fa\u6765\u308b\uff0c\u3066\u3093\u304b\u3093\u8a3a\u7642\u9023\u643a\uff0e\u305d\u308c\u305e\u308c\u306e\u8077\u7a2e\u304b\u3089\uff0e\u3066\u3093\u304b\u3093\u8a3a\u7642\u9023\u643a\u30d5\u30a9\u30fc\u30e9\u30e0\uff0e2017.9.22\uff0e\u5c0f\u8af8\u4f50\u4e45\uff0e<\/li>\n\n\n\n
                                                                                                            38. \u68ee\u7530 \u8ce2\u53f2\uff0c\u7530\u4e2d \u96c5\u7f8e\uff0c\u6c34\u9593 \u77e5\u4e16\uff0c\u5f71\u5c71 \u7950\u5b50\uff0c\u5bbf\u8c37 \u8ce2\u4e00\uff0c\u66fd\u6839 \u4f38\u6cbb\uff0c\u5409\u7530 \u8f1d\u5f66\uff0c\u4e0b\u6fa4 \u9054\u96c4\uff0c\u77e2\u51a8 \u88d5\uff0e\u5c3f\u4e2d\u5c3f\u7d30\u7ba1\u4e0a\u76ae\u7d30\u80de\u3068\u814e\u969c\u5bb3\u3068\u306e\u95a2\u9023\u6027\u306e\u691c\u8a0e\uff0e\u7b2c13\u56de \u814e\u30fb\u6ccc\u5c3f\u5668\u691c\u67fb\u7814\u7a76\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2017.3.12-13. \u5ca1\u5c71\uff0e<\/li>\n\n\n\n
                                                                                                            39. \u68ee\u7530 \u8ce2\u53f2\uff0e\u5c3f\u7d30\u7ba1\u969c\u5bb3\u30de\u30fc\u30ab\u30fc\u3068\u5c3f\u7d30\u7ba1\u4e0a\u76ae\u7d30\u80de\u306e\u6570\u306e\u5909\u52d5\uff0e\u7b2c13\u56de \u814e\u30fb\u6ccc\u5c3f\u5668\u691c\u67fb\u7814\u7a76\u4f1a\u5b66\u8853\u96c6\u4f1a\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u2160 \uff5eICU\u306b\u304a\u3051\u308b\u81e8\u5e8a\u691c\u67fb\uff5e\uff0e2017.3.12-13. \u5ca1\u5c71\uff0e<\/li>\n\n\n\n
                                                                                                            40. \u68ee\u7530 \u8ce2\u53f2\uff0c\u7530\u4e2d \u96c5\u7f8e\uff0c\u6c34\u9593 \u77e5\u4e16\uff0c\u5f71\u5c71 \u7950\u5b50\uff0c\u5bbf\u8c37 \u8ce2\u4e00\uff0c\u66fd\u6839 \u4f38\u6cbb\uff0c\u4e0b\u6fa4 \u9054\u96c4\uff0c\u77e2\u51a8 \u88d5\uff0e\u5168\u81ea\u52d5\u5c3f\u5206\u6790\u88c5\u7f6eUS-3500\u306b\u304a\u3051\u308b\u30af\u30ec\u30a2\u30c1\u30cb\u30f3\u5224\u5b9a\u57fa\u6e96\u5909\u66f4\u306b\u4f34\u3046\u30c7\u30fc\u30bf\u691c\u8a0e\uff0e\u7b2c66\u56de \u65e5\u672c\u533b\u5b66\u691c\u67fb\u5b66\u4f1a\uff0e2017.06.17-18\uff0e\u5343\u8449\uff0e<\/li>\n\n\n\n
                                                                                                            41. \u68ee\u7530 \u8ce2\u53f2\uff0c\u7530\u4e2d \u96c5\u7f8e\uff0c\u6c34\u9593 \u77e5\u4e16\uff0c\u5f71\u5c71 \u7950\u5b50\uff0c\u5bbf\u8c37 \u8ce2\u4e00\uff0c\u66fd\u6839 \u4f38\u6cbb\uff0c\u4e0b\u6fa4 \u9054\u96c4\uff0c\u77e2\u51a8 \u88d5\uff0e\u5c3f\u6c88\u6e23\u306b\u3088\u308bAKI\u306e\u75c5\u614b\u89e3\u6790\u3078\u306e\u8a66\u307f\uff0e\u7b2c66\u56de \u65e5\u672c\u533b\u5b66\u691c\u67fb\u5b66\u4f1a\uff0e2017.06.17-18\uff0e\u5343\u8449\uff0e<\/li>\n\n\n\n
                                                                                                            42. \u68ee\u7530 \u8ce2\u53f2\uff0c\u7530\u4e2d \u96c5\u7f8e\uff0c\u6c34\u9593 \u77e5\u4e16\uff0c\u4e45\u672b \u5d07\u53f8\uff0c\u5bbf\u8c37 \u8ce2\u4e00\uff0c\u66fd\u6839 \u4f38\u6cbb\uff0c\u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0e\u5c3f\u81ea\u52d5\u5206\u6790\u88c5\u7f6eUS-1200\u306e\u57fa\u790e\u7684\u691c\u8a0e\uff0e\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u81ea\u52d5\u5316\u5b66\u4f1a \u7b2c49\u56de\u5927\u4f1a\uff0e2017.09.21-23\uff0e\u6a2a\u6d5c\uff0e<\/li>\n\n\n\n
                                                                                                            43. \u5b89\u5ddd \u6075\u5b50\uff0c\u85e4\u91ce \u7950\u4ecb\uff0c\u77f3\u6a4b \u307f\u3069\u308a\uff0c\u6cb3\u91ce \u6b63\u81e3\uff0c\u66fd\u6839 \u4f38\u6cbb\uff0c\u4e0b\u6fa4 \u9054\u96c4\uff0c\u6c60\u7530 \u5747\uff0c\u77e2\u51a8 \u88d5\uff0e\u9084\u5143\u578b\u30fb\u9178\u5316\u578b\u30a2\u30eb\u30d6\u30df\u30f3\u3068\u51a0\u52d5\u8108\u75be\u60a3\u3068\u306e\u95a2\u9023\u306b\u3064\u3044\u3066\u306e\u4e88\u5099\u691c\u8a0e\uff0e\u7b2c57\u56de \u65e5\u672c\u81e8\u5e8a\u5316\u5b66\u4f1a\u5e74\u6b21\u5b66\u8853\u96c6\u4f1a\uff0e2017.10.6\uff0e\u672d\u5e4c\uff0e<\/li>\n\n\n\n
                                                                                                            44. \u5b89\u672c \u7be4\u53f2\uff0cYiyue Jiang\uff0cCheng Lei\uff0c\u76f8\u5742 \u6709\u7406\uff0c\u4f0a\u85e4 \u5353\u90ce\uff0cBaoshan Guo\uff0c\u5c0f\u6797 \u535a\u6587\uff0c\u65b0\u7530 \u5c1a\uff0c\u673d\u540d \u590f\u9ebf\uff0c\u5c0f\u95a2 \u6cf0\u4e4b\uff0c\u4e2d\u5ddd \u6566\u5bdb\uff0c\u5408\u7530 \u572d\u4ecb\uff0c\u77e2\u51a8 \u88d5\uff0e\u975e\u6a19\u8b58\u30ea\u30a2\u30eb\u30bf\u30a4\u30e0\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u88c5\u7f6e\u3092\u7528\u3044\u305f\u8840\u5c0f\u677f\u51dd\u96c6\u584a\u306e\u691c\u51fa\u6cd5\u306e\u78ba\u7acb\uff0e\u7b2c39\u56de \u65e5\u672c\u8840\u6813\u6b62\u8840\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2017.6.8-10\uff0e\u540d\u53e4\u5c4b\uff0e<\/li>\n\n\n\n
                                                                                                            45. \u6e6f\u672c \u771f\u4eba\uff0e\u6559\u80b2\u8b1b\u6f14\u300c\u8074\u899a\u523a\u6fc0\u5217\u306e\u7d71\u8a08\u5b66\u7fd2\u306e\u795e\u7d4c\u751f\u7406\u5b66\u7684\u7814\u7a76\u300d\uff0e\u7b2c22\u56de \u8a8d\u77e5\u795e\u7d4c\u79d1\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2017.7.29-30\uff0e\u6771\u4eac\uff0e<\/li>\n\n\n\n
                                                                                                            46. \u4fdd\u7530 \u5948\u7dd2\u7f8e\uff0c\u4e0b\u5742 \u6d69\u5247\uff0c\u66fd\u6839 \u4f38\u6cbb\uff0c\u6c60\u7530 \u5747\uff0c\u77e2\u51a8 \u88d5\uff0e\u6297dsDNA\u6297\u4f53\u691c\u67fb\u8a66\u85ac\u306e\u6bd4\u8f03\u304a\u3088\u3073\u81e8\u5e8a\u7684\u8a55\u4fa1\uff0e\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u81ea\u52d5\u5316\u5b66\u4f1a \u7b2c49\u56de\u5927\u4f1a\uff0e2017.9.21-23\uff0e\u6a2a\u6d5c\uff0e<\/li>\n<\/ol>\n\n\n\n

                                                                                                              \u82f1\u6587\u7dcf\u8aac\uff1aEnglish Review Articles<\/h4>\n\n\n\n
                                                                                                                \n
                                                                                                              1. Nakao,T., Morita, H. Omega-3 Polyunsaturated Fatty Acid and Coronary Ather
                                                                                                                osclerotic Plaques. Int. Heart J.<\/strong><\/em>                                                                                                                 58: 837-839<\/a>, 2017.<\/li>\n<\/ol>\n\n\n\n

                                                                                                                \u56fd\u969b\u5b66\u4f1a\u767a\u8868\uff1aInternational Conference Presentation<\/h4>\n\n\n\n
                                                                                                                  \n
                                                                                                                1. Daikoku, T. and Yumoto, M. Right hemisphere dominance in concurrent statistical learning of attended and ignored auditory sequences. Biomagnetic Sendai 2017. 2017. 5. 22-24. Sendai, Japan.<\/li>\n\n\n\n
                                                                                                                2. Daikoku, T., Okano, T., and Yumoto, M. Relative difficulty of auditory statistical learning based on tone transition diversity modulates chunk length in the learning strategy. Biomagnetic Sendai 2017. 2017. 5. 22-24. Sendai, Japan.<\/li>\n\n\n\n
                                                                                                                3. Kobayashi, T., Kurano, M., Mishima, Y., Nojiri, T., Ohkawa, R., Tozuka, M., and Yatomi, Y. Glycation of Apolipoprotein M attenuated its capacity to bind Sphingosine-1 Phosphate. The 29th World Congress of World Association of Societies of Pathology and Laboratory Medicine (WASPaLM). 2017. 11. 15-17. Kyoto, Japan.<\/li>\n\n\n\n
                                                                                                                4. Kurano, M., Kano, K., Dohi, T., Ikeda, H., Aoki, J., and Yatomi Y. Possible involvement of glycero-lysophopholipids in the pathogenesis of ACS, revealed by an LC\/MS technique. The 29th World Congress of World Association of Societies of Pathology and Laboratory Medicine (WASPaLM). 2017. 11. 15-17. Kyoto, Japan.<\/li>\n\n\n\n
                                                                                                                5. Mikami ,Y., Matsuzaki, H., Ishimori, T., Saito, M., Sakamoto, Y., Yamauchi, Y., Yatomi, Y., Takai D., Nagase T., and Jo, T. Evaluation of postoperative pulmonary complications in FEV1\/FVC < 0.7 patients. European Respiratory Society International Congress 2017. 2017. 9. 9-13. Milan, Italy.<\/li>\n\n\n\n
                                                                                                                6. Mishima,Y., Kurano,M., Kobayahsi,T., Nishikawa,M., Ohkawa,R., Tozuka,M.,Yatomi,Y Difference between sphingosine 1-phosphate and dihydrosphingosine 1-phosphate in their preference to HDL or albumin. The 29th World Congress of World Association of Societies of Pathology and Laboratory Medicine (WASPaLM). 2017. 11. 15-17. Kyoto, Japan.<\/li>\n\n\n\n
                                                                                                                7. Morita, Y., Shukuya, K., Tanaka, M., Sone, S., Kurano, M., and Yatomi, Y. Case report of a patient with acute kidney injury, showing morphological changes in urine sediment tests. The 29th World Congress of World Association of Societies of Pathology and Laboratory Medicine (WASPaLM). 2017. 11. 15-17. Kyoto, Japan.<\/li>\n\n\n\n
                                                                                                                8. Nishikawa, M., Kurano, M., Shimamoto, S., Igarashi, K., Yatomi, Y. Clinical Significance of Autotaxin in the field of Hematology. The 29th World Congress of World Association of Societies of Pathology and Laboratory Medicine (WASPaLM). 2017. 11. 15-17. Kyoto, Japan.<\/li>\n\n\n\n
                                                                                                                9. Nojiri, T., Kurano, M., Nakawatari, K. Shimamoto,S., Igarashi, K., Sone, S., Ikeda, H., and Yatomi, Y. Serum autotaxin is increased and correlated with thyroid hormone in Graves’ disease. The 29th World Congress of World Association of Societies of Pathology and Laboratory Medicine (WASPaLM). 2017. 11. 15-17. Kyoto, Japan.<\/li>\n\n\n\n
                                                                                                                10. Nonobe, R., Ono, Y., Sato, M., Kageyama, Y., Shimizu, K., Madate, E., Noda, S., Takahashi, M., Sone, S., Kurano, M., Yatomi, Y. Clinical Importance of CGM and Roles of the Medical Technologist with CDE Certification. The 29th World Congress of World Association of Societies of Pathology and Laboratory Medicine (WASPaLM). 2017. 11. 15-17. Kyoto, Japan.<\/li>\n\n\n\n
                                                                                                                11. Okano, T., Daikoku, T., Ugawa, Y., and Yumoto, M. Difficulty in auditory statistical learning is reflected in neuromagnetic P1m and N1m responses. Biomagnetic Sendai 2017. 2017. 5. 22-24. Sendai, Japan.<\/li>\n\n\n\n
                                                                                                                12. Uranbileg, B., Nishikawa,T., Ikeda, H., Kurano, M., Sato, M., Saigusa, D., Aoki, J., Watanabe, T., and Yatomi, Y. S1P is actively metabolized and transported to extracellular spaces with increased receptors expression in colon cancer. The 29th World Congress of World Association of Societies of Pathology and Laboratory Medicine (WASPaLM). 2017. 11. 15-17. Kyoto, Japan.<\/li>\n\n\n\n
                                                                                                                13. Yasumoto, A., Tokuoka, MS., Kita, Y., Shimizu, T., and Yatomi, Y. Multiplex quantitative analysis of eicosanoids in human plasma, serum, and platelets: possible introduction into clinical testing. International Society for Laboratory Hematology (ISLH) 2017. 2017. 5. 4-6. Honolulu, Hawaii.<\/li>\n\n\n\n
                                                                                                                14. Yasumoto, A., Yatomi, Y. Regulation of Fc\u03b3RIIa-mediated platelet activation by a cytochalasin-sensitive cytoskeletal rearrangement: its clinical application to the detection of functional HIT antibody. International Society on Thrombosis and Haemostasis (ISTH) 2017. 2017. 7. 8-13. Berlin, Germany.<\/li>\n\n\n\n
                                                                                                                15. Yatomi, Y. Development of clinical laboratory tests from the viewpoint of lipoquality. International Conference on Lipoquality. 2017. 9. 22. Tokyo, Japan.<\/li>\n\n\n\n
                                                                                                                16. Yasukawa, K. Glycated protein and new biomarkers “Standardization of glycated albumin; can it be achieved?” Biomarkers for Diabetes 23rd IFCC Worldlab 2017(Durban) Satellite Meeting. 2017. 10. 26-27. Paarl, South Africa.<\/li>\n\n\n\n
                                                                                                                17. Yumoto, M., Daikoku, T., Okano, T., and Yatomi, Y. Statistical information embedded in the stimulus sequence figures a neuromagnetic probe for human auditory function. Biomagnetic Sendai 2017. 2017. 5. 22-24. Sendai, Japan.<\/li>\n<\/ol>\n\n\n\n

                                                                                                                  \u548c\u6587\u539f\u8457\u8ad6\u6587\uff1aJapanese Original Articles<\/h4>\n\n\n\n
                                                                                                                    \n
                                                                                                                  1. \u5c0f\u91ce \u4f73\u4e00\uff0c\u66fd\u6839 \u4f38\u6cbb\uff0c\u77e2\u51a8 \u88d5\uff0e\u6771\u5927\u75c5\u9662\u691c\u67fb\u90e8\u306eISO15189\u306e\u73fe\u72b6\uff0e\u81e8\u5e8a\u75c5\u7406 65\uff1a1117-1124\uff0c2017\uff0e<\/li>\n\n\n\n
                                                                                                                  2. \u5927\u91d1 \u4e9c\u5f25\uff0c\u5409\u5ddd \u76f4\u4e4b\uff0c\u5e38\u540d \u653f\u5f18\uff0c\u5897\u7530 \u4e9c\u5e0c\u5b50\uff0c\u66fd\u6839 \u4f38\u6cbb\uff0c\u77e2\u51a8 \u88d5\uff0e\u591a\u9805\u76ee\u81ea\u52d5\u8840\u7403\u5206\u6790\u88c5\u7f6eXN-550\u3092\u7528\u3044\u305f\u4f53\u8154\u6db2\u6e2c\u5b9a\u30e2\u30fc\u30c9\u306e\u57fa\u790e\u7684\u6027\u80fd\u8a55\u4fa1\u304a\u3088\u3073\u81e8\u5e8a\u7684\u6709\u7528\u6027\u306e\u691c\u8a0e\uff0e\u65e5\u672c\u691c\u67fb\u8840\u6db2\u5b66\u4f1a\u96d1\u8a8c 18\uff1a240-248\uff0c2017\uff0e<\/li>\n\n\n\n
                                                                                                                  3. \u4f50\u85e4 \u7f8e\u77e5\u5b50\uff0c\u6c38\u53cb \u5229\u6d25\u5b50\uff0c\u5c0f\u91ce \u4f73\u4e00\uff0c\u91ce\u3005\u90e8 \u4eae\u5b50\uff0c\u5f71\u5c71 \u7950\u5b50\uff0c\u9234\u6728 \u6df3\u53f2\uff0c\u4e45\u7c73 \u5e78\u592b\uff0c\u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0ePOCT\u6a5f\u5668 : \u30b0\u30eb\u30b3\u30fc\u30b9\u5206\u6790\u88c5\u7f6e\u300c\u30ef\u30f3\u30bf\u30c3\u30c1\u30d9\u30ea\u30aa\u30d7\u30ed\u30d7\u30e9\u30b9(TM)\u300d\u306e\u57fa\u790e\u7684\u6027\u80fd\u8a55\u4fa1\uff0e\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u81ea\u52d5\u5316\u5b66\u4f1a\u4f1a\u8a8c 42\uff1a59-64\uff0c2017\uff0e<\/li>\n\n\n\n
                                                                                                                  4. \u6fa4\u7530 \u826f\u5b50\uff0c \u540d\u5009 \u8c4a\uff0c\u66fd\u6839 \u4f38\u6cbb\uff0c\u77e2\u51a8 \u88d5\uff0c\u4f50\u85e4 \u7f8e\u77e5\u5b50\uff0c\u5ca1\u5d0e \u4ec1\uff0eHBs\u6297\u539f\u5b9a\u91cf\u8a66\u85ac\u306b\u95a2\u3059\u308b4\u793e\u306e\u6bd4\u8f03\u691c\u8a0e\uff0e\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u81ea\u52d5\u5316\u5b66\u4f1a\u4f1a\u8a8c 42\uff1a296-302\uff0c2017\uff0e<\/li>\n\n\n\n
                                                                                                                  5. \u91ce\u3005\u90e8 \u4eae\u5b50\uff0c\u68ee\u7530 \u8ce2\u53f2\uff0c\u9ad8\u6a4b \u6075\uff0c\u76db\u7530 \u548c\u6cbb\uff0c\u66fd\u6839 \u4f38\u6cbb\uff0c\u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0e\u7d4c\u53e3\u30d6\u30c9\u30a6\u7cd6\u8ca0\u8377\u8a66\u9a13\u306e\u305f\u3081\u306e\u63a1\u8840\u7ba1\u4f9b\u7d66\u30b7\u30b9\u30c6\u30e0\u306e\u69cb\u7bc9\uff0e\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u81ea\u52d5\u5316\u5b66\u4f1a\u4f1a\u8a8c 42\uff1a242-247\uff0c2017\uff0e<\/li>\n\n\n\n
                                                                                                                  6. \u76db\u7530 \u548c\u6cbb\uff0c\u91d1\u5b50 \u8aa0\uff0c\u66fd\u6839 \u4f38\u6cbb\uff0c\u77e2\u51a8 \u88d5\uff0e\u63a1\u8840\u5ba4\u306b\u304a\u3051\u308b\u60a3\u8005\u30a2\u30e1\u30cb\u30c6\u30a3\u6539\u5584\u306e\u53d6\u308a\u7d44\u307f\u30fc\u63a1\u8840\u5ba4\u30ea\u30cb\u30e5\u30fc\u30a2\u30eb\u304a\u3088\u3073\u696d\u52d9\u6539\u5584\u306e\u524d\u5f8c\u306b\u5b9f\u65bd\u3057\u305f\u30a2\u30f3\u30b1\u30fc\u30c8\u8abf\u67fb\u7d50\u679c\u304b\u3089\u308f\u304b\u3063\u305f\u3053\u3068\u30fc\uff0e\u533b\u5b66\u691c\u67fb 66\uff1a17\u201024\uff0c2017\uff0e<\/li>\n<\/ol>\n\n\n\n

                                                                                                                    \u548c\u6587\u7dcf\u8aac\uff1aJapanese Review Articles<\/h4>\n\n\n\n
                                                                                                                      \n
                                                                                                                    1. \u671d\u5009 \u82f1\u7b56\uff0c\u9ad8\u6a4b \u82b3\u53f3\uff0c\u5185\u5c71 \u4fca\u6b63\uff0c\u6c5f\u53e3 \u8c4a\uff0c\u5ca1\u672c \u597d\u53f8\uff0c\u5ddd\u6749 \u548c\u592b\uff0c\u5c0f\u6797 \u9686\u592b\uff0c\u7027 \u6b63\u5fd7\uff0c\u8fbb\u4ef2 \u5229\u653f\uff0c\u677e\u4e0b \u6b63\uff0c\u677e\u91ce \u4e00\u5f66\uff0c\u7a93\u5ca9 \u6e05\u6cbb\uff0c\u77e2\u51a8 \u88d5\uff0c\u548c\u7530 \u82f1\u592b\uff0cDIC\u8a3a\u65ad\u57fa\u6e96\u4f5c\u6210\u59d4\u54e1\u4f1a\uff0c\u65e5\u672c\u8840\u6813\u6b62\u8840\u5b66\u4f1a\u5b66\u8853\u6a19\u6e96\u5316\u59d4\u54e1\u4f1aDIC\u90e8\u4f1a\uff0e\u65e5\u672c\u8840\u6813\u6b62\u8840\u5b66\u4f1a DIC\u8a3a\u65ad\u57fa\u6e96 2017\u5e74\u7248\uff0e\u65e5\u672c\u8840\u6813\u6b62\u8840\u5b66\u4f1a\u8a8c 28\uff1a369-391\uff0c2017\uff0e<\/li>\n\n\n\n
                                                                                                                    2. \u77f3\u6e21 \u6df3\u5e73\uff0c\u5927\u9580 \u96c5\u592b\uff0e\u80a5\u5927\u578b\u5fc3\u7b4b\u75c7\u306e\u8a3a\u65ad\uff1a\u5fc3\u30a8\u30b3\u30fc\u306e\u7acb\u5834\u304b\u3089\uff0e\u5faa\u74b0\u5668\u5185\u79d1 82\uff1a525-530\uff0c2017\uff0e<\/li>\n\n\n\n
                                                                                                                    3. \u4e00\u702c \u767d\u5e1d\uff0c\u548c\u7530 \u82f1\u592b\uff0c\u60e3\u5b87\u5229 \u6b63\u5584\uff0c\u6a4b\u53e3 \u7167\u4eba\uff0c\u77e2\u51a8 \u88d5\uff0c\u5c0f\u5ddd \u5b54\u5e78\uff0c\u5317\u5cf6 \u52f2\uff0c\u671d\u5009 \u82f1\u7b56\uff0c\u5ca1\u672c \u597d\u53f8\uff0c\u5bb6\u5b50 \u6b63\u88d5\uff0c\u5c71\u672c \u6643\u58eb\uff0c\u6c5f\u53e3 \u8c4a\uff0c\u4fdd\u7530 \u664b\u52a9\uff0c\u677e\u672c \u529f\uff0c\u81ea\u5df1\u514d\u75ab\u6027\u51fa\u8840\u75c5FXIII\/13\u65e5\u672c\u8840\u6813\u6b62\u8840\u5b66\u4f1a\u8a3a\u7642\u30ac\u30a4\u30c9\u4f5c\u6210\u59d4\u54e1\u4f1a\uff0c\u65e5\u672c\u8840\u6813\u6b62\u8840\u5b66\u4f1a\u5b66\u8853\u6a19\u6e96\u5316\u59d4\u54e1\u4f1a\uff0e\u81ea\u5df1\u514d\u75ab\u6027\u51fa\u8840\u75c5FXIII\/13\u8a3a\u7642\u30ac\u30a4\u30c9\uff0e\u65e5\u672c\u8840\u6813\u6b62\u8840\u5b66\u4f1a\u8a8c 28\uff1a393-420\uff0c2017\uff0e<\/li>\n\n\n\n
                                                                                                                    4. \u5c0f\u91ce \u4f73\u4e00\uff0c\u77e2\u51a8 \u88d5\uff0eISO15189\u53d6\u5f97\u306e\u610f\u7fa9\uff0e\u81e8\u5e8a\u691c\u67fb 61\uff1a580-585\uff0c2017\uff0e<\/li>\n\n\n\n
                                                                                                                    5. \u4f50\u85e4 \u512a\u5b9f\u5b50\uff0c\u5897\u7530 \u4e9c\u5e0c\u5b50\uff0c\u77e2\u51a8 \u88d5\uff0e\u6025\u6027\u524d\u9aa8\u9ac4\u7403\u6027\u767d\u8840\u75c5\u306b\u304a\u3051\u308b\u907a\u4f1d\u5b50\u691c\u67fb\u306e\u610f\u7fa9\uff1aPML-RARA\uff0e\u81e8\u5e8a\u75c5\u7406 65\uff1a37-43\uff0c2017\uff0e<\/li>\n\n\n\n
                                                                                                                    6. \u5bbf\u8c37 \u8ce2\u4e00\uff0c\u7530\u4e2d \u96c5\u7f8e\uff0e\u4e00\u822c\u691c\u67fb\u306e\u7cbe\u5ea6\u7ba1\u7406\uff0e\u77e5\u3063\u3066\u304a\u304d\u305f\u3044\u81e8\u5e8a\u691c\u67fb\u6a5f\u5668\u306e\u5b89\u5168\u7ba1\u7406\u3068\u30c8\u30e9\u30d6\u30eb\u30b7\u30e5\u30fc\u30c6\u30a3\u30f3\u30b0\uff0eMedical Technology 45\uff1a1476-1479\uff0c2017\uff0e<\/li>\n\n\n\n
                                                                                                                    7. \u5bbf\u8c37 \u8ce2\u4e00\uff0c\u4e0b\u6fa4 \u9054\u96c4\uff0e\u8840\u6db2\u50cf\u3084\u5c3f\u6c88\u6e23\u306a\u3069\u306e\u93e1\u691c\u6cd5\u306e\u5185\u90e8\u7cbe\u5ea6\u7ba1\u7406\uff0e\u81e8\u5e8a\u691c\u67fb\u30b9\u30bf\u30fc\u30bf\u30fc\u30ba\u30ac\u30a4\u30c9\uff0e\u81e8\u5e8a\u691c\u67fb 61(4) \uff1a542-543\uff0e\u533b\u5b66\u66f8\u9662\uff0c\u6771\u4eac\uff0e2017\uff0e<\/li>\n\n\n\n
                                                                                                                    8. \u5927\u9580 \u96c5\u592b\uff0e\u62e1\u5f35\u6027\u5fc3\u4e0d\u5168\u306e\u7406\u89e3\u306b\u5fc5\u8981\u306a\u62e1\u5f35\u6a5f\u80fd\uff0e\u6210\u4eba\u3068\u751f\u6d3b\u75c5 47\uff1a294-301\uff0c2017\uff0e<\/li>\n\n\n\n
                                                                                                                    9. \u5ca1\u91ce \u667a\u5b50\uff0c\u4e2d\u5c3e \u502b\u5b50\uff0c\u5927\u9580\u96c5\u592b\uff0e\u81e8\u5e8a\u691c\u67fb\u3068\u6a19\u6e96\u5316\uff0d\u5404\u691c\u67fb\u9818\u57df\u306b\u304a\u3051\u308b\u6a19\u6e96\u5316\u306e\u73fe\u72b6\u3068\u8ab2\u984c\uff0d(2) \u751f\u7406\u691c\u67fb\u306e\u6a19\u6e96\u5316 (\u5fc3\u81d3\u8d85\u97f3\u6ce2\u691c\u67fb\u306b\u3064\u3044\u3066)\uff0e\u81e8\u5e8a\u75c5\u7406 65\uff1a1275-1277\uff0c2017\uff0e<\/li>\n\n\n\n
                                                                                                                    10. \u4e2d\u5c3e \u502b\u5b50\uff0e\u80a5\u5927\u578b\u5fc3\u7b4b\u75c7\u3068\u62d8\u675f\u578b\u5fc3\u7b4b\u75c7\u306b\u304a\u3051\u308b\u5de6\u5ba4\u5145\u6e80\u5727\u306e\u63a8\u5b9a\uff0e\u5fc3\u30a8\u30b3\u30fc 18\uff1a46-52\uff0c2017\uff0e<\/li>\n\n\n\n
                                                                                                                    11. \u5ee3\u702c \u90a6\u7ae0\uff0c\u5927\u9580 \u96c5\u592b\uff0e\u6297\u304c\u3093\u85ac\u5fc3\u7b4b\u969c\u5bb3\uff0e\u6210\u4eba\u75c5\u3068\u751f\u6d3b\u7fd2\u6163\u75c5 47\uff1a1272-1278\uff0c2017\uff0e<\/li>\n\n\n\n
                                                                                                                    12. \u5b89\u672c \u7be4\u53f2\uff0c\u77e2\u51a8 \u88d5\uff0e\u5468\u8853\u671f\u306e\u6b62\u8840\u6a5f\u80fd\u7570\u5e38\u306b\u5bfe\u3059\u308b\u30b9\u30af\u30ea\u30fc\u30cb\u30f3\u30b0\u691c\u67fb\uff0e\u81e8\u5e8a\u5916\u79d1 72\uff1a166-169\uff0c2017\uff0e<\/li>\n\n\n\n
                                                                                                                    13. \u5b89\u672c \u7be4\u53f2\uff0c\u77e2\u51a8 \u88d5\uff0e\u30d8\u30d1\u30ea\u30f3\u8d77\u56e0\u6027\u8840\u5c0f\u677f\u6e1b\u5c11\u75c7\uff08HIT\uff09\u306e\u6700\u65b0\u306e\u8a3a\u65ad\u30fb\u691c\u67fb 61\uff1a140-145\uff0c2017\uff0e<\/li>\n\n\n\n
                                                                                                                    14. \u5b89\u672c \u7be4\u53f2\uff0c\u77e2\u51a8 \u88d5\uff0e\u30d8\u30d1\u30ea\u30f3\u8d77\u56e0\u6027\u8840\u5c0f\u677f\u6e1b\u5c11\u75c7\uff08HIT\uff09\u8a3a\u65ad\u306e\u6700\u65b0\u691c\u67fb. \u533b\u5b66\u306e\u3042\u3086\u307f 263\uff1a1163-1168\uff0c2017\uff0e<\/li>\n\n\n\n
                                                                                                                    15. \u6e6f\u672c \u771f\u4eba\uff0e\u3066\u3093\u304b\u3093\uff0dNew Guideline compact \u8133\u78c1\u56f3\uff0eClinical Neuroscience 35\uff1a830-834\uff0c2017\uff0e<\/li>\n<\/ol>\n\n\n\n

                                                                                                                      \u548c\u6587\u8457\u66f8\uff1aJapanese Book Chapter<\/h4>\n\n\n\n
                                                                                                                        \n
                                                                                                                      1. \u5927\u4e45\u4fdd \u6ecb\u592b, \u4e45\u672b \u76f4\u5b50. \u7b2c\u2163\u90e85.1\uff5e5.2. ISO 15189:2012 \u304c\u81e8\u5e8a\u691c\u67fb\u5ba4\u3092\u5909\u3048\u308b\uff1c\u7b2c3\u7248\uff1e pp. 43-50. \u4e00\u822c\u793e\u56e3\u6cd5\u4ebaRMA, 2017.<\/li>\n\n\n\n
                                                                                                                      2. \u6fa4\u7530 \u76f4\u5b50\uff0c\u5927\u9580 \u96c5\u592b\uff0e\u5927\u52d5\u8108\u5f01\u9589\u9396\u4e0d\u5168\u75c7\uff0eNew\u5c02\u9580\u533b\u3092\u76ee\u6307\u3059\u30b1\u30fc\u30b9\u30fb\u30e1\u30bd\u30c3\u30c9\u30fb\u30a2\u30d7\u30ed\u30fc\u30c1\uff0e\u5faa\u74b0\u5668\u75be\u60a3\uff08\u8fd1\u68ee \u5927\u5fd7\u90ce\uff0c\u5c71\u79d1 \u7ae0 \u7de8\uff09pp. 145-152\uff0e\u65e5\u672c\u533b\u4e8b\u65b0\u5831\u793e\uff0c\u6771\u4eac\uff0c2017\uff0e<\/li>\n\n\n\n
                                                                                                                      3. \u5bbf\u8c37 \u8ce2\u4e00\uff0e\u30ab\u30e9\u30fc\u56f3\u8b5c \u5c3f\u6c88\u6e23\uff0e\u81e8\u5e8a\u691c\u67fb\u30c7\u30fc\u30bf\u30d6\u30c3\u30af2017-2018\uff08\u9ad8\u4e45 \u53f2\u9ebf \u76e3\u4fee\uff09pp. 30-32\uff0e\u533b\u5b66\u66f8\u9662\uff0c\u6771\u4eac\uff0c2017\uff0e<\/li>\n\n\n\n
                                                                                                                      4. \u5bbf\u8c37 \u8ce2\u4e00\uff0c\u5317\u6751 \u8056\uff0e\u4e00\u822c\u5c3f\u691c\u67fb\u306e\u63a1\u5c3f\u30fb\u5b9a\u6027\u30fb\u6c88\u6e23\uff0e\u81e8\u5e8a\u691c\u67fb\u30c7\u30fc\u30bf\u30d6\u30c3\u30af2017-2018\uff08\u9ad8\u4e45 \u53f2\u9ebf \u76e3\u4fee\uff09pp. 74-76\uff0e\u533b\u5b66\u66f8\u9662\uff0c\u6771\u4eac\uff0c2017\uff0e<\/li>\n\n\n\n
                                                                                                                      5. \u5bbf\u8c37 \u8ce2\u4e00\uff0c\u5317\u6751 \u8056\uff0e\u4fbf\u6f5c\u8840\u691c\u67fb\u306e\u63a1\u4fbf\uff0e\u81e8\u5e8a\u691c\u67fb\u30c7\u30fc\u30bf\u30d6\u30c3\u30af2017-2018\uff08\u9ad8\u4e45 \u53f2\u9ebf \u76e3\u4fee\uff09pp. 77-78\uff0e\u533b\u5b66\u66f8\u9662\uff0c\u6771\u4eac\uff0c2017\uff0e<\/li>\n\n\n\n
                                                                                                                      6. \u5bbf\u8c37 \u8ce2\u4e00\uff0c\u4e0b\u6fa4 \u9054\u96c4\uff0e\u80c3\u6db2\uff0e\u81e8\u5e8a\u691c\u67fb\u30c7\u30fc\u30bf\u30d6\u30c3\u30af2017-2018\uff08\u9ad8\u4e45\u53f2\u9ebf \u76e3\u4fee\uff09pp. 719-721\uff0e\u533b\u5b66\u66f8\u9662\uff0c\u6771\u4eac\uff0c2017\uff0e<\/li>\n\n\n\n
                                                                                                                      7. \u5bbf\u8c37 \u8ce2\u4e00\uff0c\u4e0b\u6fa4 \u9054\u96c4\uff0e\u9ac4\u6db2\uff08CSF\uff09\uff0e\u81e8\u5e8a\u691c\u67fb\u30c7\u30fc\u30bf\u30d6\u30c3\u30af2017-2018\uff08\u9ad8\u4e45 \u53f2\u9ebf \u76e3\u4fee\uff09pp. 726-728\uff0e\u533b\u5b66\u66f8\u9662\uff0c\u6771\u4eac\uff0c2017\uff0e<\/li>\n\n\n\n
                                                                                                                      8. \u5bbf\u8c37 \u8ce2\u4e00\uff0c\u4e0b\u6fa4 \u9054\u96c4\uff0e\u80c6\u6c41\uff0e\u81e8\u5e8a\u691c\u67fb\u30c7\u30fc\u30bf\u30d6\u30c3\u30af2017-2018\uff08\u9ad8\u4e45 \u53f2\u9ebf \u76e3\u4fee\uff09pp. 731-732\uff0e\u533b\u5b66\u66f8\u9662\uff0c\u6771\u4eac\uff0c2017\uff0e<\/li>\n\n\n\n
                                                                                                                      9. \u5bbf\u8c37 \u8ce2\u4e00\uff0c\u4e0b\u6fa4 \u9054\u96c4\uff0e\u8179\u6c34\uff0e\u81e8\u5e8a\u691c\u67fb\u30c7\u30fc\u30bf\u30d6\u30c3\u30af2017-2018\uff08\u9ad8\u4e45 \u53f2\u9ebf \u76e3\u4fee\uff09pp. 734-735\uff0e\u533b\u5b66\u66f8\u9662\uff0c\u6771\u4eac\uff0c2017\uff0e<\/li>\n\n\n\n
                                                                                                                      10. \u5bbf\u8c37 \u8ce2\u4e00\uff0c\u4e0b\u6fa4 \u9054\u96c4\uff0e\u4fbf\u6f5c\u8840\uff08\u4fbf\u4e2d\u30d8\u30e2\u30b0\u30ed\u30d3\u30f3\uff09\uff0e\u81e8\u5e8a\u691c\u67fb\u30c7\u30fc\u30bf\u30d6\u30c3\u30af2017-2018\uff08\u9ad8\u4e45 \u53f2\u9ebf \u76e3\u4fee\uff09pp. 710-711\uff0e\u533b\u5b66\u66f8\u9662\uff0c\u6771\u4eac\uff0c2017\uff0e<\/li>\n\n\n\n
                                                                                                                      11. \u83c5\u539f \u5c06\u4ee3\uff0e\u3010\u9ad8\u9f62\u8005\u306e\u30a8\u30b3\u30fc\u306e\u64ae\u308a\u65b9\u30fb\u8aad\u307f\u65b9\u3011\u9ad8\u9f62\u8005\u306e\u8840\u7ba1\u30a8\u30b3\u30fc\uff1a\u6b63\u5e38\u306a\u52a0\u9f62\u3068\u75c5\u7684\u5909\u5316\u306e\u898b\u6975\u3081\u306f\uff1f\uff08\u5927\u9580 \u96c5\u592b \u7de8\uff09pp.178-185.\u6587\u5149\u5802\uff0c\u6771\u4eac\uff0c2017.<\/li>\n\n\n\n
                                                                                                                      12. \u5927\u9580 \u96c5\u592b\u3000Question 55\uff5e57\u3000\u5faa\u74b0\u5668\uff0eMedicina 2017\u5897\u520a\u53f7\uff1a\u7dcf\u5408\u5185\u79d1\u533b\u306e\u5fc5\u4fee\u81e8\u5e8a\u554f\u984c182\u554f\uff0cVol. 54, No.4, pp.294-301. \u533b\u5b66\u66f8\u9662\uff0c\u6771\u4eac\uff0c2017\uff0e<\/li>\n\n\n\n
                                                                                                                      13. \u5927\u9580 \u96c5\u592b\uff0e\u5fc3\u4e0d\u5168\u306b\u5408\u4f75\u3059\u308b\u5fc3\u81d3\u5f01\u819c\u75c7\u3068\u306f\uff0e\u5fc3\u4e0d\u5168\u60a3\u8005\u306e\u5931\u6557\u3057\u306a\u3044\u5f01\u819c\u75c7\u6cbb\u7642\uff08\u5927\u9580 \u96c5\u592b \u7de8\uff09pp. 2-5\uff0c\u6587\u5149\u5802\uff0c\u6771\u4eac\uff0c2017\uff0e<\/li>\n\n\n\n
                                                                                                                      14. \u5927\u9580 \u96c5\u592b\uff0e\u5fc3\u81d3\u5f01\u819c\u75c7\u306e\u4fb5\u8972\u7684\u6cbb\u7642\u306b\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u3092\u6d3b\u304b\u3059\uff0e\u5fc3\u4e0d\u5168\u60a3\u8005\u306e\u5931\u6557\u3057\u306a\u3044\u5f01\u819c\u75c7\u6cbb\u7642\uff08\u5927\u9580 \u96c5\u592b \u7de8\uff09pp. 26-32\uff0c\u6587\u5149\u5802\uff0c\u6771\u4eac\uff0c2017\uff0e<\/li>\n\n\n\n
                                                                                                                      15. \u5927\u9580 \u96c5\u592b\uff0e\u8d85\u9ad8\u9f62\u5316\u793e\u4f1a\u306b\u304a\u3051\u308b\u5927\u52d5\u8108\u5f01\u72ed\u7a84\u75c7\u306b\u3088\u308b\u5fc3\u4e0d\u5168\u306e\u75c5\u614b\uff0e\u5fc3\u4e0d\u5168\u60a3\u8005\u306e\u5931\u6557\u3057\u306a\u3044\u5f01\u819c\u75c7\u6cbb\u7642\uff08\u5927\u9580 \u96c5\u592b \u7de8\uff09pp. 34-41\uff0e\u6587\u5149\u5802\uff0c\u6771\u4eac\uff0c2017\uff0e<\/li>\n\n\n\n
                                                                                                                      16. \u5927\u9580 \u96c5\u592b\uff0e\u5fc3\u7b4b\u865a\u8840\u3068\u306f\uff1f\u72ed\u5fc3\u75c7\u30fb\u5fc3\u7b4b\u6897\u585e\u30fb\u6025\u6027\u51a0\u75c7\u5019\u7fa4\u3068\u306f\uff1f\u5fc3\u30a8\u30b3\u30fc\uff1a\u7279\u96c6\u865a\u8840\u6027\u5fc3\u75be\u60a3\u3092\u75c5\u614b\u304b\u3089\u7406\u89e3\u3059\u308b\uff08\u6d45\u6cbc \u4fca\u5f66\uff0c\u4e2d\u8c37 \u654f \u7de8\uff09pp. 304-313\uff0e\u6587\u5149\u5802\uff0c\u6771\u4eac\uff0c2017\uff0e<\/li>\n\n\n\n
                                                                                                                      17. \u5ee3\u702c \u90a6\u7ae0\uff0c\u5927\u9580 \u96c5\u592b\uff0e\u611f\u67d3\u6027\u5fc3\u5185\u819c\u708e\uff0eMedical Practice\uff1a\u7279\u96c6\u300c\u5b9f\u5730\u533b\u5bb6\u304c\u5b9f\u8df5\u3059\u3079\u304d\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u3092\u8e0f\u307e\u3048\u305f\u611f\u67d3\u75c7\u6cbb\u7642\u300d(\u5965\u5ddd \u5468 \u7de8\uff09pp. 411-416\uff0e\u6587\u5149\u5802\uff0c\u6771\u4eac\uff0c2017\uff0e<\/li>\n\n\n\n
                                                                                                                      18. \u5ee3\u702c \u90a6\u7ae0\uff0c\u5927\u9580 \u96c5\u592b\uff0eMR\u60a3\u8005\u306e\u81e8\u5e8a\u7d4c\u904e\u3092\u7406\u89e3\u3057\u3088\u3046\uff0eThe Best Treatment \u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u3092\u6df1\u8aad\u307f\u3057\uff0c\u5148\u8aad\u307f\u3059\u308b\uff08\u4f0a\u85e4 \u6d69 \u7de8\uff09pp. 2-6\uff0e\u6587\u5149\u5802\uff0c\u6771\u4eac\uff0c2017\uff0e<\/li>\n\n\n\n
                                                                                                                      19. \u6e6f\u672c \u771f\u4eba\uff0e\u8133\u6ce2\u691c\u67fb \u8133\u78c1\u56f3\u306e\u6709\u7528\u6027\uff0e\u81e8\u5e8a\u795e\u7d4c\u751f\u7406\u691c\u67fb\u5165\u9580\uff08\u5b87\u5ddd \u7fa9\u4e00 \u7de8\uff09pp. 150-164\uff0e\u4e2d\u5c71\u66f8\u5e97\uff0c\u6771\u4eac\uff0c2017\uff0e<\/li>\n<\/ol>\n\n\n\n

                                                                                                                        \u548c\u6587\u7de8\u8457\u7b49\uff1aJapanese Book Editing<\/h4>\n\n\n\n
                                                                                                                          \n
                                                                                                                        1. \u5927\u9580 \u96c5\u592b \u7de8\uff0e\u5fc3\u30a8\u30b3\u30fc \u300c\u65b0\u3057\u304f\u306a\u3063\u305fASE\u62e1\u5f35\u80fd\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u300d\uff0e\u6587\u5149\u5802\uff0c\u6771\u4eac\uff0c2017\uff0e<\/li>\n\n\n\n
                                                                                                                        2. \u5927\u9580 \u96c5\u592b \u7de8\uff0e\u5fc3\u30a8\u30b3\u30fc \u300c\u9ad8\u9f62\u8005\u306e\u30a8\u30b3\u30fc\u306e\u64ae\u308a\u65b9\u30fb\u8aad\u307f\u65b9\u300d\uff0e\u6587\u5149\u5802\uff0c\u6771\u4eac\uff0c2017\uff0e<\/li>\n\n\n\n
                                                                                                                        3. \u5927\u9580\u96c5\u592b \u7de8\uff0e\u5fc3\u81d3 \u7279\u5225\u53f7\u300c\u5f01\u819c\u75c7 \u50e7\u5e3d\u5f01\u72ed\u7a84\u3068\u9006\u6d41\u300d\uff0e\u5fc3\u81d3\u8ca1\u56e3\uff0c\u6771\u4eac\uff0c2017\uff0e<\/li>\n\n\n\n
                                                                                                                        4. \u5927\u9580 \u96c5\u592b \u7de8\uff0e\u5fc3\u4e0d\u5168\u60a3\u8005\u306e\u5931\u6557\u3057\u306a\u3044\u5f01\u819c\u75c7\u6cbb\u7642\uff0e\u6587\u5149\u5802\uff0c\u6771\u4eac\uff0c2017\uff0e<\/li>\n\n\n\n
                                                                                                                        5. \u5927\u9580 \u96c5\u592b \u7de8\uff0e\u5185\u79d1\u7dcf\u5408\u8a8c Medical Practice\uff0e\u5f01\u819c\u75c7\uff1a\u5b9f\u5730\u533b\u5bb6\u304c\u77e5\u3063\u3066\u304a\u304f\u3079\u304d\u73fe\u4ee3\u306e\u5f01\u819c\u75c7\uff0e\u6587\u5149\u5802\uff0c\u6771\u4eac\uff0c2017\uff0e<\/li>\n<\/ol>\n<\/div><\/div>\n\n\n\n
                                                                                                                          \n

                                                                                                                          2016\u5e74<\/h3>\n\n\n\n

                                                                                                                          \u82f1\u6587\u539f\u8457\u8ad6\u6587\uff1aEnglish Original Articles<\/h4>\n\n\n\n
                                                                                                                            \n
                                                                                                                          1. Akaishi, M., Asanuma, T., Izumi, C., Iwanaga, S., Kawai, H., Daimon, M., Toide, H., Hashimoto, S., Hayashida, A., Yamada, H.,and Nakatani, S. Guidelines for conducting transesophageal echocardiography (TEE) : Task force for guidelines for conducting TEE: November 15, 2015. J. Echocardiogr.<\/em><\/strong> 14: 47-48<\/a>, 2016.<\/li>\n\n\n\n
                                                                                                                          2. Altinel K., Hashimoto K., Wei Y., Neuveut C., Gupta I., Suzuki AM., Dos Santos A., Moreau P., Xia T., Kojima S., Kato S., Takikawa Y., Hidaka I., Shimizu M., Matsuura T., Tsubota A., Ikeda H., Nagoshi S., Suzuki H., Michel ML., Samuel D., Buendia MA., Faivre J., and Carninci P. Single-Nucleotide Resolution Mapping of Hepatitis B Virus Promoters in Infected Human Livers and Hepatocellular Carcinoma. J Virol.<\/strong><\/em> 90: 10811-10822<\/a>, 2016.<\/li>\n\n\n\n
                                                                                                                          3. Chiang, SJ., Daimon, M., Miyazaki, S., Kawata, T., Ichikawa-Morimoto, R., Maruyama, M., Ohmura, H., Miyauchi, K., Lee, SL., Daida, H. When and how aortic stenosis is first diagnosed: a single-center observational study. J. Cardiol.<\/strong><\/em> 68: 324\u2013328<\/a>, 2016.<\/li>\n\n\n\n
                                                                                                                          4. Daikoku, T., Yatomi, Y., and Yumoto, M. Pitch-class distribution modulates the statistical learning of atonal chord sequences. Brain Cogn.<\/strong><\/em> 108: 1-10<\/a>, 2016.<\/li>\n\n\n\n
                                                                                                                          5. Enooku, K., Uranbileg, B., Ikeda, H., Kurano, M., Sato, M., Kudo, H., Maki, H., Koike, K., Hasegawa, K., Kokudo, N., and Yatomi, Y. Higher LPA2 and LPA6 mRNA levels in hepatocellular carcinoma are associated with poorer differentiation, microvascular invasion and earlier recurrence with higher serum autotaxin levels. PLoS One.<\/strong><\/em> 11: e0161825<\/a>, 2016.<\/li>\n\n\n\n
                                                                                                                          6. Hirohama, D., Kawakami-Mori, F., Ogura, S., Mu, S., Jimbo, R., Uetake, U., Yatomi, Y., Nangaku, M., Fujita, T., and Shimosawa, T. Renal Denervation Improves Cardiac Diastolic Dysfunction by Restoring Serca2a Transcription in Uninephrectomized Rats. J. Hypertens. (Los Angel)<\/strong><\/em> 5: 225. doi:10.4172\/2167-1095.1000225<\/a>, 2016.<\/li>\n\n\n\n
                                                                                                                          7. Hirokawa, M., Daimon, M., Lee, S.L., Nakao, T., Kawata, T., Kimura, K., Kato, T.S., Mizuno, Y., Watanabe, M., Yatomi, Y., Yamazaki, T., and Komuro, I. Early menopause does not influence left ventricular diastolic dysfunction: A clinical observational study in healthy subjects. J. Cardiol.<\/strong><\/em> 68: 548\u2013553<\/a>, 2016.<\/li>\n\n\n\n
                                                                                                                          8. Ishikawa, R., Amano, Y., Kawakami, M., Sunohara, M., Watanabe, K., Kage, H., Ohishi, N., Yatomi, Y., Nakajima, J., Fukayama, M., Nagase, T., and Takai, D. The chimeric transcript RUNX1-GLRX5: a biomarker for good postoperative prognosis in stage IA non-small cell lung cancer. Jpn. J. Clin. Oncol. <\/strong><\/em>46: 185-189<\/a>, 2016.<\/li>\n\n\n\n
                                                                                                                          9. Kido, Y., Takahashi, M., Fukuma, N., Kawata, T., Tanaka, A., Hayashi, A., Shibahara, J., Daimon, M., Morita, H., Akazawa, H., and Komuro, I. Heart Failure Complicated by Alveolar Hemorrhage due to Vascular Collapse and Amyloid Deposits in Wild-Type Transthyretin Amyloidosis. Cardiology.<\/strong><\/em> 135: 216-220<\/a>, 2016.<\/li>\n\n\n\n
                                                                                                                          10. Kimura, K., Morita, H., Daimon, M., Horio, M., Kawata, T., Nakao, T., Hirokawa, M., Kitao, R., Watanabe, D., Komori, T., Nagata, T., Takeda, S., Komaki, H., Segawa, K., Nakajima, T., Takenaka, K., and Komuro, I. Utility of Cystatin C for Estimating Glomerular Filtration Rate in Patients With Muscular Dystrophy. Int. Heart J. <\/em><\/strong>57: 386-388<\/a>, 2016.<\/li>\n\n\n\n
                                                                                                                          11. Kurano, M., Hara, M., Nojiri, T., Ikeda, H., Tsukamoto, K., and Yatomi, Y. Resveratrol exerts a biphasic effect on apolipoprotein M. Br. J. Pharmacol.<\/strong><\/em> 173: 222-233<\/a>, 2016.<\/li>\n\n\n\n
                                                                                                                          12. Kurano, M., Tsukamoto, K., Kamitsuji, S., Kamatani, N., Hara, M., Ishikawa, T., Kim B.J., Moon S., Kim Y.J., and Teramoto, T. Genome-wide association study of serum lipids confirms previously reported, associations as well as new associations of common SNPs within PCSK7 gene with triglyceride. J. Hum. Genet.<\/strong><\/em> 61: 427-433<\/a>, 2016.<\/li>\n\n\n\n
                                                                                                                          13. Lee, SL., Daimon, M., Nakao, T., Singer, DE., Shinozaki, T., Kawata, T., Kimura, K., Hirokawa, M.,\u3000Kato, TS., Mizuno, Y., Watanabe, M., Yatomi, Y., Yamazaki, .T, and Komuro, I. Factors Influencing Left Atrial Volume in a Population with Preserved Ejection Fraction: Left Ventricular Diastolic Dysfunction or Clinical Factors?\u3000J. Cardiol.<\/em><\/strong> 68: 275\u2013281<\/a>, 2016.<\/li>\n\n\n\n
                                                                                                                          14. Lee, SL., Daimon, M., Di, Tullio, MR., Homma, S., Nakao, T., Kawata, T., Kimura, K., Shinozaki, T., Hirokawa, M., Kato, T.S., Mizuno, Y., Watanabe, M., Yatomi, Y., Yamazaki, T., and Komuro, I. Relationship of Left Ventricular Diastolic Function to Obesity and Overweight in a Japanese Population With Preserved Left Ventricular Ejection Fraction. Circ. J. <\/strong><\/em>80: 1951-1956<\/a>, 2016.<\/li>\n\n\n\n
                                                                                                                          15. Morita, K., Nakamura, F., Taoka, K., Satoh, Y., Iizuka, H., Masuda, A., Seo, S., Nannya, Y., Yatomi, Y., and Kurokawa M. Incidentally-detected t(9;22)(q34;q11)\/BCR-ABL1- positive clone developing into chronic phase chronic myeloid leukaemia after four years of dormancy. Br. J. Haematol.<\/strong><\/em> 174: 815-817<\/a>, 2016.<\/li>\n\n\n\n
                                                                                                                          16. Murata, A., Inoue, K., Maruyama, S., Iguchi, S., Sugita, M., Hiki, M., Okazaki, S., Okai, I., Fujiwara, Y., Sumiyoshi, M., Yamamoto, T., Amano, A., Daimon, M., and Daida, H. Enormous Pedunculated Vegetation Originating in the Left Ventricular Apex in a Patient with Infective Endocarditis. Intern. Med.<\/strong><\/em> 55: 2971-2973<\/a>, 2016.<\/li>\n\n\n\n
                                                                                                                          17. Nagura, Y., Tsuno, NH., Kano, K., Inoue, A., Aoki, J., Hirowatari, Y., Kaneko, M., Kurano, M., Matsuhashi, M., Ohkawa, R., Tozuka, M., Yatomi, Y., and Okazaki, H. Regulation of the lysophosphatidylserine and sphingosine 1-phosphate levels in autologous whole blood by the pre-storage leukocyte reduction. Transfus Med. <\/em><\/strong>26: 365-372<\/a>, 2016.<\/li>\n\n\n\n
                                                                                                                          18. Nishimura, Y., Kawakubo, Y., Suga, M., Hashimoto, K., Takei, Y., Takei, K., Inoue, H., Yumoto, M., Takizawa, R., and Kasai, K. Familial Influences on Mismatch Negativity and Its Association with Plasma Glutamate Level: A Magnetoencephalographic Study in Twins. Mol. Neuropsychiatry<\/strong><\/em> 2:161-172<\/a>, 2016.<\/li>\n\n\n\n
                                                                                                                          19. Otsuka, A., Yumoto, M., Kuriki, S., Hotehama, T., and Nakagawa, S. Frequency characteristics of neuromagnetic auditory steady-state responses to sinusoidally amplitude-modulated sweep tones. Clin. Neurophysiol.<\/strong><\/em> 127: 790-802<\/a>, 2016.<\/li>\n\n\n\n
                                                                                                                          20. Sato M, Ikeda H, Uranbileg B, Kurano M, Saigusa D, Aoki J, Maki H, Kudo H, Hasegawa K, Kokudo N, Yatomi Y. Sphingosine kinase-1, S1P transporter spinster homolog 2 and S1P2 mRNA expressions are increased in liver with advanced fibrosis in human. Sci. Rep.<\/strong><\/em> 6: 32119.<\/a> , 2016.<\/li>\n\n\n\n
                                                                                                                          21. Sato, M., Ohkawa, R., Yoshimoto, A., Yano, K., Ichimura, N, Nishimori, M., Okubo, S., Yatomi, Y., and Tozuka, M. Effects of serum amyloid A on the structure and antioxidant ability of high-density lipoprotein. Biosci. Rep.<\/strong><\/em> 36: e00369<\/a>, 2016.<\/li>\n\n\n\n
                                                                                                                          22. Shibayama, K. , Daimon, M., Watanabe, H., Kawata, T., Miyazaki, S., Morimoto-Ichikawa, R., Maruyama, M., Chiang, S.J., Miyauchi, K., and Daida, H. Significance of Coronary Artery Disease and Left Ventricular Afterload in Unoperated Asymptomatic Aortic Stenosis. Circ J.<\/strong><\/em> 80: 519-525<\/a>, 2016.<\/li>\n\n\n\n
                                                                                                                          23. Shimizu, M., Furuichi, K., Toyama, T., Yamahana, J., Ohkawa, R., Igarashi, K., Aoki, J., Kaneko, S., Yatomi, Y., and Wada, T. Serum autotaxin levels are associated with proteinuria and kidney lesions in Japanese type 2 diabetic patients with biopsy-proven diabetic nephropathy. Internal Medicine<\/strong><\/em> 55: 215-221<\/a>, 2016.<\/li>\n\n\n\n
                                                                                                                          24. Shinohara, K., Hamasaki, N., Takagi, Y., Yatomi, Y., Kikuchi, H., Hosogaya, S., Kawai, Y., Miyachi, H., Kaneko, K., Miyajima, Y., Matsumoto, H., Yamamoto, Y., Iwagami, M., Osawa, S., Umeda, M., Koide, H., Yoshimura, D., and Kato, H. Multi-analyte conventional reference material (MacRM): a useful tool for nationwide standardization of laboratory measurements for medical care (a model study in Japan). Clin. Chem. <\/strong><\/em>62: 392-406<\/a>, 2016.<\/li>\n\n\n\n
                                                                                                                          25. Shukuya, K., Ogura, S., Tokuhara, Y., Okubo, S., Yatomi, Y., Tozuka, M., and Shimosawa, T. Novel Round Cells in Urine Sediment and Their Clinical Implications Clin. Chim. Acta.<\/strong><\/em> 457: 142-149<\/a>, 2016. Corrigendum inClin Chim Acta.<\/em><\/strong>2017472:104<\/a>, 2017.<\/li>\n\n\n\n
                                                                                                                          26. Soroida, Y., Sato, M., Hikita, H., Hagiwara, S., Sato, M., Gotoh, H., Kato, S., Iwai, T., Yamazaki, T., Yatomi, Y., Sasano, T., and Ikeda, H. Pancreatic cysts in general population on ultrasonography: Prevalence and development of risk score. J. Gastroenterol.<\/strong><\/em> 51: 1133-1140<\/a>, 2016.<\/li>\n\n\n\n
                                                                                                                          27. Suga, M., Nishimura, Y., Kawakubo, Y., Yumoto, M., and Kasai, K. MEG recording of auditory mismatch negativity in response to duration and frequency deviants in a single session in patients with schizophrenia. Psychiatry Clin. Neurosci.<\/strong><\/em> 70: 295-302<\/a>, 2016.<\/li>\n\n\n\n
                                                                                                                          28. Tanaka, M., Shukuya,K., Morita,Y., Kagaeyama,Y., Okubo.S.,Shimosawa,T., and Yatomi,Y. Performance Evaluation of the XN-550 Automated Hematology Analyzer Body Fluid Mode \u2013 Considerations for Operational Conditions for Cell Counting With Cerebrospinal and Synovial Fluids. Sysmex Journal International<\/strong><\/em> 26(1): 1-9, 2016.<\/li>\n\n\n\n
                                                                                                                          29. Tokushige, S., Terao, Y., Uchio, N., Tsuji, S., and Yumoto, M. Adult onset ictal aphasia with epileptic discharges in Broca’s and Wernicke’s areas. Clin. Neurophysiol.<\/strong><\/em> 127: 1754-1756<\/a>, 2016.<\/li>\n\n\n\n
                                                                                                                          30. Uranbileg, B., Ikeda, H., Kurano, M., Enooku, K., Sato, M., Saigusa, D., Aoki, J., Ishizawa, T., Hasegawa, K., Kokudo, N., and Yatomi, Y. Increased mRNA Levels of Sphingosine Kinases and S1P Lyase and Reduced Levels of S1P Were Observed in Hepatocellular Carcinoma in Association with Poorer Differentiation and Earlier Recurrence. PLoS One.<\/strong><\/em> 11: e0149462<\/a>, 2016.<\/li>\n\n\n\n
                                                                                                                          31. Yoshikawa, N., Masuda, A., Jona, M., Okubo, S., Nannya, Y., Yokota, H., Kurokawa, M., and Yatomi, Y. Evaluation of Immature Platelet Fraction Measurements Using a Automated Hematology Analyzer, Sysmex XN. Rinsho Byori (The official journal of Japanese Society of Laboratory Medicine)<\/strong><\/em> 64: 1220-1228<\/a>, 2016.<\/li>\n<\/ol>\n\n\n\n

                                                                                                                            \u56fd\u5185\u5b66\u4f1a\u767a\u8868\uff1aDomestic Conference Presentation<\/h4>\n\n\n\n
                                                                                                                              \n
                                                                                                                            1. \u5c0f\u91ce \u4f73\u4e00\uff0c\u5b89\u672c \u7be4\u53f2\uff0c\u4e45\u7c73 \u5e78\u592b\uff0c\u5927\u4e45\u4fdd \u6ecb\u592b\uff0c\u77e2\u51a8 \u88d5\uff0e\u5f53\u9662\u3067\u7d4c\u9a13\u3057\u305f\u30eb\u30fc\u30d7\u30b9\u30a2\u30f3\u30c1\u30b3\u30a2\u30b0\u30e9\u30f3\u30c8\u967d\u6027\u30fb\u4f4e\u30d7\u30ed\u30c8\u30ed\u30f3\u30d3\u30f3\u8840\u75c7\u306e\u4e00\u75c7\u4f8b\uff0e\u7b2c17\u56de \u65e5\u672c\u691c\u67fb\u8840\u6db2\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2016.8.6\uff0e\u798f\u5ca1\uff0e<\/li>\n\n\n\n
                                                                                                                            2. \u4e45\u7c73 \u5e78\u592b\uff0c\u91ce\u7530 \u91cc\u7f8e\uff0c\u4f0a\u9054 \u4e9c\u7406\u6c99\uff0c\u4f50\u85e4 \u7f8e\u77e5\u5b50\uff0c\u5e38\u540d \u653f\u5f18\uff0c\u66fd\u6839 \u4f38\u4e8c\uff0c\u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0e\u938c\u72b6\u8d64\u8840\u7403\u75c7\u60a3\u8005\u306eHbA1c\u306e\u65e5\u5e38\u6e2c\u5b9a\u6cd5\u3067\u306e\u6e2c\u5b9a\u7d50\u679c\uff0e\u7b2c56\u56de \u65e5\u672c\u81e8\u5e8a\u5316\u5b66\u4f1a\u5e74\u6b21\u5b66\u8853\u96c6\u4f1a\uff0e2016.12.2-4\uff0e\u718a\u672c\uff0e<\/li>\n\n\n\n
                                                                                                                            3. \u4e45\u7c73 \u5e78\u592b\uff0c\u5927\u4e45\u4fdd \u6ecb\u592b\uff0c\u77e2\u51a8 \u88d5\uff0e\u6771\u4eac\u5927\u5b66\u533b\u5b66\u90e8\u9644\u5c5e\u75c5\u9662\u3067\u306e\u81e8\u5730\u5b9f\u7fd2\u4e8b\u4f8b\uff0e\u7b2c26\u56de \u65e5\u672c\u751f\u7269\u8a66\u6599\u5206\u6790\u79d1\u5b66\u4f1a\uff0e2016.2.20-21\uff0e\u6c96\u7e04\uff0e<\/li>\n\n\n\n
                                                                                                                            4. \u5f8c\u85e4 \u5bdb\u662d\uff0c\u5c0f\u6797 \u7389\u5b9c\uff0c\u624b\u5d8b \u6843\u6c5f\uff0c\u758b\u7530 \u5b8f\u7f8e\uff0c\u5c0f\u5ba4 \u8cb4\u5b50\uff0c\u5927\u4e45\u4fdd \u6ecb\u592b\uff0c\u77e2\u51a8 \u88d5\uff0e\u8d85\u97f3\u6ce2\u691c\u67fb\u3067\u7d4c\u6642\u7684\u5909\u5316\u3092\u8ffd\u3048\u305f\u9670\u56a2\u81bf\u760d\u306e\u4e00\u75c7\u4f8b\uff0e\u7b2c65\u56de \u65e5\u672c\u533b\u5b66\u691c\u67fb\u5b66\u4f1a\uff0e2016.9.2-4\uff0e\u795e\u6238\uff0e<\/li>\n\n\n\n
                                                                                                                            5. \u8535\u91ce \u4fe1\uff0c\u539f \u771e\u7d14\uff0c\u77e2\u51a8 \u88d5\uff0c\u585a\u672c \u548c\u4e45\uff0e\u809d\u7d30\u80de\u306e\u30b3\u30ec\u30b9\u30c6\u30ed\u30fc\u30eb\u5897\u52a0\u7d4c\u8def\u306b\u3088\u308b\u7cd6\u4ee3\u8b1d\u4fee\u98fe\u306e\u76f8\u9055\uff0e \u7b2c59\u56de \u65e5\u672c\u7cd6\u5c3f\u75c5\u5b66\u4f1a\u5e74\u6b21\u5b66\u8853\u96c6\u4f1a\uff0e2016.5.21\uff0e\u4eac\u90fd\uff0e<\/li>\n\n\n\n
                                                                                                                            6. \u8535\u91ce \u4fe1\uff0ePossible Involvement of Minor Lysophospholipids in the Pathogenesis of Acute Coronary Syndrome. (\u5e73\u621028\u5e74\u5ea6\u65e5\u672c\u8840\u6813\u6b62\u8840\u5b66\u4f1a\u5b66\u8853\u5968\u52b1\u8cde \u53d7\u8cde\u8b1b\u6f14) \u7b2c38\u56de \u65e5\u672c\u8840\u6813\u6b62\u8840\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2016.6.16\uff0e\u5948\u826f\uff0e<\/li>\n\n\n\n
                                                                                                                            7. \u8535\u91ce \u4fe1\uff0c\u5e38\u5c71 \u5e78\u4e00\uff0c\u5e38\u540d \u653f\u5f18\uff0c\u77e2\u51a8 \u88d5\uff0e\u30a2\u30dd\u86cb\u767d\uff2d\u3092\u7528\u3044\u305f\u64ad\u7a2e\u6027\u8840\u7ba1\u5185\u51dd\u56fa\u75c7\u5019\u7fa4\uff0c\u591a\u81d3\u5668\u4e0d\u5168\u306e\u65b0\u898f\u6cbb\u7642\u6cd5\u306e\u958b\u767a\uff0e \u7b2c38\u56de \u65e5\u672c\u8840\u6813\u6b62\u8840\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2016.6.18\uff0e\u5948\u826f\uff0e<\/li>\n\n\n\n
                                                                                                                            8. \u8535\u91ce \u4fe1\uff0ePossible Involvement of Minor Lysophospholipids in the Increase in Plasma Lysophosphatidic Acid in Acute Coronary Syndrome. (\u82e5\u624b\u7814\u7a76\u8005\u5968\u52b1\u8cde\u9078\u8003\u767a\u8868\u4f1a) \u7b2c48\u56de \u65e5\u672c\u52d5\u8108\u786c\u5316\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2016.7.14\uff0e\u6771\u4eac\uff0e<\/li>\n\n\n\n
                                                                                                                            9. \u8535\u91ce \u4fe1\uff0c\u6e05\u6c34 \u77e5\uff0c\u4e94\u5341\u5d50 \u6d69\u4e8c\uff0c\u539f \u771e\u7d14\uff0c\u585a\u672c \u548c\u4e45\uff0c\u77e2\u51a8 \u88d5\uff0e2\u578b\u7cd6\u5c3f\u75c5\u60a3\u8005\u306b\u304a\u3051\u308b\u30ea\u30be\u30ea\u30f3\u8102\u8cea\u95a2\u9023\u86cb\u767d\u3068\u5408\u4f75\u75c7\u306e\u95a2\u4fc2\uff0e \u7b2c48\u56de \u65e5\u672c\u52d5\u8108\u786c\u5316\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2016.7.15\uff0e\u6771\u4eac\uff0e<\/li>\n\n\n\n
                                                                                                                            10. \u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0eIgA\u814e\u75c7\u306b\u304a\u3051\u308b\u30b9\u30d5\u30a3\u30f3\u30b4\u30b7\u30f31-\u30ea\u30f3\u9178\u306e\u5f79\u5272\uff0e \u7b2c63\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2016.9.2\uff0e\u795e\u6238\uff0e<\/li>\n\n\n\n
                                                                                                                            11. \u8535\u91ce \u4fe1\uff0c\u585a\u672c \u548c\u4e45\uff0c\u77e2\u51a8 \u88d5\uff0e\u30a2\u30dd\u86cb\u767dM\u306e\u6297\u7cd6\u5c3f\u75c5\u6027\u814e\u75c7\u4f5c\u7528\uff0e\u7b2c31\u56de \u65e5\u672c\u7cd6\u5c3f\u75c5\u5408\u4f75\u75c7\u5b66\u4f1a\uff0e2016.10.8\uff0e\u4ed9\u53f0\uff0e<\/li>\n\n\n\n
                                                                                                                            12. \u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0e\u30a2\u30dd\u86cb\u767dM\u3092\u7528\u3044\u305f\u64ad\u7a2e\u6027\u8840\u7ba1\u5185\u51dd\u56fa\u75c7\u5019\u7fa4\uff0c\u591a\u81d3\u5668\u4e0d\u5168\u306e\u65b0\u898f\u6cbb\u7642\u6cd5\u306e\u958b\u767a\uff0e \u7b2c23\u56de \u52d5\u8108\u786c\u5316\u82e5\u624b\u7814\u7a76\u4f1a\uff0e2016.10.29\uff0e\u6771\u4eac\uff0e<\/li>\n\n\n\n
                                                                                                                            13. \u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0e\u30ea\u30b3\u30f3\u30d3\u30ca\u30f3\u30c8\u30a2\u30dd\u86cb\u767dM\u3092\u5229\u7528\u3057\u305f\u591a\u81d3\u5668\u4e0d\u5168\u306b\u5bfe\u3059\u308b\u65b0\u898f\u6cbb\u7642\u6cd5\u306e\u958b\u767a\uff0e \u7b2c56\u56de \u65e5\u672c\u81e8\u5e8a\u5316\u5b66\u4f1a\u5e74\u6b21\u5b66\u8853\u96c6\u4f1a\uff0e2016.12.3\uff0e\u718a\u672c\uff0e<\/li>\n\n\n\n
                                                                                                                            14. \u67f4\u5c71 \u8b19\u592a\u90ce\uff0c\u5927\u9580 \u96c5\u592b\uff0c\u6e21\u8fba \u5f18\u4e4b\uff0c\u5ddd\u7530 \u8cb4\u4e4b\uff0c\u5bae\u5d0e \u5f69\u8a18\u5b50\uff0c\u68ee\u672c \u826f\u5b50\uff0c\u5713\u5c71 \u96c5\u5df1\uff0c Shuo-ju Chiang\uff0c\u5bae\u5185 \u514b\u5df1\uff0c\u4ee3\u7530\u6d69\u4e4b\uff0eSignificance of coronary artery disease and left ventricular afterload in unoperated asymptomatic aortic stenosis. \u7b2c27\u56de \u65e5\u672c\u5fc3\u30a8\u30b3\u30fc\u56f3\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2016.4.22-24\uff0e\u5927\u962a\uff0e<\/li>\n\n\n\n
                                                                                                                            15. \u5bbf\u8c37 \u8ce2\u4e00\uff0e\u6559\u80b2\u8b1b\u6f14\u300c\u5c3f\u6c88\u6e23\u304b\u3089\u75c5\u614b\u3092\u63a8\u6e2c\u3059\u308b\u300d\uff0e\u7b2c65\u56de \u65e5\u672c\u533b\u5b66\u691c\u67fb\u5b66\u4f1a\uff0e2016.9.3-4\uff0e\u795e\u6238\uff0e<\/li>\n\n\n\n
                                                                                                                            16. \u5bbf\u8c37 \u8ce2\u4e00\uff0c\u7530\u4e2d \u96c5\u7f8e\uff0c\u6c34\u9593 \u77e5\u4e16\uff0c\u68ee\u7530 \u8ce2\u53f2\uff0c\u5f71\u5c71 \u7950\u5b50\uff0c\u4e0b\u6fa4 \u9054\u96c4\uff0c\u77e2\u51a8 \u88d5\uff0e\u5168\u81ea\u52d5\u5c3f\u4e2d\u6709\u5f62\u6210\u5206\u64ae\u50cf\u30e6\u30cb\u30c3\u30c8UD-10\u306b\u304a\u3051\u308b\u64ae\u50cf\u6027\u80fd\u306b\u3064\u3044\u3066\uff0e\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u81ea\u52d5\u5316\u5b66\u4f1a \u7b2c48\u56de\u5927\u4f1a\uff0e2016.9.22-24\uff0e\u6a2a\u6d5c\uff0e<\/li>\n\n\n\n
                                                                                                                            17. \u5bbf\u8c37 \u8ce2\u4e00\uff0e\u5320\u304b\u3089\u306e\u9053\u3057\u308b\u3079 \u65b0\u4eba\u304c\u304b\u304b\u3048\u308b\u7591\u554f\u70b9\u3092\u89e3\u6d88\u3057\u307e\u3059\uff0e\u7b2c53\u56de \u65e5\u81e8\u6280\u95a2\u7532\u4fe1\u652f\u90e8\u30fb\u9996\u90fd\u570f\u652f\u90e8\u533b\u5b66\u691c\u67fb\u5b66\u4f1a\uff0e\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\uff0e2016.10.29-30\uff0e\u7532\u5e9c\uff0e<\/li>\n\n\n\n
                                                                                                                            18. \u5713\u5c71 \u96c5\u5df1\uff0c\u52a0\u85e4 \u502b\u5b50\uff0c\u68ee\u672c \u826f\u5b50\uff0c\u7530\u6df5 \u6674\u540d\uff0c\u5bae\u5d0e \u5f69\u8a18\u5b50\uff0c\u5927\u9580 \u96c5\u592b\uff0c\u5927\u6751 \u5bdb\u654f\uff0c\u4ee3\u7530\u6d69\u4e4b\uff0e\u8170\u90e8\u795e\u7d4c\u7dda\u7dad\u816b\u3067\u7d4c\u904e\u89b3\u5bdf\u4e2d\u306b\uff0c\u5de6\u5ba4\u5fc3\u5c16\u90e8\u816b\u760d\u3092\u81f3\u9069\u3055\u308c\u305f1\u4f8b\uff0e\u7b2c27\u56de \u65e5\u672c\u5fc3\u30a8\u30b3\u30fc\u56f3\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2016.4.22-24\uff0e\u5927\u962a\uff0e<\/li>\n\n\n\n
                                                                                                                            19. \u5927\u9580 \u96c5\u592b\uff0c\u674e \u653f\u54f2\uff0c\u5ddd\u7530 \u8cb4\u4e4b\uff0c\u4e2d\u5c3e \u502b\u5b50\uff0c\u6728\u6751 \u516c\u4e00\uff0c\u5ee3\u5ddd \u611b\u7f8e\uff0c\u5f90 \u535a\u537f\uff0c\u5b87\u91ce \u6f22\u6210\uff0c\u7af9\u4e2d \u514b\uff0c\u77e2\u51a8 \u88d5\uff0c\u5c0f\u5ba4 \u4e00\u6210\uff0e\u65e5\u672c\u4eba\u306b\u304a\u3051\u308b\u80a5\u6e80\u304c\u5fc3\u6a5f\u80fd\u306b\u4e0e\u3048\u308b\u5f71\u97ff\uff0e\u7b2c18\u56de \u5fc3\u7b4b\u4f1a\uff0e2016.2.6\uff0e\u6771\u4eac\uff0e<\/li>\n\n\n\n
                                                                                                                            20. \u5927\u9580 \u96c5\u592b\uff0e\u9ad8\u9f62\u8005\u30fb\u8d85\u9ad8\u9f62\u8005\u306b\u304a\u3051\u308b\u5fc3\u30a8\u30b3\u30fc\u691c\u67fb\u9ad8\u9f62\u8005\u306e\u5fc3\u30a8\u30b3\u30fc\u8a08\u6e2c\u5024\u306e\u7279\u5fb4\uff0e\u65e5\u672c\u8d85\u97f3\u6ce2\u533b\u5b66\u4f1a \u7b2c89\u56de\u5b66\u8853\u96c6\u4f1a\uff0e2016.5.27-29\uff0e\u4eac\u90fd\uff0e<\/li>\n\n\n\n
                                                                                                                            21. \u7530\u5d8b \u6c5f\u91cc\u5b50\uff0c\u6e6f\u672c \u771f\u4eba\uff0c\u6301\u7530 \u667a\u4e4b\uff0c\u8429\u539f \u79c0\uff0c\u771f\u5d0e \u6842\uff0c\u6e6f\u6d45 \u85ab\uff0c\u5927\u4e45\u4fdd \u6ecb\u592b\uff0c\u77e2\u51a8 \u88d5\uff0e\u5178\u578b\u7684\u306a\u6210\u4eba\u6f5c\u5728\u6027\u5f8b\u52d5\u6027\u8133\u6ce2\u767a\u5c04\u3092\u5448\u3057\u305f\u75c7\u4f8b\uff0e\u7b2c65\u56de \u65e5\u672c\u533b\u5b66\u691c\u67fb\u5b66\u4f1a\uff0e2016.9.2-4\uff0e\u795e\u6238\uff0e<\/li>\n\n\n\n
                                                                                                                            22. \u7530\u4e2d \u96c5\u7f8e\uff0c\u6c34\u9593 \u77e5\u4e16\uff0c\u68ee\u7530 \u8ce2\u53f2\uff0c\u5f71\u5c71 \u7950\u5b50\uff0c\u5bbf\u8c37 \u8ce2\u4e00\uff0c\u66fd\u6839 \u4f38\u6cbb\uff0e\u5c3f\u6c88\u6e23\u691c\u67fb\u306e\u6709\u7528\u6027\u306b\u95a2\u3059\u308b\u691c\u8a0e\u2010\u691c\u67fb\u4f9d\u983c\u6642\u306b\u5c3f\u8def\u816b\u760d\u306e\u7591\u3044\u304c\u306a\u304f\u7570\u578b\u7d30\u80de\u3092\u691c\u51fa\u3057\u305f\u75c7\u4f8b\u306e\u89e3\u6790\u2010\uff0e\u7b2c53\u56de \u65e5\u81e8\u6280\u95a2\u7532\u4fe1\u652f\u90e8\u30fb\u9996\u90fd\u570f\u652f\u90e8\u533b\u5b66\u691c\u67fb\u5b66\u4f1a\uff0e2016.10.29-30\uff0e\u7532\u5e9c\uff0e<\/li>\n\n\n\n
                                                                                                                            23. \u897f\u5ddd \u771f\u5b50\uff0c\u90f7\uff0c\u614e\u53f8\uff0cVeillon Lucas\uff0c\u4e95\u30ce\u53e3 \u4ec1\u4e00\uff0c\u9ad9\u6a4b \u5343\u6625\uff0c \u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0e \u8840\u6db2\u75be\u60a3\u60a3\u8005\u306b\u304a\u3051\u308b\u672b\u68a2\u8840\u7403\u6570\u3068 \u8840\u6e05\u30ac\u30f3\u30b0\u30ea\u30aa\u30b7\u30c9\u306e\u95a2\u9023\u306e\u691c\u8a0e\uff0e\u7b2c63\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2016.9.1-4\uff0e\u795e\u6238\uff0e<\/li>\n\n\n\n
                                                                                                                            24. \u897f\u5ddd \u771f\u5b50\uff0eRCPC1\u300c\u8a8d\u77e5\u75c7\u3067\u7ba1\u7406\u4e2d\uff0c\u5b9a\u671f\u691c\u67fb\u3067\u8ca7\u8840\u3092\u6307\u6458\u3055\u308c\u305f 80\u6b73\u4ee3\u5973\u6027\u300d\uff0e\u7b2c63\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2016.9.1-4\uff0e\u795e\u6238\uff0e<\/li>\n\n\n\n
                                                                                                                            25. \u91ce\u3005\u90e8 \u4eae\u5b50\uff0e\u68ee\u7530 \u8ce2\u53f2\uff0e\u9ad8\u6a4b \u6075\uff0e\u76db\u7530 \u548c\u6cbb\uff0e\u66fd\u6839 \u4f38\u6cbb\uff0e\u77e2\u51a8\u88d5\uff0e\u8840\u7cd6\u8ca0\u8377\u8a66\u9a13\u306b\u304a\u3051\u308b\u63a1\u8840\u7ba1\u4f9b\u7d66\u30b7\u30b9\u30c6\u30e0\u306e\u69cb\u7bc9\uff0e\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u81ea\u52d5\u5316\u5b66\u4f1a \u7b2c48\u56de\u5927\u4f1a\uff0e2016.9.22-24\uff0e\u6a2a\u6d5c\uff0e<\/li>\n\n\n\n
                                                                                                                            26. \u6e05\u6c34 \u5eb7\u5e73\uff0c\u7267\u5143 \u4e45\u6a39\uff0c\u85e4\u751f \u514b\u4ec1\uff0c\u5c0f\u5ba4 \u8cb4\u5b50\uff0c\u5927\u9580 \u96c5\u592b\uff0c\u7db2\u8c37 \u82f1\u4ecb\uff0c\u77e2\u51a8 \u88d5\uff0c\u5c0f\u5ba4 \u4e00\u6210\uff0e\u6162\u6027\u814e\u81d3\u75c5\u306e\u6709\u7121\u306b\u3088\u308b\u03b1\u03b2\u906e\u65ad\u85ac\u3068\u03b2\u906e\u65ad\u85ac\u306e\u5fc3\u81d3\u81ea\u5f8b\u795e\u7d4c\u6a5f\u80fd\u306b\u5bfe\u3059\u308b\u4f5c\u7528\u306e\u9055\u3044\u306b\u3064\u3044\u3066\u306e\u691c\u8a0e\uff0e\u7b2c64\u56de \u65e5\u672c\u5fc3\u81d3\u75c5\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2016.9.23-25\uff0e\u6771\u4eac\uff0e<\/li>\n\n\n\n
                                                                                                                            27. \u5fd7\u6751 \u62d3\u4e5f\uff0c\u98db\u7530 \u660e\u5b50\uff0c\u4fdd\u7530 \u5948\u7dd2\u7f8e\uff0c\u4e0b\u5742 \u6d69\u5247\uff0e\u5927\u4e45\u4fdd \u6ecb\u592b\uff0c\u6c60\u7530 \u5747\uff0c\u77e2\u51a8 \u88d5\uff0e\u5168\u81ea\u52d5\u5316\u5b66\u767a\u5149\u9175\u7d20\u514d\u75ab\u6e2c\u5b9a\u88c5\u7f6eAIA-CL2400\u306b\u3088\u308bPIVKA-II\u6e2c\u5b9a\u8a66\u85ac\u306e\u57fa\u790e\u7684\u691c\u8a0e\uff0e\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u81ea\u52d5\u5316\u5b66\u4f1a \u7b2c48\u56de\u5927\u4f1a\uff0e2016.9.22-24\uff0e\u6a2a\u6d5c\uff0e<\/li>\n\n\n\n
                                                                                                                            28. \u4e2d\u6e21 \u4e00\u8cb4\uff0c\u98db\u7530 \u660e\u5b50\uff0c\u5409\u5ddd \u76f4\u4e4b\uff0c\u4e0b\u5742 \u6d69\u5247\uff0c\u5927\u4e45\u4fdd \u6ecb\u592b\uff0c\u6c60\u7530 \u5747\uff0c\u77e2\u51a8 \u88d5\uff0e\u5168\u81ea\u52d5\u5316\u5b66\u767a\u5149\u9175\u7d20\u514d\u75ab\u6e2c\u5b9a\u88c5\u7f6eAIA\u2010CL2400\u3092\u7528\u3044\u305f\u30d5\u30a7\u30ea\u30c1\u30f3\u6e2c\u5b9a\u306e\u57fa\u790e\u7684\u691c\u8a0e\uff0e\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u81ea\u52d5\u5316\u5b66\u4f1a\u3000\u7b2c48\u56de\u5927\u4f1a\uff0e2016.9.22-24\uff0e\u6a2a\u6d5c\uff0e<\/li>\n\n\n\n
                                                                                                                            29. \u4e2d\u6e21 \u4e00\u8cb4\uff0c\u98db\u7530 \u660e\u5b50\uff0c\u5409\u5ddd \u76f4\u4e4b\uff0c\u4e0b\u5742 \u6d69\u5247\uff0c\u5927\u4e45\u4fdd \u6ecb\u592b\uff0c\u6c60\u7530 \u5747\uff0c\u77e2\u51a8 \u88d5\uff0e\u5168\u81ea\u52d5\u5316\u5b66\u767a\u5149\u9175\u7d20\u514d\u75ab\u6e2c\u5b9a\u88c5\u7f6eAIA\u2010CL2400\u3092\u7528\u3044\u305f\u30d5\u30a7\u30ea\u30c1\u30f3\u6e2c\u5b9a\u306e\u57fa\u790e\u7684\u691c\u8a0e\uff0e\u7b2c34\u56de \u95a2\u6771\u81e8\u5e8a\u514d\u75ab\u5316\u5b66\u7814\u7a76\u4f1a\uff0e2016.10.22\uff0e\u6771\u4eac\uff0e<\/li>\n\n\n\n
                                                                                                                            30. \u539f \u771e\u7d14\uff0c\u6749\u6d66 \u674f\u5948\uff0c\u9ad8\u4e95 \u6566\u5b50\uff0c\u8535\u91ce \u4fe1\uff0c\u5c71\u7530 \u9686\u6cbb\uff0c\u585a\u672c \u548c\u4e45\uff0e\u8077\u57df\u5065\u8a3a\u3092\u5229\u7528\u3057\u305f\u5bb6\u65cf\u6027\u9ad8\u30b3\u30ec\u30b9\u30c6\u30ed\u30fc\u30eb\u8840\u75c7\u8a3a\u65ad\u306e\u8a66\u307f\uff0e \u7b2c48\u56de \u65e5\u672c\u52d5\u8108\u786c\u5316\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2016.7.14\uff0e\u6771\u4eac\uff0e<\/li>\n\n\n\n
                                                                                                                            31. Megumi Hirokawa, Masao Daimon, Keitaro Mahara, Hajime Kim, Shuichiro Takanashi, Yasutaka Hirata, Haruo Yamauchi, Hitonobu Tomoike, Issei Komuro. Postoperative Change of Right Ventricular Systolic Function in Patients Undergoing Surgery for Isolated Severe Tricuspid Regurgitation. \u7b2c80\u56de \u65e5\u672c\u5faa\u74b0\u5668\u75c5\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2016.3.18-20\uff0e\u4ed9\u53f0\uff0e<\/li>\n\n\n\n
                                                                                                                            32. Hisaki Makimoto, Katsuhito Fujiu, Kohei Shimizu, Eisuke Amiya, Toshiya Kojima, Masao Daimon, Christian Meyer, Issei Komuro. Divergent Effect of Sympatholytic Therapy on Cardiac Autonomic Activity Depending on Chronic Kidney Disease. \u7b2c80\u56de \u65e5\u672c\u5faa\u74b0\u5668\u75c5\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2016.3.18-20\uff0e\u4ed9\u53f0\uff0e<\/li>\n\n\n\n
                                                                                                                            33. Makimoto, H., Fujiu,K., Shimizu, K., Amiya,E., Kojima, T., Daimon, M., Meyer, C., and Komuro, I. Different Responses of Sympathovagal-balance to Alpha- and Beta-blocking Effect Depending on Chronic Kidney Disease. \u7b2c80\u56de \u65e5\u672c\u5faa\u74b0\u5668\u5b66\u4f1a\uff0c2016.3.18-3.20\uff0e\u4ed9\u53f0\uff0e<\/li>\n\n\n\n
                                                                                                                            34. \u6c34\u9593\u77e5\u4e16\uff0c\u5e38\u540d\u653f\u5f18\uff0c\u5409\u5ddd\u76f4\u4e4b\uff0c\u5927\u91d1\u4e9c\u5f25\uff0c\u4e38\u5c3e\u7406\u6075\uff0c\u5bfa\u5cf6\u9053\u5b50\uff0c\u7530\u9089\u4e45\u7f8e\u5b50\uff0c\u5897\u7530\u4e9c\u5e0c\u5b50\uff0c\u5927\u4e45\u4fdd\u6ecb\u592b\uff0c\u77e2\u51a8\u88d5\uff0e\u6cbb\u7642\u95a2\u9023MDS\u306b\u8d64\u82bd\u7403\u7646\u3092\u4f34\u3063\u305f\u4e00\u75c7\u4f8b\uff0e\u7b2c17\u56de\u65e5\u672c\u691c\u67fb\u8840\u6db2\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2016.8.6-7\uff0e\u798f\u5ca1\uff0e<\/li>\n\n\n\n
                                                                                                                            35. \u68ee\u7530 \u8ce2\u53f2\uff0c\u5bbf\u8c37 \u8ce2\u4e00\uff0c\u7530\u4e2d \u96c5\u7f8e\uff0c\u4e45\u672b \u76f4\u5b50\uff0c\u5f71\u5c71 \u7950\u5b50\uff0c\u5927\u4e45\u4fdd \u6ecb\u592b\uff0c\u4e0b\u6fa4 \u9054\u96c4\uff0c\u77e2\u51a8 \u88d5\uff0e\u7a7a\u80de\u5909\u6027\u5186\u67f1\u3092\u591a\u6570\u8a8d\u3081\u305f\u591a\u767a\u6027\u9aa8\u9ac4\u816b\u306e\u4e00\u75c7\u4f8b\uff0e\u7b2c12\u56de \u814e\u30fb\u6ccc\u5c3f\u5668\u691c\u67fb\u7814\u7a76\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2016.3.26-27\uff0e\u6771\u4eac\uff0e<\/li>\n\n\n\n
                                                                                                                            36. \u68ee\u7530 \u8ce2\u53f2\uff0c\u7530\u4e2d \u96c5\u7f8e\uff0c\u4e45\u672b \u76f4\u5b50\uff0c\u5f71\u5c71 \u7950\u5b50\uff0c\u5e38\u540d \u653f\u5f18\uff0c\u5bbf\u8c37 \u8ce2\u4e00\uff0c\u5927\u4e45\u4fdd \u6ecb\u592b\uff0c\u5897\u7530 \u4e9c\u5e0c\u5b50\uff0c\u4e0b\u6fa4 \u9054\u96c4\uff0c\u77e2\u51a8 \u88d5\uff0e\u4e2d\u67a2\u795e\u7d4c\u6d78\u6f64\u3092\u304d\u305f\u3057\u305f\u767d\u8840\u75c5\u304a\u3088\u3073\u60aa\u6027\u30ea\u30f3\u30d1\u816b\u75c7\u4f8b\u306b\u95a2\u3059\u308b\u691c\u8a0e\uff0e\u7b2c17\u56de \u65e5\u672c\u691c\u67fb\u8840\u6db2\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2016.8.6-7\uff0e\u798f\u5ca1\uff0e<\/li>\n\n\n\n
                                                                                                                            37. \u68ee\u7530 \u8ce2\u53f2\uff0c\u7530\u4e2d \u96c5\u7f8e\uff0c\u6c34\u9593 \u77e5\u4e16\uff0c\u5f71\u5c71 \u7950\u5b50\uff0c\u5bbf\u8c37 \u8ce2\u4e00\uff0c\u4e0b\u6fa4 \u9054\u96c4\uff0c\u77e2\u51a8 \u88d5\uff0e\u5f53\u9662\u3067\u7d4c\u9a13\u3057\u305f\u597d\u9178\u7403\u6027\u9ac4\u819c\u708e\u306e4\u75c7\u4f8b\uff0e\u7b2c12\u56de \u6771\u4eac\u90fd\u533b\u5b66\u691c\u67fb\u5b66\u4f1a\uff0e2016.10.2\uff0e\u6771\u4eac\uff0e<\/li>\n\n\n\n
                                                                                                                            38. \u68ee\u7530 \u8ce2\u53f2\uff0c\u5bbf\u8c37 \u8ce2\u4e00\uff0c\u6c34\u9593 \u77e5\u4e16\uff0c\u5f71\u5c71 \u7950\u5b50\uff0c\u7530\u4e2d \u96c5\u7f8e\uff0c\u66fd\u6839 \u4f38\u6cbb\uff0e\u30af\u30ea\u30cb\u30c6\u30c3\u30af\u30ce\u30fc\u30d0\u30b9\u306b\u304a\u3051\u308b\u30d6\u30c9\u30a6\u7cd6\u5224\u5b9a\u57fa\u6e96\u5909\u66f4\u306b\u4f34\u3046\u30c7\u30fc\u30bf\u691c\u8a0e\uff0e\u7b2c53\u56de \u65e5\u81e8\u6280\u95a2\u7532\u4fe1\u652f\u90e8\u30fb\u9996\u90fd\u570f\u652f\u90e8\u533b\u5b66\u691c\u67fb\u5b66\u4f1a\uff0e2016.10.29-30\uff0e\u7532\u5e9c\uff0e<\/li>\n\n\n\n
                                                                                                                            39. \u5b89\u5ddd \u6075\u5b50\uff0e\u30a2\u30eb\u30d6\u30df\u30f3\u306e\u7cd6\u5316\u3068\u9178\u5316\uff0e\uff5e\u9178\u5316\u578b\u30a2\u30eb\u30d6\u30df\u30f3\u306e\u6e2c\u5b9a\u65b9\u6cd5\u306e\u958b\u767a\uff5e\uff0e\u7b2c24\u56de \u65e5\u672c\u81e8\u5e8a\u5316\u5b66\u4f1a \u95a2\u6771\u652f\u90e8\u7dcf\u4f1a\uff0e2016.6.4\uff0e\u6771\u4eac\uff0e<\/li>\n\n\n\n
                                                                                                                            40. \u5b89\u5ddd \u6075\u5b50\uff0c\u4e0b\u6fa4 \u9054\u96c4\uff0c\u5927\u4e45\u4fdd \u6ecb\u592b\uff0c\u77e2\u51a8 \u88d5\uff0e\u9084\u5143\u578b\u30fb\u9178\u5316\u578b\u30a2\u30eb\u30d6\u30df\u30f3\u6e2c\u5b9a\u306e\u305f\u3081\u306e\u691c\u4f53\u5b89\u5b9a\u5316\u306e\u691c\u8a0e\uff0e\u7b2c63\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\uff0e2016.9.2\uff0e\u6771\u4eac\uff0e<\/li>\n\n\n\n
                                                                                                                            41. \u5b89\u5ddd \u6075\u5b50\uff0c\u4e0b\u6fa4 \u9054\u96c4\uff0c\u5927\u4e45\u4fdd \u6ecb\u592b\uff0c\u77e2\u51a8 \u88d5\uff0e\u9084\u5143\u578b\u30fb\u9178\u5316\u578b\u30a2\u30eb\u30d6\u30df\u30f3\u306e\u57fa\u6e96\u7bc4\u56f2\u306e\u8a2d\u5b9a\u3068Nonalcoholic Fatty Liver Disease (NAFLD) \u75c7\u4f8b\u306e\u809d\u764c\u767a\u75c7\u30ea\u30b9\u30af\u3068\u306e\u95a2\u9023\uff0e\u7b2c63\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2016.9.1-4\uff0e\u795e\u6238\uff0e<\/li>\n\n\n\n
                                                                                                                            42. \u5b89\u672c \u7be4\u53f2\uff0c\u5fb3\u5ca1 \u6dbc\u7f8e\uff0c\u5317 \u82b3\u535a\uff0c\u6e05\u6c34 \u5b5d\u96c4\uff0c\u77e2\u51a8 \u88d5\uff0e\u30a8\u30a4\u30b3\u30b5\u30ce\u30a4\u30c9\u9ad8\u611f\u5ea6\u4e00\u6589\u5b9a\u91cf\u306b\u3088\u308b\u8840\u5c0f\u677f\u6a5f\u80fd\u8a55\u4fa1\u306e\u57fa\u790e\u691c\u8a0e\uff0e\u7b2c38\u56de \u65e5\u672c\u8840\u6813\u6b62\u8840\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2016.6.16-18\uff0e\u5948\u826f\uff0e<\/li>\n\n\n\n
                                                                                                                            43. \u5b89\u672c \u7be4\u53f2\uff0c\u5fb3\u5ca1 \u6dbc\u7f8e\uff0c\u5317 \u82b3\u535a\uff0c\u6e05\u6c34 \u5b5d\u96c4\uff0c\u77e2\u51a8 \u88d5\uff0e\u30a8\u30a4\u30b3\u30b5\u30ce\u30a4\u30c9\u9ad8\u611f\u5ea6\u4e00\u6589\u5b9a\u91cf\u306e\u8840\u6f3f\u30fb\u8840\u6e05\u81e8\u5e8a\u691c\u4f53\u3078\u306e\u5fdc\u7528\u306b\u5411\u3051\u305f\u57fa\u790e\u691c\u8a0e\uff0e\u7b2c63\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2016.9.1-4\uff0e\u795e\u6238\uff0e<\/li>\n\n\n\n
                                                                                                                            44. Atsushi Yasumoto, Mitsunaga Narushima, Tsukasa Osaki, Masayoshi Souri, Akitada Ichinose, Yutaka Yatomi. Successful treatment with dabigatran for coagulopathy associated with vascular malformation. \u7b2c78\u56de \u65e5\u672c\u8840\u6db2\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a. 2016.10.13-15\uff0e\u6a2a\u6d5c\uff0e<\/li>\n\n\n\n
                                                                                                                            45. Boqing Xu, Takayuki Kawata, Masao Daimon, Koichi Kimura, Tomoko Nakao, Cheng-Che Lee, Megumi Hirokawa, Aya Yoshinaga, Masafumi Watanabe, Yutaka Yatomi, Issei Komuro. Simple Echocardiographic Parameter, Right Ventricular Systolic to Diastolic Duration Ratio Predicts One-year Outcome in Advanced Heart Failure. \u7b2c80\u56de \u65e5\u672c\u5faa\u74b0\u5668\u75c5\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2016.3.18-20\uff0e\u4ed9\u53f0\uff0e<\/li>\n\n\n\n
                                                                                                                            46. Uranbileg, B., Ikeda, H., Kurano, M., and Yatomi, Y. A potential role of LPA receptors in pathophysiology of hepatocellular Carcinoma. \u7b2c63\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2016.9.2\uff0e\u795e\u6238\uff0e<\/li>\n\n\n\n
                                                                                                                            47. Uranbileg, B., Ikeda, H., Kurano, M., and Yatomi, Y. Involvement of Lysophosphatidylserine in the Pathophysiology of hepatocellular carcinoma. \u7b2c56\u56de \u65e5\u672c\u81e8\u5e8a\u5316\u5b66\u4f1a\u5e74\u6b21\u5b66\u8853\u96c6\u4f1a\uff0e2016.12.4\uff0e\u718a\u672c\uff0e<\/li>\n<\/ol>\n\n\n\n

                                                                                                                              \u82f1\u6587\u7dcf\u8aac\uff1aEnglish Review Articles<\/h4>\n\n\n\n
                                                                                                                                \n
                                                                                                                              1. Kimura, K., Morita, H., Nakamura, A., Takenaka, K., and Daimon, M.Therapeutic strategy for Heart Failure in Becker Muscular Dystrophy. Int. Heart. J.<\/strong><\/em> 57: 527-529<\/a>, 2016.<\/li>\n\n\n\n
                                                                                                                              2. Nakao, T., Morita, H. Neuromuscular Electrical Stimulation in Patients With Acute
                                                                                                                                Myocardial Infarction. Int. Heart J.<\/strong><\/em>                                                                                                                                 57: 659-660<\/a>, 2016.<\/li>\n\n\n\n
                                                                                                                              3. Ogura,S., Latapati, R., Shimosawa, T. and Nakayama, T. Vascular Inflammation and Hypertension. Austin J. Cardiovasc. Dis. Atherosclerosis<\/strong><\/em> 3: 1017<\/a>, 2016.<\/li>\n\n\n\n
                                                                                                                              4. Otsuji, Y., Seo, Y., Daimon, M., Takeuchi, M., and Yuasa, T. Echocardiographic diagnosis of adult valvular heart disease. Journal of Medical Ultrasonic<\/strong><\/em> 43: 557-597, 2016.<\/li>\n\n\n\n
                                                                                                                              5. Uetake, U., Akabayashi, A., and Yatomi, Y. Environment for Research Ethics in Japan. Clinical Case Reports, Research & Trials<\/strong><\/em> 1: 1-4<\/a>, 2016.<\/li>\n\n\n\n
                                                                                                                              6. Xu, B., Daimon, M. Cardiac aging phenomenon and its clinical features by echocardiography. J. Echocardiogr.<\/strong><\/em> 14: 139\u2013145<\/a>, 2016.<\/li>\n<\/ol>\n\n\n\n

                                                                                                                                \u56fd\u969b\u5b66\u4f1a\u767a\u8868\uff1aInternational Conference Presentation<\/h4>\n\n\n\n
                                                                                                                                  \n
                                                                                                                                1. Hisasue, N., Kurano, M., Morimoto, Y., Tsuneyama, K., Kubota, T., and Yatomi, Y. Detection and Regulation of Apolipoprotein M in Central Nervous System. The 32nd World Congress of Biomedical Laboratory Science 2016 IFBLS. 2016. 8. 31 – 9. 4. Kobe, Japan.<\/li>\n\n\n\n
                                                                                                                                2. Kawata, T., Daimon, M., Kimura, K., Nakao, T., Hirokawa, M., Watanabe, M., Yatomi, Y., and Komuro, I. Tissue Doppler derived right ventricular isovolumic contraction velocity predicts prognosis in advanced heart failure patients with dilated cardiomyopathy. Heart Failure 2016. 2016. 5. 21 – 24. Florence, Italy.<\/li>\n\n\n\n
                                                                                                                                3. Kume, Y., Takahashi, M., Ono, Y., Jyouna, M., Ookubo, S., Kurano, M., and Yatomi., Y. The Interference of Hydroxyurea in the Measurement for Plasma Glucose by Glucose Oxidase Hydrogen Peroxide Electrode Method. The 32nd World Congress of Biomedical Laboratory Science 2016 IFBLS. 2016. 8. 31 – 9. 4. Kobe, Japan.<\/li>\n\n\n\n
                                                                                                                                4. Kobayashi, T., Kurano, M., Nojiri, T., Ohkawa, R., Tozuka, M., Okubo, S., and Yatomi, Y. Oxidation and Glycation Modulate HDL Capacity to Carry Sphingosine 1-Phosphate, an Anti-Atherosclerotic Bioactive Lipid. The 32nd World Congress of Biomedical Laboratory Science 2016 IFBLS. 2016. 8. 31 – 9. 4. Kobe, Japan.<\/li>\n\n\n\n
                                                                                                                                5. Mori, E., Tobita, A, Shimosaka, H., Okubo, S., Kurano, M., Ikeda, H., and Yatomi, Y.Evaluation of TSH, FT4 and FT3 assay using a novel automated analyzer for chemiluminescent enzyme immunoassay (AIA-CL2400).68th American Association of Clinical Chemistry Annual Scientific Meeting. 2016. 7. 31-8. 4. Philadelhpia, Pennsylvania, USA.<\/li>\n\n\n\n
                                                                                                                                6. Mori,E., Kurano, M., Tobita, A., Shimosaka, H., Okubo,S., and Yatomi, Y. Identification of association of squamous cell carcinoma antigen with IgA. The 32nd World Congress of the International Federation od Biomedical Laboratory Science. 2016. 8. 31 – 9. 4. Kobe, Japan.<\/li>\n\n\n\n
                                                                                                                                7. Takahashi, C., Kurano, M., Nishikawa, M., and Yatomi, Y. Carrier-dependent Effects of Sphingosine 1-phosphate on Plasminogen Activator Inhibitor-1 Expression in Adipocytes. The 9th Congress of the Asia Pacific Society on Thrombosis and Hemostasis.2016. 10. 6 – 9. Taipei, China.<\/li>\n\n\n\n
                                                                                                                                8. Takahashi, C., Kurano, M., Nishikawa, M., Kano, K., Dohi, T., Miyauchi, K., Daida, H., Shimizu, T., Aoki, J., and Yatomi, Y. Sphingosine 1-Phosphate Possesses the Carrier-dependent Effects on the Plasminogen Activator Inhibitor 1 Expression in Adipocytes. AHA Scientific Sessions 2016. 2016. 11. 12 – 16. New Orleans, Louisiana, USA.<\/li>\n\n\n\n
                                                                                                                                9. Yamauchi, H., Nawata, K., Nakao, T., Daimon, M., Kawata, T., Hirokawa, M., Kinoshita, O., Itoda, Y., Kimura, M., Komuro, I., and Ono, M. Long-Term Outcomes and Aortic Valve Motion After Reimplantation Techniques of Valve Sparing Aortic Root Replacement, Using Grafts With Pseudosinuses of Valsalva. American College of Cardiology 65st Annual Scientific Session. 2016. 4. 2 – 4. Chicago, Illinois, USA.<\/li>\n\n\n\n
                                                                                                                                10. Yatomi, Y., Kurano, M., Ikeda, H., and Aoki, J. The laboratory medicine of lysophospholipids. Korea-Japan Bioactive Lipid Joint Symposium. 2016. 5. 11 – 13. Jeju Island, South Korea.<\/li>\n<\/ol>\n\n\n\n

                                                                                                                                  \u548c\u6587\u539f\u8457\u8ad6\u6587\uff1aJapanese Original Articles<\/h4>\n\n\n\n
                                                                                                                                    \n
                                                                                                                                  1. \u5c0f\u91ce \u4f73\u4e00\uff0c\u91d1\u5b50 \u8aa0\uff0c\u4e45\u7c73 \u5e78\u592b\uff0c\u5e38\u540d \u6b63\u5f18\uff0c\u5927\u4e45\u4fdd \u6ecb\u592b\uff0c\u77e2\u51a8 \u88d5\uff0e\u8840\u6db2\u691c\u67fb\u5ba4\u30fb\u8840\u6813\u6b62\u8840\u691c\u67fb\u5ba4\u3068ISO\u306e\u54c1\u8cea\u4fdd\u8a3c\uff0e\u65e5\u672c\u691c\u67fb\u8840\u6db2\u5b66\u4f1a\u96d1\u8a8c 17\uff1a114-122\uff0c2016\uff0e<\/li>\n\n\n\n
                                                                                                                                  2. \u5f71\u5c71 \u7950\u5b50\uff0c\u5bbf\u8c37 \u8ce2\u4e00\uff0c\u7530\u4e2d \u96c5\u7f8e\uff0c\u4e45\u672b \u5d07\u53f8\uff0c\u4e45\u672b \u76f4\u5b50\uff0c\u68ee\u7530 \u8ce2\u53f2\uff0c\u5927\u4e45\u4fdd \u6ecb\u592b\uff0c\u77e2\u51a8 \u88d5\uff0c\u4e0b\u6fa4 \u9054\u96c4\uff0e\u30d5\u30ed\u30fc\u30b5\u30a4\u30c8\u30e1\u30c8\u30ea\u30fc(FCM)\u6cd5\u306b\u3088\u308b\u5c3f\u4e2d\u8d64\u8840\u7403\u5f62\u614b\u5224\u5b9a\u306e\u4fe1\u983c\u6027\u306b\u3064\u3044\u3066\uff0e\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u81ea\u52d5\u5316\u5b66\u4f1a\u4f1a\u8a8c 41\uff1a635-641\uff0c2016\uff0e<\/li>\n\n\n\n
                                                                                                                                  3. \u4e45\u7c73 \u5e78\u592b\uff0c\u9ad9\u6a4b \u6075\uff0c\u5c0f\u91ce \u4f73\u4e00\uff0c\u5e38\u540d \u653f\u5f18\uff0c\u5927\u4e45\u4fdd \u6ecb\u592b\uff0c\u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0e\u6211\u304c\u56fd\u306b\u304a\u3051\u308b\u65e5\u5e38\u691c\u67fb\u306b\u304a\u3051\u308bIFCC\u30b0\u30ea\u30b3\u30d8\u30e2\u30b0\u30ed\u30d3\u30f3\u4e00\u6b21\u6a19\u6e96\u54c1\u4f7f\u7528\u306e\u53ef\u80fd\u6027\u3068\u554f\u984c\u70b9\uff0e \u81e8\u5e8a\u5316\u5b66 45: 252-261\uff0c2016\uff0e<\/li>\n\n\n\n
                                                                                                                                  4. \u5c0f\u5ba4 \u8cb4\u5b50\uff0e\u6771\u4eac\u5927\u5b66\u533b\u5b66\u90e8\u9644\u5c5e\u75c5\u9662 \u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u306e\u767a\u5c55\u3068\u533b\u7642\u4eba\u306e\u80b2\u6210\u306b\u52aa\u3081\uff0c\u500b\u3005\u306e\u60a3\u8005\u306b\u6700\u9069\u306a\u533b\u7642\u3092\u63d0\u4f9b\u3059\u308b\uff0e\u81e8\u5e8a\u691c\u67fb60\uff1a1356-1360\uff0c2016\uff0e<\/li>\n\n\n\n
                                                                                                                                  5. \u66fd\u6839 \u4f38\u6cbb\uff0c\u5927\u4e45\u4fdd \u6ecb\u592b\uff0c\u5ca1\u5d0e \u4ec1\uff0c\u77e2\u51a8 \u88d5\uff0e\u63a1\u8840\u30b7\u30b9\u30c6\u30e0\u306e\u66f4\u65b0\u306b\u3088\u308b\u5916\u6765\u63a1\u8840\u5ba4\u306e\u5f85\u3061\u6642\u9593\u77ed\u7e2e\u306e\u53d6\u308a\u7d44\u307f\uff0e\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u81ea\u52d5\u5316\u5b66\u4f1a\u8a8c 41\uff1a314-320\uff0c2016\uff0e<\/li>\n\n\n\n
                                                                                                                                  6. \u7530\u4e2d \u96c5\u7f8e\uff0c\u5bbf\u8c37 \u8ce2\u4e00\uff0c\u68ee\u7530 \u8ce2\u53f2\uff0c\u5f71\u5c71 \u7950\u5b50\uff0c\u5927\u4e45\u4fdd \u6ecb\u592b\uff0c\u4e0b\u6fa4 \u9054\u96c4\uff0c\u77e2\u51a8 \u88d5\uff0e\u591a\u9805\u76ee\u81ea\u52d5\u8840\u7403\u5206\u6790\u88c5\u7f6eXN-550\u306b\u304a\u3051\u308b\u4f53\u8154\u6db2\u30e2\u30fc\u30c9\u306e\u6027\u80fd\u8a55\u4fa1 \u2015\u9ac4\u6db2\uff0c\u95a2\u7bc0\u6db2\u7d30\u80de\u6570\u7b97\u5b9a\u306e\u904b\u7528\u6761\u4ef6\u306b\u304a\u3051\u308b\u7559\u610f\u70b9\u2015\uff0e Sysmex Journal Web 17(2)\uff1a1-10\uff0c2016\uff0e<\/li>\n\n\n\n
                                                                                                                                  7. \u897f\u5ddd \u771f\u5b50\uff0c\u5897\u7530 \u4e9c\u5e0c\u5b50\uff0c\u5e38\u540d \u653f\u5f18\uff0c\u9ed2\u5ddd \u5cf0\u592b\uff0c\u77e2\u51a8 \u88d5\uff0eB\/T-Cell\u306e\u5f62\u8cea\u3092\u6709\u3059\u308b\u6df7\u5408\u8868\u73fe\u578b\u6025\u6027\u767d\u8840\u75c5\u306e1\u75c7\u4f8b\uff0e\u65e5\u672c\u691c\u67fb\u8840\u6db2\u5b66\u4f1a\u96d1\u8a8c 17:202-207\uff0c2016\uff0e<\/li>\n\n\n\n
                                                                                                                                  8. \u91ce\u5c3b \u5353\u5b8f\uff0c\u5897\u7530 \u4e9c\u5e0c\u5b50\uff0c\u5927\u5ddd \u9f8d\u4e4b\u4ecb\uff0c\u5927\u4e45\u4fdd \u6ecb\u592b\uff0c\u8535\u91ce \u4fe1\uff0c\u6c60\u7530 \u5747\uff0c\u77e2\u51a8 \u88d5\uff0e\u30cf\u30d7\u30c8\u30b0\u30ed\u30d3\u30f3\u6e2c\u5b9a\u306b\u5f71\u97ff\u3092\u53ca\u307c\u3057\u305fIgM-\u03bb\u578bM\u86cb\u767d\u8840\u75c7\uff0e\u81e8\u5e8a\u75c5\u7406 64\uff1a1236-1242\uff0c2016\uff0e<\/li>\n\n\n\n
                                                                                                                                  9. \u91ce\u5c3b \u5353\u5b8f\uff0c\u5927\u5ddd \u9f8d\u4e4b\u4ecb\uff0c\u4e0b\u5742 \u6d69\u5247\uff0c\u5927\u4e45\u4fdd \u6ecb\u592b\uff0c\u8535\u91ce \u4fe1\uff0c\u6c60\u7530 \u5747\uff0c\u77e2\u51a8 \u88d5\uff0e\u30e9\u30c6\u30c3\u30af\u30b9\u514d\u75ab\u6bd4\u6fc1\u6cd5\u3092\u7528\u3044\u305fMMP-3\u6e2c\u5b9a\u8a66\u85ac\u306e\u57fa\u790e\u6027\u80fd\u304a\u3088\u3073\u63a1\u8840\u7ba1\u6dfb\u52a0\u5264\u306b\u3088\u308b\u507d\u4f4e\u5024\u5316\u306b\u3064\u3044\u3066\u306e\u691c\u8a0e\uff0e\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u81ea\u52d5\u5316\u5b66\u4f1a\u4f1a\u8a8c 41\uff1a83-93\uff0c2016\uff0e<\/li>\n\n\n\n
                                                                                                                                  10. \u4e45\u672b \u5d07\u53f8\uff0c\u5bbf\u8c37 \u8ce2\u4e00\uff0c\u7530\u4e2d \u96c5\u7f8e\uff0c\u5e38\u540d \u653f\u5f18\uff0c\u5927\u4e45\u4fdd \u6ecb\u592b\uff0c\u5897\u7530 \u4e9c\u5e0c\u5b50\uff0c\u4e0b\u6fa4 \u9054\u96c4\uff0c\u77e2\u51a8 \u88d5\uff0e\u4e2d\u67a2\u795e\u7d4c\u6d78\u6f64\u3092\u8a8d\u3081\u305f\u591a\u767a\u6027\u9aa8\u9ac4\u816b\u306e1\u75c7\u4f8b\uff0e\u533b\u5b66\u691c\u67fb 65\uff1a685-689\uff0c2016\uff0e<\/li>\n\n\n\n
                                                                                                                                  11. \u68ee\u7530 \u8ce2\u53f2\uff0c\u91d1\u5b50 \u8aa0\uff0c\u76db\u7530 \u548c\u6cbb\uff0c\u66fd\u6839 \u4f38\u6cbb\uff0c\u5927\u4e45\u4fdd \u6ecb\u592b\uff0c\u77e2\u51a8 \u88d5\uff0e\u533b\u7642\u5f93\u4e8b\u8005\u306e\u63a1\u8840\u30fb\u691c\u4f53\u306e\u53d6\u308a\u6271\u3044\u306b\u95a2\u3059\u308b\u8a8d\u8b58\u3059\u3079\u304d\u4e8b\u9805 \u2015\u30a2\u30f3\u30b1\u30fc\u30c8\u7d50\u679c\u306e\u89e3\u6790\u304b\u3089\u2015\uff0e\u533b\u5b66\u691c\u67fb 65\uff1a235-239\uff0c2016\uff0e<\/li>\n\n\n\n
                                                                                                                                  12. \u5409\u5ddd \u76f4\u4e4b\uff0c\u5897\u7530 \u4e9c\u5e0c\u5b50\uff0c\u5e38\u540d \u653f\u5f18\uff0c\u5927\u4e45\u4fdd \u6ecb\u592b\uff0c\u77e2\u51a8 \u88d5\uff0e\u81ea\u52d5\u8840\u7403\u5206\u6790\u88c5\u7f6e\u3068\u514d\u75ab\u5b66\u7684\u6e2c\u5b9a(CD61\u6cd5)\u306e\u8840\u5c0f\u677f\u6570\u6e2c\u5b9a\u306e\u6bd4\u8f03\u691c\u8a0e\uff0e\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u81ea\u52d5\u5316\u5b66\u4f1a\u4f1a\u8a8c 41\uff1a56-62\uff0c2016\uff0e<\/li>\n<\/ol>\n\n\n\n

                                                                                                                                    \u548c\u6587\u7dcf\u8aac\uff1aJapanese Review Articles<\/h4>\n\n\n\n
                                                                                                                                      \n
                                                                                                                                    1. \u52a0\u85e4 \u5e78\u5b50\uff0c\u9ad8\u4e95 \u5927\u54c9\uff0e\u30af\u30ed\u30fc\u30b8\u30f3\u30b0\u30dc\u30ea\u30e5\u30fc\u30e0\u6e2c\u5b9a\uff0e\u81e8\u5e8a\u691c\u67fb 60\uff1a202-209\uff0c2016\uff0e<\/li>\n\n\n\n
                                                                                                                                    2. \u91d1\u5b50 \u8aa0\uff0c\u66fd\u6839 \u4f38\u6cbb\uff0c\u76db\u7530 \u548c\u6cbb\uff0c\u5927\u4e45\u4fdd \u6ecb\u592b\uff0c\u77e2\u51a8 \u88d5\uff0e\u691c\u67fb\u90e8\u63a1\u8840\u5ba4\u306e\u7ba1\u7406\u30fb\u904b\u55b6 \u63a1\u8840\u696d\u52d9\u306b\u304a\u3051\u308b\u8a3a\u7642\u652f\u63f4\u3068\u60a3\u8005\u30b5\u30fc\u30d3\u30b9\u5411\u4e0a\u3092\u76ee\u6307\u3057\u3066\uff0e\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u81ea\u52d5\u5316\u5b66\u4f1a\u4f1a\u8a8c 41\uff1a3-12\uff0c2016\uff0e<\/li>\n\n\n\n
                                                                                                                                    3. \u8535\u91ce \u4fe1\uff0e\u30a2\u30dd\u86cb\u767dM\u3092\u901a\u3058\u305f\u30b9\u30d5\u30a3\u30f3\u30b4\u30b7\u30f31-\u30ea\u30f3\u9178\u5b66\u306e\u69cb\u7bc9\uff0e\u81e8\u5e8a\u5316\u5b66 45\uff1a52-59\uff0c2016\uff0e<\/li>\n\n\n\n
                                                                                                                                    4. \u8535\u91ce \u4fe1\uff0e\u809d\u75be\u60a3\u306b\u3088\u308b\u4e8c\u6b21\u6027\u8102\u8cea\u7570\u5e38\u75c7\uff0e\u81e8\u5e8a\u75c5\u7406 64\uff1a518-526\uff0c2016\uff0e<\/li>\n\n\n\n
                                                                                                                                    5. \u8535\u91ce \u4fe1\uff0e\u6025\u6027\u51a0\u75c7\u5019\u7fa4\u306e\u75c5\u614b\u751f\u7406\u306b\u304a\u3051\u308b\u30de\u30a4\u30ca\u30fc\u30ea\u30be\u30ea\u30f3\u8102\u8cea\u306e\u95a2\u4e0e\u306e\u53ef\u80fd\u6027\uff0e\u65e5\u672c\u8840\u6813\u6b62\u8840\u5b66\u4f1a\u8a8c 27\uff1a460-465\uff0c2016\uff0e<\/li>\n\n\n\n
                                                                                                                                    6. \u8535\u91ce \u4fe1\uff0eHDL\u306e\u6297\u8840\u6813\u4f5c\u7528\uff0e\u81e8\u5e8a\u75c5\u7406 64\uff1a66-71\uff0c2016\uff0e<\/li>\n\n\n\n
                                                                                                                                    7. \u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0e\u30b9\u30d5\u30a3\u30f3\u30b4\u30b7\u30f31\uff0d\u30ea\u30f3\u9178\u3068HDL\uff0e\u533b\u5b66\u306e\u3042\u3086\u307f 259\uff1a878-879\uff0c2016\uff0e<\/li>\n\n\n\n
                                                                                                                                    8. \u5bbf\u8c37 \u8ce2\u4e00\uff0e\u5c3f\u691c\u67fb\u8a8c\u4e0a\u76f8\u8ac7\u5ba4\u30fb\u8d64\u8840\u7403\u5f62\u614b\uff0eMedical Technology 44\uff1a132-133\uff0c2016\uff0e<\/li>\n\n\n\n
                                                                                                                                    9. \u66fd\u6839 \u4f38\u6cbb\uff0e\u691c\u4f53\u691c\u67fb\u5ba4\u306b\u304a\u3051\u308b\u611f\u67d3\u9632\u5fa1\u5bfe\u7b56\uff0e\u691c\u67fb\u3068\u6280\u8853 44\uff1a24-30\uff0c2016\uff0e<\/li>\n\n\n\n
                                                                                                                                    10. \u66fd\u6839 \u4f38\u6cbb\uff0e\u8a8d\u5b9a\u8f38\u8840\u691c\u67fb\u6280\u5e2b\uff0e\u81e8\u5e8a\u691c\u67fb 60\uff1a864-870\uff0c2016\uff0e<\/li>\n\n\n\n
                                                                                                                                    11. \u66fd\u6839 \u4f38\u6cbb\uff0e\u63a1\u8840\u696d\u52d9\u306e\u52b9\u7387\u5316\u30fb\u5186\u6ed1\u5316\u304a\u3088\u3073\u611f\u67d3\u5bfe\u7b56\uff0eMedical Technology 44\uff1a1068-1073\uff0c2016\uff0e<\/li>\n\n\n\n
                                                                                                                                    12. \u5927\u9580 \u96c5\u592b\uff0e\u611f\u67d3\u6027\u5fc3\u5185\u819c\u708e \u5185\u79d1\u6cbb\u7642\uff0e\u65e5\u672c\u5185\u79d1\u5b66\u4f1a\u8a8c 105\uff1a245-252\uff0c2016\uff0e<\/li>\n\n\n\n
                                                                                                                                    13. \u7530\u4e2d \u96c5\u7f8e\uff0c\u5bbf\u8c37 \u8ce2\u4e00\uff0e\u4f53\u8154\u6db2\u691c\u67fb\uff0eMedical Technology 44\uff1a745-749\uff0c2016\uff0e<\/li>\n\n\n\n
                                                                                                                                    14. \u5343\u660e \u771f\u5f13\uff0c \u5927\u9580 \u96c5\u592b\uff0e\u30ab\u30e9\u30fc\u30c9\u30d7\u30e9\u6cd5\u306b\u3088\u308b\u5f01\u9006\u6d41\u306e\u91cd\u75c7\u5ea6\u8a55\u4fa1\uff0e\u5fc3\u30a8\u30b3\u30fc 17\uff1a 923-930\uff0c2016\uff0e<\/li>\n\n\n\n
                                                                                                                                    15. \u51a8\u5c71 \u4f73\u662d\uff0c\u4f50\u85e4 \u91d1\u592b\uff0c\u5c3e\u5d0e \u7531\u57fa\u7537\uff0c\u6e05\u6c34 \u7f8e\u8863\uff0c\u7530\u6751 \u5178\u5b50\uff0c\u897f\u5ddd \u653f\u52dd\uff0c\u91ce\u6751 \u660c\u4f5c\uff0c\u5800\u5185 \u4e45\u5fb3\uff0c\u677e\u539f \u7531\u7f8e\u5b50\uff0c\u77e2\u51a8 \u88d5\uff0c\u5c71\u5d0e \u660c\u5b50\uff0c\u7fbd\u85e4 \u9ad8\u660e\uff0c\u5b66\u8853\u6a19\u6e96\u5316\u59d4\u54e1\u4f1a\u8840\u5c0f\u677f\u90e8\u4f1a\uff0e\u300c\u900f\u904e\u5149\u8840\u5c0f\u677f\u51dd\u96c6\u691c\u67fb\u6cd5\u306e\u6a19\u6e96\u5316:\u56fd\u969b\u8840\u6813\u6b62\u8840\u5b66\u4f1a\u8840\u5c0f\u677f\u6a5f\u80fd\u6a19\u6e96\u5316\u90e8\u4f1a\u304b\u3089\u306e\u63d0\u8a00\u300d\u306e\u7d39\u4ecb\u3068\u89e3\u8aac\uff0e\u65e5\u672c\u8840\u6813\u6b62\u8840\u5b66\u4f1a\u8a8c 27\uff1a365-369\uff0c2016\uff0e<\/li>\n\n\n\n
                                                                                                                                    16. \u897f\u5ddd \u771f\u5b50\uff0e\u598a\u5a20\u3068\u8ca7\u8840\uff0eMedical Practice 33:1392-1396\uff0c2016\uff0e<\/li>\n\n\n\n
                                                                                                                                    17. \u897f\u68ee \u307e\u3069\u304b\uff0c\u6c38\u53cb \u5229\u6d25\u5b50\uff0c\u4e0b\u5742 \u6d69\u5247\uff0c\u5927\u4e45\u4fdd \u6ecb\u592b\uff0c\u6c60\u7530 \u5747\uff0c\u77e2\u51a8 \u88d5\uff0e\u65b0\u898f\u6297Sm\u6297\u4f53\u691c\u67fb\u8a66\u85ac\u300c\u30a8\u30ea\u30a2 SmDp\u300d\u306e\u57fa\u790e\u691c\u8a0e\uff0e\u533b\u5b66\u691c\u67fb 65\uff1a551-556\uff0c2016\uff0e<\/li>\n\n\n\n
                                                                                                                                    18. \u4e45\u672b \u76f4\u5b50\uff0eSTEP 7 \u5b66\u4f1a\u5834\u3067\u4f7f\u3048\u308b\u82f1\u4f1a\u8a71\u30ec\u30c3\u30b9\u30f3 Part 1\uff0eMedical Technology 44\uff1a530-533\uff0c2016\uff0e<\/li>\n\n\n\n
                                                                                                                                    19. \u4e45\u672b \u76f4\u5b50\uff0eSTEP 8 \u5b66\u4f1a\u5834\u3067\u4f7f\u3048\u308b\u82f1\u4f1a\u8a71\u30ec\u30c3\u30b9\u30f3 Part 2\uff0eMedical Technology 44\uff1a632-636\uff0c2016\uff0e<\/li>\n\n\n\n
                                                                                                                                    20. \u5b89\u672c \u7be4\u53f2\uff0c\u77e2\u51a8 \u88d5\uff0e\u75c5\u6c17\u306e\u306f\u306a\u3057 \u8840\u53cb\u75c5. \u691c\u67fb\u3068\u6280\u8853 44\uff1a272-277\uff0c2016\uff0e<\/li>\n\n\n\n
                                                                                                                                    21. \u5b89\u672c \u7be4\u53f2\uff0c\u77e2\u51a8 \u88d5\uff0e\u8840\u53cb\u75c5\u306b\u5bfe\u3059\u308bRNA\u6cbb\u7642\u306e\u53ef\u80fd\u6027. \u8840\u6db2\u5185\u79d172\uff1a237-242\uff0c2016\uff0e<\/li>\n\n\n\n
                                                                                                                                    22. \u5b89\u672c \u7be4\u53f2\uff0c\u77e2\u51a8\u88d5\uff0e\u30d5\u30ed\u30fc\u30c1\u30e3\u30fc\u30c8\u3067\u6574\u7406\u3059\u308b\u51fa\u8840\u50be\u5411\u3092\u793a\u3059\u60a3\u8005\u306e\u8a3a\u7642\u306e\u6d41\u308c. Medical Technology 44\uff1a338-344\uff0c2016\uff0e<\/li>\n<\/ol>\n\n\n\n

                                                                                                                                      \u548c\u6587\u8457\u66f8\uff1aJapanese Book Chapter<\/h4>\n\n\n\n
                                                                                                                                        \n
                                                                                                                                      1. \u5c0f\u91ce \u4f73\u4e00\uff0c\u77e2\u51a8 \u88d5\uff0e\u30c1\u30fc\u30e0\u533b\u7642\uff0e\u65b0\u4f53\u7cfb\u770b\u8b77\u5b66\u5168\u66f8 \u6cbb\u7642\u6cd5\u6982\u8aac\uff08\u67f4 \u8f1d\u7537\uff0c\u5b89\u539f \u6d0b \u7de8\uff09pp. 197-210\uff0e\u30e1\u30c7\u30a3\u30ab\u30eb\u30d5\u30ec\u30f3\u30c9\u793e\uff0c\u6771\u4eac\uff0c2016\uff0e<\/li>\n\n\n\n
                                                                                                                                      2. \u8535\u91ce \u4fe1\uff0e\u691c\u67fb\u5024\u306e\u8aad\u307f\u65b9\uff0e\u3055\u304b\u3048\uff08\u65e5\u672c\u7cd6\u5c3f\u75c5\u5354\u4f1a \u7de8\uff09pp. 6-10\uff0e\u65e5\u672c\u7cd6\u5c3f\u75c5\u5354\u4f1a\uff0c\u6771\u4eac\uff0c2016\uff0e<\/li>\n\n\n\n
                                                                                                                                      3. \u5bbf\u8c37 \u8ce2\u4e00\uff0e\u6982\u8ad6 \u4e00\u822c\u691c\u67fb\uff0e\u4e00\u822c\u691c\u67fb\u5b66\uff08\u4e09\u6751 \u90a6\u88d5\uff0c\u5bbf\u8c37 \u8ce2\u4e00 \u7de8\uff09pp. 1-4\uff0e\u533b\u6b6f\u85ac\u51fa\u7248\uff0c\u6771\u4eac\uff0e2016\uff0e<\/li>\n\n\n\n
                                                                                                                                      4. \u5bbf\u8c37 \u8ce2\u4e00\uff0e\u5c3f \u57fa\u790e\u77e5\u8b58\uff0e\u4e00\u822c\u691c\u67fb\u5b66\uff08\u4e09\u6751 \u90a6\u88d5\uff0c\u5bbf\u8c37 \u8ce2\u4e00 \u7de8\uff09pp. 5-6\uff0e\u533b\u6b6f\u85ac\u51fa\u7248\uff0c\u6771\u4eac\uff0e2016\uff0e<\/li>\n\n\n\n
                                                                                                                                      5. \u5bbf\u8c37 \u8ce2\u4e00\uff0e\u5c3f \u691c\u4f53\u63a1\u53d6\u6cd5\u30fb\u53d6\u308a\u6271\u3044\u6cd5\uff0e\u4e00\u822c\u691c\u67fb\u5b66\uff08\u4e09\u6751 \u90a6\u88d5\uff0c\u5bbf\u8c37 \u8ce2\u4e00 \u7de8\uff09pp. 6-9\uff0e\u533b\u6b6f\u85ac\u51fa\u7248\uff0c\u6771\u4eac\uff0e2016\uff0e<\/li>\n\n\n\n
                                                                                                                                      6. \u5bbf\u8c37 \u8ce2\u4e00\uff0e\u5c3f \u4e00\u822c\u7684\u6027\u72b6\uff0e\u4e00\u822c\u691c\u67fb\u5b66\uff08\u4e09\u6751 \u90a6\u88d5\uff0c\u5bbf\u8c37 \u8ce2\u4e00 \u7de8\uff09pp. 9-10\uff0e\u533b\u6b6f\u85ac\u51fa\u7248\uff0c\u6771\u4eac\uff0e2016\uff0e<\/li>\n\n\n\n
                                                                                                                                      7. \u5bbf\u8c37 \u8ce2\u4e00\uff0e\u5c3f \u5c3f\u5b9a\u6027\u8a66\u9a13\u7d19\u306e\u53d6\u308a\u6271\u3044\uff0e\u4e00\u822c\u691c\u67fb\u5b66\uff08\u4e09\u6751 \u90a6\u88d5\uff0c\u5bbf\u8c37 \u8ce2\u4e00 \u7de8\uff09pp. 11-13\uff0e\u533b\u6b6f\u85ac\u51fa\u7248\uff0c\u6771\u4eac\uff0e2016\uff0e<\/li>\n\n\n\n
                                                                                                                                      8. \u5bbf\u8c37 \u8ce2\u4e00\uff0e\u5c3f \u5c3f\u6c88\u6e23\u306e\u5f62\u614b\u5b66\u7684\u691c\u67fb\u6cd5\uff0e\u4e00\u822c\u691c\u67fb\u5b66\uff08\u4e09\u6751 \u90a6\u88d5\uff0c\u5bbf\u8c37 \u8ce2\u4e00 \u7de8\uff09pp. 50-84\uff0e\u533b\u6b6f\u85ac\u51fa\u7248\uff0c\u6771\u4eac\uff0e2016\uff0e<\/li>\n\n\n\n
                                                                                                                                      9. \u5bbf\u8c37 \u8ce2\u4e00\uff0e\u5c3f \u81ea\u52d5\u5206\u6790\u88c5\u7f6e\uff0e\u4e00\u822c\u691c\u67fb\u5b66\uff08\u4e09\u6751 \u90a6\u88d5\uff0c\u5bbf\u8c37 \u8ce2\u4e00 \u7de8\uff09pp. 85-87\uff0e\u533b\u6b6f\u85ac\u51fa\u7248\uff0c\u6771\u4eac\uff0e2016\uff0e<\/li>\n\n\n\n
                                                                                                                                      10. \u5bbf\u8c37 \u8ce2\u4e00\uff0e\u8133\u810a\u9ac4\u6db2 \uff0e\u4e00\u822c\u691c\u67fb\u5b66\uff08\u4e09\u6751 \u90a6\u88d5\uff0c\u5bbf\u8c37 \u8ce2\u4e00 \u7de8\uff09pp. 99-106\uff0e\u533b\u6b6f\u85ac\u51fa\u7248\uff0c\u6771\u4eac\uff0e2016\uff0e<\/li>\n\n\n\n
                                                                                                                                      11. \u5bbf\u8c37 \u8ce2\u4e00\uff0e\u7d50\u77f3\uff0e\u4e00\u822c\u691c\u67fb\u5b66\uff08\u4e09\u6751 \u90a6\u88d5\uff0c\u5bbf\u8c37 \u8ce2\u4e00 \u7de8\uff09pp. 147-148\uff0e\u533b\u6b6f\u85ac\u51fa\u7248\uff0c\u6771\u4eac\uff0e2016\uff0e<\/li>\n\n\n\n
                                                                                                                                      12. \u5bbf\u8c37 \u8ce2\u4e00\uff0c\u4e0b\u6fa4 \u9054\u96c4\uff0e\u814e\u30fb\u6ccc\u5c3f\u5668\u9818\u57df\u306e\u8d85\u97f3\u6ce2\u691c\u67fb\uff08\u5343\u8449 \u7950\uff0c\u9f4b\u85e4 \u5f25\u7a42\uff0c\u95a2\u6839 \u667a\u7d00 \u7de8pp. 116-120\uff0e\u533b\u6b6f\u85ac\u51fa\u7248\uff0c\u6771\u4eac\uff0e2016\uff0e<\/li>\n\n\n\n
                                                                                                                                      13. \u83c5\u539f \u5c06\u4ee3\uff0e\u4eca\u5e74\u306f\u3053\u3046\u3057\u3066\u5fc3\u30a8\u30b3\u30fc\u6280\u8853\u3092\u5b66\u3076 \u8cc7\u683c\u306e\u53d6\u308a\u65b9\u6d3b\u304b\u3057\u65b9\uff1a\u8840\u7ba1\u8a3a\u7642\u6280\u5e2b\uff08CVT\uff09\uff08\u5927\u9580 \u96c5\u592b \u7de8\uff09pp.74-76\uff0e\u6587\u5149\u5802\uff0c\u6771\u4eac\uff0e2016\uff0e<\/li>\n\n\n\n
                                                                                                                                      14. \u66fd\u6839 \u4f38\u6cbb\uff0e\u63a1\u53d6\u90e8\u4f4d\uff0e\u691c\u4f53\u63a1\u53d6\u8005\u306e\u305f\u3081\u306e\u30cf\u30f3\u30c9\u30d6\u30c3\u30af\uff08\u65e5\u672c\u81e8\u5e8a\u885b\u751f\u691c\u67fb\u6280\u5e2b\u4f1a \u76e3\u4fee\uff09pp. 182-184\uff0e\u3058\u307b\u3046\uff0c\u6771\u4eac\uff0c2016\uff0e<\/li>\n\n\n\n
                                                                                                                                      15. \u66fd\u6839 \u4f38\u6cbb\uff0e\u63a1\u8840\u7ba1\u306e\u7a2e\u985e\u3068\u63a1\u8840\u306e\u9806\u756a\uff0e\u691c\u4f53\u63a1\u53d6\u8005\u306e\u305f\u3081\u306e\u30cf\u30f3\u30c9\u30d6\u30c3\u30af\uff08\u65e5\u672c\u81e8\u5e8a\u885b\u751f\u691c\u67fb\u6280\u5e2b\u4f1a \u76e3\u4fee\uff09pp. 201-203\uff0e\u3058\u307b\u3046\uff0c\u6771\u4eac\uff0c2016\uff0e<\/li>\n\n\n\n
                                                                                                                                      16. \u5927\u9580 \u96c5\u592b\uff0e\u907a\u4f1d\u6027\u5fc3\u7b4b\u75be\u60a3\u3092\u30a8\u30b3\u30fc\u3067\u3069\u3046\u8a3a\u308b\u304b\uff0eHeart View\uff08\u78ef\u90e8 \u5149\u7ae0\uff0c\u524d\u5d8b \u5eb7\u6d69 \u7de8\uff09pp. 9-16\uff0e\u30e1\u30b8\u30ab\u30eb\u30d3\u30e5\u30fc\u793e\uff0c\u6771\u4eac\uff0e2016\uff0e<\/li>\n\n\n\n
                                                                                                                                      17. \u5927\u9580 \u96c5\u592b\uff0e\u8ca0\u8377\u691c\u67fb\u306e\u8a55\u4fa1\u306f\u5fc3\u96fb\u56f3\u305d\u308c\u3068\u3082\u5fc3\u30a8\u30b3\u30fc? \u5b9f\u8df5\u306e\u305f\u3081\u306eQ\uff06A\uff1a\u5fc3\u8840\u7ba1\u4e8b\u6545\u3092\u4e88\u9632\u3059\u308b\u305f\u3081\u306e\u7cd6\u5c3f\u75c5\u6cbb\u7642\u6226\u7565\uff08\u4f0a\u85e4 \u6d69 \u7de8\uff09pp. 87-88\uff0e\u6587\u5149\u5802\uff0c\u6771\u4eac\uff0e2016\uff0e<\/li>\n\n\n\n
                                                                                                                                      18. \u5927\u9580 \u96c5\u592b\uff0e\u73fe\u4ee3\u306b\u304a\u3051\u308b\u5927\u52d5\u8108\u5f01\u72ed\u7a84\u75c7\u306e\u75c5\u50cf\u3068\u306f\uff0e\u5fc3\u81d3\uff08\u5927\u9580 \u96c5\u592b \u7de8\uff09pp. 1-9\uff0e\u5fc3\u81d3\u8ca1\u56e3\uff0c\u6771\u4eac\uff0e2016\uff0e<\/li>\n\n\n\n
                                                                                                                                      19. \u5927\u9580 \u96c5\u592b\uff0e\u5fc3\u30a8\u30b3\u30fc\uff0e\u5faa\u74b0\u5668\u7814\u4fee\u30ce\u30fc\u30c8\uff08\u6c38\u4e95 \u826f\u4e09 \u76e3\u4fee\uff09pp. 127-132\uff0e\u8a3a\u65ad\u3068\u6cbb\u7642\u793e\uff0c\u6771\u4eac\uff0e2016\uff0e<\/li>\n\n\n\n
                                                                                                                                      20. \u5927\u9580 \u96c5\u592b\uff0e\u9838\u52d5\u8108\u30a8\u30b3\u30fc\uff0e\u5faa\u74b0\u5668\u7814\u4fee\u30ce\u30fc\u30c8\uff08\u6c38\u4e95 \u826f\u4e09 \u76e3\u4fee\uff09pp. 157-159\uff0e\u8a3a\u65ad\u3068\u6cbb\u7642\u793e\uff0c\u6771\u4eac\uff0e2016\uff0e<\/li>\n\n\n\n
                                                                                                                                      21. \u5927\u9580 \u96c5\u592b\uff0e\u611f\u67d3\u6027\u5fc3\u5185\u819c\u708e\uff0e\u5faa\u74b0\u5668\u7814\u4fee\u30ce\u30fc\u30c8\uff08\u6c38\u4e95 \u826f\u4e09 \u76e3\u4fee\uff09pp. 423-426\uff0e\u8a3a\u65ad\u3068\u6cbb\u7642\u793e\uff0c\u6771\u4eac\uff0e2016\uff0e<\/li>\n\n\n\n
                                                                                                                                      22. \u5927\u9580 \u96c5\u592b\uff0e\u4eba\u5de5\u5f01\u7f6e\u63db\u8853\u5f8c\u306e\u7ba1\u7406\uff0e\u5faa\u74b0\u5668\u7814\u4fee\u30ce\u30fc\u30c8\uff08\u6c38\u4e95 \u826f\u4e09 \u76e3\u4fee\uff09pp. 427-430\uff0e\u8a3a\u65ad\u3068\u6cbb\u7642\u793e\uff0c\u6771\u4eac\uff0e2016\uff0e<\/li>\n\n\n\n
                                                                                                                                      23. \u5927\u9580 \u96c5\u592b\uff0e\u53f3\u5ba4\u53ce\u7e2e\u30fb\u62e1\u5f35\u80fd\u3092\u3069\u306e\u3088\u3046\u306b\u8a55\u4fa1\u3059\u308b\uff1f \u53f3\u5fc3\u4e0d\u5168\u3092\u8b58\u308a\u8a55\u4fa1\u3057\u3066\u6cbb\u7642\u306b\u6d3b\u304b\u3059\uff08\u4e2d\u6751 \u4e00\u6587 \u7de8\uff09pp. 14-22\uff0e\u6587\u5149\u5802\uff0c\u6771\u4eac\uff0e2016\uff0e<\/li>\n\n\n\n
                                                                                                                                      24. \u5927\u9580 \u96c5\u592b\uff0e\u4e2d\u5fc3\u9759\u8108\u5727\uff0e\u5fc3\u30a8\u30b3\u30fc\u30cf\u30f3\u30c9\u30d6\u30c3\u30af \u5fc3\u4e0d\u5168 \uff08\u7af9\u4e2d \u514b\uff0c\u6238\u51fa \u6d69\u4e4b \u7de8\uff09pp. 43-45\uff0e\u91d1\u82b3\u5802\uff0c\u4eac\u90fd\uff0e2016\uff0e<\/li>\n\n\n\n
                                                                                                                                      25. \u7530\u4e2d \u96c5\u7f8e\uff0c\u5bbf\u8c37 \u8ce2\u4e00\uff0e\u5c3f\u63a1\u53d6\uff0e\u691c\u4f53\u63a1\u53d6\u8005\u306e\u305f\u3081\u306e\u30cf\u30f3\u30c9\u30d6\u30c3\u30af\uff08\u65e5\u672c\u81e8\u5e8a\u885b\u751f\u691c\u67fb\u6280\u5e2b\u4f1a \u76e3\u4fee\uff09pp. 162-163\uff0e\u3058\u307b\u3046\uff0c\u6771\u4eac\uff0e2016\uff0e<\/li>\n\n\n\n
                                                                                                                                      26. \u7530\u4e2d \u96c5\u7f8e\uff0c\u5bbf\u8c37 \u8ce2\u4e00\uff0e\u5c3f\u6c88\u6e23\u691c\u67fb\uff0e\u691c\u4f53\u63a1\u53d6\u8005\u306e\u305f\u3081\u306e\u30cf\u30f3\u30c9\u30d6\u30c3\u30af\uff08\u65e5\u672c\u81e8\u5e8a\u885b\u751f\u691c\u67fb\u6280\u5e2b\u4f1a \u76e3\u4fee\uff09pp. 164-165\uff0e\u3058\u307b\u3046\uff0c\u6771\u4eac\uff0e2016\uff0e<\/li>\n\n\n\n
                                                                                                                                      27. \u5ee3\u5ddd \u611b\u7f8e\uff0c\u5927\u9580 \u96c5\u592b\uff0e\u7d4c\u98df\u5802\u5fc3\u30a8\u30b3\u30fc\u6cd5\u306eABC\uff0eHeart View \uff08\u7530\u908a \u4e00\u660e \u7de8\uff09pp. 30-36\uff0e\u30e1\u30b8\u30ab\u30eb\u30d3\u30e5\u30fc\u793e\uff0c\u6771\u4eac\uff0e2016\uff0e<\/li>\n\n\n\n
                                                                                                                                      28. \u4fdd\u7530 \u5948\u7dd2\u7f8e\uff0e\u514d\u75ab\u30fb\u8840\u6e05 \u6297\u6838\u6297\u4f53\u967d\u6027\u30d1\u30bf\u30fc\u30f3\uff0e\u300c\u691c\u67fb\u3068\u6280\u8853\u300d \u5897\u520a\u53f7\u300c\u306f\u3058\u3081\u3066\u51fa\u4f1a\u3046\u691c\u67fb\u753b\u50cf\u300d\uff0e\uff08\u9ad8\u6728 \u5eb7 \u4f01\u753b\uff09pp. 926-932\uff0e\u533b\u5b66\u66f8\u9662\uff0c\u6771\u4eac\uff0e2016\uff0e<\/li>\n\n\n\n
                                                                                                                                      29. \u6771\u4eac\u5927\u5b66\u533b\u5b66\u90e8\u9644\u5c5e\u75c5\u9662 \u82f1\u8a9e\u30de\u30cb\u30e5\u30a2\u30eb\u51fa\u7248 \u30d7\u30ed\u30b8\u30a7\u30af\u30c8\u30c1\u30fc\u30e0\uff08\u5ca1 \u967d\u4ecb\uff0c\u660e\u5e73 \u548c\u4e45\uff0c\u5b87\u5ddd \u660e\u7f8e\uff0c\u5927\u53cb \u82f1\u5b50\uff0c\u4f50\u3005\u6728 \u73e0\u4e43\uff0c\u5869\u8c37 \u8cb4\u5b50\uff0c\u9234\u6728 \u6c5f\u5229\u5b50\uff0c\u95a2\u53e3 \u3072\u308d\u307f\uff0c\u9ad9\u6a4b \u82f1\u667a\uff0c\u67d8\u690d \u7f8e\u6075\uff0c\u4e45\u672b \u76f4\u5b50\uff0c\u53e4\u6fa4 \u5bff\u4f9d\uff0c\u677e\u6c38 \u660e\u5b50\uff0c\u5c71\u53e3 \u8ad2\uff0c\u7530\u6751 \u7d14\u4eba\uff0c\u5c71\u7530 \u79c0\u81e3\uff0c\u83c5\u91ce \u7950\u8863\uff09\uff0e\u6771\u5927\u75c5\u9662\u767a \u533b\u7642\u30b9\u30bf\u30c3\u30d5\u306e\u305f\u3081\u306e\u82f1\u4f1a\u8a71\uff0e\u30d9\u30ec\u51fa\u7248\uff0c\u6771\u4eac\uff0epp. 162-179\uff0e2016\uff0e<\/li>\n<\/ol>\n\n\n\n

                                                                                                                                        \u548c\u6587\u7de8\u8457\u7b49\uff1aJapanese Book Editing<\/h4>\n\n\n\n
                                                                                                                                          \n
                                                                                                                                        1. \u5927\u9580 \u96c5\u592b \u7de8\uff0e\u5fc3\u81d3\uff0e\u7279\u5225\u53f7\u300c\u5f01\u819c\u75c7 \u5927\u52d5\u8108\u5f01\u72ed\u7a84\u3068\u9006\u6d41\u300d\uff0e\u5fc3\u81d3\u8ca1\u56e3\uff0c\u6771\u4eac\uff0e2016\uff0e<\/li>\n\n\n\n
                                                                                                                                        2. \u5927\u9580 \u96c5\u592b \u7de8\uff0e\u5fc3\u30a8\u30b3\u30fc \u300c\u65b0\u3057\u304f\u306a\u3063\u305fASE\u5fc3\u8154\u8a08\u6e2c\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u300d\uff0e\u6587\u5149\u5802\uff0c\u6771\u4eac\uff0e2016\uff0e<\/li>\n<\/ol>\n<\/div><\/div>\n\n\n\n
                                                                                                                                          \n

                                                                                                                                          2015\u5e74<\/h3>\n\n\n\n

                                                                                                                                          \u82f1\u6587\u539f\u8457\u8ad6\u6587\uff1aEnglish Original Articles<\/h4>\n\n\n\n
                                                                                                                                            \n
                                                                                                                                          1. Amano, Y., Ishikawa, R., Sakatani, T., Ichinose, J., Sunohara, M., Watanabe, K., Kage, H., Nakajima, J., Nagase, T., Ohishi, N., and Takai, D. Oncogenic TPM3-ALK activation requires dimerization through the coiled-coil structure of TPM3. Biochem. Biophys. Res. Commun.<\/strong><\/em> 457: 457-460<\/a>, 2015.<\/li>\n\n\n\n
                                                                                                                                          2. Chiang, SJ., Daimon, M., Miyazaki, S., Kawata, T., Ichikawa-Morimoto, R., Maruyama, M., Ohmura, H., Miyauchi, K., Lee, SL., Daida, H. When and how aortic stenosis is first diagnosed: a single-center observational study. J. Cardiol.<\/strong><\/em> doi: 10.1016\/j.jjcc.2015.10.007<\/a>, 2015.<\/li>\n\n\n\n
                                                                                                                                          3. Chiang, SJ., Daimon, M., Wang, LH., Hung, MJ., Chang, NC., Lin, HC. Association between Mitral Valve Prolapse and Open-Angle Glaucoma. Heart.<\/strong><\/em> 101: 609-615<\/a>, 2015.<\/li>\n\n\n\n
                                                                                                                                          4. Daikoku, T., Yatomi, Y., and Yumoto, M. Statistical learning of music- and language-like sequences and tolerance for spectral shifts. Neurobiol. Learn. Mem.<\/strong><\/em> 118: 8\u201319<\/a>, 2015.<\/li>\n\n\n\n
                                                                                                                                          5. Fukuda, S., Watanabe, H., Iwakura, K., Daimon, M., Ito, H., Yoshikawa, J. Multi-center Investigations of the Prevalence of Abdominal Aortic Aneurysm in Elderly Japanese Patients with Hypertension: the AAA Japan Study. Circ. J.<\/strong><\/em> 79: 524-529<\/a>, 2015.<\/li>\n\n\n\n
                                                                                                                                          6. Ichikawa, M., Nagamatsu, T., Schust, D.J., Kawai-Iwasawa, Y., Kawana, K., Yamashita, T., Osuga, Y., Aoki, J., Yatomi, Y., and Fujii, T. Placental autotaxin expression is diminished in women with pre-eclampsia. J. Obstet. Gynaecol. Res.<\/strong><\/em> 41: 1406-1411<\/a>, 2015.<\/li>\n\n\n\n
                                                                                                                                          7. Kawata, T., Daimon, M., Miyazaki, S., Ichikawa, R., Maruyama, M., Chiang, SJ., Ito, C., Sato, F., Watada, H., Daida, H. Coronary microvascular function is independently associated with left ventricular filling pressure in patients with type 2 diabetes mellitus. Cardiovasc. Diabetol.<\/strong><\/em> 14: 98<\/a>, 2015.<\/li>\n\n\n\n
                                                                                                                                          8. Kimura, K., Daimon, M., Morita, H., Kawata, T., Nakao, T., Okano, T., Lee, S.L., Takenaka, K., Nagai, R., Yatomi, Y., and Komuro, I. Evaluation of right ventricle by speckle tracking and conventional echocardiography in rats with right ventricular heart failure. Int. Heart. J<\/strong><\/em>. 56: 349-353<\/a>, 2015.<\/li>\n\n\n\n
                                                                                                                                          9. Kimura, K., Morita, K., Daimon, M., Kawata, T., Nakao, T., Lee, SL., Hirokawa, M., Ebihara, A., Nakajima, T., Ozawa, T., Yonemochi, Y., Aida, I., Motoyoshi, Y., Mikata, T., Uchida, I., Komori, T., Kitao, R., Nagata, T., Takeda, S., Komaki, H., Segawa, K., Takenaka, K., Komuro, I. Prognostic Impact of Venous Thromboembolism in Patients with Duchenne Muscular Dystrophy: Prospective Multicenter 5-Year Cohort Study. Int. J. Cardiol.<\/strong><\/em> 191: 178-180<\/a>, 2015.<\/li>\n\n\n\n
                                                                                                                                          10. Kurano, M., Dohi, T., Nojiri, T., Kobayashi, T., Hirowatari, Y., Inoue, A., Kano, K., Matsumoto, H., Igarashi,K., Nishikawa, M., Miyauchi, K., Daida, H., Ikeda, H. Aoki, J. , and Yatomi, Y. Blood levels of serotonin are specifically correlated with plasma lysophosphatidylserine among the glycero-lysophospholipids.
                                                                                                                                            BBA Clinical.<\/strong><\/em>                                                                                                                                             4: 92\u201398<\/a>, 2015.<\/li>\n\n\n\n
                                                                                                                                          11. Kurano, M., Hara, M., Satoh, H., and Tsukamoto, K. Hepatic NPC1L1 Overexpression Ameliorates Glucose Metabolism in Diabetic Mice Via Suppression of Gluconeogenesis. Metabolism. <\/strong><\/em>64: 588-596<\/a>, 2015.<\/li>\n\n\n\n
                                                                                                                                          12. Kurano, M., Tsukamoto, K., Hara, M., Ohkawa, R., Ikeda, H., and Yatomi, Y. LDL Receptor and ApoE are Involved in the Clearance of ApoM-associated Sphingosine 1-phosphate. J. Biol. Chem.<\/strong><\/em> 290: 2477-2488<\/a>, 2015.<\/li>\n\n\n\n
                                                                                                                                          13. Kurano, M., Suzuki, A., Inoue, A., Tokuhara, Y., Kano, K., Matsumoto, H., Igarashi, K., Ohkawa, R., Nakamura, K., Dohi, T., Miyauchi, K., Daida, H., Tsukamoto, K., Ikeda, H., Aoki, J., and Yatomi, Y. Possible Involvement of Minor Lysophospholipids in the Increase in Plasma Lysophosphatidic Acid in Acute Coronary Syndrome. Arterioscler. Thromb. Vasc. Biol.<\/strong><\/em> 35: 463-470<\/a>, 2015.<\/li>\n\n\n\n
                                                                                                                                          14. Makimoto, H., Fujiu, K., Shimizu, K., Amiya, E., Asada, K., Kojima, T., Daimon, M., Meyer, C., Komuro, I. Impaired heart rate variability in patients with non-diabetic chronic kidney disease – prominent disruption of vagal control and daily fluctuation. IJC Metabolic & Endocrine.<\/strong><\/em> 9: 22-27<\/a>, 2015.<\/li>\n\n\n\n
                                                                                                                                          15. Maruo, T., Seo, Y., Yamada, S., Arita, T., Ishizu, T., Shiga, T., Dohi, K., Toide, H., Furugen, A., Inoue, K., Daimon, M., Kawai, H., Tsuruta, H., Nishigami, K., Yuda, S., Ozawa, T., Izumi, C., Fumikura, Y., Wada, Y., Doi, M., Okada, M., Takenaka, K., Aonuma, K. The Speckle Tracking Imaging for the Assessment of Cardiac Resynchronization Therapy (START) Study. Circ. J.<\/strong><\/em> 79: 613-622<\/a>, 2015.<\/li>\n\n\n\n
                                                                                                                                          16. Masuda, A., Jona, M., Satoh, Y., Terashima, M., Shimosaka, H., Nannya, Y., Yokota, H., Kurokawa, M., and Yatomi, Y. The criteria to suspect chronic myeloid leukemia using absolute basophil counts in peripheral blood. Int. J. Hematol.<\/strong><\/em> 101: 626-628<\/a>, 2015.<\/li>\n\n\n\n
                                                                                                                                          17. Mikami, S., Tateishi, R., Hagiwara, S., Sato, M., Minami, T., Uchino, K., Enooku, K., Sato, T., Nakagawa, H., Masuzaki, R., Asaoka, Y., Kondo, Y., Shiina, S., Ikeda, H., Omata, M., Yoshida, H., and Koike, K. Tumor markers are more useful in patients undergoing surveillance for hepatocellular carcinoma with unreliable results by ultrasonography. Hepatol. Res.<\/strong><\/em> 45: 415-422<\/a>, 2015.<\/li>\n\n\n\n
                                                                                                                                          18. Miyazaki, K., Koike, Y., Kunishima, S., Ishii, R., Danbara, M., Horie, R., Yatomi, Y., and Higashihara, M. Immature platelet fraction measurement is influenced by platelet size and is a useful parameter for discrimination of macrothrombocytopenia. Hematology<\/strong><\/em> 20: 587-592<\/a>, 2015.<\/li>\n\n\n\n
                                                                                                                                          19. Murono, K., Kazama, S., Yamaguchi, H., Kawai, K., Ishihara, S., Sunami, E., Kitayama, J., Satoh, Y., Kurihara, M., Yatomi, Y., and Watanabe, T. Detection of carcinoembryonic antigen mRNA in peritoneal lavage by the transcription-reverse transcription concerted method indicates poor prognosis in patients with stage II and III colon cancer. Surgery <\/strong><\/em>157: 322-330<\/a>, 2015.<\/li>\n\n\n\n
                                                                                                                                          20. Nagai, H., Kuwahira, I., Schwenke, D.O., Tsuchimochi, H., Nara, A., Ogura, S., Sonobe, T., Inagaki, T., Fujii, Y., Yamaguchi, R., Wingenfeld, L., Umetani, K., Shimosawa. T,, Yoshida, K., Uemura, K., Pearson, J.T., and Shirai, M. Pulmonary Macrophages Attenuate Hypoxic Pulmonary Vasoconstriction via \u03b23AR\/iNOS Pathway in Rats Exposed to Chronic Intermittent Hypoxia. PLoS One.<\/em><\/strong> 10: e0131923<\/a>, 2015.<\/li>\n\n\n\n
                                                                                                                                          21. Nakatani, S., Akaishi, M., Asanuma, T., Hashimoto, S., Izumi, C., Iwanaga, S., Kawai, H., Daimon, M., Toide, H., Hayashida, H., Yamada, H. Guidelines from the Japanese Society of Echocardiography: Guidance for the management and maintenance of echocardiography equipment. J. Echocardiogr.<\/strong><\/em> 13: 1\u20135<\/a>, 2015.<\/li>\n\n\n\n
                                                                                                                                          22. Nara, A., Nagai, H., Shintani-Ishida, K., Ogura, S., Shimosawa, T., Kuwahira, I., Shirai, M., and Yoshida, KI. Pulmonary Arterial Hypertension in Rats Due to Age-related Arginase Activation in Intermittent Hypoxia. Am. J. Respir. Cell Mol. Biol.<\/strong><\/em> 53: 184-192<\/a>, 2015.<\/li>\n\n\n\n
                                                                                                                                          23. Nishikawa, M., Kurano, M., Ikeda, H., Aoki, J., and Yatomi, Y. Lysophosphatidylserine has Bilateral Effects on Macrophages in the Pathogenesis of Atherosclerosis. J. Atheroscler. Thromb.<\/strong><\/em> 22: 518-526<\/a>, 2015.<\/li>\n\n\n\n
                                                                                                                                          24. Nomura Y, Kaneko M, Miyata K, Yatomi Y, and Yanagi Y. Bevacizumab and Aflibercept Activate Platelets via Fc\u03b3RIIa. Invest. Ophthalmol. Vis. Sci.<\/strong><\/em> 56: 8075-8082<\/a>, 2015.<\/li>\n\n\n\n
                                                                                                                                          25. Ohkawa, R., Kurano, M., Mishima, Y., Nojiri, T., Tokuhara, Y., Kishimoto, T., Nakamura, K., Okubo, S., Hosogaya, S., Ozaki, Y., Yokota, H., Igarashi, K., Ikeda, H., Tozuka, M., and Yatomi, Y. Possible involvement of sphingomyelin in the regulation of the plasma sphingosine 1-phosphate level in human subjects. Clin. Biochem<\/strong><\/em>. 48: 690-697<\/a>, 2015.<\/li>\n\n\n\n
                                                                                                                                          26. Ohta, S., Nishiyama, T., Sakoda, M., Machioka, K., Fuke, M., Ichimura, S., Inagaki, F., Shimizu, A., Hasegawa, K., Kokudo, N., Kaneko, M., Yatomi, Y., and Ito, T. Development of carboxymethyl cellulose nonwoven sheet as a novel hemostatic agent. J. Biosci. Bioeng.<\/strong><\/em> 119: 718-723<\/a>, 2015.<\/li>\n\n\n\n
                                                                                                                                          27. Oyama, D., Adachi, Y., Yumoto, M., Hashimoto, I., and Uehara, G. Dry phantom for magnetoencephalography -Configuration, calibration, and contribution. J. Neurosci Methods.<\/strong><\/em> 251: 24-36<\/a>, 2015.<\/li>\n\n\n\n
                                                                                                                                          28. Sakamoto, K., Nakata, H., Yumoto, M., Sadato, N., and Kakigi, R. Mastication accelerates Go\/No-go decisional processing: An event-related potential study. Clin Neurophysiol.<\/strong><\/em> 126: 2099-2107<\/a>, 2015.<\/li>\n\n\n\n
                                                                                                                                          29. Sato, M., Hikita, H., Hagiwara, S., Sato, M., Soroida, Y., Suzuki, A., Gotoh, H., Iwai, T., Kojima, S., Matsuura, T., Yotsuyanagi, H., Koike, K., Yatomi, Y., and Ikeda, H. Potential associations between perihepatic lymph node enlargement and liver fibrosis, hepatocellular injury, or hepatocarcinogenesis in chronic hepatitis B virus Infection. Hepatol. Res.<\/strong><\/em> 45: 397-404<\/a>, 2015.<\/li>\n\n\n\n
                                                                                                                                          30. Tokuhara, Y., Kurano, M., Shimamoto, S., Igarashi, K., Nojiri, T., Kobayashi, T., Masuda, A., Ikeda, H., Nagamatsu, T., Fujii, T., Aoki, J., and Yatomi, Y. PLoS One.<\/strong><\/em> 10: e0130074<\/a>, 2015.<\/li>\n\n\n\n
                                                                                                                                          31. Uetake, Y., Ikeda, H., Irie, R., Tejima, K., Matsui, H., Ogura, S., Wang, H., Mu, S., Hirohama, D., Ando, K., Sawamura, T., Yatomi, Y., Fujita, T.,and Shimosawa, T. High-salt in addition to high-fat diet may enhance inflammation and fibrosis in liver steatosis induced by oxidative stress and dyslipidemia in mice. Lipids in Health and Disease<\/strong><\/em> 14: 6<\/a>, 2015.<\/li>\n\n\n\n
                                                                                                                                          32. Veillon, L., Go, S., Matsuyama, W., Suzuki, A., Nagasaki, M., Yatomi, Y., and Inokuchi, J. Identification of Ganglioside GM3 Molecular Species in Human Serum Associated with Risk Factors of Metabolic Syndrome. PLoS One<\/strong><\/em> 10: e0129645<\/a>, 2015.<\/li>\n\n\n\n
                                                                                                                                          33. Wanaka, K., Asada, R., Miyashita, K., Kaneko, M., Endo, H., and Yatomi, Y. Novel HIT antibody detection method using Sonoclot\u00ae coagulation analyzer. Thromb. Res. <\/strong><\/em>135: 127-129<\/a>, 2015.<\/li>\n\n\n\n
                                                                                                                                          34. Watanabe, K., Amano, Y., Ishikawa, R., Sunohara, M., Kage, H., Ichinose, J., Sano, A., Nakajima, J., Fukayama, M., Yatomi, Y., Nagase, T., Ohishi, N., and Takai, D. Histone methylation-mediated silencing of miR-139 enhances invasion of non-small-cell lung cancer. Cancer Med. <\/em><\/strong>4: 1573-1582<\/a>, 2015.<\/li>\n<\/ol>\n\n\n\n

                                                                                                                                            \u56fd\u5185\u5b66\u4f1a\u767a\u8868\uff1aDomestic Conference Presentation<\/h4>\n\n\n\n
                                                                                                                                              \n
                                                                                                                                            1. \u5927\u91d1 \u4e9c\u5f25\uff0c\u5409\u5ddd \u76f4\u4e4b\uff0c\u5e38\u540d \u653f\u5f18\uff0c\u5897\u7530 \u4e9c\u5e0c\u5b50\uff0c\u5927\u4e45\u4fdd \u6ecb\u592b\uff0c\u77e2\u51a8 \u88d5\uff0e\u65b0\u898f\u591a\u9805\u76ee\u81ea\u52d5\u8840\u7403\u5206\u6790\u88c5\u7f6eXN-550\u3092\u7528\u3044\u305f\u4f53\u8154\u6db2\u6e2c\u5b9a\u306e\u57fa\u790e\u7684\u691c\u8a0e\uff0e\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u81ea\u52d5\u5316\u5b66\u4f1a \u7b2c47\u56de\u5927\u4f1a.\u30002015.10.8-10\uff0e\u6a2a\u6d5c\uff0e<\/li>\n\n\n\n
                                                                                                                                            2. \u5927\u91d1 \u4e9c\u5f25\uff0c\u5e38\u540d \u653f\u5f18\uff0c\u5409\u5ddd \u76f4\u4e4b\uff0c\u6c34\u9593 \u77e5\u4e16\uff0c\u4e38\u5c3e \u7406\u6075\uff0c\u5bfa\u5cf6 \u9053\u5b50\uff0c\u7530\u9089 \u4e45\u7f8e\u5b50\uff0c\u5897\u7530 \u4e9c\u5e0c\u5b50\uff0c\u5927\u4e45\u4fdd \u6ecb\u592b\uff0c\u77e2\u51a8 \u88d5\uff0e\u30c7\u30f3\u30b0\u71b1\u306e\u691c\u67fb\u6240\u898b\u306e\u7279\u5fb4 \u5f53\u9662\u3067\u7d4c\u9a13\u3057\u305f\u75c7\u4f8b\u306e\u89e3\u6790\uff0e\u7b2c16\u56de \u65e5\u672c\u691c\u67fb\u8840\u6db2\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2015.7.11-12\uff0e\u540d\u53e4\u5c4b\uff0e<\/li>\n\n\n\n
                                                                                                                                            3. \u5c0f\u91ce \u4f73\u4e00\uff0c\u5e38\u540d \u653f\u5f18\uff0c\u5927\u4e45\u4fdd \u6ecb\u592b\uff0c\u77e2\u51a8 \u88d5\uff0c\u91d1\u5b50 \u8aa0\uff0eISO15189\u3092\u7528\u3044\u305f\u8840\u6db2\u30fb\u8840\u6813\u6b62\u8840\u691c\u67fb\u5ba4\u306e\u54c1\u8cea\u4fdd\u8a3c\uff0e\u7b2c16\u56de \u65e5\u672c\u691c\u67fb\u8840\u6db2\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2015.7.11\uff0e\u540d\u53e4\u5c4b\uff0e<\/li>\n\n\n\n
                                                                                                                                            4. \u5f71\u5c71 \u7950\u5b50\uff0c\u5bbf\u8c37 \u8ce2\u4e00\uff0c\u68ee\u7530 \u8ce2\u53f2\uff0c\u4e45\u672b \u76f4\u5b50\uff0c\u7530\u4e2d \u96c5\u7f8e\uff0c\u5927\u4e45\u4fdd \u6ecb\u592b\uff0c\u4e0b\u6fa4 \u9054\u96c4\uff0c\u77e2\u51a8 \u88d5\uff0e\u9aa8\u9ac4\u816b\u306b\u4f34\u3046\u4e8c\u6b21\u6027Fanconi\u75c7\u5019\u7fa4\u306b\u3088\u308b\u3068\u601d\u308f\u308c\u305f\u30df\u30aa\u30b0\u30ed\u30d3\u30f3\u5c3f\u306e\u4e00\u4f8b\uff0e\u7b2c7\u56de \u65e5\u672c\u81e8\u5e8a\u4e00\u822c\u691c\u67fb\u5b66\u4f1a\uff0e2015.9.12\uff0e\u6625\u65e5\u4e95\uff0e<\/li>\n\n\n\n
                                                                                                                                            5. \u5f71\u5c71 \u7950\u5b50\uff0c\u5bbf\u8c37 \u8ce2\u4e00\uff0c\u68ee\u7530 \u8ce2\u53f2\uff0c\u4e45\u672b \u76f4\u5b50\uff0c\u7530\u4e2d \u96c5\u7f8e\uff0c\u5927\u4e45\u4fdd \u6ecb\u592b\uff0c\u4e0b\u6fa4 \u9054\u96c4\uff0c\u77e2\u51a8 \u88d5\uff0e\u6a2a\u7d0b\u7b4b\u878d\u89e3\u75c7\u3092\u4f34\u308f\u306a\u3044\u30df\u30aa\u30b0\u30ed\u30d3\u30f3\u5c3f\u306e\u75c7\u4f8b\uff0e\u7b2c11\u56de \u6771\u4eac\u90fd\u533b\u5b66\u691c\u67fb\u5b66\u4f1a\uff0e2015.11.1\uff0e\u7acb\u5ddd\uff0e<\/li>\n\n\n\n
                                                                                                                                            6. \u5f71\u5c71 \u7950\u5b50\uff0c\u5c0f\u91ce \u4f73\u4e00\uff0c\u91ce\u3005\u90e8 \u4eae\u5b50\uff0c\u4f50\u85e4 \u7f8e\u77e5\u5b50\uff0c\u6e6f\u6d45 \u85ab\uff0c\u8535\u91ce \u4fe1\uff0c\u5927\u4e45\u4fdd \u6ecb\u592b\uff0c\u77e2\u51a8 \u88d5\uff0e\u6804\u990a\u6307\u5c0e\u3068\u30ea\u30f3\u30af\u3057\u305fCGM\u691c\u67fb\u306e\u5c0e\u5165\u3068\u305d\u306e\u52b9\u679c\uff0e\u7b2c62\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a2015.11.19-22\uff0e\u5c90\u961c\uff0e<\/li>\n\n\n\n
                                                                                                                                            7. \u5ddd\u7530 \u8cb4\u4e4b\uff0c\u5927\u9580 \u96c5\u592b\uff0c\u6728\u6751 \u516c\u4e00\uff0c\u4e2d\u5c3e \u502b\u5b50\uff0c\u674e \u653f\u54f2\uff0c\u5ee3\u5ddd \u611b\u7f8e\uff0c\u5b87\u91ce \u6f22\u6210\uff0c\u7af9\u4e2d \u514b\uff0c\u6e21\u8fba \u660c\u6587\uff0c\u77e2\u51a8 \u88d5\uff0c\u5c0f\u5ba4 \u4e00\u6210\uff0e\u91cd\u75c7\u5fc3\u4e0d\u5168\u3092\u5448\u3057\u305f\u62e1\u5f35\u578b\u5fc3\u7b4b\u75c7\u4f8b\u306b\u304a\u3051\u308b\u4e09\u5c16\u5f01\u8f2a\u7b49\u5bb9\u53ce\u7e2e\u671f\u79fb\u52d5\u901f\u5ea6\u306e\u6709\u7528\u6027\uff0e\u7b2c26\u56de \u65e5\u672c\u5fc3\u30a8\u30b3\u30fc\u56f3\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a. 2015.3.26-28. \u798f\u5ca1\uff0e<\/li>\n\n\n\n
                                                                                                                                            8. \u6728\u6751 \u516c\u4e00\uff0c\u68ee\u7530 \u5553\u884c\uff0c\u5927\u9580 \u96c5\u592b\uff0c\u4e2d\u5c3e \u502b\u5b50\uff0c\u674e \u653f\u54f2\uff0c\u5ee3\u5ddd \u611b\u7f8e\uff0c\u7af9\u4e2d \u514b\uff0c\u5c0f\u5ba4 \u4e00\u6210\uff0e\u7b4b\u30b8\u30b9\u30c8\u30ed\u30d5\u30a3\u30fc\u60a3\u8005\u306b\u304a\u3051\u308b\u9759\u8108\u8840\u6813\u75c7\uff0e\u7b2c63\u56de \u65e5\u672c\u5fc3\u81d3\u75c5\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2015.9.18-20\uff0e\u6a2a\u6d5c\uff0e<\/li>\n\n\n\n
                                                                                                                                            9. \u4e45\u7c73 \u5e78\u592b\uff0c \u5c0f\u91ce \u4f73\u4e00\uff0c \u5e38\u540d \u653f\u5f18\uff0c \u5927\u4e45\u4fdd \u6ecb\u592b\uff0c \u8535\u91ce \u4fe1\uff0c \u77e2\u51a8 \u88d5\uff0eDM-JACK Ex\u3092\u7528\u3044\u305f\u30e1\u30bf\u30dc\u30ea\u30fc\u30c9HbA1c\u306e\u57fa\u790e\u7684\u691c\u8a0e\uff0e\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u81ea\u52d5\u5316\u5b66\u4f1a \u7b2c47\u56de\u5927\u4f1a\uff0e2015.10.8-10\uff0e\u6a2a\u6d5c\uff0e<\/li>\n\n\n\n
                                                                                                                                            10. \u4e45\u7c73 \u5e78\u592b\uff0c\u5c0f\u91ce \u4f73\u4e00\uff0c\u5e38\u540d \u653f\u5f18\uff0c\u5927\u4e45\u4fdd \u6ecb\u592b\uff0c\u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0eIFCC HbA1c\u6a19\u6e96\u6db2Lot Istanbul\u3068ReCCS JCCRM411-3\u306e\u95a2\u4fc2\u6027 \u30a2\u30fc\u30af\u30ec\u30a4HA8181\u3068\u6771\u30bd\u30fcG9\u3067\u306e\u6bd4\u8f03\u691c\u8a0e \u7b2c55\u56de \u65e5\u672c\u81e8\u5e8a\u5316\u5b66\u4f1a\u5e74\u6b21\u5b66\u8853\u96c6\u4f1a\uff0e2015.10.30-1\uff0e\u5927\u962a\uff0e<\/li>\n\n\n\n
                                                                                                                                            11. \u8535\u91ce \u4fe1\uff0c\u539f \u771e\u7d14\uff0c\u5e38\u5c71 \u5e78\u4e00\uff0c\u77e2\u51a8 \u88d5\uff0c\u585a\u672c \u548c\u4e45\uff0e\u809d\u81d3\u30fc\u80c6\u6c41\u9593\u306e\u30b3\u30ec\u30b9\u30c6\u30ed\u30fc\u30eb\u30cf\u30f3\u30c9\u30ea\u30f3\u30b0\u306e\u7cd6\u4ee3\u8b1d\u3078\u306e\u5f71\u97ff\uff0e\u7b2c52\u56de \u65e5\u672c\u81e8\u5e8a\u5206\u5b50\u533b\u5b66\u4f1a \u5e74\u6b21\u5b66\u8853\u96c6\u4f1a\uff0e2015.4.10\uff0e\u4eac\u90fd\uff0e<\/li>\n\n\n\n
                                                                                                                                            12. \u8535\u91ce \u4fe1\uff0c\u6e05\u6c34 \u77e5\uff0c\u5bae\u5d0e \u4fee\uff0c\u539f \u771e\u7d14\uff0c\u585a\u672c \u548c\u4e45\uff0c\u77e2\u51a8 \u88d5\uff0e\u30a2\u30dd\u86cb\u767dM\u306e\u6297\u30a4\u30f3\u30b9\u30ea\u30f3\u62b5\u6297\u6027\u4f5c\u7528\u30fb\u6297\u7cd6\u5c3f\u6027\u814e\u75c7\u4f5c\u7528\uff0e\u7b2c58\u56de \u65e5\u672c\u7cd6\u5c3f\u75c5\u5b66\u4f1a \u5e74\u6b21\u5b66\u8853\u96c6\u4f1a\uff0e2015.5.21\uff0e\u4e0b\u95a2\uff0e<\/li>\n\n\n\n
                                                                                                                                            13. \u8535\u91ce \u4fe1\uff0c\u5e38\u5c71 \u5e78\u4e00\uff0c\u539f \u771e\u7d14\uff0c\u77e2\u51a8 \u88d5\uff0c\u585a\u672c \u548c\u4e45\uff0eHuman Hepatic ABCG5 lacks the potency for sterol excretion\uff0e\u7b2c47\u56de \u65e5\u672c\u52d5\u8108\u786c\u5316\u5b66\u4f1a\u5e74\u6b21\u5b66\u8853\u96c6\u4f1a\uff0e2015.7.9\uff0e\u4ed9\u53f0\uff0e<\/li>\n\n\n\n
                                                                                                                                            14. \u8535\u91ce \u4fe1\uff0c\u6c60\u7530 \u5747\uff0c\u77e2\u51a8 \u88d5\uff0eCETP\u306f\uff0c\u30ea\u30dd\u86cb\u767d\u306b\u304a\u3051\u308b\u30a2\u30dd\u86cb\u767dM\uff0c\u30b9\u30d5\u30a3\u30f3\u30b4\u30b7\u30f31-\u30ea\u30f3\u9178\u306e\u5206\u5e03\u3092\u5909\u5316\u3055\u305b\u308b\uff0e\u7b2c55\u56de \u65e5\u672c\u81e8\u5e8a\u5316\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2015.10.31\uff0e\u5927\u962a\uff0e<\/li>\n\n\n\n
                                                                                                                                            15. \u8535\u91ce \u4fe1\uff0e\u30a2\u30dd\u86cb\u767dM\u3092\u901a\u3058\u305f\u30b9\u30d5\u30a3\u30f3\u30b4\u30b7\u30f31-\u30ea\u30f3\u9178\u5b66\u306e\u69cb\u7bc9\uff0e\u7b2c55\u56de \u65e5\u672c\u81e8\u5e8a\u5316\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2015.10.31\uff0e\u5927\u962a\uff0e<\/li>\n\n\n\n
                                                                                                                                            16. \u8535\u91ce \u4fe1\uff0e\u809d\u75be\u60a3\u306b\u3088\u308b\u4e8c\u6b21\u6027\u8102\u8cea\u7570\u5e38\u75c7\uff0e\u7b2c61\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a \u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\uff0e2015.11.21\uff0e\u5c90\u961c\uff0e<\/li>\n\n\n\n
                                                                                                                                            17. \u8535\u91ce \u4fe1\uff0c\u6e05\u6c34 \u77e5\uff0c\u77e2\u51a8 \u88d5\uff0e\u7cd6\u5c3f\u75c5\u6027\u814e\u75c7\u306b\u304a\u3051\u308b\u30a2\u30dd\u86cb\u767dM\u306e\u5f79\u5272\uff0e\u7b2c61\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2015.11.22\uff0e\u5c90\u961c\uff0e<\/li>\n\n\n\n
                                                                                                                                            18. \u5f8c\u85e4 \u5bdb\u662d\uff0c\u624b\u5d8b \u6843\u6c5f\uff0c\u758b\u7530 \u5b8f\u7f8e\uff0c\u5c0f\u5ba4 \u8cb4\u5b50\uff0c\u5927\u4e45\u4fdd \u6ecb\u592b\uff0c\u77e2\u51a8 \u88d5\uff0e\u814e\u7d30\u80de\u764c\u3068\u306e\u9451\u5225\u306b\u96e3\u6e0b\u3057\u305f\u814e\u8840\u7ba1\u7b4b\u8102\u80aa\u816b\u306e1\u75c7\u4f8b\uff0e\u7b2c64\u56de \u65e5\u672c\u533b\u5b66\u691c\u67fb\u5b66\u4f1a\uff0e2015.5.16-17\uff0e\u798f\u5ca1\uff0e<\/li>\n\n\n\n
                                                                                                                                            19. \u5c0f\u5ba4 \u8cb4\u5b50\uff0c\u68ee \u548c\u5f66\uff0c\u5c71\u5f62 \u7814\u4e00\u90ce\uff0c\u5b87\u91ce \u6f22\u6210\uff0c\u6e05\u6c34 \u5eb7\u5e73\uff0c\u7530\u5d8b \u6c5f\u91cc\u5b50\uff0c\u98ef\u91ce \u5f18\u5b50\uff0c\u585a\u672c \u88d5\u7f8e\uff0c\u6728\u6751 \u6075\u7f8e\u5b50\uff0c\u5927\u4e45\u4fdd \u6ecb\u592b\uff0c\u4e2d\u5c3e \u502b\u5b50\uff0c\u5927\u9580 \u96c5\u592b\uff0c\u702c\u6238 \u6cf0\u4e4b\uff0c\u77e2\u51a8 \u88d5\uff0e\u98df\u9053\u518d\u5efa\u8853\u5f8c\u306e\u5fc3\u96fb\u56f3\u30fb\u5fc3\u6a5f\u80fd\u5909\u5316\u3068\u8853\u5f0f\u306e\u95a2\u9023\u306b\u3064\u3044\u3066\u306e\u691c\u8a0e\uff0e\u7b2c62\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2015.11.19-22\uff0e\u5c90\u961c\uff0e<\/li>\n\n\n\n
                                                                                                                                            20. \u6e05\u6c34 \u5eb7\u5e73\uff0c\u7267\u5143 \u4e45\u6a39\uff0c\u85e4\u751f \u514b\u4ec1\uff0c\u5c0f\u5ba4 \u8cb4\u5b50\uff0c\u5927\u4e45\u4fdd \u6ecb\u592b\uff0c\u5927\u9580 \u96c5\u592b\uff0c\u7db2\u8c37 \u82f1\u4ecb\uff0c\u77e2\u51a8 \u88d5\uff0c\u5c0f\u5ba4 \u4e00\u6210\uff0e\u6162\u6027\u814e\u81d3\u75c5\u306f\u591c\u9593\u7279\u7570\u7684\u306b\u5fc3\u81d3\u526f\u4ea4\u611f\u795e\u7d4c\u6d3b\u6027\u3092\u4f4e\u4e0b\u3055\u305b\u308b\uff0e\u7b2c79\u56de \u65e5\u672c\u5faa\u74b0\u5668\u5b66\u4f1a\uff0c2015.4.24-26\uff0e\u5927\u962a\uff0e<\/li>\n\n\n\n
                                                                                                                                            21. \u5bbf\u8c37 \u8ce2\u4e00\uff0e\u8840\u5c3f\u8a3a\u65ad\u30ac\u30a4\u30c9\u30e9\u30a4\u30f32013\u767a\u520a\u3092\u53d7\u3051\u3066\uff0e\u814e\u30fb\u6ccc\u5c3f\u5668\u691c\u67fb\u7814\u7a76\u4f1a \u7b2c11\u56de\u5b66\u8853\u96c6\u4f1a\uff0c\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\uff0e2015.3.21\uff0e\u6771\u4eac\uff0e<\/li>\n\n\n\n
                                                                                                                                            22. \u5bbf\u8c37 \u8ce2\u4e00\uff0e\u5c3f\u6c88\u6e23\u691c\u67fb\u306b\u304a\u3051\u308b\u30a8\u30d3\u30c7\u30f3\u30b9\u306e\u69cb\u7bc9\u3092\u76ee\u6307\u3057\u3066\uff0e\u814e\u30fb\u6ccc\u5c3f\u5668\u691c\u67fb\u7814\u7a76\u4f1a \u7b2c11\u56de\u5b66\u8853\u96c6\u4f1a\uff0c\u516c\u958b\u8a0e\u8ad6\u4f1a\uff0e2015.3.21\uff0e\u6771\u4eac\uff0e<\/li>\n\n\n\n
                                                                                                                                            23. \u5bbf\u8c37 \u8ce2\u4e00\uff0e\u5c3f\u691c\u67fb\u304b\u3089\u8003\u3048\u308b\u75c5\u614b\u3000\u5c3f\u6c88\u6e23\u691c\u67fb\u3067\u3053\u3053\u307e\u3067\u308f\u304b\u308b\uff0e\u7b2c64\u56de \u65e5\u672c\u533b\u5b66\u691c\u67fb\u5b66\u4f1a\uff0e\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\uff0e2015.5.16-17\uff0e\u798f\u5ca1\uff0e<\/li>\n\n\n\n
                                                                                                                                            24. \u5bbf\u8c37 \u8ce2\u4e00\uff0c\u7530\u4e2d \u96c5\u7f8e\uff0c\u68ee\u7530 \u8ce2\u53f2\uff0c\u4e45\u672b \u76f4\u5b50\uff0c\u5f71\u5c71 \u7950\u5b50\uff0c\u5927\u4e45\u4fdd \u6ecb\u592b\uff0c\u4e0b\u6fa4 \u9054\u96c4\uff0c\u77e2\u51a8 \u88d5\uff0e\u65b0\u898f\u5c3f\u4e2d\u6709\u5f62\u6210\u5206\u5206\u6790\u88c5\u7f6e\uff08\u8a66\u4f5c\u6a5f\uff09\u306b\u304a\u3051\u308b\u7570\u578b\u7d30\u80de\u691c\u51fa\u306e\u53ef\u80fd\u6027\u306b\u3064\u3044\u3066\uff0e\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u81ea\u52d5\u5316\u5b66\u4f1a \u7b2c47\u56de\u5927\u4f1a\uff0e2015.10.8-10\uff0e\u6a2a\u6d5c\uff0e<\/li>\n\n\n\n
                                                                                                                                            25. \u5bbf\u8c37\u8ce2\u4e00\uff0c\u5f71\u5c71 \u7950\u5b50\uff0c\u4e0b\u6fa4 \u9054\u96c4\uff0e\u5c3f\u6c88\u6e23\u691c\u67fb\u6cd5JCCLS GP1-P4\u306b\u304a\u3051\u308b\u5c3f\u4e2d\u8d64\u8840\u7403\u5f62\u614b\u3068\u4eca\u5f8c\u306e\u5c55\u958b\uff0e\u7b2c7\u56de\u65e5\u672c\u81e8\u5e8a\u4e00\u822c\u691c\u67fb\u5b66\u4f1a \u30d1\u30cd\u30eb\u30c7\u30a3\u30b9\u30ab\u30c3\u30b7\u30e7\u30f3\uff0e2015.9.12\uff0e\u6625\u65e5\u4e95\uff0e<\/li>\n\n\n\n
                                                                                                                                            26. \u5bbf\u8c37 \u8ce2\u4e00\uff0e\u3053\u308c\u304b\u3089\u306e\u9ac4\u6db2\u691c\u67fb\u6cd5\u3000\u9ac4\u6db2\u691c\u67fb\u6cd52002\u304b\u3089\u306e\u5909\u66f4\u306e\u30dd\u30a4\u30f3\u30c8\uff0e\u5e73\u621027\u5e74\u5ea6\u65e5\u81e8\u6280\u95a2\u7532\u4fe1\u652f\u90e8\u533b\u5b66\u691c\u67fb\u5b66\u4f1a(\u7b2c52\u56de)\uff0e\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\uff0e2015.10.16-\uff0e\u9577\u91ce\uff0e<\/li>\n\n\n\n
                                                                                                                                            27. \u5bbf\u8c37 \u8ce2\u4e00\uff0c\u5f71\u5c71 \u7950\u5b50\uff0c\u4e0b\u6fa4 \u9054\u96c4\uff0c\u5927\u4e45\u4fdd \u6ecb\u592b\uff0c\u77e2\u51a8 \u88d5\uff0eJCCLS GP1-P4\u306b\u304a\u3051\u308b\u5c3f\u4e2d\u8d64\u8840\u7403\u5f62\u614b\u3068\u4eca\u5f8c\u306e\u5c55\u958b\uff0e\u7b2c62\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a \u30b7\u30f3\u30dd\u30b8\u30a6\u30e013\u300c\u65b0\u305f\u306a\u8840\u5c3f\u8a3a\u65ad\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u3068\u691c\u5c3f\u306e\u4eca\u5f8c\u300d\uff0e2015.11.19-22\uff0e\u5c90\u961c\uff0e<\/li>\n\n\n\n
                                                                                                                                            28. \u5713\u5c71 \u96c5\u5df1\uff0c\u52a0\u85e4 \u502b\u5b50\uff0c\u68ee\u672c \u826f\u5b50\uff0c\u5bae\u5d0e \u5f69\u8a18\u5b50\uff0c\u5927\u9580 \u96c5\u592b\uff0c\u5927\u6751 \u5bdb\u654f\uff0c\u5929\u91ce \u7be4\uff0c\u4ee3\u7530 \u6d69\u4e4b\uff0e\u5927\u52d5\u8108\u5f01\u72ed\u7a84\u75c7\u60a3\u8005\u306b\u304a\u3051\u308b\u5f01\u7f6e\u63db\u30fb\u51a0\u52d5\u8108\u30d0\u30a4\u30d1\u30b9\u8853\u540c\u6642\u65bd\u884c\u4f8b\u306b\u304a\u3051\u308b\u8853\u5f8c\u5fc3\u623f\u7d30\u52d5\u767a\u75c7\u306b\u95a2\u308f\u308b\u56e0\u5b50\u306e\u691c\u8a0e\uff0e\u7b2c26\u56de \u65e5\u672c\u5fc3\u30a8\u30b3\u30fc\u56f3\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2015.3.26-28\uff0e\u798f\u5ca1\uff0e<\/li>\n\n\n\n
                                                                                                                                            29. \u5927\u9ed2 \u9054\u4e5f\uff0c\u77e2\u51a8 \u88d5\uff0c\u6e6f\u672c \u771f\u4eba\uff0e\u8074\u899a\u8a98\u767a\u8133\u78c1\u5834\u5fdc\u7b54\u3092\u7528\u3044\u305f\u30d2\u30c8\u306e\u7d71\u8a08\u5b66\u7fd2\u306e\u89e3\u660e\uff0c\u7b2c17\u56de\u65e5\u672c\u30d2\u30c8\u8133\u6a5f\u80fd\u30de\u30c3\u30d4\u30f3\u30b0\u5b66\u4f1a\uff0e2015.7.2-3\uff0e\u5927\u962a.<\/li>\n\n\n\n
                                                                                                                                            30. \u5927\u9ed2 \u9054\u4e5f\uff0c\u77e2\u51a8 \u88d5\uff0c\u6e6f\u672c \u771f\u4eba\uff0ePitch class\u8a8d\u77e5\u3068\u7121\u8abf\u548c\u97f3\u5217\u306e\u7d71\u8a08\u5b66\u7fd2\u306e\u95a2\u9023\u6027\uff0e\u7b2c17\u56de \u65e5\u672c\u30d2\u30c8\u8133\u6a5f\u80fd\u30de\u30c3\u30d4\u30f3\u30b0\u5b66\u4f1a\uff0e2015.7.2-3\uff0e\u5927\u962a.<\/li>\n\n\n\n
                                                                                                                                            31. \u5927\u9ed2 \u9054\u4e5f\uff0c\u77e2\u51a8 \u88d5\uff0c\u6e6f\u672c \u771f\u4eba\uff0e\u9855\u5728\u30fb\u6f5c\u5728\u7d71\u8a08\u5b66\u7fd2\u306e\u795e\u7d4c\u751f\u7406\u5b66\u7684\u6307\u6a19\uff0e\u7b2c20\u56de \u8a8d\u77e5\u795e\u7d4c\u79d1\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2015.8.8-9\uff0e\u6771\u4eac\uff0c<\/li>\n\n\n\n
                                                                                                                                            32. \u5927\u9ed2 \u9054\u4e5f\uff0c\u77e2\u51a8 \u88d5\uff0c\u6e6f\u672c \u771f\u4eba\uff0c\u795e\u7d4c\u751f\u7406\u5b66\u7684\u6307\u6a19\u3092\u7528\u3044\u305f\u9818\u57df\u4e00\u822c\u7684\u7d71\u8a08\u5b66\u7fd2\u306e\u89e3\u660e\uff0e\u7b2c45\u56de \u65e5\u672c\u81e8\u5e8a\u795e\u7d4c\u751f\u7406\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a\uff0c2015.11.5-7\uff0e\u5927\u962a\uff0e<\/li>\n\n\n\n
                                                                                                                                            33. \u5927\u9ed2 \u9054\u4e5f\uff0c\u6e6f\u672c \u771f\u4eba\uff0c\u6f5c\u5728\u30fb\u9855\u5728\u6761\u4ef6\u306b\u304a\u3051\u308b\u9818\u57df\u4e00\u822c\u7684\u5b66\u7fd2\u306e\u795e\u7d4c\u751f\u7406\u5b66\u7684\u6307\u6a19\uff0c\u7b2c24\u56de \u65e5\u672c\u67d4\u9053\u6574\u5fa9\u63a5\u9aa8\u533b\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a\uff0c2015.11.7-8\uff0c\u65b0\u6f5f\uff0c<\/li>\n\n\n\n
                                                                                                                                            34. \u5927\u9580 \u96c5\u592b\uff0c\u5ddd\u7530 \u8cb4\u4e4b\uff0c\u4e2d\u5c3e \u502b\u5b50\uff0c\u6728\u6751 \u516c\u4e00\uff0c\u674e \u653f\u54f2\uff0c\u5ee3\u5ddd \u611b\u7f8e\uff0c\u5b87\u91ce \u6f22\u6210\uff0c\u7af9\u4e2d \u514b\uff0e\u52a0\u9f62\u306b\u4f34\u3046\u5fc3\u30a8\u30b3\u30fc\u56f3\u6307\u6a19\u306e\u5909\u5316\u306b\u3064\u3044\u3066\uff0e\u7b2c16\u56de \u5fc3\u7b4b\u4f1a. 2015.1.31\uff0e\u6771\u4eac\uff0e<\/li>\n\n\n\n
                                                                                                                                            35. \u9ad8\u6728 \u529b\uff0c\u798f\u7530 \u7965\u5927\uff0c\u6e21\u8fba \u5f18\u4e4b\uff0c\u5ca9\u5009 \u514b\u81e3\uff0c\u5927\u9580 \u96c5\u592b\uff0c\u4f0a\u85e4 \u6d69\uff0c\u5409\u5ddd \u7d14\u4e00\uff0e\u9ad8\u9f62\u9ad8\u8840\u5727\u60a3\u8005\u306b\u304a\u3051\u308b\u5fc3\u623f\u7d30\u52d5\u60a3\u8005\u306e\u983b\u5ea6\u3068\u75c5\u614b The AAA Japan Study\u30b5\u30d6\u89e3\u6790\uff0e\u7b2c63\u56de \u65e5\u672c\u5fc3\u81d3\u75c5\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2015.9.18-20\uff0e\u6a2a\u6d5c\uff0e<\/li>\n\n\n\n
                                                                                                                                            36. \u9ad8\u6a4b \u52c7\u4e8c\uff0c\u5927\u9ed2 \u9054\u4e5f\uff0c\u4e8c\u795e \u5f18\u5b50\uff0c\u6a3d\u672c \u4fee\u548c\uff0c\u5b89\u7530 \u79c0\u559c\uff0e\u904b\u52d5\u304c\u7d71\u8a08\u5b66\u7fd2\u3068\u305d\u306e\u5468\u6ce2\u6570\u30b9\u30da\u30af\u30c8\u30eb\u5909\u5316\u306b\u5bfe\u3059\u308b\u8010\u6027\u306b\u53ca\u307c\u3059\u5f71\u97ff\uff0e\u7b2c20\u56de \u8a8d\u77e5\u795e\u7d4c\u79d1\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2015.8.8-9\uff0e\u6771\u4eac\uff0c<\/li>\n\n\n\n
                                                                                                                                            37. \u9ad8\u6a4b \u52c7\u4e8c\uff0c\u5927\u9ed2 \u9054\u4e5f\uff0c\u4e8c\u795e \u5f18\u5b50\uff0c\u6a3d\u672c \u4fee\u548c\uff0c\u5b89\u7530 \u79c0\u559c\uff0e\u5f8b\u52d5\u7684\u904b\u52d5\u304c\u9818\u57df\u4e00\u822c\u7684\u5b66\u7fd2\u3068\u305d\u306e\u5468\u6ce2\u6570\u30b9\u30da\u30af\u30c8\u30eb\u5909\u5316\u306b\u5bfe\u3059\u308b\u8010\u6027\u306b\u53ca\u307c\u3059\u5f71\u97ff\uff0e\u7b2c24\u56de \u65e5\u672c\u67d4\u9053\u6574\u5fa9\u63a5\u9aa8\u533b\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a\uff0e2015.11.7-8\uff0e\u65b0\u6f5f\uff0c<\/li>\n\n\n\n
                                                                                                                                            38. \u4f0a\u9054 \u4e9c\u7406\u6c99\uff0c\u9ad8\u6a4b \u6075\uff0c\u68ee\u7530 \u8ce2\u53f2\uff0c\u5824 \u7531\u7d00\u5b50\uff0c\u4e45\u672b \u5d07\u53f8\uff0c\u66fd\u6839 \u4f38\u6cbb\uff0c\u5927\u4e45\u4fdd \u6ecb\u592b\uff0c\u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0e\u63a1\u8840\u6642\u306e\u30c8\u30e9\u30d6\u30eb\u6e1b\u5c11\u306b\u5411\u3051\u305f\u53d6\u308a\u7d44\u307f\uff0e\u7b2c62\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2015.11.19-22\uff0e\u5c90\u961c\uff0e<\/li>\n\n\n\n
                                                                                                                                            39. \u7530\u4e2d \u96c5\u7f8e\uff0c\u5f71\u5c71 \u7950\u5b50\uff0c\u5ddd\u53e3 \u76f4\u5b50\uff0c\u4e45\u672b \u5d07\u53f8\uff0c\u5bbf\u8c37 \u8ce2\u4e00\uff0c\u5927\u4e45\u4fdd \u6ecb\u592b\uff0c\u77e2\u51a8 \u88d5\uff0e\u5c0f\u578b\u306e\u591a\u9805\u76ee\u81ea\u52d5\u8840\u7403\u5206\u6790\u88c5\u7f6e\uff08\u8a66\u4f5c\u6a5f\uff09\u3092\u7528\u3044\u305f\u9ac4\u6db2\u7d30\u80de\u7b97\u5b9a\u306e\u57fa\u790e\u7684\u691c\u8a0e\uff0e\u7b2c64\u56de \u65e5\u672c\u533b\u5b66\u691c\u67fb\u5b66\u4f1a\uff0e2015.5.16-17\uff0e\u798f\u5ca1\uff0e<\/li>\n\n\n\n
                                                                                                                                            40. \u7530\u4e2d \u96c5\u7f8e\uff0c\u5bbf\u8c37 \u8ce2\u4e00\uff0c\u68ee\u7530 \u8ce2\u53f2\uff0c\u4e45\u672b \u76f4\u5b50\uff0c\u5f71\u5c71 \u7950\u5b50\uff0c\u5927\u4e45\u4fdd \u6ecb\u592b\uff0c\u4e0b\u6fa4 \u9054\u96c4\uff0c\u77e2\u51a8 \u88d5\uff0e\u65b0\u898f\u5c3f\u4e2d\u6709\u5f62\u6210\u5206\u5206\u6790\u88c5\u7f6e\uff08\u8a66\u4f5c\u6a5f\uff09\u300c\u4f53\u6db2\u6e2c\u5b9a\u30e2\u30fc\u30c9\u300d\u306e\u57fa\u790e\u7684\u691c\u8a0e\uff0e\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u81ea\u52d5\u5316\u5b66\u4f1a \u7b2c47\u56de\u5927\u4f1a\uff0e2015.10.8-10\uff0e\u6a2a\u6d5c\uff0e<\/li>\n\n\n\n
                                                                                                                                            41. \u7530\u9089 \u4e45\u7f8e\u5b50\uff0c\u5897\u7530 \u4e9c\u5e0c\u5b50\uff0c\u5bfa\u5cf6 \u9053\u5b50\uff0c\u4f50\u85e4 \u512a\u5b9f\u5b50\uff0c\u5e38\u540d \u653f\u5f18\uff0c\u5927\u4e45\u4fdd \u6ecb\u592b\uff0c\u77e2\u51a8 \u88d5\uff0eBCR-ABL1\u3092\u4f34\u3046T\u30ea\u30f3\u30d1\u82bd\u7403\u6027\u767d\u8840\u75c5\u306e\u4e00\u75c7\u4f8b\uff0e\u7b2c25\u56de \u65e5\u672c\u30b5\u30a4\u30c8\u30e1\u30c8\u30ea\u30fc\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2015.7.11-12\uff0e\u6771\u4eac\uff0e<\/li>\n\n\n\n
                                                                                                                                            42. \u5343\u660e \u771f\u5f13\uff0c\u5b87\u91ce \u6f22\u6210\uff0c\u5927\u9580 \u96c5\u592b\uff0c\u4e2d\u5c3e \u502b\u5b50\uff0c\u5ddd\u7530 \u8cb4\u4e4b\uff0c\u6728\u6751 \u516c\u4e00\uff0c\u674e \u653f\u54f2\uff0c\u5ee3\u5ddd \u611b\u7f8e\uff0c\u4f50\u3005\u6728 \u8cc0\u6d25\u4e43\uff0c\u5ca1\u91ce \u667a\u5b50\uff0c\u5bae\u5d0e \u4ee4\u5b50\uff0c\u83c5\u539f \u5c06\u4ee3\uff0c\u5b89\u6771 \u6075\uff0c\u7af9\u4e2d \u514b\uff0c\u77e2\u51a8 \u88d5\uff0e\u7c21\u4fbf\u306a\u904b\u52d5\u8ca0\u8377\u5fc3\u30a8\u30b3\u30fc\u304c\u52b4\u4f5c\u6642\u606f\u5207\u308c\u306e\u8a3a\u65ad\u306b\u6709\u52b9\u3067\u3042\u3063\u305f\u4e00\u4f8b\uff0e\u7b2c26\u56de \u65e5\u672c\u5fc3\u30a8\u30b3\u30fc\u56f3\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2015.3.26-28\uff0e\u798f\u5ca1\uff0e<\/li>\n\n\n\n
                                                                                                                                            43. \u5343\u660e \u771f\u5f13\uff0c\u5b87\u91ce \u6f22\u6210\uff0c\u5927\u9580 \u96c5\u592b\uff0c\u4e2d\u5c3e \u502b\u5b50\uff0c\u5ddd\u7530 \u8cb4\u4e4b\uff0c\u6728\u6751 \u516c\u4e00\uff0c\u674e \u653f\u54f2\uff0c\u5ee3\u5ddd \u611b\u7f8e\uff0c\u7af9\u4e2d \u514b\uff0c\u77e2\u51a8 \u88d5\uff0e\u7c21\u4fbf\u306a\u904b\u52d5\u8ca0\u8377\u5fc3\u30a8\u30b3\u30fc\u304c\u52b4\u4f5c\u6642\u606f\u5207\u308c\u306e\u8a3a\u65ad\u306b\u6709\u52b9\u3060\u3063\u305f\u4e00\u4f8b\uff0e\u7b2c26\u56de \u65e5\u672c\u5fc3\u30a8\u30b3\u30fc\u56f3\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2015.3.26-28\uff0e\u798f\u5ca1\uff0e<\/li>\n\n\n\n
                                                                                                                                            44. \u98db\u7530 \u660e\u5b50\uff0c\u4e0b\u5742 \u6d69\u5247\uff0c\u5965\u5c71 \u6075\u7406\u5b50\uff0c\u5927\u4e45\u4fdd \u6ecb\u592b\uff0c\u6c60\u7530 \u5747\uff0c\u77e2\u51a8 \u88d5\uff0eAIA-CL2400\u306b\u3088\u308bBNP\u6e2c\u5b9a\u8a66\u85ac\u306e\u57fa\u672c\u7684\u6027\u80fd\u8a55\u4fa1\uff0e\u7b2c47\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u81ea\u52d5\u5316\u5b66\u4f1a\u5927\u4f1a\uff0e2015.10.10\uff0e\u6a2a\u6d5c\uff0e<\/li>\n\n\n\n
                                                                                                                                            45. \u4e2d\u5c3e \u502b\u5b50\uff0c\u5927\u9580 \u96c5\u592b\uff0c\u4e0a\u539f \u96c5\u6075\uff0c\u7e04\u7530 \u5bdb\uff0c\u5ee3\u5ddd \u611b\u7f8e\uff0c\u6728\u6751 \u516c\u4e00\uff0c\u5ddd\u7530 \u8cb4\u4e4b\uff0c\u5c0f\u91ce \u7a14\uff0c\u5c0f\u5ba4 \u4e00\u6210\uff0e\u50e7\u5e3d\u5f01\u4f4d\u611f\u67d3\u6027\u5fc3\u5185\u819c\u708e\u306b\u5bfe\u3059\u308b\u50e7\u5e3d\u5f01\u5f62\u6210\u8853\u5f8c\u306b\u4eee\u6027\u5fc3\u5ba4\u7624\u3092\u5f62\u6210\u3057\u305f\u75c7\u4f8b\uff0e\u7b2c6\u56de \u65e5\u672c\u5fc3\u81d3\u5f01\u819c\u75c7\u5b66\u4f1a\uff0e2015.12.4-5\uff0e\u6771\u4eac\uff0e<\/li>\n\n\n\n
                                                                                                                                            46. \u897f\u68ee \u307e\u3069\u304b\uff0c\u6c38\u53cb \u5229\u6d25\u5b50\uff0c\u4e0b\u5742 \u6d69\u5247\uff0c\u5927\u4e45\u4fdd \u6ecb\u592b\uff0c\u77e2\u51a8 \u88d5\uff0e\u65b0\u898f\u8a66\u85ac\u6297Sm\u6297\u4f53\u691c\u67fb\u30ad\u30c3\u30c8\u300c\u30a8\u30ea\u30a2 SmDp\u300d\u306e\u57fa\u790e\u691c\u8a0e\uff0e\u7b2c64\u56de \u65e5\u672c\u533b\u5b66\u691c\u67fb\u5b66\u4f1a\uff0e2015.5.16\uff0e\u798f\u5ca1\uff0e<\/li>\n\n\n\n
                                                                                                                                            47. \u65e9\u5ddd \u660e\u5b50\uff0c\u5c71\u53e3 \u3072\u308d\u5b50\uff0c\u5965\u5c71 \u6075\u7406\u5b50\uff0c\u5927\u7af9 \u5948\u90fd\u5b50\uff0c\u4e0b\u5742 \u6d69\u5247\uff0c\u5927\u4e45\u4fdd \u6ecb\u592b\uff0c\u77e2\u51a8 \u88d5\uff0e\u5168\u81ea\u52d5\u5316\u5b66\u767a\u5149\u9175\u7d20\u514d\u75ab\u6e2c\u5b9a\u88c5\u7f6eAIA-CL\u306b\u3088\u308bTg\u6e2c\u5b9a\u8a66\u85ac\u306e\u57fa\u790e\u7684\u691c\u8a0e\uff0e\u7b2c64\u56de \u65e5\u672c\u533b\u5b66\u691c\u67fb\u5b66\u4f1a\uff0e2015.5.16\uff0e\u798f\u5ca1\uff0e<\/li>\n\n\n\n
                                                                                                                                            48. \u4e45\u672b \u5d07\u53f8\uff0c\u5bbf\u8c37 \u8ce2\u4e00\uff0c\u4e45\u672b \u76f4\u5b50\uff0c\u5f71\u5c71 \u7950\u5b50\uff0c\u7530\u4e2d \u96c5\u7f8e\uff0c\u5927\u4e45\u4fdd \u6ecb\u592b\uff0c\u4e0b\u6fa4 \u9054\u96c4\uff0c\u77e2\u51a8 \u88d5\uff0e\u95a2\u7bc0\u6db2\u304c\u767d\u8272\u3092\u5448\u3057\u305f\u75db\u98a8\u306e\u4e00\u75c7\u4f8b\uff0e\u7b2c11\u56de \u6771\u4eac\u90fd\u533b\u5b66\u691c\u67fb\u5b66\u4f1a\uff0e2015.11.1\uff0e\u7acb\u5ddd\uff0e<\/li>\n\n\n\n
                                                                                                                                            49. \u4e45\u672b \u76f4\u5b50\uff0c\u5bbf\u8c37 \u8ce2\u4e00\uff0c\u68ee\u7530 \u8ce2\u53f2\uff0c\u5f71\u5c71 \u7950\u5b50\uff0c\u7530\u4e2d \u96c5\u7f8e\uff0c\u5927\u4e45\u4fdd \u6ecb\u592b\uff0c\u4e0b\u6fa4 \u9054\u96c4\uff0c\u77e2\u51a8 \u88d5\uff0e\u30df\u30a8\u30ed\u30fc\u30de\u5186\u67f1\u3092\u8a8d\u3081\u305f3\u75c7\u4f8b\uff0e\u7b2c11\u56de \u6771\u4eac\u90fd\u533b\u5b66\u691c\u67fb\u5b66\u4f1a\uff0e2015.11.1\uff0e\u7acb\u5ddd\uff0e<\/li>\n\n\n\n
                                                                                                                                            50. \u5ee3\u5ddd \u611b\u7f8e\uff0c\u5927\u9580 \u96c5\u592b\uff0c\u5ddd\u7530 \u8cb4\u4e4b\uff0c\u6728\u6751 \u516c\u4e00\uff0c\u4e2d\u5c3e \u502b\u5b50\uff0c\u674e \u653f\u54f2\uff0c\u5b87\u91ce \u6f22\u6210\uff0c\u7af9\u4e2d \u514b\uff0c\u52a0\u85e4 \u502b\u5b50\uff0c\u6e21\u8fba \u660c\u6587\uff0c\u5c71\u5d0e \u529b\uff0c\u5c0f\u5ba4 \u4e00\u6210\uff0e\u9ad8\u9f62\u5973\u6027\u306b\u304a\u3051\u308b\u5de6\u5ba4\u62e1\u5f35\u969c\u5bb3\uff1a\u9589\u7d4c\u6642\u671f\u306e\u9055\u3044\u3068\u305d\u306e\u5f8c\u306e\u5de6\u5ba4\u62e1\u5f35\u969c\u5bb3\u306e\u95a2\u4fc2\uff0e\u7b2c26\u56de \u65e5\u672c\u5fc3\u30a8\u30b3\u30fc\u56f3\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2015.3.26-28\uff0e\u798f\u5ca1\uff0e<\/li>\n\n\n\n
                                                                                                                                            51. Megumi Hirokawa, Masao Daimon, Takayuki Kawata, Koichi Kimura, Tomoko Nakao, Cheng-Che Lee, Tomoko Katoh, Masafumi Watanabe, Tsutomu Yamazaki, Issei Komuro\uff0eInfluence of Early Menopause on Left Ventricular Diastolic Dysfunction\uff1aA Clinical Observational Study in Healthy Subjects\uff0e\u7b2c79\u56de \u65e5\u672c\u5faa\u74b0\u5668\u75c5\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2015.4.24-26\uff0e\u5927\u962a\uff0e<\/li>\n\n\n\n
                                                                                                                                            52. \u5ee3\u5ddd \u611b\u7f8e\uff0c\u5927\u9580 \u96c5\u592b\uff0c\u99ac\u539f \u5553\u592a\u90ce\uff0c\u91d1 \u4e00\uff0c\u9ad8\u68a8 \u79c0\u4e00\u90ce\uff0c\u53cb\u6c60 \u4ec1\u66a2\uff0c\u5c0f\u5ba4 \u4e00\u6210\uff0e\u9ad8\u5ea6\u4e09\u5c16\u5f01\u9006\u6d41\u306b\u5bfe\u3059\u308b\u5358\u72ec\u5916\u79d1\u7684\u6cbb\u7642\u5f8c\u306e\u53f3\u5fc3\u6a5f\u80fd\u8a55\u4fa1\u306b\u3064\u3044\u3066. \u7b2c6\u56de \u65e5\u672c\u5fc3\u81d3\u5f01\u819c\u75c7\u5b66\u4f1a\uff0e2015.12.4-5\uff0e\u6771\u4eac\uff0e<\/li>\n\n\n\n
                                                                                                                                            53. \u5897\u7530 \u4e9c\u5e0c\u5b50\uff0e\u7b2c5\u56de\u8840\u6db2\u691c\u67fb\u6a5f\u5668\u6280\u8853\u30bb\u30df\u30ca\uff0d \u81e8\u5e8a\u533b\u304c\u6c42\u3081\u308b\u8840\u6db2\u691c\u67fb\u306e\u5831\u544a \uff5e\u7dca\u6025\u6027\u306e\u9ad8\u3044\u691c\u67fb\u30c7\u30fc\u30bf\u3068\u306f\uff1f\uff5e\uff0e\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u81ea\u52d5\u5316\u5b66\u4f1a \u7b2c47\u56de\u5927\u4f1a.\u30002015.10.8\uff0e\u6a2a\u6d5c\uff0e<\/li>\n\n\n\n
                                                                                                                                            54. \u677e\u672c \u5f69\uff0c\u4ef2\u6751 \u6075\uff0c\u82e5\u6797 \u7950\u91cc\u6c5f\uff0c\u6c38\u677e \u660e\u7f8e\uff0c\u4f50\u85e4 \u9ebb\u53cb\u5b50\uff0c\u91d1\u5b50 \u771f\u4f50\u7f8e\uff0c\u67f3\u7530 \u9053\u5b5d\uff0c\u4e0b\u5742 \u6d69\u5247\uff0c\u5f71\u5c71 \u7950\u5b50\uff0c\u5bae\u672c \u548c\u5b50\uff0c\u6e21\u90e8 \u6b4c\u7e54\uff0c\u68ee\u8c4a \u9686\u5fd7\uff0c\u5c71\u5d0e \u529b\uff0c\u6771\u5927\u75c5\u9662P1\u30e6\u30cb\u30c3\u30c8\u8a66\u9a13\u5b9f\u65bd\u30b0\u30eb\u30fc\u30d7\uff0eARO\u6a5f\u80fd\u3092\u6d3b\u7528\u3057\u3066\u81e8\u5e8a\u8a66\u9a13\u3092\u5b9f\u65bd\u3059\u308b\u6771\u5927\u75c5\u9662P1\u30e6\u30cb\u30c3\u30c8\uff0eARO\u5354\u8b70\u4f1a \u7b2c3\u56de\u5b66\u8853\u96c6\u4f1a\uff0e2015.9.18-19\uff0e\u6771\u4eac\uff0e<\/li>\n\n\n\n
                                                                                                                                            55. \u4e38\u5c3e \u7406\u6075\uff0c\u91d1\u5b50 \u8aa0\uff0c\u83c5\u91ce \u4fe1\u5b50\uff0c\u4f50\u85e4 \u91d1\u592b\uff0c\u5c0f\u91ce \u4f73\u4e00\uff0c\u4e45\u7c73 \u5e78\u592b\uff0c\u5e38\u540d \u653f\u5f18\uff0c\u5927\u4e45\u4fdd \u6ecb\u592b\uff0c\u5c3e\u5d0e \u7531\u57fa\u7537\uff0c\u77e2\u51a8 \u88d5\uff0e\u8840\u5c0f\u677f\u51dd\u96c6\u80fd\u691c\u67fb\u306e\u81ea\u52d5\u6e2c\u5b9a\u5316\uff1a\u6e2c\u5b9a\u6cd5\u6a19\u6e96\u5316\u3068\u6297\u8840\u5c0f\u677f\u85ac\u52b9\u679c\u5224\u5b9a\u306b\u5411\u3051\u3066\uff0e\u7b2c16\u56de \u65e5\u672c\u691c\u67fb\u8840\u6db2\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2015.7.11-12\uff0e\u540d\u53e4\u5c4b\uff0e<\/li>\n\n\n\n
                                                                                                                                            56. \u4e38\u5c3e \u7406\u6075\uff0c\u91d1\u5b50 \u8aa0\uff0c\u83c5\u91ce \u4fe1\u5b50\uff0c\u6e21\u908a \u3086\u308a\uff0c\u4f50\u85e4 \u91d1\u592b\uff0c\u5e38\u540d \u653f\u5f18\uff0c\u5927\u4e45\u4fdd \u6ecb\u592b\uff0c\u5c3e\u5d0e \u7531\u57fa\u7537\uff0c\u77e2\u51a8 \u88d5\uff0e\u5168\u81ea\u52d5\u8840\u6db2\u51dd\u56fa\u6e2c\u5b9a\u88c5\u7f6eCS-2000i\u3067\u306e\u8840\u5c0f\u677f\u51dd\u96c6\u80fd\u691c\u67fb\uff1a\u6642\u9593\u7d4c\u904e\u306b\u304a\u3051\u308b\u51dd\u96c6\u80fd\u306e\u5b89\u5b9a\u6027\uff0e\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u81ea\u52d5\u5316\u5b66\u4f1a \u7b2c47\u56de\u5927\u4f1a\uff0e2015.10.8-10\uff0e\u6a2a\u6d5c\uff0e<\/li>\n\n\n\n
                                                                                                                                            57. \u6c34\u9593\u77e5\u4e16\uff0c\u5e38\u540d\u653f\u5f18\uff0c\u5409\u5ddd\u76f4\u4e4b\uff0c\u5897\u7530\u4e9c\u5e0c\u5b50\uff0c\u5927\u4e45\u4fdd\u6ecb\u592b\uff0c\u77e2\u51a8\u88d5.\u30d5\u30ed\u30fc\u30b5\u30a4\u30c8\u30e1\u30c8\u30ea\u30fc\u304c\u8a3a\u65ad\u306b\u6709\u7528\u3067\u3042\u3063\u305f\u6025\u6027\u578b\u6210\u4ebaT\u7d30\u80de\u767d\u8840\u75c5\u306e\u4e00\u75c7\u4f8b\uff0e\u7b2c11\u56de\u6771\u4eac\u90fd\u533b\u5b66\u691c\u67fb\u5b66\u4f1a\uff0e2015.11.1.\u6771\u4eac.<\/li>\n\n\n\n
                                                                                                                                            58. \u68ee\u7530 \u8ce2\u53f2\uff0c\u7530\u4e2d \u96c5\u7f8e\uff0c\u4e45\u672b \u76f4\u5b50\uff0c\u5f71\u5c71 \u7950\u5b50\uff0c\u5bbf\u8c37 \u8ce2\u4e00\uff0c\u5927\u4e45\u4fdd \u6ecb\u592b\uff0c\u4e0b\u6fa4 \u9054\u96c4\uff0c\u77e2\u51a8 \u88d5\uff0e\u9ac4\u6db2\u4e00\u822c\u691c\u67fb\u306b\u304a\u3051\u308b\u9ac4\u6db2\u7570\u578b\u7d30\u80de\u306e\u691c\u51fa\u7387\uff0e\u7b2c7\u56de\u65e5\u672c\u81e8\u5e8a\u4e00\u822c\u691c\u67fb\u5b66\u4f1a\uff0e2015.9.12\uff0e\u6625\u65e5\u4e95\uff0e<\/li>\n\n\n\n
                                                                                                                                            59. \u68ee\u7530 \u8ce2\u53f2\uff0c\u7530\u4e2d \u96c5\u7f8e\uff0c\u4e45\u672b \u76f4\u5b50\uff0c\u5f71\u5c71 \u7950\u5b50\uff0c\u5bbf\u8c37 \u8ce2\u4e00\uff0c\u5927\u4e45\u4fdd \u6ecb\u592b\uff0c\u4e0b\u6fa4 \u9054\u96c4\uff0c\u77e2\u51a8 \u88d5\uff0e\u30b5\u30e0\u30bd\u30f3\u67d3\u8272\u306b\u3088\u308b\u9ac4\u6db2\u7570\u578b\u7d30\u80de\u306e\u691c\u51fa\u72b6\u6cc1\uff0e\u7b2c11\u56de \u6771\u4eac\u90fd\u533b\u5b66\u691c\u67fb\u5b66\u4f1a\uff0e2015.11.1\uff0e\u7acb\u5ddd\uff0e<\/li>\n\n\n\n
                                                                                                                                            60. \u68ee\u672c \u826f\u5b50\uff0c\u5927\u9580 \u96c5\u592b\uff0c\u559c\u591a\u6751 \u5065\u4e00\uff0c\u9ad8\u6a4b \u7531\u4f73\u91cc\uff0c\u5713\u5c71 \u96c5\u5df1\uff0c\u5bae\u5d0e \u5f69\u8a18\u5b50\uff0c\u52a0\u85e4 \u502b\u5b50,\u5927\u6751 \u5bdb\u654f\uff0c\u4ee3\u7530 \u6d69\u4e4b\uff0e\u5fc3\u30b5\u30eb\u30b3\u30a4\u30c9\u30fc\u30b7\u30b9\u306e\u75c5\u52e2\u8a55\u4fa1\u306b\u5bfe\u3057\u3066\u5fc3\u30a8\u30b3\u30fc\u30b9\u30da\u30c3\u30af\u30c8\u30e9\u30c3\u30ad\u30f3\u30b0\u6cd5\u30b9\u30c8\u30ec\u30a4\u30f3\u5024\u304c\u6709\u7528\u3067\u3042\u3063\u305f\u4e00\u4f8b\uff0e\u7b2c63\u56de \u65e5\u672c\u5fc3\u81d3\u75c5\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2015.9.18-20\uff0e\u6a2a\u6d5c\uff0e<\/li>\n\n\n\n
                                                                                                                                            61. \u68ee\u672c \u826f\u5b50\uff0c\u5927\u9580 \u96c5\u592b\uff0c\u5bae\u5d0e \u5f69\u8a18\u5b50\uff0c\u5713\u5c71 \u96c5\u5df1\uff0c\u52a0\u85e4 \u502b\u5b50\uff0c\u5927\u6751 \u5bdb\u654f\uff0c\u4ee3\u7530 \u6d69\u4e4b\uff0e\u9aa8\u7c97\u9b06\u75c7\u6cbb\u7642\u85ac\u306e\u5927\u52d5\u8108\u5f01\u72ed\u7a84\u75c7\u9032\u5c55\u6291\u5236\u52b9\u679c\u306b\u304a\u3051\u308b\u691c\u8a0e\uff0e\u7b2c26\u56de \u65e5\u672c\u5fc3\u30a8\u30b3\u30fc\u56f3\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2015.3.26-28\uff0e\u798f\u5ca1\uff0e<\/li>\n\n\n\n
                                                                                                                                            62. \u5b89\u5ddd \u6075\u5b50\uff0c\u4e0b\u6fa4\u9054\u96c4\uff0c\u5927\u4e45\u4fdd\u6ecb\u592b\uff0c\u77e2\u51a8\u88d5\uff0e\u9084\u5143\u30fb\u9178\u5316\u30a2\u30eb\u30d6\u30df\u30f3\u306e\u5b9f\u7528\u7684\u6e2c\u5b9a\u6cd5\u306e\u958b\u767a\uff0e\u7b2c55\u56de \u65e5\u672c\u81e8\u5e8a\u5316\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2015.10.31\uff0e\u5927\u962a\uff0e<\/li>\n\n\n\n
                                                                                                                                            63. \u77e2\u51a8 \u88d5\uff0e\u691c\u67fb\u7d50\u679c\u306e\u898b\u304b\u305f\uff0e\u7b2c32\u56de \u6771\u4eac\u5927\u5b66\u533b\u5e2b\u4f1a \u516c\u958b\u8b1b\u5ea7\uff0e2015.2.20\uff0e\u6771\u4eac\uff0e<\/li>\n\n\n\n
                                                                                                                                            64. \u77e2\u51a8 \u88d5\uff0e\u8102\u8cea\u30e1\u30c7\u30a3\u30a8\u30fc\u30bf\u30fc\u306e\u81e8\u5e8a\u691c\u67fb\uff0e\u7b2c10\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u7279\u5225\u4f8b\u4f1a\u300c\u30b7\u30f3\u30dd\u30b8\u30a6\u30e01\uff1a\u672a\u6765\u7684\u81e8\u5e8a\u691c\u67fb\u306e\u30d1\u30fc\u30b9\u30da\u30af\u30c6\u30a3\u30d6\u300d\uff0e2015.4.13\uff0e\u4eac\u90fd\uff0e<\/li>\n\n\n\n
                                                                                                                                            65. \u77e2\u51a8 \u88d5\uff0eR-CPC\uff0e\u7b2c64\u56de \u65e5\u672c\u533b\u5b66\u691c\u67fb\u5b66\u4f1a\uff0e2015.5.16-17\uff0e\u798f\u5ca1\uff0e<\/li>\n\n\n\n
                                                                                                                                            66. \u77e2\u51a8 \u88d5\uff0e\u5b66\u8853\u8b1b\u6f142\u300c\u30aa\u30fc\u30c8\u30bf\u30ad\u30b7\u30f3\u306e\u81e8\u5e8a\u691c\u67fb\u3078\u306e\u5c0e\u5165\u3092\u76ee\u6307\u3057\u3066\u300d\uff0e\u7b2c33\u56de \u65e5\u672c\u81e8\u5e8a\u5316\u5b66\u4f1a \u7532\u4fe1\u8d8a\u652f\u90e8\u7dcf\u4f1a\uff0e2015.6.6-7\uff0e\u677e\u672c\uff0e<\/li>\n\n\n\n
                                                                                                                                            67. \u77e2\u51a8 \u88d5\uff0e\u8840\u5c0f\u677f\u306e\u81e8\u5e8a\u691c\u67fb\uff0e\u5927\u962a\u5e9c\u533b\u5e2b\u4f1a\u533b\u5b66\u4f1a \u5b66\u8853\u8b1b\u6f14\u4f1a\uff0e2015.6.25\uff0e\u5927\u962a\uff0e<\/li>\n\n\n\n
                                                                                                                                            68. \u5409\u5ddd \u76f4\u4e4b\uff0c\u5897\u7530 \u4e9c\u5e0c\u5b50\uff0c\u5e38\u540d \u653f\u5f18\uff0c\u5927\u4e45\u4fdd \u6ecb\u592b\uff0c\u77e2\u51a8 \u88d5\uff0e\u65b0\u898f\u591a\u9805\u76ee\u81ea\u52d5\u8840\u7403\u5206\u6790\u88c5\u7f6eXN-550\u306e\u57fa\u790e\u7684\u691c\u8a0e\uff0e\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u81ea\u52d5\u5316\u5b66\u4f1a \u7b2c47\u56de\u5927\u4f1a.\u30002015.10.8-10\uff0e\u6a2a\u6d5c.<\/li>\n\n\n\n
                                                                                                                                            69. \u674e \u653f\u54f2\uff0c\u5927\u9580 \u96c5\u592b\uff0c\u4e2d\u5c3e \u502b\u5b50\uff0c\u5ddd\u7530 \u8cb4\u4e4b\uff0c\u6728\u6751 \u516c\u4e00\uff0c\u5ee3\u5ddd \u611b\u7f8e\uff0c\u5b87\u91ce \u6f22\u6210\uff0c\u7af9\u4e2d \u514b\uff0c\u5c71\u5d0e \u529b\uff0c\u5c0f\u5ba4 \u4e00\u6210. \u5de6\u623f\u5bb9\u7a4d\u306e\u6c7a\u5b9a\u56e0\u5b50\uff1a\u5de6\u623f\u5bb9\u7a4d\u306f\u5de6\u5ba4\u62e1\u5f35\u80fd\u306e\u307f\u3067\u898f\u5b9a\u3055\u308c\u308b\u306e\u304b\uff1f \u7b2c26\u56de \u65e5\u672c\u5fc3\u30a8\u30b3\u30fc\u56f3\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2015.3.26-28\uff0e\u798f\u5ca1\uff0e<\/li>\n\n\n\n
                                                                                                                                            70. \u5f90 \u535a\u537f\uff0c\u4e2d\u5c3e \u502b\u5b50\uff0c\u5927\u9580 \u96c5\u592b\uff0c\u5ddd\u7530 \u8cb4\u4e4b\uff0c\u6728\u6751 \u516c\u4e00\uff0c\u5ee3\u5ddd \u611b\u7f8e\uff0c\u5b87\u91ce \u6f22\u6210\uff0c\u7af9\u4e2d \u514b\uff0c\u77e2\u51a8 \u88d5\uff0c\u5c0f\u5ba4 \u4e00\u6210\uff0e\u82e5\u5e74\u3067\u96e3\u6cbb\u6027\u306e\u62e1\u5f35\u6027\u5fc3\u4e0d\u5168\u3092\u5448\u3057\u305f\u4e00\u4f8b\uff0e \u7b2c58\u56de \u6771\u4eac\u5fc3\u30a8\u30b3\u30fc\u56f3\u7814\u7a76\u4f1a\uff0e2015.11.21\uff0e\u6771\u4eac\uff0e<\/li>\n<\/ol>\n\n\n\n

                                                                                                                                              \u82f1\u6587\u7dcf\u8aac\uff1aEnglish Review Articles<\/h4>\n\n\n\n
                                                                                                                                                \n
                                                                                                                                              1. Daimon, M. Can We Predict or Prevent Progression of Aortic Stenosis?\u00a0Circ. J.<\/strong><\/em>\u00a079: 1908-1909<\/a>, 2015.<\/li>\n<\/ol>\n\n\n\n

                                                                                                                                                \u56fd\u969b\u5b66\u4f1a\u767a\u8868\uff1aInternational Conference Presentation<\/h4>\n\n\n\n
                                                                                                                                                  \n
                                                                                                                                                1. Daikoku, T., Yatomi, Y., and Yumoto, M. Domain-specific pitch-class facilitates domain-general statistical learning of chord sequences. The 9th ICME International Conference on Complex Medical Engineering. 2015. 7. 18 – 21. Okayama, Japan.<\/li>\n\n\n\n
                                                                                                                                                2. Kawata, T., Daimon, M., Kimura, K., Nakao, T., Lee, SL., Hirokawa, M., Watanabe, M., Yatomi, Y., Komuro, I. Echocardiographic assessment of right ventricular function in a routine practice: Which parameters are useful to predict one-year outcome in advanced heart failure patients with dilated cardiomyopathy? American College of Cardiology 64st Annual Scientific Session. 2015. 3. 14 – 16. San Diego, California, USA.<\/li>\n\n\n\n
                                                                                                                                                3. Makimoto, H., Fujiu, K., Shimizu, K., Amiya, E., Kojima, T., Daimon, M., Meyer, C., and, Komuro, I. Diverge Responses of Cardiac Autonomic Function to Beta-blocker Therapy Depending on Chronic Kidney Disease. European Society of Cardiology. 2015. 8. 31 – 9. 2. London, United Kingdom.<\/li>\n\n\n\n
                                                                                                                                                4. Uranbileg, B., Ikeda, H., Kurano, M., Saigusa, D., Aoki, J., Enooku, K., Ishizawa, T., Hasegawa, K., Kokudo, N., and Yatomi, Y. Sphingosine kinases and S1P lyase are enhanced in hepatocellular carcinoma with poorer differentiation and recurrence. 6th International conference on phospholipase A2 and lipid mediators (PLM2015). 2015. 2. 10 – 12. Tokyo, Japan.<\/li>\n\n\n\n
                                                                                                                                                5. Yatomi, Y. Autotaxin and lysophosphatidic acid as clinical biomarkers. The 14th International Conference on Bioactive Lipids in Cancer, Inflammation and Related Diseases. 2015. 7. 12 – 15. Budapest, Hungary.<\/li>\n<\/ol>\n\n\n\n

                                                                                                                                                  \u548c\u6587\u539f\u8457\u8ad6\u6587\uff1aJapanese Original Articles<\/h4>\n\n\n\n
                                                                                                                                                    \n
                                                                                                                                                  1. \u77f3\u4e95 \u6e05\uff0c\u7530\u90e8 \u967d\u5b50\uff0c\u4f50\u91ce \u9ebb\u8863\uff0c\u5ca9\u5d0e \u967d\u4ecb\uff0c\u6e05\u6c34 \u9577\u5b50\uff0c\u5897\u7530 \u4e9c\u5e0c\u5b50\uff0c\u5800\u4e95 \u9686\uff0c\u4f50\u85e4 \u5c1a\u6b66\uff0c\u4e09\u4e95\u7530 \u5b5d\uff0c\u5927\u5742 \u986f\u901a\uff0e\u8840\u6db2\u691c\u67fb\u52b9\u7387\u5316\u306b\u8cc7\u3059\u308b\u8840\u6db2\u50cf\u76ee\u8996\u518d\u691c\u57fa\u6e96\u306e\u8a2d\u5b9a\u3068\u8a55\u4fa1\u30fc\u81ea\u52d5\u8840\u7403\u5206\u6790\u88c5\u7f6e XE-5000\u3092\u7528\u3044\u305f\u5834\u5408\u30fc. \u65e5\u672c\u691c\u67fb\u8840\u6db2\u5b66\u4f1a\u96d1\u8a8c 16\uff1a20-27\uff0c2015\uff0e<\/li>\n\n\n\n
                                                                                                                                                  2. \u5927\u91d1 \u4e9c\u5f25\uff0c\u5409\u5ddd \u76f4\u4e4b\uff0c\u5e38\u540d \u653f\u5f18\uff0c\u5897\u7530 \u4e9c\u5e0c\u5b50\uff0c\u5927\u4e45\u4fdd \u6ecb\u592b\uff0c\u77e2\u51a8 \u88d5\uff0e\u591a\u9805\u76ee\u81ea\u52d5\u8840\u7403\u5206\u6790\u88c5\u7f6eXN-9000\u4f53\u8154\u6db2\u6e2c\u5b9a\u30e2\u30fc\u30c9\u306e\u57fa\u790e\u7684\u691c\u8a0e\u304a\u3088\u3073\u7570\u5e38\u7d30\u80de\u691c\u51fa\u80fd\u306b\u3064\u3044\u3066\uff0e\u65e5\u672c\u691c\u67fb\u8840\u6db2\u5b66\u4f1a\u96d1\u8a8c 16\uff1a253-261\uff0c2015\uff0e<\/li>\n\n\n\n
                                                                                                                                                  3. \u5ddd\u53e3 \u76f4\u5b50\uff0c\u795e\u7530 \u6d69\u5b50\uff0c\u6c38\u53cb \u5229\u6d25\u5b50\uff0c\u4e0b\u5742 \u6d69\u5247\uff0c\u5927\u4e45\u4fdd \u6ecb\u592b\uff0c\u6c60\u7530 \u5747\uff0c\u77e2\u51a8 \u88d5\uff0e\u81a0\u539f\u75c5\u60a3\u8005\u306b\u304a\u3051\u308bBioPlex2200 ANA Screen\u3092\u7528\u3044\u305f\u81ea\u5df1\u6297\u4f53\u6e2c\u5b9a\u306e\u8a55\u4fa1\uff0e\u533b\u5b66\u691c\u67fb 64\uff1a337-342\uff0c2015\uff0e<\/li>\n\n\n\n
                                                                                                                                                  4. \u6817\u539f \u771f\u5e0c\u5b50\uff0c\u4f50\u85e4 \u512a\u5b9f\u5b50\uff0c\u5927\u4e45\u4fdd \u6ecb\u592b\uff0c\u77e2\u51a8 \u88d5\uff0e\u30d1\u30a4\u30ed\u30b7\u30fc\u30af\u30a8\u30f3\u30b9\u6cd5\u306b\u3088\u308bHCV\u907a\u4f1d\u5b50\u578b\u5224\u5b9a\u6cd5\u306e\u69cb\u7bc9\u3068\u8a55\u4fa1\uff0e\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u81ea\u52d5\u5316\u5b66\u4f1a\u4f1a\u8a8c 40\uff1a16-20\uff0c2015\uff0e<\/li>\n\n\n\n
                                                                                                                                                  5. \u4f50\u85e4 \u512a\u5b9f\u5b50\uff0c\u5c71\u53e3 \u535a\u7d00\uff0c\u9ad8\u4e95 \u5927\u54c9\uff0c\u5317\u5c71 \u4e08\u4e8c\uff0c\u5927\u4e45\u4fdd \u6ecb\u592b\uff0c\u77e2\u51a8\u3000\u88d5\uff0eTRC\u6cd5\u3092\u7528\u3044\u305f\u8179\u8154\u5185\u6d17\u6d44\u6db2CEA mRNA\u5b9a\u91cf\u691c\u67fb\u306e\u6cbb\u7642\u52b9\u679c\u5224\u5b9a\u306b\u304a\u3051\u308b\u6709\u7528\u6027\uff0e\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u81ea\u52d5\u5316\u5b66\u4f1a\u4f1a\u8a8c 40: 603-609\uff0c2015\uff0e<\/li>\n\n\n\n
                                                                                                                                                  6. \u5bbf\u8c37 \u8ce2\u4e00\uff0c\u7530\u4e2d \u96c5\u7f8e\uff0c\u4e45\u672b \u5d07\u53f8\uff0c\u5ddd\u53e3 \u76f4\u5b50\uff0c\u5f71\u5c71 \u7950\u5b50\uff0c\u5fb3\u539f \u5eb7\u54f2\uff0c\u7530\u6240 \u82f1\u55e3\uff0c\u4f0a\u85e4 \u6709\u5e02\uff0c\u5927\u4e45\u4fdd \u6ecb\u592b\uff0c\u77e2\u51a8 \u88d5\uff0e\u691c\u67fb\u6a5f\u5668\u30fb\u8a66\u85ac\u3000\u5168\u81ea\u52d5\u5c3f\u5206\u6ce8\u88c5\u7f6e\u300cIDS-CLAS\u30fbHr\u300d\u57fa\u672c\u6027\u80fd\u306e\u691c\u8a0e\uff0e\u533b\u7642\u3068\u691c\u67fb\u6a5f\u5668\u30fb\u8a66\u85ac 38\uff1a191-196\uff0c2015\uff0e<\/li>\n\n\n\n
                                                                                                                                                  7. \u7530\u4e2d \u96c5\u7f8e\uff0c\u5bbf\u8c37 \u8ce2\u4e00\uff0c\u68ee\u7530 \u8ce2\u53f2\uff0c\u4e45\u672b \u76f4\u5b50\uff0c\u5f71\u5c71 \u7950\u5b50\uff0c\u5927\u4e45\u4fdd \u6ecb\u592b\uff0c\u4e0b\u6fa4 \u9054\u96c4\uff0c\u77e2\u51a8 \u88d5\uff0e\u591a\u9805\u76ee\u81ea\u52d5\u8840\u7403\u5206\u6790\u88c5\u7f6eXN-550\u3092\u7528\u3044\u305f\u9ac4\u6db2\u7d30\u80de\u6570\u7b97\u5b9a\u306e\u57fa\u790e\u7684\u691c\u8a0e\uff0e\u533b\u5b66\u691c\u67fb 64\uff1a749-754\uff0c2015\uff0e<\/li>\n\n\n\n
                                                                                                                                                  8. \u7530\u4e2d \u96c5\u7f8e\uff0c\u5bbf\u8c37 \u8ce2\u4e00\uff0c\u4e45\u672b \u5d07\u53f8\uff0c\u68ee\u7530 \u8ce2\u53f2\uff0c\u4e45\u672b \u76f4\u5b50\uff0c\u5f71\u5c71 \u7950\u5b50\uff0c\u5927\u4e45\u4fdd \u6ecb\u592b\uff0c\u4e0b\u6fa4 \u9054\u96c4\uff0c\u77e2\u51a8 \u88d5\uff0e\u5168\u81ea\u52d5\u5c3f\u7d71\u5408\u5206\u6790\u88c5\u7f6eUX-2000\u306b\u3088\u308b\u5c3f\u4e2d\u30a2\u30eb\u30d6\u30df\u30f3\u8a66\u9a13\u7d19\u306e\u6027\u80fd\u8a55\u4fa1\uff0eSysmex Journal 16\uff1a\uff0c2015\uff0e<\/li>\n\n\n\n
                                                                                                                                                  9. \u540d\u5009 \u8c4a\uff0c\u66fd\u6839 \u4f38\u6cbb\uff0c\u4e09\u5cf6 \u7531\u7950\u5b50\uff0c\u6fa4\u7530 \u826f\u5b50\uff0c\u6d25\u91ce \u5bdb\u548c\uff0c\u77e2\u51a8 \u88d5\uff0c\u5ca1\u5d0e \u4ec1\uff0e\u7b2c4\u4e16\u4ee3HIV\u30b9\u30af\u30ea\u30fc\u30cb\u30f3\u30b0\u691c\u67fb\u8a66\u85ac\u306e3\u793e\u540c\u6642\u6bd4\u8f03\u691c\u8a0e\uff0e\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u81ea\u52d5\u5316\u5b66\u4f1a\u4f1a\u8a8c 40\uff1a596-602\uff0c2015\uff0e<\/li>\n\n\n\n
                                                                                                                                                  10. \u4e45\u672b \u5d07\u53f8\uff0c\u7530\u4e2d \u96c5\u7f8e\uff0c\u5bbf\u8c37 \u8ce2\u4e00\uff0c\u5927\u4e45\u4fdd \u6ecb\u592b\uff0c\u4e0b\u6fa4 \u9054\u96c4\uff0c\u77e2\u51a8 \u88d5\uff0e\u5168\u81ea\u52d5\u5c3f\u5206\u6790\u88c5\u7f6eUS-3100R plus\u306e\u57fa\u790e\u7684\u691c\u8a0e\uff0e\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u81ea\u52d5\u5316\u5b66\u4f1a\u4f1a\u8a8c 40\uff1a150-156\uff0c2015\uff0e<\/li>\n\n\n\n
                                                                                                                                                  11. \u65e9\u5ddd \u660e\u5b50\uff0c\u5c71\u53e3 \u3072\u308d\u5b50\uff0c\u6c34\u672c \u597d\u7f8e\uff0c\u4e0b\u5742 \u6d69\u5247\uff0c\u5927\u4e45\u4fdd \u6ecb\u592b\uff0c\u6c60\u7530\u5747\uff0c\u77e2\u51a8 \u88d5\uff0e\u5168\u81ea\u52d5\u5316\u5b66\u767a\u5149\u9175\u7d20\u514d\u75ab\u6e2c\u5b9a\u88c5\u7f6eAIA-CL2400\u3092\u7528\u3044\u305fTSH\uff0cFT4\uff0cFT3\u6e2c\u5b9a\u306e\u57fa\u790e\u7684\u691c\u8a0e\uff0e\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u81ea\u52d5\u5316\u5b66\u4f1a\u4f1a\u8a8c 40\uff1a257-264\uff0c2015\uff0e<\/li>\n\n\n\n
                                                                                                                                                  12. \u5897\u7530 \u4e9c\u5e0c\u5b50\uff0c\u5e38\u540d \u653f\u5f18\uff0c\u672c\u7530 \u6643\uff0c\u4f50\u85e4 \u512a\u5b9f\u5b50\uff0c\u9ed2\u5ddd \u5cf0\u592b\uff0c\u77e2\u51a8 \u88d5\uff0e\u672b\u68a2\u8840\u8d64\u82bd\u7403\u51fa\u73fe\u3068\u30d5\u30a7\u30ea\u30c1\u30f3\u7570\u5e38\u9ad8\u5024\u3092\u5951\u6a5f\u306b\u8a3a\u65ad\u3055\u308c\u305f\u7279\u767a\u6027\u8840\u7403\u7570\u5f62\u6210 (IDUS)\uff0e\u81e8\u5e8a\u8840\u6db2 56\uff1a2462-2466<\/a>\uff0c2015\uff0e<\/li>\n\n\n\n
                                                                                                                                                  13. \u5897\u6238 \u68a8\u6075\uff0c\u6c38\u53cb \u5229\u6d25\u5b50\uff0c\u4fdd\u7530 \u5948\u7dd2\u7f8e\uff0c\u5927\u4e45\u4fdd \u6ecb\u592b\uff0c\u6c60\u7530 \u5747\uff0c\u77e2\u51a8 \u88d5\uff0e\u5168\u81ea\u52d5\u96fb\u6c17\u5316\u5b66\u767a\u5149\u514d\u75ab\u6e2c\u5b9a\u88c5\u7f6ecobas e411\u306b\u3088\u308b\u6297TP\u6297\u4f53\u6e2c\u5b9a\u8a66\u85ac\u300c\u30a8\u30af\u30eb\u30fc\u30b7\u30b9\u8a66\u85acAnti-TP\u300d\u306e\u57fa\u790e\u7684\u691c\u8a0e\uff0e\u533b\u5b66\u3068\u85ac\u5b66 72\uff1a919-929\uff0c2015\uff0e<\/li>\n\n\n\n
                                                                                                                                                  14. \u5897\u6238 \u68a8\u6075\uff0c\u5c71\u53e3 \u3072\u308d\u5b50\uff0c\u65e9\u5ddd \u660e\u5b50\uff0c\u5927\u4e45\u4fdd \u6ecb\u592b\uff0c\u6c60\u7530 \u5747\uff0c\u77e2\u51a8 \u88d5\uff0e\u5168\u81ea\u52d5\u30a8\u30f3\u30b6\u30a4\u30e0\u30a4\u30e0\u30ce\u30a2\u30c3\u30bb\u30a4\u88c5\u7f6eaia-2000\u306b\u3088\u308b\u30b5\u30a4\u30ed\u30b0\u30ed\u30d6\u30ea\u30f3\u6e2c\u5b9a\u306e\u57fa\u790e\u7684\u691c\u8a0e\uff0e\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u81ea\u52d5\u5316\u5b66\u4f1a\u4f1a\u8a8c 40\uff1a63-68\uff0c2015\uff0e<\/li>\n\n\n\n
                                                                                                                                                  15. \u5897\u6238 \u68a8\u6075\uff0c\u5c71\u53e3 \u3072\u308d\u5b50\uff0c\u65e9\u5ddd \u660e\u5b50\uff0c\u5927\u4e45\u4fdd \u6ecb\u592b\uff0c\u6c60\u7530 \u5747\uff0c\u77e2\u51a8 \u88d5\uff0e\u5168\u81ea\u52d5\u96fb\u6c17\u5316\u5b66\u767a\u5149\u514d\u75ab\u6e2c\u5b9a\u88c5\u7f6eCobas 6000<e601>\u306b\u3088\u308b\u30b5\u30a4\u30ed\u30b0\u30ed\u30d6\u30ea\u30f3\u6e2c\u5b9a\u306e\u57fa\u790e\u7684\u691c\u8a0e\uff0e\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u81ea\u52d5\u5316\u5b66\u4f1a\u4f1a\u8a8c 40\uff1a650-654\uff0c2015\uff0e<\/li>\n\n\n\n
                                                                                                                                                  16. \u5897\u6238 \u68a8\u6075\uff0c\u5c71\u53e3 \u3072\u308d\u5b50\uff0c\u65e9\u5ddd \u660e\u5b50\uff0c\u5927\u4e45\u4fdd \u6ecb\u592b\uff0c\u6c60\u7530 \u5747\uff0c\u77e2\u51a8 \u88d5\uff0e\u5168\u81ea\u52d5\u96fb\u6c17\u5316\u5b66\u767a\u5149\u514d\u75ab\u6e2c\u5b9a\u88c5\u7f6eCobas 6000 \u306b\u3088\u308b\u6297\u30b5\u30a4\u30ed\u30b0\u30ed\u30d6\u30ea\u30f3\u6297\u4f53\u304a\u3088\u3073\u6297\u7532\u72b6\u817a\u30da\u30eb\u30aa\u30ad\u30b7\u30c0\u30fc\u30bc\u6297\u4f53\u6e2c\u5b9a\u306e\u57fa\u790e\u7684\u691c\u8a0e\uff0e\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u81ea\u52d5\u5316\u5b66\u4f1a\u4f1a\u8a8c 40\uff1a265-271\uff0c2015\uff0e<\/li>\n\n\n\n
                                                                                                                                                  17. \u6751\u4e0a \u6b63\u5df3\uff0c\u67cf\u6728 \u539a\u5178\uff0c\u6b66\u4e95 \u6cc9\uff0c\u96e8\u5bae \u4f38\uff0c\u77f3\u6a4b \u307f\u3069\u308a\uff0c\u690d\u6728 \u6d69\u4e8c\u90ce\uff0c\u4f50\u85e4 \u9ebb\u5b50\uff0c\u6c38\u5cf0 \u5eb7\u5b5d\uff0c\u524d\u5ddd \u771f\u4eba\uff0c\u77e2\u51a8 \u88d5\uff0cHbA1c\u9069\u6b63\u904b\u7528\u6a5f\u69cb\uff0eHbA1c NGSP\u5024\u306e\u30b5\u30fc\u30d9\u30a4\uff0e\u7cd6\u5c3f\u75c5 58\uff1a45-50\uff0c2015\uff0e<\/li>\n\n\n\n
                                                                                                                                                  18. \u6bdb\u5229 \u771f\u7406\u5b50\uff0c\u7530\u4e2d \u96c5\u7f8e\uff0c\u5f71\u5c71 \u7950\u5b50\uff0c\u5bbf\u8c37 \u8ce2\u4e00\uff0c\u5927\u4e45\u4fdd \u6ecb\u592b\uff0c\u85e4\u57ce \u7dd1\uff0c\u4e0b\u6fa4 \u9054\u96c4\uff0c\u77e2\u51a8 \u88d5\uff0e\u6b21\u4e9c\u5869\u7d20\u9178\u30ca\u30c8\u30ea\u30a6\u30e0\u3092\u7528\u3044\u305f\u30a2\u30eb\u30ab\u30d7\u30c8\u30f3\u5c3f\u306e\u7c21\u6613\u691c\u67fb\u6cd5\uff0e\u533b\u5b66\u691c\u67fb 64\uff1a324-329\uff0c2015\uff0e<\/li>\n\n\n\n
                                                                                                                                                  19. \u4fdd\u7530 \u5948\u7dd2\u7f8e\uff0c\u4e0b\u5742 \u6d69\u5247\uff0c\u5927\u4e45\u4fdd \u6ecb\u592b\uff0c\u6c60\u7530 \u5747\uff0c\u77e2\u51a8 \u88d5\uff0e\u7279\u7570\u7684IgE\u6297\u4f53\u6e2c\u5b9a\u8a66\u85ac\u30a2\u30e9\u30b9\u30bf\u30c3\u30c83gAllergy\u306e\u6027\u80fd\u8a55\u4fa1\u3068\u30a4\u30e0\u30ce\u30ad\u30e3\u30c3\u30d7\u6cd5\u3068\u306e\u6bd4\u8f03\uff0e\u533b\u5b66\u691c\u67fb 64\uff1a727-736\uff0c2015\uff0e<\/li>\n\n\n\n
                                                                                                                                                  20. \u5409\u5ddd \u76f4\u4e4b\uff0c\u5897\u7530 \u4e9c\u5e0c\u5b50\uff0c\u5e38\u540d \u653f\u5f18\uff0c\u5927\u4e45\u4fdd \u6ecb\u592b\uff0c\u77e2\u51a8 \u88d5\uff0eADVIA 2120i\u3092\u7528\u3044\u305f\u5927\u578b\u8840\u5c0f\u677f\u6bd4\u7387\u306e\u6e2c\u5b9a\u3000\u8840\u5c0f\u677f\u7523\u751f\u80fd\u306e\u6307\u6a19\u3068\u3057\u3066\u306e\u81e8\u5e8a\u7684\u6709\u7528\u6027\uff0e\u65e5\u672c\u691c\u67fb\u8840\u6db2\u5b66\u4f1a\u96d1\u8a8c 16\uff1a272-281\uff0c2015\uff0e<\/li>\n<\/ol>\n\n\n\n

                                                                                                                                                    \u548c\u6587\u7dcf\u8aac\uff1aJapanese Review Articles<\/h4>\n\n\n\n
                                                                                                                                                      \n
                                                                                                                                                    1. \u4e00\u702c \u767d\u5e1d\uff0c\u548c\u7530 \u82f1\u592b\uff0c\u60e3\u5b87\u5229 \u6b63\u5584\uff0c\u6a4b\u53e3 \u7167\u4eba\uff0c\u77e2\u51a8 \u88d5\uff0c\u5c0f\u5ddd \u5b54\u5e78\uff0c\u5317\u5cf6 \u52f2\uff0c\u671d\u5009 \u82f1\u7b56\uff0c\u5ca1\u672c \u597d\u53f8\uff0c\u5bb6\u5b50 \u6b63\u88d5\uff0c\u5c71\u672c \u6643\u58eb\uff0c\u6c5f\u53e3 \u8c4a\uff0c\u81ea\u5df1\u514d\u75ab\u6027\u51fa\u8840\u75c5FXIII\/13\u65e5\u672c\u8840\u6813\u6b62\u8840\u5b66\u4f1a\u8a3a\u65ad\u57fa\u6e96\u4f5c\u6210\u59d4\u54e1\u4f1a\uff0e\u81ea\u5df1\u514d\u75ab\u6027\u51fa\u8840\u75c5FXIII\/13\u8a3a\u65ad\u30ac\u30a4\u30c9\uff0e\u65e5\u672c\u8840\u6813\u6b62\u8840\u5b66\u4f1a\u8a8c 26\uff1a658-668\uff0c2015\uff0e<\/li>\n\n\n\n
                                                                                                                                                    2. \u5ddd\u53e3 \u76f4\u5b50\uff0e\u7b2c31\u56de\u4e16\u754c\u533b\u5b66\u691c\u67fb\u5b66\u4f1a\uff08IFBLS\uff09\u306b\u53c2\u52a0\u3057\u3066\uff0eMedical Technology 43\uff1a202-203\uff0c2015\uff0e<\/li>\n\n\n\n
                                                                                                                                                    3. \u4e45\u7c73\u5e78\u592b\uff0e\u816b\u760d\u30de\u30fc\u30ab\u30fc\u691c\u67fb\uff0eMedical Technology 43: 581-586\uff0c2015\uff0e<\/li>\n\n\n\n
                                                                                                                                                    4. \u8535\u91ce \u4fe1\uff0c\u77e2\u51a8 \u88d5\uff0e\u30ea\u30be\u30ea\u30f3\u8102\u8cea\u3068\u52d5\u8108\u786c\u5316\uff1a\u865a\u8840\u6027\u5fc3\u75be\u60a3\u4e88\u9632\u3078\u306e\u65b0\u305f\u306a\u30a2\u30d7\u30ed\u30fc\u30c1\u3068\u3057\u3066\u306e\u53ef\u80fd\u6027\uff0e\u547c\u5438\u3068\u5faa\u74b0 63\uff1a847-851\uff0c2015\uff0e<\/li>\n\n\n\n
                                                                                                                                                    5. \u8535\u91ce \u4fe1\uff0c\u53ef\u91ce \u90a6\u884c\uff0c\u77e2\u51a8 \u88d5\uff0c\u9752\u6728 \u6df3\u8ce2\uff0e\u8102\u8cea\u3092\u6a19\u7684\u3068\u3057\u305f\u8a3a\u65ad\u30fb\u5275\u85ac\uff1a\u30ea\u30be\u30ea\u30f3\u8102\u8cea\u3092\u6a19\u7684\u3068\u3057\u305f\u8a3a\u65ad\u3068\u5275\u85ac\uff0e\u5b9f\u9a13\u533b\u5b66 33\uff1a2500-2507\uff0c2015\uff0e<\/li>\n\n\n\n
                                                                                                                                                    6. \u4e0b\u6fa4 \u9054\u96c4\uff0e\u9ad8\u8840\u5727\u60a3\u8005\u3078\u306e\u30a2\u30d7\u30ed\u30fc\u30c1\uff0e\u65e5\u672c\u5185\u79d1\u5b66\u4f1a\u96d1\u8a8c 104\uff1a211-217<\/a>\uff0c2015\uff0e<\/li>\n\n\n\n
                                                                                                                                                    7. \u4e0b\u6fa4 \u9054\u96c4\uff0e\u9ad8\u8840\u5727\u6cbb\u7642\u306b\u304a\u3051\u308b\u691c\u67fb\u30fb\u8a3a\u65ad\u306e\u610f\u7fa9\uff1a\u30d0\u30a4\u30aa\u30de\u30fc\u30ab\u30fc\uff0e\u65e5\u672c\u81e8\u7240 73\uff1a1833-1835<\/a>\uff0c2015\uff0e<\/li>\n\n\n\n
                                                                                                                                                    8. \u66fd\u6839 \u4f38\u6cbb\uff0e\u591c\u52e4\u306e\u305f\u3081\u306e\u7814\u4fee-\u3069\u3093\u306a\u6559\u80b2\u304c\u5fc5\u8981\u304b\uff0e\u81e8\u5e8a\u691c\u67fb 59\uff1a281-287\uff0c2015\uff0e<\/li>\n\n\n\n
                                                                                                                                                    9. \u5927\u9580 \u96c5\u592b\uff0e\u5fc3\u81d3\u306e\u30a2\u30f3\u30c1\u30a8\u30a4\u30b8\u30f3\u30b0\u306e\u6307\u6a19\u306f\u4f55\u304b\uff1fAnti-aging Medicine 11\uff1a494-502\uff0c2015\uff0e<\/li>\n\n\n\n
                                                                                                                                                    10. \u4e38\u5c3e \u7406\u6075\uff0c\u91d1\u5b50 \u8aa0\uff0e\u8840\u5c0f\u677f\u6a5f\u80fd\u691c\u67fb\uff0e\u691c\u67fb\u3068\u6280\u8853 43\uff1a110-116\uff0c2015\uff0e<\/li>\n\n\n\n
                                                                                                                                                    11. \u77e2\u51a8 \u88d5\uff0e\u8cea\u91cf\u5206\u6790\u306b\u3088\u308b\u304c\u3093\u8a3a\u65ad\u3078\u306e\u53d6\u308a\u7d44\u307f\uff0d\u53f8\u4f1a\u306e\u3053\u3068\u3070\uff0d \u81e8\u5e8a\u75c5\u7406 63\uff1a1080-1081<\/a>\uff0c2015\uff0e<\/li>\n\n\n\n
                                                                                                                                                    12. \u77e2\u51a8 \u88d5\uff0e\u8102\u8cea\u30e1\u30c7\u30a3\u30a8\u30fc\u30bf\u30fc\u306e\u81e8\u5e8a\u691c\u67fb\uff0e\u81e8\u5e8a\u75c5\u7406 63\uff1a1183-1186<\/a>\uff0c2015\uff0e<\/li>\n\n\n\n
                                                                                                                                                    13. \u77e2\u51a8 \u88d5\uff0e\u30ea\u30be\u30ea\u30f3\u8102\u8cea\u3068\u514d\u75ab\u5236\u5fa1 \u57fa\u790e\u304b\u3089\u5fdc\u7528\u3078 \u30aa\u30fc\u30c8\u30bf\u30ad\u30b7\u30f3\uff0e\u708e\u75c7\u3068\u514d\u75ab 23\uff1a280-284\uff0c2015\uff0e<\/li>\n\n\n\n
                                                                                                                                                    14. \u77e2\u51a8 \u88d5\uff0e\u533b\u7642\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u5275\u51fa\u30cd\u30c3\u30c8\u30ef\u30fc\u30af\u306e\u73fe\u72b6\u3068\u5c55\u671b \u65b0\u3057\u3044\u30d5\u30a7\u30fc\u30ba\u306b\u5165\u3063\u305f\u30a2\u30ab\u30c7\u30df\u30a2\u306e\u30b7\u30fc\u30ba\u958b\u767a \u30b7\u30fc\u30ba\u767a\u8868\u30fb\u533b\u7642\u6a5f\u5668 \u30d0\u30a4\u30aa\u30de\u30fc\u30ab\u30fc\u3068\u3057\u3066\u306e\u30ea\u30be\u30ea\u30f3\u8102\u8cea\u7523\u751f\u9175\u7d20 \u81e8\u5e8a\u691c\u67fb\u3078\u306e\u5fdc\u7528\uff0e\u81e8\u5e8a\u8a55\u4fa1 43\uff1a179-181\uff0c2015\uff0e<\/li>\n\n\n\n
                                                                                                                                                    15. \u77e2\u51a8 \u88d5\uff0e\u672a\u6765\u7684\u81e8\u5e8a\u691c\u67fb\u306e\u30d1\u30fc\u30b9\u30da\u30af\u30c6\u30a3\u30d6 \u8102\u8cea\u30e1\u30c7\u30a3\u30a8\u30fc\u30bf\u30fc\u306e\u81e8\u5e8a\u691c\u67fb\uff0e\u81e8\u5e8a\u75c5\u7406 63\uff1a1183-1186\uff0c2015\uff0e<\/li>\n\n\n\n
                                                                                                                                                    16. \u77e2\u51a8 \u88d5\uff0e\u30aa\u30fc\u30c8\u30bf\u30ad\u30b7\u30f3\uff0e\u708e\u75c7\u3068\u514d\u75ab 23\uff1a280-284\uff0c2015\uff0e<\/li>\n\n\n\n
                                                                                                                                                    17. \u77e2\u51a8 \u88d5\uff0e\u8840\u5c0f\u677f\u51dd\u96c6\u80fd\uff0eMedicina 52\uff1a82-83\uff0c2015\uff0e<\/li>\n\n\n\n
                                                                                                                                                    18. \u77e2\u51a8 \u88d5\uff0e\u8840\u5c0f\u677f\u6570\uff0eMedicina 52\uff1a56-58\uff0c2015\uff0e<\/li>\n\n\n\n
                                                                                                                                                    19. \u6e21\u8fba \u6e05\u660e\uff0c\u77e2\u51a8 \u88d5\uff0c\u5927\u5cf6 \u5145\u4e00\uff0c\u5bae\u5730 \u52c7\u4eba\uff0e\u81e8\u5e8a\u691c\u67fb\u2015\u57fa\u6e96\u7bc4\u56f2\u3092\u8003\u3048\u308b\uff0eVita 32\uff1a1-23\uff0c2015\uff0e<\/li>\n\n\n\n
                                                                                                                                                    20. Veillon Lucas\uff0c\u90f7 \u614e\u53f8\uff0c\u677e\u5c71 \u548c\u4f73\u5948\uff0c\u9234\u6728 \u660e\u8eab\uff0c\u9577\u5d0e \u5b9f\u4f73\uff0c\u77e2\u51a8 \u88d5\uff0c\u4e95\u30ce\u53e3 \u4ec1\u4e00\uff0eIdentification of Ganglioside GM3 Molecular Species in Human Serum Associated With Risk Factors of Metabolic Syndrome\uff0e\u8102\u8cea\u751f\u5316\u5b66\u7814\u7a76 57\uff1a217-222\uff0c2015\uff0e<\/li>\n<\/ol>\n\n\n\n

                                                                                                                                                      \u548c\u6587\u8457\u66f8\uff1aJapanese Book Chapter<\/h4>\n\n\n\n
                                                                                                                                                        \n
                                                                                                                                                      1. \u5927\u4e45\u4fdd \u6ecb\u592b, \u5ddd\u53e3 \u76f4\u5b50. 5.1\uff5e5.2\u7ae0. ISO 15189:2012 \u304c\u81e8\u5e8a\u691c\u67fb\u5ba4\u3092\u5909\u3048\u308b pp. 27-31. \u4e00\u822c\u793e\u56e3\u6cd5\u4ebaJAB\u8a66\u9a13\u6240\u5354\u8b70\u4f1a(JABLAS), 2015.<\/li>\n\n\n\n
                                                                                                                                                      2. \u4e45\u7c73 \u5e78\u592b\uff0e\u8840\u6813\u6027\u8840\u5c0f\u677f\u6e1b\u5c11\u6027\u7d2b\u6591\u75c5\uff08TTP\uff09\uff0c\u6eb6\u8840\u6027\u5c3f\u6bd2\u75c7\u75c7\u5019\u7fa4\uff08HUS\uff09\uff0e\u300c\u691c\u67fb\u3068\u6280\u8853\u300d \u5897\u520a\u53f7\u300c\u8840\u6db2\u5f62\u614b\u30a2\u30c8\u30e9\u30b9\u300d\uff0e\uff08\u77e2\u51a8 \u88d5\uff0c\u5897\u7530 \u4e9c\u5e0c\u5b50\uff0c\u5e38\u540d \u653f\u5f18 \u7de8\uff09pp. 1072-1074\uff0cpp. 1075-1077\uff0e\u533b\u5b66\u66f8\u9662\uff0c\u6771\u4eac\uff0e2015\uff0e<\/li>\n\n\n\n
                                                                                                                                                      3. \u8535\u91ce \u4fe1\uff0e\u7cd6\u5c3f\u75c5\u8a3a\u65ad\u306e\u305f\u3081\u306e\u691c\u67fb \u6771\u5927\u75c5\u9662\u7cd6\u5c3f\u75c5\u6559\u5ba4\uff0e\uff08\u9580\u8107 \u5b5d \u7de8\uff09pp. 35\uff0e\u533b\u85ac\u30b8\u30e3\u30fc\u30ca\u30eb\u793e\uff0e\u5927\u962a\uff0e2015.<\/li>\n\n\n\n
                                                                                                                                                      4. \u8535\u91ce \u4fe1\uff0e\u708e\u75c7\u6027\u30b5\u30a4\u30c8\u30ab\u30a4\u30f3\uff0e\u52d5\u8108\u786c\u5316\u4e88\u9632\uff0e\uff08\u5bfa\u672c \u6c11\u751f \u7de8\uff09 pp. 52-57\uff0e\u30e1\u30b8\u30ab\u30eb\u30d3\u30e5\u30fc\u793e\uff0c\u6771\u4eac\uff0e2015\uff0e<\/li>\n\n\n\n
                                                                                                                                                      5. \u8535\u91ce \u4fe1\uff0c\u53ef\u91ce \u90a6\u884c\uff0c\u77e2\u51a8 \u88d5\uff0c\u9752\u6728 \u9806\u8ce2\uff0e\u30ea\u30be\u30ea\u30f3\u8102\u8cea\u3092\u6a19\u7684\u3068\u3057\u305f\u8a3a\u65ad\u3068\u5275\u85ac\uff0e(\u6751\u4e0a \u8aa0\uff0c\u6a2a\u6e9d \u5cb3\u5f66 \u7de8)\u300c\u5b9f\u9a13\u533b\u5b66 \u5897\u520a\u53f7\u300d Vol.33 No.15\uff0cpp. 178-185\uff0e\u7f8a\u571f\u793e\uff0c\u6771\u4eac\uff0e2015.<\/li>\n\n\n\n
                                                                                                                                                      6. \u8535\u91ce \u4fe1\uff0c\u585a\u672c \u548c\u4e45\uff0eNPC1L1\uff0cNPC1\uff0e\u8102\u8cea\u4ee3\u8b1d\u7570\u5e38\u3068\u95a2\u9023\u75be\u60a3\uff1c\u4e0a\u5dfb\uff1e\uff08\u5c3e\u6c60 \u96c4\u4e00\uff0c\u4f50\u3005\u6728 \u96c4\u5f66\uff0c\u6751\u4e0a \u8aa0\uff0c\u77e2\u4f5c \u76f4\u4e5f \u7de8\uff09 pp. 221-228\uff0e\u30a8\u30eb\u30fb\u30a2\u30a4\u30fb\u30b7\u30fc\uff0c\u6771\u4eac\uff0e2015<\/li>\n\n\n\n
                                                                                                                                                      7. \u8535\u91ce \u4fe1\uff0c\u6728\u4e0b \u8aa0\uff0eABCG5\/8\uff0e \u8102\u8cea\u4ee3\u8b1d\u7570\u5e38\u3068\u95a2\u9023\u75be\u60a3\uff1c\u4e0a\u5dfb\uff1e\uff08\u5c3e\u6c60 \u96c4\u4e00\uff0c\u4f50\u3005\u6728 \u96c4\u5f66\uff0c\u6751\u4e0a \u8aa0\uff0c\u77e2\u4f5c \u76f4\u4e5f \u7de8\uff09 pp. 327-332\uff0e\u30a8\u30eb\u30fb\u30a2\u30a4\u30fb\u30b7\u30fc\uff0c\u6771\u4eac\uff0e2015\uff0e<\/li>\n\n\n\n
                                                                                                                                                      8. \u8535\u91ce \u4fe1\uff0c\u585a\u672c \u548c\u4e45\uff0ePON1\uff0e\u8102\u8cea\u4ee3\u8b1d\u7570\u5e38\u3068\u95a2\u9023\u75be\u60a3\uff1c\u4e0a\u5dfb\uff1e\uff08\u5c3e\u6c60 \u96c4\u4e00\uff0c\u4f50\u3005\u6728 \u96c4\u5f66\uff0c\u6751\u4e0a \u8aa0\uff0c\u77e2\u4f5c \u76f4\u4e5f \u7de8\uff09 pp. 429-433\uff0e\u30a8\u30eb\u30fb\u30a2\u30a4\u30fb\u30b7\u30fc\uff0c\u6771\u4eac\uff0e2015\uff0e<\/li>\n\n\n\n
                                                                                                                                                      9. \u5bbf\u8c37 \u8ce2\u4e00\uff0e\u30ab\u30e9\u30fc\u56f3\u8b5c \u5c3f\u6c88\u6e23\uff0e\u81e8\u5e8a\u691c\u67fb\u30c7\u30fc\u30bf\u30d6\u30c3\u30af2015-2016\uff08\u9ad8\u4e45 \u53f2\u9ebf \u76e3\u4fee\uff09pp. 30-32\uff0e\u533b\u5b66\u66f8\u9662\uff0c\u6771\u4eac\uff0e2015\uff0e<\/li>\n\n\n\n
                                                                                                                                                      10. \u5bbf\u8c37 \u8ce2\u4e00\uff0c\u5317\u6751 \u8056\uff0e\u4e00\u822c\u5c3f\u691c\u67fb\u306e\u63a1\u5c3f\u30fb\u5b9a\u6027\u30fb\u6c88\u6e23\uff0e\u81e8\u5e8a\u691c\u67fb\u30c7\u30fc\u30bf\u30d6\u30c3\u30af2015-2016\uff08\u9ad8\u4e45 \u53f2\u9ebf \u76e3\u4fee\uff09pp. 80-82\uff0e\u533b\u5b66\u66f8\u9662\uff0c\u6771\u4eac\uff0e2015\uff0e<\/li>\n\n\n\n
                                                                                                                                                      11. \u5bbf\u8c37 \u8ce2\u4e00\uff0c\u5317\u6751 \u8056\uff0e\u4fbf\u6f5c\u8840\u691c\u67fb\u306e\u63a1\u4fbf\uff0e\u81e8\u5e8a\u691c\u67fb\u30c7\u30fc\u30bf\u30d6\u30c3\u30af2015-2016\uff08\u9ad8\u4e45 \u53f2\u9ebf \u76e3\u4fee\uff09pp. 83-84\uff0e\u533b\u5b66\u66f8\u9662\uff0c\u6771\u4eac\uff0e2015\uff0e<\/li>\n\n\n\n
                                                                                                                                                      12. \u5bbf\u8c37 \u8ce2\u4e00\uff0c\u4e0b\u6fa4 \u9054\u96c4\uff0e\u80c3\u6db2\uff0e\u81e8\u5e8a\u691c\u67fb\u30c7\u30fc\u30bf\u30d6\u30c3\u30af2015-2016\uff08\u9ad8\u4e45\u53f2\u9ebf \u76e3\u4fee\uff09pp. 727-729\uff0e\u533b\u5b66\u66f8\u9662\uff0c\u6771\u4eac\uff0e2015\uff0e<\/li>\n\n\n\n
                                                                                                                                                      13. \u5bbf\u8c37 \u8ce2\u4e00\uff0c\u4e0b\u6fa4 \u9054\u96c4\uff0e\u9ac4\u6db2\uff08CSF\uff09\uff0e\u81e8\u5e8a\u691c\u67fb\u30c7\u30fc\u30bf\u30d6\u30c3\u30af2015-2016\uff08\u9ad8\u4e45 \u53f2\u9ebf \u76e3\u4fee\uff09pp. 734-736\uff0e\u533b\u5b66\u66f8\u9662\uff0c\u6771\u4eac\uff0e2015\uff0e<\/li>\n\n\n\n
                                                                                                                                                      14. \u5bbf\u8c37 \u8ce2\u4e00\uff0c\u4e0b\u6fa4 \u9054\u96c4\uff0e\u80c6\u6c41\uff0e\u81e8\u5e8a\u691c\u67fb\u30c7\u30fc\u30bf\u30d6\u30c3\u30af2015-2016\uff08\u9ad8\u4e45 \u53f2\u9ebf \u76e3\u4fee\uff09pp. 739-740\uff0e\u533b\u5b66\u66f8\u9662\uff0c\u6771\u4eac\uff0e2015\uff0e<\/li>\n\n\n\n
                                                                                                                                                      15. \u5bbf\u8c37 \u8ce2\u4e00\uff0c\u4e0b\u6fa4 \u9054\u96c4\uff0e\u8179\u6c34\uff0e\u81e8\u5e8a\u691c\u67fb\u30c7\u30fc\u30bf\u30d6\u30c3\u30af2015-2016\uff08\u9ad8\u4e45 \u53f2\u9ebf \u76e3\u4fee\uff09pp. 742-743\uff0e\u533b\u5b66\u66f8\u9662\uff0c\u6771\u4eac\uff0e2015\uff0e<\/li>\n\n\n\n
                                                                                                                                                      16. \u5bbf\u8c37 \u8ce2\u4e00\uff0c\u4e0b\u6fa4 \u9054\u96c4\uff0e\u4fbf\u6f5c\u8840\uff08\u4fbf\u4e2d\u30d8\u30e2\u30b0\u30ed\u30d3\u30f3\uff09\uff0e\u81e8\u5e8a\u691c\u67fb\u30c7\u30fc\u30bf\u30d6\u30c3\u30af2015-2016\uff08\u9ad8\u4e45 \u53f2\u9ebf \u76e3\u4fee\uff09pp. 718-719\uff0e\u533b\u5b66\u66f8\u9662\uff0c\u6771\u4eac\uff0e2015\uff0e<\/li>\n\n\n\n
                                                                                                                                                      17. \u5bbf\u8c37 \u8ce2\u4e00\uff0e\u5c3f\u6c88\u6e23\uff0e\u81e8\u5e8a\u691c\u67fb\u30ac\u30a4\u30c92015\u5e74\u6539\u8a02\u7248\uff08\u4e09\u6a4b \u77e5\u660e \u7de8\u96c6\uff09pp. 1082-1084\uff0e\u6587\u5149\u5802\uff0c\u6771\u4eac\uff0e2015\uff0e<\/li>\n\n\n\n
                                                                                                                                                      18. \u5bbf\u8c37 \u8ce2\u4e00\uff0e\u9ac4\u6db2\u7d30\u80de\u306e\u89b3\u5bdf\uff0e\u9ac4\u6db2\u691c\u67fb\u6280\u8853\u6559\u672c\uff08\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u6280\u5e2b\u4f1a \u76e3\u4fee\uff09pp. 31-38\uff0e\u4e38\u5584\u51fa\u7248\uff0c\u6771\u4eac\uff0e2015\uff0e<\/li>\n\n\n\n
                                                                                                                                                      19. \u5927\u9580 \u96c5\u592b\uff0e\u53ce\u7e2e\u80fd\u304c\u4fdd\u305f\u308c\u305f\u5fc3\u4e0d\u5168HFpEF\uff0e\u8a3a\u65ad\u3068\u6cbb\u7642\uff0epp\uff0e47-53\uff0e\u8a3a\u65ad\u3068\u6cbb\u7642\u793e\uff0c\u6771\u4eac\uff0e2015\uff0e<\/li>\n\n\n\n
                                                                                                                                                      20. \u5927\u9580 \u96c5\u592b\uff0e\u5f01\u819c\u75c7\uff0eHeart View \uff08\u526f\u5d8b \u5f18\u6587\uff0c\u5c0f\u5ddd \u4e45\u96c4 \u4f01\u753b\/\u69cb\u6210)pp\uff0e59-64\uff0e\u30e1\u30b8\u30ab\u30eb\u30d3\u30e5\u30fc\u793e\uff0c\u6771\u4eac\uff0e2015\uff0e<\/li>\n\n\n\n
                                                                                                                                                      21. \u4e2d\u5c3e \u502b\u5b50\uff0c\u5927\u9580 \u96c5\u592b\uff0e\u5fc3\u7b4b\u75c7\u306e\u5fc3\u81d3\u8d85\u97f3\u6ce2\u691c\u67fb\u6240\u898b\uff0e\u533b\u5b66\u306e\u3042\u3086\u307f\uff08\u5c71\u672c \u4e00\u535a \u7de8)pp. 1047-1054\uff0e\u533b\u6b6f\u85ac\u51fa\u7248\u793e\uff0c\u6771\u4eac\uff0e2015\uff0e<\/li>\n\n\n\n
                                                                                                                                                      22. \u4e2d\u5c3e \u502b\u5b50\uff0c\u5927\u9580 \u96c5\u592b\uff0e\u5fc3\u4e0d\u5168\u8a3a\u7642\u306e\u305f\u3081\u306e\u5fc3\u30a8\u30b3\u30fc\u56f3\u691c\u67fb\uff1a2\uff09\u62e1\u5f35\u80fd\u3092\u3044\u304b\u306b\u3068\u3089\u3048\u308b\u304b\uff0e\u8a3a\u65ad\u3068\u6cbb\u7642\uff0epp\uff0e77-83\uff0e\u8a3a\u65ad\u3068\u6cbb\u7642\u793e\uff0c\u6771\u4eac\uff0e2015\uff0e<\/li>\n\n\n\n
                                                                                                                                                      23. \u5ee3\u5ddd \u611b\u7f8e\uff0c\u5927\u9580 \u96c5\u592b\uff0e\u9ad8\u9f62\u8005\u306e\u62e1\u5f35\u4e0d\u5168\u306f\u5fc5\u305a\u3057\u3082\u5de6\u5ba4\u80a5\u5927\u3092\u4f34\u308f\u306a\u3044\u3068\u805e\u304d\u307e\u3057\u305f\u3002\u305d\u308c\u306f\u306a\u305c\u3067\u3057\u3087\u3046\u304b\uff1f\u3000\u62e1\u5f35\u4e0d\u5168\u306eQ\uff06A\uff08\u4f0a\u85e4 \u6d69 \u7de8\uff09pp\uff0e49-51\uff0e\u4e2d\u5916\u533b\u5b66\u793e\uff0c\u6771\u4eac\uff0e2015\uff0e<\/li>\n\n\n\n
                                                                                                                                                      24. \u5ee3\u5ddd \u611b\u7f8e\uff0c\u5927\u9580 \u96c5\u592b\uff0e\u5fc3\u30a8\u30b3\u30fc\u56f3\u691c\u67fb\u306e\u6b63\u5e38\u5024\u306e\u52a0\u9f62\u306b\u4f34\u3046\u5909\u5316\u306b\u95a2\u3057\u3066\u6559\u3048\u3066\u304f\u3060\u3055\u3044\uff0e\u62e1\u5f35\u4e0d\u5168\u306eQ\uff06A\uff08\u4f0a\u85e4 \u6d69 \u7de8\uff09pp\uff0e100\uff0d103\uff0e\u4e2d\u5916\u533b\u5b66\u793e\uff0c\u6771\u4eac\uff0e 2015\uff0e<\/li>\n\n\n\n
                                                                                                                                                      25. \u5ee3\u5ddd \u611b\u7f8e\uff0c\u5927\u9580 \u96c5\u592b\uff0e\u50e7\u5e3d\u5f01\u75be\u60a3\uff0e\u81e8\u5e8a\u96d1\u8a8c\u5185\u79d1\uff08\u6c38\u4e95 \u826f\u4e09 \u7de8\uff09pp\uff0e1061-1064\uff0e\u5357\u6c5f\u5802\uff0c\u6771\u4eac\uff0e2015\uff0e<\/li>\n\n\n\n
                                                                                                                                                      26. \u5ee3\u5ddd \u611b\u7f8e\uff0c\u5927\u9580 \u96c5\u592b\uff0e\u62e1\u5f35\u578b\u5fc3\u7b4b\u75c7\u6cbb\u7642\u6226\u7565\u69cb\u7bc9\u306e\u305f\u3081\u306e\u8a55\u4fa1\u30dd\u30a4\u30f3\u30c8\uff0e\u5fc3\u30a8\u30b3\u30fc \uff08\u5742\u7530 \u6cf0\u53f2 \u7de8)pp\uff0e1014\uff0d1023\uff0e\u6587\u5149\u5802\uff0c\u6771\u4eac\uff0e2015\uff0e<\/li>\n\n\n\n
                                                                                                                                                      27. \u5897\u7530 \u4e9c\u5e0c\u5b50\uff0e\u514d\u75ab\u30b0\u30ed\u30d6\u30ea\u30f3\u904a\u96e2L\u9396\u03ba\/\u03bb\u6bd4\uff0emedicina\u5897\u520a\u53f7\u300c\u3053\u308c\u3060\u3051\u306f\u77e5\u3063\u3066\u304a\u304d\u305f\u3044\u691c\u67fb\u306e\u30dd\u30a4\u30f3\u30c8-\u7b2c9\u96c6\u300d\uff0e\uff08\u77e2\u51a8 \u88d5 \u7de8\uff09pp. 148-149\uff0e\u533b\u5b66\u66f8\u9662\uff0c\u6771\u4eac\uff0e2015\uff0e<\/li>\n\n\n\n
                                                                                                                                                      28. \u5897\u7530 \u4e9c\u5e0c\u5b50\uff0e\u53ef\u6eb6\u6027IL-2\u30ec\u30bb\u30d7\u30bf\u30fc\uff0emedicina\u5897\u520a\u53f7\u300c\u3053\u308c\u3060\u3051\u306f\u77e5\u3063\u3066\u304a\u304d\u305f\u3044\u691c\u67fb\u306e\u30dd\u30a4\u30f3\u30c8-\u7b2c9\u96c6\u300d\uff0e\uff08\u77e2\u51a8 \u88d5 \u7de8\uff09pp. 150-151\uff0e\u533b\u5b66\u66f8\u9662\uff0c\u6771\u4eac\uff0e2015\uff0e<\/li>\n\n\n\n
                                                                                                                                                      29. \u5897\u7530 \u4e9c\u5e0c\u5b50\uff0e WHO\u5206\u985e(\u7b2c4\u7248)\u306b\u57fa\u3065\u304f\u8840\u6db2\u75be\u60a3\u5206\u985e,\u82bd\u7403\u5f62\u8cea\u7d30\u80de\u69d8\u6a39\u72b6\u7d30\u80de\u816b\u760d(BPDCN)\uff0c\u6162\u6027\u9aa8\u9ac4\u6027\u767d\u8840\u75c5(CML)\uff0c\u6162\u6027\u597d\u9178\u7403\u6027\u767d\u8840\u75c5(CEL)\uff0c\u9aa8\u9ac4\u7570\u5f62\u6210\u75c7\u5019\u7fa4\u306e\u6982\u7565\uff0c\u7279\u767a\u6027\u8840\u7403\u7570\u5f62\u6210(IDUS)\uff0c\u7279\u767a\u6027\u8840\u7403\u6e1b\u5c11\u75c7(ICUS)\uff0c\u7bc0\u5916\u6027\u6ffe\u80de\u8fba\u7e01\u5e2f\u7c98\u819c\u95a2\u9023\u30ea\u30f3\u30d1\u7d44\u7e54\u578b\u30ea\u30f3\u30d1\u816b(MALT\u30ea\u30f3\u30d1\u816b)\uff0c\u539f\u767a\u6027\u30a2\u30df\u30ed\u30a4\u30c9\u30fc\u30b7\u30b9\uff0c\u672b\u68a2\u6027T\u7d30\u80de\u30ea\u30f3\u30d1\u816b\uff0c\u975e\u7279\u5b9a\u578b(PTCL,NOS)\uff0c\u672a\u5206\u5316\u5927\u7d30\u80de\u578b\u30ea\u30f3\u30d1\u816b(ALCL)\uff0cT\u7d30\u80de\u5927\u9846\u7c92\u30ea\u30f3\u30d1\u7403\u6027\u767d\u8840\u75c5(T-LGLL)\uff0cHematogones(HGs)\uff0e\u300c\u691c\u67fb\u3068\u6280\u8853\u300d \u5897\u520a\u53f7\u300c\u8840\u6db2\u5f62\u614b\u30a2\u30c8\u30e9\u30b9\u300d\uff0e\uff08\u77e2\u51a8 \u88d5\uff0c\u5897\u7530 \u4e9c\u5e0c\u5b50\uff0c\u5e38\u540d \u653f\u5f18 \u7de8\uff09\u533b\u5b66\u66f8\u9662\uff0c\u6771\u4eac\uff0e2015\uff0e<\/li>\n\n\n\n
                                                                                                                                                      30. \u674e \u653f\u54f2\uff0c\u5927\u9580 \u96c5\u592b\uff0e\u53f3\u5fc3\u6a5f\u80fd\u306e\u8a55\u4fa1\u3068\u53f3\u5fc3\u4e0d\u5168\u306e\u6cbb\u7642\uff0e\u5faa\u74b0\u5668\uff08\u5c0f\u5ba4 \u4e00\u6210\uff0c\u4f50\u5730 \u52c9\uff0c\u5742\u7530 \u9686\u9020 \u7de8\uff09pp\uff0e36-45\uff0e\u4e2d\u5916\u533b\u5b66\u793e\uff0c\u6771\u4eac\uff0e2015\uff0e<\/li>\n\n\n\n
                                                                                                                                                      31. \u6771\u4eac\u5927\u5b66\u533b\u5b66\u90e8\u9644\u5c5e\u75c5\u9662\u691c\u67fb\u90e8 \u8840\u6db2\u691c\u67fb\u5ba4\u30b9\u30bf\u30c3\u30d5\uff08\u77e2\u51a8\u88d5\uff0c\u5897\u7530\u4e9c\u5e0c\u5b50\uff0c\u5e38\u540d\u653f\u5f18\uff0c\u9ad9\u6a4b \u5343\u6625\uff0c\u897f\u5ddd\u771f\u5b50\uff0c\u91d1\u5b50\u8aa0\uff0c\u4e45\u7c73 \u5e78\u592b\uff0c\u5c0f\u91ce\u4f73\u4e00\uff0c\u5409\u5ddd\u76f4\u4e4b\uff0c\u7530\u9089\u4e45\u7f8e\u5b50\uff0c\u5bfa\u5cf6\u9053\u5b50\uff0c\u91ce\u3005\u90e8\u4eae\u5b50\uff0c\u4e38\u5c3e\u7406\u6075\uff0c\u5927\u91d1\u4e9c\u5f25\uff0c\u6c34\u9593\u77e5\u4e16\uff09\uff0e\u300c\u691c\u67fb\u3068\u6280\u8853\u300d\u5897\u520a\u53f7\u300c\u8840\u6db2\u5f62\u614b\u30a2\u30c8\u30e9\u30b9\u300d\uff0e\u533b\u5b66\u66f8\u9662\uff0e\u6771\u4eac\uff0e2015\uff0e<\/li>\n<\/ol>\n\n\n\n

                                                                                                                                                        \u548c\u6587\u7de8\u8457\u7b49\uff1aJapanese Book Editing<\/h4>\n\n\n\n
                                                                                                                                                          \n
                                                                                                                                                        1. \u5c0f\u5ba4 \u4e00\u6210 \u76e3\u4fee\uff0e\u5927\u9580 \u96c5\u592b\uff0c\u6e21\u8fba \u5f18\u4e4b\uff0c\u5ddd\u7530 \u8cb4\u4e4b \u7de8\uff0e\u5b9f\u8df5\u7684\u5fc3\u30a8\u30b3\u30fc\u5165\u9580\uff0e\u4e2d\u5c71\u66f8\u5e97\uff0c\u6771\u4eac\uff0e2015\uff0e<\/li>\n\n\n\n
                                                                                                                                                        2. \u5927\u9580 \u96c5\u592b \u7de8\uff0e\u5fc3\u30a8\u30b3\u30fc \u300c\u65b0\u3057\u3044AHA\/ACC\u5f01\u819c\u75c7\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u3092\u77e5\u308b\u300d\uff0e\u6587\u5149\u5802\uff0c\u6771\u4eac\uff0e2015\uff0e<\/li>\n\n\n\n
                                                                                                                                                        3. \u5927\u9580 \u96c5\u592b \u7de8\uff0e\u5fc3\u30a8\u30b3\u30fc \u7279\u96c6\u300c\u816b\u760d\u3001\u75a3\u816b\u3001\u305d\u308c\u3068\u3082\u8840\u6813\uff1f\u300d\uff0e\u6587\u5149\u5802\uff0c\u6771\u4eac\uff0e2015\uff0e<\/li>\n\n\n\n
                                                                                                                                                        4. \u5927\u9580 \u96c5\u592b \u7de8\uff0eHeart View \u7279\u96c6\u300c\u53f3\u5fc3\u6a5f\u80fd\u306e\u91cd\u8981\u6027\u3092\u8003\u3048\u308b\u300d\uff0e\u30e1\u30b8\u30ab\u30eb\u30d3\u30e5\u30fc\u793e\uff0e\u6771\u4eac\uff0e2015\uff0e<\/li>\n\n\n\n
                                                                                                                                                        5. \u5927\u9580 \u96c5\u592b \u7de8\uff0e\u5fc3\u30a8\u30b3\u30fc \u5f01\u819c\u75c7\u306e\u30ae\u30e2\u30f3 A to Z\uff0e\u6587\u5149\u5802\uff0c\u6771\u4eac\uff0e2015\uff0e\u91d1\u4e95 \u6b63\u5149 \u76e3\u4fee\uff0e\u5965\u6751 \u4f38\u751f\uff0c\u6238\u585a \u5b9f\uff0c\u77e2\u51a8 \u88d5 \u7de8\u96c6\uff0e\u81e8\u5e8a\u691c\u67fb\u6cd5\u63d0\u8981 \u6539\u8a02\u7b2c34\u7248\uff0e\u91d1\u539f\u51fa\u7248\uff0c\u6771\u4eac\uff0e2015\uff0e<\/li>\n\n\n\n
                                                                                                                                                        6. \u6afb\u6797 \u90c1\u4e4b\u4ecb \u76e3\u4fee\uff0e\u77e2\u51a8 \u88d5\uff0c\u5ee3\u7551 \u4fca\u6210\uff0c\u5c71\u7530 \u4fca\u5e78\uff0c\u77f3\u9ed2 \u539a\u81f3 \u7de8\u96c6\uff0e\u4eca\u65e5\u306e\u81e8\u5e8a\u691c\u67fb2015-2016\uff0e\u5357\u6c5f\u5802\uff0c\u6771\u4eac\uff0e2015\uff0e<\/li>\n\n\n\n
                                                                                                                                                        7. \u77e2\u51a8 \u88d5\uff0c\u5897\u7530 \u4e9c\u5e0c\u5b50\uff0c\u5e38\u540d \u653f\u5f18 \u7de8\uff0e\u300c\u691c\u67fb\u3068\u6280\u8853\u300d\u5897\u520a\u53f7\u300c\u8840\u6db2\u5f62\u614b\u30a2\u30c8\u30e9\u30b9\u300d\uff0e\u533b\u5b66\u66f8\u9662\uff0c\u6771\u4eac\uff0e2015\uff0e<\/li>\n\n\n\n
                                                                                                                                                        8. \u77e2\u51a8 \u88d5\uff0c\u91ce\u7530 \u5149\u5f66 \u7de8\uff0e\u6700\u65b0 \u5065\u5eb7\u8a3a\u65ad\u3068\u691c\u67fb\u304c\u3059\u3079\u3066\u308f\u304b\u308b\u672c\uff0e\u6642\u4e8b\u901a\u4fe1\u793e\uff0c\u6771\u4eac\uff0e2015\uff0e<\/li>\n\n\n\n
                                                                                                                                                        9. \u77e2\u51a8 \u88d5 \u7de8\uff0emedicina\u5897\u520a\u53f7\u300c\u3053\u308c\u3060\u3051\u306f\u77e5\u3063\u3066\u304a\u304d\u305f\u3044\u691c\u67fb\u306e\u30dd\u30a4\u30f3\u30c8-\u7b2c9\u96c6\u300d\uff0e\u533b\u5b66\u66f8\u9662\uff0c\u6771\u4eac\uff0e2015\uff0e<\/li>\n<\/ol>\n<\/div><\/div>\n\n\n\n

                                                                                                                                                          2014\u5e74\u4ee5\u524d<\/h3>\n\n\n\n

                                                                                                                                                          2014\u5e74\u4ee5\u524d\u306e\u696d\u7e3e\u306f\u3053\u3061\u3089\uff08\u65e7 \u6771\u4eac\u5927\u5b66\u533b\u5b66\u90e8\u9644\u5c5e\u75c5\u9662\u691c\u67fb\u90e8HP\uff09<\/a>\u304b\u3089\u3054\u89a7\u3044\u305f\u3060\u3051\u307e\u3059\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"

                                                                                                                                                          2024\u5e74 \u82f1\u6587\u539f\u8457\u8ad6\u6587\uff1aEnglish Original Articles \u56fd\u5185\u5b66\u4f1a\u767a\u8868\uff1aDomestic Conference Presentation \u82f1\u6587\u7dcf\u8aac\uff1aEnglish Review Articles \u56fd\u969b […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":155,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"page-achievements.php","meta":{"footnotes":"","_wp_rev_ctl_limit":""},"class_list":["post-157","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/plaza.umin.ac.jp\/~lab-tky\/wp-json\/wp\/v2\/pages\/157","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/plaza.umin.ac.jp\/~lab-tky\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/plaza.umin.ac.jp\/~lab-tky\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/plaza.umin.ac.jp\/~lab-tky\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/plaza.umin.ac.jp\/~lab-tky\/wp-json\/wp\/v2\/comments?post=157"}],"version-history":[{"count":9,"href":"https:\/\/plaza.umin.ac.jp\/~lab-tky\/wp-json\/wp\/v2\/pages\/157\/revisions"}],"predecessor-version":[{"id":957,"href":"https:\/\/plaza.umin.ac.jp\/~lab-tky\/wp-json\/wp\/v2\/pages\/157\/revisions\/957"}],"up":[{"embeddable":true,"href":"https:\/\/plaza.umin.ac.jp\/~lab-tky\/wp-json\/wp\/v2\/pages\/155"}],"wp:attachment":[{"href":"https:\/\/plaza.umin.ac.jp\/~lab-tky\/wp-json\/wp\/v2\/media?parent=157"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}